drugbank-id,description,name
DB13327,The risk or severity of bleeding can be increased when Picotamide is combined with Reteplase.,Picotamide
DB13367,The risk or severity of bleeding can be increased when Cloricromen is combined with Reteplase.,Cloricromen
DB13400,The risk or severity of bleeding can be increased when Linsidomine is combined with Reteplase.,Linsidomine
DB13510,The risk or severity of bleeding can be increased when Buflomedil is combined with Reteplase.,Buflomedil
DB13929,The risk or severity of bleeding can be increased when Relcovaptan is combined with Reteplase.,Relcovaptan
DB00374,The risk or severity of adverse effects can be increased when Reteplase is combined with Treprostinil.,Treprostinil
DB03404,Hemin may increase the anticoagulant activities of Reteplase.,Hemin
DB13783,The risk or severity of bleeding and hemorrhage can be increased when Acemetacin is combined with Reteplase.,Acemetacin
DB00624,Testosterone may increase the anticoagulant activities of Reteplase.,Testosterone
DB01420,Testosterone propionate may increase the anticoagulant activities of Reteplase.,Testosterone propionate
DB01481,1-Testosterone may increase the anticoagulant activities of Reteplase.,1-Testosterone
DB01485,4-Hydroxytestosterone may increase the anticoagulant activities of Reteplase.,4-Hydroxytestosterone
DB01510,Dehydrochloromethyltestosterone may increase the anticoagulant activities of Reteplase.,Dehydrochloromethyltestosterone
DB01541,Boldenone may increase the anticoagulant activities of Reteplase.,Boldenone
DB01543,18-methyl-19-nortestosterone may increase the anticoagulant activities of Reteplase.,18-methyl-19-nortestosterone
DB01564,Calusterone may increase the anticoagulant activities of Reteplase.,Calusterone
DB01569,Formebolone may increase the anticoagulant activities of Reteplase.,Formebolone
DB01572,Methyl-1-testosterone may increase the anticoagulant activities of Reteplase.,Methyl-1-testosterone
DB02901,Stanolone may increase the anticoagulant activities of Reteplase.,Stanolone
DB07447,5beta-dihydrotestosterone may increase the anticoagulant activities of Reteplase.,5beta-dihydrotestosterone
DB08619,Testosterone succinate may increase the anticoagulant activities of Reteplase.,Testosterone succinate
DB11429,Mibolerone may increase the anticoagulant activities of Reteplase.,Mibolerone
DB13943,Testosterone cypionate may increase the anticoagulant activities of Reteplase.,Testosterone cypionate
DB13944,Testosterone enanthate may increase the anticoagulant activities of Reteplase.,Testosterone enanthate
DB13946,Testosterone undecanoate may increase the anticoagulant activities of Reteplase.,Testosterone undecanoate
DB13947,Testosterone enantate benzilic acid hydrazone may increase the anticoagulant activities of Reteplase.,Testosterone enantate benzilic acid hydrazone
DB13951,Stanolone acetate may increase the anticoagulant activities of Reteplase.,Stanolone acetate
DB13958,Trestolone acetate may increase the anticoagulant activities of Reteplase.,Trestolone acetate
DB14093,"(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Reteplase.","(1,2,6,7-3H)Testosterone"
DB14655,Drostanolone propionate may increase the anticoagulant activities of Reteplase.,Drostanolone propionate
DB11051,The risk or severity of adverse effects can be increased when Reteplase is combined with Azficel-T.,Azficel-T
DB09568,The therapeutic efficacy of Reteplase can be increased when used in combination with Omega-3-carboxylic acids.,Omega-3-carboxylic acids
DB00258,The therapeutic efficacy of Calcium acetate can be decreased when used in combination with Reteplase.,Calcium acetate
DB01164,The therapeutic efficacy of Calcium chloride can be decreased when used in combination with Reteplase.,Calcium chloride
DB01373,The therapeutic efficacy of Calcium can be decreased when used in combination with Reteplase.,Calcium
DB11126,The therapeutic efficacy of Calcium gluconate can be decreased when used in combination with Reteplase.,Calcium gluconate
DB11608,The therapeutic efficacy of Eftrenonacog alfa can be decreased when used in combination with Reteplase.,Eftrenonacog alfa
DB13884,The therapeutic efficacy of Albutrepenonacog alfa can be decreased when used in combination with Reteplase.,Albutrepenonacog alfa
DB13923,The therapeutic efficacy of Emicizumab can be decreased when used in combination with Reteplase.,Emicizumab
DB14738,The therapeutic efficacy of Turoctocog alfa pegol can be decreased when used in combination with Reteplase.,Turoctocog alfa pegol
DB00025,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Reteplase.","Antihemophilic factor, human recombinant"
DB00036,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Reteplase.,Coagulation factor VIIa Recombinant Human
DB00100,The therapeutic efficacy of Coagulation Factor IX (Recombinant) can be decreased when used in combination with Reteplase.,Coagulation Factor IX (Recombinant)
DB01783,The therapeutic efficacy of Pantothenic acid can be decreased when used in combination with Reteplase.,Pantothenic acid
DB01942,The therapeutic efficacy of Formic acid can be decreased when used in combination with Reteplase.,Formic acid
DB02261,The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Reteplase.,Platelet Activating Factor
DB06724,The therapeutic efficacy of Calcium carbonate can be decreased when used in combination with Reteplase.,Calcium carbonate
DB09109,The therapeutic efficacy of Turoctocog alfa can be decreased when used in combination with Reteplase.,Turoctocog alfa
DB09222,The therapeutic efficacy of Fibrinogen human can be decreased when used in combination with Reteplase.,Fibrinogen human
DB09310,The therapeutic efficacy of Catridecacog can be decreased when used in combination with Reteplase.,Catridecacog
DB09329,"The therapeutic efficacy of Antihemophilic Factor (Recombinant), PEGylated can be decreased when used in combination with Reteplase.","Antihemophilic Factor (Recombinant), PEGylated"
DB11093,The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Reteplase.,Calcium citrate
DB11168,The therapeutic efficacy of Calcium threonate can be decreased when used in combination with Reteplase.,Calcium threonate
DB11311,The therapeutic efficacy of Prothrombin can be decreased when used in combination with Reteplase.,Prothrombin
DB11330,The therapeutic efficacy of Factor IX Complex (Human) can be decreased when used in combination with Reteplase.,Factor IX Complex (Human)
DB11348,The therapeutic efficacy of Calcium Phosphate can be decreased when used in combination with Reteplase.,Calcium Phosphate
DB11606,The therapeutic efficacy of Susoctocog alfa can be decreased when used in combination with Reteplase.,Susoctocog alfa
DB11668,The therapeutic efficacy of Rusalatide acetate can be decreased when used in combination with Reteplase.,Rusalatide acetate
DB12409,The therapeutic efficacy of Vatreptacog alfa can be decreased when used in combination with Reteplase.,Vatreptacog alfa
DB12909,The therapeutic efficacy of Factor XIII (human) can be decreased when used in combination with Reteplase.,Factor XIII (human)
DB13133,The therapeutic efficacy of Von Willebrand Factor Human can be decreased when used in combination with Reteplase.,Von Willebrand Factor Human
DB13148,The therapeutic efficacy of Coagulation factor X human can be decreased when used in combination with Reteplase.,Coagulation factor X human
DB13150,The therapeutic efficacy of Coagulation factor VII human can be decreased when used in combination with Reteplase.,Coagulation factor VII human
DB13151,The therapeutic efficacy of Anti-inhibitor coagulant complex can be decreased when used in combination with Reteplase.,Anti-inhibitor coagulant complex
DB13152,The therapeutic efficacy of Coagulation Factor IX Human can be decreased when used in combination with Reteplase.,Coagulation Factor IX Human
DB13192,The therapeutic efficacy of Antihemophilic factor human can be decreased when used in combination with Reteplase.,Antihemophilic factor human
DB13197,The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Reteplase.,Kallidinogenase
DB13201,The therapeutic efficacy of Trenonacog alfa can be decreased when used in combination with Reteplase.,Trenonacog alfa
DB13933,The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Reteplase.,Nonacog beta pegol
DB13999,The therapeutic efficacy of Moroctocog alfa can be decreased when used in combination with Reteplase.,Moroctocog alfa
DB14473,The therapeutic efficacy of Beroctocog alfa can be decreased when used in combination with Reteplase.,Beroctocog alfa
DB14562,The therapeutic efficacy of Andexanet alfa can be decreased when used in combination with Reteplase.,Andexanet alfa
DB14577,The therapeutic efficacy of Calcium cation can be decreased when used in combination with Reteplase.,Calcium cation
DB14700,The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Reteplase.,Damoctocog alfa pegol
DB00176,The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Reteplase.,Fluvoxamine
DB00215,The risk or severity of hemorrhage can be increased when Citalopram is combined with Reteplase.,Citalopram
DB00472,The risk or severity of hemorrhage can be increased when Fluoxetine is combined with Reteplase.,Fluoxetine
DB00715,The risk or severity of hemorrhage can be increased when Paroxetine is combined with Reteplase.,Paroxetine
DB01149,The risk or severity of hemorrhage can be increased when Nefazodone is combined with Reteplase.,Nefazodone
DB04832,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Reteplase.,Zimelidine
DB04884,The risk or severity of hemorrhage can be increased when Dapoxetine is combined with Reteplase.,Dapoxetine
DB06731,The risk or severity of hemorrhage can be increased when Seproxetine is combined with Reteplase.,Seproxetine
DB08953,The risk or severity of hemorrhage can be increased when Indalpine is combined with Reteplase.,Indalpine
DB12693,The risk or severity of hemorrhage can be increased when Ritanserin is combined with Reteplase.,Ritanserin
DB13233,The risk or severity of hemorrhage can be increased when Alaproclate is combined with Reteplase.,Alaproclate
DB00476,The risk or severity of hemorrhage can be increased when Duloxetine is combined with Reteplase.,Duloxetine
DB01105,The risk or severity of hemorrhage can be increased when Sibutramine is combined with Reteplase.,Sibutramine
DB04896,The risk or severity of hemorrhage can be increased when Milnacipran is combined with Reteplase.,Milnacipran
DB06700,The risk or severity of hemorrhage can be increased when Desvenlafaxine is combined with Reteplase.,Desvenlafaxine
DB08918,The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Reteplase.,Levomilnacipran
DB00285,Venlafaxine may increase the antiplatelet activities of Reteplase.,Venlafaxine
DB00182,The risk or severity of bleeding and hemorrhage can be increased when Amphetamine is combined with Reteplase.,Amphetamine
DB00601,The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Reteplase.,Linezolid
DB00614,The risk or severity of bleeding and hemorrhage can be increased when Furazolidone is combined with Reteplase.,Furazolidone
DB00721,The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Reteplase.,Procaine
DB00752,The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Reteplase.,Tranylcypromine
DB00780,The risk or severity of bleeding and hemorrhage can be increased when Phenelzine is combined with Reteplase.,Phenelzine
DB00805,The risk or severity of bleeding and hemorrhage can be increased when Minaprine is combined with Reteplase.,Minaprine
DB01037,The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Reteplase.,Selegiline
DB01168,The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Reteplase.,Procarbazine
DB01171,The risk or severity of bleeding and hemorrhage can be increased when Moclobemide is combined with Reteplase.,Moclobemide
DB01247,The risk or severity of bleeding and hemorrhage can be increased when Isocarboxazid is combined with Reteplase.,Isocarboxazid
DB01367,The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Reteplase.,Rasagiline
DB01626,The risk or severity of bleeding and hemorrhage can be increased when Pargyline is combined with Reteplase.,Pargyline
DB04017,The risk or severity of bleeding and hemorrhage can be increased when Clorgiline is combined with Reteplase.,Clorgiline
DB04818,The risk or severity of bleeding and hemorrhage can be increased when Iproniazid is combined with Reteplase.,Iproniazid
DB04820,The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Reteplase.,Nialamide
DB06654,The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Reteplase.,Safinamide
DB08550,"The risk or severity of bleeding and hemorrhage can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Reteplase.","7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline"
DB09241,The risk or severity of bleeding and hemorrhage can be increased when Methylene blue is combined with Reteplase.,Methylene blue
DB09243,The risk or severity of bleeding and hemorrhage can be increased when Hydracarbazine is combined with Reteplase.,Hydracarbazine
DB09244,The risk or severity of bleeding and hemorrhage can be increased when Pirlindole is combined with Reteplase.,Pirlindole
DB09245,The risk or severity of bleeding and hemorrhage can be increased when Toloxatone is combined with Reteplase.,Toloxatone
DB09246,The risk or severity of bleeding and hemorrhage can be increased when Benmoxin is combined with Reteplase.,Benmoxin
DB09248,The risk or severity of bleeding and hemorrhage can be increased when Mebanazine is combined with Reteplase.,Mebanazine
DB09249,The risk or severity of bleeding and hemorrhage can be increased when Octamoxin is combined with Reteplase.,Octamoxin
DB09250,The risk or severity of bleeding and hemorrhage can be increased when Pheniprazine is combined with Reteplase.,Pheniprazine
DB09251,The risk or severity of bleeding and hemorrhage can be increased when Phenoxypropazine is combined with Reteplase.,Phenoxypropazine
DB09252,The risk or severity of bleeding and hemorrhage can be increased when Pivhydrazine is combined with Reteplase.,Pivhydrazine
DB09253,The risk or severity of bleeding and hemorrhage can be increased when Safrazine is combined with Reteplase.,Safrazine
DB09254,The risk or severity of bleeding and hemorrhage can be increased when Caroxazone is combined with Reteplase.,Caroxazone
DB13875,The risk or severity of bleeding and hemorrhage can be increased when Harmaline is combined with Reteplase.,Harmaline
DB13876,The risk or severity of bleeding and hemorrhage can be increased when Brofaromine is combined with Reteplase.,Brofaromine
DB00006,The risk or severity of bleeding can be increased when Bivalirudin is combined with Reteplase.,Bivalirudin
DB00266,The risk or severity of bleeding can be increased when Dicoumarol is combined with Reteplase.,Dicoumarol
DB00278,The risk or severity of bleeding can be increased when Argatroban is combined with Reteplase.,Argatroban
DB00407,The risk or severity of bleeding can be increased when Ardeparin is combined with Reteplase.,Ardeparin
DB00498,The risk or severity of bleeding can be increased when Phenindione is combined with Reteplase.,Phenindione
DB00569,The risk or severity of bleeding can be increased when Fondaparinux is combined with Reteplase.,Fondaparinux
DB00682,The risk or severity of bleeding can be increased when Warfarin is combined with Reteplase.,Warfarin
DB00946,The risk or severity of bleeding can be increased when Phenprocoumon is combined with Reteplase.,Phenprocoumon
DB00974,The risk or severity of bleeding can be increased when Edetic acid is combined with Reteplase.,Edetic acid
DB01109,The risk or severity of bleeding can be increased when Heparin is combined with Reteplase.,Heparin
DB01225,The risk or severity of bleeding can be increased when Enoxaparin is combined with Reteplase.,Enoxaparin
DB01418,The risk or severity of bleeding can be increased when Acenocoumarol is combined with Reteplase.,Acenocoumarol
DB04898,The risk or severity of bleeding can be increased when Ximelagatran is combined with Reteplase.,Ximelagatran
DB05099,The risk or severity of bleeding can be increased when Ancrod is combined with Reteplase.,Ancrod
DB06271,The risk or severity of bleeding can be increased when Sulodexide is combined with Reteplase.,Sulodexide
DB06406,The risk or severity of bleeding can be increased when Idraparinux is combined with Reteplase.,Idraparinux
DB06635,The risk or severity of bleeding can be increased when Otamixaban is combined with Reteplase.,Otamixaban
DB06754,The risk or severity of bleeding can be increased when Danaparoid is combined with Reteplase.,Danaparoid
DB06779,The risk or severity of bleeding can be increased when Dalteparin is combined with Reteplase.,Dalteparin
DB07767,The risk or severity of bleeding can be increased when Ferulic acid is combined with Reteplase.,Ferulic acid
DB08794,The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Reteplase.,Ethyl biscoumacetate
DB08813,The risk or severity of bleeding can be increased when Nadroparin is combined with Reteplase.,Nadroparin
DB09255,The risk or severity of bleeding can be increased when Dextran is combined with Reteplase.,Dextran
DB09259,The risk or severity of bleeding can be increased when Reviparin is combined with Reteplase.,Reviparin
DB09261,The risk or severity of bleeding can be increased when Certoparin is combined with Reteplase.,Certoparin
DB11095,The risk or severity of bleeding can be increased when Desirudin is combined with Reteplase.,Desirudin
DB11268,The risk or severity of bleeding can be increased when Protocatechualdehyde is combined with Reteplase.,Protocatechualdehyde
DB11312,The risk or severity of bleeding can be increased when Protein C is combined with Reteplase.,Protein C
DB11598,The risk or severity of bleeding can be increased when Antithrombin III human is combined with Reteplase.,Antithrombin III human
DB11984,The risk or severity of bleeding can be increased when Letaxaban is combined with Reteplase.,Letaxaban
DB12289,The risk or severity of bleeding can be increased when Darexaban is combined with Reteplase.,Darexaban
DB12598,The risk or severity of bleeding can be increased when Nafamostat is combined with Reteplase.,Nafamostat
DB12831,The risk or severity of bleeding can be increased when Gabexate is combined with Reteplase.,Gabexate
DB13124,The risk or severity of bleeding can be increased when Troxerutin is combined with Reteplase.,Troxerutin
DB13136,The risk or severity of bleeding can be increased when Fluindione is combined with Reteplase.,Fluindione
DB13149,The risk or severity of bleeding can be increased when Protein S human is combined with Reteplase.,Protein S human
DB13616,The risk or severity of bleeding can be increased when Melagatran is combined with Reteplase.,Melagatran
DB09125,The risk or severity of bleeding can be increased when Potassium citrate is combined with Reteplase.,Potassium citrate
DB09154,The risk or severity of bleeding can be increased when Sodium citrate is combined with Reteplase.,Sodium citrate
DB00031,The risk or severity of bleeding can be increased when Tenecteplase is combined with Reteplase.,Tenecteplase
DB00055,The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Reteplase.,Drotrecogin alfa
DB06822,The risk or severity of bleeding can be increased when Tinzaparin is combined with Reteplase.,Tinzaparin
DB13199,The risk or severity of bleeding can be increased when Brinase is combined with Reteplase.,Brinase
DB13646,The risk or severity of bleeding can be increased when Saruplase is combined with Reteplase.,Saruplase
DB00086,The risk or severity of bleeding can be increased when Streptokinase is combined with Reteplase.,Streptokinase
DB04925,The risk or severity of bleeding can be increased when Desmoteplase is combined with Reteplase.,Desmoteplase
DB05254,The risk or severity of bleeding can be increased when Fibrinolysin is combined with Reteplase.,Fibrinolysin
DB06543,The risk or severity of bleeding can be increased when Astaxanthin is combined with Reteplase.,Astaxanthin
DB08994,The risk or severity of bleeding can be increased when Ditazole is combined with Reteplase.,Ditazole
DB09258,The risk or severity of bleeding can be increased when Bemiparin is combined with Reteplase.,Bemiparin
DB09260,The risk or severity of bleeding can be increased when Parnaparin is combined with Reteplase.,Parnaparin
DB13275,The risk or severity of bleeding can be increased when Clorindione is combined with Reteplase.,Clorindione
DB13347,The risk or severity of bleeding can be increased when Diphenadione is combined with Reteplase.,Diphenadione
DB13451,The risk or severity of bleeding can be increased when Tioclomarol is combined with Reteplase.,Tioclomarol
DB00001,The risk or severity of bleeding can be increased when Lepirudin is combined with Reteplase.,Lepirudin
DB00009,The risk or severity of bleeding can be increased when Alteplase is combined with Reteplase.,Alteplase
DB00029,The risk or severity of bleeding can be increased when Reteplase is combined with Anistreplase.,Anistreplase
DB14094,The risk or severity of bleeding can be increased when Reteplase is combined with Tocopherylquinone.,Tocopherylquinone
DB06679,The risk or severity of bleeding can be increased when Reteplase is combined with Amediplase.,Amediplase
DB03410,The risk or severity of bleeding can be increased when Reteplase is combined with 4-hydroxycoumarin.,4-hydroxycoumarin
DB08496,The risk or severity of bleeding can be increased when Reteplase is combined with (R)-warfarin.,(R)-warfarin
DB14055,The risk or severity of bleeding can be increased when Reteplase is combined with (S)-Warfarin.,(S)-Warfarin
DB12364,The risk or severity of bleeding can be increased when Reteplase is combined with Betrixaban.,Betrixaban
DB14598,The risk or severity of bleeding can be increased when Reteplase is combined with Edetate calcium disodium anhydrous.,Edetate calcium disodium anhydrous
DB11154,The risk or severity of bleeding can be increased when Reteplase is combined with Zinc citrate.,Zinc citrate
DB11166,The risk or severity of bleeding can be increased when Reteplase is combined with Antithrombin Alfa.,Antithrombin Alfa
DB04665,The risk or severity of bleeding can be increased when Reteplase is combined with Coumarin.,Coumarin
DB14726,The risk or severity of bleeding can be increased when Reteplase is combined with Dabigatran.,Dabigatran
DB06294,The risk or severity of bleeding can be increased when Reteplase is combined with Semuloparin.,Semuloparin
DB12726,The risk or severity of bleeding can be increased when Reteplase is combined with Monteplase.,Monteplase
DB00177,The risk or severity of angioedema can be increased when Reteplase is combined with Valsartan.,Valsartan
DB00178,The risk or severity of angioedema can be increased when Reteplase is combined with Ramipril.,Ramipril
DB00230,The risk or severity of angioedema can be increased when Reteplase is combined with Pregabalin.,Pregabalin
DB00492,The risk or severity of angioedema can be increased when Reteplase is combined with Fosinopril.,Fosinopril
DB00519,The risk or severity of angioedema can be increased when Reteplase is combined with Trandolapril.,Trandolapril
DB00542,The risk or severity of angioedema can be increased when Reteplase is combined with Benazepril.,Benazepril
DB00584,The risk or severity of angioedema can be increased when Reteplase is combined with Enalapril.,Enalapril
DB00678,The risk or severity of angioedema can be increased when Reteplase is combined with Losartan.,Losartan
DB00691,The risk or severity of angioedema can be increased when Reteplase is combined with Moexipril.,Moexipril
DB00722,The risk or severity of angioedema can be increased when Reteplase is combined with Lisinopril.,Lisinopril
DB00790,The risk or severity of angioedema can be increased when Reteplase is combined with Perindopril.,Perindopril
DB00876,The risk or severity of angioedema can be increased when Reteplase is combined with Eprosartan.,Eprosartan
DB00877,The risk or severity of angioedema can be increased when Reteplase is combined with Sirolimus.,Sirolimus
DB00881,The risk or severity of angioedema can be increased when Reteplase is combined with Quinapril.,Quinapril
DB00886,The risk or severity of angioedema can be increased when Reteplase is combined with Omapatrilat.,Omapatrilat
DB00966,The risk or severity of angioedema can be increased when Reteplase is combined with Telmisartan.,Telmisartan
DB01050,The risk or severity of angioedema can be increased when Reteplase is combined with Ibuprofen.,Ibuprofen
DB01180,The risk or severity of angioedema can be increased when Reteplase is combined with Rescinnamine.,Rescinnamine
DB01197,The risk or severity of angioedema can be increased when Reteplase is combined with Captopril.,Captopril
DB01261,The risk or severity of angioedema can be increased when Reteplase is combined with Sitagliptin.,Sitagliptin
DB01340,The risk or severity of angioedema can be increased when Reteplase is combined with Cilazapril.,Cilazapril
DB01342,The risk or severity of angioedema can be increased when Reteplase is combined with Forasartan.,Forasartan
DB01347,The risk or severity of angioedema can be increased when Reteplase is combined with Saprisartan.,Saprisartan
DB01348,The risk or severity of angioedema can be increased when Reteplase is combined with Spirapril.,Spirapril
DB04876,The risk or severity of angioedema can be increased when Reteplase is combined with Vildagliptin.,Vildagliptin
DB06011,The risk or severity of angioedema can be increased when Reteplase is combined with AMG-222.,AMG-222
DB06127,The risk or severity of angioedema can be increased when Reteplase is combined with Bisegliptin.,Bisegliptin
DB06196,The risk or severity of angioedema can be increased when Reteplase is combined with Icatibant.,Icatibant
DB06203,The risk or severity of angioedema can be increased when Reteplase is combined with Alogliptin.,Alogliptin
DB06245,The risk or severity of angioedema can be increased when Reteplase is combined with Lanoteplase.,Lanoteplase
DB06287,The risk or severity of angioedema can be increased when Reteplase is combined with Temsirolimus.,Temsirolimus
DB06335,The risk or severity of angioedema can be increased when Reteplase is combined with Saxagliptin.,Saxagliptin
DB08382,The risk or severity of angioedema can be increased when Reteplase is combined with Gosogliptin.,Gosogliptin
DB08822,The risk or severity of angioedema can be increased when Reteplase is combined with Azilsartan medoxomil.,Azilsartan medoxomil
DB08836,The risk or severity of angioedema can be increased when Reteplase is combined with Temocapril.,Temocapril
DB08882,The risk or severity of angioedema can be increased when Reteplase is combined with Linagliptin.,Linagliptin
DB09292,The risk or severity of angioedema can be increased when Reteplase is combined with Sacubitril.,Sacubitril
DB09477,The risk or severity of angioedema can be increased when Reteplase is combined with Enalaprilat.,Enalaprilat
DB11723,The risk or severity of angioedema can be increased when Reteplase is combined with Dutogliptin.,Dutogliptin
DB11783,The risk or severity of angioedema can be increased when Reteplase is combined with Imidapril.,Imidapril
DB11950,The risk or severity of angioedema can be increased when Reteplase is combined with Teneligliptin.,Teneligliptin
DB11992,The risk or severity of angioedema can be increased when Reteplase is combined with Omarigliptin.,Omarigliptin
DB12268,The risk or severity of angioedema can be increased when Reteplase is combined with Carmegliptin.,Carmegliptin
DB12412,The risk or severity of angioedema can be increased when Reteplase is combined with Gemigliptin.,Gemigliptin
DB12417,The risk or severity of angioedema can be increased when Reteplase is combined with Anagliptin.,Anagliptin
DB12625,The risk or severity of angioedema can be increased when Reteplase is combined with Evogliptin.,Evogliptin
DB13166,The risk or severity of angioedema can be increased when Reteplase is combined with Zofenopril.,Zofenopril
DB13312,The risk or severity of angioedema can be increased when Reteplase is combined with Delapril.,Delapril
DB14125,The risk or severity of angioedema can be increased when Reteplase is combined with Benazeprilat.,Benazeprilat
DB14207,The risk or severity of angioedema can be increased when Reteplase is combined with Fosinoprilat.,Fosinoprilat
DB14208,The risk or severity of angioedema can be increased when Reteplase is combined with Ramiprilat.,Ramiprilat
DB14209,The risk or severity of angioedema can be increased when Reteplase is combined with Trandolaprilat.,Trandolaprilat
DB14210,The risk or severity of angioedema can be increased when Reteplase is combined with Moexiprilat.,Moexiprilat
DB14213,The risk or severity of angioedema can be increased when Reteplase is combined with Perindoprilat.,Perindoprilat
DB14217,The risk or severity of angioedema can be increased when Reteplase is combined with Quinaprilat.,Quinaprilat
DB14231,The risk or severity of angioedema can be increased when Reteplase is combined with Quinoline Yellow WS.,Quinoline Yellow WS
DB00203,The risk or severity of hemorrhage can be increased when Reteplase is combined with Sildenafil.,Sildenafil
DB00008,The risk or severity of bleeding can be increased when Reteplase is combined with Peginterferon alfa-2a.,Peginterferon alfa-2a
DB00011,The risk or severity of bleeding can be increased when Reteplase is combined with Interferon alfa-n1.,Interferon alfa-n1
DB00018,The risk or severity of bleeding can be increased when Reteplase is combined with Interferon alfa-n3.,Interferon alfa-n3
DB00022,The risk or severity of bleeding can be increased when Reteplase is combined with Peginterferon alfa-2b.,Peginterferon alfa-2b
DB00033,The risk or severity of bleeding can be increased when Reteplase is combined with Interferon gamma-1b.,Interferon gamma-1b
DB00034,"The risk or severity of bleeding can be increased when Reteplase is combined with Interferon alfa-2a, Recombinant.","Interferon alfa-2a, Recombinant"
DB00041,The risk or severity of bleeding can be increased when Reteplase is combined with Aldesleukin.,Aldesleukin
DB00056,The risk or severity of bleeding can be increased when Reteplase is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin
DB00068,The risk or severity of bleeding can be increased when Reteplase is combined with Interferon beta-1b.,Interferon beta-1b
DB00069,The risk or severity of bleeding can be increased when Reteplase is combined with Interferon alfacon-1.,Interferon alfacon-1
DB00073,The risk or severity of bleeding can be increased when Reteplase is combined with Rituximab.,Rituximab
DB00078,The risk or severity of bleeding can be increased when Reteplase is combined with Ibritumomab tiuxetan.,Ibritumomab tiuxetan
DB00087,The risk or severity of bleeding can be increased when Reteplase is combined with Alemtuzumab.,Alemtuzumab
DB00105,The risk or severity of bleeding can be increased when Reteplase is combined with Interferon alfa-2b.,Interferon alfa-2b
DB00120,The risk or severity of bleeding can be increased when Reteplase is combined with Phenylalanine.,Phenylalanine
DB00188,The risk or severity of bleeding can be increased when Reteplase is combined with Bortezomib.,Bortezomib
DB00242,The risk or severity of bleeding can be increased when Reteplase is combined with Cladribine.,Cladribine
DB00262,The risk or severity of bleeding can be increased when Reteplase is combined with Carmustine.,Carmustine
DB00276,The risk or severity of bleeding can be increased when Reteplase is combined with Amsacrine.,Amsacrine
DB00291,The risk or severity of bleeding can be increased when Reteplase is combined with Chlorambucil.,Chlorambucil
DB00293,The risk or severity of bleeding can be increased when Reteplase is combined with Raltitrexed.,Raltitrexed
DB00305,The risk or severity of bleeding can be increased when Reteplase is combined with Mitomycin.,Mitomycin
DB00307,The risk or severity of bleeding can be increased when Reteplase is combined with Bexarotene.,Bexarotene
DB00309,The risk or severity of bleeding can be increased when Reteplase is combined with Vindesine.,Vindesine
DB00322,The risk or severity of bleeding can be increased when Reteplase is combined with Floxuridine.,Floxuridine
DB00352,The risk or severity of bleeding can be increased when Reteplase is combined with Tioguanine.,Tioguanine
DB00361,The risk or severity of bleeding can be increased when Reteplase is combined with Vinorelbine.,Vinorelbine
DB00380,The risk or severity of bleeding can be increased when Reteplase is combined with Dexrazoxane.,Dexrazoxane
DB00398,The risk or severity of bleeding can be increased when Reteplase is combined with Sorafenib.,Sorafenib
DB00428,The risk or severity of bleeding can be increased when Reteplase is combined with Streptozocin.,Streptozocin
DB00441,The risk or severity of bleeding can be increased when Reteplase is combined with Gemcitabine.,Gemcitabine
DB00444,The risk or severity of bleeding can be increased when Reteplase is combined with Teniposide.,Teniposide
DB00445,The risk or severity of bleeding can be increased when Reteplase is combined with Epirubicin.,Epirubicin
DB00446,The risk or severity of bleeding can be increased when Reteplase is combined with Chloramphenicol.,Chloramphenicol
DB00480,The risk or severity of bleeding can be increased when Reteplase is combined with Lenalidomide.,Lenalidomide
DB00488,The risk or severity of bleeding can be increased when Reteplase is combined with Altretamine.,Altretamine
DB00495,The risk or severity of bleeding can be increased when Reteplase is combined with Zidovudine.,Zidovudine
DB00515,The risk or severity of bleeding can be increased when Reteplase is combined with Cisplatin.,Cisplatin
DB00526,The risk or severity of bleeding can be increased when Reteplase is combined with Oxaliplatin.,Oxaliplatin
DB00531,The risk or severity of bleeding can be increased when Reteplase is combined with Cyclophosphamide.,Cyclophosphamide
DB00544,The risk or severity of bleeding can be increased when Reteplase is combined with Fluorouracil.,Fluorouracil
DB00552,The risk or severity of bleeding can be increased when Reteplase is combined with Pentostatin.,Pentostatin
DB00563,The risk or severity of bleeding can be increased when Reteplase is combined with Methotrexate.,Methotrexate
DB00564,The risk or severity of bleeding can be increased when Reteplase is combined with Carbamazepine.,Carbamazepine
DB00570,The risk or severity of bleeding can be increased when Reteplase is combined with Vinblastine.,Vinblastine
DB00619,The risk or severity of bleeding can be increased when Reteplase is combined with Imatinib.,Imatinib
DB00631,The risk or severity of bleeding can be increased when Reteplase is combined with Clofarabine.,Clofarabine
DB00642,The risk or severity of bleeding can be increased when Reteplase is combined with Pemetrexed.,Pemetrexed
DB00694,The risk or severity of bleeding can be increased when Reteplase is combined with Daunorubicin.,Daunorubicin
DB00762,The risk or severity of bleeding can be increased when Reteplase is combined with Irinotecan.,Irinotecan
DB00773,The risk or severity of bleeding can be increased when Reteplase is combined with Etoposide.,Etoposide
DB00851,The risk or severity of bleeding can be increased when Reteplase is combined with Dacarbazine.,Dacarbazine
DB00853,The risk or severity of bleeding can be increased when Reteplase is combined with Temozolomide.,Temozolomide
DB00859,The risk or severity of bleeding can be increased when Reteplase is combined with Penicillamine.,Penicillamine
DB00864,The risk or severity of bleeding can be increased when Reteplase is combined with Tacrolimus.,Tacrolimus
DB00888,The risk or severity of bleeding can be increased when Reteplase is combined with Mechlorethamine.,Mechlorethamine
DB00928,The risk or severity of bleeding can be increased when Reteplase is combined with Azacitidine.,Azacitidine
DB00958,The risk or severity of bleeding can be increased when Reteplase is combined with Carboplatin.,Carboplatin
DB00970,The risk or severity of bleeding can be increased when Reteplase is combined with Dactinomycin.,Dactinomycin
DB00987,The risk or severity of bleeding can be increased when Reteplase is combined with Cytarabine.,Cytarabine
DB00997,The risk or severity of bleeding can be increased when Reteplase is combined with Doxorubicin.,Doxorubicin
DB01005,The risk or severity of bleeding can be increased when Reteplase is combined with Hydroxyurea.,Hydroxyurea
DB01008,The risk or severity of bleeding can be increased when Reteplase is combined with Busulfan.,Busulfan
DB01030,The risk or severity of bleeding can be increased when Reteplase is combined with Topotecan.,Topotecan
DB01033,The risk or severity of bleeding can be increased when Reteplase is combined with Mercaptopurine.,Mercaptopurine
DB01041,The risk or severity of bleeding can be increased when Reteplase is combined with Thalidomide.,Thalidomide
DB01042,The risk or severity of bleeding can be increased when Reteplase is combined with Melphalan.,Melphalan
DB01073,The risk or severity of bleeding can be increased when Reteplase is combined with Fludarabine.,Fludarabine
DB01099,The risk or severity of bleeding can be increased when Reteplase is combined with Flucytosine.,Flucytosine
DB01101,The risk or severity of bleeding can be increased when Reteplase is combined with Capecitabine.,Capecitabine
DB01169,The risk or severity of bleeding can be increased when Reteplase is combined with Arsenic trioxide.,Arsenic trioxide
DB01177,The risk or severity of bleeding can be increased when Reteplase is combined with Idarubicin.,Idarubicin
DB01204,The risk or severity of bleeding can be increased when Reteplase is combined with Mitoxantrone.,Mitoxantrone
DB01206,The risk or severity of bleeding can be increased when Reteplase is combined with Lomustine.,Lomustine
DB01229,The risk or severity of bleeding can be increased when Reteplase is combined with Paclitaxel.,Paclitaxel
DB01248,The risk or severity of bleeding can be increased when Reteplase is combined with Docetaxel.,Docetaxel
DB01262,The risk or severity of bleeding can be increased when Reteplase is combined with Decitabine.,Decitabine
DB01280,The risk or severity of bleeding can be increased when Reteplase is combined with Nelarabine.,Nelarabine
DB01590,The risk or severity of bleeding can be increased when Reteplase is combined with Everolimus.,Everolimus
DB02546,The risk or severity of bleeding can be increased when Reteplase is combined with Vorinostat.,Vorinostat
DB04572,The risk or severity of bleeding can be increased when Reteplase is combined with Thiotepa.,Thiotepa
DB04845,The risk or severity of bleeding can be increased when Reteplase is combined with Ixabepilone.,Ixabepilone
DB04868,The risk or severity of bleeding can be increased when Reteplase is combined with Nilotinib.,Nilotinib
DB05015,The risk or severity of bleeding can be increased when Reteplase is combined with Belinostat.,Belinostat
DB05109,The risk or severity of bleeding can be increased when Reteplase is combined with Trabectedin.,Trabectedin
DB05258,The risk or severity of bleeding can be increased when Reteplase is combined with Interferon alfa.,Interferon alfa
DB05472,The risk or severity of bleeding can be increased when Reteplase is combined with omega interferon.,omega interferon
DB05773,The risk or severity of bleeding can be increased when Reteplase is combined with Trastuzumab emtansine.,Trastuzumab emtansine
DB06616,The risk or severity of bleeding can be increased when Reteplase is combined with Bosutinib.,Bosutinib
DB06769,The risk or severity of bleeding can be increased when Reteplase is combined with Bendamustine.,Bendamustine
DB06772,The risk or severity of bleeding can be increased when Reteplase is combined with Cabazitaxel.,Cabazitaxel
DB08871,The risk or severity of bleeding can be increased when Reteplase is combined with Eribulin.,Eribulin
DB08877,The risk or severity of bleeding can be increased when Reteplase is combined with Ruxolitinib.,Ruxolitinib
DB08889,The risk or severity of bleeding can be increased when Reteplase is combined with Carfilzomib.,Carfilzomib
DB08895,The risk or severity of bleeding can be increased when Reteplase is combined with Tofacitinib.,Tofacitinib
DB08901,The risk or severity of bleeding can be increased when Reteplase is combined with Ponatinib.,Ponatinib
DB08910,The risk or severity of bleeding can be increased when Reteplase is combined with Pomalidomide.,Pomalidomide
DB09042,The risk or severity of bleeding can be increased when Reteplase is combined with Tedizolid phosphate.,Tedizolid phosphate
DB09052,The risk or severity of bleeding can be increased when Reteplase is combined with Blinatumomab.,Blinatumomab
DB09073,The risk or severity of bleeding can be increased when Reteplase is combined with Palbociclib.,Palbociclib
DB09074,The risk or severity of bleeding can be increased when Reteplase is combined with Olaparib.,Olaparib
DB09077,The risk or severity of bleeding can be increased when Reteplase is combined with Dinutuximab.,Dinutuximab
DB09122,The risk or severity of bleeding can be increased when Reteplase is combined with Peginterferon beta-1a.,Peginterferon beta-1a
DB12814,The risk or severity of bleeding can be increased when Reteplase is combined with Cepeginterferon alfa-2B.,Cepeginterferon alfa-2B
DB00229,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefotiam.,Cefotiam
DB00267,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefmenoxime.,Cefmenoxime
DB00274,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefmetazole.,Cefmetazole
DB00430,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefpiramide.,Cefpiramide
DB00438,The therapeutic efficacy of Reteplase can be decreased when used in combination with Ceftazidime.,Ceftazidime
DB00447,The therapeutic efficacy of Reteplase can be decreased when used in combination with Loracarbef.,Loracarbef
DB00456,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefalotin.,Cefalotin
DB00493,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefotaxime.,Cefotaxime
DB00535,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefdinir.,Cefdinir
DB00567,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cephalexin.,Cephalexin
DB00671,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefixime.,Cefixime
DB00689,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cephaloglycin.,Cephaloglycin
DB00833,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefaclor.,Cefaclor
DB00923,The therapeutic efficacy of Reteplase can be decreased when used in combination with Ceforanide.,Ceforanide
DB01066,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefditoren.,Cefditoren
DB01112,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefuroxime.,Cefuroxime
DB01139,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefapirin.,Cefapirin
DB01140,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefadroxil.,Cefadroxil
DB01150,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefprozil.,Cefprozil
DB01212,The therapeutic efficacy of Reteplase can be decreased when used in combination with Ceftriaxone.,Ceftriaxone
DB01326,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefamandole.,Cefamandole
DB01327,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefazolin.,Cefazolin
DB01328,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefonicid.,Cefonicid
DB01329,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefoperazone.,Cefoperazone
DB01330,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefotetan.,Cefotetan
DB01331,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefoxitin.,Cefoxitin
DB01332,The therapeutic efficacy of Reteplase can be decreased when used in combination with Ceftizoxime.,Ceftizoxime
DB01333,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefradine.,Cefradine
DB01413,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefepime.,Cefepime
DB01414,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefacetrile.,Cefacetrile
DB01415,The therapeutic efficacy of Reteplase can be decreased when used in combination with Ceftibuten.,Ceftibuten
DB01416,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefpodoxime.,Cefpodoxime
DB04570,The therapeutic efficacy of Reteplase can be decreased when used in combination with Latamoxef.,Latamoxef
DB04918,The therapeutic efficacy of Reteplase can be decreased when used in combination with Ceftobiprole.,Ceftobiprole
DB06590,The therapeutic efficacy of Reteplase can be decreased when used in combination with Ceftaroline fosamil.,Ceftaroline fosamil
DB09008,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefaloridine.,Cefaloridine
DB09050,The therapeutic efficacy of Reteplase can be decreased when used in combination with Ceftolozane.,Ceftolozane
DB09062,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefminox.,Cefminox
DB11367,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefroxadine.,Cefroxadine
DB11935,The therapeutic efficacy of Reteplase can be decreased when used in combination with Flomoxef.,Flomoxef
DB13266,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefatrizine.,Cefatrizine
DB13461,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefcapene.,Cefcapene
DB13470,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefodizime.,Cefodizime
DB13499,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefsulodin.,Cefsulodin
DB13504,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefetamet.,Cefetamet
DB13638,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefbuperazone.,Cefbuperazone
DB13667,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefozopran.,Cefozopran
DB13682,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefpirome.,Cefpirome
DB13778,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefazedone.,Cefazedone
DB13821,The therapeutic efficacy of Reteplase can be decreased when used in combination with Ceftezole.,Ceftezole
DB14725,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefamandole nafate.,Cefamandole nafate
DB00254,The risk or severity of bleeding can be increased when Doxycycline is combined with Reteplase.,Doxycycline
DB00207,The risk or severity of adverse effects can be increased when Azithromycin is combined with Reteplase.,Azithromycin
DB09539,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Reteplase.,Omega-3-acid ethyl esters
DB00945,Acetylsalicylic acid may increase the anticoagulant activities of Reteplase.,Acetylsalicylic acid
DB01606,The risk or severity of bleeding can be increased when Tazobactam is combined with Reteplase.,Tazobactam
DB00727,The therapeutic efficacy of Reteplase can be decreased when used in combination with Nitroglycerin.,Nitroglycerin
DB00199,The risk or severity of bleeding can be increased when Erythromycin is combined with Reteplase.,Erythromycin
DB00656,The risk or severity of bleeding can be increased when Trazodone is combined with Reteplase.,Trazodone
DB00620,The therapeutic efficacy of Reteplase can be decreased when used in combination with Triamcinolone.,Triamcinolone
DB09079,The risk or severity of bleeding can be increased when Reteplase is combined with Nintedanib.,Nintedanib
DB01175,The risk or severity of bleeding can be increased when Escitalopram is combined with Reteplase.,Escitalopram
DB01104,The risk or severity of bleeding can be increased when Sertraline is combined with Reteplase.,Sertraline
DB00232,The therapeutic efficacy of Reteplase can be decreased when used in combination with Methyclothiazide.,Methyclothiazide
DB00436,The therapeutic efficacy of Reteplase can be decreased when used in combination with Bendroflumethiazide.,Bendroflumethiazide
DB00562,The therapeutic efficacy of Reteplase can be decreased when used in combination with Benzthiazide.,Benzthiazide
DB00606,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cyclothiazide.,Cyclothiazide
DB00774,The therapeutic efficacy of Reteplase can be decreased when used in combination with Hydroflumethiazide.,Hydroflumethiazide
DB00880,The therapeutic efficacy of Reteplase can be decreased when used in combination with Chlorothiazide.,Chlorothiazide
DB00999,The therapeutic efficacy of Reteplase can be decreased when used in combination with Hydrochlorothiazide.,Hydrochlorothiazide
DB01021,The therapeutic efficacy of Reteplase can be decreased when used in combination with Trichlormethiazide.,Trichlormethiazide
DB01324,The therapeutic efficacy of Reteplase can be decreased when used in combination with Polythiazide.,Polythiazide
DB13430,The therapeutic efficacy of Reteplase can be decreased when used in combination with Mebutizide.,Mebutizide
DB13532,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cyclopenthiazide.,Cyclopenthiazide
DB00480,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lenalidomide.,Lenalidomide
DB01041,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Thalidomide.,Thalidomide
DB08910,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pomalidomide.,Pomalidomide
DB00002,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cetuximab.,Cetuximab
DB00004,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Denileukin diftitox.,Denileukin diftitox
DB00007,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Leuprolide.,Leuprolide
DB00008,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Peginterferon alfa-2a.,Peginterferon alfa-2a
DB00014,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Goserelin.,Goserelin
DB00023,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Asparaginase Escherichia coli.,Asparaginase Escherichia coli
DB00041,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Aldesleukin.,Aldesleukin
DB00056,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin
DB00059,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pegaspargase.,Pegaspargase
DB00072,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Trastuzumab.,Trastuzumab
DB00073,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rituximab.,Rituximab
DB00081,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tositumomab.,Tositumomab
DB00087,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Alemtuzumab.,Alemtuzumab
DB00104,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Octreotide.,Octreotide
DB00105,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Interferon alfa-2b.,Interferon alfa-2b
DB00112,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bevacizumab.,Bevacizumab
DB00179,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Masoprocol.,Masoprocol
DB00188,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bortezomib.,Bortezomib
DB00236,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pipobroman.,Pipobroman
DB00242,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cladribine.,Cladribine
DB00248,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cabergoline.,Cabergoline
DB00261,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Anagrelide.,Anagrelide
DB00262,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Carmustine.,Carmustine
DB00269,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Chlorotrianisene.,Chlorotrianisene
DB00276,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Amsacrine.,Amsacrine
DB00282,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pamidronic acid.,Pamidronic acid
DB00290,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bleomycin.,Bleomycin
DB00291,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Chlorambucil.,Chlorambucil
DB00293,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Raltitrexed.,Raltitrexed
DB00305,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mitomycin.,Mitomycin
DB00307,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bexarotene.,Bexarotene
DB00313,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Valproic acid.,Valproic acid
DB00317,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Gefitinib.,Gefitinib
DB00322,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Floxuridine.,Floxuridine
DB00351,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Megestrol acetate.,Megestrol acetate
DB00352,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tioguanine.,Tioguanine
DB00357,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Aminoglutethimide.,Aminoglutethimide
DB00385,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Valrubicin.,Valrubicin
DB00398,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Sorafenib.,Sorafenib
DB00428,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Streptozocin.,Streptozocin
DB00432,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Trifluridine.,Trifluridine
DB00441,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Gemcitabine.,Gemcitabine
DB00444,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Teniposide.,Teniposide
DB00445,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Epirubicin.,Epirubicin
DB00488,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Altretamine.,Altretamine
DB00499,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Flutamide.,Flutamide
DB00515,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cisplatin.,Cisplatin
DB00523,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Alitretinoin.,Alitretinoin
DB00526,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Oxaliplatin.,Oxaliplatin
DB00530,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Erlotinib.,Erlotinib
DB00539,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Toremifene.,Toremifene
DB00544,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Fluorouracil.,Fluorouracil
DB00552,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pentostatin.,Pentostatin
DB00563,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Methotrexate.,Methotrexate
DB00603,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Medroxyprogesterone acetate.,Medroxyprogesterone acetate
DB00619,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Imatinib.,Imatinib
DB00631,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Clofarabine.,Clofarabine
DB00635,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Prednisone.,Prednisone
DB00642,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pemetrexed.,Pemetrexed
DB00648,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mitotane.,Mitotane
DB00665,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nilutamide.,Nilutamide
DB00675,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tamoxifen.,Tamoxifen
DB00694,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Daunorubicin.,Daunorubicin
DB00707,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Porfimer sodium.,Porfimer sodium
DB00755,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tretinoin.,Tretinoin
DB00762,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Irinotecan.,Irinotecan
DB00773,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Etoposide.,Etoposide
DB00791,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Uracil mustard.,Uracil mustard
DB00851,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dacarbazine.,Dacarbazine
DB00853,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Temozolomide.,Temozolomide
DB00855,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Aminolevulinic acid.,Aminolevulinic acid
DB00860,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Prednisolone.,Prednisolone
DB00888,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mechlorethamine.,Mechlorethamine
DB00894,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Testolactone.,Testolactone
DB00928,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Azacitidine.,Azacitidine
DB00947,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Fulvestrant.,Fulvestrant
DB00958,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Carboplatin.,Carboplatin
DB00959,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Methylprednisolone.,Methylprednisolone
DB00970,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dactinomycin.,Dactinomycin
DB00987,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cytarabine.,Cytarabine
DB00990,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Exemestane.,Exemestane
DB00997,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Doxorubicin.,Doxorubicin
DB01005,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Hydroxyurea.,Hydroxyurea
DB01006,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Letrozole.,Letrozole
DB01008,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Busulfan.,Busulfan
DB01030,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Topotecan.,Topotecan
DB01033,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mercaptopurine.,Mercaptopurine
DB01042,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Melphalan.,Melphalan
DB01073,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Fludarabine.,Fludarabine
DB01101,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Capecitabine.,Capecitabine
DB01108,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Trilostane.,Trilostane
DB01128,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bicalutamide.,Bicalutamide
DB01157,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Trimetrexate.,Trimetrexate
DB01168,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Procarbazine.,Procarbazine
DB01169,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Arsenic trioxide.,Arsenic trioxide
DB01177,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Idarubicin.,Idarubicin
DB01181,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ifosfamide.,Ifosfamide
DB01196,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Estramustine.,Estramustine
DB01204,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mitoxantrone.,Mitoxantrone
DB01206,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lomustine.,Lomustine
DB01217,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Anastrozole.,Anastrozole
DB01229,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Paclitaxel.,Paclitaxel
DB01234,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dexamethasone.,Dexamethasone
DB01248,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Docetaxel.,Docetaxel
DB01254,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dasatinib.,Dasatinib
DB01259,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lapatinib.,Lapatinib
DB01262,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Decitabine.,Decitabine
DB01268,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Sunitinib.,Sunitinib
DB01269,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Panitumumab.,Panitumumab
DB01280,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nelarabine.,Nelarabine
DB01590,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Everolimus.,Everolimus
DB01645,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Genistein.,Genistein
DB01667,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 8-azaguanine.,8-azaguanine
DB01873,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Epothilone D.,Epothilone D
DB01933,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 7-Hydroxystaurosporine.,7-Hydroxystaurosporine
DB02109,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Hadacidin.,Hadacidin
DB02342,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 2-Methoxyestradiol.,2-Methoxyestradiol
DB02424,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Geldanamycin.,Geldanamycin
DB02546,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vorinostat.,Vorinostat
DB02640,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Fumagillin.,Fumagillin
DB03010,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Patupilone.,Patupilone
DB03172,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tubercidin.,Tubercidin
DB03459,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Sparfosic acid.,Sparfosic acid
DB03496,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Alvocidib.,Alvocidib
DB03509,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide.,2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide
DB03523,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Brequinar.,Brequinar
DB03695,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Piritrexim.,Piritrexim
DB03825,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rhodamine 6G.,Rhodamine 6G
DB03880,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Batimastat.,Batimastat
DB03946,"The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 3,4-Dihydroxybenzoic Acid.","3,4-Dihydroxybenzoic Acid"
DB04106,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Fotemustine.,Fotemustine
DB04222,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Sparsomycin.,Sparsomycin
DB04253,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tretazicar.,Tretazicar
DB04258,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Seocalcitol.,Seocalcitol
DB04331,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Monastrol.,Monastrol
DB04440,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nebularine.,Nebularine
DB04468,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Afimoxifene.,Afimoxifene
DB04572,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Thiotepa.,Thiotepa
DB04576,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Fleroxacin.,Fleroxacin
DB04655,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Metoprine.,Metoprine
DB04690,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Camptothecin.,Camptothecin
DB04786,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Suramin.,Suramin
DB04827,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Urethane.,Urethane
DB04839,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cyproterone acetate.,Cyproterone acetate
DB04845,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ixabepilone.,Ixabepilone
DB04849,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cediranib.,Cediranib
DB04858,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tirapazamine.,Tirapazamine
DB04865,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Omacetaxine mepesuccinate.,Omacetaxine mepesuccinate
DB04866,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Halofuginone.,Halofuginone
DB04868,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nilotinib.,Nilotinib
DB04894,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vapreotide.,Vapreotide
DB04900,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Thymalfasin.,Thymalfasin
DB04901,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Galiximab.,Galiximab
DB04907,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Sitimagene ceradenovec.,Sitimagene ceradenovec
DB04950,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ranpirnase.,Ranpirnase
DB04951,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pirfenidone.,Pirfenidone
DB04958,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Epratuzumab.,Epratuzumab
DB04960,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tipifarnib.,Tipifarnib
DB04961,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Troxacitabine.,Troxacitabine
DB04964,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Oregovomab.,Oregovomab
DB04975,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Banoxantrone.,Banoxantrone
DB04977,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Plitidepsin.,Plitidepsin
DB04996,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Satraplatin.,Satraplatin
DB05015,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Belinostat.,Belinostat
DB05022,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Amonafide.,Amonafide
DB05076,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Fenretinide.,Fenretinide
DB05088,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tetrathiomolybdate.,Tetrathiomolybdate
DB05097,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Labetuzumab.,Labetuzumab
DB05109,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Trabectedin.,Trabectedin
DB05129,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Elsamitrucin.,Elsamitrucin
DB05136,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bavituximab.,Bavituximab
DB05223,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pracinostat.,Pracinostat
DB05239,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cobimetinib.,Cobimetinib
DB05260,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Gallium nitrate.,Gallium nitrate
DB05265,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ecabet.,Ecabet
DB05294,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vandetanib.,Vandetanib
DB05374,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rindopepimut.,Rindopepimut
DB05424,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Canertinib.,Canertinib
DB05428,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Motexafin gadolinium.,Motexafin gadolinium
DB05482,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 7-ethyl-10-hydroxycamptothecin.,7-ethyl-10-hydroxycamptothecin
DB05524,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pelitinib.,Pelitinib
DB05540,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Alanosine.,Alanosine
DB05578,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ramucirumab.,Ramucirumab
DB05595,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Farletuzumab.,Farletuzumab
DB05656,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Veltuzumab.,Veltuzumab
DB05668,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Palifosfamide.,Palifosfamide
DB05697,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with AP 12009.,AP 12009
DB05773,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Trastuzumab emtansine.,Trastuzumab emtansine
DB05779,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Oglufanide.,Oglufanide
DB05786,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Irofulven.,Irofulven
DB05812,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Abiraterone.,Abiraterone
DB05889,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Inotuzumab ozogamicin.,Inotuzumab ozogamicin
DB05903,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with KOS-1584.,KOS-1584
DB05916,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with CT-011.,CT-011
DB05974,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Transcrocetinate.,Transcrocetinate
DB05996,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Glembatumumab vedotin.,Glembatumumab vedotin
DB06013,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Aldoxorubicin.,Aldoxorubicin
DB06021,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with AV-412.,AV-412
DB06040,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Filanesib.,Filanesib
DB06043,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Olaratumab.,Olaratumab
DB06159,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rubitecan.,Rubitecan
DB06160,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Garenoxacin.,Garenoxacin
DB06163,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Plevitrexed.,Plevitrexed
DB06171,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Paclitaxel trevatide.,Paclitaxel trevatide
DB06176,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Romidepsin.,Romidepsin
DB06181,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with IMO-2055.,IMO-2055
DB06186,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ipilimumab.,Ipilimumab
DB06192,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nimotuzumab.,Nimotuzumab
DB06193,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pixantrone.,Pixantrone
DB06195,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Seliciclib.,Seliciclib
DB06199,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Atrasentan.,Atrasentan
DB06233,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ridaforolimus.,Ridaforolimus
DB06235,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vadimezan.,Vadimezan
DB06246,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Exisulind.,Exisulind
DB06263,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Amrubicin.,Amrubicin
DB06266,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lonidamine.,Lonidamine
DB06272,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Maxacalcitol.,Maxacalcitol
DB06287,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Temsirolimus.,Temsirolimus
DB06317,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Elotuzumab.,Elotuzumab
DB06334,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tucidinostat.,Tucidinostat
DB06365,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Sapacitabine.,Sapacitabine
DB06366,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pertuzumab.,Pertuzumab
DB06370,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Indisulam.,Indisulam
DB06420,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Annamycin.,Annamycin
DB06423,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Endostatin.,Endostatin
DB06433,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tezacitabine.,Tezacitabine
DB06436,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Semaxanib.,Semaxanib
DB06445,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Diethylnorspermine.,Diethylnorspermine
DB06461,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Squalamine.,Squalamine
DB06478,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Porfiromycin.,Porfiromycin
DB06517,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with MLN576.,MLN576
DB06589,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pazopanib.,Pazopanib
DB06595,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Midostaurin.,Midostaurin
DB06603,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Panobinostat.,Panobinostat
DB06607,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Catumaxomab.,Catumaxomab
DB06616,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bosutinib.,Bosutinib
DB06626,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Axitinib.,Axitinib
DB06647,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Volociximab.,Volociximab
DB06650,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ofatumumab.,Ofatumumab
DB06699,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Degarelix.,Degarelix
DB06710,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Methyltestosterone.,Methyltestosterone
DB06719,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Buserelin.,Buserelin
DB06748,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ginsenoside C.,Ginsenoside C
DB06769,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bendamustine.,Bendamustine
DB06772,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cabazitaxel.,Cabazitaxel
DB06789,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Hydroxyprogesterone caproate.,Hydroxyprogesterone caproate
DB06791,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lanreotide.,Lanreotide
DB06810,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Plicamycin.,Plicamycin
DB06813,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pralatrexate.,Pralatrexate
DB06825,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Triptorelin.,Triptorelin
DB07232,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Veliparib.,Veliparib
DB07931,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Hexestrol.,Hexestrol
DB08313,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nocodazole.,Nocodazole
DB08437,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Puromycin.,Puromycin
DB08486,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Efaproxiral.,Efaproxiral
DB08633,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with TNP-470.,TNP-470
DB08828,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vismodegib.,Vismodegib
DB08865,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Crizotinib.,Crizotinib
DB08870,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Brentuximab vedotin.,Brentuximab vedotin
DB08871,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Eribulin.,Eribulin
DB08875,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cabozantinib.,Cabozantinib
DB08877,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ruxolitinib.,Ruxolitinib
DB08881,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vemurafenib.,Vemurafenib
DB08886,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Asparaginase Erwinia chrysanthemi.,Asparaginase Erwinia chrysanthemi
DB08889,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Carfilzomib.,Carfilzomib
DB08896,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Regorafenib.,Regorafenib
DB08899,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Enzalutamide.,Enzalutamide
DB08901,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ponatinib.,Ponatinib
DB08905,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Formestane.,Formestane
DB08911,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Trametinib.,Trametinib
DB08912,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dabrafenib.,Dabrafenib
DB08913,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Radium Ra 223 dichloride.,Radium Ra 223 dichloride
DB08916,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Afatinib.,Afatinib
DB08935,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Obinutuzumab.,Obinutuzumab
DB08972,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Flumequine.,Flumequine
DB09010,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Carmofur.,Carmofur
DB09031,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Miltefosine.,Miltefosine
DB09035,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nivolumab.,Nivolumab
DB09036,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Siltuximab.,Siltuximab
DB09037,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pembrolizumab.,Pembrolizumab
DB09052,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Blinatumomab.,Blinatumomab
DB09053,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ibrutinib.,Ibrutinib
DB09054,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Idelalisib.,Idelalisib
DB09063,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ceritinib.,Ceritinib
DB09073,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Palbociclib.,Palbociclib
DB09074,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Olaparib.,Olaparib
DB09077,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dinutuximab.,Dinutuximab
DB09078,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lenvatinib.,Lenvatinib
DB09079,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nintedanib.,Nintedanib
DB09123,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dienogest.,Dienogest
DB09143,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Sonidegib.,Sonidegib
DB09239,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Niguldipine.,Niguldipine
DB09256,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tegafur.,Tegafur
DB09274,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Artesunate.,Artesunate
DB09298,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Silibinin.,Silibinin
DB09330,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Osimertinib.,Osimertinib
DB09331,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Daratumumab.,Daratumumab
DB09559,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Necitumumab.,Necitumumab
DB09570,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ixazomib.,Ixazomib
DB11363,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Alectinib.,Alectinib
DB11366,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Roquinimex.,Roquinimex
DB11526,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Masitinib.,Masitinib
DB11581,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Venetoclax.,Venetoclax
DB11595,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Atezolizumab.,Atezolizumab
DB11616,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pirarubicin.,Pirarubicin
DB11617,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Aclarubicin.,Aclarubicin
DB11618,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Zorubicin.,Zorubicin
DB11630,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Temoporfin.,Temoporfin
DB11646,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Conatumumab.,Conatumumab
DB11651,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dactolisib.,Dactolisib
DB11662,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rabusertib.,Rabusertib
DB11669,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ortataxel.,Ortataxel
DB11678,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Treosulfan.,Treosulfan
DB11688,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 2-chloroethyl-3-sarcosinamide-1-nitrosourea.,2-chloroethyl-3-sarcosinamide-1-nitrosourea
DB11694,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ilorasertib.,Ilorasertib
DB11714,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Durvalumab.,Durvalumab
DB11716,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Misonidazole.,Misonidazole
DB11717,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Epacadostat.,Epacadostat
DB11718,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Encorafenib.,Encorafenib
DB11727,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Endostar.,Endostar
DB11730,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ribociclib.,Ribociclib
DB11737,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Icotinib.,Icotinib
DB11752,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bryostatin 1.,Bryostatin 1
DB11760,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Talazoparib.,Talazoparib
DB11771,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tremelimumab.,Tremelimumab
DB11793,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Niraparib.,Niraparib
DB11795,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with GSK-2636771.,GSK-2636771
DB11800,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tivozanib.,Tivozanib
DB11805,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Saracatinib.,Saracatinib
DB11812,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Talaporfin.,Talaporfin
DB11828,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Neratinib.,Neratinib
DB11830,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mocetinostat.,Mocetinostat
DB11832,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Crenolanib.,Crenolanib
DB11841,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Entinostat.,Entinostat
DB11880,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Acridine Carboxamide.,Acridine Carboxamide
DB11886,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Infigratinib.,Infigratinib
DB11891,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with CUDC-907.,CUDC-907
DB11894,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Efatutazone.,Efatutazone
DB11901,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Apalutamide.,Apalutamide
DB11907,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rociletinib.,Rociletinib
DB11918,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Guadecitabine.,Guadecitabine
DB11919,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 6-O-benzylguanine.,6-O-benzylguanine
DB11945,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Avelumab.,Avelumab
DB11960,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Carboxyamidotriazole.,Carboxyamidotriazole
DB11963,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dacomitinib.,Dacomitinib
DB11967,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Binimetinib.,Binimetinib
DB11972,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rilotumumab.,Rilotumumab
DB11973,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tesevatinib.,Tesevatinib
DB11978,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Glasdegib.,Glasdegib
DB11986,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Entrectinib.,Entrectinib
DB11999,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vosaroxin.,Vosaroxin
DB12001,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Abemaciclib.,Abemaciclib
DB12015,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Alpelisib.,Alpelisib
DB12025,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Triptolide.,Triptolide
DB12028,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Broxuridine.,Broxuridine
DB12036,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Naquotinib.,Naquotinib
DB12056,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Trebananib.,Trebananib
DB12081,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Anecortave.,Anecortave
DB12082,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vesnarinone.,Vesnarinone
DB12083,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mafosfamide.,Mafosfamide
DB12085,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with LCL-161.,LCL-161
DB12089,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lorvotuzumab mertansine.,Lorvotuzumab mertansine
DB12108,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Taselisib.,Taselisib
DB12124,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Namitecan.,Namitecan
DB12130,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lorlatinib.,Lorlatinib
DB12141,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Gilteritinib.,Gilteritinib
DB12142,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Duligotuzumab.,Duligotuzumab
DB12146,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rigosertib.,Rigosertib
DB12147,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Erdafitinib.,Erdafitinib
DB12156,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cordycepin.,Cordycepin
DB12174,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with CUDC-101.,CUDC-101
DB12182,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Binetrakin.,Binetrakin
DB12185,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Exatecan.,Exatecan
DB12202,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Zalutumumab.,Zalutumumab
DB12222,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lurtotecan.,Lurtotecan
DB12232,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with KRN-7000.,KRN-7000
DB12257,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Platinum.,Platinum
DB12259,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with CG-200745.,CG-200745
DB12266,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Epofolate.,Epofolate
DB12267,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Brigatinib.,Brigatinib
DB12279,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with OBP-801.,OBP-801
DB12332,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rucaparib.,Rucaparib
DB12340,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Navitoclax.,Navitoclax
DB12352,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bizelesin.,Bizelesin
DB12376,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ricolinostat.,Ricolinostat
DB12379,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Indirubin.,Indirubin
DB12381,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Merestinib.,Merestinib
DB12382,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with R-306465.,R-306465
DB12385,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 10-hydroxycamptothecin.,10-hydroxycamptothecin
DB12391,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Sagopilone.,Sagopilone
DB12422,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Sulforaphane.,Sulforaphane
DB12459,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Belotecan.,Belotecan
DB12473,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Taurolidine.,Taurolidine
DB12480,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Betulinic Acid.,Betulinic Acid
DB12483,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Copanlisib.,Copanlisib
DB12498,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mogamulizumab.,Mogamulizumab
DB12515,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 9-aminocamptothecin.,9-aminocamptothecin
DB12525,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Molgramostim.,Molgramostim
DB12539,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Oltipraz.,Oltipraz
DB12549,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pyrazoloacridine.,Pyrazoloacridine
DB12565,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Abexinostat.,Abexinostat
DB12577,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Fosbretabulin.,Fosbretabulin
DB12589,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dacetuzumab.,Dacetuzumab
DB12593,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Apaziquone.,Apaziquone
DB12596,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Combretastatin.,Combretastatin
DB12617,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mizoribine.,Mizoribine
DB12637,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Onapristone.,Onapristone
DB12638,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with PU-H71.,PU-H71
DB12645,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Givinostat.,Givinostat
DB12671,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Beloranib.,Beloranib
DB12677,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Soblidotin.,Soblidotin
DB12681,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Salirasib.,Salirasib
DB12688,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Moxetumomab Pasudotox.,Moxetumomab Pasudotox
DB12692,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Gusperimus.,Gusperimus
DB12695,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Phenethyl Isothiocyanate.,Phenethyl Isothiocyanate
DB12697,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Methylselenocysteine.,Methylselenocysteine
DB12701,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Intetumumab.,Intetumumab
DB12730,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dolastatin 10.,Dolastatin 10
DB12736,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Etanidazole.,Etanidazole
DB12769,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lometrexol.,Lometrexol
DB12797,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ecromeximab.,Ecromeximab
DB12832,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Prednimustine.,Prednimustine
DB12870,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Buthionine Sulfoximine.,Buthionine Sulfoximine
DB12873,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dianhydrogalactitol.,Dianhydrogalactitol
DB12881,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Indole-3-carbinol.,Indole-3-carbinol
DB12901,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Fiacitabine.,Fiacitabine
DB12902,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Trofosfamide.,Trofosfamide
DB12912,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nolatrexed.,Nolatrexed
DB12916,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mitolactol.,Mitolactol
DB12920,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pinometostat.,Pinometostat
DB12947,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Doxifluridine.,Doxifluridine
DB12948,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Didox.,Didox
DB12967,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mitoguazone.,Mitoguazone
DB12978,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pexidartinib.,Pexidartinib
DB12987,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Penclomedine.,Penclomedine
DB12991,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Deoxyspergualin.,Deoxyspergualin
DB12996,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Acteoside.,Acteoside
DB13005,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rebastinib.,Rebastinib
DB13014,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Hypericin.,Hypericin
DB13046,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tocladesine.,Tocladesine
DB13066,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Liarozole.,Liarozole
DB13069,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nimustine.,Nimustine
DB13104,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with X-396.,X-396
DB13128,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Sizofiran.,Sizofiran
DB13145,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nedaplatin.,Nedaplatin
DB13164,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Olmutinib.,Olmutinib
DB13182,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Daidzein.,Daidzein
DB13243,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tiazofurine.,Tiazofurine
DB13304,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Triaziquone.,Triaziquone
DB13318,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Demecolcine.,Demecolcine
DB13334,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mannosulfan.,Mannosulfan
DB13339,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Etoglucid.,Etoglucid
DB13375,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Edrecolomab.,Edrecolomab
DB13480,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lentinan.,Lentinan
DB13543,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mitobronitol.,Mitobronitol
DB13627,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Oxolinic acid.,Oxolinic acid
DB13647,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Semustine.,Semustine
DB13677,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Carboquone.,Carboquone
DB13767,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vorozole.,Vorozole
DB13809,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Paclitaxel poliglumex.,Paclitaxel poliglumex
DB13811,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Oblimersen.,Oblimersen
DB13832,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ranimustine.,Ranimustine
DB13874,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Enasidenib.,Enasidenib
DB13877,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Iniparib.,Iniparib
DB13896,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Talimogene laherparepvec.,Talimogene laherparepvec
DB13912,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Coumermycin A1.,Coumermycin A1
DB13916,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Toyocamycin.,Toyocamycin
DB14031,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tretamine.,Tretamine
DB14066,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tetrandrine.,Tetrandrine
DB14067,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dofequidar.,Dofequidar
DB14068,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dexniguldipine.,Dexniguldipine
DB14568,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ivosidenib.,Ivosidenib
DB14644,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Methylprednisolone hemisuccinate.,Methylprednisolone hemisuccinate
DB14646,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Prednisone acetate.,Prednisone acetate
DB14680,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Combretastatin A4.,Combretastatin A4
DB14707,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cemiplimab.,Cemiplimab
DB14723,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Larotrectinib.,Larotrectinib
DB14731,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tagraxofusp.,Tagraxofusp
DB14765,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rivoceranib.,Rivoceranib
DB14792,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with AZD-5991.,AZD-5991
DB14844,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with ONC-201.,ONC-201
DB14860,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ensartinib.,Ensartinib
DB14865,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Human interleukin-2.,Human interleukin-2
DB14877,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lintuzumab.,Lintuzumab
DB14947,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bermekimab.,Bermekimab
DB14951,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Etirinotecan pegol.,Etirinotecan pegol
DB15035,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Zanubrutinib.,Zanubrutinib
DB15057,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with NUC-1031.,NUC-1031
DB15157,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Voruciclib.,Voruciclib
DB15215,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with KRN-5500.,KRN-5500
DB15289,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Perillyl alcohol.,Perillyl alcohol
DB15321,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tefinostat.,Tefinostat
DB15334,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Biochanin A.,Biochanin A
DB15351,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dihematoporphyrin ether.,Dihematoporphyrin ether
DB15366,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with SOR-C13.,SOR-C13
DB15383,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pidilizumab.,Pidilizumab
DB15419,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nanatinostat.,Nanatinostat
DB15466,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tallimustine.,Tallimustine
DB12062,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Volasertib.,Volasertib
DB14811,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Isatuximab.,Isatuximab
DB15102,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pemigatinib.,Pemigatinib
DB11791,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Capmatinib.,Capmatinib
DB15685,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Selpercatinib.,Selpercatinib
DB00531,The risk or severity of pulmonary toxicity can be increased when Erythropoietin is combined with Cyclophosphamide.,Cyclophosphamide
DB00984,The therapeutic efficacy of Erythropoietin can be increased when used in combination with Nandrolone phenpropionate.,Nandrolone phenpropionate
DB08804,The therapeutic efficacy of Erythropoietin can be increased when used in combination with Nandrolone decanoate.,Nandrolone decanoate
DB13169,The therapeutic efficacy of Erythropoietin can be increased when used in combination with Nandrolone.,Nandrolone
DB00178,The serum concentration of Erythropoietin can be decreased when it is combined with Ramipril.,Ramipril
DB00492,The serum concentration of Erythropoietin can be decreased when it is combined with Fosinopril.,Fosinopril
DB00519,The serum concentration of Erythropoietin can be decreased when it is combined with Trandolapril.,Trandolapril
DB00542,The serum concentration of Erythropoietin can be decreased when it is combined with Benazepril.,Benazepril
DB00584,The serum concentration of Erythropoietin can be decreased when it is combined with Enalapril.,Enalapril
DB00691,The serum concentration of Erythropoietin can be decreased when it is combined with Moexipril.,Moexipril
DB00722,The serum concentration of Erythropoietin can be decreased when it is combined with Lisinopril.,Lisinopril
DB00790,The serum concentration of Erythropoietin can be decreased when it is combined with Perindopril.,Perindopril
DB00881,The serum concentration of Erythropoietin can be decreased when it is combined with Quinapril.,Quinapril
DB00886,The serum concentration of Erythropoietin can be decreased when it is combined with Omapatrilat.,Omapatrilat
DB01180,The serum concentration of Erythropoietin can be decreased when it is combined with Rescinnamine.,Rescinnamine
DB01197,The serum concentration of Erythropoietin can be decreased when it is combined with Captopril.,Captopril
DB01340,The serum concentration of Erythropoietin can be decreased when it is combined with Cilazapril.,Cilazapril
DB01348,The serum concentration of Erythropoietin can be decreased when it is combined with Spirapril.,Spirapril
DB08836,The serum concentration of Erythropoietin can be decreased when it is combined with Temocapril.,Temocapril
DB09477,The serum concentration of Erythropoietin can be decreased when it is combined with Enalaprilat.,Enalaprilat
DB11783,The serum concentration of Erythropoietin can be decreased when it is combined with Imidapril.,Imidapril
DB13166,The serum concentration of Erythropoietin can be decreased when it is combined with Zofenopril.,Zofenopril
DB13312,The serum concentration of Erythropoietin can be decreased when it is combined with Delapril.,Delapril
DB14125,The serum concentration of Erythropoietin can be decreased when it is combined with Benazeprilat.,Benazeprilat
DB14207,The serum concentration of Erythropoietin can be decreased when it is combined with Fosinoprilat.,Fosinoprilat
DB14208,The serum concentration of Erythropoietin can be decreased when it is combined with Ramiprilat.,Ramiprilat
DB14209,The serum concentration of Erythropoietin can be decreased when it is combined with Trandolaprilat.,Trandolaprilat
DB14210,The serum concentration of Erythropoietin can be decreased when it is combined with Moexiprilat.,Moexiprilat
DB14213,The serum concentration of Erythropoietin can be decreased when it is combined with Perindoprilat.,Perindoprilat
DB14217,The serum concentration of Erythropoietin can be decreased when it is combined with Quinaprilat.,Quinaprilat
DB14231,The serum concentration of Erythropoietin can be decreased when it is combined with Quinoline Yellow WS.,Quinoline Yellow WS
DB15565,The serum concentration of Erythropoietin can be decreased when it is combined with Cilazaprilat.,Cilazaprilat
DB00309,The risk or severity of peripheral neuropathy can be increased when Erythropoietin is combined with Vindesine.,Vindesine
DB00361,The risk or severity of peripheral neuropathy can be increased when Erythropoietin is combined with Vinorelbine.,Vinorelbine
DB00541,The risk or severity of peripheral neuropathy can be increased when Erythropoietin is combined with Vincristine.,Vincristine
DB00570,The risk or severity of peripheral neuropathy can be increased when Erythropoietin is combined with Vinblastine.,Vinblastine
DB05168,The risk or severity of peripheral neuropathy can be increased when Erythropoietin is combined with Vintafolide.,Vintafolide
DB11641,The risk or severity of peripheral neuropathy can be increased when Erythropoietin is combined with Vinflunine.,Vinflunine
DB13374,The risk or severity of peripheral neuropathy can be increased when Erythropoietin is combined with Vincamine.,Vincamine
DB00215,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Citalopram.,Citalopram
DB00472,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Fluoxetine.,Fluoxetine
DB00656,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Trazodone.,Trazodone
DB01104,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Sertraline.,Sertraline
DB01175,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Escitalopram.,Escitalopram
DB04832,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Zimelidine.,Zimelidine
DB04884,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Dapoxetine.,Dapoxetine
DB06731,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Seproxetine.,Seproxetine
DB08953,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Indalpine.,Indalpine
DB12693,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Ritanserin.,Ritanserin
DB13233,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Alaproclate.,Alaproclate
DB00715,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Paroxetine.,Paroxetine
DB00399,The risk or severity of hypocalcemia can be increased when Salmon calcitonin is combined with Zoledronic acid.,Zoledronic acid
DB00630,The risk or severity of hypocalcemia can be increased when Salmon calcitonin is combined with Alendronic acid.,Alendronic acid
DB00710,The risk or severity of hypocalcemia can be increased when Salmon calcitonin is combined with Ibandronate.,Ibandronate
DB00720,The risk or severity of hypocalcemia can be increased when Salmon calcitonin is combined with Clodronic acid.,Clodronic acid
DB00884,The risk or severity of hypocalcemia can be increased when Salmon calcitonin is combined with Risedronic acid.,Risedronic acid
DB01077,The risk or severity of hypocalcemia can be increased when Salmon calcitonin is combined with Etidronic acid.,Etidronic acid
DB06255,The risk or severity of hypocalcemia can be increased when Salmon calcitonin is combined with Incadronic acid.,Incadronic acid
DB00282,The risk or severity of hypocalcemia can be increased when Pamidronic acid is combined with Salmon calcitonin.,Pamidronic acid
DB01133,The risk or severity of hypocalcemia can be increased when Salmon calcitonin is combined with Tiludronic acid.,Tiludronic acid
DB01356,Salmon calcitonin may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy.,Lithium cation
DB14507,Salmon calcitonin may increase the excretion rate of Lithium citrate which could result in a lower serum level and potentially a reduction in efficacy.,Lithium citrate
DB14509,Salmon calcitonin may increase the excretion rate of Lithium carbonate which could result in a lower serum level and potentially a reduction in efficacy.,Lithium carbonate
DB14506,Salmon calcitonin may increase the excretion rate of Lithium hydroxide which could result in a lower serum level and potentially a reduction in efficacy.,Lithium hydroxide
DB00091,Cyclosporine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cyclosporine
DB00159,Icosapent may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Icosapent
DB00229,Cefotiam may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefotiam
DB00244,Mesalazine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Mesalazine
DB00267,Cefmenoxime may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefmenoxime
DB00274,Cefmetazole may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefmetazole
DB00300,Tenofovir disoproxil may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Tenofovir disoproxil
DB00328,Indomethacin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Indomethacin
DB00369,Cidofovir may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cidofovir
DB00384,Triamterene may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Triamterene
DB00430,Cefpiramide may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefpiramide
DB00438,Ceftazidime may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Ceftazidime
DB00447,Loracarbef may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Loracarbef
DB00456,Cefalotin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefalotin
DB00461,Nabumetone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Nabumetone
DB00465,Ketorolac may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Ketorolac
DB00469,Tenoxicam may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Tenoxicam
DB00482,Celecoxib may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Celecoxib
DB00493,Cefotaxime may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefotaxime
DB00500,Tolmetin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Tolmetin
DB00529,Foscarnet may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Foscarnet
DB00533,Rofecoxib may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Rofecoxib
DB00554,Piroxicam may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Piroxicam
DB00563,Methotrexate may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Methotrexate
DB00567,Cephalexin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cephalexin
DB00573,Fenoprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Fenoprofen
DB00577,Valaciclovir may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Valaciclovir
DB00580,Valdecoxib may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Valdecoxib
DB00586,Diclofenac may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Diclofenac
DB00605,Sulindac may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Sulindac
DB00626,Bacitracin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Bacitracin
DB00681,Amphotericin B may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Amphotericin B
DB00689,Cephaloglycin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cephaloglycin
DB00712,Flurbiprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Flurbiprofen
DB00718,Adefovir dipivoxil may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Adefovir dipivoxil
DB00738,Pentamidine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Pentamidine
DB00742,Mannitol may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Mannitol
DB00749,Etodolac may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Etodolac
DB00784,Mefenamic acid may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Mefenamic acid
DB00787,Acyclovir may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Acyclovir
DB00788,Naproxen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Naproxen
DB00795,Sulfasalazine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Sulfasalazine
DB00812,Phenylbutazone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Phenylbutazone
DB00814,Meloxicam may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Meloxicam
DB00821,Carprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Carprofen
DB00833,Cefaclor may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefaclor
DB00861,Diflunisal may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Diflunisal
DB00864,Tacrolimus may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Tacrolimus
DB00903,Etacrynic acid may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Etacrynic acid
DB00923,Ceforanide may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Ceforanide
DB00936,Salicylic acid may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Salicylic acid
DB00939,Meclofenamic acid may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Meclofenamic acid
DB00945,Acetylsalicylic acid may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Acetylsalicylic acid
DB00958,Carboplatin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Carboplatin
DB00991,Oxaprozin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Oxaprozin
DB00999,Hydrochlorothiazide may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Hydrochlorothiazide
DB01009,Ketoprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Ketoprofen
DB01014,Balsalazide may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Balsalazide
DB01050,Ibuprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Ibuprofen
DB01066,Cefditoren may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefditoren
DB01072,Atazanavir may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Atazanavir
DB01111,Colistimethate may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Colistimethate
DB01112,Cefuroxime may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefuroxime
DB01139,Cefapirin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefapirin
DB01140,Cefadroxil may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefadroxil
DB01150,Cefprozil may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefprozil
DB01212,Ceftriaxone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Ceftriaxone
DB01250,Olsalazine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Olsalazine
DB01283,Lumiracoxib may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Lumiracoxib
DB01326,Cefamandole may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefamandole
DB01327,Cefazolin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefazolin
DB01328,Cefonicid may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefonicid
DB01329,Cefoperazone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefoperazone
DB01330,Cefotetan may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefotetan
DB01331,Cefoxitin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefoxitin
DB01332,Ceftizoxime may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Ceftizoxime
DB01333,Cefradine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefradine
DB01397,Magnesium salicylate may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Magnesium salicylate
DB01399,Salsalate may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Salsalate
DB01401,Choline magnesium trisalicylate may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Choline magnesium trisalicylate
DB01413,Cefepime may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefepime
DB01414,Cefacetrile may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefacetrile
DB01415,Ceftibuten may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Ceftibuten
DB01416,Cefpodoxime may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefpodoxime
DB01419,Antrafenine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Antrafenine
DB01424,Aminophenazone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Aminophenazone
DB01435,Antipyrine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Antipyrine
DB01600,Tiaprofenic acid may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Tiaprofenic acid
DB01601,Lopinavir may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Lopinavir
DB01628,Etoricoxib may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Etoricoxib
DB02247,Hydrolyzed Cephalothin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Hydrolyzed Cephalothin
DB03450,Cephalothin Group may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cephalothin Group
DB03585,Oxyphenbutazone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Oxyphenbutazone
DB04552,Niflumic acid may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Niflumic acid
DB04570,Latamoxef may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Latamoxef
DB04743,Nimesulide may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Nimesulide
DB04812,Benoxaprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Benoxaprofen
DB04817,Metamizole may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Metamizole
DB04828,Zomepirac may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Zomepirac
DB04918,Ceftobiprole may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Ceftobiprole
DB05095,Cimicoxib may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cimicoxib
DB06590,Ceftaroline fosamil may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Ceftaroline fosamil
DB06725,Lornoxicam may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Lornoxicam
DB06736,Aceclofenac may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Aceclofenac
DB06737,Zaltoprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Zaltoprofen
DB07402,Azapropazone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Azapropazone
DB07477,Felbinac may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Felbinac
DB08439,Parecoxib may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Parecoxib
DB08797,Salicylamide may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Salicylamide
DB08940,Kebuzone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Kebuzone
DB08942,Isoxicam may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Isoxicam
DB08951,Indoprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Indoprofen
DB08955,Ibuproxam may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Ibuproxam
DB08976,Floctafenine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Floctafenine
DB08981,Fenbufen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Fenbufen
DB08984,Etofenamate may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Etofenamate
DB08991,Epirizole may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Epirizole
DB09008,Cefaloridine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefaloridine
DB09062,Cefminox may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefminox
DB09084,Benzydamine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Benzydamine
DB09212,Loxoprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Loxoprofen
DB09213,Dexibuprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Dexibuprofen
DB09214,Dexketoprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Dexketoprofen
DB09215,Droxicam may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Droxicam
DB09216,Tolfenamic acid may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Tolfenamic acid
DB09217,Firocoxib may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Firocoxib
DB09218,Clonixin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Clonixin
DB09285,Morniflumate may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Morniflumate
DB09288,Propacetamol may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Propacetamol
DB09295,Talniflumate may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Talniflumate
DB09299,Tenofovir alafenamide may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Tenofovir alafenamide
DB11367,Cefroxadine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefroxadine
DB11455,Robenacoxib may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Robenacoxib
DB11466,Tepoxalin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Tepoxalin
DB11518,Flunixin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Flunixin
DB11935,Flomoxef may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Flomoxef
DB12151,Brincidofovir may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Brincidofovir
DB12445,Nitroaspirin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Nitroaspirin
DB12545,Indobufen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Indobufen
DB13001,Tinoridine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Tinoridine
DB13167,Alclofenac may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Alclofenac
DB13217,Fentiazac may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Fentiazac
DB13232,Suxibuzone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Suxibuzone
DB13266,Cefatrizine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefatrizine
DB13286,Bumadizone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Bumadizone
DB13314,Alminoprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Alminoprofen
DB13317,Flunoxaprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Flunoxaprofen
DB13364,Feprazone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Feprazone
DB13371,Difenpiramide may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Difenpiramide
DB13407,Nifenazone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Nifenazone
DB13432,Lonazolac may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Lonazolac
DB13461,Cefcapene may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefcapene
DB13470,Cefodizime may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefodizime
DB13481,Tenidap may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Tenidap
DB13499,Cefsulodin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefsulodin
DB13501,Bendazac may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Bendazac
DB13504,Cefetamet may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefetamet
DB13514,Pranoprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Pranoprofen
DB13524,Propyphenazone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Propyphenazone
DB13527,Proglumetacin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Proglumetacin
DB13538,Guacetisal may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Guacetisal
DB13544,Ethenzamide may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Ethenzamide
DB13612,Carbaspirin calcium may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Carbaspirin calcium
DB13629,Mofebutazone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Mofebutazone
DB13638,Cefbuperazone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefbuperazone
DB13649,Proquazone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Proquazone
DB13657,Benorilate may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Benorilate
DB13667,Cefozopran may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefozopran
DB13682,Cefpirome may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefpirome
DB13722,Pirprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Pirprofen
DB13778,Cefazedone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Cefazedone
DB13783,Acemetacin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Acemetacin
DB13821,Ceftezole may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Ceftezole
DB13860,Imidazole salicylate may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Imidazole salicylate
DB13868,Adefovir may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Adefovir
DB14059,SC-236 may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,SC-236
DB14060,NS-398 may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,NS-398
DB14126,Tenofovir may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Tenofovir
DB14713,Inotersen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Inotersen
DB01438,Phenazopyridine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Phenazopyridine
DB15066,Givosiran may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Givosiran
DB00007,Leuprolide may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Leuprolide
DB00014,Goserelin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Goserelin
DB00035,Salmon calcitonin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Desmopressin
DB00080,Salmon calcitonin may decrease the excretion rate of Daptomycin which could result in a higher serum level.,Daptomycin
DB00081,Salmon calcitonin may decrease the excretion rate of Tositumomab which could result in a higher serum level.,Tositumomab
DB00115,Salmon calcitonin may decrease the excretion rate of Cyanocobalamin which could result in a higher serum level.,Cyanocobalamin
DB00158,Salmon calcitonin may decrease the excretion rate of Folic acid which could result in a higher serum level.,Folic acid
DB00165,Salmon calcitonin may decrease the excretion rate of Pyridoxine which could result in a higher serum level.,Pyridoxine
DB00176,Salmon calcitonin may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.,Fluvoxamine
DB00181,Salmon calcitonin may decrease the excretion rate of Baclofen which could result in a higher serum level.,Baclofen
DB00185,Salmon calcitonin may decrease the excretion rate of Cevimeline which could result in a higher serum level.,Cevimeline
DB00186,Salmon calcitonin may decrease the excretion rate of Lorazepam which could result in a higher serum level.,Lorazepam
DB00190,Salmon calcitonin may decrease the excretion rate of Carbidopa which could result in a higher serum level.,Carbidopa
DB00193,Salmon calcitonin may decrease the excretion rate of Tramadol which could result in a higher serum level.,Tramadol
DB00196,Salmon calcitonin may decrease the excretion rate of Fluconazole which could result in a higher serum level.,Fluconazole
DB00198,Salmon calcitonin may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,Oseltamivir
DB00200,Salmon calcitonin may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,Hydroxocobalamin
DB00206,Salmon calcitonin may decrease the excretion rate of Reserpine which could result in a higher serum level.,Reserpine
DB00208,Salmon calcitonin may decrease the excretion rate of Ticlopidine which could result in a higher serum level.,Ticlopidine
DB00213,Salmon calcitonin may decrease the excretion rate of Pantoprazole which could result in a higher serum level.,Pantoprazole
DB00225,Salmon calcitonin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,Gadodiamide
DB00230,Salmon calcitonin may decrease the excretion rate of Pregabalin which could result in a higher serum level.,Pregabalin
DB00231,Salmon calcitonin may decrease the excretion rate of Temazepam which could result in a higher serum level.,Temazepam
DB00235,Salmon calcitonin may decrease the excretion rate of Milrinone which could result in a higher serum level.,Milrinone
DB00237,Salmon calcitonin may decrease the excretion rate of Butabarbital which could result in a higher serum level.,Butabarbital
DB00243,Salmon calcitonin may decrease the excretion rate of Ranolazine which could result in a higher serum level.,Ranolazine
DB00245,Salmon calcitonin may decrease the excretion rate of Benzatropine which could result in a higher serum level.,Benzatropine
DB00254,Salmon calcitonin may decrease the excretion rate of Doxycycline which could result in a higher serum level.,Doxycycline
DB00262,Salmon calcitonin may decrease the excretion rate of Carmustine which could result in a higher serum level.,Carmustine
DB00264,Salmon calcitonin may decrease the excretion rate of Metoprolol which could result in a higher serum level.,Metoprolol
DB00270,Salmon calcitonin may decrease the excretion rate of Isradipine which could result in a higher serum level.,Isradipine
DB00271,Salmon calcitonin may decrease the excretion rate of Diatrizoate which could result in a higher serum level.,Diatrizoate
DB00273,Salmon calcitonin may decrease the excretion rate of Topiramate which could result in a higher serum level.,Topiramate
DB00279,Salmon calcitonin may decrease the excretion rate of Liothyronine which could result in a higher serum level.,Liothyronine
DB00280,Salmon calcitonin may decrease the excretion rate of Disopyramide which could result in a higher serum level.,Disopyramide
DB00284,Salmon calcitonin may decrease the excretion rate of Acarbose which could result in a higher serum level.,Acarbose
DB00285,Salmon calcitonin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,Venlafaxine
DB00286,Salmon calcitonin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.,Conjugated estrogens
DB00289,Salmon calcitonin may decrease the excretion rate of Atomoxetine which could result in a higher serum level.,Atomoxetine
DB00290,Salmon calcitonin may decrease the excretion rate of Bleomycin which could result in a higher serum level.,Bleomycin
DB00292,Salmon calcitonin may decrease the excretion rate of Etomidate which could result in a higher serum level.,Etomidate
DB00294,Salmon calcitonin may decrease the excretion rate of Etonogestrel which could result in a higher serum level.,Etonogestrel
DB00296,Salmon calcitonin may decrease the excretion rate of Ropivacaine which could result in a higher serum level.,Ropivacaine
DB00303,Salmon calcitonin may decrease the excretion rate of Ertapenem which could result in a higher serum level.,Ertapenem
DB00308,Salmon calcitonin may decrease the excretion rate of Ibutilide which could result in a higher serum level.,Ibutilide
DB00312,Salmon calcitonin may decrease the excretion rate of Pentobarbital which could result in a higher serum level.,Pentobarbital
DB00316,Salmon calcitonin may decrease the excretion rate of Acetaminophen which could result in a higher serum level.,Acetaminophen
DB00319,Salmon calcitonin may decrease the excretion rate of Piperacillin which could result in a higher serum level.,Piperacillin
DB00322,Salmon calcitonin may decrease the excretion rate of Floxuridine which could result in a higher serum level.,Floxuridine
DB00323,Salmon calcitonin may decrease the excretion rate of Tolcapone which could result in a higher serum level.,Tolcapone
DB00325,Salmon calcitonin may decrease the excretion rate of Nitroprusside which could result in a higher serum level.,Nitroprusside
DB00327,Salmon calcitonin may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,Hydromorphone
DB00330,Salmon calcitonin may decrease the excretion rate of Ethambutol which could result in a higher serum level.,Ethambutol
DB00331,Salmon calcitonin may decrease the excretion rate of Metformin which could result in a higher serum level.,Metformin
DB00333,Salmon calcitonin may decrease the excretion rate of Methadone which could result in a higher serum level.,Methadone
DB00339,Salmon calcitonin may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.,Pyrazinamide
DB00341,Salmon calcitonin may decrease the excretion rate of Cetirizine which could result in a higher serum level.,Cetirizine
DB00349,Salmon calcitonin may decrease the excretion rate of Clobazam which could result in a higher serum level.,Clobazam
DB00351,Salmon calcitonin may decrease the excretion rate of Megestrol acetate which could result in a higher serum level.,Megestrol acetate
DB00355,Salmon calcitonin may decrease the excretion rate of Aztreonam which could result in a higher serum level.,Aztreonam
DB00356,Salmon calcitonin may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.,Chlorzoxazone
DB00359,Salmon calcitonin may decrease the excretion rate of Sulfadiazine which could result in a higher serum level.,Sulfadiazine
DB00363,Salmon calcitonin may decrease the excretion rate of Clozapine which could result in a higher serum level.,Clozapine
DB00364,Salmon calcitonin may decrease the excretion rate of Sucralfate which could result in a higher serum level.,Sucralfate
DB00372,Salmon calcitonin may decrease the excretion rate of Thiethylperazine which could result in a higher serum level.,Thiethylperazine
DB00373,Salmon calcitonin may decrease the excretion rate of Timolol which could result in a higher serum level.,Timolol
DB00377,Salmon calcitonin may decrease the excretion rate of Palonosetron which could result in a higher serum level.,Palonosetron
DB00380,Salmon calcitonin may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.,Dexrazoxane
DB00401,Salmon calcitonin may decrease the excretion rate of Nisoldipine which could result in a higher serum level.,Nisoldipine
DB00402,Salmon calcitonin may decrease the excretion rate of Eszopiclone which could result in a higher serum level.,Eszopiclone
DB00404,Salmon calcitonin may decrease the excretion rate of Alprazolam which could result in a higher serum level.,Alprazolam
DB00412,Salmon calcitonin may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.,Rosiglitazone
DB00413,Salmon calcitonin may decrease the excretion rate of Pramipexole which could result in a higher serum level.,Pramipexole
DB00415,Salmon calcitonin may decrease the excretion rate of Ampicillin which could result in a higher serum level.,Ampicillin
DB00418,Salmon calcitonin may decrease the excretion rate of Secobarbital which could result in a higher serum level.,Secobarbital
DB00422,Salmon calcitonin may decrease the excretion rate of Methylphenidate which could result in a higher serum level.,Methylphenidate
DB00432,Salmon calcitonin may decrease the excretion rate of Trifluridine which could result in a higher serum level.,Trifluridine
DB00435,Salmon calcitonin may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.,Nitric Oxide
DB00437,Salmon calcitonin may decrease the excretion rate of Allopurinol which could result in a higher serum level.,Allopurinol
DB00440,Salmon calcitonin may decrease the excretion rate of Trimethoprim which could result in a higher serum level.,Trimethoprim
DB00441,Salmon calcitonin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,Gemcitabine
DB00476,Salmon calcitonin may decrease the excretion rate of Duloxetine which could result in a higher serum level.,Duloxetine
DB00477,Salmon calcitonin may decrease the excretion rate of Chlorpromazine which could result in a higher serum level.,Chlorpromazine
DB00480,Salmon calcitonin may decrease the excretion rate of Lenalidomide which could result in a higher serum level.,Lenalidomide
DB00490,Salmon calcitonin may decrease the excretion rate of Buspirone which could result in a higher serum level.,Buspirone
DB00492,Salmon calcitonin may decrease the excretion rate of Fosinopril which could result in a higher serum level.,Fosinopril
DB00499,Salmon calcitonin may decrease the excretion rate of Flutamide which could result in a higher serum level.,Flutamide
DB00501,Salmon calcitonin may decrease the excretion rate of Cimetidine which could result in a higher serum level.,Cimetidine
DB00502,Salmon calcitonin may decrease the excretion rate of Haloperidol which could result in a higher serum level.,Haloperidol
DB00535,Salmon calcitonin may decrease the excretion rate of Cefdinir which could result in a higher serum level.,Cefdinir
DB00537,Salmon calcitonin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.,Ciprofloxacin
DB00548,Salmon calcitonin may decrease the excretion rate of Azelaic acid which could result in a higher serum level.,Azelaic acid
DB00553,Salmon calcitonin may decrease the excretion rate of Methoxsalen which could result in a higher serum level.,Methoxsalen
DB00555,Salmon calcitonin may decrease the excretion rate of Lamotrigine which could result in a higher serum level.,Lamotrigine
DB00558,Salmon calcitonin may decrease the excretion rate of Zanamivir which could result in a higher serum level.,Zanamivir
DB00569,Salmon calcitonin may decrease the excretion rate of Fondaparinux which could result in a higher serum level.,Fondaparinux
DB00571,Salmon calcitonin may decrease the excretion rate of Propranolol which could result in a higher serum level.,Propranolol
DB00583,Salmon calcitonin may decrease the excretion rate of Levocarnitine which could result in a higher serum level.,Levocarnitine
DB00591,Salmon calcitonin may decrease the excretion rate of Fluocinolone acetonide which could result in a higher serum level.,Fluocinolone acetonide
DB00597,Salmon calcitonin may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,Gadoteridol
DB00603,Salmon calcitonin may decrease the excretion rate of Medroxyprogesterone acetate which could result in a higher serum level.,Medroxyprogesterone acetate
DB00608,Salmon calcitonin may decrease the excretion rate of Chloroquine which could result in a higher serum level.,Chloroquine
DB00612,Salmon calcitonin may decrease the excretion rate of Bisoprolol which could result in a higher serum level.,Bisoprolol
DB00624,Salmon calcitonin may decrease the excretion rate of Testosterone which could result in a higher serum level.,Testosterone
DB00628,Salmon calcitonin may decrease the excretion rate of Clorazepic acid which could result in a higher serum level.,Clorazepic acid
DB00631,Salmon calcitonin may decrease the excretion rate of Clofarabine which could result in a higher serum level.,Clofarabine
DB00633,Salmon calcitonin may decrease the excretion rate of Dexmedetomidine which could result in a higher serum level.,Dexmedetomidine
DB00635,Salmon calcitonin may decrease the excretion rate of Prednisone which could result in a higher serum level.,Prednisone
DB00651,Salmon calcitonin may decrease the excretion rate of Dyphylline which could result in a higher serum level.,Dyphylline
DB00657,Salmon calcitonin may decrease the excretion rate of Mecamylamine which could result in a higher serum level.,Mecamylamine
DB00660,Salmon calcitonin may decrease the excretion rate of Metaxalone which could result in a higher serum level.,Metaxalone
DB00661,Salmon calcitonin may decrease the excretion rate of Verapamil which could result in a higher serum level.,Verapamil
DB00665,Salmon calcitonin may decrease the excretion rate of Nilutamide which could result in a higher serum level.,Nilutamide
DB00669,Salmon calcitonin may decrease the excretion rate of Sumatriptan which could result in a higher serum level.,Sumatriptan
DB00683,Salmon calcitonin may decrease the excretion rate of Midazolam which could result in a higher serum level.,Midazolam
DB00688,Salmon calcitonin may decrease the excretion rate of Mycophenolate mofetil which could result in a higher serum level.,Mycophenolate mofetil
DB00690,Salmon calcitonin may decrease the excretion rate of Flurazepam which could result in a higher serum level.,Flurazepam
DB00692,Salmon calcitonin may decrease the excretion rate of Phentolamine which could result in a higher serum level.,Phentolamine
DB00698,Salmon calcitonin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.,Nitrofurantoin
DB00706,Salmon calcitonin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.,Tamsulosin
DB00709,Salmon calcitonin may decrease the excretion rate of Lamivudine which could result in a higher serum level.,Lamivudine
DB00713,Salmon calcitonin may decrease the excretion rate of Oxacillin which could result in a higher serum level.,Oxacillin
DB00716,Salmon calcitonin may decrease the excretion rate of Nedocromil which could result in a higher serum level.,Nedocromil
DB00722,Salmon calcitonin may decrease the excretion rate of Lisinopril which could result in a higher serum level.,Lisinopril
DB00730,Salmon calcitonin may decrease the excretion rate of Thiabendazole which could result in a higher serum level.,Thiabendazole
DB00731,Salmon calcitonin may decrease the excretion rate of Nateglinide which could result in a higher serum level.,Nateglinide
DB00733,Salmon calcitonin may decrease the excretion rate of Pralidoxime which could result in a higher serum level.,Pralidoxime
DB00743,Salmon calcitonin may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,Gadobenic acid
DB00759,Salmon calcitonin may decrease the excretion rate of Tetracycline which could result in a higher serum level.,Tetracycline
DB00760,Salmon calcitonin may decrease the excretion rate of Meropenem which could result in a higher serum level.,Meropenem
DB00761,Salmon calcitonin may decrease the excretion rate of Potassium chloride which could result in a higher serum level.,Potassium chloride
DB00763,Salmon calcitonin may decrease the excretion rate of Methimazole which could result in a higher serum level.,Methimazole
DB00775,Salmon calcitonin may decrease the excretion rate of Tirofiban which could result in a higher serum level.,Tirofiban
DB00780,Salmon calcitonin may decrease the excretion rate of Phenelzine which could result in a higher serum level.,Phenelzine
DB00782,Salmon calcitonin may decrease the excretion rate of Propantheline which could result in a higher serum level.,Propantheline
DB00783,Salmon calcitonin may decrease the excretion rate of Estradiol which could result in a higher serum level.,Estradiol
DB00789,Salmon calcitonin may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,Gadopentetic acid
DB00790,Salmon calcitonin may decrease the excretion rate of Perindopril which could result in a higher serum level.,Perindopril
DB00800,Salmon calcitonin may decrease the excretion rate of Fenoldopam which could result in a higher serum level.,Fenoldopam
DB00804,Salmon calcitonin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.,Dicyclomine
DB00806,Salmon calcitonin may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.,Pentoxifylline
DB00811,Salmon calcitonin may decrease the excretion rate of Ribavirin which could result in a higher serum level.,Ribavirin
DB00820,Salmon calcitonin may decrease the excretion rate of Tadalafil which could result in a higher serum level.,Tadalafil
DB00828,Salmon calcitonin may decrease the excretion rate of Fosfomycin which could result in a higher serum level.,Fosfomycin
DB00842,Salmon calcitonin may decrease the excretion rate of Oxazepam which could result in a higher serum level.,Oxazepam
DB00851,Salmon calcitonin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.,Dacarbazine
DB00853,Salmon calcitonin may decrease the excretion rate of Temozolomide which could result in a higher serum level.,Temozolomide
DB00863,Salmon calcitonin may decrease the excretion rate of Ranitidine which could result in a higher serum level.,Ranitidine
DB00894,Salmon calcitonin may decrease the excretion rate of Testolactone which could result in a higher serum level.,Testolactone
DB00897,Salmon calcitonin may decrease the excretion rate of Triazolam which could result in a higher serum level.,Triazolam
DB00900,Salmon calcitonin may decrease the excretion rate of Didanosine which could result in a higher serum level.,Didanosine
DB00911,Salmon calcitonin may decrease the excretion rate of Tinidazole which could result in a higher serum level.,Tinidazole
DB00915,Salmon calcitonin may decrease the excretion rate of Amantadine which could result in a higher serum level.,Amantadine
DB00918,Salmon calcitonin may decrease the excretion rate of Almotriptan which could result in a higher serum level.,Almotriptan
DB00928,Salmon calcitonin may decrease the excretion rate of Azacitidine which could result in a higher serum level.,Azacitidine
DB00934,Salmon calcitonin may decrease the excretion rate of Maprotiline which could result in a higher serum level.,Maprotiline
DB00951,Salmon calcitonin may decrease the excretion rate of Isoniazid which could result in a higher serum level.,Isoniazid
DB00953,Salmon calcitonin may decrease the excretion rate of Rizatriptan which could result in a higher serum level.,Rizatriptan
DB00960,Salmon calcitonin may decrease the excretion rate of Pindolol which could result in a higher serum level.,Pindolol
DB00961,Salmon calcitonin may decrease the excretion rate of Mepivacaine which could result in a higher serum level.,Mepivacaine
DB00962,Salmon calcitonin may decrease the excretion rate of Zaleplon which could result in a higher serum level.,Zaleplon
DB00968,Salmon calcitonin may decrease the excretion rate of Methyldopa which could result in a higher serum level.,Methyldopa
DB00980,Salmon calcitonin may decrease the excretion rate of Ramelteon which could result in a higher serum level.,Ramelteon
DB00993,Salmon calcitonin may decrease the excretion rate of Azathioprine which could result in a higher serum level.,Azathioprine
DB00995,Salmon calcitonin may decrease the excretion rate of Auranofin which could result in a higher serum level.,Auranofin
DB01001,Salmon calcitonin may decrease the excretion rate of Salbutamol which could result in a higher serum level.,Salbutamol
DB01002,Salmon calcitonin may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.,Levobupivacaine
DB01004,Salmon calcitonin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,Ganciclovir
DB01010,Salmon calcitonin may decrease the excretion rate of Edrophonium which could result in a higher serum level.,Edrophonium
DB01011,Salmon calcitonin may decrease the excretion rate of Metyrapone which could result in a higher serum level.,Metyrapone
DB01015,Salmon calcitonin may decrease the excretion rate of Sulfamethoxazole which could result in a higher serum level.,Sulfamethoxazole
DB01018,Salmon calcitonin may decrease the excretion rate of Guanfacine which could result in a higher serum level.,Guanfacine
DB01020,Salmon calcitonin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.,Isosorbide mononitrate
DB01022,Salmon calcitonin may decrease the excretion rate of Phylloquinone which could result in a higher serum level.,Phylloquinone
DB01024,Salmon calcitonin may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.,Mycophenolic acid
DB01030,Salmon calcitonin may decrease the excretion rate of Topotecan which could result in a higher serum level.,Topotecan
DB01032,Salmon calcitonin may decrease the excretion rate of Probenecid which could result in a higher serum level.,Probenecid
DB01036,Salmon calcitonin may decrease the excretion rate of Tolterodine which could result in a higher serum level.,Tolterodine
DB01039,Salmon calcitonin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.,Fenofibrate
DB01043,Salmon calcitonin may decrease the excretion rate of Memantine which could result in a higher serum level.,Memantine
DB01046,Salmon calcitonin may decrease the excretion rate of Lubiprostone which could result in a higher serum level.,Lubiprostone
DB01048,Salmon calcitonin may decrease the excretion rate of Abacavir which could result in a higher serum level.,Abacavir
DB01060,Salmon calcitonin may decrease the excretion rate of Amoxicillin which could result in a higher serum level.,Amoxicillin
DB01068,Salmon calcitonin may decrease the excretion rate of Clonazepam which could result in a higher serum level.,Clonazepam
DB01069,Salmon calcitonin may decrease the excretion rate of Promethazine which could result in a higher serum level.,Promethazine
DB01093,Salmon calcitonin may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.,Dimethyl sulfoxide
DB01099,Salmon calcitonin may decrease the excretion rate of Flucytosine which could result in a higher serum level.,Flucytosine
DB01101,Salmon calcitonin may decrease the excretion rate of Capecitabine which could result in a higher serum level.,Capecitabine
DB01105,Salmon calcitonin may decrease the excretion rate of Sibutramine which could result in a higher serum level.,Sibutramine
DB01115,Salmon calcitonin may decrease the excretion rate of Nifedipine which could result in a higher serum level.,Nifedipine
DB01129,Salmon calcitonin may decrease the excretion rate of Rabeprazole which could result in a higher serum level.,Rabeprazole
DB01135,Salmon calcitonin may decrease the excretion rate of Doxacurium which could result in a higher serum level.,Doxacurium
DB01137,Salmon calcitonin may decrease the excretion rate of Levofloxacin which could result in a higher serum level.,Levofloxacin
DB01148,Salmon calcitonin may decrease the excretion rate of Flavoxate which could result in a higher serum level.,Flavoxate
DB01149,Salmon calcitonin may decrease the excretion rate of Nefazodone which could result in a higher serum level.,Nefazodone
DB01156,Salmon calcitonin may decrease the excretion rate of Bupropion which could result in a higher serum level.,Bupropion
DB01157,Salmon calcitonin may decrease the excretion rate of Trimetrexate which could result in a higher serum level.,Trimetrexate
DB01166,Salmon calcitonin may decrease the excretion rate of Cilostazol which could result in a higher serum level.,Cilostazol
DB01169,Salmon calcitonin may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.,Arsenic trioxide
DB01170,Salmon calcitonin may decrease the excretion rate of Guanethidine which could result in a higher serum level.,Guanethidine
DB01181,Salmon calcitonin may decrease the excretion rate of Ifosfamide which could result in a higher serum level.,Ifosfamide
DB01183,Salmon calcitonin may decrease the excretion rate of Naloxone which could result in a higher serum level.,Naloxone
DB01203,Salmon calcitonin may decrease the excretion rate of Nadolol which could result in a higher serum level.,Nadolol
DB01205,Salmon calcitonin may decrease the excretion rate of Flumazenil which could result in a higher serum level.,Flumazenil
DB01213,Salmon calcitonin may decrease the excretion rate of Fomepizole which could result in a higher serum level.,Fomepizole
DB01215,Salmon calcitonin may decrease the excretion rate of Estazolam which could result in a higher serum level.,Estazolam
DB01221,Salmon calcitonin may decrease the excretion rate of Ketamine which could result in a higher serum level.,Ketamine
DB01222,Salmon calcitonin may decrease the excretion rate of Budesonide which could result in a higher serum level.,Budesonide
DB01224,Salmon calcitonin may decrease the excretion rate of Quetiapine which could result in a higher serum level.,Quetiapine
DB01240,Salmon calcitonin may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,Epoprostenol
DB01241,Salmon calcitonin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,Gemfibrozil
DB01249,Salmon calcitonin may decrease the excretion rate of Iodixanol which could result in a higher serum level.,Iodixanol
DB01261,Salmon calcitonin may decrease the excretion rate of Sitagliptin which could result in a higher serum level.,Sitagliptin
DB01267,Salmon calcitonin may decrease the excretion rate of Paliperidone which could result in a higher serum level.,Paliperidone
DB01273,Salmon calcitonin may decrease the excretion rate of Varenicline which could result in a higher serum level.,Varenicline
DB01274,Salmon calcitonin may decrease the excretion rate of Arformoterol which could result in a higher serum level.,Arformoterol
DB01275,Salmon calcitonin may decrease the excretion rate of Hydralazine which could result in a higher serum level.,Hydralazine
DB01359,Salmon calcitonin may decrease the excretion rate of Penbutolol which could result in a higher serum level.,Penbutolol
DB01367,Salmon calcitonin may decrease the excretion rate of Rasagiline which could result in a higher serum level.,Rasagiline
DB01394,Salmon calcitonin may decrease the excretion rate of Colchicine which could result in a higher serum level.,Colchicine
DB01409,Salmon calcitonin may decrease the excretion rate of Tiotropium which could result in a higher serum level.,Tiotropium
DB01420,Salmon calcitonin may decrease the excretion rate of Testosterone propionate which could result in a higher serum level.,Testosterone propionate
DB01427,Salmon calcitonin may decrease the excretion rate of Amrinone which could result in a higher serum level.,Amrinone
DB01428,Salmon calcitonin may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,Oxybenzone
DB01431,Salmon calcitonin may decrease the excretion rate of Allylestrenol which could result in a higher serum level.,Allylestrenol
DB01550,Salmon calcitonin may decrease the excretion rate of Fenproporex which could result in a higher serum level.,Fenproporex
DB01558,Salmon calcitonin may decrease the excretion rate of Bromazepam which could result in a higher serum level.,Bromazepam
DB01563,Salmon calcitonin may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.,Chloral hydrate
DB01587,Salmon calcitonin may decrease the excretion rate of Ketazolam which could result in a higher serum level.,Ketazolam
DB01610,Salmon calcitonin may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,Valganciclovir
DB01638,Salmon calcitonin may decrease the excretion rate of Sorbitol which could result in a higher serum level.,Sorbitol
DB01656,Salmon calcitonin may decrease the excretion rate of Roflumilast which could result in a higher serum level.,Roflumilast
DB01685,Salmon calcitonin may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,Topiroxostat
DB04574,Salmon calcitonin may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.,Estrone sulfate
DB04871,Salmon calcitonin may decrease the excretion rate of Lorcaserin which could result in a higher serum level.,Lorcaserin
DB04895,Salmon calcitonin may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,Pegaptanib
DB04896,Salmon calcitonin may decrease the excretion rate of Milnacipran which could result in a higher serum level.,Milnacipran
DB04920,Salmon calcitonin may decrease the excretion rate of Clevidipine which could result in a higher serum level.,Clevidipine
DB04948,Salmon calcitonin may decrease the excretion rate of Lofexidine which could result in a higher serum level.,Lofexidine
DB04953,Salmon calcitonin may decrease the excretion rate of Ezogabine which could result in a higher serum level.,Ezogabine
DB05018,Salmon calcitonin may decrease the excretion rate of Migalastat which could result in a higher serum level.,Migalastat
DB05541,Salmon calcitonin may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,Brivaracetam
DB05676,Salmon calcitonin may decrease the excretion rate of Apremilast which could result in a higher serum level.,Apremilast
DB06154,Salmon calcitonin may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,Pentaerythritol tetranitrate
DB06186,Salmon calcitonin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,Ipilimumab
DB06196,Salmon calcitonin may decrease the excretion rate of Icatibant which could result in a higher serum level.,Icatibant
DB06203,Salmon calcitonin may decrease the excretion rate of Alogliptin which could result in a higher serum level.,Alogliptin
DB06209,Salmon calcitonin may decrease the excretion rate of Prasugrel which could result in a higher serum level.,Prasugrel
DB06211,Salmon calcitonin may decrease the excretion rate of Doripenem which could result in a higher serum level.,Doripenem
DB06228,Salmon calcitonin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.,Rivaroxaban
DB06230,Salmon calcitonin may decrease the excretion rate of Nalmefene which could result in a higher serum level.,Nalmefene
DB06262,Salmon calcitonin may decrease the excretion rate of Droxidopa which could result in a higher serum level.,Droxidopa
DB06282,Salmon calcitonin may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,Levocetirizine
DB06335,Salmon calcitonin may decrease the excretion rate of Saxagliptin which could result in a higher serum level.,Saxagliptin
DB06402,Salmon calcitonin may decrease the excretion rate of Telavancin which could result in a higher serum level.,Telavancin
DB06480,Salmon calcitonin may decrease the excretion rate of Prucalopride which could result in a higher serum level.,Prucalopride
DB06623,Salmon calcitonin may decrease the excretion rate of Flupirtine which could result in a higher serum level.,Flupirtine
DB06637,Salmon calcitonin may decrease the excretion rate of Dalfampridine which could result in a higher serum level.,Dalfampridine
DB06695,Salmon calcitonin may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.,Dabigatran etexilate
DB06700,Salmon calcitonin may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.,Desvenlafaxine
DB06702,Salmon calcitonin may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,Fesoterodine
DB06705,Salmon calcitonin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,Gadofosveset trisodium
DB06710,Salmon calcitonin may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,Methyltestosterone
DB06767,Salmon calcitonin may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.,Ammonium chloride
DB06782,Salmon calcitonin may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,Dimercaprol
DB06796,Salmon calcitonin may decrease the excretion rate of Mangafodipir which could result in a higher serum level.,Mangafodipir
DB06800,Salmon calcitonin may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,Methylnaltrexone
DB06809,Salmon calcitonin may decrease the excretion rate of Plerixafor which could result in a higher serum level.,Plerixafor
DB06813,Salmon calcitonin may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,Pralatrexate
DB06823,Salmon calcitonin may decrease the excretion rate of Tiopronin which could result in a higher serum level.,Tiopronin
DB06824,Salmon calcitonin may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,Triethylenetetramine
DB08824,Salmon calcitonin may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.,Ioflupane I-123
DB08826,Salmon calcitonin may decrease the excretion rate of Deferiprone which could result in a higher serum level.,Deferiprone
DB08840,Salmon calcitonin may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,N-methylnicotinamide
DB08872,Salmon calcitonin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,Gabapentin enacarbil
DB08893,Salmon calcitonin may decrease the excretion rate of Mirabegron which could result in a higher serum level.,Mirabegron
DB08894,Salmon calcitonin may decrease the excretion rate of Peginesatide which could result in a higher serum level.,Peginesatide
DB08897,Salmon calcitonin may decrease the excretion rate of Aclidinium which could result in a higher serum level.,Aclidinium
DB08899,Salmon calcitonin may decrease the excretion rate of Enzalutamide which could result in a higher serum level.,Enzalutamide
DB08900,Salmon calcitonin may decrease the excretion rate of Teduglutide which could result in a higher serum level.,Teduglutide
DB08904,Salmon calcitonin may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,Certolizumab pegol
DB08905,Salmon calcitonin may decrease the excretion rate of Formestane which could result in a higher serum level.,Formestane
DB08909,Salmon calcitonin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,Glycerol phenylbutyrate
DB08910,Salmon calcitonin may decrease the excretion rate of Pomalidomide which could result in a higher serum level.,Pomalidomide
DB08911,Salmon calcitonin may decrease the excretion rate of Trametinib which could result in a higher serum level.,Trametinib
DB08918,Salmon calcitonin may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.,Levomilnacipran
DB08932,Salmon calcitonin may decrease the excretion rate of Macitentan which could result in a higher serum level.,Macitentan
DB08934,Salmon calcitonin may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,Sofosbuvir
DB08964,Salmon calcitonin may decrease the excretion rate of Gemeprost which could result in a higher serum level.,Gemeprost
DB09027,Salmon calcitonin may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,Ledipasvir
DB09050,Salmon calcitonin may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,Ceftolozane
DB09066,Salmon calcitonin may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,Corifollitropin alfa
DB09068,Salmon calcitonin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,Vortioxetine
DB09071,Salmon calcitonin may decrease the excretion rate of Tasimelteon which could result in a higher serum level.,Tasimelteon
DB09075,Salmon calcitonin may decrease the excretion rate of Edoxaban which could result in a higher serum level.,Edoxaban
DB09081,Salmon calcitonin may decrease the excretion rate of Idebenone which could result in a higher serum level.,Idebenone
DB09082,Salmon calcitonin may decrease the excretion rate of Vilanterol which could result in a higher serum level.,Vilanterol
DB09089,Salmon calcitonin may decrease the excretion rate of Trimebutine which could result in a higher serum level.,Trimebutine
DB09091,Salmon calcitonin may decrease the excretion rate of Tixocortol which could result in a higher serum level.,Tixocortol
DB09103,Salmon calcitonin may decrease the excretion rate of Ancestim which could result in a higher serum level.,Ancestim
DB09104,Salmon calcitonin may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.,Magnesium hydroxide
DB09106,Salmon calcitonin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,Hydroxyethyl Starch
DB09111,Salmon calcitonin may decrease the excretion rate of Pentastarch which could result in a higher serum level.,Pentastarch
DB09118,Salmon calcitonin may decrease the excretion rate of Stiripentol which could result in a higher serum level.,Stiripentol
DB09121,Salmon calcitonin may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.,Aurothioglucose
DB09123,Salmon calcitonin may decrease the excretion rate of Dienogest which could result in a higher serum level.,Dienogest
DB09129,Salmon calcitonin may decrease the excretion rate of Chromic chloride which could result in a higher serum level.,Chromic chloride
DB09132,Salmon calcitonin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,Gadoteric acid
DB09133,Salmon calcitonin may decrease the excretion rate of Iothalamic acid which could result in a higher serum level.,Iothalamic acid
DB09134,Salmon calcitonin may decrease the excretion rate of Ioversol which could result in a higher serum level.,Ioversol
DB09135,Salmon calcitonin may decrease the excretion rate of Ioxilan which could result in a higher serum level.,Ioxilan
DB09136,Salmon calcitonin may decrease the excretion rate of Isosulfan blue which could result in a higher serum level.,Isosulfan blue
DB09137,Salmon calcitonin may decrease the excretion rate of Technetium Tc-99m mebrofenin which could result in a higher serum level.,Technetium Tc-99m mebrofenin
DB09139,Salmon calcitonin may decrease the excretion rate of Technetium Tc-99m oxidronate which could result in a higher serum level.,Technetium Tc-99m oxidronate
DB09148,Salmon calcitonin may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.,Florbetaben (18F)
DB09149,Salmon calcitonin may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.,Florbetapir (18F)
DB09156,Salmon calcitonin may decrease the excretion rate of Iopromide which could result in a higher serum level.,Iopromide
DB09163,Salmon calcitonin may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.,Technetium Tc-99m exametazime
DB09165,Salmon calcitonin may decrease the excretion rate of Technetium Tc-99m pyrophosphate which could result in a higher serum level.,Technetium Tc-99m pyrophosphate
DB09185,Salmon calcitonin may decrease the excretion rate of Viloxazine which could result in a higher serum level.,Viloxazine
DB09194,Salmon calcitonin may decrease the excretion rate of Etoperidone which could result in a higher serum level.,Etoperidone
DB09195,Salmon calcitonin may decrease the excretion rate of Lorpiprazole which could result in a higher serum level.,Lorpiprazole
DB09204,Salmon calcitonin may decrease the excretion rate of Arotinolol which could result in a higher serum level.,Arotinolol
DB09205,Salmon calcitonin may decrease the excretion rate of Moxisylyte which could result in a higher serum level.,Moxisylyte
DB09209,Salmon calcitonin may decrease the excretion rate of Pholcodine which could result in a higher serum level.,Pholcodine
DB09210,Salmon calcitonin may decrease the excretion rate of Piracetam which could result in a higher serum level.,Piracetam
DB09219,Salmon calcitonin may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,Bisoxatin
DB09220,Salmon calcitonin may decrease the excretion rate of Nicorandil which could result in a higher serum level.,Nicorandil
DB09223,Salmon calcitonin may decrease the excretion rate of Blonanserin which could result in a higher serum level.,Blonanserin
DB09224,Salmon calcitonin may decrease the excretion rate of Melperone which could result in a higher serum level.,Melperone
DB09241,Salmon calcitonin may decrease the excretion rate of Methylene blue which could result in a higher serum level.,Methylene blue
DB09244,Salmon calcitonin may decrease the excretion rate of Pirlindole which could result in a higher serum level.,Pirlindole
DB09245,Salmon calcitonin may decrease the excretion rate of Toloxatone which could result in a higher serum level.,Toloxatone
DB09255,Salmon calcitonin may decrease the excretion rate of Dextran which could result in a higher serum level.,Dextran
DB09256,Salmon calcitonin may decrease the excretion rate of Tegafur which could result in a higher serum level.,Tegafur
DB09257,Salmon calcitonin may decrease the excretion rate of Gimeracil which could result in a higher serum level.,Gimeracil
DB09262,Salmon calcitonin may decrease the excretion rate of Imidafenacin which could result in a higher serum level.,Imidafenacin
DB09264,Salmon calcitonin may decrease the excretion rate of Idarucizumab which could result in a higher serum level.,Idarucizumab
DB09265,Salmon calcitonin may decrease the excretion rate of Lixisenatide which could result in a higher serum level.,Lixisenatide
DB09268,Salmon calcitonin may decrease the excretion rate of Picosulfuric acid which could result in a higher serum level.,Picosulfuric acid
DB09276,Salmon calcitonin may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.,Sodium aurothiomalate
DB09277,Salmon calcitonin may decrease the excretion rate of Choline C 11 which could result in a higher serum level.,Choline C 11
DB09281,Salmon calcitonin may decrease the excretion rate of Magnesium trisilicate which could result in a higher serum level.,Magnesium trisilicate
DB09292,Salmon calcitonin may decrease the excretion rate of Sacubitril which could result in a higher serum level.,Sacubitril
DB09301,Salmon calcitonin may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.,Chondroitin sulfate
DB09317,"Salmon calcitonin may decrease the excretion rate of Synthetic Conjugated Estrogens, A which could result in a higher serum level.","Synthetic Conjugated Estrogens, A"
DB09318,"Salmon calcitonin may decrease the excretion rate of Synthetic Conjugated Estrogens, B which could result in a higher serum level.","Synthetic Conjugated Estrogens, B"
DB09320,Salmon calcitonin may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.,Procaine benzylpenicillin
DB09324,Salmon calcitonin may decrease the excretion rate of Sulbactam which could result in a higher serum level.,Sulbactam
DB09325,Salmon calcitonin may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.,Sodium fluoride
DB09329,"Salmon calcitonin may decrease the excretion rate of Antihemophilic Factor (Recombinant), PEGylated which could result in a higher serum level.","Antihemophilic Factor (Recombinant), PEGylated"
DB09344,Salmon calcitonin may decrease the excretion rate of Invert sugar which could result in a higher serum level.,Invert sugar
DB09357,Salmon calcitonin may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.,Dexpanthenol
DB09394,Salmon calcitonin may decrease the excretion rate of Phosphoric acid which could result in a higher serum level.,Phosphoric acid
DB09395,Salmon calcitonin may decrease the excretion rate of Sodium acetate which could result in a higher serum level.,Sodium acetate
DB09407,Salmon calcitonin may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.,Magnesium chloride
DB09418,Salmon calcitonin may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.,Potassium perchlorate
DB09472,Salmon calcitonin may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.,Sodium sulfate
DB09477,Salmon calcitonin may decrease the excretion rate of Enalaprilat which could result in a higher serum level.,Enalaprilat
DB09481,Salmon calcitonin may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.,Magnesium carbonate
DB09488,Salmon calcitonin may decrease the excretion rate of Acrivastine which could result in a higher serum level.,Acrivastine
DB09496,Salmon calcitonin may decrease the excretion rate of Octinoxate which could result in a higher serum level.,Octinoxate
DB09502,Salmon calcitonin may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.,Fludeoxyglucose (18F)
DB09546,Salmon calcitonin may decrease the excretion rate of Iobenguane sulfate I-123 which could result in a higher serum level.,Iobenguane sulfate I-123
DB09570,Salmon calcitonin may decrease the excretion rate of Ixazomib which could result in a higher serum level.,Ixazomib
DB11077,Salmon calcitonin may decrease the excretion rate of Polyethylene glycol 400 which could result in a higher serum level.,Polyethylene glycol 400
DB11090,Salmon calcitonin may decrease the excretion rate of Potassium nitrate which could result in a higher serum level.,Potassium nitrate
DB11098,Salmon calcitonin may decrease the excretion rate of Potassium bicarbonate which could result in a higher serum level.,Potassium bicarbonate
DB11102,Salmon calcitonin may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,N-acetyltyrosine
DB11114,Salmon calcitonin may decrease the excretion rate of Eucalyptus oil which could result in a higher serum level.,Eucalyptus oil
DB11127,Salmon calcitonin may decrease the excretion rate of Selenious acid which could result in a higher serum level.,Selenious acid
DB11130,Salmon calcitonin may decrease the excretion rate of Opium which could result in a higher serum level.,Opium
DB11135,Salmon calcitonin may decrease the excretion rate of Selenium which could result in a higher serum level.,Selenium
DB11136,Salmon calcitonin may decrease the excretion rate of Chromium which could result in a higher serum level.,Chromium
DB11145,Salmon calcitonin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,Oxyquinoline
DB11156,Salmon calcitonin may decrease the excretion rate of Pyrantel which could result in a higher serum level.,Pyrantel
DB11164,Salmon calcitonin may decrease the excretion rate of Bicisate which could result in a higher serum level.,Bicisate
DB11251,Salmon calcitonin may decrease the excretion rate of Tocopherol which could result in a higher serum level.,Tocopherol
DB11278,Salmon calcitonin may decrease the excretion rate of DL-Methylephedrine which could result in a higher serum level.,DL-Methylephedrine
DB11328,Salmon calcitonin may decrease the excretion rate of Tetradecyl hydrogen sulfate (ester) which could result in a higher serum level.,Tetradecyl hydrogen sulfate (ester)
DB11338,Salmon calcitonin may decrease the excretion rate of Clove oil which could result in a higher serum level.,Clove oil
DB11358,Salmon calcitonin may decrease the excretion rate of Evening primrose oil which could result in a higher serum level.,Evening primrose oil
DB11364,Salmon calcitonin may decrease the excretion rate of Pidotimod which could result in a higher serum level.,Pidotimod
DB11560,Salmon calcitonin may decrease the excretion rate of Lesinurad which could result in a higher serum level.,Lesinurad
DB11577,Salmon calcitonin may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.,Indigotindisulfonic acid
DB11587,Salmon calcitonin may decrease the excretion rate of Etafedrine which could result in a higher serum level.,Etafedrine
DB11598,Salmon calcitonin may decrease the excretion rate of Antithrombin III human which could result in a higher serum level.,Antithrombin III human
DB11642,Salmon calcitonin may decrease the excretion rate of Pitolisant which could result in a higher serum level.,Pitolisant
DB11691,Salmon calcitonin may decrease the excretion rate of Naldemedine which could result in a higher serum level.,Naldemedine
DB11699,Salmon calcitonin may decrease the excretion rate of Tropisetron which could result in a higher serum level.,Tropisetron
DB11817,Salmon calcitonin may decrease the excretion rate of Baricitinib which could result in a higher serum level.,Baricitinib
DB11901,Salmon calcitonin may decrease the excretion rate of Apalutamide which could result in a higher serum level.,Apalutamide
DB11915,Salmon calcitonin may decrease the excretion rate of Valbenazine which could result in a higher serum level.,Valbenazine
DB11943,Salmon calcitonin may decrease the excretion rate of Delafloxacin which could result in a higher serum level.,Delafloxacin
DB11989,Salmon calcitonin may decrease the excretion rate of Benznidazole which could result in a higher serum level.,Benznidazole
DB12007,Salmon calcitonin may decrease the excretion rate of Isoflavone which could result in a higher serum level.,Isoflavone
DB12107,Salmon calcitonin may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,Vaborbactam
DB12161,Salmon calcitonin may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.,Deutetrabenazine
DB12278,Salmon calcitonin may decrease the excretion rate of Propiverine which could result in a higher serum level.,Propiverine
DB12783,Salmon calcitonin may decrease the excretion rate of Benserazide which could result in a higher serum level.,Benserazide
DB13025,Salmon calcitonin may decrease the excretion rate of Tiapride which could result in a higher serum level.,Tiapride
DB13139,Salmon calcitonin may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,Levosalbutamol
DB13156,Salmon calcitonin may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.,Inosine pranobex
DB13178,Salmon calcitonin may decrease the excretion rate of Inositol which could result in a higher serum level.,Inositol
DB13185,Salmon calcitonin may decrease the excretion rate of Oxabolone cipionate which could result in a higher serum level.,Oxabolone cipionate
DB13191,Salmon calcitonin may decrease the excretion rate of Phosphocreatine which could result in a higher serum level.,Phosphocreatine
DB13269,Salmon calcitonin may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.,Dichlorobenzyl alcohol
DB13293,Salmon calcitonin may decrease the excretion rate of Ipecac which could result in a higher serum level.,Ipecac
DB13595,Salmon calcitonin may decrease the excretion rate of Almasilate which could result in a higher serum level.,Almasilate
DB13873,Salmon calcitonin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.,Fenofibric acid
DB13884,Salmon calcitonin may decrease the excretion rate of Albutrepenonacog alfa which could result in a higher serum level.,Albutrepenonacog alfa
DB13909,Salmon calcitonin may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,Bismuth subgallate
DB13943,Salmon calcitonin may decrease the excretion rate of Testosterone cypionate which could result in a higher serum level.,Testosterone cypionate
DB13944,Salmon calcitonin may decrease the excretion rate of Testosterone enanthate which could result in a higher serum level.,Testosterone enanthate
DB13946,Salmon calcitonin may decrease the excretion rate of Testosterone undecanoate which could result in a higher serum level.,Testosterone undecanoate
DB13952,Salmon calcitonin may decrease the excretion rate of Estradiol acetate which could result in a higher serum level.,Estradiol acetate
DB13954,Salmon calcitonin may decrease the excretion rate of Estradiol cypionate which could result in a higher serum level.,Estradiol cypionate
DB13955,Salmon calcitonin may decrease the excretion rate of Estradiol dienanthate which could result in a higher serum level.,Estradiol dienanthate
DB13956,Salmon calcitonin may decrease the excretion rate of Estradiol valerate which could result in a higher serum level.,Estradiol valerate
DB13967,Salmon calcitonin may decrease the excretion rate of Patent Blue which could result in a higher serum level.,Patent Blue
DB14006,Salmon calcitonin may decrease the excretion rate of Choline salicylate which could result in a higher serum level.,Choline salicylate
DB14007,Salmon calcitonin may decrease the excretion rate of Pentetic acid which could result in a higher serum level.,Pentetic acid
DB14498,Salmon calcitonin may decrease the excretion rate of Potassium acetate which could result in a higher serum level.,Potassium acetate
DB14499,Salmon calcitonin may decrease the excretion rate of Potassium sulfate which could result in a higher serum level.,Potassium sulfate
DB14526,Salmon calcitonin may decrease the excretion rate of Chromic citrate which could result in a higher serum level.,Chromic citrate
DB14527,Salmon calcitonin may decrease the excretion rate of Chromic nitrate which could result in a higher serum level.,Chromic nitrate
DB14528,Salmon calcitonin may decrease the excretion rate of Chromium gluconate which could result in a higher serum level.,Chromium gluconate
DB14529,Salmon calcitonin may decrease the excretion rate of Chromium nicotinate which could result in a higher serum level.,Chromium nicotinate
DB14530,Salmon calcitonin may decrease the excretion rate of Chromous sulfate which could result in a higher serum level.,Chromous sulfate
DB14754,Salmon calcitonin may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,Solriamfetol
DB06815,Salmon calcitonin may decrease the excretion rate of Pyrithione which could result in a higher serum level.,Pyrithione
DB11121,Salmon calcitonin may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.,Chloroxylenol
DB15593,Salmon calcitonin may decrease the excretion rate of Golodirsen which could result in a higher serum level.,Golodirsen
DB00318,Salmon calcitonin may decrease the excretion rate of Codeine which could result in a higher serum level.,Codeine
DB00454,Salmon calcitonin may decrease the excretion rate of Meperidine which could result in a higher serum level.,Meperidine
DB00813,Salmon calcitonin may decrease the excretion rate of Fentanyl which could result in a higher serum level.,Fentanyl
DB00879,Salmon calcitonin may decrease the excretion rate of Emtricitabine which could result in a higher serum level.,Emtricitabine
DB00452,Framycetin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Framycetin
DB00479,Amikacin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Amikacin
DB00684,Tobramycin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Tobramycin
DB00798,Gentamicin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Gentamicin
DB00955,Netilmicin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Netilmicin
DB00994,Neomycin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Neomycin
DB01082,Streptomycin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Streptomycin
DB01172,Kanamycin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Kanamycin
DB01421,Paromomycin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Paromomycin
DB03615,Ribostamycin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Ribostamycin
DB04263,Geneticin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Geneticin
DB04626,Apramycin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Apramycin
DB04729,Gentamicin C1a may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Gentamicin C1a
DB04808,Neamine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Neamine
DB06696,Arbekacin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Arbekacin
DB08437,Puromycin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Puromycin
DB11512,Dihydrostreptomycin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Dihydrostreptomycin
DB11520,Hygromycin B may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Hygromycin B
DB12604,Sisomicin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Sisomicin
DB13270,Dibekacin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Dibekacin
DB13274,Micronomicin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Micronomicin
DB13540,Isepamicin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Isepamicin
DB13673,Bekanamycin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.,Bekanamycin
DB00552,Salmon calcitonin may decrease the excretion rate of Pentostatin which could result in a higher serum level.,Pentostatin
DB13145,Salmon calcitonin may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,Nedaplatin
DB00314,Salmon calcitonin may decrease the excretion rate of Capreomycin which could result in a higher serum level.,Capreomycin
DB00390,Salmon calcitonin may decrease the excretion rate of Digoxin which could result in a higher serum level.,Digoxin
DB00512,Salmon calcitonin may decrease the excretion rate of Vancomycin which could result in a higher serum level.,Vancomycin
DB00515,Salmon calcitonin may decrease the excretion rate of Cisplatin which could result in a higher serum level.,Cisplatin
DB00564,Salmon calcitonin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.,Carbamazepine
DB00642,Salmon calcitonin may decrease the excretion rate of Pemetrexed which could result in a higher serum level.,Pemetrexed
DB00682,Salmon calcitonin may decrease the excretion rate of Warfarin which could result in a higher serum level.,Warfarin
DB00908,Salmon calcitonin may decrease the excretion rate of Quinidine which could result in a higher serum level.,Quinidine
DB00982,Salmon calcitonin may decrease the excretion rate of Isotretinoin which could result in a higher serum level.,Isotretinoin
DB01035,Salmon calcitonin may decrease the excretion rate of Procainamide which could result in a higher serum level.,Procainamide
DB12615,Salmon calcitonin may decrease the excretion rate of Plazomicin which could result in a higher serum level.,Plazomicin
DB00524,Salmon calcitonin may increase the excretion rate of Metolazone which could result in a lower serum level and potentially a reduction in efficacy.,Metolazone
DB00695,Salmon calcitonin may increase the excretion rate of Furosemide which could result in a lower serum level and potentially a reduction in efficacy.,Furosemide
DB00808,Salmon calcitonin may increase the excretion rate of Indapamide which could result in a lower serum level and potentially a reduction in efficacy.,Indapamide
DB00887,Salmon calcitonin may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.,Bumetanide
DB00909,Salmon calcitonin may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy.,Zonisamide
DB08907,Salmon calcitonin may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.,Canagliflozin
DB09338,Salmon calcitonin may increase the excretion rate of Mersalyl which could result in a lower serum level and potentially a reduction in efficacy.,Mersalyl
DB00214,Torasemide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Torasemide
DB00232,Methyclothiazide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Methyclothiazide
DB00310,Chlorthalidone may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Chlorthalidone
DB00311,Ethoxzolamide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Ethoxzolamide
DB00421,Spironolactone may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Spironolactone
DB00436,Bendroflumethiazide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Bendroflumethiazide
DB00562,Benzthiazide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Benzthiazide
DB00594,Amiloride may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Amiloride
DB00606,Cyclothiazide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Cyclothiazide
DB00700,Eplerenone may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Eplerenone
DB00703,Methazolamide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Methazolamide
DB00774,Hydroflumethiazide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Hydroflumethiazide
DB00819,Acetazolamide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Acetazolamide
DB00872,Conivaptan may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Conivaptan
DB00880,Chlorothiazide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Chlorothiazide
DB01021,Trichlormethiazide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Trichlormethiazide
DB01119,Diazoxide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Diazoxide
DB01144,Diclofenamide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Diclofenamide
DB01324,Polythiazide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Polythiazide
DB01325,Quinethazone may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Quinethazone
DB01395,Drospirenone may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Drospirenone
DB01412,Theobromine may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Theobromine
DB02925,Piretanide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Piretanide
DB04831,Tienilic acid may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Tienilic acid
DB05034,Ularitide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Ularitide
DB06212,Tolvaptan may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Tolvaptan
DB06292,Dapagliflozin may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Dapagliflozin
DB06370,Indisulam may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Indisulam
DB08961,Azosemide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Azosemide
DB09015,Canrenoic acid may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Canrenoic acid
DB09125,Potassium citrate may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Potassium citrate
DB09235,Efonidipine may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Efonidipine
DB09401,Isosorbide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Isosorbide
DB11827,Ertugliflozin may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Ertugliflozin
DB12221,Canrenone may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Canrenone
DB12670,Rolofylline may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Rolofylline
DB12704,Spiradoline may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Spiradoline
DB12766,Cicletanine may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Cicletanine
DB13284,Meticrane may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Meticrane
DB13316,Ibopamine may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Ibopamine
DB13405,Mefruside may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Mefruside
DB13430,Mebutizide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Mebutizide
DB13532,Cyclopenthiazide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Cyclopenthiazide
DB13617,Clorexolone may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Clorexolone
DB13663,Clofenamide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Clofenamide
DB13708,Fenquizone may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Fenquizone
DB13792,Clopamide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Clopamide
DB13801,Muzolimine may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Muzolimine
DB13803,Xipamide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Xipamide
DB13989,Epitizide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Epitizide
DB14018,Bromotheophylline may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Bromotheophylline
DB14500,Potassium may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.,Potassium
DB00191,The risk or severity of adverse effects can be increased when Phentermine is combined with Salmon calcitonin.,Phentermine
DB00211,The risk or severity of adverse effects can be increased when Midodrine is combined with Salmon calcitonin.,Midodrine
DB00368,The risk or severity of adverse effects can be increased when Norepinephrine is combined with Salmon calcitonin.,Norepinephrine
DB00388,The risk or severity of adverse effects can be increased when Phenylephrine is combined with Salmon calcitonin.,Phenylephrine
DB00397,The risk or severity of adverse effects can be increased when Phenylpropanolamine is combined with Salmon calcitonin.,Phenylpropanolamine
DB00610,The risk or severity of adverse effects can be increased when Metaraminol is combined with Salmon calcitonin.,Metaraminol
DB00668,The risk or severity of adverse effects can be increased when Epinephrine is combined with Salmon calcitonin.,Epinephrine
DB00723,The risk or severity of adverse effects can be increased when Methoxamine is combined with Salmon calcitonin.,Methoxamine
DB00816,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Salmon calcitonin.,Orciprenaline
DB00830,The risk or severity of adverse effects can be increased when Phenmetrazine is combined with Salmon calcitonin.,Phenmetrazine
DB00852,The risk or severity of adverse effects can be increased when Pseudoephedrine is combined with Salmon calcitonin.,Pseudoephedrine
DB00865,The risk or severity of adverse effects can be increased when Benzphetamine is combined with Salmon calcitonin.,Benzphetamine
DB00867,The risk or severity of adverse effects can be increased when Ritodrine is combined with Salmon calcitonin.,Ritodrine
DB00935,The risk or severity of adverse effects can be increased when Oxymetazoline is combined with Salmon calcitonin.,Oxymetazoline
DB00937,The risk or severity of adverse effects can be increased when Diethylpropion is combined with Salmon calcitonin.,Diethylpropion
DB01064,The risk or severity of adverse effects can be increased when Isoprenaline is combined with Salmon calcitonin.,Isoprenaline
DB01255,The risk or severity of adverse effects can be increased when Lisdexamfetamine is combined with Salmon calcitonin.,Lisdexamfetamine
DB01288,The risk or severity of adverse effects can be increased when Fenoterol is combined with Salmon calcitonin.,Fenoterol
DB01364,The risk or severity of adverse effects can be increased when Ephedrine is combined with Salmon calcitonin.,Ephedrine
DB01365,The risk or severity of adverse effects can be increased when Mephentermine is combined with Salmon calcitonin.,Mephentermine
DB01366,The risk or severity of adverse effects can be increased when Procaterol is combined with Salmon calcitonin.,Procaterol
DB01407,The risk or severity of adverse effects can be increased when Clenbuterol is combined with Salmon calcitonin.,Clenbuterol
DB01442,The risk or severity of adverse effects can be increased when MMDA is combined with Salmon calcitonin.,MMDA
DB01454,The risk or severity of adverse effects can be increased when Midomafetamine is combined with Salmon calcitonin.,Midomafetamine
DB01467,"The risk or severity of adverse effects can be increased when 2,5-Dimethoxy-4-ethylamphetamine is combined with Salmon calcitonin.","2,5-Dimethoxy-4-ethylamphetamine"
DB01484,"The risk or severity of adverse effects can be increased when 4-Bromo-2,5-dimethoxyamphetamine is combined with Salmon calcitonin.","4-Bromo-2,5-dimethoxyamphetamine"
DB01509,The risk or severity of adverse effects can be increased when Tenamfetamine is combined with Salmon calcitonin.,Tenamfetamine
DB01556,The risk or severity of adverse effects can be increased when Chlorphentermine is combined with Salmon calcitonin.,Chlorphentermine
DB01566,The risk or severity of adverse effects can be increased when Methylenedioxyethamphetamine is combined with Salmon calcitonin.,Methylenedioxyethamphetamine
DB01576,The risk or severity of adverse effects can be increased when Dextroamphetamine is combined with Salmon calcitonin.,Dextroamphetamine
DB06152,The risk or severity of adverse effects can be increased when Nylidrin is combined with Salmon calcitonin.,Nylidrin
DB06764,The risk or severity of adverse effects can be increased when Tetryzoline is combined with Salmon calcitonin.,Tetryzoline
DB08841,The risk or severity of adverse effects can be increased when Tyramine is combined with Salmon calcitonin.,Tyramine
DB08941,The risk or severity of adverse effects can be increased when Isoxsuprine is combined with Salmon calcitonin.,Isoxsuprine
DB08985,The risk or severity of adverse effects can be increased when Etilefrine is combined with Salmon calcitonin.,Etilefrine
DB09203,The risk or severity of adverse effects can be increased when Synephrine is combined with Salmon calcitonin.,Synephrine
DB09480,The risk or severity of adverse effects can be increased when Iofetamine I-123 is combined with Salmon calcitonin.,Iofetamine I-123
DB11124,The risk or severity of adverse effects can be increased when Racepinephrine is combined with Salmon calcitonin.,Racepinephrine
DB12080,The risk or severity of adverse effects can be increased when Ritobegron is combined with Salmon calcitonin.,Ritobegron
DB13064,The risk or severity of adverse effects can be increased when Tramazoline is combined with Salmon calcitonin.,Tramazoline
DB13108,The risk or severity of adverse effects can be increased when Mephedrone is combined with Salmon calcitonin.,Mephedrone
DB13341,The risk or severity of adverse effects can be increased when Fenozolone is combined with Salmon calcitonin.,Fenozolone
DB13624,The risk or severity of adverse effects can be increased when Methoxyphenamine is combined with Salmon calcitonin.,Methoxyphenamine
DB13692,The risk or severity of adverse effects can be increased when Tretoquinol is combined with Salmon calcitonin.,Tretoquinol
DB13703,The risk or severity of adverse effects can be increased when Gepefrine is combined with Salmon calcitonin.,Gepefrine
DB13777,The risk or severity of adverse effects can be increased when Prenalterol is combined with Salmon calcitonin.,Prenalterol
DB13852,The risk or severity of adverse effects can be increased when Mefenorex is combined with Salmon calcitonin.,Mefenorex
DB13940,"The risk or severity of adverse effects can be increased when 2,5-Dimethoxy-4-ethylthioamphetamine is combined with Salmon calcitonin.","2,5-Dimethoxy-4-ethylthioamphetamine"
DB00182,The risk or severity of adverse effects can be increased when Salmon calcitonin is combined with Amphetamine.,Amphetamine
DB00598,The risk or severity of adverse effects can be increased when Salmon calcitonin is combined with Labetalol.,Labetalol
DB00841,The risk or severity of adverse effects can be increased when Salmon calcitonin is combined with Dobutamine.,Dobutamine
DB00871,The risk or severity of adverse effects can be increased when Salmon calcitonin is combined with Terbutaline.,Terbutaline
DB00988,The risk or severity of adverse effects can be increased when Salmon calcitonin is combined with Dopamine.,Dopamine
DB01577,The risk or severity of adverse effects can be increased when Salmon calcitonin is combined with Metamfetamine.,Metamfetamine
DB01193,The risk or severity of adverse effects can be increased when Acebutolol is combined with Salmon calcitonin.,Acebutolol
DB04846,The risk or severity of adverse effects can be increased when Celiprolol is combined with Salmon calcitonin.,Celiprolol
DB12752,The risk or severity of adverse effects can be increased when Bucindolol is combined with Salmon calcitonin.,Bucindolol
DB13757,The risk or severity of adverse effects can be increased when Epanolol is combined with Salmon calcitonin.,Epanolol
DB00317,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Gefitinib.,Gefitinib
DB00530,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Erlotinib.,Erlotinib
DB00619,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Imatinib.,Imatinib
DB01254,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Dasatinib.,Dasatinib
DB01259,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Lapatinib.,Lapatinib
DB01268,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Sunitinib.,Sunitinib
DB01645,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Genistein.,Genistein
DB02058,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with 3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone.,3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone
DB02424,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Geldanamycin.,Geldanamycin
DB02567,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with PD173955.,PD173955
DB03758,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Radicicol.,Radicicol
DB04849,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Cediranib.,Cediranib
DB04868,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Nilotinib.,Nilotinib
DB04879,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Vatalanib.,Vatalanib
DB05294,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Vandetanib.,Vandetanib
DB05424,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Canertinib.,Canertinib
DB05465,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Tandutinib.,Tandutinib
DB05575,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Motesanib.,Motesanib
DB05928,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Dovitinib.,Dovitinib
DB06302,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Glesatinib.,Glesatinib
DB06469,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Lestaurtinib.,Lestaurtinib
DB06589,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Pazopanib.,Pazopanib
DB06595,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Midostaurin.,Midostaurin
DB06616,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Bosutinib.,Bosutinib
DB06626,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Axitinib.,Axitinib
DB08399,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Piceatannol.,Piceatannol
DB08865,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Crizotinib.,Crizotinib
DB08875,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Cabozantinib.,Cabozantinib
DB08881,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Vemurafenib.,Vemurafenib
DB08896,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Regorafenib.,Regorafenib
DB08901,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Ponatinib.,Ponatinib
DB08916,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Afatinib.,Afatinib
DB09053,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Ibrutinib.,Ibrutinib
DB09063,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Ceritinib.,Ceritinib
DB09078,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Lenvatinib.,Lenvatinib
DB09079,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Nintedanib.,Nintedanib
DB09330,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Osimertinib.,Osimertinib
DB11363,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Alectinib.,Alectinib
DB11689,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Selumetinib.,Selumetinib
DB11697,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Pacritinib.,Pacritinib
DB11703,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Acalabrutinib.,Acalabrutinib
DB11737,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Icotinib.,Icotinib
DB11805,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Saracatinib.,Saracatinib
DB11828,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Neratinib.,Neratinib
DB11832,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Crenolanib.,Crenolanib
DB11904,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Flumatinib.,Flumatinib
DB11963,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Dacomitinib.,Dacomitinib
DB11973,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Tesevatinib.,Tesevatinib
DB11986,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Entrectinib.,Entrectinib
DB12010,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Fostamatinib.,Fostamatinib
DB12048,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Savolitinib.,Savolitinib
DB12141,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Gilteritinib.,Gilteritinib
DB12147,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Erdafitinib.,Erdafitinib
DB12267,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Brigatinib.,Brigatinib
DB12307,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Foretinib.,Foretinib
DB12323,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Radotinib.,Radotinib
DB14723,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Larotrectinib.,Larotrectinib
DB00398,The therapeutic efficacy of Sorafenib can be decreased when used in combination with Salmon calcitonin.,Sorafenib
DB08877,The therapeutic efficacy of Ruxolitinib can be decreased when used in combination with Salmon calcitonin.,Ruxolitinib
DB12978,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Pexidartinib.,Pexidartinib
DB12500,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Fedratinib.,Fedratinib
DB11652,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Tucatinib.,Tucatinib
DB11791,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Capmatinib.,Capmatinib
DB15685,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Selpercatinib.,Selpercatinib
DB05258,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Interferon alfa.,Interferon alfa
DB00041,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Aldesleukin.,Aldesleukin
DB00227,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Lovastatin.,Lovastatin
DB00609,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Ethionamide.,Ethionamide
DB00850,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Perphenazine.,Perphenazine
DB14651,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Perphenazine enanthate.,Perphenazine enanthate
DB00829,The therapeutic efficacy of Diazepam can be decreased when used in combination with Salmon calcitonin.,Diazepam
DB01233,The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Salmon calcitonin.,Metoclopramide
DB00233,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Aminosalicylic acid.,Aminosalicylic acid
DB11085,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Resorcinol.,Resorcinol
DB00672,The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Salmon calcitonin.,Chlorpropamide
DB00839,The therapeutic efficacy of Tolazamide can be decreased when used in combination with Salmon calcitonin.,Tolazamide
DB01067,The therapeutic efficacy of Glipizide can be decreased when used in combination with Salmon calcitonin.,Glipizide
DB01124,The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Salmon calcitonin.,Tolbutamide
DB00222,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Salmon calcitonin.,Glimepiride
DB00414,The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Salmon calcitonin.,Acetohexamide
DB01016,The therapeutic efficacy of Glyburide can be decreased when used in combination with Salmon calcitonin.,Glyburide
DB01120,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Salmon calcitonin.,Gliclazide
DB01251,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Salmon calcitonin.,Gliquidone
DB01289,The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Salmon calcitonin.,Glisoxepide
DB08962,The therapeutic efficacy of Glibornuride can be decreased when used in combination with Salmon calcitonin.,Glibornuride
DB13406,The therapeutic efficacy of Carbutamide can be decreased when used in combination with Salmon calcitonin.,Carbutamide
DB13675,The therapeutic efficacy of Metahexamide can be decreased when used in combination with Salmon calcitonin.,Metahexamide
DB01151,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Desipramine.,Desipramine
DB01242,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Clomipramine.,Clomipramine
DB08996,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Dimetacrine.,Dimetacrine
DB00540,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Nortriptyline.,Nortriptyline
DB00321,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Amitriptyline.,Amitriptyline
DB00344,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Protriptyline.,Protriptyline
DB00458,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Imipramine.,Imipramine
DB00543,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Amoxapine.,Amoxapine
DB00726,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Trimipramine.,Trimipramine
DB01142,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Doxepin.,Doxepin
DB04836,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Amineptine.,Amineptine
DB09016,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Butriptyline.,Butriptyline
DB09167,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Dosulepin.,Dosulepin
DB09289,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Tianeptine.,Tianeptine
DB09307,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Oxaprotiline.,Oxaprotiline
DB12930,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Opipramol.,Opipramol
DB13114,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Amitriptylinoxide.,Amitriptylinoxide
DB13225,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Dibenzepin.,Dibenzepin
DB13246,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Quinupramine.,Quinupramine
DB13384,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Melitracen.,Melitracen
DB13411,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Lofepramine.,Lofepramine
DB13496,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Iprindole.,Iprindole
DB13782,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Imipramine oxide.,Imipramine oxide
DB06643,The risk or severity of adverse effects can be increased when Denosumab is combined with Interferon alfa-n3.,Denosumab
DB00005,The risk or severity of adverse effects can be increased when Etanercept is combined with Interferon alfa-n3.,Etanercept
DB00008,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Interferon alfa-n3.,Peginterferon alfa-2a
DB00011,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Interferon alfa-n3.,Interferon alfa-n1
DB00022,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Peginterferon alfa-2b.,Peginterferon alfa-2b
DB00026,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Anakinra.,Anakinra
DB00033,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Interferon gamma-1b.,Interferon gamma-1b
DB00034,"The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Interferon alfa-2a, Recombinant.","Interferon alfa-2a, Recombinant"
DB00051,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Adalimumab.,Adalimumab
DB00056,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin
DB00059,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Pegaspargase.,Pegaspargase
DB00065,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Infliximab.,Infliximab
DB00068,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Interferon beta-1b.,Interferon beta-1b
DB00069,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Interferon alfacon-1.,Interferon alfacon-1
DB00073,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Rituximab.,Rituximab
DB00074,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Basiliximab.,Basiliximab
DB00075,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Muromonab.,Muromonab
DB00078,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Ibritumomab tiuxetan.,Ibritumomab tiuxetan
DB00081,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Tositumomab.,Tositumomab
DB00087,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Alemtuzumab.,Alemtuzumab
DB00092,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Alefacept.,Alefacept
DB00095,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Efalizumab.,Efalizumab
DB00098,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Antithymocyte immunoglobulin (rabbit).,Antithymocyte immunoglobulin (rabbit)
DB00105,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Interferon alfa-2b.,Interferon alfa-2b
DB00111,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Daclizumab.,Daclizumab
DB00112,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Bevacizumab.,Bevacizumab
DB00120,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Phenylalanine.,Phenylalanine
DB00180,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Flunisolide.,Flunisolide
DB00188,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Bortezomib.,Bortezomib
DB00242,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Cladribine.,Cladribine
DB00262,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Carmustine.,Carmustine
DB00276,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Amsacrine.,Amsacrine
DB00290,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Bleomycin.,Bleomycin
DB00291,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Chlorambucil.,Chlorambucil
DB00293,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Raltitrexed.,Raltitrexed
DB00305,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Mitomycin.,Mitomycin
DB00307,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Bexarotene.,Bexarotene
DB00309,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Vindesine.,Vindesine
DB00322,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Floxuridine.,Floxuridine
DB00328,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Indomethacin.,Indomethacin
DB00352,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Tioguanine.,Tioguanine
DB00361,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Vinorelbine.,Vinorelbine
DB00380,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Dexrazoxane.,Dexrazoxane
DB00394,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Beclomethasone dipropionate.,Beclomethasone dipropionate
DB00398,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Sorafenib.,Sorafenib
DB00428,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Streptozocin.,Streptozocin
DB00432,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Trifluridine.,Trifluridine
DB00441,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Gemcitabine.,Gemcitabine
DB00443,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Betamethasone.,Betamethasone
DB00444,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Teniposide.,Teniposide
DB00445,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Epirubicin.,Epirubicin
DB00446,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Chloramphenicol.,Chloramphenicol
DB00480,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Lenalidomide.,Lenalidomide
DB00488,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Altretamine.,Altretamine
DB00495,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Zidovudine.,Zidovudine
DB00515,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Cisplatin.,Cisplatin
DB00526,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Oxaliplatin.,Oxaliplatin
DB00531,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Cyclophosphamide.,Cyclophosphamide
DB00541,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Vincristine.,Vincristine
DB00544,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Fluorouracil.,Fluorouracil
DB00550,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Propylthiouracil.,Propylthiouracil
DB00552,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Pentostatin.,Pentostatin
DB00563,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Methotrexate.,Methotrexate
DB00564,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Carbamazepine.,Carbamazepine
DB00570,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Vinblastine.,Vinblastine
DB00588,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Fluticasone propionate.,Fluticasone propionate
DB00591,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Fluocinolone acetonide.,Fluocinolone acetonide
DB00601,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Linezolid.,Linezolid
DB00619,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Imatinib.,Imatinib
DB00620,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Triamcinolone.,Triamcinolone
DB00631,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Clofarabine.,Clofarabine
DB00635,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Prednisone.,Prednisone
DB00642,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Pemetrexed.,Pemetrexed
DB00687,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Fludrocortisone.,Fludrocortisone
DB00688,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Mycophenolate mofetil.,Mycophenolate mofetil
DB00694,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Daunorubicin.,Daunorubicin
DB00755,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Tretinoin.,Tretinoin
DB00762,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Irinotecan.,Irinotecan
DB00763,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Methimazole.,Methimazole
DB00764,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Mometasone.,Mometasone
DB00773,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Etoposide.,Etoposide
DB00795,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Sulfasalazine.,Sulfasalazine
DB00851,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Dacarbazine.,Dacarbazine
DB00853,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Temozolomide.,Temozolomide
DB00859,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Penicillamine.,Penicillamine
DB00860,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Prednisolone.,Prednisolone
DB00877,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Sirolimus.,Sirolimus
DB00888,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Mechlorethamine.,Mechlorethamine
DB00928,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Azacitidine.,Azacitidine
DB00958,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Carboplatin.,Carboplatin
DB00959,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Methylprednisolone.,Methylprednisolone
DB00970,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Dactinomycin.,Dactinomycin
DB00987,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Cytarabine.,Cytarabine
DB00993,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Azathioprine.,Azathioprine
DB00997,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Doxorubicin.,Doxorubicin
DB01005,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Hydroxyurea.,Hydroxyurea
DB01008,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Busulfan.,Busulfan
DB01024,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Mycophenolic acid.,Mycophenolic acid
DB01030,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Topotecan.,Topotecan
DB01033,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Mercaptopurine.,Mercaptopurine
DB01041,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Thalidomide.,Thalidomide
DB01042,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Melphalan.,Melphalan
DB01073,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Fludarabine.,Fludarabine
DB01099,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Flucytosine.,Flucytosine
DB01101,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Capecitabine.,Capecitabine
DB01108,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Trilostane.,Trilostane
DB01168,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Procarbazine.,Procarbazine
DB01169,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Arsenic trioxide.,Arsenic trioxide
DB01177,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Idarubicin.,Idarubicin
DB01181,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Ifosfamide.,Ifosfamide
DB01196,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Estramustine.,Estramustine
DB01204,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Mitoxantrone.,Mitoxantrone
DB01206,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Lomustine.,Lomustine
DB01222,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Budesonide.,Budesonide
DB01229,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Paclitaxel.,Paclitaxel
DB01234,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Dexamethasone.,Dexamethasone
DB01248,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Docetaxel.,Docetaxel
DB01254,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Dasatinib.,Dasatinib
DB01257,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Eculizumab.,Eculizumab
DB01262,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Decitabine.,Decitabine
DB01268,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Sunitinib.,Sunitinib
DB01280,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Nelarabine.,Nelarabine
DB01281,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Abatacept.,Abatacept
DB01285,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Corticotropin.,Corticotropin
DB01380,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Cortisone acetate.,Cortisone acetate
DB01384,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Paramethasone.,Paramethasone
DB01394,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Colchicine.,Colchicine
DB01410,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Ciclesonide.,Ciclesonide
DB01423,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Stepronin.,Stepronin
DB01590,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Everolimus.,Everolimus
DB01611,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Hydroxychloroquine.,Hydroxychloroquine
DB01816,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Castanospermine.,Castanospermine
DB02546,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Vorinostat.,Vorinostat
DB02806,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with 2-Methoxyethanol.,2-Methoxyethanol
DB03523,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Brequinar.,Brequinar
DB04572,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Thiotepa.,Thiotepa
DB04630,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Aldosterone.,Aldosterone
DB04845,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Ixabepilone.,Ixabepilone
DB04868,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Nilotinib.,Nilotinib
DB04951,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Pirfenidone.,Pirfenidone
DB04956,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Afelimomab.,Afelimomab
DB05015,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Belinostat.,Belinostat
DB05109,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Trabectedin.,Trabectedin
DB05258,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Interferon alfa.,Interferon alfa
DB05259,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Glatiramer.,Glatiramer
DB05260,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Gallium nitrate.,Gallium nitrate
DB05459,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Briakinumab.,Briakinumab
DB05472,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with omega interferon.,omega interferon
DB05676,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Apremilast.,Apremilast
DB05773,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Trastuzumab emtansine.,Trastuzumab emtansine
DB06168,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Canakinumab.,Canakinumab
DB06273,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Tocilizumab.,Tocilizumab
DB06287,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Temsirolimus.,Temsirolimus
DB06372,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Rilonacept.,Rilonacept
DB06589,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Pazopanib.,Pazopanib
DB06603,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Panobinostat.,Panobinostat
DB06612,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Mepolizumab.,Mepolizumab
DB06616,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Bosutinib.,Bosutinib
DB06662,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Abetimus.,Abetimus
DB06674,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Golimumab.,Golimumab
DB06681,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Belatacept.,Belatacept
DB06769,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Bendamustine.,Bendamustine
DB06772,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Cabazitaxel.,Cabazitaxel
DB06813,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Pralatrexate.,Pralatrexate
DB08059,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Wortmannin.,Wortmannin
DB08870,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Brentuximab vedotin.,Brentuximab vedotin
DB08871,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Eribulin.,Eribulin
DB08877,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Ruxolitinib.,Ruxolitinib
DB08879,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Belimumab.,Belimumab
DB08880,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Teriflunomide.,Teriflunomide
DB08889,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Carfilzomib.,Carfilzomib
DB08901,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Ponatinib.,Ponatinib
DB08904,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Certolizumab pegol.,Certolizumab pegol
DB08906,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Fluticasone furoate.,Fluticasone furoate
DB08908,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Dimethyl fumarate.,Dimethyl fumarate
DB08910,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Pomalidomide.,Pomalidomide
DB08935,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Obinutuzumab.,Obinutuzumab
DB08970,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Fluprednidene.,Fluprednidene
DB08971,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Fluocortolone.,Fluocortolone
DB09029,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Secukinumab.,Secukinumab
DB09033,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Vedolizumab.,Vedolizumab
DB09036,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Siltuximab.,Siltuximab
DB09052,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Blinatumomab.,Blinatumomab
DB09053,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Ibrutinib.,Ibrutinib
DB09054,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Idelalisib.,Idelalisib
DB09073,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Palbociclib.,Palbociclib
DB09074,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Olaparib.,Olaparib
DB09077,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Dinutuximab.,Dinutuximab
DB09082,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Vilanterol.,Vilanterol
DB09091,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Tixocortol.,Tixocortol
DB09122,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Peginterferon beta-1a.,Peginterferon beta-1a
DB09312,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Antilymphocyte immunoglobulin (horse).,Antilymphocyte immunoglobulin (horse)
DB09378,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Fluprednisolone.,Fluprednisolone
DB09383,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Meprednisone.,Meprednisone
DB11466,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Tepoxalin.,Tepoxalin
DB11487,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Dexamethasone isonicotinate.,Dexamethasone isonicotinate
DB11529,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Melengestrol.,Melengestrol
DB11569,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Ixekizumab.,Ixekizumab
DB11580,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Ravulizumab.,Ravulizumab
DB11616,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Pirarubicin.,Pirarubicin
DB11693,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Voclosporin.,Voclosporin
DB11708,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Peficitinib.,Peficitinib
DB11750,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Clobetasol.,Clobetasol
DB11767,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Sarilumab.,Sarilumab
DB11776,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Brodalumab.,Brodalumab
DB11803,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Sirukumab.,Sirukumab
DB11817,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Baricitinib.,Baricitinib
DB11834,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Guselkumab.,Guselkumab
DB11921,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Deflazacort.,Deflazacort
DB11988,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Ocrelizumab.,Ocrelizumab
DB12025,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Triptolide.,Triptolide
DB12371,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Siponimod.,Siponimod
DB12612,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Ozanimod.,Ozanimod
DB12617,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Mizoribine.,Mizoribine
DB12692,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Gusperimus.,Gusperimus
DB12814,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Cepeginterferon alfa-2B.,Cepeginterferon alfa-2B
DB12902,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Trofosfamide.,Trofosfamide
DB12947,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Doxifluridine.,Doxifluridine
DB12991,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Deoxyspergualin.,Deoxyspergualin
DB12996,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Acteoside.,Acteoside
DB13003,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Cortivazol.,Cortivazol
DB13014,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Hypericin.,Hypericin
DB13068,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.,9-(N-methyl-L-isoleucine)-cyclosporin A
DB13208,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Prednylidene.,Prednylidene
DB13223,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Fluocortin.,Fluocortin
DB13241,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Begelomab.,Begelomab
DB13491,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Fluperolone.,Fluperolone
DB13664,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Formocortal.,Formocortal
DB13728,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Halometasone.,Halometasone
DB13843,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Cloprednol.,Cloprednol
DB13856,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Fluclorolone.,Fluclorolone
DB13867,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Fluticasone.,Fluticasone
DB14066,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Tetrandrine.,Tetrandrine
DB14219,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Monomethyl fumarate.,Monomethyl fumarate
DB14512,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Mometasone furoate.,Mometasone furoate
DB14538,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Hydrocortisone aceponate.,Hydrocortisone aceponate
DB14539,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Hydrocortisone acetate.,Hydrocortisone acetate
DB14545,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Hydrocortisone succinate.,Hydrocortisone succinate
DB14724,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Emapalumab.,Emapalumab
DB14762,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Risankizumab.,Risankizumab
DB14919,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Rozanolixizumab.,Rozanolixizumab
DB15253,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Bleselumab.,Bleselumab
DB00108,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Natalizumab.,Natalizumab
DB00337,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Interferon alfa-n3.,Pimecrolimus
DB01656,Roflumilast may increase the immunosuppressive activities of Interferon alfa-n3.,Roflumilast
DB06688,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Interferon alfa-n3.,Sipuleucel-T
DB00041,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Aldesleukin.,Aldesleukin
DB00363,The risk or severity of neutropenia can be increased when Interferon alfa-n3 is combined with Clozapine.,Clozapine
DB00333,The serum concentration of Methadone can be increased when it is combined with Interferon alfa-n3.,Methadone
DB00811,The risk or severity of anemia can be increased when Interferon alfa-n3 is combined with Ribavirin.,Ribavirin
DB00315,The metabolism of Zolmitriptan can be decreased when combined with Interferon alfa-n3.,Zolmitriptan
DB01015,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Interferon alfa-n3.,Sulfamethoxazole
DB01265,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Telbivudine.,Telbivudine
DB01097,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Leflunomide.,Leflunomide
DB08895,Interferon alfa-n3 may increase the immunosuppressive activities of Tofacitinib.,Tofacitinib
DB00072,Trastuzumab may increase the neutropenic activities of Interferon alfa-n3.,Trastuzumab
DB08868,Interferon alfa-n3 may increase the immunosuppressive activities of Fingolimod.,Fingolimod
DB00864,Tacrolimus may increase the immunosuppressive activities of Interferon alfa-n3.,Tacrolimus
DB00201,The metabolism of Caffeine can be decreased when combined with Interferon alfa-n3.,Caffeine
DB00651,The metabolism of Dyphylline can be decreased when combined with Interferon alfa-n3.,Dyphylline
DB00806,The metabolism of Pentoxifylline can be decreased when combined with Interferon alfa-n3.,Pentoxifylline
DB01303,The metabolism of Oxtriphylline can be decreased when combined with Interferon alfa-n3.,Oxtriphylline
DB01412,The metabolism of Theobromine can be decreased when combined with Interferon alfa-n3.,Theobromine
DB01482,The metabolism of Fenethylline can be decreased when combined with Interferon alfa-n3.,Fenethylline
DB01667,The metabolism of 8-azaguanine can be decreased when combined with Interferon alfa-n3.,8-azaguanine
DB01978,"The metabolism of 7,9-Dimethylguanine can be decreased when combined with Interferon alfa-n3.","7,9-Dimethylguanine"
DB02134,The metabolism of Xanthine can be decreased when combined with Interferon alfa-n3.,Xanthine
DB02245,The metabolism of 7-Deazaguanine can be decreased when combined with Interferon alfa-n3.,7-Deazaguanine
DB02377,The metabolism of Guanine can be decreased when combined with Interferon alfa-n3.,Guanine
DB02489,The metabolism of 9-Methylguanine can be decreased when combined with Interferon alfa-n3.,9-Methylguanine
DB02568,The metabolism of Peldesine can be decreased when combined with Interferon alfa-n3.,Peldesine
DB04076,The metabolism of Hypoxanthine can be decreased when combined with Interferon alfa-n3.,Hypoxanthine
DB04356,The metabolism of 9-Deazaguanine can be decreased when combined with Interferon alfa-n3.,9-Deazaguanine
DB06479,The metabolism of Propentofylline can be decreased when combined with Interferon alfa-n3.,Propentofylline
DB06575,The metabolism of Valomaciclovir can be decreased when combined with Interferon alfa-n3.,Valomaciclovir
DB07954,The metabolism of 3-isobutyl-1-methyl-7H-xanthine can be decreased when combined with Interferon alfa-n3.,3-isobutyl-1-methyl-7H-xanthine
DB08844,The metabolism of Uric acid can be decreased when combined with Interferon alfa-n3.,Uric acid
DB09273,The metabolism of Doxofylline can be decreased when combined with Interferon alfa-n3.,Doxofylline
DB11919,The metabolism of 6-O-benzylguanine can be decreased when combined with Interferon alfa-n3.,6-O-benzylguanine
DB12406,The metabolism of Lisofylline can be decreased when combined with Interferon alfa-n3.,Lisofylline
DB12531,The metabolism of Lobucavir can be decreased when combined with Interferon alfa-n3.,Lobucavir
DB12926,The metabolism of Cafedrine can be decreased when combined with Interferon alfa-n3.,Cafedrine
DB12927,The metabolism of Theodrenaline can be decreased when combined with Interferon alfa-n3.,Theodrenaline
DB13203,The metabolism of Bamifylline can be decreased when combined with Interferon alfa-n3.,Bamifylline
DB13449,The metabolism of Proxyphylline can be decreased when combined with Interferon alfa-n3.,Proxyphylline
DB13573,The metabolism of Acefylline can be decreased when combined with Interferon alfa-n3.,Acefylline
DB13592,The metabolism of Etamiphylline can be decreased when combined with Interferon alfa-n3.,Etamiphylline
DB13634,The metabolism of Pentifylline can be decreased when combined with Interferon alfa-n3.,Pentifylline
DB13812,The metabolism of Bufylline can be decreased when combined with Interferon alfa-n3.,Bufylline
DB14018,The metabolism of Bromotheophylline can be decreased when combined with Interferon alfa-n3.,Bromotheophylline
DB14029,The metabolism of Furafylline can be decreased when combined with Interferon alfa-n3.,Furafylline
DB14132,The metabolism of 8-chlorotheophylline can be decreased when combined with Interferon alfa-n3.,8-chlorotheophylline
DB15122,The metabolism of PCS-499 can be decreased when combined with Interferon alfa-n3.,PCS-499
DB04914,The therapeutic efficacy of G17DT can be decreased when used in combination with Interferon alfa-n3.,G17DT
DB05144,The therapeutic efficacy of PEV3A can be decreased when used in combination with Interferon alfa-n3.,PEV3A
DB05325,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Interferon alfa-n3.,INGN 225
DB05374,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Interferon alfa-n3.,Rindopepimut
DB05440,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Interferon alfa-n3.,SRP 299
DB05942,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Interferon alfa-n3.,GI-5005
DB06400,The therapeutic efficacy of Vitespen can be decreased when used in combination with Interferon alfa-n3.,Vitespen
DB06584,The therapeutic efficacy of TG4010 can be decreased when used in combination with Interferon alfa-n3.,TG4010
DB09057,The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Interferon alfa-n3.,Anthrax immune globulin human
DB10062,"The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Interferon alfa-n3.","Rabies virus inactivated antigen, B"
DB10076,The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Interferon alfa-n3.,Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen
DB10276,The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Interferon alfa-n3.,Rotavirus vaccine
DB10283,"The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Interferon alfa-n3.","Rabies virus inactivated antigen, A"
DB10342,The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Interferon alfa-n3.,Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen
DB10583,The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-n3.,Clostridium tetani toxoid antigen (formaldehyde inactivated)
DB10584,The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-n3.,Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)
DB10600,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-n3.,Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated)
DB10769,The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-n3.,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated)
DB10794,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-n3.,Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated)
DB10803,The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Interferon alfa-n3.,Typhoid Vi polysaccharide vaccine
DB10989,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Interferon alfa-n3.,Hepatitis A Vaccine
DB10990,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Interferon alfa-n3.,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen
DB11038,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-n3.,Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated)
DB11040,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-n3.,Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated)
DB11041,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-n3.,Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)
DB11044,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-n3.,Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated)
DB11603,The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Interferon alfa-n3.,Human rabies virus immune globulin
DB11627,The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Interferon alfa-n3.,Hepatitis B Vaccine (Recombinant)
DB12568,The therapeutic efficacy of Tecemotide can be decreased when used in combination with Interferon alfa-n3.,Tecemotide
DB14022,The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Interferon alfa-n3.,Typhoid vaccine
DB14384,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-n3.,Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated)
DB14385,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-n3.,Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated)
DB14394,The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with Interferon alfa-n3.,Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen
DB14445,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-n3.,Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated)
DB14449,The therapeutic efficacy of Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen can be decreased when used in combination with Interferon alfa-n3.,Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen
DB14619,The therapeutic efficacy of Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-n3.,Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated)
DB14620,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-n3.,Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated)
DB14711,The therapeutic efficacy of Vaccinia virus strain new york city board of health live antigen can be decreased when used in combination with Interferon alfa-n3.,Vaccinia virus strain new york city board of health live antigen
DB15274,The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Interferon alfa-n3.,Pertussis vaccine
DB15461,The therapeutic efficacy of Yersinia pestis 195/p antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-n3.,Yersinia pestis 195/p antigen (formaldehyde inactivated)
DB13924,The therapeutic efficacy of Varicella Zoster Vaccine (Recombinant) can be decreased when used in combination with Interferon alfa-n3.,Varicella Zoster Vaccine (Recombinant)
DB15483,The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Interferon alfa-n3.,Modified vaccinia ankara
DB15595,"The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Interferon alfa-n3.","Ebola Zaire vaccine (live, attenuated)"
DB00054,The risk or severity of bleeding can be increased when Abciximab is combined with Interferon alfa-n3.,Abciximab
DB00063,The risk or severity of bleeding can be increased when Eptifibatide is combined with Interferon alfa-n3.,Eptifibatide
DB00208,The risk or severity of bleeding can be increased when Ticlopidine is combined with Interferon alfa-n3.,Ticlopidine
DB00775,The risk or severity of bleeding can be increased when Tirofiban is combined with Interferon alfa-n3.,Tirofiban
DB00945,The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Interferon alfa-n3.,Acetylsalicylic acid
DB00975,The risk or severity of bleeding can be increased when Dipyridamole is combined with Interferon alfa-n3.,Dipyridamole
DB01088,The risk or severity of bleeding can be increased when Iloprost is combined with Interferon alfa-n3.,Iloprost
DB01138,The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Interferon alfa-n3.,Sulfinpyrazone
DB01207,The risk or severity of bleeding can be increased when Ridogrel is combined with Interferon alfa-n3.,Ridogrel
DB01236,The risk or severity of bleeding can be increased when Sevoflurane is combined with Interferon alfa-n3.,Sevoflurane
DB01240,The risk or severity of bleeding can be increased when Epoprostenol is combined with Interferon alfa-n3.,Epoprostenol
DB04743,The risk or severity of bleeding can be increased when Nimesulide is combined with Interferon alfa-n3.,Nimesulide
DB04905,The risk or severity of bleeding can be increased when Tesmilifene is combined with Interferon alfa-n3.,Tesmilifene
DB04932,The risk or severity of bleeding can be increased when Defibrotide is combined with Interferon alfa-n3.,Defibrotide
DB05229,The risk or severity of bleeding can be increased when Beraprost is combined with Interferon alfa-n3.,Beraprost
DB05266,The risk or severity of bleeding can be increased when Ibudilast is combined with Interferon alfa-n3.,Ibudilast
DB05767,The risk or severity of bleeding can be increased when Andrographolide is combined with Interferon alfa-n3.,Andrographolide
DB06081,The risk or severity of bleeding can be increased when Caplacizumab is combined with Interferon alfa-n3.,Caplacizumab
DB06209,The risk or severity of bleeding can be increased when Prasugrel is combined with Interferon alfa-n3.,Prasugrel
DB06441,The risk or severity of bleeding can be increased when Cangrelor is combined with Interferon alfa-n3.,Cangrelor
DB07615,The risk or severity of bleeding can be increased when Tranilast is combined with Interferon alfa-n3.,Tranilast
DB08814,The risk or severity of bleeding can be increased when Triflusal is combined with Interferon alfa-n3.,Triflusal
DB08816,The risk or severity of bleeding can be increased when Ticagrelor is combined with Interferon alfa-n3.,Ticagrelor
DB08887,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Interferon alfa-n3.,Icosapent ethyl
DB09030,The risk or severity of bleeding can be increased when Vorapaxar is combined with Interferon alfa-n3.,Vorapaxar
DB09283,The risk or severity of bleeding can be increased when Trapidil is combined with Interferon alfa-n3.,Trapidil
DB12092,The risk or severity of bleeding can be increased when Naftopidil is combined with Interferon alfa-n3.,Naftopidil
DB12163,The risk or severity of bleeding can be increased when Sarpogrelate is combined with Interferon alfa-n3.,Sarpogrelate
DB12321,The risk or severity of bleeding can be increased when Ifetroban is combined with Interferon alfa-n3.,Ifetroban
DB12445,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Interferon alfa-n3.,Nitroaspirin
DB12465,The risk or severity of bleeding can be increased when Ketanserin is combined with Interferon alfa-n3.,Ketanserin
DB12545,The risk or severity of bleeding can be increased when Indobufen is combined with Interferon alfa-n3.,Indobufen
DB12749,The risk or severity of bleeding can be increased when Butylphthalide is combined with Interferon alfa-n3.,Butylphthalide
DB12771,The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Interferon alfa-n3.,Hydroxytyrosol
DB13036,The risk or severity of bleeding can be increased when Ramatroban is combined with Interferon alfa-n3.,Ramatroban
DB13327,The risk or severity of bleeding can be increased when Picotamide is combined with Interferon alfa-n3.,Picotamide
DB13367,The risk or severity of bleeding can be increased when Cloricromen is combined with Interferon alfa-n3.,Cloricromen
DB13400,The risk or severity of bleeding can be increased when Linsidomine is combined with Interferon alfa-n3.,Linsidomine
DB13510,The risk or severity of bleeding can be increased when Buflomedil is combined with Interferon alfa-n3.,Buflomedil
DB13929,The risk or severity of bleeding can be increased when Relcovaptan is combined with Interferon alfa-n3.,Relcovaptan
DB13200,Interferon alfa-n3 may increase the myelosuppressive activities of Lipegfilgrastim.,Lipegfilgrastim
DB10317,The risk or severity of infection can be increased when Rubella virus vaccine is combined with Interferon alfa-n3.,Rubella virus vaccine
DB10318,The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Interferon alfa-n3.,Varicella Zoster Vaccine (Live/attenuated)
DB10343,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Interferon alfa-n3.,Bacillus calmette-guerin substrain tice live antigen
DB10804,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Interferon alfa-n3.,Bacillus calmette-guerin substrain connaught live antigen
DB10805,The risk or severity of infection can be increased when Yellow Fever Vaccine is combined with Interferon alfa-n3.,Yellow Fever Vaccine
DB11003,The risk or severity of infection can be increased when Anthrax vaccine is combined with Interferon alfa-n3.,Anthrax vaccine
DB11050,The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Interferon alfa-n3.,Typhoid Vaccine Live
DB12386,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain danish 1331 live antigen is combined with Interferon alfa-n3.,Bacillus calmette-guerin substrain danish 1331 live antigen
DB12768,The risk or severity of infection can be increased when BCG vaccine is combined with Interferon alfa-n3.,BCG vaccine
DB14409,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Interferon alfa-n3.,Human adenovirus e serotype 4 strain cl-68578 antigen
DB14443,The risk or severity of infection can be increased when Vibrio cholerae CVD 103-HgR strain live antigen is combined with Interferon alfa-n3.,Vibrio cholerae CVD 103-HgR strain live antigen
DB14685,The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Interferon alfa-n3.,Adenovirus type 7 vaccine live
DB00039,The therapeutic efficacy of Palifermin can be decreased when used in combination with Interferon alfa-n3.,Palifermin
DB00176,The metabolism of Fluvoxamine can be decreased when combined with Interferon alfa-n3.,Fluvoxamine
DB00184,The metabolism of Nicotine can be decreased when combined with Interferon alfa-n3.,Nicotine
DB00195,The metabolism of Betaxolol can be decreased when combined with Interferon alfa-n3.,Betaxolol
DB00261,The metabolism of Anagrelide can be decreased when combined with Interferon alfa-n3.,Anagrelide
DB00280,The metabolism of Disopyramide can be decreased when combined with Interferon alfa-n3.,Disopyramide
DB00281,The metabolism of Lidocaine can be decreased when combined with Interferon alfa-n3.,Lidocaine
DB00286,The metabolism of Conjugated estrogens can be decreased when combined with Interferon alfa-n3.,Conjugated estrogens
DB00296,The metabolism of Ropivacaine can be decreased when combined with Interferon alfa-n3.,Ropivacaine
DB00316,The metabolism of Acetaminophen can be decreased when combined with Interferon alfa-n3.,Acetaminophen
DB00334,The metabolism of Olanzapine can be decreased when combined with Interferon alfa-n3.,Olanzapine
DB00356,The metabolism of Chlorzoxazone can be decreased when combined with Interferon alfa-n3.,Chlorzoxazone
DB00365,The metabolism of Grepafloxacin can be decreased when combined with Interferon alfa-n3.,Grepafloxacin
DB00370,The metabolism of Mirtazapine can be decreased when combined with Interferon alfa-n3.,Mirtazapine
DB00379,The metabolism of Mexiletine can be decreased when combined with Interferon alfa-n3.,Mexiletine
DB00382,The metabolism of Tacrine can be decreased when combined with Interferon alfa-n3.,Tacrine
DB00384,The metabolism of Triamterene can be decreased when combined with Interferon alfa-n3.,Triamterene
DB00420,The metabolism of Promazine can be decreased when combined with Interferon alfa-n3.,Promazine
DB00425,The metabolism of Zolpidem can be decreased when combined with Interferon alfa-n3.,Zolpidem
DB00442,The metabolism of Entecavir can be decreased when combined with Interferon alfa-n3.,Entecavir
DB00461,The metabolism of Nabumetone can be decreased when combined with Interferon alfa-n3.,Nabumetone
DB00468,The metabolism of Quinine can be decreased when combined with Interferon alfa-n3.,Quinine
DB00472,The metabolism of Fluoxetine can be decreased when combined with Interferon alfa-n3.,Fluoxetine
DB00476,The metabolism of Duloxetine can be decreased when combined with Interferon alfa-n3.,Duloxetine
DB00477,The metabolism of Chlorpromazine can be decreased when combined with Interferon alfa-n3.,Chlorpromazine
DB00499,The metabolism of Flutamide can be decreased when combined with Interferon alfa-n3.,Flutamide
DB00502,The metabolism of Haloperidol can be decreased when combined with Interferon alfa-n3.,Haloperidol
DB00518,The metabolism of Albendazole can be decreased when combined with Interferon alfa-n3.,Albendazole
DB00533,The metabolism of Rofecoxib can be decreased when combined with Interferon alfa-n3.,Rofecoxib
DB00568,The metabolism of Cinnarizine can be decreased when combined with Interferon alfa-n3.,Cinnarizine
DB00571,The metabolism of Propranolol can be decreased when combined with Interferon alfa-n3.,Propranolol
DB00586,The metabolism of Diclofenac can be decreased when combined with Interferon alfa-n3.,Diclofenac
DB00629,The metabolism of Guanabenz can be decreased when combined with Interferon alfa-n3.,Guanabenz
DB00661,The metabolism of Verapamil can be decreased when combined with Interferon alfa-n3.,Verapamil
DB00715,The metabolism of Paroxetine can be decreased when combined with Interferon alfa-n3.,Paroxetine
DB00730,The metabolism of Thiabendazole can be decreased when combined with Interferon alfa-n3.,Thiabendazole
DB00740,The metabolism of Riluzole can be decreased when combined with Interferon alfa-n3.,Riluzole
DB00744,The metabolism of Zileuton can be decreased when combined with Interferon alfa-n3.,Zileuton
DB00758,The metabolism of Clopidogrel can be decreased when combined with Interferon alfa-n3.,Clopidogrel
DB00783,The metabolism of Estradiol can be decreased when combined with Interferon alfa-n3.,Estradiol
DB00787,The metabolism of Acyclovir can be decreased when combined with Interferon alfa-n3.,Acyclovir
DB00788,The metabolism of Naproxen can be decreased when combined with Interferon alfa-n3.,Naproxen
DB00831,The metabolism of Trifluoperazine can be decreased when combined with Interferon alfa-n3.,Trifluoperazine
DB00850,The metabolism of Perphenazine can be decreased when combined with Interferon alfa-n3.,Perphenazine
DB00857,The metabolism of Terbinafine can be decreased when combined with Interferon alfa-n3.,Terbinafine
DB00863,The metabolism of Ranitidine can be decreased when combined with Interferon alfa-n3.,Ranitidine
DB00898,The metabolism of Ethanol can be decreased when combined with Interferon alfa-n3.,Ethanol
DB00934,The metabolism of Maprotiline can be decreased when combined with Interferon alfa-n3.,Maprotiline
DB00969,The metabolism of Alosetron can be decreased when combined with Interferon alfa-n3.,Alosetron
DB00978,The metabolism of Lomefloxacin can be decreased when combined with Interferon alfa-n3.,Lomefloxacin
DB00980,The metabolism of Ramelteon can be decreased when combined with Interferon alfa-n3.,Ramelteon
DB00998,The metabolism of Frovatriptan can be decreased when combined with Interferon alfa-n3.,Frovatriptan
DB01002,The metabolism of Levobupivacaine can be decreased when combined with Interferon alfa-n3.,Levobupivacaine
DB01012,The metabolism of Cinacalcet can be decreased when combined with Interferon alfa-n3.,Cinacalcet
DB01037,The metabolism of Selegiline can be decreased when combined with Interferon alfa-n3.,Selegiline
DB01056,The metabolism of Tocainide can be decreased when combined with Interferon alfa-n3.,Tocainide
DB01058,The metabolism of Praziquantel can be decreased when combined with Interferon alfa-n3.,Praziquantel
DB01065,The metabolism of Melatonin can be decreased when combined with Interferon alfa-n3.,Melatonin
DB01087,The metabolism of Primaquine can be decreased when combined with Interferon alfa-n3.,Primaquine
DB01094,The metabolism of Hesperetin can be decreased when combined with Interferon alfa-n3.,Hesperetin
DB01115,The metabolism of Nifedipine can be decreased when combined with Interferon alfa-n3.,Nifedipine
DB01136,The metabolism of Carvedilol can be decreased when combined with Interferon alfa-n3.,Carvedilol
DB01166,The metabolism of Cilostazol can be decreased when combined with Interferon alfa-n3.,Cilostazol
DB01182,The metabolism of Propafenone can be decreased when combined with Interferon alfa-n3.,Propafenone
DB01184,The metabolism of Domperidone can be decreased when combined with Interferon alfa-n3.,Domperidone
DB01191,The metabolism of Dexfenfluramine can be decreased when combined with Interferon alfa-n3.,Dexfenfluramine
DB01367,The metabolism of Rasagiline can be decreased when combined with Interferon alfa-n3.,Rasagiline
DB01405,The metabolism of Temafloxacin can be decreased when combined with Interferon alfa-n3.,Temafloxacin
DB01424,The metabolism of Aminophenazone can be decreased when combined with Interferon alfa-n3.,Aminophenazone
DB01435,The metabolism of Antipyrine can be decreased when combined with Interferon alfa-n3.,Antipyrine
DB01558,The metabolism of Bromazepam can be decreased when combined with Interferon alfa-n3.,Bromazepam
DB01623,The metabolism of Thiothixene can be decreased when combined with Interferon alfa-n3.,Thiothixene
DB01628,The metabolism of Etoricoxib can be decreased when combined with Interferon alfa-n3.,Etoricoxib
DB01645,The metabolism of Genistein can be decreased when combined with Interferon alfa-n3.,Genistein
DB02709,The metabolism of Resveratrol can be decreased when combined with Interferon alfa-n3.,Resveratrol
DB03783,The metabolism of Phenacetin can be decreased when combined with Interferon alfa-n3.,Phenacetin
DB04574,The metabolism of Estrone sulfate can be decreased when combined with Interferon alfa-n3.,Estrone sulfate
DB04841,The metabolism of Flunarizine can be decreased when combined with Interferon alfa-n3.,Flunarizine
DB04871,The metabolism of Lorcaserin can be decreased when combined with Interferon alfa-n3.,Lorcaserin
DB04948,The metabolism of Lofexidine can be decreased when combined with Interferon alfa-n3.,Lofexidine
DB06148,The metabolism of Mianserin can be decreased when combined with Interferon alfa-n3.,Mianserin
DB06210,The metabolism of Eltrombopag can be decreased when combined with Interferon alfa-n3.,Eltrombopag
DB06216,The metabolism of Asenapine can be decreased when combined with Interferon alfa-n3.,Asenapine
DB06235,The metabolism of Vadimezan can be decreased when combined with Interferon alfa-n3.,Vadimezan
DB06292,The metabolism of Dapagliflozin can be decreased when combined with Interferon alfa-n3.,Dapagliflozin
DB06594,The metabolism of Agomelatine can be decreased when combined with Interferon alfa-n3.,Agomelatine
DB06626,The metabolism of Axitinib can be decreased when combined with Interferon alfa-n3.,Axitinib
DB06770,The metabolism of Benzyl alcohol can be decreased when combined with Interferon alfa-n3.,Benzyl alcohol
DB06774,The metabolism of Capsaicin can be decreased when combined with Interferon alfa-n3.,Capsaicin
DB08496,The metabolism of (R)-warfarin can be decreased when combined with Interferon alfa-n3.,(R)-warfarin
DB08883,The metabolism of Perampanel can be decreased when combined with Interferon alfa-n3.,Perampanel
DB09071,The metabolism of Tasimelteon can be decreased when combined with Interferon alfa-n3.,Tasimelteon
DB09118,The metabolism of Stiripentol can be decreased when combined with Interferon alfa-n3.,Stiripentol
DB09225,The metabolism of Zotepine can be decreased when combined with Interferon alfa-n3.,Zotepine
DB09288,The metabolism of Propacetamol can be decreased when combined with Interferon alfa-n3.,Propacetamol
DB09290,The metabolism of Ramosetron can be decreased when combined with Interferon alfa-n3.,Ramosetron
DB11967,The metabolism of Binimetinib can be decreased when combined with Interferon alfa-n3.,Binimetinib
DB12026,The metabolism of Voxilaprevir can be decreased when combined with Interferon alfa-n3.,Voxilaprevir
DB12245,The metabolism of Triclabendazole can be decreased when combined with Interferon alfa-n3.,Triclabendazole
DB12332,The metabolism of Rucaparib can be decreased when combined with Interferon alfa-n3.,Rucaparib
DB12945,The metabolism of Dihydralazine can be decreased when combined with Interferon alfa-n3.,Dihydralazine
DB13952,The metabolism of Estradiol acetate can be decreased when combined with Interferon alfa-n3.,Estradiol acetate
DB13953,The metabolism of Estradiol benzoate can be decreased when combined with Interferon alfa-n3.,Estradiol benzoate
DB13954,The metabolism of Estradiol cypionate can be decreased when combined with Interferon alfa-n3.,Estradiol cypionate
DB13955,The metabolism of Estradiol dienanthate can be decreased when combined with Interferon alfa-n3.,Estradiol dienanthate
DB13956,The metabolism of Estradiol valerate can be decreased when combined with Interferon alfa-n3.,Estradiol valerate
DB11757,The metabolism of Istradefylline can be decreased when combined with Interferon alfa-n3.,Istradefylline
DB00972,The metabolism of Azelastine can be decreased when combined with Interferon alfa-n3.,Azelastine
DB00625,The metabolism of Efavirenz can be decreased when combined with Interferon alfa-n3.,Efavirenz
DB01233,The metabolism of Metoclopramide can be decreased when combined with Interferon alfa-n3.,Metoclopramide
DB04889,The metabolism of Bicifadine can be decreased when combined with Interferon alfa-n3.,Bicifadine
DB05708,The metabolism of GTS-21 can be decreased when combined with Interferon alfa-n3.,GTS-21
DB01195,The metabolism of Flecainide can be decreased when combined with Interferon alfa-n3.,Flecainide
DB00977,The metabolism of Ethinylestradiol can be decreased when combined with Interferon alfa-n3.,Ethinylestradiol
DB00321,The metabolism of Amitriptyline can be decreased when combined with Interferon alfa-n3.,Amitriptyline
DB00458,The metabolism of Imipramine can be decreased when combined with Interferon alfa-n3.,Imipramine
DB01142,The metabolism of Doxepin can be decreased when combined with Interferon alfa-n3.,Doxepin
DB00532,The metabolism of Mephenytoin can be decreased when combined with Interferon alfa-n3.,Mephenytoin
DB00540,The metabolism of Nortriptyline can be decreased when combined with Interferon alfa-n3.,Nortriptyline
DB00575,The metabolism of Clonidine can be decreased when combined with Interferon alfa-n3.,Clonidine
DB00924,The metabolism of Cyclobenzaprine can be decreased when combined with Interferon alfa-n3.,Cyclobenzaprine
DB01151,The metabolism of Desipramine can be decreased when combined with Interferon alfa-n3.,Desipramine
DB01242,The metabolism of Clomipramine can be decreased when combined with Interferon alfa-n3.,Clomipramine
DB11689,The metabolism of Selumetinib can be decreased when combined with Interferon alfa-n3.,Selumetinib
DB00277,The metabolism of Theophylline can be decreased when combined with Interferon alfa-n3.,Theophylline
DB00682,The metabolism of Warfarin can be decreased when combined with Interferon alfa-n3.,Warfarin
DB00697,The metabolism of Tizanidine can be decreased when combined with Interferon alfa-n3.,Tizanidine
DB01100,The metabolism of Pimozide can be decreased when combined with Interferon alfa-n3.,Pimozide
DB01223,The metabolism of Aminophylline can be decreased when combined with Interferon alfa-n3.,Aminophylline
DB01418,The metabolism of Acenocoumarol can be decreased when combined with Interferon alfa-n3.,Acenocoumarol
DB00530,The metabolism of Erlotinib can be decreased when combined with Interferon alfa-n3.,Erlotinib
DB09256,The metabolism of Tegafur can be decreased when combined with Interferon alfa-n3.,Tegafur
DB13874,The metabolism of Enasidenib can be decreased when combined with Interferon alfa-n3.,Enasidenib
DB00675,The metabolism of Tamoxifen can be decreased when combined with Interferon alfa-n3.,Tamoxifen
DB00001,The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon alfa-n3.,Lepirudin
DB00006,The risk or severity of bleeding can be increased when Bivalirudin is combined with Interferon alfa-n3.,Bivalirudin
DB00009,The risk or severity of bleeding can be increased when Alteplase is combined with Interferon alfa-n3.,Alteplase
DB00013,The risk or severity of bleeding can be increased when Urokinase is combined with Interferon alfa-n3.,Urokinase
DB00015,The risk or severity of bleeding can be increased when Reteplase is combined with Interferon alfa-n3.,Reteplase
DB00029,The risk or severity of bleeding can be increased when Anistreplase is combined with Interferon alfa-n3.,Anistreplase
DB00031,The risk or severity of bleeding can be increased when Tenecteplase is combined with Interferon alfa-n3.,Tenecteplase
DB00055,The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Interferon alfa-n3.,Drotrecogin alfa
DB00086,The risk or severity of bleeding can be increased when Streptokinase is combined with Interferon alfa-n3.,Streptokinase
DB00266,The risk or severity of bleeding can be increased when Dicoumarol is combined with Interferon alfa-n3.,Dicoumarol
DB00278,The risk or severity of bleeding can be increased when Argatroban is combined with Interferon alfa-n3.,Argatroban
DB00407,The risk or severity of bleeding can be increased when Ardeparin is combined with Interferon alfa-n3.,Ardeparin
DB00498,The risk or severity of bleeding can be increased when Phenindione is combined with Interferon alfa-n3.,Phenindione
DB00569,The risk or severity of bleeding can be increased when Fondaparinux is combined with Interferon alfa-n3.,Fondaparinux
DB00686,The risk or severity of bleeding can be increased when Pentosan polysulfate is combined with Interferon alfa-n3.,Pentosan polysulfate
DB00946,The risk or severity of bleeding can be increased when Phenprocoumon is combined with Interferon alfa-n3.,Phenprocoumon
DB01109,The risk or severity of bleeding can be increased when Heparin is combined with Interferon alfa-n3.,Heparin
DB01225,The risk or severity of bleeding can be increased when Enoxaparin is combined with Interferon alfa-n3.,Enoxaparin
DB03410,The risk or severity of bleeding can be increased when 4-hydroxycoumarin is combined with Interferon alfa-n3.,4-hydroxycoumarin
DB04665,The risk or severity of bleeding can be increased when Coumarin is combined with Interferon alfa-n3.,Coumarin
DB04898,The risk or severity of bleeding can be increased when Ximelagatran is combined with Interferon alfa-n3.,Ximelagatran
DB04925,The risk or severity of bleeding can be increased when Desmoteplase is combined with Interferon alfa-n3.,Desmoteplase
DB05099,The risk or severity of bleeding can be increased when Ancrod is combined with Interferon alfa-n3.,Ancrod
DB05254,The risk or severity of bleeding can be increased when Fibrinolysin is combined with Interferon alfa-n3.,Fibrinolysin
DB06228,The risk or severity of bleeding can be increased when Rivaroxaban is combined with Interferon alfa-n3.,Rivaroxaban
DB06271,The risk or severity of bleeding can be increased when Sulodexide is combined with Interferon alfa-n3.,Sulodexide
DB06294,The risk or severity of bleeding can be increased when Semuloparin is combined with Interferon alfa-n3.,Semuloparin
DB06406,The risk or severity of bleeding can be increased when Idraparinux is combined with Interferon alfa-n3.,Idraparinux
DB06543,The risk or severity of bleeding can be increased when Astaxanthin is combined with Interferon alfa-n3.,Astaxanthin
DB06605,The risk or severity of bleeding can be increased when Apixaban is combined with Interferon alfa-n3.,Apixaban
DB06635,The risk or severity of bleeding can be increased when Otamixaban is combined with Interferon alfa-n3.,Otamixaban
DB06679,The risk or severity of bleeding can be increased when Amediplase is combined with Interferon alfa-n3.,Amediplase
DB06695,The risk or severity of bleeding can be increased when Dabigatran etexilate is combined with Interferon alfa-n3.,Dabigatran etexilate
DB06754,The risk or severity of bleeding can be increased when Danaparoid is combined with Interferon alfa-n3.,Danaparoid
DB06779,The risk or severity of bleeding can be increased when Dalteparin is combined with Interferon alfa-n3.,Dalteparin
DB06822,The risk or severity of bleeding can be increased when Tinzaparin is combined with Interferon alfa-n3.,Tinzaparin
DB07767,The risk or severity of bleeding can be increased when Ferulic acid is combined with Interferon alfa-n3.,Ferulic acid
DB08794,The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Interferon alfa-n3.,Ethyl biscoumacetate
DB08813,The risk or severity of bleeding can be increased when Nadroparin is combined with Interferon alfa-n3.,Nadroparin
DB08994,The risk or severity of bleeding can be increased when Ditazole is combined with Interferon alfa-n3.,Ditazole
DB09075,The risk or severity of bleeding can be increased when Edoxaban is combined with Interferon alfa-n3.,Edoxaban
DB09125,The risk or severity of bleeding can be increased when Potassium citrate is combined with Interferon alfa-n3.,Potassium citrate
DB09154,The risk or severity of bleeding can be increased when Sodium citrate is combined with Interferon alfa-n3.,Sodium citrate
DB09255,The risk or severity of bleeding can be increased when Dextran is combined with Interferon alfa-n3.,Dextran
DB09258,The risk or severity of bleeding can be increased when Bemiparin is combined with Interferon alfa-n3.,Bemiparin
DB09259,The risk or severity of bleeding can be increased when Reviparin is combined with Interferon alfa-n3.,Reviparin
DB09260,The risk or severity of bleeding can be increased when Parnaparin is combined with Interferon alfa-n3.,Parnaparin
DB09261,The risk or severity of bleeding can be increased when Certoparin is combined with Interferon alfa-n3.,Certoparin
DB11095,The risk or severity of bleeding can be increased when Desirudin is combined with Interferon alfa-n3.,Desirudin
DB11154,The risk or severity of bleeding can be increased when Zinc citrate is combined with Interferon alfa-n3.,Zinc citrate
DB11166,The risk or severity of bleeding can be increased when Antithrombin Alfa is combined with Interferon alfa-n3.,Antithrombin Alfa
DB11312,The risk or severity of bleeding can be increased when Protein C is combined with Interferon alfa-n3.,Protein C
DB11598,The risk or severity of bleeding can be increased when Antithrombin III human is combined with Interferon alfa-n3.,Antithrombin III human
DB11984,The risk or severity of bleeding can be increased when Letaxaban is combined with Interferon alfa-n3.,Letaxaban
DB12289,The risk or severity of bleeding can be increased when Darexaban is combined with Interferon alfa-n3.,Darexaban
DB12364,The risk or severity of bleeding can be increased when Betrixaban is combined with Interferon alfa-n3.,Betrixaban
DB12598,The risk or severity of bleeding can be increased when Nafamostat is combined with Interferon alfa-n3.,Nafamostat
DB12726,The risk or severity of bleeding can be increased when Monteplase is combined with Interferon alfa-n3.,Monteplase
DB12831,The risk or severity of bleeding can be increased when Gabexate is combined with Interferon alfa-n3.,Gabexate
DB13136,The risk or severity of bleeding can be increased when Fluindione is combined with Interferon alfa-n3.,Fluindione
DB13149,The risk or severity of bleeding can be increased when Protein S human is combined with Interferon alfa-n3.,Protein S human
DB13199,The risk or severity of bleeding can be increased when Brinase is combined with Interferon alfa-n3.,Brinase
DB13275,The risk or severity of bleeding can be increased when Clorindione is combined with Interferon alfa-n3.,Clorindione
DB13347,The risk or severity of bleeding can be increased when Diphenadione is combined with Interferon alfa-n3.,Diphenadione
DB13451,The risk or severity of bleeding can be increased when Tioclomarol is combined with Interferon alfa-n3.,Tioclomarol
DB13616,The risk or severity of bleeding can be increased when Melagatran is combined with Interferon alfa-n3.,Melagatran
DB13646,The risk or severity of bleeding can be increased when Saruplase is combined with Interferon alfa-n3.,Saruplase
DB14055,The risk or severity of bleeding can be increased when (S)-Warfarin is combined with Interferon alfa-n3.,(S)-Warfarin
DB14094,The risk or severity of bleeding can be increased when Tocopherylquinone is combined with Interferon alfa-n3.,Tocopherylquinone
DB14598,The risk or severity of bleeding can be increased when Edetate calcium disodium anhydrous is combined with Interferon alfa-n3.,Edetate calcium disodium anhydrous
DB14726,The risk or severity of bleeding can be increased when Dabigatran is combined with Interferon alfa-n3.,Dabigatran
DB00232,The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Interferon alfa-n3.,Methyclothiazide
DB00436,The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Interferon alfa-n3.,Bendroflumethiazide
DB00562,The risk or severity of neutropenia and thrombocytopenia can be increased when Benzthiazide is combined with Interferon alfa-n3.,Benzthiazide
DB00606,The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclothiazide is combined with Interferon alfa-n3.,Cyclothiazide
DB00774,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Interferon alfa-n3.,Hydroflumethiazide
DB00880,The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Interferon alfa-n3.,Chlorothiazide
DB00999,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Interferon alfa-n3.,Hydrochlorothiazide
DB01021,The risk or severity of neutropenia and thrombocytopenia can be increased when Trichlormethiazide is combined with Interferon alfa-n3.,Trichlormethiazide
DB01324,The risk or severity of neutropenia and thrombocytopenia can be increased when Polythiazide is combined with Interferon alfa-n3.,Polythiazide
DB13430,The risk or severity of neutropenia and thrombocytopenia can be increased when Mebutizide is combined with Interferon alfa-n3.,Mebutizide
DB13532,The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclopenthiazide is combined with Interferon alfa-n3.,Cyclopenthiazide
DB09042,The risk or severity of myelosuppression can be increased when Interferon alfa-n3 is combined with Tedizolid phosphate.,Tedizolid phosphate
DB00091,Interferon alfa-n3 may increase the immunosuppressive activities of Cyclosporine.,Cyclosporine
DB00268,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Ropinirole.,Ropinirole
DB00115,The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Interferon alfa-n3.,Cyanocobalamin
DB00437,The risk or severity of adverse effects can be increased when Allopurinol is combined with Interferon alfa-n3.,Allopurinol
DB14513,The serum concentration of Magnesium can be decreased when it is combined with Interferon alfa-n3.,Magnesium
DB01601,The serum concentration of Interferon alfa-n3 can be increased when it is combined with Lopinavir.,Lopinavir
DB12530,The risk or severity of infection can be increased when Interferon alfa-n3 is combined with Inebilizumab.,Inebilizumab
DB00531,The risk or severity of pulmonary toxicity can be increased when Pegfilgrastim is combined with Cyclophosphamide.,Cyclophosphamide
DB01030,The risk or severity of neutropenia can be increased when Pegfilgrastim is combined with Topotecan.,Topotecan
DB00008,The therapeutic efficacy of Pegfilgrastim can be decreased when used in combination with Peginterferon alfa-2a.,Peginterferon alfa-2a
DB00022,The therapeutic efficacy of Peginterferon alfa-2b can be decreased when used in combination with Pegfilgrastim.,Peginterferon alfa-2b
DB00059,The therapeutic efficacy of Pegaspargase can be decreased when used in combination with Pegfilgrastim.,Pegaspargase
DB00061,The therapeutic efficacy of Pegademase can be decreased when used in combination with Pegfilgrastim.,Pegademase
DB00082,The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Pegfilgrastim.,Pegvisomant
DB01839,The therapeutic efficacy of Propylene glycol can be decreased when used in combination with Pegfilgrastim.,Propylene glycol
DB03394,The therapeutic efficacy of Heptaethylene glycol can be decreased when used in combination with Pegfilgrastim.,Heptaethylene glycol
DB04895,The therapeutic efficacy of Pegaptanib can be decreased when used in combination with Pegfilgrastim.,Pegaptanib
DB05202,The therapeutic efficacy of Egaptivon pegol can be decreased when used in combination with Pegfilgrastim.,Egaptivon pegol
DB05321,The therapeutic efficacy of PEG-uricase can be decreased when used in combination with Pegfilgrastim.,PEG-uricase
DB05860,The therapeutic efficacy of Peginterferon alfacon-1 can be decreased when used in combination with Pegfilgrastim.,Peginterferon alfacon-1
DB06022,The therapeutic efficacy of GlycoPEG-GCSF can be decreased when used in combination with Pegfilgrastim.,GlycoPEG-GCSF
DB06293,The therapeutic efficacy of Pegnivacogin can be decreased when used in combination with Pegfilgrastim.,Pegnivacogin
DB06325,The therapeutic efficacy of Pegpleranib can be decreased when used in combination with Pegfilgrastim.,Pegpleranib
DB06611,The therapeutic efficacy of Pegsunercept can be decreased when used in combination with Pegfilgrastim.,Pegsunercept
DB06811,The therapeutic efficacy of Polidocanol can be decreased when used in combination with Pegfilgrastim.,Polidocanol
DB08894,The therapeutic efficacy of Peginesatide can be decreased when used in combination with Pegfilgrastim.,Peginesatide
DB08904,The therapeutic efficacy of Certolizumab pegol can be decreased when used in combination with Pegfilgrastim.,Certolizumab pegol
DB09107,The therapeutic efficacy of Methoxy polyethylene glycol-epoetin beta can be decreased when used in combination with Pegfilgrastim.,Methoxy polyethylene glycol-epoetin beta
DB09122,The therapeutic efficacy of Peginterferon beta-1a can be decreased when used in combination with Pegfilgrastim.,Peginterferon beta-1a
DB09208,The therapeutic efficacy of Pegloticase can be decreased when used in combination with Pegfilgrastim.,Pegloticase
DB09287,The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Pegfilgrastim.,Polyethylene glycol
DB09329,"The therapeutic efficacy of Antihemophilic Factor (Recombinant), PEGylated can be decreased when used in combination with Pegfilgrastim.","Antihemophilic Factor (Recombinant), PEGylated"
DB11077,The therapeutic efficacy of Polyethylene glycol 400 can be decreased when used in combination with Pegfilgrastim.,Polyethylene glycol 400
DB11567,The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Pegfilgrastim.,Insulin peglispro
DB11661,The therapeutic efficacy of Eptacog alfa pegol (activated) can be decreased when used in combination with Pegfilgrastim.,Eptacog alfa pegol (activated)
DB11707,The therapeutic efficacy of Olaptesed Pegol can be decreased when used in combination with Pegfilgrastim.,Olaptesed Pegol
DB12258,The therapeutic efficacy of Abicipar Pegol can be decreased when used in combination with Pegfilgrastim.,Abicipar Pegol
DB12578,The therapeutic efficacy of Lexaptepid Pegol can be decreased when used in combination with Pegfilgrastim.,Lexaptepid Pegol
DB12814,The therapeutic efficacy of Cepeginterferon alfa-2B can be decreased when used in combination with Pegfilgrastim.,Cepeginterferon alfa-2B
DB12839,The therapeutic efficacy of Pegvaliase can be decreased when used in combination with Pegfilgrastim.,Pegvaliase
DB12842,The therapeutic efficacy of Pegamotecan can be decreased when used in combination with Pegfilgrastim.,Pegamotecan
DB13200,The therapeutic efficacy of Lipegfilgrastim can be decreased when used in combination with Pegfilgrastim.,Lipegfilgrastim
DB13933,The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Pegfilgrastim.,Nonacog beta pegol
DB14700,The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Pegfilgrastim.,Damoctocog alfa pegol
DB14712,The therapeutic efficacy of Elapegademase can be decreased when used in combination with Pegfilgrastim.,Elapegademase
DB00309,The risk or severity of peripheral neuropathy can be increased when Pegfilgrastim is combined with Vindesine.,Vindesine
DB00361,The risk or severity of peripheral neuropathy can be increased when Pegfilgrastim is combined with Vinorelbine.,Vinorelbine
DB00541,The risk or severity of peripheral neuropathy can be increased when Pegfilgrastim is combined with Vincristine.,Vincristine
DB00570,The risk or severity of peripheral neuropathy can be increased when Pegfilgrastim is combined with Vinblastine.,Vinblastine
DB05168,The risk or severity of peripheral neuropathy can be increased when Pegfilgrastim is combined with Vintafolide.,Vintafolide
DB11641,The risk or severity of peripheral neuropathy can be increased when Pegfilgrastim is combined with Vinflunine.,Vinflunine
DB13374,The risk or severity of peripheral neuropathy can be increased when Pegfilgrastim is combined with Vincamine.,Vincamine
DB00290,The risk or severity of adverse effects can be increased when Sargramostim is combined with Bleomycin.,Bleomycin
DB00531,The risk or severity of adverse effects can be increased when Cyclophosphamide is combined with Sargramostim.,Cyclophosphamide
DB00309,The risk or severity of peripheral neuropathy can be increased when Sargramostim is combined with Vindesine.,Vindesine
DB00361,The risk or severity of peripheral neuropathy can be increased when Sargramostim is combined with Vinorelbine.,Vinorelbine
DB00541,The risk or severity of peripheral neuropathy can be increased when Sargramostim is combined with Vincristine.,Vincristine
DB00570,The risk or severity of peripheral neuropathy can be increased when Sargramostim is combined with Vinblastine.,Vinblastine
DB05168,The risk or severity of peripheral neuropathy can be increased when Sargramostim is combined with Vintafolide.,Vintafolide
DB11641,The risk or severity of peripheral neuropathy can be increased when Sargramostim is combined with Vinflunine.,Vinflunine
DB13374,The risk or severity of peripheral neuropathy can be increased when Sargramostim is combined with Vincamine.,Vincamine
DB06643,The risk or severity of adverse effects can be increased when Denosumab is combined with Peginterferon alfa-2b.,Denosumab
DB00005,The risk or severity of adverse effects can be increased when Etanercept is combined with Peginterferon alfa-2b.,Etanercept
DB00008,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Peginterferon alfa-2b.,Peginterferon alfa-2a
DB00011,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Peginterferon alfa-2b.,Interferon alfa-n1
DB00018,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Peginterferon alfa-2b.,Interferon alfa-n3
DB00026,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Anakinra.,Anakinra
DB00033,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Interferon gamma-1b.,Interferon gamma-1b
DB00034,"The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Interferon alfa-2a, Recombinant.","Interferon alfa-2a, Recombinant"
DB00051,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Adalimumab.,Adalimumab
DB00056,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin
DB00059,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Pegaspargase.,Pegaspargase
DB00065,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Infliximab.,Infliximab
DB00068,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Interferon beta-1b.,Interferon beta-1b
DB00069,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Interferon alfacon-1.,Interferon alfacon-1
DB00073,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Rituximab.,Rituximab
DB00074,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Basiliximab.,Basiliximab
DB00075,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Muromonab.,Muromonab
DB00078,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Ibritumomab tiuxetan.,Ibritumomab tiuxetan
DB00081,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Tositumomab.,Tositumomab
DB00087,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Alemtuzumab.,Alemtuzumab
DB00092,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Alefacept.,Alefacept
DB00095,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Efalizumab.,Efalizumab
DB00098,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Antithymocyte immunoglobulin (rabbit).,Antithymocyte immunoglobulin (rabbit)
DB00105,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Interferon alfa-2b.,Interferon alfa-2b
DB00111,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Daclizumab.,Daclizumab
DB00112,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Bevacizumab.,Bevacizumab
DB00120,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Phenylalanine.,Phenylalanine
DB00180,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Flunisolide.,Flunisolide
DB00242,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Cladribine.,Cladribine
DB00276,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Amsacrine.,Amsacrine
DB00290,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Bleomycin.,Bleomycin
DB00291,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Chlorambucil.,Chlorambucil
DB00293,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Raltitrexed.,Raltitrexed
DB00305,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Mitomycin.,Mitomycin
DB00307,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Bexarotene.,Bexarotene
DB00309,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Vindesine.,Vindesine
DB00322,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Floxuridine.,Floxuridine
DB00328,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Indomethacin.,Indomethacin
DB00352,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Tioguanine.,Tioguanine
DB00361,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Vinorelbine.,Vinorelbine
DB00380,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Dexrazoxane.,Dexrazoxane
DB00394,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Beclomethasone dipropionate.,Beclomethasone dipropionate
DB00428,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Streptozocin.,Streptozocin
DB00432,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Trifluridine.,Trifluridine
DB00441,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Gemcitabine.,Gemcitabine
DB00443,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Betamethasone.,Betamethasone
DB00444,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Teniposide.,Teniposide
DB00445,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Epirubicin.,Epirubicin
DB00446,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Chloramphenicol.,Chloramphenicol
DB00480,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Lenalidomide.,Lenalidomide
DB00488,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Altretamine.,Altretamine
DB00515,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Cisplatin.,Cisplatin
DB00526,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Oxaliplatin.,Oxaliplatin
DB00531,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Cyclophosphamide.,Cyclophosphamide
DB00541,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Vincristine.,Vincristine
DB00550,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Propylthiouracil.,Propylthiouracil
DB00552,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Pentostatin.,Pentostatin
DB00563,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Methotrexate.,Methotrexate
DB00570,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Vinblastine.,Vinblastine
DB00588,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Fluticasone propionate.,Fluticasone propionate
DB00591,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Fluocinolone acetonide.,Fluocinolone acetonide
DB00601,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Linezolid.,Linezolid
DB00620,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Triamcinolone.,Triamcinolone
DB00631,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Clofarabine.,Clofarabine
DB00635,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Prednisone.,Prednisone
DB00687,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Fludrocortisone.,Fludrocortisone
DB00688,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Mycophenolate mofetil.,Mycophenolate mofetil
DB00694,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Daunorubicin.,Daunorubicin
DB00755,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Tretinoin.,Tretinoin
DB00762,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Irinotecan.,Irinotecan
DB00763,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Methimazole.,Methimazole
DB00764,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Mometasone.,Mometasone
DB00795,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Sulfasalazine.,Sulfasalazine
DB00853,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Temozolomide.,Temozolomide
DB00859,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Penicillamine.,Penicillamine
DB00860,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Prednisolone.,Prednisolone
DB00877,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Sirolimus.,Sirolimus
DB00888,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Mechlorethamine.,Mechlorethamine
DB00928,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Azacitidine.,Azacitidine
DB00958,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Carboplatin.,Carboplatin
DB00959,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Methylprednisolone.,Methylprednisolone
DB00970,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Dactinomycin.,Dactinomycin
DB00987,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Cytarabine.,Cytarabine
DB00997,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Doxorubicin.,Doxorubicin
DB01005,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Hydroxyurea.,Hydroxyurea
DB01008,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Busulfan.,Busulfan
DB01024,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Mycophenolic acid.,Mycophenolic acid
DB01030,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Topotecan.,Topotecan
DB01033,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Mercaptopurine.,Mercaptopurine
DB01041,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Thalidomide.,Thalidomide
DB01042,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Melphalan.,Melphalan
DB01073,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Fludarabine.,Fludarabine
DB01099,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Flucytosine.,Flucytosine
DB01108,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Trilostane.,Trilostane
DB01168,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Procarbazine.,Procarbazine
DB01169,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Arsenic trioxide.,Arsenic trioxide
DB01177,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Idarubicin.,Idarubicin
DB01181,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Ifosfamide.,Ifosfamide
DB01196,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Estramustine.,Estramustine
DB01204,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Mitoxantrone.,Mitoxantrone
DB01206,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Lomustine.,Lomustine
DB01222,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Budesonide.,Budesonide
DB01229,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Paclitaxel.,Paclitaxel
DB01234,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Dexamethasone.,Dexamethasone
DB01248,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Docetaxel.,Docetaxel
DB01257,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Eculizumab.,Eculizumab
DB01262,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Decitabine.,Decitabine
DB01268,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Sunitinib.,Sunitinib
DB01280,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Nelarabine.,Nelarabine
DB01281,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Abatacept.,Abatacept
DB01285,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Corticotropin.,Corticotropin
DB01380,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Cortisone acetate.,Cortisone acetate
DB01384,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Paramethasone.,Paramethasone
DB01394,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Colchicine.,Colchicine
DB01410,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Ciclesonide.,Ciclesonide
DB01423,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Stepronin.,Stepronin
DB01590,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Everolimus.,Everolimus
DB01611,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Hydroxychloroquine.,Hydroxychloroquine
DB01816,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Castanospermine.,Castanospermine
DB02546,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Vorinostat.,Vorinostat
DB02806,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with 2-Methoxyethanol.,2-Methoxyethanol
DB03523,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Brequinar.,Brequinar
DB04572,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Thiotepa.,Thiotepa
DB04630,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Aldosterone.,Aldosterone
DB04845,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Ixabepilone.,Ixabepilone
DB04868,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Nilotinib.,Nilotinib
DB04956,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Afelimomab.,Afelimomab
DB05258,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Interferon alfa.,Interferon alfa
DB05259,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Glatiramer.,Glatiramer
DB05260,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Gallium nitrate.,Gallium nitrate
DB05459,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Briakinumab.,Briakinumab
DB05472,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with omega interferon.,omega interferon
DB05773,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Trastuzumab emtansine.,Trastuzumab emtansine
DB06168,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Canakinumab.,Canakinumab
DB06273,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Tocilizumab.,Tocilizumab
DB06287,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Temsirolimus.,Temsirolimus
DB06372,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Rilonacept.,Rilonacept
DB06603,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Panobinostat.,Panobinostat
DB06612,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Mepolizumab.,Mepolizumab
DB06616,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Bosutinib.,Bosutinib
DB06662,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Abetimus.,Abetimus
DB06674,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Golimumab.,Golimumab
DB06681,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Belatacept.,Belatacept
DB06772,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Cabazitaxel.,Cabazitaxel
DB06813,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Pralatrexate.,Pralatrexate
DB08059,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Wortmannin.,Wortmannin
DB08870,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Brentuximab vedotin.,Brentuximab vedotin
DB08871,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Eribulin.,Eribulin
DB08877,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Ruxolitinib.,Ruxolitinib
DB08879,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Belimumab.,Belimumab
DB08880,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Teriflunomide.,Teriflunomide
DB08889,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Carfilzomib.,Carfilzomib
DB08901,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Ponatinib.,Ponatinib
DB08904,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Certolizumab pegol.,Certolizumab pegol
DB08906,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Fluticasone furoate.,Fluticasone furoate
DB08908,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Dimethyl fumarate.,Dimethyl fumarate
DB08935,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Obinutuzumab.,Obinutuzumab
DB08970,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Fluprednidene.,Fluprednidene
DB08971,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Fluocortolone.,Fluocortolone
DB09029,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Secukinumab.,Secukinumab
DB09033,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Vedolizumab.,Vedolizumab
DB09036,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Siltuximab.,Siltuximab
DB09052,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Blinatumomab.,Blinatumomab
DB09053,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Ibrutinib.,Ibrutinib
DB09054,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Idelalisib.,Idelalisib
DB09073,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Palbociclib.,Palbociclib
DB09074,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Olaparib.,Olaparib
DB09077,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Dinutuximab.,Dinutuximab
DB09082,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Vilanterol.,Vilanterol
DB09091,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Tixocortol.,Tixocortol
DB09122,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Peginterferon beta-1a.,Peginterferon beta-1a
DB09312,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Antilymphocyte immunoglobulin (horse).,Antilymphocyte immunoglobulin (horse)
DB09378,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Fluprednisolone.,Fluprednisolone
DB09383,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Meprednisone.,Meprednisone
DB11466,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Tepoxalin.,Tepoxalin
DB11487,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Dexamethasone isonicotinate.,Dexamethasone isonicotinate
DB11529,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Melengestrol.,Melengestrol
DB11569,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Ixekizumab.,Ixekizumab
DB11580,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Ravulizumab.,Ravulizumab
DB11616,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Pirarubicin.,Pirarubicin
DB11693,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Voclosporin.,Voclosporin
DB11708,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Peficitinib.,Peficitinib
DB11750,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Clobetasol.,Clobetasol
DB11767,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Sarilumab.,Sarilumab
DB11776,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Brodalumab.,Brodalumab
DB11803,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Sirukumab.,Sirukumab
DB11817,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Baricitinib.,Baricitinib
DB11834,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Guselkumab.,Guselkumab
DB11921,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Deflazacort.,Deflazacort
DB11988,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Ocrelizumab.,Ocrelizumab
DB12025,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Triptolide.,Triptolide
DB12612,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Ozanimod.,Ozanimod
DB12617,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Mizoribine.,Mizoribine
DB12692,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Gusperimus.,Gusperimus
DB12814,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Cepeginterferon alfa-2B.,Cepeginterferon alfa-2B
DB12902,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Trofosfamide.,Trofosfamide
DB12947,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Doxifluridine.,Doxifluridine
DB12991,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Deoxyspergualin.,Deoxyspergualin
DB12996,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Acteoside.,Acteoside
DB13003,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Cortivazol.,Cortivazol
DB13014,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Hypericin.,Hypericin
DB13068,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.,9-(N-methyl-L-isoleucine)-cyclosporin A
DB13208,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Prednylidene.,Prednylidene
DB13223,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Fluocortin.,Fluocortin
DB13241,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Begelomab.,Begelomab
DB13491,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Fluperolone.,Fluperolone
DB13664,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Formocortal.,Formocortal
DB13728,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Halometasone.,Halometasone
DB13843,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Cloprednol.,Cloprednol
DB13856,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Fluclorolone.,Fluclorolone
DB13867,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Fluticasone.,Fluticasone
DB14066,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Tetrandrine.,Tetrandrine
DB14219,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Monomethyl fumarate.,Monomethyl fumarate
DB14512,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Mometasone furoate.,Mometasone furoate
DB14538,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Hydrocortisone aceponate.,Hydrocortisone aceponate
DB14539,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Hydrocortisone acetate.,Hydrocortisone acetate
DB14545,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Hydrocortisone succinate.,Hydrocortisone succinate
DB14724,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Emapalumab.,Emapalumab
DB14762,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Risankizumab.,Risankizumab
DB14919,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Rozanolixizumab.,Rozanolixizumab
DB15253,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Bleselumab.,Bleselumab
DB12371,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Siponimod.,Siponimod
DB00108,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Natalizumab.,Natalizumab
DB00337,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Peginterferon alfa-2b.,Pimecrolimus
DB01656,Roflumilast may increase the immunosuppressive activities of Peginterferon alfa-2b.,Roflumilast
DB06688,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Peginterferon alfa-2b.,Sipuleucel-T
DB00041,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Aldesleukin.,Aldesleukin
DB00363,The risk or severity of neutropenia can be increased when Peginterferon alfa-2b is combined with Clozapine.,Clozapine
DB00333,The serum concentration of Methadone can be increased when it is combined with Peginterferon alfa-2b.,Methadone
DB00495,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Zidovudine.,Zidovudine
DB00472,The serum concentration of Fluoxetine can be decreased when it is combined with Peginterferon alfa-2b.,Fluoxetine
DB01265,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Telbivudine.,Telbivudine
DB00675,The serum concentration of Tamoxifen can be increased when it is combined with Peginterferon alfa-2b.,Tamoxifen
DB00972,The serum concentration of Azelastine can be increased when it is combined with Peginterferon alfa-2b.,Azelastine
DB00176,The serum concentration of Fluvoxamine can be increased when it is combined with Peginterferon alfa-2b.,Fluvoxamine
DB00184,The serum concentration of Nicotine can be increased when it is combined with Peginterferon alfa-2b.,Nicotine
DB00188,The serum concentration of Bortezomib can be increased when it is combined with Peginterferon alfa-2b.,Bortezomib
DB00195,The serum concentration of Betaxolol can be increased when it is combined with Peginterferon alfa-2b.,Betaxolol
DB00201,The serum concentration of Caffeine can be increased when it is combined with Peginterferon alfa-2b.,Caffeine
DB00261,The serum concentration of Anagrelide can be increased when it is combined with Peginterferon alfa-2b.,Anagrelide
DB00262,The serum concentration of Carmustine can be increased when it is combined with Peginterferon alfa-2b.,Carmustine
DB00277,The serum concentration of Theophylline can be increased when it is combined with Peginterferon alfa-2b.,Theophylline
DB00280,The serum concentration of Disopyramide can be increased when it is combined with Peginterferon alfa-2b.,Disopyramide
DB00281,The serum concentration of Lidocaine can be increased when it is combined with Peginterferon alfa-2b.,Lidocaine
DB00286,The serum concentration of Conjugated estrogens can be increased when it is combined with Peginterferon alfa-2b.,Conjugated estrogens
DB00296,The serum concentration of Ropivacaine can be increased when it is combined with Peginterferon alfa-2b.,Ropivacaine
DB00316,The serum concentration of Acetaminophen can be increased when it is combined with Peginterferon alfa-2b.,Acetaminophen
DB00334,The serum concentration of Olanzapine can be increased when it is combined with Peginterferon alfa-2b.,Olanzapine
DB00356,The serum concentration of Chlorzoxazone can be increased when it is combined with Peginterferon alfa-2b.,Chlorzoxazone
DB00365,The serum concentration of Grepafloxacin can be increased when it is combined with Peginterferon alfa-2b.,Grepafloxacin
DB00370,The serum concentration of Mirtazapine can be increased when it is combined with Peginterferon alfa-2b.,Mirtazapine
DB00379,The serum concentration of Mexiletine can be increased when it is combined with Peginterferon alfa-2b.,Mexiletine
DB00382,The serum concentration of Tacrine can be increased when it is combined with Peginterferon alfa-2b.,Tacrine
DB00384,The serum concentration of Triamterene can be increased when it is combined with Peginterferon alfa-2b.,Triamterene
DB00398,The serum concentration of Sorafenib can be increased when it is combined with Peginterferon alfa-2b.,Sorafenib
DB00420,The serum concentration of Promazine can be increased when it is combined with Peginterferon alfa-2b.,Promazine
DB00425,The serum concentration of Zolpidem can be increased when it is combined with Peginterferon alfa-2b.,Zolpidem
DB00442,The serum concentration of Entecavir can be increased when it is combined with Peginterferon alfa-2b.,Entecavir
DB00458,The serum concentration of Imipramine can be increased when it is combined with Peginterferon alfa-2b.,Imipramine
DB00461,The serum concentration of Nabumetone can be increased when it is combined with Peginterferon alfa-2b.,Nabumetone
DB00468,The serum concentration of Quinine can be increased when it is combined with Peginterferon alfa-2b.,Quinine
DB00476,The serum concentration of Duloxetine can be increased when it is combined with Peginterferon alfa-2b.,Duloxetine
DB00477,The serum concentration of Chlorpromazine can be increased when it is combined with Peginterferon alfa-2b.,Chlorpromazine
DB00499,The serum concentration of Flutamide can be increased when it is combined with Peginterferon alfa-2b.,Flutamide
DB00518,The serum concentration of Albendazole can be increased when it is combined with Peginterferon alfa-2b.,Albendazole
DB00530,The serum concentration of Erlotinib can be increased when it is combined with Peginterferon alfa-2b.,Erlotinib
DB00532,The serum concentration of Mephenytoin can be increased when it is combined with Peginterferon alfa-2b.,Mephenytoin
DB00533,The serum concentration of Rofecoxib can be increased when it is combined with Peginterferon alfa-2b.,Rofecoxib
DB00540,The serum concentration of Nortriptyline can be increased when it is combined with Peginterferon alfa-2b.,Nortriptyline
DB00544,The serum concentration of Fluorouracil can be increased when it is combined with Peginterferon alfa-2b.,Fluorouracil
DB00564,The serum concentration of Carbamazepine can be increased when it is combined with Peginterferon alfa-2b.,Carbamazepine
DB00568,The serum concentration of Cinnarizine can be increased when it is combined with Peginterferon alfa-2b.,Cinnarizine
DB00571,The serum concentration of Propranolol can be increased when it is combined with Peginterferon alfa-2b.,Propranolol
DB00575,The serum concentration of Clonidine can be increased when it is combined with Peginterferon alfa-2b.,Clonidine
DB00586,The serum concentration of Diclofenac can be increased when it is combined with Peginterferon alfa-2b.,Diclofenac
DB00619,The serum concentration of Imatinib can be increased when it is combined with Peginterferon alfa-2b.,Imatinib
DB00629,The serum concentration of Guanabenz can be increased when it is combined with Peginterferon alfa-2b.,Guanabenz
DB00642,The serum concentration of Pemetrexed can be increased when it is combined with Peginterferon alfa-2b.,Pemetrexed
DB00661,The serum concentration of Verapamil can be increased when it is combined with Peginterferon alfa-2b.,Verapamil
DB00682,The serum concentration of Warfarin can be increased when it is combined with Peginterferon alfa-2b.,Warfarin
DB00697,The serum concentration of Tizanidine can be increased when it is combined with Peginterferon alfa-2b.,Tizanidine
DB00715,The serum concentration of Paroxetine can be increased when it is combined with Peginterferon alfa-2b.,Paroxetine
DB00730,The serum concentration of Thiabendazole can be increased when it is combined with Peginterferon alfa-2b.,Thiabendazole
DB00740,The serum concentration of Riluzole can be increased when it is combined with Peginterferon alfa-2b.,Riluzole
DB00744,The serum concentration of Zileuton can be increased when it is combined with Peginterferon alfa-2b.,Zileuton
DB00758,The serum concentration of Clopidogrel can be increased when it is combined with Peginterferon alfa-2b.,Clopidogrel
DB00773,The serum concentration of Etoposide can be increased when it is combined with Peginterferon alfa-2b.,Etoposide
DB00783,The serum concentration of Estradiol can be increased when it is combined with Peginterferon alfa-2b.,Estradiol
DB00787,The serum concentration of Acyclovir can be increased when it is combined with Peginterferon alfa-2b.,Acyclovir
DB00788,The serum concentration of Naproxen can be increased when it is combined with Peginterferon alfa-2b.,Naproxen
DB00806,The serum concentration of Pentoxifylline can be increased when it is combined with Peginterferon alfa-2b.,Pentoxifylline
DB00831,The serum concentration of Trifluoperazine can be increased when it is combined with Peginterferon alfa-2b.,Trifluoperazine
DB00850,The serum concentration of Perphenazine can be increased when it is combined with Peginterferon alfa-2b.,Perphenazine
DB00851,The serum concentration of Dacarbazine can be increased when it is combined with Peginterferon alfa-2b.,Dacarbazine
DB00857,The serum concentration of Terbinafine can be increased when it is combined with Peginterferon alfa-2b.,Terbinafine
DB00863,The serum concentration of Ranitidine can be increased when it is combined with Peginterferon alfa-2b.,Ranitidine
DB00898,The serum concentration of Ethanol can be increased when it is combined with Peginterferon alfa-2b.,Ethanol
DB00924,The serum concentration of Cyclobenzaprine can be increased when it is combined with Peginterferon alfa-2b.,Cyclobenzaprine
DB00934,The serum concentration of Maprotiline can be increased when it is combined with Peginterferon alfa-2b.,Maprotiline
DB00969,The serum concentration of Alosetron can be increased when it is combined with Peginterferon alfa-2b.,Alosetron
DB00978,The serum concentration of Lomefloxacin can be increased when it is combined with Peginterferon alfa-2b.,Lomefloxacin
DB00980,The serum concentration of Ramelteon can be increased when it is combined with Peginterferon alfa-2b.,Ramelteon
DB00993,The serum concentration of Azathioprine can be increased when it is combined with Peginterferon alfa-2b.,Azathioprine
DB00998,The serum concentration of Frovatriptan can be increased when it is combined with Peginterferon alfa-2b.,Frovatriptan
DB01002,The serum concentration of Levobupivacaine can be increased when it is combined with Peginterferon alfa-2b.,Levobupivacaine
DB01012,The serum concentration of Cinacalcet can be increased when it is combined with Peginterferon alfa-2b.,Cinacalcet
DB01037,The serum concentration of Selegiline can be increased when it is combined with Peginterferon alfa-2b.,Selegiline
DB01056,The serum concentration of Tocainide can be increased when it is combined with Peginterferon alfa-2b.,Tocainide
DB01058,The serum concentration of Praziquantel can be increased when it is combined with Peginterferon alfa-2b.,Praziquantel
DB01065,The serum concentration of Melatonin can be increased when it is combined with Peginterferon alfa-2b.,Melatonin
DB01087,The serum concentration of Primaquine can be increased when it is combined with Peginterferon alfa-2b.,Primaquine
DB01094,The serum concentration of Hesperetin can be increased when it is combined with Peginterferon alfa-2b.,Hesperetin
DB01100,The serum concentration of Pimozide can be increased when it is combined with Peginterferon alfa-2b.,Pimozide
DB01115,The serum concentration of Nifedipine can be increased when it is combined with Peginterferon alfa-2b.,Nifedipine
DB01136,The serum concentration of Carvedilol can be increased when it is combined with Peginterferon alfa-2b.,Carvedilol
DB01142,The serum concentration of Doxepin can be increased when it is combined with Peginterferon alfa-2b.,Doxepin
DB01151,The serum concentration of Desipramine can be increased when it is combined with Peginterferon alfa-2b.,Desipramine
DB01166,The serum concentration of Cilostazol can be increased when it is combined with Peginterferon alfa-2b.,Cilostazol
DB01182,The serum concentration of Propafenone can be increased when it is combined with Peginterferon alfa-2b.,Propafenone
DB01184,The serum concentration of Domperidone can be increased when it is combined with Peginterferon alfa-2b.,Domperidone
DB01191,The serum concentration of Dexfenfluramine can be increased when it is combined with Peginterferon alfa-2b.,Dexfenfluramine
DB01223,The serum concentration of Aminophylline can be increased when it is combined with Peginterferon alfa-2b.,Aminophylline
DB01242,The serum concentration of Clomipramine can be increased when it is combined with Peginterferon alfa-2b.,Clomipramine
DB01254,The serum concentration of Dasatinib can be increased when it is combined with Peginterferon alfa-2b.,Dasatinib
DB01303,The serum concentration of Oxtriphylline can be increased when it is combined with Peginterferon alfa-2b.,Oxtriphylline
DB01367,The serum concentration of Rasagiline can be increased when it is combined with Peginterferon alfa-2b.,Rasagiline
DB01405,The serum concentration of Temafloxacin can be increased when it is combined with Peginterferon alfa-2b.,Temafloxacin
DB01412,The serum concentration of Theobromine can be increased when it is combined with Peginterferon alfa-2b.,Theobromine
DB01418,The serum concentration of Acenocoumarol can be increased when it is combined with Peginterferon alfa-2b.,Acenocoumarol
DB01424,The serum concentration of Aminophenazone can be increased when it is combined with Peginterferon alfa-2b.,Aminophenazone
DB01435,The serum concentration of Antipyrine can be increased when it is combined with Peginterferon alfa-2b.,Antipyrine
DB01482,The serum concentration of Fenethylline can be increased when it is combined with Peginterferon alfa-2b.,Fenethylline
DB01558,The serum concentration of Bromazepam can be increased when it is combined with Peginterferon alfa-2b.,Bromazepam
DB01623,The serum concentration of Thiothixene can be increased when it is combined with Peginterferon alfa-2b.,Thiothixene
DB01628,The serum concentration of Etoricoxib can be increased when it is combined with Peginterferon alfa-2b.,Etoricoxib
DB01645,The serum concentration of Genistein can be increased when it is combined with Peginterferon alfa-2b.,Genistein
DB01667,The serum concentration of 8-azaguanine can be increased when it is combined with Peginterferon alfa-2b.,8-azaguanine
DB02134,The serum concentration of Xanthine can be increased when it is combined with Peginterferon alfa-2b.,Xanthine
DB02489,The serum concentration of 9-Methylguanine can be increased when it is combined with Peginterferon alfa-2b.,9-Methylguanine
DB02568,The serum concentration of Peldesine can be increased when it is combined with Peginterferon alfa-2b.,Peldesine
DB02709,The serum concentration of Resveratrol can be increased when it is combined with Peginterferon alfa-2b.,Resveratrol
DB03783,The serum concentration of Phenacetin can be increased when it is combined with Peginterferon alfa-2b.,Phenacetin
DB04076,The serum concentration of Hypoxanthine can be increased when it is combined with Peginterferon alfa-2b.,Hypoxanthine
DB04356,The serum concentration of 9-Deazaguanine can be increased when it is combined with Peginterferon alfa-2b.,9-Deazaguanine
DB04574,The serum concentration of Estrone sulfate can be increased when it is combined with Peginterferon alfa-2b.,Estrone sulfate
DB04841,The serum concentration of Flunarizine can be increased when it is combined with Peginterferon alfa-2b.,Flunarizine
DB04871,The serum concentration of Lorcaserin can be increased when it is combined with Peginterferon alfa-2b.,Lorcaserin
DB04948,The serum concentration of Lofexidine can be increased when it is combined with Peginterferon alfa-2b.,Lofexidine
DB04951,The serum concentration of Pirfenidone can be increased when it is combined with Peginterferon alfa-2b.,Pirfenidone
DB05676,The serum concentration of Apremilast can be increased when it is combined with Peginterferon alfa-2b.,Apremilast
DB06148,The serum concentration of Mianserin can be increased when it is combined with Peginterferon alfa-2b.,Mianserin
DB06210,The serum concentration of Eltrombopag can be increased when it is combined with Peginterferon alfa-2b.,Eltrombopag
DB06216,The serum concentration of Asenapine can be increased when it is combined with Peginterferon alfa-2b.,Asenapine
DB06235,The serum concentration of Vadimezan can be increased when it is combined with Peginterferon alfa-2b.,Vadimezan
DB06292,The serum concentration of Dapagliflozin can be increased when it is combined with Peginterferon alfa-2b.,Dapagliflozin
DB06479,The serum concentration of Propentofylline can be increased when it is combined with Peginterferon alfa-2b.,Propentofylline
DB06589,The serum concentration of Pazopanib can be increased when it is combined with Peginterferon alfa-2b.,Pazopanib
DB06594,The serum concentration of Agomelatine can be increased when it is combined with Peginterferon alfa-2b.,Agomelatine
DB06626,The serum concentration of Axitinib can be increased when it is combined with Peginterferon alfa-2b.,Axitinib
DB06769,The serum concentration of Bendamustine can be increased when it is combined with Peginterferon alfa-2b.,Bendamustine
DB06770,The serum concentration of Benzyl alcohol can be increased when it is combined with Peginterferon alfa-2b.,Benzyl alcohol
DB06774,The serum concentration of Capsaicin can be increased when it is combined with Peginterferon alfa-2b.,Capsaicin
DB08496,The serum concentration of (R)-warfarin can be increased when it is combined with Peginterferon alfa-2b.,(R)-warfarin
DB08883,The serum concentration of Perampanel can be increased when it is combined with Peginterferon alfa-2b.,Perampanel
DB08910,The serum concentration of Pomalidomide can be increased when it is combined with Peginterferon alfa-2b.,Pomalidomide
DB09071,The serum concentration of Tasimelteon can be increased when it is combined with Peginterferon alfa-2b.,Tasimelteon
DB09118,The serum concentration of Stiripentol can be increased when it is combined with Peginterferon alfa-2b.,Stiripentol
DB09225,The serum concentration of Zotepine can be increased when it is combined with Peginterferon alfa-2b.,Zotepine
DB09256,The serum concentration of Tegafur can be increased when it is combined with Peginterferon alfa-2b.,Tegafur
DB09273,The serum concentration of Doxofylline can be increased when it is combined with Peginterferon alfa-2b.,Doxofylline
DB09288,The serum concentration of Propacetamol can be increased when it is combined with Peginterferon alfa-2b.,Propacetamol
DB09290,The serum concentration of Ramosetron can be increased when it is combined with Peginterferon alfa-2b.,Ramosetron
DB11919,The serum concentration of 6-O-benzylguanine can be increased when it is combined with Peginterferon alfa-2b.,6-O-benzylguanine
DB11967,The serum concentration of Binimetinib can be increased when it is combined with Peginterferon alfa-2b.,Binimetinib
DB12026,The serum concentration of Voxilaprevir can be increased when it is combined with Peginterferon alfa-2b.,Voxilaprevir
DB12245,The serum concentration of Triclabendazole can be increased when it is combined with Peginterferon alfa-2b.,Triclabendazole
DB12332,The serum concentration of Rucaparib can be increased when it is combined with Peginterferon alfa-2b.,Rucaparib
DB12406,The serum concentration of Lisofylline can be increased when it is combined with Peginterferon alfa-2b.,Lisofylline
DB12531,The serum concentration of Lobucavir can be increased when it is combined with Peginterferon alfa-2b.,Lobucavir
DB12926,The serum concentration of Cafedrine can be increased when it is combined with Peginterferon alfa-2b.,Cafedrine
DB12927,The serum concentration of Theodrenaline can be increased when it is combined with Peginterferon alfa-2b.,Theodrenaline
DB12945,The serum concentration of Dihydralazine can be increased when it is combined with Peginterferon alfa-2b.,Dihydralazine
DB13203,The serum concentration of Bamifylline can be increased when it is combined with Peginterferon alfa-2b.,Bamifylline
DB13449,The serum concentration of Proxyphylline can be increased when it is combined with Peginterferon alfa-2b.,Proxyphylline
DB13573,The serum concentration of Acefylline can be increased when it is combined with Peginterferon alfa-2b.,Acefylline
DB13592,The serum concentration of Etamiphylline can be increased when it is combined with Peginterferon alfa-2b.,Etamiphylline
DB13634,The serum concentration of Pentifylline can be increased when it is combined with Peginterferon alfa-2b.,Pentifylline
DB13812,The serum concentration of Bufylline can be increased when it is combined with Peginterferon alfa-2b.,Bufylline
DB13874,The serum concentration of Enasidenib can be increased when it is combined with Peginterferon alfa-2b.,Enasidenib
DB13952,The serum concentration of Estradiol acetate can be increased when it is combined with Peginterferon alfa-2b.,Estradiol acetate
DB13953,The serum concentration of Estradiol benzoate can be increased when it is combined with Peginterferon alfa-2b.,Estradiol benzoate
DB13954,The serum concentration of Estradiol cypionate can be increased when it is combined with Peginterferon alfa-2b.,Estradiol cypionate
DB13955,The serum concentration of Estradiol dienanthate can be increased when it is combined with Peginterferon alfa-2b.,Estradiol dienanthate
DB13956,The serum concentration of Estradiol valerate can be increased when it is combined with Peginterferon alfa-2b.,Estradiol valerate
DB14018,The serum concentration of Bromotheophylline can be increased when it is combined with Peginterferon alfa-2b.,Bromotheophylline
DB14132,The serum concentration of 8-chlorotheophylline can be increased when it is combined with Peginterferon alfa-2b.,8-chlorotheophylline
DB01195,The serum concentration of Flecainide can be increased when it is combined with Peginterferon alfa-2b.,Flecainide
DB01233,The serum concentration of Metoclopramide can be increased when it is combined with Peginterferon alfa-2b.,Metoclopramide
DB11757,The serum concentration of Istradefylline can be increased when it is combined with Peginterferon alfa-2b.,Istradefylline
DB00625,The serum concentration of Efavirenz can be increased when it is combined with Peginterferon alfa-2b.,Efavirenz
DB04889,The serum concentration of Bicifadine can be increased when it is combined with Peginterferon alfa-2b.,Bicifadine
DB05708,The serum concentration of GTS-21 can be increased when it is combined with Peginterferon alfa-2b.,GTS-21
DB00977,The serum concentration of Ethinylestradiol can be increased when it is combined with Peginterferon alfa-2b.,Ethinylestradiol
DB11689,The serum concentration of Selumetinib can be increased when it is combined with Peginterferon alfa-2b.,Selumetinib
DB00315,The metabolism of Zolmitriptan can be decreased when combined with Peginterferon alfa-2b.,Zolmitriptan
DB00289,The metabolism of Atomoxetine can be decreased when combined with Peginterferon alfa-2b.,Atomoxetine
DB01015,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Peginterferon alfa-2b.,Sulfamethoxazole
DB04817,The risk or severity of myelosuppression can be increased when Metamizole is combined with Peginterferon alfa-2b.,Metamizole
DB01097,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Leflunomide.,Leflunomide
DB08895,Peginterferon alfa-2b may increase the immunosuppressive activities of Tofacitinib.,Tofacitinib
DB00072,Trastuzumab may increase the neutropenic activities of Peginterferon alfa-2b.,Trastuzumab
DB00019,The therapeutic efficacy of Peginterferon alfa-2b can be decreased when used in combination with Pegfilgrastim.,Pegfilgrastim
DB00061,The therapeutic efficacy of Pegademase can be decreased when used in combination with Peginterferon alfa-2b.,Pegademase
DB00082,The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Peginterferon alfa-2b.,Pegvisomant
DB01839,The therapeutic efficacy of Propylene glycol can be decreased when used in combination with Peginterferon alfa-2b.,Propylene glycol
DB03394,The therapeutic efficacy of Heptaethylene glycol can be decreased when used in combination with Peginterferon alfa-2b.,Heptaethylene glycol
DB04895,The therapeutic efficacy of Pegaptanib can be decreased when used in combination with Peginterferon alfa-2b.,Pegaptanib
DB05202,The therapeutic efficacy of Egaptivon pegol can be decreased when used in combination with Peginterferon alfa-2b.,Egaptivon pegol
DB05321,The therapeutic efficacy of PEG-uricase can be decreased when used in combination with Peginterferon alfa-2b.,PEG-uricase
DB05860,The therapeutic efficacy of Peginterferon alfacon-1 can be decreased when used in combination with Peginterferon alfa-2b.,Peginterferon alfacon-1
DB06022,The therapeutic efficacy of GlycoPEG-GCSF can be decreased when used in combination with Peginterferon alfa-2b.,GlycoPEG-GCSF
DB06293,The therapeutic efficacy of Pegnivacogin can be decreased when used in combination with Peginterferon alfa-2b.,Pegnivacogin
DB06325,The therapeutic efficacy of Pegpleranib can be decreased when used in combination with Peginterferon alfa-2b.,Pegpleranib
DB06611,The therapeutic efficacy of Pegsunercept can be decreased when used in combination with Peginterferon alfa-2b.,Pegsunercept
DB06811,The therapeutic efficacy of Polidocanol can be decreased when used in combination with Peginterferon alfa-2b.,Polidocanol
DB08894,The therapeutic efficacy of Peginesatide can be decreased when used in combination with Peginterferon alfa-2b.,Peginesatide
DB09107,The therapeutic efficacy of Methoxy polyethylene glycol-epoetin beta can be decreased when used in combination with Peginterferon alfa-2b.,Methoxy polyethylene glycol-epoetin beta
DB09208,The therapeutic efficacy of Pegloticase can be decreased when used in combination with Peginterferon alfa-2b.,Pegloticase
DB09287,The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Peginterferon alfa-2b.,Polyethylene glycol
DB09329,"The therapeutic efficacy of Antihemophilic Factor (Recombinant), PEGylated can be decreased when used in combination with Peginterferon alfa-2b.","Antihemophilic Factor (Recombinant), PEGylated"
DB11077,The therapeutic efficacy of Polyethylene glycol 400 can be decreased when used in combination with Peginterferon alfa-2b.,Polyethylene glycol 400
DB11567,The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Peginterferon alfa-2b.,Insulin peglispro
DB11661,The therapeutic efficacy of Eptacog alfa pegol (activated) can be decreased when used in combination with Peginterferon alfa-2b.,Eptacog alfa pegol (activated)
DB11707,The therapeutic efficacy of Olaptesed Pegol can be decreased when used in combination with Peginterferon alfa-2b.,Olaptesed Pegol
DB12258,The therapeutic efficacy of Abicipar Pegol can be decreased when used in combination with Peginterferon alfa-2b.,Abicipar Pegol
DB12578,The therapeutic efficacy of Lexaptepid Pegol can be decreased when used in combination with Peginterferon alfa-2b.,Lexaptepid Pegol
DB12839,The therapeutic efficacy of Pegvaliase can be decreased when used in combination with Peginterferon alfa-2b.,Pegvaliase
DB12842,The therapeutic efficacy of Pegamotecan can be decreased when used in combination with Peginterferon alfa-2b.,Pegamotecan
DB13933,The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Peginterferon alfa-2b.,Nonacog beta pegol
DB14700,The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Peginterferon alfa-2b.,Damoctocog alfa pegol
DB14712,The therapeutic efficacy of Elapegademase can be decreased when used in combination with Peginterferon alfa-2b.,Elapegademase
DB08868,Peginterferon alfa-2b may increase the immunosuppressive activities of Fingolimod.,Fingolimod
DB00864,Tacrolimus may increase the immunosuppressive activities of Peginterferon alfa-2b.,Tacrolimus
DB00651,The metabolism of Dyphylline can be decreased when combined with Peginterferon alfa-2b.,Dyphylline
DB01978,"The metabolism of 7,9-Dimethylguanine can be decreased when combined with Peginterferon alfa-2b.","7,9-Dimethylguanine"
DB02245,The metabolism of 7-Deazaguanine can be decreased when combined with Peginterferon alfa-2b.,7-Deazaguanine
DB02377,The metabolism of Guanine can be decreased when combined with Peginterferon alfa-2b.,Guanine
DB06575,The metabolism of Valomaciclovir can be decreased when combined with Peginterferon alfa-2b.,Valomaciclovir
DB07954,The metabolism of 3-isobutyl-1-methyl-7H-xanthine can be decreased when combined with Peginterferon alfa-2b.,3-isobutyl-1-methyl-7H-xanthine
DB08844,The metabolism of Uric acid can be decreased when combined with Peginterferon alfa-2b.,Uric acid
DB14029,The metabolism of Furafylline can be decreased when combined with Peginterferon alfa-2b.,Furafylline
DB15122,The metabolism of PCS-499 can be decreased when combined with Peginterferon alfa-2b.,PCS-499
DB04914,The therapeutic efficacy of G17DT can be decreased when used in combination with Peginterferon alfa-2b.,G17DT
DB05144,The therapeutic efficacy of PEV3A can be decreased when used in combination with Peginterferon alfa-2b.,PEV3A
DB05325,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Peginterferon alfa-2b.,INGN 225
DB05374,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Peginterferon alfa-2b.,Rindopepimut
DB05440,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Peginterferon alfa-2b.,SRP 299
DB05942,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Peginterferon alfa-2b.,GI-5005
DB06400,The therapeutic efficacy of Vitespen can be decreased when used in combination with Peginterferon alfa-2b.,Vitespen
DB06584,The therapeutic efficacy of TG4010 can be decreased when used in combination with Peginterferon alfa-2b.,TG4010
DB09057,The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Peginterferon alfa-2b.,Anthrax immune globulin human
DB10062,"The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Peginterferon alfa-2b.","Rabies virus inactivated antigen, B"
DB10076,The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Peginterferon alfa-2b.,Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen
DB10276,The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Peginterferon alfa-2b.,Rotavirus vaccine
DB10283,"The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Peginterferon alfa-2b.","Rabies virus inactivated antigen, A"
DB10342,The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Peginterferon alfa-2b.,Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen
DB10583,The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2b.,Clostridium tetani toxoid antigen (formaldehyde inactivated)
DB10584,The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2b.,Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)
DB10600,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Peginterferon alfa-2b.,Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated)
DB10769,The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2b.,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated)
DB10794,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2b.,Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated)
DB10803,The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Peginterferon alfa-2b.,Typhoid Vi polysaccharide vaccine
DB10989,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Peginterferon alfa-2b.,Hepatitis A Vaccine
DB10990,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Peginterferon alfa-2b.,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen
DB11038,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Peginterferon alfa-2b.,Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated)
DB11040,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Peginterferon alfa-2b.,Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated)
DB11041,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Peginterferon alfa-2b.,Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)
DB11044,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated) can be decreased when used in combination with Peginterferon alfa-2b.,Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated)
DB11603,The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Peginterferon alfa-2b.,Human rabies virus immune globulin
DB11627,The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Peginterferon alfa-2b.,Hepatitis B Vaccine (Recombinant)
DB12568,The therapeutic efficacy of Tecemotide can be decreased when used in combination with Peginterferon alfa-2b.,Tecemotide
DB14022,The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Peginterferon alfa-2b.,Typhoid vaccine
DB14384,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2b.,Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated)
DB14385,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2b.,Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated)
DB14394,The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with Peginterferon alfa-2b.,Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen
DB14445,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2b.,Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated)
DB14449,The therapeutic efficacy of Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen can be decreased when used in combination with Peginterferon alfa-2b.,Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen
DB14619,The therapeutic efficacy of Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated) can be decreased when used in combination with Peginterferon alfa-2b.,Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated)
DB14620,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Peginterferon alfa-2b.,Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated)
DB14711,The therapeutic efficacy of Vaccinia virus strain new york city board of health live antigen can be decreased when used in combination with Peginterferon alfa-2b.,Vaccinia virus strain new york city board of health live antigen
DB15274,The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Peginterferon alfa-2b.,Pertussis vaccine
DB15461,The therapeutic efficacy of Yersinia pestis 195/p antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2b.,Yersinia pestis 195/p antigen (formaldehyde inactivated)
DB13924,The therapeutic efficacy of Varicella Zoster Vaccine (Recombinant) can be decreased when used in combination with Peginterferon alfa-2b.,Varicella Zoster Vaccine (Recombinant)
DB15483,The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Peginterferon alfa-2b.,Modified vaccinia ankara
DB15595,"The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Peginterferon alfa-2b.","Ebola Zaire vaccine (live, attenuated)"
DB00054,The risk or severity of bleeding can be increased when Abciximab is combined with Peginterferon alfa-2b.,Abciximab
DB00063,The risk or severity of bleeding can be increased when Eptifibatide is combined with Peginterferon alfa-2b.,Eptifibatide
DB00208,The risk or severity of bleeding can be increased when Ticlopidine is combined with Peginterferon alfa-2b.,Ticlopidine
DB00775,The risk or severity of bleeding can be increased when Tirofiban is combined with Peginterferon alfa-2b.,Tirofiban
DB00945,The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Peginterferon alfa-2b.,Acetylsalicylic acid
DB00975,The risk or severity of bleeding can be increased when Dipyridamole is combined with Peginterferon alfa-2b.,Dipyridamole
DB01088,The risk or severity of bleeding can be increased when Iloprost is combined with Peginterferon alfa-2b.,Iloprost
DB01138,The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Peginterferon alfa-2b.,Sulfinpyrazone
DB01207,The risk or severity of bleeding can be increased when Ridogrel is combined with Peginterferon alfa-2b.,Ridogrel
DB01236,The risk or severity of bleeding can be increased when Sevoflurane is combined with Peginterferon alfa-2b.,Sevoflurane
DB01240,The risk or severity of bleeding can be increased when Epoprostenol is combined with Peginterferon alfa-2b.,Epoprostenol
DB04743,The risk or severity of bleeding can be increased when Nimesulide is combined with Peginterferon alfa-2b.,Nimesulide
DB04905,The risk or severity of bleeding can be increased when Tesmilifene is combined with Peginterferon alfa-2b.,Tesmilifene
DB04932,The risk or severity of bleeding can be increased when Defibrotide is combined with Peginterferon alfa-2b.,Defibrotide
DB05229,The risk or severity of bleeding can be increased when Beraprost is combined with Peginterferon alfa-2b.,Beraprost
DB05266,The risk or severity of bleeding can be increased when Ibudilast is combined with Peginterferon alfa-2b.,Ibudilast
DB05767,The risk or severity of bleeding can be increased when Andrographolide is combined with Peginterferon alfa-2b.,Andrographolide
DB06081,The risk or severity of bleeding can be increased when Caplacizumab is combined with Peginterferon alfa-2b.,Caplacizumab
DB06209,The risk or severity of bleeding can be increased when Prasugrel is combined with Peginterferon alfa-2b.,Prasugrel
DB06441,The risk or severity of bleeding can be increased when Cangrelor is combined with Peginterferon alfa-2b.,Cangrelor
DB07615,The risk or severity of bleeding can be increased when Tranilast is combined with Peginterferon alfa-2b.,Tranilast
DB08814,The risk or severity of bleeding can be increased when Triflusal is combined with Peginterferon alfa-2b.,Triflusal
DB08816,The risk or severity of bleeding can be increased when Ticagrelor is combined with Peginterferon alfa-2b.,Ticagrelor
DB08887,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Peginterferon alfa-2b.,Icosapent ethyl
DB09030,The risk or severity of bleeding can be increased when Vorapaxar is combined with Peginterferon alfa-2b.,Vorapaxar
DB09283,The risk or severity of bleeding can be increased when Trapidil is combined with Peginterferon alfa-2b.,Trapidil
DB12092,The risk or severity of bleeding can be increased when Naftopidil is combined with Peginterferon alfa-2b.,Naftopidil
DB12163,The risk or severity of bleeding can be increased when Sarpogrelate is combined with Peginterferon alfa-2b.,Sarpogrelate
DB12321,The risk or severity of bleeding can be increased when Ifetroban is combined with Peginterferon alfa-2b.,Ifetroban
DB12445,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Peginterferon alfa-2b.,Nitroaspirin
DB12465,The risk or severity of bleeding can be increased when Ketanserin is combined with Peginterferon alfa-2b.,Ketanserin
DB12545,The risk or severity of bleeding can be increased when Indobufen is combined with Peginterferon alfa-2b.,Indobufen
DB12749,The risk or severity of bleeding can be increased when Butylphthalide is combined with Peginterferon alfa-2b.,Butylphthalide
DB12771,The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Peginterferon alfa-2b.,Hydroxytyrosol
DB13036,The risk or severity of bleeding can be increased when Ramatroban is combined with Peginterferon alfa-2b.,Ramatroban
DB13327,The risk or severity of bleeding can be increased when Picotamide is combined with Peginterferon alfa-2b.,Picotamide
DB13367,The risk or severity of bleeding can be increased when Cloricromen is combined with Peginterferon alfa-2b.,Cloricromen
DB13400,The risk or severity of bleeding can be increased when Linsidomine is combined with Peginterferon alfa-2b.,Linsidomine
DB13510,The risk or severity of bleeding can be increased when Buflomedil is combined with Peginterferon alfa-2b.,Buflomedil
DB13929,The risk or severity of bleeding can be increased when Relcovaptan is combined with Peginterferon alfa-2b.,Relcovaptan
DB13200,Peginterferon alfa-2b may increase the myelosuppressive activities of Lipegfilgrastim.,Lipegfilgrastim
DB10318,The risk or severity of infection can be increased when Peginterferon alfa-2b is combined with Varicella Zoster Vaccine (Live/attenuated).,Varicella Zoster Vaccine (Live/attenuated)
DB10317,The risk or severity of infection can be increased when Rubella virus vaccine is combined with Peginterferon alfa-2b.,Rubella virus vaccine
DB10343,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Peginterferon alfa-2b.,Bacillus calmette-guerin substrain tice live antigen
DB10804,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Peginterferon alfa-2b.,Bacillus calmette-guerin substrain connaught live antigen
DB10805,The risk or severity of infection can be increased when Yellow Fever Vaccine is combined with Peginterferon alfa-2b.,Yellow Fever Vaccine
DB11003,The risk or severity of infection can be increased when Anthrax vaccine is combined with Peginterferon alfa-2b.,Anthrax vaccine
DB11050,The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Peginterferon alfa-2b.,Typhoid Vaccine Live
DB12386,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain danish 1331 live antigen is combined with Peginterferon alfa-2b.,Bacillus calmette-guerin substrain danish 1331 live antigen
DB12768,The risk or severity of infection can be increased when BCG vaccine is combined with Peginterferon alfa-2b.,BCG vaccine
DB14409,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Peginterferon alfa-2b.,Human adenovirus e serotype 4 strain cl-68578 antigen
DB14443,The risk or severity of infection can be increased when Vibrio cholerae CVD 103-HgR strain live antigen is combined with Peginterferon alfa-2b.,Vibrio cholerae CVD 103-HgR strain live antigen
DB14685,The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Peginterferon alfa-2b.,Adenovirus type 7 vaccine live
DB01238,The metabolism of Aripiprazole can be decreased when combined with Peginterferon alfa-2b.,Aripiprazole
DB14185,The metabolism of Aripiprazole lauroxil can be decreased when combined with Peginterferon alfa-2b.,Aripiprazole lauroxil
DB00039,The therapeutic efficacy of Palifermin can be decreased when used in combination with Peginterferon alfa-2b.,Palifermin
DB00757,The metabolism of Dolasetron can be decreased when combined with Peginterferon alfa-2b.,Dolasetron
DB00182,The metabolism of Amphetamine can be decreased when combined with Peginterferon alfa-2b.,Amphetamine
DB00185,The metabolism of Cevimeline can be decreased when combined with Peginterferon alfa-2b.,Cevimeline
DB00187,The metabolism of Esmolol can be decreased when combined with Peginterferon alfa-2b.,Esmolol
DB00215,The metabolism of Citalopram can be decreased when combined with Peginterferon alfa-2b.,Citalopram
DB00243,The metabolism of Ranolazine can be decreased when combined with Peginterferon alfa-2b.,Ranolazine
DB00245,The metabolism of Benzatropine can be decreased when combined with Peginterferon alfa-2b.,Benzatropine
DB00264,The metabolism of Metoprolol can be decreased when combined with Peginterferon alfa-2b.,Metoprolol
DB00297,The metabolism of Bupivacaine can be decreased when combined with Peginterferon alfa-2b.,Bupivacaine
DB00317,The metabolism of Gefitinib can be decreased when combined with Peginterferon alfa-2b.,Gefitinib
DB00318,The metabolism of Codeine can be decreased when combined with Peginterferon alfa-2b.,Codeine
DB00335,The metabolism of Atenolol can be decreased when combined with Peginterferon alfa-2b.,Atenolol
DB00342,The metabolism of Terfenadine can be decreased when combined with Peginterferon alfa-2b.,Terfenadine
DB00377,The metabolism of Palonosetron can be decreased when combined with Peginterferon alfa-2b.,Palonosetron
DB00409,The metabolism of Remoxipride can be decreased when combined with Peginterferon alfa-2b.,Remoxipride
DB00433,The metabolism of Prochlorperazine can be decreased when combined with Peginterferon alfa-2b.,Prochlorperazine
DB00490,The metabolism of Buspirone can be decreased when combined with Peginterferon alfa-2b.,Buspirone
DB00496,The metabolism of Darifenacin can be decreased when combined with Peginterferon alfa-2b.,Darifenacin
DB00497,The metabolism of Oxycodone can be decreased when combined with Peginterferon alfa-2b.,Oxycodone
DB00503,The metabolism of Ritonavir can be decreased when combined with Peginterferon alfa-2b.,Ritonavir
DB00589,The metabolism of Lisuride can be decreased when combined with Peginterferon alfa-2b.,Lisuride
DB00592,The metabolism of Piperazine can be decreased when combined with Peginterferon alfa-2b.,Piperazine
DB00608,The metabolism of Chloroquine can be decreased when combined with Peginterferon alfa-2b.,Chloroquine
DB00637,The metabolism of Astemizole can be decreased when combined with Peginterferon alfa-2b.,Astemizole
DB00641,The metabolism of Simvastatin can be decreased when combined with Peginterferon alfa-2b.,Simvastatin
DB00647,The metabolism of Dextropropoxyphene can be decreased when combined with Peginterferon alfa-2b.,Dextropropoxyphene
DB00656,The metabolism of Trazodone can be decreased when combined with Peginterferon alfa-2b.,Trazodone
DB00674,The metabolism of Galantamine can be decreased when combined with Peginterferon alfa-2b.,Galantamine
DB00679,The metabolism of Thioridazine can be decreased when combined with Peginterferon alfa-2b.,Thioridazine
DB00699,The metabolism of Nicergoline can be decreased when combined with Peginterferon alfa-2b.,Nicergoline
DB00705,The metabolism of Delavirdine can be decreased when combined with Peginterferon alfa-2b.,Delavirdine
DB00706,The metabolism of Tamsulosin can be decreased when combined with Peginterferon alfa-2b.,Tamsulosin
DB00734,The metabolism of Risperidone can be decreased when combined with Peginterferon alfa-2b.,Risperidone
DB00737,The metabolism of Meclizine can be decreased when combined with Peginterferon alfa-2b.,Meclizine
DB00738,The metabolism of Pentamidine can be decreased when combined with Peginterferon alfa-2b.,Pentamidine
DB00805,The metabolism of Minaprine can be decreased when combined with Peginterferon alfa-2b.,Minaprine
DB00836,The metabolism of Loperamide can be decreased when combined with Peginterferon alfa-2b.,Loperamide
DB00866,The metabolism of Alprenolol can be decreased when combined with Peginterferon alfa-2b.,Alprenolol
DB00914,The metabolism of Phenformin can be decreased when combined with Peginterferon alfa-2b.,Phenformin
DB00918,The metabolism of Almotriptan can be decreased when combined with Peginterferon alfa-2b.,Almotriptan
DB00932,The metabolism of Tipranavir can be decreased when combined with Peginterferon alfa-2b.,Tipranavir
DB00933,The metabolism of Mesoridazine can be decreased when combined with Peginterferon alfa-2b.,Mesoridazine
DB00956,The metabolism of Hydrocodone can be decreased when combined with Peginterferon alfa-2b.,Hydrocodone
DB00960,The metabolism of Pindolol can be decreased when combined with Peginterferon alfa-2b.,Pindolol
DB01069,The metabolism of Promethazine can be decreased when combined with Peginterferon alfa-2b.,Promethazine
DB01071,The metabolism of Mequitazine can be decreased when combined with Peginterferon alfa-2b.,Mequitazine
DB01074,The metabolism of Perhexiline can be decreased when combined with Peginterferon alfa-2b.,Perhexiline
DB01079,The metabolism of Tegaserod can be decreased when combined with Peginterferon alfa-2b.,Tegaserod
DB01114,The metabolism of Chlorpheniramine can be decreased when combined with Peginterferon alfa-2b.,Chlorpheniramine
DB01149,The metabolism of Nefazodone can be decreased when combined with Peginterferon alfa-2b.,Nefazodone
DB01175,The metabolism of Escitalopram can be decreased when combined with Peginterferon alfa-2b.,Escitalopram
DB01192,The metabolism of Oxymorphone can be decreased when combined with Peginterferon alfa-2b.,Oxymorphone
DB01193,The metabolism of Acebutolol can be decreased when combined with Peginterferon alfa-2b.,Acebutolol
DB01203,The metabolism of Nadolol can be decreased when combined with Peginterferon alfa-2b.,Nadolol
DB01224,The metabolism of Quetiapine can be decreased when combined with Peginterferon alfa-2b.,Quetiapine
DB01228,The metabolism of Encainide can be decreased when combined with Peginterferon alfa-2b.,Encainide
DB01244,The metabolism of Bepridil can be decreased when combined with Peginterferon alfa-2b.,Bepridil
DB01255,The metabolism of Lisdexamfetamine can be decreased when combined with Peginterferon alfa-2b.,Lisdexamfetamine
DB01267,The metabolism of Paliperidone can be decreased when combined with Peginterferon alfa-2b.,Paliperidone
DB01295,The metabolism of Bevantolol can be decreased when combined with Peginterferon alfa-2b.,Bevantolol
DB01297,The metabolism of Practolol can be decreased when combined with Peginterferon alfa-2b.,Practolol
DB01359,The metabolism of Penbutolol can be decreased when combined with Peginterferon alfa-2b.,Penbutolol
DB01392,The metabolism of Yohimbine can be decreased when combined with Peginterferon alfa-2b.,Yohimbine
DB01403,The metabolism of Methotrimeprazine can be decreased when combined with Peginterferon alfa-2b.,Methotrimeprazine
DB01409,The metabolism of Tiotropium can be decreased when combined with Peginterferon alfa-2b.,Tiotropium
DB01429,The metabolism of Aprindine can be decreased when combined with Peginterferon alfa-2b.,Aprindine
DB01454,The metabolism of Midomafetamine can be decreased when combined with Peginterferon alfa-2b.,Midomafetamine
DB01466,The metabolism of Ethylmorphine can be decreased when combined with Peginterferon alfa-2b.,Ethylmorphine
DB01472,The metabolism of 4-Methoxyamphetamine can be decreased when combined with Peginterferon alfa-2b.,4-Methoxyamphetamine
DB01551,The metabolism of Dihydrocodeine can be decreased when combined with Peginterferon alfa-2b.,Dihydrocodeine
DB01576,The metabolism of Dextroamphetamine can be decreased when combined with Peginterferon alfa-2b.,Dextroamphetamine
DB01577,The metabolism of Metamfetamine can be decreased when combined with Peginterferon alfa-2b.,Metamfetamine
DB01580,The metabolism of Oxprenolol can be decreased when combined with Peginterferon alfa-2b.,Oxprenolol
DB01591,The metabolism of Solifenacin can be decreased when combined with Peginterferon alfa-2b.,Solifenacin
DB01621,The metabolism of Pipotiazine can be decreased when combined with Peginterferon alfa-2b.,Pipotiazine
DB01624,The metabolism of Zuclopenthixol can be decreased when combined with Peginterferon alfa-2b.,Zuclopenthixol
DB02703,The metabolism of Fusidic acid can be decreased when combined with Peginterferon alfa-2b.,Fusidic acid
DB04829,The metabolism of Lysergic acid diethylamide can be decreased when combined with Peginterferon alfa-2b.,Lysergic acid diethylamide
DB04840,The metabolism of Debrisoquine can be decreased when combined with Peginterferon alfa-2b.,Debrisoquine
DB04844,The metabolism of Tetrabenazine can be decreased when combined with Peginterferon alfa-2b.,Tetrabenazine
DB04846,The metabolism of Celiprolol can be decreased when combined with Peginterferon alfa-2b.,Celiprolol
DB04861,The metabolism of Nebivolol can be decreased when combined with Peginterferon alfa-2b.,Nebivolol
DB04884,The metabolism of Dapoxetine can be decreased when combined with Peginterferon alfa-2b.,Dapoxetine
DB04920,The metabolism of Clevidipine can be decreased when combined with Peginterferon alfa-2b.,Clevidipine
DB04946,The metabolism of Iloperidone can be decreased when combined with Peginterferon alfa-2b.,Iloperidone
DB05271,The metabolism of Rotigotine can be decreased when combined with Peginterferon alfa-2b.,Rotigotine
DB06016,The metabolism of Cariprazine can be decreased when combined with Peginterferon alfa-2b.,Cariprazine
DB06144,The metabolism of Sertindole can be decreased when combined with Peginterferon alfa-2b.,Sertindole
DB06203,The metabolism of Alogliptin can be decreased when combined with Peginterferon alfa-2b.,Alogliptin
DB06217,The metabolism of Vernakalant can be decreased when combined with Peginterferon alfa-2b.,Vernakalant
DB06506,The metabolism of Repinotan can be decreased when combined with Peginterferon alfa-2b.,Repinotan
DB06608,The metabolism of Tafenoquine can be decreased when combined with Peginterferon alfa-2b.,Tafenoquine
DB06678,The metabolism of Esmirtazapine can be decreased when combined with Peginterferon alfa-2b.,Esmirtazapine
DB06684,The metabolism of Vilazodone can be decreased when combined with Peginterferon alfa-2b.,Vilazodone
DB06702,The metabolism of Fesoterodine can be decreased when combined with Peginterferon alfa-2b.,Fesoterodine
DB06726,The metabolism of Bufuralol can be decreased when combined with Peginterferon alfa-2b.,Bufuralol
DB06727,The metabolism of Sparteine can be decreased when combined with Peginterferon alfa-2b.,Sparteine
DB06735,The metabolism of Enclomiphene can be decreased when combined with Peginterferon alfa-2b.,Enclomiphene
DB08807,The metabolism of Bopindolol can be decreased when combined with Peginterferon alfa-2b.,Bopindolol
DB08808,The metabolism of Bupranolol can be decreased when combined with Peginterferon alfa-2b.,Bupranolol
DB08893,The metabolism of Mirabegron can be decreased when combined with Peginterferon alfa-2b.,Mirabegron
DB08918,The metabolism of Levomilnacipran can be decreased when combined with Peginterferon alfa-2b.,Levomilnacipran
DB08922,The metabolism of Perospirone can be decreased when combined with Peginterferon alfa-2b.,Perospirone
DB08952,The metabolism of Indenolol can be decreased when combined with Peginterferon alfa-2b.,Indenolol
DB09013,The metabolism of Befunolol can be decreased when combined with Peginterferon alfa-2b.,Befunolol
DB09039,The metabolism of Eliglustat can be decreased when combined with Peginterferon alfa-2b.,Eliglustat
DB09076,The metabolism of Umeclidinium can be decreased when combined with Peginterferon alfa-2b.,Umeclidinium
DB09128,The metabolism of Brexpiprazole can be decreased when combined with Peginterferon alfa-2b.,Brexpiprazole
DB09183,The metabolism of Dasabuvir can be decreased when combined with Peginterferon alfa-2b.,Dasabuvir
DB09195,The metabolism of Lorpiprazole can be decreased when combined with Peginterferon alfa-2b.,Lorpiprazole
DB09204,The metabolism of Arotinolol can be decreased when combined with Peginterferon alfa-2b.,Arotinolol
DB09351,The metabolism of Levobetaxolol can be decreased when combined with Peginterferon alfa-2b.,Levobetaxolol
DB09555,The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Peginterferon alfa-2b.,Dexchlorpheniramine maleate
DB11130,The metabolism of Opium can be decreased when combined with Peginterferon alfa-2b.,Opium
DB11770,The metabolism of Talinolol can be decreased when combined with Peginterferon alfa-2b.,Talinolol
DB11785,The metabolism of Anisodamine can be decreased when combined with Peginterferon alfa-2b.,Anisodamine
DB11855,The metabolism of Revefenacin can be decreased when combined with Peginterferon alfa-2b.,Revefenacin
DB11915,The metabolism of Valbenazine can be decreased when combined with Peginterferon alfa-2b.,Valbenazine
DB11979,The metabolism of Elagolix can be decreased when combined with Peginterferon alfa-2b.,Elagolix
DB12070,The metabolism of Letermovir can be decreased when combined with Peginterferon alfa-2b.,Letermovir
DB12161,The metabolism of Deutetrabenazine can be decreased when combined with Peginterferon alfa-2b.,Deutetrabenazine
DB12212,The metabolism of Landiolol can be decreased when combined with Peginterferon alfa-2b.,Landiolol
DB12752,The metabolism of Bucindolol can be decreased when combined with Peginterferon alfa-2b.,Bucindolol
DB13293,The metabolism of Ipecac can be decreased when combined with Peginterferon alfa-2b.,Ipecac
DB13443,The metabolism of Esatenolol can be decreased when combined with Peginterferon alfa-2b.,Esatenolol
DB13508,The metabolism of Cloranolol can be decreased when combined with Peginterferon alfa-2b.,Cloranolol
DB13530,The metabolism of Mepindolol can be decreased when combined with Peginterferon alfa-2b.,Mepindolol
DB13679,The metabolism of Dexchlorpheniramine can be decreased when combined with Peginterferon alfa-2b.,Dexchlorpheniramine
DB13757,The metabolism of Epanolol can be decreased when combined with Peginterferon alfa-2b.,Epanolol
DB13775,The metabolism of Tertatolol can be decreased when combined with Peginterferon alfa-2b.,Tertatolol
DB09173,The metabolism of Butyrfentanyl can be decreased when combined with Peginterferon alfa-2b.,Butyrfentanyl
DB00598,The metabolism of Labetalol can be decreased when combined with Peginterferon alfa-2b.,Labetalol
DB14010,"The metabolism of 5-methoxy-N,N-dimethyltryptamine can be decreased when combined with Peginterferon alfa-2b.","5-methoxy-N,N-dimethyltryptamine"
DB11642,The metabolism of Pitolisant can be decreased when combined with Peginterferon alfa-2b.,Pitolisant
DB00344,The metabolism of Protriptyline can be decreased when combined with Peginterferon alfa-2b.,Protriptyline
DB00454,The metabolism of Meperidine can be decreased when combined with Peginterferon alfa-2b.,Meperidine
DB00543,The metabolism of Amoxapine can be decreased when combined with Peginterferon alfa-2b.,Amoxapine
DB12930,The metabolism of Opipramol can be decreased when combined with Peginterferon alfa-2b.,Opipramol
DB05109,The metabolism of Trabectedin can be decreased when combined with Peginterferon alfa-2b.,Trabectedin
DB11963,The metabolism of Dacomitinib can be decreased when combined with Peginterferon alfa-2b.,Dacomitinib
DB00489,The metabolism of Sotalol can be decreased when combined with Peginterferon alfa-2b.,Sotalol
DB01035,The metabolism of Procainamide can be decreased when combined with Peginterferon alfa-2b.,Procainamide
DB09167,The metabolism of Dosulepin can be decreased when combined with Peginterferon alfa-2b.,Dosulepin
DB11718,The metabolism of Encorafenib can be decreased when combined with Peginterferon alfa-2b.,Encorafenib
DB01118,The metabolism of Amiodarone can be decreased when combined with Peginterferon alfa-2b.,Amiodarone
DB00001,The risk or severity of bleeding can be increased when Lepirudin is combined with Peginterferon alfa-2b.,Lepirudin
DB00006,The risk or severity of bleeding can be increased when Bivalirudin is combined with Peginterferon alfa-2b.,Bivalirudin
DB00009,The risk or severity of bleeding can be increased when Alteplase is combined with Peginterferon alfa-2b.,Alteplase
DB00013,The risk or severity of bleeding can be increased when Urokinase is combined with Peginterferon alfa-2b.,Urokinase
DB00015,The risk or severity of bleeding can be increased when Reteplase is combined with Peginterferon alfa-2b.,Reteplase
DB00029,The risk or severity of bleeding can be increased when Anistreplase is combined with Peginterferon alfa-2b.,Anistreplase
DB00031,The risk or severity of bleeding can be increased when Tenecteplase is combined with Peginterferon alfa-2b.,Tenecteplase
DB00055,The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Peginterferon alfa-2b.,Drotrecogin alfa
DB00086,The risk or severity of bleeding can be increased when Streptokinase is combined with Peginterferon alfa-2b.,Streptokinase
DB00278,The risk or severity of bleeding can be increased when Argatroban is combined with Peginterferon alfa-2b.,Argatroban
DB00407,The risk or severity of bleeding can be increased when Ardeparin is combined with Peginterferon alfa-2b.,Ardeparin
DB00498,The risk or severity of bleeding can be increased when Phenindione is combined with Peginterferon alfa-2b.,Phenindione
DB00569,The risk or severity of bleeding can be increased when Fondaparinux is combined with Peginterferon alfa-2b.,Fondaparinux
DB00686,The risk or severity of bleeding can be increased when Pentosan polysulfate is combined with Peginterferon alfa-2b.,Pentosan polysulfate
DB01109,The risk or severity of bleeding can be increased when Heparin is combined with Peginterferon alfa-2b.,Heparin
DB01225,The risk or severity of bleeding can be increased when Enoxaparin is combined with Peginterferon alfa-2b.,Enoxaparin
DB03410,The risk or severity of bleeding can be increased when 4-hydroxycoumarin is combined with Peginterferon alfa-2b.,4-hydroxycoumarin
DB04665,The risk or severity of bleeding can be increased when Coumarin is combined with Peginterferon alfa-2b.,Coumarin
DB04898,The risk or severity of bleeding can be increased when Ximelagatran is combined with Peginterferon alfa-2b.,Ximelagatran
DB04925,The risk or severity of bleeding can be increased when Desmoteplase is combined with Peginterferon alfa-2b.,Desmoteplase
DB05099,The risk or severity of bleeding can be increased when Ancrod is combined with Peginterferon alfa-2b.,Ancrod
DB05254,The risk or severity of bleeding can be increased when Fibrinolysin is combined with Peginterferon alfa-2b.,Fibrinolysin
DB06228,The risk or severity of bleeding can be increased when Rivaroxaban is combined with Peginterferon alfa-2b.,Rivaroxaban
DB06271,The risk or severity of bleeding can be increased when Sulodexide is combined with Peginterferon alfa-2b.,Sulodexide
DB06294,The risk or severity of bleeding can be increased when Semuloparin is combined with Peginterferon alfa-2b.,Semuloparin
DB06406,The risk or severity of bleeding can be increased when Idraparinux is combined with Peginterferon alfa-2b.,Idraparinux
DB06543,The risk or severity of bleeding can be increased when Astaxanthin is combined with Peginterferon alfa-2b.,Astaxanthin
DB06605,The risk or severity of bleeding can be increased when Apixaban is combined with Peginterferon alfa-2b.,Apixaban
DB06635,The risk or severity of bleeding can be increased when Otamixaban is combined with Peginterferon alfa-2b.,Otamixaban
DB06679,The risk or severity of bleeding can be increased when Amediplase is combined with Peginterferon alfa-2b.,Amediplase
DB06695,The risk or severity of bleeding can be increased when Dabigatran etexilate is combined with Peginterferon alfa-2b.,Dabigatran etexilate
DB06754,The risk or severity of bleeding can be increased when Danaparoid is combined with Peginterferon alfa-2b.,Danaparoid
DB06779,The risk or severity of bleeding can be increased when Dalteparin is combined with Peginterferon alfa-2b.,Dalteparin
DB06822,The risk or severity of bleeding can be increased when Tinzaparin is combined with Peginterferon alfa-2b.,Tinzaparin
DB07767,The risk or severity of bleeding can be increased when Ferulic acid is combined with Peginterferon alfa-2b.,Ferulic acid
DB08794,The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Peginterferon alfa-2b.,Ethyl biscoumacetate
DB08813,The risk or severity of bleeding can be increased when Nadroparin is combined with Peginterferon alfa-2b.,Nadroparin
DB08994,The risk or severity of bleeding can be increased when Ditazole is combined with Peginterferon alfa-2b.,Ditazole
DB09075,The risk or severity of bleeding can be increased when Edoxaban is combined with Peginterferon alfa-2b.,Edoxaban
DB09125,The risk or severity of bleeding can be increased when Potassium citrate is combined with Peginterferon alfa-2b.,Potassium citrate
DB09154,The risk or severity of bleeding can be increased when Sodium citrate is combined with Peginterferon alfa-2b.,Sodium citrate
DB09255,The risk or severity of bleeding can be increased when Dextran is combined with Peginterferon alfa-2b.,Dextran
DB09258,The risk or severity of bleeding can be increased when Bemiparin is combined with Peginterferon alfa-2b.,Bemiparin
DB09259,The risk or severity of bleeding can be increased when Reviparin is combined with Peginterferon alfa-2b.,Reviparin
DB09260,The risk or severity of bleeding can be increased when Parnaparin is combined with Peginterferon alfa-2b.,Parnaparin
DB09261,The risk or severity of bleeding can be increased when Certoparin is combined with Peginterferon alfa-2b.,Certoparin
DB11095,The risk or severity of bleeding can be increased when Desirudin is combined with Peginterferon alfa-2b.,Desirudin
DB11154,The risk or severity of bleeding can be increased when Zinc citrate is combined with Peginterferon alfa-2b.,Zinc citrate
DB11166,The risk or severity of bleeding can be increased when Antithrombin Alfa is combined with Peginterferon alfa-2b.,Antithrombin Alfa
DB11312,The risk or severity of bleeding can be increased when Protein C is combined with Peginterferon alfa-2b.,Protein C
DB11598,The risk or severity of bleeding can be increased when Antithrombin III human is combined with Peginterferon alfa-2b.,Antithrombin III human
DB11984,The risk or severity of bleeding can be increased when Letaxaban is combined with Peginterferon alfa-2b.,Letaxaban
DB12289,The risk or severity of bleeding can be increased when Darexaban is combined with Peginterferon alfa-2b.,Darexaban
DB12364,The risk or severity of bleeding can be increased when Betrixaban is combined with Peginterferon alfa-2b.,Betrixaban
DB12598,The risk or severity of bleeding can be increased when Nafamostat is combined with Peginterferon alfa-2b.,Nafamostat
DB12726,The risk or severity of bleeding can be increased when Monteplase is combined with Peginterferon alfa-2b.,Monteplase
DB12831,The risk or severity of bleeding can be increased when Gabexate is combined with Peginterferon alfa-2b.,Gabexate
DB13149,The risk or severity of bleeding can be increased when Protein S human is combined with Peginterferon alfa-2b.,Protein S human
DB13199,The risk or severity of bleeding can be increased when Brinase is combined with Peginterferon alfa-2b.,Brinase
DB13275,The risk or severity of bleeding can be increased when Clorindione is combined with Peginterferon alfa-2b.,Clorindione
DB13347,The risk or severity of bleeding can be increased when Diphenadione is combined with Peginterferon alfa-2b.,Diphenadione
DB13451,The risk or severity of bleeding can be increased when Tioclomarol is combined with Peginterferon alfa-2b.,Tioclomarol
DB13616,The risk or severity of bleeding can be increased when Melagatran is combined with Peginterferon alfa-2b.,Melagatran
DB13646,The risk or severity of bleeding can be increased when Saruplase is combined with Peginterferon alfa-2b.,Saruplase
DB14055,The risk or severity of bleeding can be increased when (S)-Warfarin is combined with Peginterferon alfa-2b.,(S)-Warfarin
DB14094,The risk or severity of bleeding can be increased when Tocopherylquinone is combined with Peginterferon alfa-2b.,Tocopherylquinone
DB14598,The risk or severity of bleeding can be increased when Edetate calcium disodium anhydrous is combined with Peginterferon alfa-2b.,Edetate calcium disodium anhydrous
DB14726,The risk or severity of bleeding can be increased when Dabigatran is combined with Peginterferon alfa-2b.,Dabigatran
DB00177,The metabolism of Valsartan can be increased when combined with Peginterferon alfa-2b.,Valsartan
DB00197,The metabolism of Troglitazone can be increased when combined with Peginterferon alfa-2b.,Troglitazone
DB00203,The metabolism of Sildenafil can be increased when combined with Peginterferon alfa-2b.,Sildenafil
DB00214,The metabolism of Torasemide can be increased when combined with Peginterferon alfa-2b.,Torasemide
DB00216,The metabolism of Eletriptan can be increased when combined with Peginterferon alfa-2b.,Eletriptan
DB00222,The metabolism of Glimepiride can be increased when combined with Peginterferon alfa-2b.,Glimepiride
DB00238,The metabolism of Nevirapine can be increased when combined with Peginterferon alfa-2b.,Nevirapine
DB00250,The metabolism of Dapsone can be increased when combined with Peginterferon alfa-2b.,Dapsone
DB00285,The metabolism of Venlafaxine can be increased when combined with Peginterferon alfa-2b.,Venlafaxine
DB00304,The metabolism of Desogestrel can be increased when combined with Peginterferon alfa-2b.,Desogestrel
DB00327,The metabolism of Hydromorphone can be increased when combined with Peginterferon alfa-2b.,Hydromorphone
DB00338,The metabolism of Omeprazole can be increased when combined with Peginterferon alfa-2b.,Omeprazole
DB00343,The metabolism of Diltiazem can be increased when combined with Peginterferon alfa-2b.,Diltiazem
DB00347,The metabolism of Trimethadione can be increased when combined with Peginterferon alfa-2b.,Trimethadione
DB00374,The metabolism of Treprostinil can be increased when combined with Peginterferon alfa-2b.,Treprostinil
DB00396,The metabolism of Progesterone can be increased when combined with Peginterferon alfa-2b.,Progesterone
DB00404,The metabolism of Alprazolam can be increased when combined with Peginterferon alfa-2b.,Alprazolam
DB00412,The metabolism of Rosiglitazone can be increased when combined with Peginterferon alfa-2b.,Rosiglitazone
DB00414,The metabolism of Acetohexamide can be increased when combined with Peginterferon alfa-2b.,Acetohexamide
DB00440,The metabolism of Trimethoprim can be increased when combined with Peginterferon alfa-2b.,Trimethoprim
DB00448,The metabolism of Lansoprazole can be increased when combined with Peginterferon alfa-2b.,Lansoprazole
DB00469,The metabolism of Tenoxicam can be increased when combined with Peginterferon alfa-2b.,Tenoxicam
DB00470,The metabolism of Dronabinol can be increased when combined with Peginterferon alfa-2b.,Dronabinol
DB00471,The metabolism of Montelukast can be increased when combined with Peginterferon alfa-2b.,Montelukast
DB00482,The metabolism of Celecoxib can be increased when combined with Peginterferon alfa-2b.,Celecoxib
DB00514,The metabolism of Dextromethorphan can be increased when combined with Peginterferon alfa-2b.,Dextromethorphan
DB00549,The metabolism of Zafirlukast can be increased when combined with Peginterferon alfa-2b.,Zafirlukast
DB00554,The metabolism of Piroxicam can be increased when combined with Peginterferon alfa-2b.,Piroxicam
DB00559,The metabolism of Bosentan can be increased when combined with Peginterferon alfa-2b.,Bosentan
DB00580,The metabolism of Valdecoxib can be increased when combined with Peginterferon alfa-2b.,Valdecoxib
DB00582,The metabolism of Voriconazole can be increased when combined with Peginterferon alfa-2b.,Voriconazole
DB00590,The metabolism of Doxazosin can be increased when combined with Peginterferon alfa-2b.,Doxazosin
DB00617,The metabolism of Paramethadione can be increased when combined with Peginterferon alfa-2b.,Paramethadione
DB00624,The metabolism of Testosterone can be increased when combined with Peginterferon alfa-2b.,Testosterone
DB00672,The metabolism of Chlorpropamide can be increased when combined with Peginterferon alfa-2b.,Chlorpropamide
DB00678,The metabolism of Losartan can be increased when combined with Peginterferon alfa-2b.,Losartan
DB00701,The metabolism of Amprenavir can be increased when combined with Peginterferon alfa-2b.,Amprenavir
DB00712,The metabolism of Flurbiprofen can be increased when combined with Peginterferon alfa-2b.,Flurbiprofen
DB00731,The metabolism of Nateglinide can be increased when combined with Peginterferon alfa-2b.,Nateglinide
DB00749,The metabolism of Etodolac can be increased when combined with Peginterferon alfa-2b.,Etodolac
DB00784,The metabolism of Mefenamic acid can be increased when combined with Peginterferon alfa-2b.,Mefenamic acid
DB00794,The metabolism of Primidone can be increased when combined with Peginterferon alfa-2b.,Primidone
DB00796,The metabolism of Candesartan cilexetil can be increased when combined with Peginterferon alfa-2b.,Candesartan cilexetil
DB00812,The metabolism of Phenylbutazone can be increased when combined with Peginterferon alfa-2b.,Phenylbutazone
DB00814,The metabolism of Meloxicam can be increased when combined with Peginterferon alfa-2b.,Meloxicam
DB00818,The metabolism of Propofol can be increased when combined with Peginterferon alfa-2b.,Propofol
DB00829,The metabolism of Diazepam can be increased when combined with Peginterferon alfa-2b.,Diazepam
DB00839,The metabolism of Tolazamide can be increased when combined with Peginterferon alfa-2b.,Tolazamide
DB00843,The metabolism of Donepezil can be increased when combined with Peginterferon alfa-2b.,Donepezil
DB00904,The metabolism of Ondansetron can be increased when combined with Peginterferon alfa-2b.,Ondansetron
DB00921,The metabolism of Buprenorphine can be increased when combined with Peginterferon alfa-2b.,Buprenorphine
DB00936,The metabolism of Salicylic acid can be increased when combined with Peginterferon alfa-2b.,Salicylic acid
DB00983,The metabolism of Formoterol can be increased when combined with Peginterferon alfa-2b.,Formoterol
DB01016,The metabolism of Glyburide can be increased when combined with Peginterferon alfa-2b.,Glyburide
DB01028,The metabolism of Methoxyflurane can be increased when combined with Peginterferon alfa-2b.,Methoxyflurane
DB01029,The metabolism of Irbesartan can be increased when combined with Peginterferon alfa-2b.,Irbesartan
DB01036,The metabolism of Tolterodine can be increased when combined with Peginterferon alfa-2b.,Tolterodine
DB01050,The metabolism of Ibuprofen can be increased when combined with Peginterferon alfa-2b.,Ibuprofen
DB01067,The metabolism of Glipizide can be increased when combined with Peginterferon alfa-2b.,Glipizide
DB01072,The metabolism of Atazanavir can be increased when combined with Peginterferon alfa-2b.,Atazanavir
DB01075,The metabolism of Diphenhydramine can be increased when combined with Peginterferon alfa-2b.,Diphenhydramine
DB01095,The metabolism of Fluvastatin can be increased when combined with Peginterferon alfa-2b.,Fluvastatin
DB01098,The metabolism of Rosuvastatin can be increased when combined with Peginterferon alfa-2b.,Rosuvastatin
DB01104,The metabolism of Sertraline can be increased when combined with Peginterferon alfa-2b.,Sertraline
DB01120,The metabolism of Gliclazide can be increased when combined with Peginterferon alfa-2b.,Gliclazide
DB01124,The metabolism of Tolbutamide can be increased when combined with Peginterferon alfa-2b.,Tolbutamide
DB01131,The metabolism of Proguanil can be increased when combined with Peginterferon alfa-2b.,Proguanil
DB01154,The metabolism of Thiamylal can be increased when combined with Peginterferon alfa-2b.,Thiamylal
DB01156,The metabolism of Bupropion can be increased when combined with Peginterferon alfa-2b.,Bupropion
DB01159,The metabolism of Halothane can be increased when combined with Peginterferon alfa-2b.,Halothane
DB01171,The metabolism of Moclobemide can be increased when combined with Peginterferon alfa-2b.,Moclobemide
DB01174,The metabolism of Phenobarbital can be increased when combined with Peginterferon alfa-2b.,Phenobarbital
DB01198,The metabolism of Zopiclone can be increased when combined with Peginterferon alfa-2b.,Zopiclone
DB01221,The metabolism of Ketamine can be increased when combined with Peginterferon alfa-2b.,Ketamine
DB01251,The metabolism of Gliquidone can be increased when combined with Peginterferon alfa-2b.,Gliquidone
DB01274,The metabolism of Arformoterol can be increased when combined with Peginterferon alfa-2b.,Arformoterol
DB01283,The metabolism of Lumiracoxib can be increased when combined with Peginterferon alfa-2b.,Lumiracoxib
DB01289,The metabolism of Glisoxepide can be increased when combined with Peginterferon alfa-2b.,Glisoxepide
DB01355,The metabolism of Hexobarbital can be increased when combined with Peginterferon alfa-2b.,Hexobarbital
DB01357,The metabolism of Mestranol can be increased when combined with Peginterferon alfa-2b.,Mestranol
DB01544,The metabolism of Flunitrazepam can be increased when combined with Peginterferon alfa-2b.,Flunitrazepam
DB01589,The metabolism of Quazepam can be increased when combined with Peginterferon alfa-2b.,Quazepam
DB03756,The metabolism of Doconexent can be increased when combined with Peginterferon alfa-2b.,Doconexent
DB04557,The metabolism of Arachidonic Acid can be increased when combined with Peginterferon alfa-2b.,Arachidonic Acid
DB04725,The metabolism of Licofelone can be increased when combined with Peginterferon alfa-2b.,Licofelone
DB04938,The metabolism of Ospemifene can be increased when combined with Peginterferon alfa-2b.,Ospemifene
DB05541,The metabolism of Brivaracetam can be increased when combined with Peginterferon alfa-2b.,Brivaracetam
DB06204,The metabolism of Tapentadol can be increased when combined with Peginterferon alfa-2b.,Tapentadol
DB06218,The metabolism of Lacosamide can be increased when combined with Peginterferon alfa-2b.,Lacosamide
DB06268,The metabolism of Sitaxentan can be increased when combined with Peginterferon alfa-2b.,Sitaxentan
DB06370,The metabolism of Indisulam can be increased when combined with Peginterferon alfa-2b.,Indisulam
DB06414,The metabolism of Etravirine can be increased when combined with Peginterferon alfa-2b.,Etravirine
DB06652,The metabolism of Vicriviroc can be increased when combined with Peginterferon alfa-2b.,Vicriviroc
DB06697,The metabolism of Artemether can be increased when combined with Peginterferon alfa-2b.,Artemether
DB06725,The metabolism of Lornoxicam can be increased when combined with Peginterferon alfa-2b.,Lornoxicam
DB06737,The metabolism of Zaltoprofen can be increased when combined with Peginterferon alfa-2b.,Zaltoprofen
DB06738,The metabolism of Ketobemidone can be increased when combined with Peginterferon alfa-2b.,Ketobemidone
DB06739,The metabolism of Seratrodast can be increased when combined with Peginterferon alfa-2b.,Seratrodast
DB06803,The metabolism of Niclosamide can be increased when combined with Peginterferon alfa-2b.,Niclosamide
DB08439,The metabolism of Parecoxib can be increased when combined with Peginterferon alfa-2b.,Parecoxib
DB08828,The metabolism of Vismodegib can be increased when combined with Peginterferon alfa-2b.,Vismodegib
DB08860,The metabolism of Pitavastatin can be increased when combined with Peginterferon alfa-2b.,Pitavastatin
DB08875,The metabolism of Cabozantinib can be increased when combined with Peginterferon alfa-2b.,Cabozantinib
DB08899,The metabolism of Enzalutamide can be increased when combined with Peginterferon alfa-2b.,Enzalutamide
DB08962,The metabolism of Glibornuride can be increased when combined with Peginterferon alfa-2b.,Glibornuride
DB09048,The metabolism of Netupitant can be increased when combined with Peginterferon alfa-2b.,Netupitant
DB09061,The metabolism of Cannabidiol can be increased when combined with Peginterferon alfa-2b.,Cannabidiol
DB09068,The metabolism of Vortioxetine can be increased when combined with Peginterferon alfa-2b.,Vortioxetine
DB09080,The metabolism of Olodaterol can be increased when combined with Peginterferon alfa-2b.,Olodaterol
DB11560,The metabolism of Lesinurad can be increased when combined with Peginterferon alfa-2b.,Lesinurad
DB11586,The metabolism of Asunaprevir can be increased when combined with Peginterferon alfa-2b.,Asunaprevir
DB11614,The metabolism of Rupatadine can be increased when combined with Peginterferon alfa-2b.,Rupatadine
DB11823,The metabolism of Esketamine can be increased when combined with Peginterferon alfa-2b.,Esketamine
DB12474,The metabolism of Lynestrenol can be increased when combined with Peginterferon alfa-2b.,Lynestrenol
DB13406,The metabolism of Carbutamide can be increased when combined with Peginterferon alfa-2b.,Carbutamide
DB13675,The metabolism of Metahexamide can be increased when combined with Peginterferon alfa-2b.,Metahexamide
DB13919,The metabolism of Candesartan can be increased when combined with Peginterferon alfa-2b.,Candesartan
DB13941,The metabolism of Piperaquine can be increased when combined with Peginterferon alfa-2b.,Piperaquine
DB13943,The metabolism of Testosterone cypionate can be increased when combined with Peginterferon alfa-2b.,Testosterone cypionate
DB13944,The metabolism of Testosterone enanthate can be increased when combined with Peginterferon alfa-2b.,Testosterone enanthate
DB13946,The metabolism of Testosterone undecanoate can be increased when combined with Peginterferon alfa-2b.,Testosterone undecanoate
DB14009,The metabolism of Medical Cannabis can be increased when combined with Peginterferon alfa-2b.,Medical Cannabis
DB14011,The metabolism of Nabiximols can be increased when combined with Peginterferon alfa-2b.,Nabiximols
DB09213,The metabolism of Dexibuprofen can be increased when combined with Peginterferon alfa-2b.,Dexibuprofen
DB00465,The metabolism of Ketorolac can be increased when combined with Peginterferon alfa-2b.,Ketorolac
DB14975,The metabolism of Voxelotor can be increased when combined with Peginterferon alfa-2b.,Voxelotor
DB15233,The metabolism of Avapritinib can be increased when combined with Peginterferon alfa-2b.,Avapritinib
DB00726,The metabolism of Trimipramine can be increased when combined with Peginterferon alfa-2b.,Trimipramine
DB01101,The metabolism of Capecitabine can be increased when combined with Peginterferon alfa-2b.,Capecitabine
DB05015,The metabolism of Belinostat can be increased when combined with Peginterferon alfa-2b.,Belinostat
DB00252,The metabolism of Phenytoin can be increased when combined with Peginterferon alfa-2b.,Phenytoin
DB00266,The metabolism of Dicoumarol can be increased when combined with Peginterferon alfa-2b.,Dicoumarol
DB00313,The metabolism of Valproic acid can be increased when combined with Peginterferon alfa-2b.,Valproic acid
DB00908,The metabolism of Quinidine can be increased when combined with Peginterferon alfa-2b.,Quinidine
DB00946,The metabolism of Phenprocoumon can be increased when combined with Peginterferon alfa-2b.,Phenprocoumon
DB01320,The metabolism of Fosphenytoin can be increased when combined with Peginterferon alfa-2b.,Fosphenytoin
DB13136,The metabolism of Fluindione can be increased when combined with Peginterferon alfa-2b.,Fluindione
DB12147,The metabolism of Erdafitinib can be increased when combined with Peginterferon alfa-2b.,Erdafitinib
DB00232,The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Peginterferon alfa-2b.,Methyclothiazide
DB00436,The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Peginterferon alfa-2b.,Bendroflumethiazide
DB00562,The risk or severity of neutropenia and thrombocytopenia can be increased when Benzthiazide is combined with Peginterferon alfa-2b.,Benzthiazide
DB00606,The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclothiazide is combined with Peginterferon alfa-2b.,Cyclothiazide
DB00774,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Peginterferon alfa-2b.,Hydroflumethiazide
DB00880,The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Peginterferon alfa-2b.,Chlorothiazide
DB00999,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Peginterferon alfa-2b.,Hydrochlorothiazide
DB01021,The risk or severity of neutropenia and thrombocytopenia can be increased when Trichlormethiazide is combined with Peginterferon alfa-2b.,Trichlormethiazide
DB01324,The risk or severity of neutropenia and thrombocytopenia can be increased when Polythiazide is combined with Peginterferon alfa-2b.,Polythiazide
DB13430,The risk or severity of neutropenia and thrombocytopenia can be increased when Mebutizide is combined with Peginterferon alfa-2b.,Mebutizide
DB13532,The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclopenthiazide is combined with Peginterferon alfa-2b.,Cyclopenthiazide
DB09042,The risk or severity of myelosuppression can be increased when Peginterferon alfa-2b is combined with Tedizolid phosphate.,Tedizolid phosphate
DB00091,Peginterferon alfa-2b may increase the immunosuppressive activities of Cyclosporine.,Cyclosporine
DB00268,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Ropinirole.,Ropinirole
DB00321,The metabolism of Amitriptyline can be decreased when combined with Peginterferon alfa-2b.,Amitriptyline
DB00115,The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Peginterferon alfa-2b.,Cyanocobalamin
DB00437,The risk or severity of adverse effects can be increased when Allopurinol is combined with Peginterferon alfa-2b.,Allopurinol
DB00373,The metabolism of Timolol can be decreased when combined with Peginterferon alfa-2b.,Timolol
DB00193,The metabolism of Tramadol can be decreased when combined with Peginterferon alfa-2b.,Tramadol
DB14513,The serum concentration of Magnesium can be decreased when it is combined with Peginterferon alfa-2b.,Magnesium
DB01601,The serum concentration of Peginterferon alfa-2b can be increased when it is combined with Lopinavir.,Lopinavir
DB00502,The serum concentration of Haloperidol can be increased when it is combined with Peginterferon alfa-2b.,Haloperidol
DB12530,The risk or severity of infection can be increased when Peginterferon alfa-2b is combined with Inebilizumab.,Inebilizumab
DB00012,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Asparaginase Escherichia coli.,Darbepoetin alfa
DB00016,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Asparaginase Escherichia coli.,Erythropoietin
DB08894,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Asparaginase Escherichia coli.,Peginesatide
DB09107,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Asparaginase Escherichia coli.,Methoxy polyethylene glycol-epoetin beta
DB01234,The serum concentration of Dexamethasone can be increased when it is combined with Asparaginase Escherichia coli.,Dexamethasone
DB00563,The therapeutic efficacy of Methotrexate can be decreased when used in combination with Asparaginase Escherichia coli.,Methotrexate
DB00619,The risk or severity of liver damage can be increased when Asparaginase Escherichia coli is combined with Imatinib.,Imatinib
DB00252,The therapeutic efficacy of Phenytoin can be increased when used in combination with Asparaginase Escherichia coli.,Phenytoin
DB00279,The therapeutic efficacy of Liothyronine can be increased when used in combination with Asparaginase Escherichia coli.,Liothyronine
DB00451,The therapeutic efficacy of Levothyroxine can be increased when used in combination with Asparaginase Escherichia coli.,Levothyroxine
DB00532,The therapeutic efficacy of Mephenytoin can be increased when used in combination with Asparaginase Escherichia coli.,Mephenytoin
DB00564,The therapeutic efficacy of Carbamazepine can be increased when used in combination with Asparaginase Escherichia coli.,Carbamazepine
DB00695,The therapeutic efficacy of Furosemide can be increased when used in combination with Asparaginase Escherichia coli.,Furosemide
DB00698,The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Asparaginase Escherichia coli.,Nitrofurantoin
DB00754,The therapeutic efficacy of Ethotoin can be increased when used in combination with Asparaginase Escherichia coli.,Ethotoin
DB00939,The therapeutic efficacy of Meclofenamic acid can be increased when used in combination with Asparaginase Escherichia coli.,Meclofenamic acid
DB01109,The therapeutic efficacy of Heparin can be increased when used in combination with Asparaginase Escherichia coli.,Heparin
DB01219,The therapeutic efficacy of Dantrolene can be increased when used in combination with Asparaginase Escherichia coli.,Dantrolene
DB01320,The therapeutic efficacy of Fosphenytoin can be increased when used in combination with Asparaginase Escherichia coli.,Fosphenytoin
DB01583,The therapeutic efficacy of Liotrix can be increased when used in combination with Asparaginase Escherichia coli.,Liotrix
DB08899,The therapeutic efficacy of Enzalutamide can be increased when used in combination with Asparaginase Escherichia coli.,Enzalutamide
DB08984,The therapeutic efficacy of Etofenamate can be increased when used in combination with Asparaginase Escherichia coli.,Etofenamate
DB12425,The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Asparaginase Escherichia coli.,Liothyronine I-131
DB13396,The therapeutic efficacy of Neocitrullamon can be increased when used in combination with Asparaginase Escherichia coli.,Neocitrullamon
DB01344,Tolevamer can cause a decrease in the absorption of Thyrotropin alfa resulting in a reduced serum concentration and potentially a decrease in efficacy.,Tolevamer
DB00255,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Diethylstilbestrol.,Diethylstilbestrol
DB00269,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Chlorotrianisene.,Chlorotrianisene
DB00286,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Conjugated estrogens.,Conjugated estrogens
DB00783,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Estradiol.,Estradiol
DB00977,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Ethinylestradiol.,Ethinylestradiol
DB01357,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Mestranol.,Mestranol
DB04573,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Estriol.,Estriol
DB04574,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Estrone sulfate.,Estrone sulfate
DB04575,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Quinestrol.,Quinestrol
DB07931,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Hexestrol.,Hexestrol
DB09070,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Tibolone.,Tibolone
DB09317,"The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Synthetic Conjugated Estrogens, A.","Synthetic Conjugated Estrogens, A"
DB09318,"The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Synthetic Conjugated Estrogens, B.","Synthetic Conjugated Estrogens, B"
DB09369,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Polyestradiol phosphate.,Polyestradiol phosphate
DB09381,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Esterified estrogens.,Esterified estrogens
DB11478,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Zeranol.,Zeranol
DB11674,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Equol.,Equol
DB12487,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Promestriene.,Promestriene
DB13143,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Methallenestril.,Methallenestril
DB13386,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Epimestrol.,Epimestrol
DB13418,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Moxestrol.,Moxestrol
DB13952,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Estradiol acetate.,Estradiol acetate
DB13953,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Estradiol benzoate.,Estradiol benzoate
DB13954,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Estradiol cypionate.,Estradiol cypionate
DB13956,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Estradiol valerate.,Estradiol valerate
DB15334,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Biochanin A.,Biochanin A
DB15335,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Formononetin.,Formononetin
DB00176,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Fluvoxamine.,Fluvoxamine
DB00215,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Citalopram.,Citalopram
DB00472,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Fluoxetine.,Fluoxetine
DB00476,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Duloxetine.,Duloxetine
DB00656,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Trazodone.,Trazodone
DB00715,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Paroxetine.,Paroxetine
DB01104,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Sertraline.,Sertraline
DB01105,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Sibutramine.,Sibutramine
DB01149,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Nefazodone.,Nefazodone
DB01175,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Escitalopram.,Escitalopram
DB04832,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Zimelidine.,Zimelidine
DB04884,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Dapoxetine.,Dapoxetine
DB04896,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Milnacipran.,Milnacipran
DB06700,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Desvenlafaxine.,Desvenlafaxine
DB06731,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Seproxetine.,Seproxetine
DB08918,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Levomilnacipran.,Levomilnacipran
DB08953,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Indalpine.,Indalpine
DB12693,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Ritanserin.,Ritanserin
DB13233,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Alaproclate.,Alaproclate
DB00930,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Colesevelam.,Colesevelam
DB00258,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium acetate.,Calcium acetate
DB00326,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium glucoheptonate.,Calcium glucoheptonate
DB01164,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium chloride.,Calcium chloride
DB01373,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium.,Calcium
DB06724,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium carbonate.,Calcium carbonate
DB11093,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium citrate.,Calcium citrate
DB11126,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium gluconate.,Calcium gluconate
DB11348,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium Phosphate.,Calcium Phosphate
DB13142,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium glubionate anhydrous.,Calcium glubionate anhydrous
DB13231,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium lactate.,Calcium lactate
DB13365,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium lactate gluconate.,Calcium lactate gluconate
DB13590,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium pangamate.,Calcium pangamate
DB13800,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium levulinate.,Calcium levulinate
DB14577,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium cation.,Calcium cation
DB14684,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium polycarbophil.,Calcium polycarbophil
DB06792,Lanthanum carbonate can cause a decrease in the absorption of Thyrotropin alfa resulting in a reduced serum concentration and potentially a decrease in efficacy.,Lanthanum carbonate
DB09210,"The risk or severity of confusion, irritability, and sleep disorders can be increased when Thyrotropin alfa is combined with Piracetam.",Piracetam
DB00331,The therapeutic efficacy of Metformin can be decreased when used in combination with Thyrotropin alfa.,Metformin
DB00067,Thyrotropin alfa may increase the vasoconstricting activities of Vasopressin.,Vasopressin
DB00093,Thyrotropin alfa may increase the vasoconstricting activities of Felypressin.,Felypressin
DB00247,Thyrotropin alfa may increase the vasoconstricting activities of Methysergide.,Methysergide
DB00320,Thyrotropin alfa may increase the vasoconstricting activities of Dihydroergotamine.,Dihydroergotamine
DB00669,Thyrotropin alfa may increase the vasoconstricting activities of Sumatriptan.,Sumatriptan
DB00696,Thyrotropin alfa may increase the vasoconstricting activities of Ergotamine.,Ergotamine
DB00907,Thyrotropin alfa may increase the vasoconstricting activities of Cocaine.,Cocaine
DB00952,Thyrotropin alfa may increase the vasoconstricting activities of Naratriptan.,Naratriptan
DB02234,Thyrotropin alfa may increase the vasoconstricting activities of S-Ethylisothiourea.,S-Ethylisothiourea
DB02638,Thyrotropin alfa may increase the vasoconstricting activities of Terlipressin.,Terlipressin
DB02860,Thyrotropin alfa may increase the vasoconstricting activities of Calyculin A.,Calyculin A
DB06694,Thyrotropin alfa may increase the vasoconstricting activities of Xylometazoline.,Xylometazoline
DB06707,Thyrotropin alfa may increase the vasoconstricting activities of Levonordefrin.,Levonordefrin
DB06711,Thyrotropin alfa may increase the vasoconstricting activities of Naphazoline.,Naphazoline
DB09202,Thyrotropin alfa may increase the vasoconstricting activities of Cirazoline.,Cirazoline
DB11842,Thyrotropin alfa may increase the vasoconstricting activities of Angiotensin II.,Angiotensin II
DB13251,Thyrotropin alfa may increase the vasoconstricting activities of Octopamine.,Octopamine
DB13394,Thyrotropin alfa may increase the vasoconstricting activities of Adrenalone.,Adrenalone
DB13464,Thyrotropin alfa may increase the vasoconstricting activities of Ornipressin.,Ornipressin
DB13517,Thyrotropin alfa may increase the vasoconstricting activities of Angiotensinamide.,Angiotensinamide
DB14642,Thyrotropin alfa may increase the vasoconstricting activities of Lypressin.,Lypressin
DB00233,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Aminosalicylic acid.,Aminosalicylic acid
DB00244,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Mesalazine.,Mesalazine
DB00795,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Sulfasalazine.,Sulfasalazine
DB00861,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Diflunisal.,Diflunisal
DB00936,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Salicylic acid.,Salicylic acid
DB00945,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Acetylsalicylic acid.,Acetylsalicylic acid
DB01014,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Balsalazide.,Balsalazide
DB01250,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Olsalazine.,Olsalazine
DB01294,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Bismuth subsalicylate.,Bismuth subsalicylate
DB06251,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Dersalazine.,Dersalazine
DB06807,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Phenyl aminosalicylate.,Phenyl aminosalicylate
DB09543,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Methyl salicylate.,Methyl salicylate
DB12445,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Nitroaspirin.,Nitroaspirin
DB13509,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Aloxiprin.,Aloxiprin
DB13538,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Guacetisal.,Guacetisal
DB13612,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Carbaspirin calcium.,Carbaspirin calcium
DB14006,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Choline salicylate.,Choline salicylate
DB14026,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Thiosalicylic acid.,Thiosalicylic acid
DB00187,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Esmolol.,Esmolol
DB00195,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Betaxolol.,Betaxolol
DB00264,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Metoprolol.,Metoprolol
DB00335,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Atenolol.,Atenolol
DB00373,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Timolol.,Timolol
DB00489,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Sotalol.,Sotalol
DB00571,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Propranolol.,Propranolol
DB00598,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Labetalol.,Labetalol
DB00612,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Bisoprolol.,Bisoprolol
DB00866,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Alprenolol.,Alprenolol
DB00960,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Pindolol.,Pindolol
DB01136,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Carvedilol.,Carvedilol
DB01182,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Propafenone.,Propafenone
DB01193,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Acebutolol.,Acebutolol
DB01203,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Nadolol.,Nadolol
DB01295,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Bevantolol.,Bevantolol
DB01297,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Practolol.,Practolol
DB01359,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Penbutolol.,Penbutolol
DB01580,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Oxprenolol.,Oxprenolol
DB03322,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Dexpropranolol.,Dexpropranolol
DB04846,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Celiprolol.,Celiprolol
DB04861,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Nebivolol.,Nebivolol
DB06726,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Bufuralol.,Bufuralol
DB08807,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Bopindolol.,Bopindolol
DB08808,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Bupranolol.,Bupranolol
DB08952,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Indenolol.,Indenolol
DB09013,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Befunolol.,Befunolol
DB09204,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Arotinolol.,Arotinolol
DB09351,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Levobetaxolol.,Levobetaxolol
DB11770,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Talinolol.,Talinolol
DB11785,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Anisodamine.,Anisodamine
DB12212,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Landiolol.,Landiolol
DB12752,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Bucindolol.,Bucindolol
DB13443,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Esatenolol.,Esatenolol
DB13508,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Cloranolol.,Cloranolol
DB13530,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Mepindolol.,Mepindolol
DB13757,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Epanolol.,Epanolol
DB13775,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Tertatolol.,Tertatolol
DB00394,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Beclomethasone dipropionate.,Beclomethasone dipropionate
DB00443,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Betamethasone.,Betamethasone
DB00620,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Triamcinolone.,Triamcinolone
DB00635,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Prednisone.,Prednisone
DB00764,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Mometasone.,Mometasone
DB01380,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Cortisone acetate.,Cortisone acetate
DB01384,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Paramethasone.,Paramethasone
DB01410,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Ciclesonide.,Ciclesonide
DB08906,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Fluticasone furoate.,Fluticasone furoate
DB08970,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Fluprednidene.,Fluprednidene
DB08971,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Fluocortolone.,Fluocortolone
DB09383,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Meprednisone.,Meprednisone
DB11487,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Dexamethasone isonicotinate.,Dexamethasone isonicotinate
DB11750,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Clobetasol.,Clobetasol
DB11921,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Deflazacort.,Deflazacort
DB13003,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Cortivazol.,Cortivazol
DB13208,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Prednylidene.,Prednylidene
DB13728,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Halometasone.,Halometasone
DB13843,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Cloprednol.,Cloprednol
DB13867,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Fluticasone.,Fluticasone
DB14512,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Mometasone furoate.,Mometasone furoate
DB14631,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Prednisolone phosphate.,Prednisolone phosphate
DB14633,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Prednisolone hemisuccinate.,Prednisolone hemisuccinate
DB14634,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Fluprednidene acetate.,Fluprednidene acetate
DB14644,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Methylprednisolone hemisuccinate.,Methylprednisolone hemisuccinate
DB14646,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Prednisone acetate.,Prednisone acetate
DB14652,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Clocortolone acetate.,Clocortolone acetate
DB14659,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Melengestrol acetate.,Melengestrol acetate
DB14669,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Betamethasone phosphate.,Betamethasone phosphate
DB14681,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Cortisone.,Cortisone
DB01118,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Amiodarone.,Amiodarone
DB00182,The risk or severity of adverse effects can be increased when Amphetamine is combined with Thyrotropin alfa.,Amphetamine
DB00191,The risk or severity of adverse effects can be increased when Phentermine is combined with Thyrotropin alfa.,Phentermine
DB00211,The risk or severity of adverse effects can be increased when Midodrine is combined with Thyrotropin alfa.,Midodrine
DB00368,The risk or severity of adverse effects can be increased when Norepinephrine is combined with Thyrotropin alfa.,Norepinephrine
DB00388,The risk or severity of adverse effects can be increased when Phenylephrine is combined with Thyrotropin alfa.,Phenylephrine
DB00397,The risk or severity of adverse effects can be increased when Phenylpropanolamine is combined with Thyrotropin alfa.,Phenylpropanolamine
DB00610,The risk or severity of adverse effects can be increased when Metaraminol is combined with Thyrotropin alfa.,Metaraminol
DB00668,The risk or severity of adverse effects can be increased when Epinephrine is combined with Thyrotropin alfa.,Epinephrine
DB00723,The risk or severity of adverse effects can be increased when Methoxamine is combined with Thyrotropin alfa.,Methoxamine
DB00816,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Thyrotropin alfa.,Orciprenaline
DB00830,The risk or severity of adverse effects can be increased when Phenmetrazine is combined with Thyrotropin alfa.,Phenmetrazine
DB00841,The risk or severity of adverse effects can be increased when Dobutamine is combined with Thyrotropin alfa.,Dobutamine
DB00852,The risk or severity of adverse effects can be increased when Pseudoephedrine is combined with Thyrotropin alfa.,Pseudoephedrine
DB00865,The risk or severity of adverse effects can be increased when Benzphetamine is combined with Thyrotropin alfa.,Benzphetamine
DB00867,The risk or severity of adverse effects can be increased when Ritodrine is combined with Thyrotropin alfa.,Ritodrine
DB00871,The risk or severity of adverse effects can be increased when Terbutaline is combined with Thyrotropin alfa.,Terbutaline
DB00935,The risk or severity of adverse effects can be increased when Oxymetazoline is combined with Thyrotropin alfa.,Oxymetazoline
DB00937,The risk or severity of adverse effects can be increased when Diethylpropion is combined with Thyrotropin alfa.,Diethylpropion
DB00988,The risk or severity of adverse effects can be increased when Dopamine is combined with Thyrotropin alfa.,Dopamine
DB01064,The risk or severity of adverse effects can be increased when Isoprenaline is combined with Thyrotropin alfa.,Isoprenaline
DB01255,The risk or severity of adverse effects can be increased when Lisdexamfetamine is combined with Thyrotropin alfa.,Lisdexamfetamine
DB01288,The risk or severity of adverse effects can be increased when Fenoterol is combined with Thyrotropin alfa.,Fenoterol
DB01364,The risk or severity of adverse effects can be increased when Ephedrine is combined with Thyrotropin alfa.,Ephedrine
DB01365,The risk or severity of adverse effects can be increased when Mephentermine is combined with Thyrotropin alfa.,Mephentermine
DB01366,The risk or severity of adverse effects can be increased when Procaterol is combined with Thyrotropin alfa.,Procaterol
DB01407,The risk or severity of adverse effects can be increased when Clenbuterol is combined with Thyrotropin alfa.,Clenbuterol
DB01442,The risk or severity of adverse effects can be increased when MMDA is combined with Thyrotropin alfa.,MMDA
DB01454,The risk or severity of adverse effects can be increased when Midomafetamine is combined with Thyrotropin alfa.,Midomafetamine
DB01467,"The risk or severity of adverse effects can be increased when 2,5-Dimethoxy-4-ethylamphetamine is combined with Thyrotropin alfa.","2,5-Dimethoxy-4-ethylamphetamine"
DB01484,"The risk or severity of adverse effects can be increased when 4-Bromo-2,5-dimethoxyamphetamine is combined with Thyrotropin alfa.","4-Bromo-2,5-dimethoxyamphetamine"
DB01509,The risk or severity of adverse effects can be increased when Tenamfetamine is combined with Thyrotropin alfa.,Tenamfetamine
DB01556,The risk or severity of adverse effects can be increased when Chlorphentermine is combined with Thyrotropin alfa.,Chlorphentermine
DB01566,The risk or severity of adverse effects can be increased when Methylenedioxyethamphetamine is combined with Thyrotropin alfa.,Methylenedioxyethamphetamine
DB01576,The risk or severity of adverse effects can be increased when Dextroamphetamine is combined with Thyrotropin alfa.,Dextroamphetamine
DB01577,The risk or severity of adverse effects can be increased when Metamfetamine is combined with Thyrotropin alfa.,Metamfetamine
DB06152,The risk or severity of adverse effects can be increased when Nylidrin is combined with Thyrotropin alfa.,Nylidrin
DB06764,The risk or severity of adverse effects can be increased when Tetryzoline is combined with Thyrotropin alfa.,Tetryzoline
DB08841,The risk or severity of adverse effects can be increased when Tyramine is combined with Thyrotropin alfa.,Tyramine
DB08941,The risk or severity of adverse effects can be increased when Isoxsuprine is combined with Thyrotropin alfa.,Isoxsuprine
DB08985,The risk or severity of adverse effects can be increased when Etilefrine is combined with Thyrotropin alfa.,Etilefrine
DB09203,The risk or severity of adverse effects can be increased when Synephrine is combined with Thyrotropin alfa.,Synephrine
DB09480,The risk or severity of adverse effects can be increased when Iofetamine I-123 is combined with Thyrotropin alfa.,Iofetamine I-123
DB11124,The risk or severity of adverse effects can be increased when Racepinephrine is combined with Thyrotropin alfa.,Racepinephrine
DB12080,The risk or severity of adverse effects can be increased when Ritobegron is combined with Thyrotropin alfa.,Ritobegron
DB13064,The risk or severity of adverse effects can be increased when Tramazoline is combined with Thyrotropin alfa.,Tramazoline
DB13108,The risk or severity of adverse effects can be increased when Mephedrone is combined with Thyrotropin alfa.,Mephedrone
DB13341,The risk or severity of adverse effects can be increased when Fenozolone is combined with Thyrotropin alfa.,Fenozolone
DB13624,The risk or severity of adverse effects can be increased when Methoxyphenamine is combined with Thyrotropin alfa.,Methoxyphenamine
DB13692,The risk or severity of adverse effects can be increased when Tretoquinol is combined with Thyrotropin alfa.,Tretoquinol
DB13703,The risk or severity of adverse effects can be increased when Gepefrine is combined with Thyrotropin alfa.,Gepefrine
DB13777,The risk or severity of adverse effects can be increased when Prenalterol is combined with Thyrotropin alfa.,Prenalterol
DB13852,The risk or severity of adverse effects can be increased when Mefenorex is combined with Thyrotropin alfa.,Mefenorex
DB13940,"The risk or severity of adverse effects can be increased when 2,5-Dimethoxy-4-ethylthioamphetamine is combined with Thyrotropin alfa.","2,5-Dimethoxy-4-ethylthioamphetamine"
DB00317,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Gefitinib.,Gefitinib
DB00398,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Sorafenib.,Sorafenib
DB00530,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Erlotinib.,Erlotinib
DB00619,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Imatinib.,Imatinib
DB01254,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Dasatinib.,Dasatinib
DB01259,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Lapatinib.,Lapatinib
DB01268,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Sunitinib.,Sunitinib
DB01645,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Genistein.,Genistein
DB02058,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with 3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone.,3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone
DB02424,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Geldanamycin.,Geldanamycin
DB02567,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with PD173955.,PD173955
DB03758,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Radicicol.,Radicicol
DB04849,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Cediranib.,Cediranib
DB04868,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Nilotinib.,Nilotinib
DB04879,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Vatalanib.,Vatalanib
DB05294,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Vandetanib.,Vandetanib
DB05424,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Canertinib.,Canertinib
DB05465,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Tandutinib.,Tandutinib
DB05575,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Motesanib.,Motesanib
DB05928,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Dovitinib.,Dovitinib
DB06302,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Glesatinib.,Glesatinib
DB06469,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Lestaurtinib.,Lestaurtinib
DB06589,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Pazopanib.,Pazopanib
DB06595,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Midostaurin.,Midostaurin
DB06616,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Bosutinib.,Bosutinib
DB06626,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Axitinib.,Axitinib
DB08399,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Piceatannol.,Piceatannol
DB08865,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Crizotinib.,Crizotinib
DB08875,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Cabozantinib.,Cabozantinib
DB08877,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Ruxolitinib.,Ruxolitinib
DB08881,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Vemurafenib.,Vemurafenib
DB08896,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Regorafenib.,Regorafenib
DB08901,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Ponatinib.,Ponatinib
DB08916,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Afatinib.,Afatinib
DB09053,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Ibrutinib.,Ibrutinib
DB09063,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Ceritinib.,Ceritinib
DB09078,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Lenvatinib.,Lenvatinib
DB09079,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Nintedanib.,Nintedanib
DB09330,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Osimertinib.,Osimertinib
DB11363,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Alectinib.,Alectinib
DB11689,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Selumetinib.,Selumetinib
DB11697,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Pacritinib.,Pacritinib
DB11703,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Acalabrutinib.,Acalabrutinib
DB11737,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Icotinib.,Icotinib
DB11805,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Saracatinib.,Saracatinib
DB11828,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Neratinib.,Neratinib
DB11832,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Crenolanib.,Crenolanib
DB11904,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Flumatinib.,Flumatinib
DB11963,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Dacomitinib.,Dacomitinib
DB11973,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Tesevatinib.,Tesevatinib
DB11986,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Entrectinib.,Entrectinib
DB12010,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Fostamatinib.,Fostamatinib
DB12048,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Savolitinib.,Savolitinib
DB12141,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Gilteritinib.,Gilteritinib
DB12147,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Erdafitinib.,Erdafitinib
DB12267,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Brigatinib.,Brigatinib
DB12307,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Foretinib.,Foretinib
DB12323,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Radotinib.,Radotinib
DB14723,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Larotrectinib.,Larotrectinib
DB12978,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Pexidartinib.,Pexidartinib
DB12500,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Fedratinib.,Fedratinib
DB11652,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Tucatinib.,Tucatinib
DB11791,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Capmatinib.,Capmatinib
DB15685,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Selpercatinib.,Selpercatinib
DB05258,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Interferon alfa.,Interferon alfa
DB00041,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Aldesleukin.,Aldesleukin
DB00227,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Lovastatin.,Lovastatin
DB00609,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Ethionamide.,Ethionamide
DB00829,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Diazepam.,Diazepam
DB00850,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Perphenazine.,Perphenazine
DB01233,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Metoclopramide.,Metoclopramide
DB14651,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Perphenazine enanthate.,Perphenazine enanthate
DB11085,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Resorcinol.,Resorcinol
DB00201,Thyrotropin alfa may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.,Caffeine
DB00277,Thyrotropin alfa may increase the excretion rate of Theophylline which could result in a lower serum level and potentially a reduction in efficacy.,Theophylline
DB00651,Thyrotropin alfa may increase the excretion rate of Dyphylline which could result in a lower serum level and potentially a reduction in efficacy.,Dyphylline
DB00806,Thyrotropin alfa may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.,Pentoxifylline
DB01033,Thyrotropin alfa may increase the excretion rate of Mercaptopurine which could result in a lower serum level and potentially a reduction in efficacy.,Mercaptopurine
DB01223,Thyrotropin alfa may increase the excretion rate of Aminophylline which could result in a lower serum level and potentially a reduction in efficacy.,Aminophylline
DB01303,Thyrotropin alfa may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,Oxtriphylline
DB01412,Thyrotropin alfa may increase the excretion rate of Theobromine which could result in a lower serum level and potentially a reduction in efficacy.,Theobromine
DB01482,Thyrotropin alfa may increase the excretion rate of Fenethylline which could result in a lower serum level and potentially a reduction in efficacy.,Fenethylline
DB01667,Thyrotropin alfa may increase the excretion rate of 8-azaguanine which could result in a lower serum level and potentially a reduction in efficacy.,8-azaguanine
DB01978,"Thyrotropin alfa may increase the excretion rate of 7,9-Dimethylguanine which could result in a lower serum level and potentially a reduction in efficacy.","7,9-Dimethylguanine"
DB02134,Thyrotropin alfa may increase the excretion rate of Xanthine which could result in a lower serum level and potentially a reduction in efficacy.,Xanthine
DB02245,Thyrotropin alfa may increase the excretion rate of 7-Deazaguanine which could result in a lower serum level and potentially a reduction in efficacy.,7-Deazaguanine
DB02377,Thyrotropin alfa may increase the excretion rate of Guanine which could result in a lower serum level and potentially a reduction in efficacy.,Guanine
DB02489,Thyrotropin alfa may increase the excretion rate of 9-Methylguanine which could result in a lower serum level and potentially a reduction in efficacy.,9-Methylguanine
DB02568,Thyrotropin alfa may increase the excretion rate of Peldesine which could result in a lower serum level and potentially a reduction in efficacy.,Peldesine
DB04076,Thyrotropin alfa may increase the excretion rate of Hypoxanthine which could result in a lower serum level and potentially a reduction in efficacy.,Hypoxanthine
DB04356,Thyrotropin alfa may increase the excretion rate of 9-Deazaguanine which could result in a lower serum level and potentially a reduction in efficacy.,9-Deazaguanine
DB06479,Thyrotropin alfa may increase the excretion rate of Propentofylline which could result in a lower serum level and potentially a reduction in efficacy.,Propentofylline
DB06575,Thyrotropin alfa may increase the excretion rate of Valomaciclovir which could result in a lower serum level and potentially a reduction in efficacy.,Valomaciclovir
DB07954,Thyrotropin alfa may increase the excretion rate of 3-isobutyl-1-methyl-7H-xanthine which could result in a lower serum level and potentially a reduction in efficacy.,3-isobutyl-1-methyl-7H-xanthine
DB08844,Thyrotropin alfa may increase the excretion rate of Uric acid which could result in a lower serum level and potentially a reduction in efficacy.,Uric acid
DB09273,Thyrotropin alfa may increase the excretion rate of Doxofylline which could result in a lower serum level and potentially a reduction in efficacy.,Doxofylline
DB11919,Thyrotropin alfa may increase the excretion rate of 6-O-benzylguanine which could result in a lower serum level and potentially a reduction in efficacy.,6-O-benzylguanine
DB12406,Thyrotropin alfa may increase the excretion rate of Lisofylline which could result in a lower serum level and potentially a reduction in efficacy.,Lisofylline
DB12531,Thyrotropin alfa may increase the excretion rate of Lobucavir which could result in a lower serum level and potentially a reduction in efficacy.,Lobucavir
DB12926,Thyrotropin alfa may increase the excretion rate of Cafedrine which could result in a lower serum level and potentially a reduction in efficacy.,Cafedrine
DB12927,Thyrotropin alfa may increase the excretion rate of Theodrenaline which could result in a lower serum level and potentially a reduction in efficacy.,Theodrenaline
DB13203,Thyrotropin alfa may increase the excretion rate of Bamifylline which could result in a lower serum level and potentially a reduction in efficacy.,Bamifylline
DB13449,Thyrotropin alfa may increase the excretion rate of Proxyphylline which could result in a lower serum level and potentially a reduction in efficacy.,Proxyphylline
DB13573,Thyrotropin alfa may increase the excretion rate of Acefylline which could result in a lower serum level and potentially a reduction in efficacy.,Acefylline
DB13592,Thyrotropin alfa may increase the excretion rate of Etamiphylline which could result in a lower serum level and potentially a reduction in efficacy.,Etamiphylline
DB13634,Thyrotropin alfa may increase the excretion rate of Pentifylline which could result in a lower serum level and potentially a reduction in efficacy.,Pentifylline
DB13812,Thyrotropin alfa may increase the excretion rate of Bufylline which could result in a lower serum level and potentially a reduction in efficacy.,Bufylline
DB14018,Thyrotropin alfa may increase the excretion rate of Bromotheophylline which could result in a lower serum level and potentially a reduction in efficacy.,Bromotheophylline
DB14029,Thyrotropin alfa may increase the excretion rate of Furafylline which could result in a lower serum level and potentially a reduction in efficacy.,Furafylline
DB14132,Thyrotropin alfa may increase the excretion rate of 8-chlorotheophylline which could result in a lower serum level and potentially a reduction in efficacy.,8-chlorotheophylline
DB15122,Thyrotropin alfa may increase the excretion rate of PCS-499 which could result in a lower serum level and potentially a reduction in efficacy.,PCS-499
DB01432,Cholestyramine can cause a decrease in the absorption of Thyrotropin alfa resulting in a reduced serum concentration and potentially a decrease in efficacy.,Cholestyramine
DB00375,Colestipol can cause a decrease in the absorption of Thyrotropin alfa resulting in a reduced serum concentration and potentially a decrease in efficacy.,Colestipol
DB00658,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Sevelamer.,Sevelamer
DB00390,The serum concentration of Digoxin can be decreased when it is combined with Thyrotropin alfa.,Digoxin
DB13401,The serum concentration of Metildigoxin can be decreased when it is combined with Thyrotropin alfa.,Metildigoxin
DB13691,The serum concentration of Acetyldigoxin can be decreased when it is combined with Thyrotropin alfa.,Acetyldigoxin
DB00266,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with Dicoumarol.,Dicoumarol
DB00498,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with Phenindione.,Phenindione
DB00682,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with Warfarin.,Warfarin
DB00946,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with Phenprocoumon.,Phenprocoumon
DB01418,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with Acenocoumarol.,Acenocoumarol
DB03410,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with 4-hydroxycoumarin.,4-hydroxycoumarin
DB04665,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with Coumarin.,Coumarin
DB08496,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with (R)-warfarin.,(R)-warfarin
DB08794,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with Ethyl biscoumacetate.,Ethyl biscoumacetate
DB13136,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with Fluindione.,Fluindione
DB13275,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with Clorindione.,Clorindione
DB13347,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with Diphenadione.,Diphenadione
DB13451,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with Tioclomarol.,Tioclomarol
DB14055,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with (S)-Warfarin.,(S)-Warfarin
DB00222,Thyrotropin alfa may decrease the hypoglycemic activities of Glimepiride.,Glimepiride
DB00414,Thyrotropin alfa may decrease the hypoglycemic activities of Acetohexamide.,Acetohexamide
DB00672,Thyrotropin alfa may decrease the hypoglycemic activities of Chlorpropamide.,Chlorpropamide
DB00839,Thyrotropin alfa may decrease the hypoglycemic activities of Tolazamide.,Tolazamide
DB01016,Thyrotropin alfa may decrease the hypoglycemic activities of Glyburide.,Glyburide
DB01067,Thyrotropin alfa may decrease the hypoglycemic activities of Glipizide.,Glipizide
DB01120,Thyrotropin alfa may decrease the hypoglycemic activities of Gliclazide.,Gliclazide
DB01124,Thyrotropin alfa may decrease the hypoglycemic activities of Tolbutamide.,Tolbutamide
DB01251,Thyrotropin alfa may decrease the hypoglycemic activities of Gliquidone.,Gliquidone
DB01289,Thyrotropin alfa may decrease the hypoglycemic activities of Glisoxepide.,Glisoxepide
DB08962,Thyrotropin alfa may decrease the hypoglycemic activities of Glibornuride.,Glibornuride
DB13406,Thyrotropin alfa may decrease the hypoglycemic activities of Carbutamide.,Carbutamide
DB13675,Thyrotropin alfa may decrease the hypoglycemic activities of Metahexamide.,Metahexamide
DB00030,Thyrotropin alfa may decrease the hypoglycemic activities of Insulin human.,Insulin human
DB00046,Thyrotropin alfa may decrease the hypoglycemic activities of Insulin lispro.,Insulin lispro
DB00047,Thyrotropin alfa may decrease the hypoglycemic activities of Insulin glargine.,Insulin glargine
DB00071,Thyrotropin alfa may decrease the hypoglycemic activities of Insulin pork.,Insulin pork
DB00197,Thyrotropin alfa may decrease the hypoglycemic activities of Troglitazone.,Troglitazone
DB00263,Thyrotropin alfa may decrease the hypoglycemic activities of Sulfisoxazole.,Sulfisoxazole
DB00280,Thyrotropin alfa may decrease the hypoglycemic activities of Disopyramide.,Disopyramide
DB00284,Thyrotropin alfa may decrease the hypoglycemic activities of Acarbose.,Acarbose
DB00359,Thyrotropin alfa may decrease the hypoglycemic activities of Sulfadiazine.,Sulfadiazine
DB00412,Thyrotropin alfa may decrease the hypoglycemic activities of Rosiglitazone.,Rosiglitazone
DB00468,Thyrotropin alfa may decrease the hypoglycemic activities of Quinine.,Quinine
DB00491,Thyrotropin alfa may decrease the hypoglycemic activities of Miglitol.,Miglitol
DB00731,Thyrotropin alfa may decrease the hypoglycemic activities of Nateglinide.,Nateglinide
DB00738,Thyrotropin alfa may decrease the hypoglycemic activities of Pentamidine.,Pentamidine
DB00834,Thyrotropin alfa may decrease the hypoglycemic activities of Mifepristone.,Mifepristone
DB00912,Thyrotropin alfa may decrease the hypoglycemic activities of Repaglinide.,Repaglinide
DB00914,Thyrotropin alfa may decrease the hypoglycemic activities of Phenformin.,Phenformin
DB01015,Thyrotropin alfa may decrease the hypoglycemic activities of Sulfamethoxazole.,Sulfamethoxazole
DB01132,Thyrotropin alfa may decrease the hypoglycemic activities of Pioglitazone.,Pioglitazone
DB01200,Thyrotropin alfa may decrease the hypoglycemic activities of Bromocriptine.,Bromocriptine
DB01252,Thyrotropin alfa may decrease the hypoglycemic activities of Mitiglinide.,Mitiglinide
DB01261,Thyrotropin alfa may decrease the hypoglycemic activities of Sitagliptin.,Sitagliptin
DB01276,Thyrotropin alfa may decrease the hypoglycemic activities of Exenatide.,Exenatide
DB01277,Thyrotropin alfa may decrease the hypoglycemic activities of Mecasermin.,Mecasermin
DB01278,Thyrotropin alfa may decrease the hypoglycemic activities of Pramlintide.,Pramlintide
DB01306,Thyrotropin alfa may decrease the hypoglycemic activities of Insulin aspart.,Insulin aspart
DB01307,Thyrotropin alfa may decrease the hypoglycemic activities of Insulin detemir.,Insulin detemir
DB01309,Thyrotropin alfa may decrease the hypoglycemic activities of Insulin glulisine.,Insulin glulisine
DB01382,Thyrotropin alfa may decrease the hypoglycemic activities of Glymidine.,Glymidine
DB01700,Thyrotropin alfa may decrease the hypoglycemic activities of AICA ribonucleotide.,AICA ribonucleotide
DB04830,Thyrotropin alfa may decrease the hypoglycemic activities of Buformin.,Buformin
DB04876,Thyrotropin alfa may decrease the hypoglycemic activities of Vildagliptin.,Vildagliptin
DB04878,Thyrotropin alfa may decrease the hypoglycemic activities of Voglibose.,Voglibose
DB05115,Thyrotropin alfa may decrease the hypoglycemic activities of NN344.,NN344
DB05819,Thyrotropin alfa may decrease the hypoglycemic activities of NBI-6024.,NBI-6024
DB06011,Thyrotropin alfa may decrease the hypoglycemic activities of AMG-222.,AMG-222
DB06127,Thyrotropin alfa may decrease the hypoglycemic activities of Bisegliptin.,Bisegliptin
DB06203,Thyrotropin alfa may decrease the hypoglycemic activities of Alogliptin.,Alogliptin
DB06292,Thyrotropin alfa may decrease the hypoglycemic activities of Dapagliflozin.,Dapagliflozin
DB06335,Thyrotropin alfa may decrease the hypoglycemic activities of Saxagliptin.,Saxagliptin
DB06655,Thyrotropin alfa may decrease the hypoglycemic activities of Liraglutide.,Liraglutide
DB08382,Thyrotropin alfa may decrease the hypoglycemic activities of Gosogliptin.,Gosogliptin
DB08882,Thyrotropin alfa may decrease the hypoglycemic activities of Linagliptin.,Linagliptin
DB08907,Thyrotropin alfa may decrease the hypoglycemic activities of Canagliflozin.,Canagliflozin
DB09022,Thyrotropin alfa may decrease the hypoglycemic activities of Benfluorex.,Benfluorex
DB09038,Thyrotropin alfa may decrease the hypoglycemic activities of Empagliflozin.,Empagliflozin
DB09043,Thyrotropin alfa may decrease the hypoglycemic activities of Albiglutide.,Albiglutide
DB09045,Thyrotropin alfa may decrease the hypoglycemic activities of Dulaglutide.,Dulaglutide
DB09198,Thyrotropin alfa may decrease the hypoglycemic activities of Lobeglitazone.,Lobeglitazone
DB09199,Thyrotropin alfa may decrease the hypoglycemic activities of Netoglitazone.,Netoglitazone
DB09200,Thyrotropin alfa may decrease the hypoglycemic activities of Rivoglitazone.,Rivoglitazone
DB09201,Thyrotropin alfa may decrease the hypoglycemic activities of Ciglitazone.,Ciglitazone
DB09265,Thyrotropin alfa may decrease the hypoglycemic activities of Lixisenatide.,Lixisenatide
DB09456,Thyrotropin alfa may decrease the hypoglycemic activities of Insulin beef.,Insulin beef
DB09564,Thyrotropin alfa may decrease the hypoglycemic activities of Insulin degludec.,Insulin degludec
DB11567,Thyrotropin alfa may decrease the hypoglycemic activities of Insulin peglispro.,Insulin peglispro
DB11568,Thyrotropin alfa may decrease the hypoglycemic activities of Insulin tregopil.,Insulin tregopil
DB11698,Thyrotropin alfa may decrease the hypoglycemic activities of Ipragliflozin.,Ipragliflozin
DB11723,Thyrotropin alfa may decrease the hypoglycemic activities of Dutogliptin.,Dutogliptin
DB11780,Thyrotropin alfa may decrease the hypoglycemic activities of Allicin.,Allicin
DB11824,Thyrotropin alfa may decrease the hypoglycemic activities of Tofogliflozin.,Tofogliflozin
DB11827,Thyrotropin alfa may decrease the hypoglycemic activities of Ertugliflozin.,Ertugliflozin
DB11898,"Thyrotropin alfa may decrease the hypoglycemic activities of 2,4-thiazolidinedione.","2,4-thiazolidinedione"
DB11950,Thyrotropin alfa may decrease the hypoglycemic activities of Teneligliptin.,Teneligliptin
DB11992,Thyrotropin alfa may decrease the hypoglycemic activities of Omarigliptin.,Omarigliptin
DB12268,Thyrotropin alfa may decrease the hypoglycemic activities of Carmegliptin.,Carmegliptin
DB12412,Thyrotropin alfa may decrease the hypoglycemic activities of Gemigliptin.,Gemigliptin
DB12417,Thyrotropin alfa may decrease the hypoglycemic activities of Anagliptin.,Anagliptin
DB12625,Thyrotropin alfa may decrease the hypoglycemic activities of Evogliptin.,Evogliptin
DB12713,Thyrotropin alfa may decrease the hypoglycemic activities of Sotagliflozin.,Sotagliflozin
DB12781,Thyrotropin alfa may decrease the hypoglycemic activities of Balaglitazone.,Balaglitazone
DB12935,Thyrotropin alfa may decrease the hypoglycemic activities of Remogliflozin etabonate.,Remogliflozin etabonate
DB13446,Thyrotropin alfa may decrease the hypoglycemic activities of Guar gum.,Guar gum
DB13928,Thyrotropin alfa may decrease the hypoglycemic activities of Semaglutide.,Semaglutide
DB14027,Thyrotropin alfa may decrease the hypoglycemic activities of Taspoglutide.,Taspoglutide
DB14035,Thyrotropin alfa may decrease the hypoglycemic activities of Englitazone.,Englitazone
DB15171,Thyrotropin alfa may decrease the hypoglycemic activities of Tirzepatide.,Tirzepatide
DB15217,Thyrotropin alfa may decrease the hypoglycemic activities of Gastric inhibitory polypeptide.,Gastric inhibitory polypeptide
DB00540,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Nortriptyline.,Nortriptyline
DB00321,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Amitriptyline.,Amitriptyline
DB00344,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Protriptyline.,Protriptyline
DB00458,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Imipramine.,Imipramine
DB00543,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Amoxapine.,Amoxapine
DB00726,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Trimipramine.,Trimipramine
DB01142,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Doxepin.,Doxepin
DB01151,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Desipramine.,Desipramine
DB01242,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Clomipramine.,Clomipramine
DB04836,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Amineptine.,Amineptine
DB08996,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Dimetacrine.,Dimetacrine
DB09016,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Butriptyline.,Butriptyline
DB09167,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Dosulepin.,Dosulepin
DB09289,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Tianeptine.,Tianeptine
DB09307,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Oxaprotiline.,Oxaprotiline
DB12930,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Opipramol.,Opipramol
DB13114,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Amitriptylinoxide.,Amitriptylinoxide
DB13225,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Dibenzepin.,Dibenzepin
DB13246,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Quinupramine.,Quinupramine
DB13384,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Melitracen.,Melitracen
DB13411,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Lofepramine.,Lofepramine
DB13496,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Iprindole.,Iprindole
DB13782,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Imipramine oxide.,Imipramine oxide
DB00513,"The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Antihemophilic factor, human recombinant.",Aminocaproic acid
DB00058,"Alpha-1-proteinase inhibitor may increase the thrombogenic activities of Antihemophilic factor, human recombinant.",Alpha-1-proteinase inhibitor
DB00170,"Menadione may increase the thrombogenic activities of Antihemophilic factor, human recombinant.",Menadione
DB00302,"Tranexamic acid may increase the thrombogenic activities of Antihemophilic factor, human recombinant.",Tranexamic acid
DB06692,"Aprotinin may increase the thrombogenic activities of Antihemophilic factor, human recombinant.",Aprotinin
DB11091,"Hydrogen peroxide may increase the thrombogenic activities of Antihemophilic factor, human recombinant.",Hydrogen peroxide
DB13244,"Aminomethylbenzoic acid may increase the thrombogenic activities of Antihemophilic factor, human recombinant.",Aminomethylbenzoic acid
DB13729,"Camostat may increase the thrombogenic activities of Antihemophilic factor, human recombinant.",Camostat
DB12726,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Monteplase.",Monteplase
DB00001,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Lepirudin.",Lepirudin
DB00006,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Bivalirudin.",Bivalirudin
DB00009,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Alteplase.",Alteplase
DB00013,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Urokinase.",Urokinase
DB00015,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Reteplase.",Reteplase
DB00029,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Anistreplase.",Anistreplase
DB00031,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Tenecteplase.",Tenecteplase
DB00054,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Abciximab.",Abciximab
DB00055,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Drotrecogin alfa.",Drotrecogin alfa
DB00086,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Streptokinase.",Streptokinase
DB00266,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Dicoumarol.",Dicoumarol
DB00278,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Argatroban.",Argatroban
DB00407,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Ardeparin.",Ardeparin
DB00498,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Phenindione.",Phenindione
DB00569,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Fondaparinux.",Fondaparinux
DB00682,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Warfarin.",Warfarin
DB00686,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Pentosan polysulfate.",Pentosan polysulfate
DB00945,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Acetylsalicylic acid.",Acetylsalicylic acid
DB00946,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Phenprocoumon.",Phenprocoumon
DB00975,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Dipyridamole.",Dipyridamole
DB01088,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Iloprost.",Iloprost
DB01109,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Heparin.",Heparin
DB01225,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Enoxaparin.",Enoxaparin
DB01240,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Epoprostenol.",Epoprostenol
DB01418,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Acenocoumarol.",Acenocoumarol
DB03410,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with 4-hydroxycoumarin.",4-hydroxycoumarin
DB04665,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Coumarin.",Coumarin
DB04898,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Ximelagatran.",Ximelagatran
DB04925,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Desmoteplase.",Desmoteplase
DB04932,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Defibrotide.",Defibrotide
DB05099,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Ancrod.",Ancrod
DB05229,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Beraprost.",Beraprost
DB05254,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Fibrinolysin.",Fibrinolysin
DB06209,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Prasugrel.",Prasugrel
DB06228,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Rivaroxaban.",Rivaroxaban
DB06271,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Sulodexide.",Sulodexide
DB06406,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Idraparinux.",Idraparinux
DB06441,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Cangrelor.",Cangrelor
DB06543,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Astaxanthin.",Astaxanthin
DB06605,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Apixaban.",Apixaban
DB06635,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Otamixaban.",Otamixaban
DB06679,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Amediplase.",Amediplase
DB06695,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Dabigatran etexilate.",Dabigatran etexilate
DB06754,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Danaparoid.",Danaparoid
DB06779,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Dalteparin.",Dalteparin
DB06822,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Tinzaparin.",Tinzaparin
DB07767,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Ferulic acid.",Ferulic acid
DB08496,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with (R)-warfarin.",(R)-warfarin
DB08794,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Ethyl biscoumacetate.",Ethyl biscoumacetate
DB08813,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Nadroparin.",Nadroparin
DB08814,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Triflusal.",Triflusal
DB08816,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Ticagrelor.",Ticagrelor
DB08994,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Ditazole.",Ditazole
DB09030,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Vorapaxar.",Vorapaxar
DB09075,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Edoxaban.",Edoxaban
DB09125,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Potassium citrate.",Potassium citrate
DB09154,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Sodium citrate.",Sodium citrate
DB09255,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Dextran.",Dextran
DB09258,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Bemiparin.",Bemiparin
DB09259,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Reviparin.",Reviparin
DB09260,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Parnaparin.",Parnaparin
DB09261,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Certoparin.",Certoparin
DB11095,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Desirudin.",Desirudin
DB11154,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Zinc citrate.",Zinc citrate
DB11166,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Antithrombin Alfa.",Antithrombin Alfa
DB11312,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Protein C.",Protein C
DB11598,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Antithrombin III human.",Antithrombin III human
DB11984,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Letaxaban.",Letaxaban
DB12289,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Darexaban.",Darexaban
DB12364,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Betrixaban.",Betrixaban
DB12598,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Nafamostat.",Nafamostat
DB12831,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Gabexate.",Gabexate
DB13136,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Fluindione.",Fluindione
DB13149,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Protein S human.",Protein S human
DB13199,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Brinase.",Brinase
DB13275,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Clorindione.",Clorindione
DB13347,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Diphenadione.",Diphenadione
DB13451,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Tioclomarol.",Tioclomarol
DB13616,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Melagatran.",Melagatran
DB13646,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Saruplase.",Saruplase
DB14055,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with (S)-Warfarin.",(S)-Warfarin
DB14094,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Tocopherylquinone.",Tocopherylquinone
DB14598,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Edetate calcium disodium anhydrous.",Edetate calcium disodium anhydrous
DB14726,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Dabigatran.",Dabigatran
DB06294,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Semuloparin.",Semuloparin
DB00005,The risk or severity of adverse effects can be increased when Etanercept is combined with Anakinra.,Etanercept
DB00051,The risk or severity of adverse effects can be increased when Adalimumab is combined with Anakinra.,Adalimumab
DB00065,The risk or severity of adverse effects can be increased when Infliximab is combined with Anakinra.,Infliximab
DB04956,The risk or severity of adverse effects can be increased when Afelimomab is combined with Anakinra.,Afelimomab
DB06674,The risk or severity of adverse effects can be increased when Golimumab is combined with Anakinra.,Golimumab
DB08904,The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Anakinra.,Certolizumab pegol
DB06643,The risk or severity of adverse effects can be increased when Denosumab is combined with Anakinra.,Denosumab
DB00008,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Anakinra.,Peginterferon alfa-2a
DB00011,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Anakinra.,Interferon alfa-n1
DB00018,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Anakinra.,Interferon alfa-n3
DB00022,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Anakinra.,Peginterferon alfa-2b
DB00033,The risk or severity of adverse effects can be increased when Anakinra is combined with Interferon gamma-1b.,Interferon gamma-1b
DB00034,"The risk or severity of adverse effects can be increased when Anakinra is combined with Interferon alfa-2a, Recombinant.","Interferon alfa-2a, Recombinant"
DB00041,The risk or severity of adverse effects can be increased when Anakinra is combined with Aldesleukin.,Aldesleukin
DB00056,The risk or severity of adverse effects can be increased when Anakinra is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin
DB00059,The risk or severity of adverse effects can be increased when Anakinra is combined with Pegaspargase.,Pegaspargase
DB00068,The risk or severity of adverse effects can be increased when Anakinra is combined with Interferon beta-1b.,Interferon beta-1b
DB00069,The risk or severity of adverse effects can be increased when Anakinra is combined with Interferon alfacon-1.,Interferon alfacon-1
DB00073,The risk or severity of adverse effects can be increased when Anakinra is combined with Rituximab.,Rituximab
DB00074,The risk or severity of adverse effects can be increased when Anakinra is combined with Basiliximab.,Basiliximab
DB00075,The risk or severity of adverse effects can be increased when Anakinra is combined with Muromonab.,Muromonab
DB00078,The risk or severity of adverse effects can be increased when Anakinra is combined with Ibritumomab tiuxetan.,Ibritumomab tiuxetan
DB00081,The risk or severity of adverse effects can be increased when Anakinra is combined with Tositumomab.,Tositumomab
DB00087,The risk or severity of adverse effects can be increased when Anakinra is combined with Alemtuzumab.,Alemtuzumab
DB00092,The risk or severity of adverse effects can be increased when Anakinra is combined with Alefacept.,Alefacept
DB00095,The risk or severity of adverse effects can be increased when Anakinra is combined with Efalizumab.,Efalizumab
DB00098,The risk or severity of adverse effects can be increased when Anakinra is combined with Antithymocyte immunoglobulin (rabbit).,Antithymocyte immunoglobulin (rabbit)
DB00105,The risk or severity of adverse effects can be increased when Anakinra is combined with Interferon alfa-2b.,Interferon alfa-2b
DB00111,The risk or severity of adverse effects can be increased when Anakinra is combined with Daclizumab.,Daclizumab
DB00112,The risk or severity of adverse effects can be increased when Anakinra is combined with Bevacizumab.,Bevacizumab
DB00120,The risk or severity of adverse effects can be increased when Anakinra is combined with Phenylalanine.,Phenylalanine
DB00242,The risk or severity of adverse effects can be increased when Anakinra is combined with Cladribine.,Cladribine
DB00276,The risk or severity of adverse effects can be increased when Anakinra is combined with Amsacrine.,Amsacrine
DB00290,The risk or severity of adverse effects can be increased when Anakinra is combined with Bleomycin.,Bleomycin
DB00291,The risk or severity of adverse effects can be increased when Anakinra is combined with Chlorambucil.,Chlorambucil
DB00293,The risk or severity of adverse effects can be increased when Anakinra is combined with Raltitrexed.,Raltitrexed
DB00305,The risk or severity of adverse effects can be increased when Anakinra is combined with Mitomycin.,Mitomycin
DB00322,The risk or severity of adverse effects can be increased when Anakinra is combined with Floxuridine.,Floxuridine
DB00352,The risk or severity of adverse effects can be increased when Anakinra is combined with Tioguanine.,Tioguanine
DB00380,The risk or severity of adverse effects can be increased when Anakinra is combined with Dexrazoxane.,Dexrazoxane
DB00428,The risk or severity of adverse effects can be increased when Anakinra is combined with Streptozocin.,Streptozocin
DB00432,The risk or severity of adverse effects can be increased when Anakinra is combined with Trifluridine.,Trifluridine
DB00441,The risk or severity of adverse effects can be increased when Anakinra is combined with Gemcitabine.,Gemcitabine
DB00445,The risk or severity of adverse effects can be increased when Anakinra is combined with Epirubicin.,Epirubicin
DB00446,The risk or severity of adverse effects can be increased when Anakinra is combined with Chloramphenicol.,Chloramphenicol
DB00480,The risk or severity of adverse effects can be increased when Anakinra is combined with Lenalidomide.,Lenalidomide
DB00488,The risk or severity of adverse effects can be increased when Anakinra is combined with Altretamine.,Altretamine
DB00515,The risk or severity of adverse effects can be increased when Anakinra is combined with Cisplatin.,Cisplatin
DB00526,The risk or severity of adverse effects can be increased when Anakinra is combined with Oxaliplatin.,Oxaliplatin
DB00550,The risk or severity of adverse effects can be increased when Anakinra is combined with Propylthiouracil.,Propylthiouracil
DB00552,The risk or severity of adverse effects can be increased when Anakinra is combined with Pentostatin.,Pentostatin
DB00601,The risk or severity of adverse effects can be increased when Anakinra is combined with Linezolid.,Linezolid
DB00631,The risk or severity of adverse effects can be increased when Anakinra is combined with Clofarabine.,Clofarabine
DB00763,The risk or severity of adverse effects can be increased when Anakinra is combined with Methimazole.,Methimazole
DB00795,The risk or severity of adverse effects can be increased when Anakinra is combined with Sulfasalazine.,Sulfasalazine
DB00853,The risk or severity of adverse effects can be increased when Anakinra is combined with Temozolomide.,Temozolomide
DB00859,The risk or severity of adverse effects can be increased when Anakinra is combined with Penicillamine.,Penicillamine
DB00888,The risk or severity of adverse effects can be increased when Anakinra is combined with Mechlorethamine.,Mechlorethamine
DB00928,The risk or severity of adverse effects can be increased when Anakinra is combined with Azacitidine.,Azacitidine
DB00958,The risk or severity of adverse effects can be increased when Anakinra is combined with Carboplatin.,Carboplatin
DB00970,The risk or severity of adverse effects can be increased when Anakinra is combined with Dactinomycin.,Dactinomycin
DB01005,The risk or severity of adverse effects can be increased when Anakinra is combined with Hydroxyurea.,Hydroxyurea
DB01024,The risk or severity of adverse effects can be increased when Anakinra is combined with Mycophenolic acid.,Mycophenolic acid
DB01030,The risk or severity of adverse effects can be increased when Anakinra is combined with Topotecan.,Topotecan
DB01033,The risk or severity of adverse effects can be increased when Anakinra is combined with Mercaptopurine.,Mercaptopurine
DB01042,The risk or severity of adverse effects can be increased when Anakinra is combined with Melphalan.,Melphalan
DB01073,The risk or severity of adverse effects can be increased when Anakinra is combined with Fludarabine.,Fludarabine
DB01099,The risk or severity of adverse effects can be increased when Anakinra is combined with Flucytosine.,Flucytosine
DB01168,The risk or severity of adverse effects can be increased when Anakinra is combined with Procarbazine.,Procarbazine
DB01169,The risk or severity of adverse effects can be increased when Anakinra is combined with Arsenic trioxide.,Arsenic trioxide
DB01204,The risk or severity of adverse effects can be increased when Anakinra is combined with Mitoxantrone.,Mitoxantrone
DB01206,The risk or severity of adverse effects can be increased when Anakinra is combined with Lomustine.,Lomustine
DB01257,The risk or severity of adverse effects can be increased when Anakinra is combined with Eculizumab.,Eculizumab
DB01262,The risk or severity of adverse effects can be increased when Anakinra is combined with Decitabine.,Decitabine
DB01280,The risk or severity of adverse effects can be increased when Anakinra is combined with Nelarabine.,Nelarabine
DB01423,The risk or severity of adverse effects can be increased when Anakinra is combined with Stepronin.,Stepronin
DB01816,The risk or severity of adverse effects can be increased when Anakinra is combined with Castanospermine.,Castanospermine
DB02546,The risk or severity of adverse effects can be increased when Anakinra is combined with Vorinostat.,Vorinostat
DB02806,The risk or severity of adverse effects can be increased when Anakinra is combined with 2-Methoxyethanol.,2-Methoxyethanol
DB03523,The risk or severity of adverse effects can be increased when Anakinra is combined with Brequinar.,Brequinar
DB05258,The risk or severity of adverse effects can be increased when Anakinra is combined with Interferon alfa.,Interferon alfa
DB05259,The risk or severity of adverse effects can be increased when Anakinra is combined with Glatiramer.,Glatiramer
DB05260,The risk or severity of adverse effects can be increased when Anakinra is combined with Gallium nitrate.,Gallium nitrate
DB05459,The risk or severity of adverse effects can be increased when Anakinra is combined with Briakinumab.,Briakinumab
DB05472,The risk or severity of adverse effects can be increased when Anakinra is combined with omega interferon.,omega interferon
DB06273,The risk or severity of adverse effects can be increased when Anakinra is combined with Tocilizumab.,Tocilizumab
DB06372,The risk or severity of adverse effects can be increased when Anakinra is combined with Rilonacept.,Rilonacept
DB06612,The risk or severity of adverse effects can be increased when Anakinra is combined with Mepolizumab.,Mepolizumab
DB06662,The risk or severity of adverse effects can be increased when Anakinra is combined with Abetimus.,Abetimus
DB06681,The risk or severity of adverse effects can be increased when Anakinra is combined with Belatacept.,Belatacept
DB06813,The risk or severity of adverse effects can be increased when Anakinra is combined with Pralatrexate.,Pralatrexate
DB08059,The risk or severity of adverse effects can be increased when Anakinra is combined with Wortmannin.,Wortmannin
DB08871,The risk or severity of adverse effects can be increased when Anakinra is combined with Eribulin.,Eribulin
DB08879,The risk or severity of adverse effects can be increased when Anakinra is combined with Belimumab.,Belimumab
DB08880,The risk or severity of adverse effects can be increased when Anakinra is combined with Teriflunomide.,Teriflunomide
DB08889,The risk or severity of adverse effects can be increased when Anakinra is combined with Carfilzomib.,Carfilzomib
DB08908,The risk or severity of adverse effects can be increased when Anakinra is combined with Dimethyl fumarate.,Dimethyl fumarate
DB08935,The risk or severity of adverse effects can be increased when Anakinra is combined with Obinutuzumab.,Obinutuzumab
DB09029,The risk or severity of adverse effects can be increased when Anakinra is combined with Secukinumab.,Secukinumab
DB09033,The risk or severity of adverse effects can be increased when Anakinra is combined with Vedolizumab.,Vedolizumab
DB09036,The risk or severity of adverse effects can be increased when Anakinra is combined with Siltuximab.,Siltuximab
DB09052,The risk or severity of adverse effects can be increased when Anakinra is combined with Blinatumomab.,Blinatumomab
DB09077,The risk or severity of adverse effects can be increased when Anakinra is combined with Dinutuximab.,Dinutuximab
DB09091,The risk or severity of adverse effects can be increased when Anakinra is combined with Tixocortol.,Tixocortol
DB09122,The risk or severity of adverse effects can be increased when Anakinra is combined with Peginterferon beta-1a.,Peginterferon beta-1a
DB09312,The risk or severity of adverse effects can be increased when Anakinra is combined with Antilymphocyte immunoglobulin (horse).,Antilymphocyte immunoglobulin (horse)
DB11466,The risk or severity of adverse effects can be increased when Anakinra is combined with Tepoxalin.,Tepoxalin
DB11569,The risk or severity of adverse effects can be increased when Anakinra is combined with Ixekizumab.,Ixekizumab
DB11580,The risk or severity of adverse effects can be increased when Anakinra is combined with Ravulizumab.,Ravulizumab
DB11616,The risk or severity of adverse effects can be increased when Anakinra is combined with Pirarubicin.,Pirarubicin
DB11693,The risk or severity of adverse effects can be increased when Anakinra is combined with Voclosporin.,Voclosporin
DB11708,The risk or severity of adverse effects can be increased when Anakinra is combined with Peficitinib.,Peficitinib
DB11767,The risk or severity of adverse effects can be increased when Anakinra is combined with Sarilumab.,Sarilumab
DB11776,The risk or severity of adverse effects can be increased when Anakinra is combined with Brodalumab.,Brodalumab
DB11803,The risk or severity of adverse effects can be increased when Anakinra is combined with Sirukumab.,Sirukumab
DB11834,The risk or severity of adverse effects can be increased when Anakinra is combined with Guselkumab.,Guselkumab
DB11988,The risk or severity of adverse effects can be increased when Anakinra is combined with Ocrelizumab.,Ocrelizumab
DB12025,The risk or severity of adverse effects can be increased when Anakinra is combined with Triptolide.,Triptolide
DB12612,The risk or severity of adverse effects can be increased when Anakinra is combined with Ozanimod.,Ozanimod
DB12617,The risk or severity of adverse effects can be increased when Anakinra is combined with Mizoribine.,Mizoribine
DB12692,The risk or severity of adverse effects can be increased when Anakinra is combined with Gusperimus.,Gusperimus
DB12814,The risk or severity of adverse effects can be increased when Anakinra is combined with Cepeginterferon alfa-2B.,Cepeginterferon alfa-2B
DB12902,The risk or severity of adverse effects can be increased when Anakinra is combined with Trofosfamide.,Trofosfamide
DB12947,The risk or severity of adverse effects can be increased when Anakinra is combined with Doxifluridine.,Doxifluridine
DB12991,The risk or severity of adverse effects can be increased when Anakinra is combined with Deoxyspergualin.,Deoxyspergualin
DB12996,The risk or severity of adverse effects can be increased when Anakinra is combined with Acteoside.,Acteoside
DB13003,The risk or severity of adverse effects can be increased when Anakinra is combined with Cortivazol.,Cortivazol
DB13014,The risk or severity of adverse effects can be increased when Anakinra is combined with Hypericin.,Hypericin
DB13068,The risk or severity of adverse effects can be increased when Anakinra is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.,9-(N-methyl-L-isoleucine)-cyclosporin A
DB13223,The risk or severity of adverse effects can be increased when Anakinra is combined with Fluocortin.,Fluocortin
DB13241,The risk or severity of adverse effects can be increased when Anakinra is combined with Begelomab.,Begelomab
DB13491,The risk or severity of adverse effects can be increased when Anakinra is combined with Fluperolone.,Fluperolone
DB13664,The risk or severity of adverse effects can be increased when Anakinra is combined with Formocortal.,Formocortal
DB13728,The risk or severity of adverse effects can be increased when Anakinra is combined with Halometasone.,Halometasone
DB13843,The risk or severity of adverse effects can be increased when Anakinra is combined with Cloprednol.,Cloprednol
DB13856,The risk or severity of adverse effects can be increased when Anakinra is combined with Fluclorolone.,Fluclorolone
DB14219,The risk or severity of adverse effects can be increased when Anakinra is combined with Monomethyl fumarate.,Monomethyl fumarate
DB14724,The risk or severity of adverse effects can be increased when Anakinra is combined with Emapalumab.,Emapalumab
DB14762,The risk or severity of adverse effects can be increased when Anakinra is combined with Risankizumab.,Risankizumab
DB14919,The risk or severity of adverse effects can be increased when Anakinra is combined with Rozanolixizumab.,Rozanolixizumab
DB15253,The risk or severity of adverse effects can be increased when Anakinra is combined with Bleselumab.,Bleselumab
DB00180,The risk or severity of adverse effects can be increased when Anakinra is combined with Flunisolide.,Flunisolide
DB00394,The risk or severity of adverse effects can be increased when Anakinra is combined with Beclomethasone dipropionate.,Beclomethasone dipropionate
DB00443,The risk or severity of adverse effects can be increased when Anakinra is combined with Betamethasone.,Betamethasone
DB00591,The risk or severity of adverse effects can be increased when Anakinra is combined with Fluocinolone acetonide.,Fluocinolone acetonide
DB00635,The risk or severity of adverse effects can be increased when Anakinra is combined with Prednisone.,Prednisone
DB00687,The risk or severity of adverse effects can be increased when Anakinra is combined with Fludrocortisone.,Fludrocortisone
DB00764,The risk or severity of adverse effects can be increased when Anakinra is combined with Mometasone.,Mometasone
DB00860,The risk or severity of adverse effects can be increased when Anakinra is combined with Prednisolone.,Prednisolone
DB00959,The risk or severity of adverse effects can be increased when Anakinra is combined with Methylprednisolone.,Methylprednisolone
DB01196,The risk or severity of adverse effects can be increased when Anakinra is combined with Estramustine.,Estramustine
DB01285,The risk or severity of adverse effects can be increased when Anakinra is combined with Corticotropin.,Corticotropin
DB01380,The risk or severity of adverse effects can be increased when Anakinra is combined with Cortisone acetate.,Cortisone acetate
DB01384,The risk or severity of adverse effects can be increased when Anakinra is combined with Paramethasone.,Paramethasone
DB01611,The risk or severity of adverse effects can be increased when Anakinra is combined with Hydroxychloroquine.,Hydroxychloroquine
DB04630,The risk or severity of adverse effects can be increased when Anakinra is combined with Aldosterone.,Aldosterone
DB08970,The risk or severity of adverse effects can be increased when Anakinra is combined with Fluprednidene.,Fluprednidene
DB08971,The risk or severity of adverse effects can be increased when Anakinra is combined with Fluocortolone.,Fluocortolone
DB09082,The risk or severity of adverse effects can be increased when Anakinra is combined with Vilanterol.,Vilanterol
DB09378,The risk or severity of adverse effects can be increased when Anakinra is combined with Fluprednisolone.,Fluprednisolone
DB09383,The risk or severity of adverse effects can be increased when Anakinra is combined with Meprednisone.,Meprednisone
DB11487,The risk or severity of adverse effects can be increased when Anakinra is combined with Dexamethasone isonicotinate.,Dexamethasone isonicotinate
DB11529,The risk or severity of adverse effects can be increased when Anakinra is combined with Melengestrol.,Melengestrol
DB11750,The risk or severity of adverse effects can be increased when Anakinra is combined with Clobetasol.,Clobetasol
DB11817,The risk or severity of adverse effects can be increased when Anakinra is combined with Baricitinib.,Baricitinib
DB11921,The risk or severity of adverse effects can be increased when Anakinra is combined with Deflazacort.,Deflazacort
DB13208,The risk or severity of adverse effects can be increased when Anakinra is combined with Prednylidene.,Prednylidene
DB14066,The risk or severity of adverse effects can be increased when Anakinra is combined with Tetrandrine.,Tetrandrine
DB14512,The risk or severity of adverse effects can be increased when Anakinra is combined with Mometasone furoate.,Mometasone furoate
DB14545,The risk or severity of adverse effects can be increased when Anakinra is combined with Hydrocortisone succinate.,Hydrocortisone succinate
DB01222,The risk or severity of adverse effects can be increased when Anakinra is combined with Budesonide.,Budesonide
DB01394,The risk or severity of adverse effects can be increased when Anakinra is combined with Colchicine.,Colchicine
DB00108,The risk or severity of adverse effects can be increased when Anakinra is combined with Natalizumab.,Natalizumab
DB00337,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Anakinra.,Pimecrolimus
DB01656,Anakinra may increase the immunosuppressive activities of Roflumilast.,Roflumilast
DB06688,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Anakinra.,Sipuleucel-T
DB01281,The risk or severity of adverse effects can be increased when Anakinra is combined with Abatacept.,Abatacept
DB06168,Anakinra may increase the immunosuppressive activities of Canakinumab.,Canakinumab
DB08895,The risk or severity of adverse effects can be increased when Anakinra is combined with Tofacitinib.,Tofacitinib
DB01015,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Anakinra.,Sulfamethoxazole
DB01097,The risk or severity of adverse effects can be increased when Anakinra is combined with Leflunomide.,Leflunomide
DB00072,Trastuzumab may increase the neutropenic activities of Anakinra.,Trastuzumab
DB08868,Anakinra may increase the immunosuppressive activities of Fingolimod.,Fingolimod
DB00864,Tacrolimus may increase the immunosuppressive activities of Anakinra.,Tacrolimus
DB04914,The therapeutic efficacy of G17DT can be decreased when used in combination with Anakinra.,G17DT
DB05144,The therapeutic efficacy of PEV3A can be decreased when used in combination with Anakinra.,PEV3A
DB05325,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Anakinra.,INGN 225
DB05374,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Anakinra.,Rindopepimut
DB05440,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Anakinra.,SRP 299
DB05942,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Anakinra.,GI-5005
DB06400,The therapeutic efficacy of Vitespen can be decreased when used in combination with Anakinra.,Vitespen
DB06584,The therapeutic efficacy of TG4010 can be decreased when used in combination with Anakinra.,TG4010
DB09057,The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Anakinra.,Anthrax immune globulin human
DB10062,"The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Anakinra.","Rabies virus inactivated antigen, B"
DB10076,The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Anakinra.,Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen
DB10276,The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Anakinra.,Rotavirus vaccine
DB10283,"The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Anakinra.","Rabies virus inactivated antigen, A"
DB10342,The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Anakinra.,Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen
DB10583,The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Anakinra.,Clostridium tetani toxoid antigen (formaldehyde inactivated)
DB10584,The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Anakinra.,Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)
DB10600,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Anakinra.,Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated)
DB10769,The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Anakinra.,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated)
DB10794,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) can be decreased when used in combination with Anakinra.,Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated)
DB10803,The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Anakinra.,Typhoid Vi polysaccharide vaccine
DB10989,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Anakinra.,Hepatitis A Vaccine
DB10990,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Anakinra.,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen
DB11038,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Anakinra.,Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated)
DB11040,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Anakinra.,Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated)
DB11041,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Anakinra.,Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)
DB11044,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated) can be decreased when used in combination with Anakinra.,Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated)
DB11603,The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Anakinra.,Human rabies virus immune globulin
DB11627,The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Anakinra.,Hepatitis B Vaccine (Recombinant)
DB12568,The therapeutic efficacy of Tecemotide can be decreased when used in combination with Anakinra.,Tecemotide
DB14022,The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Anakinra.,Typhoid vaccine
DB14384,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Anakinra.,Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated)
DB14385,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Anakinra.,Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated)
DB14394,The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with Anakinra.,Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen
DB14445,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) can be decreased when used in combination with Anakinra.,Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated)
DB14449,The therapeutic efficacy of Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen can be decreased when used in combination with Anakinra.,Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen
DB14619,The therapeutic efficacy of Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated) can be decreased when used in combination with Anakinra.,Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated)
DB14620,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Anakinra.,Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated)
DB14711,The therapeutic efficacy of Vaccinia virus strain new york city board of health live antigen can be decreased when used in combination with Anakinra.,Vaccinia virus strain new york city board of health live antigen
DB15274,The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Anakinra.,Pertussis vaccine
DB15461,The therapeutic efficacy of Yersinia pestis 195/p antigen (formaldehyde inactivated) can be decreased when used in combination with Anakinra.,Yersinia pestis 195/p antigen (formaldehyde inactivated)
DB13924,The therapeutic efficacy of Varicella Zoster Vaccine (Recombinant) can be decreased when used in combination with Anakinra.,Varicella Zoster Vaccine (Recombinant)
DB15483,The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Anakinra.,Modified vaccinia ankara
DB15595,"The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Anakinra.","Ebola Zaire vaccine (live, attenuated)"
DB10317,The risk or severity of infection can be increased when Rubella virus vaccine is combined with Anakinra.,Rubella virus vaccine
DB10318,The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Anakinra.,Varicella Zoster Vaccine (Live/attenuated)
DB10343,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Anakinra.,Bacillus calmette-guerin substrain tice live antigen
DB10804,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Anakinra.,Bacillus calmette-guerin substrain connaught live antigen
DB10805,The risk or severity of infection can be increased when Yellow Fever Vaccine is combined with Anakinra.,Yellow Fever Vaccine
DB11003,The risk or severity of infection can be increased when Anthrax vaccine is combined with Anakinra.,Anthrax vaccine
DB11050,The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Anakinra.,Typhoid Vaccine Live
DB12386,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain danish 1331 live antigen is combined with Anakinra.,Bacillus calmette-guerin substrain danish 1331 live antigen
DB12768,The risk or severity of infection can be increased when BCG vaccine is combined with Anakinra.,BCG vaccine
DB14409,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Anakinra.,Human adenovirus e serotype 4 strain cl-68578 antigen
DB14443,The risk or severity of infection can be increased when Vibrio cholerae CVD 103-HgR strain live antigen is combined with Anakinra.,Vibrio cholerae CVD 103-HgR strain live antigen
DB14685,The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Anakinra.,Adenovirus type 7 vaccine live
DB00201,The metabolism of Caffeine can be increased when combined with Anakinra.,Caffeine
DB00176,The metabolism of Fluvoxamine can be increased when combined with Anakinra.,Fluvoxamine
DB00195,The metabolism of Betaxolol can be increased when combined with Anakinra.,Betaxolol
DB00261,The metabolism of Anagrelide can be increased when combined with Anakinra.,Anagrelide
DB00262,The metabolism of Carmustine can be increased when combined with Anakinra.,Carmustine
DB00268,The metabolism of Ropinirole can be increased when combined with Anakinra.,Ropinirole
DB00280,The metabolism of Disopyramide can be increased when combined with Anakinra.,Disopyramide
DB00286,The metabolism of Conjugated estrogens can be increased when combined with Anakinra.,Conjugated estrogens
DB00296,The metabolism of Ropivacaine can be increased when combined with Anakinra.,Ropivacaine
DB00315,The metabolism of Zolmitriptan can be increased when combined with Anakinra.,Zolmitriptan
DB00316,The metabolism of Acetaminophen can be increased when combined with Anakinra.,Acetaminophen
DB00334,The metabolism of Olanzapine can be increased when combined with Anakinra.,Olanzapine
DB00356,The metabolism of Chlorzoxazone can be increased when combined with Anakinra.,Chlorzoxazone
DB00365,The metabolism of Grepafloxacin can be increased when combined with Anakinra.,Grepafloxacin
DB00370,The metabolism of Mirtazapine can be increased when combined with Anakinra.,Mirtazapine
DB00379,The metabolism of Mexiletine can be increased when combined with Anakinra.,Mexiletine
DB00382,The metabolism of Tacrine can be increased when combined with Anakinra.,Tacrine
DB00384,The metabolism of Triamterene can be increased when combined with Anakinra.,Triamterene
DB00442,The metabolism of Entecavir can be increased when combined with Anakinra.,Entecavir
DB00477,The metabolism of Chlorpromazine can be increased when combined with Anakinra.,Chlorpromazine
DB00518,The metabolism of Albendazole can be increased when combined with Anakinra.,Albendazole
DB00544,The metabolism of Fluorouracil can be increased when combined with Anakinra.,Fluorouracil
DB00629,The metabolism of Guanabenz can be increased when combined with Anakinra.,Guanabenz
DB00642,The metabolism of Pemetrexed can be increased when combined with Anakinra.,Pemetrexed
DB00730,The metabolism of Thiabendazole can be increased when combined with Anakinra.,Thiabendazole
DB00740,The metabolism of Riluzole can be increased when combined with Anakinra.,Riluzole
DB00787,The metabolism of Acyclovir can be increased when combined with Anakinra.,Acyclovir
DB00806,The metabolism of Pentoxifylline can be increased when combined with Anakinra.,Pentoxifylline
DB00831,The metabolism of Trifluoperazine can be increased when combined with Anakinra.,Trifluoperazine
DB00863,The metabolism of Ranitidine can be increased when combined with Anakinra.,Ranitidine
DB00898,The metabolism of Ethanol can be increased when combined with Anakinra.,Ethanol
DB00934,The metabolism of Maprotiline can be increased when combined with Anakinra.,Maprotiline
DB00978,The metabolism of Lomefloxacin can be increased when combined with Anakinra.,Lomefloxacin
DB00993,The metabolism of Azathioprine can be increased when combined with Anakinra.,Azathioprine
DB00998,The metabolism of Frovatriptan can be increased when combined with Anakinra.,Frovatriptan
DB01002,The metabolism of Levobupivacaine can be increased when combined with Anakinra.,Levobupivacaine
DB01012,The metabolism of Cinacalcet can be increased when combined with Anakinra.,Cinacalcet
DB01056,The metabolism of Tocainide can be increased when combined with Anakinra.,Tocainide
DB01087,The metabolism of Primaquine can be increased when combined with Anakinra.,Primaquine
DB01094,The metabolism of Hesperetin can be increased when combined with Anakinra.,Hesperetin
DB01182,The metabolism of Propafenone can be increased when combined with Anakinra.,Propafenone
DB01191,The metabolism of Dexfenfluramine can be increased when combined with Anakinra.,Dexfenfluramine
DB01303,The metabolism of Oxtriphylline can be increased when combined with Anakinra.,Oxtriphylline
DB01367,The metabolism of Rasagiline can be increased when combined with Anakinra.,Rasagiline
DB01405,The metabolism of Temafloxacin can be increased when combined with Anakinra.,Temafloxacin
DB01412,The metabolism of Theobromine can be increased when combined with Anakinra.,Theobromine
DB01482,The metabolism of Fenethylline can be increased when combined with Anakinra.,Fenethylline
DB01558,The metabolism of Bromazepam can be increased when combined with Anakinra.,Bromazepam
DB01623,The metabolism of Thiothixene can be increased when combined with Anakinra.,Thiothixene
DB01645,The metabolism of Genistein can be increased when combined with Anakinra.,Genistein
DB01667,The metabolism of 8-azaguanine can be increased when combined with Anakinra.,8-azaguanine
DB02134,The metabolism of Xanthine can be increased when combined with Anakinra.,Xanthine
DB02489,The metabolism of 9-Methylguanine can be increased when combined with Anakinra.,9-Methylguanine
DB02568,The metabolism of Peldesine can be increased when combined with Anakinra.,Peldesine
DB02709,The metabolism of Resveratrol can be increased when combined with Anakinra.,Resveratrol
DB04076,The metabolism of Hypoxanthine can be increased when combined with Anakinra.,Hypoxanthine
DB04356,The metabolism of 9-Deazaguanine can be increased when combined with Anakinra.,9-Deazaguanine
DB04871,The metabolism of Lorcaserin can be increased when combined with Anakinra.,Lorcaserin
DB04948,The metabolism of Lofexidine can be increased when combined with Anakinra.,Lofexidine
DB04951,The metabolism of Pirfenidone can be increased when combined with Anakinra.,Pirfenidone
DB06148,The metabolism of Mianserin can be increased when combined with Anakinra.,Mianserin
DB06210,The metabolism of Eltrombopag can be increased when combined with Anakinra.,Eltrombopag
DB06216,The metabolism of Asenapine can be increased when combined with Anakinra.,Asenapine
DB06235,The metabolism of Vadimezan can be increased when combined with Anakinra.,Vadimezan
DB06479,The metabolism of Propentofylline can be increased when combined with Anakinra.,Propentofylline
DB06594,The metabolism of Agomelatine can be increased when combined with Anakinra.,Agomelatine
DB06769,The metabolism of Bendamustine can be increased when combined with Anakinra.,Bendamustine
DB06770,The metabolism of Benzyl alcohol can be increased when combined with Anakinra.,Benzyl alcohol
DB06774,The metabolism of Capsaicin can be increased when combined with Anakinra.,Capsaicin
DB08496,The metabolism of (R)-warfarin can be increased when combined with Anakinra.,(R)-warfarin
DB09071,The metabolism of Tasimelteon can be increased when combined with Anakinra.,Tasimelteon
DB09118,The metabolism of Stiripentol can be increased when combined with Anakinra.,Stiripentol
DB09225,The metabolism of Zotepine can be increased when combined with Anakinra.,Zotepine
DB09273,The metabolism of Doxofylline can be increased when combined with Anakinra.,Doxofylline
DB09290,The metabolism of Ramosetron can be increased when combined with Anakinra.,Ramosetron
DB11919,The metabolism of 6-O-benzylguanine can be increased when combined with Anakinra.,6-O-benzylguanine
DB11967,The metabolism of Binimetinib can be increased when combined with Anakinra.,Binimetinib
DB12026,The metabolism of Voxilaprevir can be increased when combined with Anakinra.,Voxilaprevir
DB12245,The metabolism of Triclabendazole can be increased when combined with Anakinra.,Triclabendazole
DB12332,The metabolism of Rucaparib can be increased when combined with Anakinra.,Rucaparib
DB12406,The metabolism of Lisofylline can be increased when combined with Anakinra.,Lisofylline
DB12531,The metabolism of Lobucavir can be increased when combined with Anakinra.,Lobucavir
DB12926,The metabolism of Cafedrine can be increased when combined with Anakinra.,Cafedrine
DB12927,The metabolism of Theodrenaline can be increased when combined with Anakinra.,Theodrenaline
DB12945,The metabolism of Dihydralazine can be increased when combined with Anakinra.,Dihydralazine
DB13203,The metabolism of Bamifylline can be increased when combined with Anakinra.,Bamifylline
DB13449,The metabolism of Proxyphylline can be increased when combined with Anakinra.,Proxyphylline
DB13573,The metabolism of Acefylline can be increased when combined with Anakinra.,Acefylline
DB13592,The metabolism of Etamiphylline can be increased when combined with Anakinra.,Etamiphylline
DB13634,The metabolism of Pentifylline can be increased when combined with Anakinra.,Pentifylline
DB13812,The metabolism of Bufylline can be increased when combined with Anakinra.,Bufylline
DB14018,The metabolism of Bromotheophylline can be increased when combined with Anakinra.,Bromotheophylline
DB14132,The metabolism of 8-chlorotheophylline can be increased when combined with Anakinra.,8-chlorotheophylline
DB11757,The metabolism of Istradefylline can be increased when combined with Anakinra.,Istradefylline
DB04889,The metabolism of Bicifadine can be increased when combined with Anakinra.,Bicifadine
DB05708,The metabolism of GTS-21 can be increased when combined with Anakinra.,GTS-21
DB00977,The metabolism of Ethinylestradiol can be increased when combined with Anakinra.,Ethinylestradiol
DB00425,The metabolism of Zolpidem can be increased when combined with Anakinra.,Zolpidem
DB00458,The metabolism of Imipramine can be increased when combined with Anakinra.,Imipramine
DB00532,The metabolism of Mephenytoin can be increased when combined with Anakinra.,Mephenytoin
DB00540,The metabolism of Nortriptyline can be increased when combined with Anakinra.,Nortriptyline
DB00575,The metabolism of Clonidine can be increased when combined with Anakinra.,Clonidine
DB00924,The metabolism of Cyclobenzaprine can be increased when combined with Anakinra.,Cyclobenzaprine
DB01242,The metabolism of Clomipramine can be increased when combined with Anakinra.,Clomipramine
DB11689,The metabolism of Selumetinib can be increased when combined with Anakinra.,Selumetinib
DB00277,The metabolism of Theophylline can be increased when combined with Anakinra.,Theophylline
DB00564,The metabolism of Carbamazepine can be increased when combined with Anakinra.,Carbamazepine
DB00682,The metabolism of Warfarin can be increased when combined with Anakinra.,Warfarin
DB00697,The metabolism of Tizanidine can be increased when combined with Anakinra.,Tizanidine
DB01100,The metabolism of Pimozide can be increased when combined with Anakinra.,Pimozide
DB01223,The metabolism of Aminophylline can be increased when combined with Anakinra.,Aminophylline
DB01418,The metabolism of Acenocoumarol can be increased when combined with Anakinra.,Acenocoumarol
DB09256,The metabolism of Tegafur can be increased when combined with Anakinra.,Tegafur
DB00851,The metabolism of Dacarbazine can be increased when combined with Anakinra.,Dacarbazine
DB08910,The metabolism of Pomalidomide can be increased when combined with Anakinra.,Pomalidomide
DB00238,The metabolism of Nevirapine can be increased when combined with Anakinra.,Nevirapine
DB00471,The metabolism of Montelukast can be increased when combined with Anakinra.,Montelukast
DB00690,The metabolism of Flurazepam can be increased when combined with Anakinra.,Flurazepam
DB00916,The metabolism of Metronidazole can be increased when combined with Anakinra.,Metronidazole
DB00983,The metabolism of Formoterol can be increased when combined with Anakinra.,Formoterol
DB01006,The metabolism of Letrozole can be increased when combined with Anakinra.,Letrozole
DB01028,The metabolism of Methoxyflurane can be increased when combined with Anakinra.,Methoxyflurane
DB01159,The metabolism of Halothane can be increased when combined with Anakinra.,Halothane
DB01236,The metabolism of Sevoflurane can be increased when combined with Anakinra.,Sevoflurane
DB01274,The metabolism of Arformoterol can be increased when combined with Anakinra.,Arformoterol
DB01544,The metabolism of Flunitrazepam can be increased when combined with Anakinra.,Flunitrazepam
DB06292,The metabolism of Dapagliflozin can be increased when combined with Anakinra.,Dapagliflozin
DB06470,The metabolism of Clomethiazole can be increased when combined with Anakinra.,Clomethiazole
DB09068,The metabolism of Vortioxetine can be increased when combined with Anakinra.,Vortioxetine
DB09327,The metabolism of Tegafur-uracil can be increased when combined with Anakinra.,Tegafur-uracil
DB11586,The metabolism of Asunaprevir can be increased when combined with Anakinra.,Asunaprevir
DB04977,The metabolism of Plitidepsin can be increased when combined with Anakinra.,Plitidepsin
DB06119,The metabolism of Cenobamate can be increased when combined with Anakinra.,Cenobamate
DB00193,The metabolism of Tramadol can be increased when combined with Anakinra.,Tramadol
DB00333,The metabolism of Methadone can be increased when combined with Anakinra.,Methadone
DB00349,The metabolism of Clobazam can be increased when combined with Anakinra.,Clobazam
DB00625,The metabolism of Efavirenz can be increased when combined with Anakinra.,Efavirenz
DB00753,The metabolism of Isoflurane can be increased when combined with Anakinra.,Isoflurane
DB00818,The metabolism of Propofol can be increased when combined with Anakinra.,Propofol
DB00835,The metabolism of Brompheniramine can be increased when combined with Anakinra.,Brompheniramine
DB00836,The metabolism of Loperamide can be increased when combined with Anakinra.,Loperamide
DB00849,The metabolism of Methylphenobarbital can be increased when combined with Anakinra.,Methylphenobarbital
DB00865,The metabolism of Benzphetamine can be increased when combined with Anakinra.,Benzphetamine
DB01069,The metabolism of Promethazine can be increased when combined with Anakinra.,Promethazine
DB01074,The metabolism of Perhexiline can be increased when combined with Anakinra.,Perhexiline
DB01221,The metabolism of Ketamine can be increased when combined with Anakinra.,Ketamine
DB01466,The metabolism of Ethylmorphine can be increased when combined with Anakinra.,Ethylmorphine
DB01559,The metabolism of Clotiazepam can be increased when combined with Anakinra.,Clotiazepam
DB04938,The metabolism of Ospemifene can be increased when combined with Anakinra.,Ospemifene
DB04975,The metabolism of Banoxantrone can be increased when combined with Anakinra.,Banoxantrone
DB05541,The metabolism of Brivaracetam can be increased when combined with Anakinra.,Brivaracetam
DB06176,The metabolism of Romidepsin can be increased when combined with Anakinra.,Romidepsin
DB06209,The metabolism of Prasugrel can be increased when combined with Anakinra.,Prasugrel
DB06697,The metabolism of Artemether can be increased when combined with Anakinra.,Artemether
DB06710,The metabolism of Methyltestosterone can be increased when combined with Anakinra.,Methyltestosterone
DB06738,The metabolism of Ketobemidone can be increased when combined with Anakinra.,Ketobemidone
DB06739,The metabolism of Seratrodast can be increased when combined with Anakinra.,Seratrodast
DB11613,The metabolism of Velpatasvir can be increased when combined with Anakinra.,Velpatasvir
DB13132,The metabolism of Artemisinin can be increased when combined with Anakinra.,Artemisinin
DB13943,The metabolism of Testosterone cypionate can be increased when combined with Anakinra.,Testosterone cypionate
DB13944,The metabolism of Testosterone enanthate can be increased when combined with Anakinra.,Testosterone enanthate
DB13946,The metabolism of Testosterone undecanoate can be increased when combined with Anakinra.,Testosterone undecanoate
DB01156,The metabolism of Bupropion can be increased when combined with Anakinra.,Bupropion
DB00956,The metabolism of Hydrocodone can be increased when combined with Anakinra.,Hydrocodone
DB14975,The metabolism of Voxelotor can be increased when combined with Anakinra.,Voxelotor
DB11837,The metabolism of Osilodrostat can be increased when combined with Anakinra.,Osilodrostat
DB13384,The metabolism of Melitracen can be increased when combined with Anakinra.,Melitracen
DB13411,The metabolism of Lofepramine can be increased when combined with Anakinra.,Lofepramine
DB00714,The metabolism of Apomorphine can be increased when combined with Anakinra.,Apomorphine
DB09167,The metabolism of Dosulepin can be increased when combined with Anakinra.,Dosulepin
DB00213,The metabolism of Pantoprazole can be increased when combined with Anakinra.,Pantoprazole
DB00215,The metabolism of Citalopram can be increased when combined with Anakinra.,Citalopram
DB00312,The metabolism of Pentobarbital can be increased when combined with Anakinra.,Pentobarbital
DB00338,The metabolism of Omeprazole can be increased when combined with Anakinra.,Omeprazole
DB00347,The metabolism of Trimethadione can be increased when combined with Anakinra.,Trimethadione
DB00395,The metabolism of Carisoprodol can be increased when combined with Anakinra.,Carisoprodol
DB00448,The metabolism of Lansoprazole can be increased when combined with Anakinra.,Lansoprazole
DB00474,The metabolism of Methohexital can be increased when combined with Anakinra.,Methohexital
DB00582,The metabolism of Voriconazole can be increased when combined with Anakinra.,Voriconazole
DB00679,The metabolism of Thioridazine can be increased when combined with Anakinra.,Thioridazine
DB00736,The metabolism of Esomeprazole can be increased when combined with Anakinra.,Esomeprazole
DB00794,The metabolism of Primidone can be increased when combined with Anakinra.,Primidone
DB00909,The metabolism of Zonisamide can be increased when combined with Anakinra.,Zonisamide
DB01129,The metabolism of Rabeprazole can be increased when combined with Anakinra.,Rabeprazole
DB01131,The metabolism of Proguanil can be increased when combined with Anakinra.,Proguanil
DB01175,The metabolism of Escitalopram can be increased when combined with Anakinra.,Escitalopram
DB01259,The metabolism of Lapatinib can be increased when combined with Anakinra.,Lapatinib
DB01323,The metabolism of St. John's Wort can be increased when combined with Anakinra.,St. John's Wort
DB01355,The metabolism of Hexobarbital can be increased when combined with Anakinra.,Hexobarbital
DB01483,The metabolism of Barbital can be increased when combined with Anakinra.,Barbital
DB05246,The metabolism of Methsuximide can be increased when combined with Anakinra.,Methsuximide
DB05351,The metabolism of Dexlansoprazole can be increased when combined with Anakinra.,Dexlansoprazole
DB06218,The metabolism of Lacosamide can be increased when combined with Anakinra.,Lacosamide
DB06414,The metabolism of Etravirine can be increased when combined with Anakinra.,Etravirine
DB06605,The metabolism of Apixaban can be increased when combined with Anakinra.,Apixaban
DB09166,The metabolism of Etizolam can be increased when combined with Anakinra.,Etizolam
DB12130,The metabolism of Lorlatinib can be increased when combined with Anakinra.,Lorlatinib
DB12474,The metabolism of Lynestrenol can be increased when combined with Anakinra.,Lynestrenol
DB13762,The metabolism of Dexrabeprazole can be increased when combined with Anakinra.,Dexrabeprazole
DB14055,The metabolism of (S)-Warfarin can be increased when combined with Anakinra.,(S)-Warfarin
DB00715,The metabolism of Paroxetine can be increased when combined with Anakinra.,Paroxetine
DB12500,The metabolism of Fedratinib can be increased when combined with Anakinra.,Fedratinib
DB04861,The metabolism of Nebivolol can be increased when combined with Anakinra.,Nebivolol
DB06684,The metabolism of Vilazodone can be increased when combined with Anakinra.,Vilazodone
DB01104,The metabolism of Sertraline can be increased when combined with Anakinra.,Sertraline
DB11823,The metabolism of Esketamine can be increased when combined with Anakinra.,Esketamine
DB00252,The metabolism of Phenytoin can be increased when combined with Anakinra.,Phenytoin
DB00599,The metabolism of Thiopental can be increased when combined with Anakinra.,Thiopental
DB01174,The metabolism of Phenobarbital can be increased when combined with Anakinra.,Phenobarbital
DB01320,The metabolism of Fosphenytoin can be increased when combined with Anakinra.,Fosphenytoin
DB00613,The metabolism of Amodiaquine can be increased when combined with Anakinra.,Amodiaquine
DB00799,The metabolism of Tazarotene can be increased when combined with Anakinra.,Tazarotene
DB05229,The metabolism of Beraprost can be increased when combined with Anakinra.,Beraprost
DB06510,The metabolism of Muraglitazar can be increased when combined with Anakinra.,Muraglitazar
DB09296,The metabolism of Ombitasvir can be increased when combined with Anakinra.,Ombitasvir
DB01217,The metabolism of Anastrozole can be increased when combined with Anakinra.,Anastrozole
DB00255,The metabolism of Diethylstilbestrol can be increased when combined with Anakinra.,Diethylstilbestrol
DB00295,The metabolism of Morphine can be increased when combined with Anakinra.,Morphine
DB00359,The metabolism of Sulfadiazine can be increased when combined with Anakinra.,Sulfadiazine
DB00402,The metabolism of Eszopiclone can be increased when combined with Anakinra.,Eszopiclone
DB00622,The metabolism of Nicardipine can be increased when combined with Anakinra.,Nicardipine
DB00912,The metabolism of Repaglinide can be increased when combined with Anakinra.,Repaglinide
DB01261,The metabolism of Sitagliptin can be increased when combined with Anakinra.,Sitagliptin
DB06670,The metabolism of Odanacatib can be increased when combined with Anakinra.,Odanacatib
DB08502,The metabolism of Capravirine can be increased when combined with Anakinra.,Capravirine
DB08931,The metabolism of Riociguat can be increased when combined with Anakinra.,Riociguat
DB09198,The metabolism of Lobeglitazone can be increased when combined with Anakinra.,Lobeglitazone
DB09199,The metabolism of Netoglitazone can be increased when combined with Anakinra.,Netoglitazone
DB09200,The metabolism of Rivoglitazone can be increased when combined with Anakinra.,Rivoglitazone
DB09201,The metabolism of Ciglitazone can be increased when combined with Anakinra.,Ciglitazone
DB11362,The metabolism of Selexipag can be increased when combined with Anakinra.,Selexipag
DB11901,The metabolism of Apalutamide can be increased when combined with Anakinra.,Apalutamide
DB11978,The metabolism of Glasdegib can be increased when combined with Anakinra.,Glasdegib
DB12781,The metabolism of Balaglitazone can be increased when combined with Anakinra.,Balaglitazone
DB01132,The metabolism of Pioglitazone can be increased when combined with Anakinra.,Pioglitazone
DB11652,The metabolism of Tucatinib can be increased when combined with Anakinra.,Tucatinib
DB00946,The metabolism of Phenprocoumon can be increased when combined with Anakinra.,Phenprocoumon
DB01229,The metabolism of Paclitaxel can be increased when combined with Anakinra.,Paclitaxel
DB00177,The metabolism of Valsartan can be increased when combined with Anakinra.,Valsartan
DB00184,The metabolism of Nicotine can be increased when combined with Anakinra.,Nicotine
DB00197,The metabolism of Troglitazone can be increased when combined with Anakinra.,Troglitazone
DB00214,The metabolism of Torasemide can be increased when combined with Anakinra.,Torasemide
DB00222,The metabolism of Glimepiride can be increased when combined with Anakinra.,Glimepiride
DB00285,The metabolism of Venlafaxine can be increased when combined with Anakinra.,Venlafaxine
DB00304,The metabolism of Desogestrel can be increased when combined with Anakinra.,Desogestrel
DB00307,The metabolism of Bexarotene can be increased when combined with Anakinra.,Bexarotene
DB00327,The metabolism of Hydromorphone can be increased when combined with Anakinra.,Hydromorphone
DB00328,The metabolism of Indomethacin can be increased when combined with Anakinra.,Indomethacin
DB00343,The metabolism of Diltiazem can be increased when combined with Anakinra.,Diltiazem
DB00374,The metabolism of Treprostinil can be increased when combined with Anakinra.,Treprostinil
DB00412,The metabolism of Rosiglitazone can be increased when combined with Anakinra.,Rosiglitazone
DB00414,The metabolism of Acetohexamide can be increased when combined with Anakinra.,Acetohexamide
DB00420,The metabolism of Promazine can be increased when combined with Anakinra.,Promazine
DB00440,The metabolism of Trimethoprim can be increased when combined with Anakinra.,Trimethoprim
DB00461,The metabolism of Nabumetone can be increased when combined with Anakinra.,Nabumetone
DB00468,The metabolism of Quinine can be increased when combined with Anakinra.,Quinine
DB00469,The metabolism of Tenoxicam can be increased when combined with Anakinra.,Tenoxicam
DB00472,The metabolism of Fluoxetine can be increased when combined with Anakinra.,Fluoxetine
DB00476,The metabolism of Duloxetine can be increased when combined with Anakinra.,Duloxetine
DB00482,The metabolism of Celecoxib can be increased when combined with Anakinra.,Celecoxib
DB00495,The metabolism of Zidovudine can be increased when combined with Anakinra.,Zidovudine
DB00502,The metabolism of Haloperidol can be increased when combined with Anakinra.,Haloperidol
DB00531,The metabolism of Cyclophosphamide can be increased when combined with Anakinra.,Cyclophosphamide
DB00533,The metabolism of Rofecoxib can be increased when combined with Anakinra.,Rofecoxib
DB00549,The metabolism of Zafirlukast can be increased when combined with Anakinra.,Zafirlukast
DB00554,The metabolism of Piroxicam can be increased when combined with Anakinra.,Piroxicam
DB00559,The metabolism of Bosentan can be increased when combined with Anakinra.,Bosentan
DB00568,The metabolism of Cinnarizine can be increased when combined with Anakinra.,Cinnarizine
DB00580,The metabolism of Valdecoxib can be increased when combined with Anakinra.,Valdecoxib
DB00586,The metabolism of Diclofenac can be increased when combined with Anakinra.,Diclofenac
DB00617,The metabolism of Paramethadione can be increased when combined with Anakinra.,Paramethadione
DB00661,The metabolism of Verapamil can be increased when combined with Anakinra.,Verapamil
DB00672,The metabolism of Chlorpropamide can be increased when combined with Anakinra.,Chlorpropamide
DB00678,The metabolism of Losartan can be increased when combined with Anakinra.,Losartan
DB00701,The metabolism of Amprenavir can be increased when combined with Anakinra.,Amprenavir
DB00712,The metabolism of Flurbiprofen can be increased when combined with Anakinra.,Flurbiprofen
DB00731,The metabolism of Nateglinide can be increased when combined with Anakinra.,Nateglinide
DB00744,The metabolism of Zileuton can be increased when combined with Anakinra.,Zileuton
DB00749,The metabolism of Etodolac can be increased when combined with Anakinra.,Etodolac
DB00755,The metabolism of Tretinoin can be increased when combined with Anakinra.,Tretinoin
DB00758,The metabolism of Clopidogrel can be increased when combined with Anakinra.,Clopidogrel
DB00783,The metabolism of Estradiol can be increased when combined with Anakinra.,Estradiol
DB00784,The metabolism of Mefenamic acid can be increased when combined with Anakinra.,Mefenamic acid
DB00788,The metabolism of Naproxen can be increased when combined with Anakinra.,Naproxen
DB00796,The metabolism of Candesartan cilexetil can be increased when combined with Anakinra.,Candesartan cilexetil
DB00812,The metabolism of Phenylbutazone can be increased when combined with Anakinra.,Phenylbutazone
DB00814,The metabolism of Meloxicam can be increased when combined with Anakinra.,Meloxicam
DB00839,The metabolism of Tolazamide can be increased when combined with Anakinra.,Tolazamide
DB00843,The metabolism of Donepezil can be increased when combined with Anakinra.,Donepezil
DB00857,The metabolism of Terbinafine can be increased when combined with Anakinra.,Terbinafine
DB00904,The metabolism of Ondansetron can be increased when combined with Anakinra.,Ondansetron
DB00921,The metabolism of Buprenorphine can be increased when combined with Anakinra.,Buprenorphine
DB00936,The metabolism of Salicylic acid can be increased when combined with Anakinra.,Salicylic acid
DB00945,The metabolism of Acetylsalicylic acid can be increased when combined with Anakinra.,Acetylsalicylic acid
DB00969,The metabolism of Alosetron can be increased when combined with Anakinra.,Alosetron
DB00972,The metabolism of Azelastine can be increased when combined with Anakinra.,Azelastine
DB00980,The metabolism of Ramelteon can be increased when combined with Anakinra.,Ramelteon
DB01016,The metabolism of Glyburide can be increased when combined with Anakinra.,Glyburide
DB01029,The metabolism of Irbesartan can be increased when combined with Anakinra.,Irbesartan
DB01036,The metabolism of Tolterodine can be increased when combined with Anakinra.,Tolterodine
DB01037,The metabolism of Selegiline can be increased when combined with Anakinra.,Selegiline
DB01041,The metabolism of Thalidomide can be increased when combined with Anakinra.,Thalidomide
DB01050,The metabolism of Ibuprofen can be increased when combined with Anakinra.,Ibuprofen
DB01065,The metabolism of Melatonin can be increased when combined with Anakinra.,Melatonin
DB01067,The metabolism of Glipizide can be increased when combined with Anakinra.,Glipizide
DB01072,The metabolism of Atazanavir can be increased when combined with Anakinra.,Atazanavir
DB01075,The metabolism of Diphenhydramine can be increased when combined with Anakinra.,Diphenhydramine
DB01095,The metabolism of Fluvastatin can be increased when combined with Anakinra.,Fluvastatin
DB01098,The metabolism of Rosuvastatin can be increased when combined with Anakinra.,Rosuvastatin
DB01120,The metabolism of Gliclazide can be increased when combined with Anakinra.,Gliclazide
DB01124,The metabolism of Tolbutamide can be increased when combined with Anakinra.,Tolbutamide
DB01136,The metabolism of Carvedilol can be increased when combined with Anakinra.,Carvedilol
DB01154,The metabolism of Thiamylal can be increased when combined with Anakinra.,Thiamylal
DB01171,The metabolism of Moclobemide can be increased when combined with Anakinra.,Moclobemide
DB01177,The metabolism of Idarubicin can be increased when combined with Anakinra.,Idarubicin
DB01198,The metabolism of Zopiclone can be increased when combined with Anakinra.,Zopiclone
DB01251,The metabolism of Gliquidone can be increased when combined with Anakinra.,Gliquidone
DB01283,The metabolism of Lumiracoxib can be increased when combined with Anakinra.,Lumiracoxib
DB01289,The metabolism of Glisoxepide can be increased when combined with Anakinra.,Glisoxepide
DB01357,The metabolism of Mestranol can be increased when combined with Anakinra.,Mestranol
DB01424,The metabolism of Aminophenazone can be increased when combined with Anakinra.,Aminophenazone
DB01435,The metabolism of Antipyrine can be increased when combined with Anakinra.,Antipyrine
DB01589,The metabolism of Quazepam can be increased when combined with Anakinra.,Quazepam
DB01628,The metabolism of Etoricoxib can be increased when combined with Anakinra.,Etoricoxib
DB03756,The metabolism of Doconexent can be increased when combined with Anakinra.,Doconexent
DB03783,The metabolism of Phenacetin can be increased when combined with Anakinra.,Phenacetin
DB04557,The metabolism of Arachidonic Acid can be increased when combined with Anakinra.,Arachidonic Acid
DB04574,The metabolism of Estrone sulfate can be increased when combined with Anakinra.,Estrone sulfate
DB04665,The metabolism of Coumarin can be increased when combined with Anakinra.,Coumarin
DB04725,The metabolism of Licofelone can be increased when combined with Anakinra.,Licofelone
DB04841,The metabolism of Flunarizine can be increased when combined with Anakinra.,Flunarizine
DB04898,The metabolism of Ximelagatran can be increased when combined with Anakinra.,Ximelagatran
DB06204,The metabolism of Tapentadol can be increased when combined with Anakinra.,Tapentadol
DB06268,The metabolism of Sitaxentan can be increased when combined with Anakinra.,Sitaxentan
DB06370,The metabolism of Indisulam can be increased when combined with Anakinra.,Indisulam
DB06652,The metabolism of Vicriviroc can be increased when combined with Anakinra.,Vicriviroc
DB06725,The metabolism of Lornoxicam can be increased when combined with Anakinra.,Lornoxicam
DB06737,The metabolism of Zaltoprofen can be increased when combined with Anakinra.,Zaltoprofen
DB06803,The metabolism of Niclosamide can be increased when combined with Anakinra.,Niclosamide
DB07615,The metabolism of Tranilast can be increased when combined with Anakinra.,Tranilast
DB08439,The metabolism of Parecoxib can be increased when combined with Anakinra.,Parecoxib
DB08828,The metabolism of Vismodegib can be increased when combined with Anakinra.,Vismodegib
DB08860,The metabolism of Pitavastatin can be increased when combined with Anakinra.,Pitavastatin
DB08875,The metabolism of Cabozantinib can be increased when combined with Anakinra.,Cabozantinib
DB08899,The metabolism of Enzalutamide can be increased when combined with Anakinra.,Enzalutamide
DB08962,The metabolism of Glibornuride can be increased when combined with Anakinra.,Glibornuride
DB09048,The metabolism of Netupitant can be increased when combined with Anakinra.,Netupitant
DB09061,The metabolism of Cannabidiol can be increased when combined with Anakinra.,Cannabidiol
DB09080,The metabolism of Olodaterol can be increased when combined with Anakinra.,Olodaterol
DB09288,The metabolism of Propacetamol can be increased when combined with Anakinra.,Propacetamol
DB11560,The metabolism of Lesinurad can be increased when combined with Anakinra.,Lesinurad
DB11614,The metabolism of Rupatadine can be increased when combined with Anakinra.,Rupatadine
DB13406,The metabolism of Carbutamide can be increased when combined with Anakinra.,Carbutamide
DB13675,The metabolism of Metahexamide can be increased when combined with Anakinra.,Metahexamide
DB13919,The metabolism of Candesartan can be increased when combined with Anakinra.,Candesartan
DB13941,The metabolism of Piperaquine can be increased when combined with Anakinra.,Piperaquine
DB13952,The metabolism of Estradiol acetate can be increased when combined with Anakinra.,Estradiol acetate
DB13953,The metabolism of Estradiol benzoate can be increased when combined with Anakinra.,Estradiol benzoate
DB13954,The metabolism of Estradiol cypionate can be increased when combined with Anakinra.,Estradiol cypionate
DB13955,The metabolism of Estradiol dienanthate can be increased when combined with Anakinra.,Estradiol dienanthate
DB13956,The metabolism of Estradiol valerate can be increased when combined with Anakinra.,Estradiol valerate
DB14009,The metabolism of Medical Cannabis can be increased when combined with Anakinra.,Medical Cannabis
DB14011,The metabolism of Nabiximols can be increased when combined with Anakinra.,Nabiximols
DB00829,The metabolism of Diazepam can be increased when combined with Anakinra.,Diazepam
DB00514,The metabolism of Dextromethorphan can be increased when combined with Anakinra.,Dextromethorphan
DB00470,The metabolism of Dronabinol can be increased when combined with Anakinra.,Dronabinol
DB09213,The metabolism of Dexibuprofen can be increased when combined with Anakinra.,Dexibuprofen
DB00465,The metabolism of Ketorolac can be increased when combined with Anakinra.,Ketorolac
DB15233,The metabolism of Avapritinib can be increased when combined with Anakinra.,Avapritinib
DB00321,The metabolism of Amitriptyline can be increased when combined with Anakinra.,Amitriptyline
DB01142,The metabolism of Doxepin can be increased when combined with Anakinra.,Doxepin
DB00216,The metabolism of Eletriptan can be increased when combined with Anakinra.,Eletriptan
DB00404,The metabolism of Alprazolam can be increased when combined with Anakinra.,Alprazolam
DB00726,The metabolism of Trimipramine can be increased when combined with Anakinra.,Trimipramine
DB01101,The metabolism of Capecitabine can be increased when combined with Anakinra.,Capecitabine
DB00266,The metabolism of Dicoumarol can be increased when combined with Anakinra.,Dicoumarol
DB00313,The metabolism of Valproic acid can be increased when combined with Anakinra.,Valproic acid
DB00908,The metabolism of Quinidine can be increased when combined with Anakinra.,Quinidine
DB13136,The metabolism of Fluindione can be increased when combined with Anakinra.,Fluindione
DB01224,The metabolism of Quetiapine can be increased when combined with Anakinra.,Quetiapine
DB00182,The metabolism of Amphetamine can be increased when combined with Anakinra.,Amphetamine
DB00187,The metabolism of Esmolol can be increased when combined with Anakinra.,Esmolol
DB00245,The metabolism of Benzatropine can be increased when combined with Anakinra.,Benzatropine
DB00289,The metabolism of Atomoxetine can be increased when combined with Anakinra.,Atomoxetine
DB00335,The metabolism of Atenolol can be increased when combined with Anakinra.,Atenolol
DB00373,The metabolism of Timolol can be increased when combined with Anakinra.,Timolol
DB00409,The metabolism of Remoxipride can be increased when combined with Anakinra.,Remoxipride
DB00592,The metabolism of Piperazine can be increased when combined with Anakinra.,Piperazine
DB00699,The metabolism of Nicergoline can be increased when combined with Anakinra.,Nicergoline
DB00737,The metabolism of Meclizine can be increased when combined with Anakinra.,Meclizine
DB00805,The metabolism of Minaprine can be increased when combined with Anakinra.,Minaprine
DB00866,The metabolism of Alprenolol can be increased when combined with Anakinra.,Alprenolol
DB00914,The metabolism of Phenformin can be increased when combined with Anakinra.,Phenformin
DB00933,The metabolism of Mesoridazine can be increased when combined with Anakinra.,Mesoridazine
DB00960,The metabolism of Pindolol can be increased when combined with Anakinra.,Pindolol
DB01071,The metabolism of Mequitazine can be increased when combined with Anakinra.,Mequitazine
DB01079,The metabolism of Tegaserod can be increased when combined with Anakinra.,Tegaserod
DB01193,The metabolism of Acebutolol can be increased when combined with Anakinra.,Acebutolol
DB01203,The metabolism of Nadolol can be increased when combined with Anakinra.,Nadolol
DB01228,The metabolism of Encainide can be increased when combined with Anakinra.,Encainide
DB01233,The metabolism of Metoclopramide can be increased when combined with Anakinra.,Metoclopramide
DB01255,The metabolism of Lisdexamfetamine can be increased when combined with Anakinra.,Lisdexamfetamine
DB01295,The metabolism of Bevantolol can be increased when combined with Anakinra.,Bevantolol
DB01297,The metabolism of Practolol can be increased when combined with Anakinra.,Practolol
DB01359,The metabolism of Penbutolol can be increased when combined with Anakinra.,Penbutolol
DB01403,The metabolism of Methotrimeprazine can be increased when combined with Anakinra.,Methotrimeprazine
DB01429,The metabolism of Aprindine can be increased when combined with Anakinra.,Aprindine
DB01454,The metabolism of Midomafetamine can be increased when combined with Anakinra.,Midomafetamine
DB01472,The metabolism of 4-Methoxyamphetamine can be increased when combined with Anakinra.,4-Methoxyamphetamine
DB01576,The metabolism of Dextroamphetamine can be increased when combined with Anakinra.,Dextroamphetamine
DB01577,The metabolism of Metamfetamine can be increased when combined with Anakinra.,Metamfetamine
DB01580,The metabolism of Oxprenolol can be increased when combined with Anakinra.,Oxprenolol
DB04840,The metabolism of Debrisoquine can be increased when combined with Anakinra.,Debrisoquine
DB04844,The metabolism of Tetrabenazine can be increased when combined with Anakinra.,Tetrabenazine
DB04846,The metabolism of Celiprolol can be increased when combined with Anakinra.,Celiprolol
DB06217,The metabolism of Vernakalant can be increased when combined with Anakinra.,Vernakalant
DB06506,The metabolism of Repinotan can be increased when combined with Anakinra.,Repinotan
DB06608,The metabolism of Tafenoquine can be increased when combined with Anakinra.,Tafenoquine
DB06678,The metabolism of Esmirtazapine can be increased when combined with Anakinra.,Esmirtazapine
DB06726,The metabolism of Bufuralol can be increased when combined with Anakinra.,Bufuralol
DB06727,The metabolism of Sparteine can be increased when combined with Anakinra.,Sparteine
DB06735,The metabolism of Enclomiphene can be increased when combined with Anakinra.,Enclomiphene
DB08807,The metabolism of Bopindolol can be increased when combined with Anakinra.,Bopindolol
DB08808,The metabolism of Bupranolol can be increased when combined with Anakinra.,Bupranolol
DB08952,The metabolism of Indenolol can be increased when combined with Anakinra.,Indenolol
DB09013,The metabolism of Befunolol can be increased when combined with Anakinra.,Befunolol
DB09076,The metabolism of Umeclidinium can be increased when combined with Anakinra.,Umeclidinium
DB09204,The metabolism of Arotinolol can be increased when combined with Anakinra.,Arotinolol
DB09351,The metabolism of Levobetaxolol can be increased when combined with Anakinra.,Levobetaxolol
DB11770,The metabolism of Talinolol can be increased when combined with Anakinra.,Talinolol
DB11785,The metabolism of Anisodamine can be increased when combined with Anakinra.,Anisodamine
DB11855,The metabolism of Revefenacin can be increased when combined with Anakinra.,Revefenacin
DB11979,The metabolism of Elagolix can be increased when combined with Anakinra.,Elagolix
DB12070,The metabolism of Letermovir can be increased when combined with Anakinra.,Letermovir
DB12212,The metabolism of Landiolol can be increased when combined with Anakinra.,Landiolol
DB12752,The metabolism of Bucindolol can be increased when combined with Anakinra.,Bucindolol
DB13443,The metabolism of Esatenolol can be increased when combined with Anakinra.,Esatenolol
DB13508,The metabolism of Cloranolol can be increased when combined with Anakinra.,Cloranolol
DB13530,The metabolism of Mepindolol can be increased when combined with Anakinra.,Mepindolol
DB13679,The metabolism of Dexchlorpheniramine can be increased when combined with Anakinra.,Dexchlorpheniramine
DB13757,The metabolism of Epanolol can be increased when combined with Anakinra.,Epanolol
DB13775,The metabolism of Tertatolol can be increased when combined with Anakinra.,Tertatolol
DB00850,The metabolism of Perphenazine can be increased when combined with Anakinra.,Perphenazine
DB09173,The metabolism of Butyrfentanyl can be increased when combined with Anakinra.,Butyrfentanyl
DB00281,The metabolism of Lidocaine can be increased when combined with Anakinra.,Lidocaine
DB00598,The metabolism of Labetalol can be increased when combined with Anakinra.,Labetalol
DB14010,"The metabolism of 5-methoxy-N,N-dimethyltryptamine can be increased when combined with Anakinra.","5-methoxy-N,N-dimethyltryptamine"
DB01410,The metabolism of Ciclesonide can be increased when combined with Anakinra.,Ciclesonide
DB00918,The metabolism of Almotriptan can be increased when combined with Anakinra.,Almotriptan
DB08918,The metabolism of Levomilnacipran can be increased when combined with Anakinra.,Levomilnacipran
DB08922,The metabolism of Perospirone can be increased when combined with Anakinra.,Perospirone
DB09183,The metabolism of Dasabuvir can be increased when combined with Anakinra.,Dasabuvir
DB00185,The metabolism of Cevimeline can be increased when combined with Anakinra.,Cevimeline
DB00243,The metabolism of Ranolazine can be increased when combined with Anakinra.,Ranolazine
DB00297,The metabolism of Bupivacaine can be increased when combined with Anakinra.,Bupivacaine
DB00318,The metabolism of Codeine can be increased when combined with Anakinra.,Codeine
DB00377,The metabolism of Palonosetron can be increased when combined with Anakinra.,Palonosetron
DB00589,The metabolism of Lisuride can be increased when combined with Anakinra.,Lisuride
DB00647,The metabolism of Dextropropoxyphene can be increased when combined with Anakinra.,Dextropropoxyphene
DB00674,The metabolism of Galantamine can be increased when combined with Anakinra.,Galantamine
DB00705,The metabolism of Delavirdine can be increased when combined with Anakinra.,Delavirdine
DB00706,The metabolism of Tamsulosin can be increased when combined with Anakinra.,Tamsulosin
DB00757,The metabolism of Dolasetron can be increased when combined with Anakinra.,Dolasetron
DB01149,The metabolism of Nefazodone can be increased when combined with Anakinra.,Nefazodone
DB01192,The metabolism of Oxymorphone can be increased when combined with Anakinra.,Oxymorphone
DB01244,The metabolism of Bepridil can be increased when combined with Anakinra.,Bepridil
DB01392,The metabolism of Yohimbine can be increased when combined with Anakinra.,Yohimbine
DB01409,The metabolism of Tiotropium can be increased when combined with Anakinra.,Tiotropium
DB01551,The metabolism of Dihydrocodeine can be increased when combined with Anakinra.,Dihydrocodeine
DB01591,The metabolism of Solifenacin can be increased when combined with Anakinra.,Solifenacin
DB01621,The metabolism of Pipotiazine can be increased when combined with Anakinra.,Pipotiazine
DB02703,The metabolism of Fusidic acid can be increased when combined with Anakinra.,Fusidic acid
DB04829,The metabolism of Lysergic acid diethylamide can be increased when combined with Anakinra.,Lysergic acid diethylamide
DB04884,The metabolism of Dapoxetine can be increased when combined with Anakinra.,Dapoxetine
DB04905,The metabolism of Tesmilifene can be increased when combined with Anakinra.,Tesmilifene
DB04920,The metabolism of Clevidipine can be increased when combined with Anakinra.,Clevidipine
DB05271,The metabolism of Rotigotine can be increased when combined with Anakinra.,Rotigotine
DB06016,The metabolism of Cariprazine can be increased when combined with Anakinra.,Cariprazine
DB06144,The metabolism of Sertindole can be increased when combined with Anakinra.,Sertindole
DB06203,The metabolism of Alogliptin can be increased when combined with Anakinra.,Alogliptin
DB06702,The metabolism of Fesoterodine can be increased when combined with Anakinra.,Fesoterodine
DB08893,The metabolism of Mirabegron can be increased when combined with Anakinra.,Mirabegron
DB09128,The metabolism of Brexpiprazole can be increased when combined with Anakinra.,Brexpiprazole
DB09195,The metabolism of Lorpiprazole can be increased when combined with Anakinra.,Lorpiprazole
DB09555,The metabolism of Dexchlorpheniramine maleate can be increased when combined with Anakinra.,Dexchlorpheniramine maleate
DB11130,The metabolism of Opium can be increased when combined with Anakinra.,Opium
DB11642,The metabolism of Pitolisant can be increased when combined with Anakinra.,Pitolisant
DB13293,The metabolism of Ipecac can be increased when combined with Anakinra.,Ipecac
DB00344,The metabolism of Protriptyline can be increased when combined with Anakinra.,Protriptyline
DB00496,The metabolism of Darifenacin can be increased when combined with Anakinra.,Darifenacin
DB00543,The metabolism of Amoxapine can be increased when combined with Anakinra.,Amoxapine
DB00932,The metabolism of Tipranavir can be increased when combined with Anakinra.,Tipranavir
DB09039,The metabolism of Eliglustat can be increased when combined with Anakinra.,Eliglustat
DB12930,The metabolism of Opipramol can be increased when combined with Anakinra.,Opipramol
DB00489,The metabolism of Sotalol can be increased when combined with Anakinra.,Sotalol
DB01035,The metabolism of Procainamide can be increased when combined with Anakinra.,Procainamide
DB01195,The metabolism of Flecainide can be increased when combined with Anakinra.,Flecainide
DB00228,The metabolism of Enflurane can be increased when combined with Anakinra.,Enflurane
DB06712,The metabolism of Nilvadipine can be increased when combined with Anakinra.,Nilvadipine
DB06728,The metabolism of Aniline can be increased when combined with Anakinra.,Aniline
DB00949,The metabolism of Felbamate can be increased when combined with Anakinra.,Felbamate
DB00593,The metabolism of Ethosuximide can be increased when combined with Anakinra.,Ethosuximide
DB00186,The metabolism of Lorazepam can be increased when combined with Anakinra.,Lorazepam
DB00191,The metabolism of Phentermine can be increased when combined with Anakinra.,Phentermine
DB00207,The metabolism of Azithromycin can be increased when combined with Anakinra.,Azithromycin
DB00208,The metabolism of Ticlopidine can be increased when combined with Anakinra.,Ticlopidine
DB00264,The metabolism of Metoprolol can be increased when combined with Anakinra.,Metoprolol
DB00426,The metabolism of Famciclovir can be increased when combined with Anakinra.,Famciclovir
DB00433,The metabolism of Prochlorperazine can be increased when combined with Anakinra.,Prochlorperazine
DB00567,The metabolism of Cephalexin can be increased when combined with Anakinra.,Cephalexin
DB00590,The metabolism of Doxazosin can be increased when combined with Anakinra.,Doxazosin
DB01039,The metabolism of Fenofibrate can be increased when combined with Anakinra.,Fenofibrate
DB01395,The metabolism of Drospirenone can be increased when combined with Anakinra.,Drospirenone
DB01411,The metabolism of Pranlukast can be increased when combined with Anakinra.,Pranlukast
DB01431,The metabolism of Allylestrenol can be increased when combined with Anakinra.,Allylestrenol
DB01624,The metabolism of Zuclopenthixol can be increased when combined with Anakinra.,Zuclopenthixol
DB06201,The metabolism of Rufinamide can be increased when combined with Anakinra.,Rufinamide
DB06480,The metabolism of Prucalopride can be increased when combined with Anakinra.,Prucalopride
DB08882,The metabolism of Linagliptin can be increased when combined with Anakinra.,Linagliptin
DB09030,The metabolism of Vorapaxar can be increased when combined with Anakinra.,Vorapaxar
DB09034,The metabolism of Suvorexant can be increased when combined with Anakinra.,Suvorexant
DB09079,The metabolism of Nintedanib can be increased when combined with Anakinra.,Nintedanib
DB09299,The metabolism of Tenofovir alafenamide can be increased when combined with Anakinra.,Tenofovir alafenamide
DB09330,The metabolism of Osimertinib can be increased when combined with Anakinra.,Osimertinib
DB11094,The metabolism of Vitamin D can be increased when combined with Anakinra.,Vitamin D
DB11273,The metabolism of Dihydroergocornine can be increased when combined with Anakinra.,Dihydroergocornine
DB11730,The metabolism of Ribociclib can be increased when combined with Anakinra.,Ribociclib
DB11952,The metabolism of Duvelisib can be increased when combined with Anakinra.,Duvelisib
DB12141,The metabolism of Gilteritinib can be increased when combined with Anakinra.,Gilteritinib
DB12515,The metabolism of 9-aminocamptothecin can be increased when combined with Anakinra.,9-aminocamptothecin
DB12952,The metabolism of Methylprednisone can be increased when combined with Anakinra.,Methylprednisone
DB13345,The metabolism of Dihydroergocristine can be increased when combined with Anakinra.,Dihydroergocristine
DB13385,The metabolism of Dihydroergocryptine can be increased when combined with Anakinra.,Dihydroergocryptine
DB14126,The metabolism of Tenofovir can be increased when combined with Anakinra.,Tenofovir
DB15444,The metabolism of Elexacaftor can be increased when combined with Anakinra.,Elexacaftor
DB06717,The metabolism of Fosaprepitant can be increased when combined with Anakinra.,Fosaprepitant
DB12825,The metabolism of Lefamulin can be increased when combined with Anakinra.,Lefamulin
DB12887,The metabolism of Tazemetostat can be increased when combined with Anakinra.,Tazemetostat
DB00454,The metabolism of Meperidine can be increased when combined with Anakinra.,Meperidine
DB01151,The metabolism of Desipramine can be increased when combined with Anakinra.,Desipramine
DB12371,The metabolism of Siponimod can be increased when combined with Anakinra.,Siponimod
DB00247,The metabolism of Methysergide can be increased when combined with Anakinra.,Methysergide
DB08827,The metabolism of Lomitapide can be increased when combined with Anakinra.,Lomitapide
DB11742,The metabolism of Ebastine can be increased when combined with Anakinra.,Ebastine
DB05015,The metabolism of Belinostat can be increased when combined with Anakinra.,Belinostat
DB01118,The metabolism of Amiodarone can be increased when combined with Anakinra.,Amiodarone
DB00675,The metabolism of Tamoxifen can be increased when combined with Anakinra.,Tamoxifen
DB00204,The metabolism of Dofetilide can be increased when combined with Anakinra.,Dofetilide
DB00342,The metabolism of Terfenadine can be increased when combined with Anakinra.,Terfenadine
DB00451,The metabolism of Levothyroxine can be increased when combined with Anakinra.,Levothyroxine
DB00604,The metabolism of Cisapride can be increased when combined with Anakinra.,Cisapride
DB00877,The metabolism of Sirolimus can be increased when combined with Anakinra.,Sirolimus
DB01008,The metabolism of Busulfan can be increased when combined with Anakinra.,Busulfan
DB01254,The metabolism of Dasatinib can be increased when combined with Anakinra.,Dasatinib
DB01396,The metabolism of Digitoxin can be increased when combined with Anakinra.,Digitoxin
DB01590,The metabolism of Everolimus can be increased when combined with Anakinra.,Everolimus
DB03410,The metabolism of 4-hydroxycoumarin can be increased when combined with Anakinra.,4-hydroxycoumarin
DB04855,The metabolism of Dronedarone can be increased when combined with Anakinra.,Dronedarone
DB06287,The metabolism of Temsirolimus can be increased when combined with Anakinra.,Temsirolimus
DB09053,The metabolism of Ibrutinib can be increased when combined with Anakinra.,Ibrutinib
DB09289,The metabolism of Tianeptine can be increased when combined with Anakinra.,Tianeptine
DB11633,The metabolism of Isavuconazole can be increased when combined with Anakinra.,Isavuconazole
DB13275,The metabolism of Clorindione can be increased when combined with Anakinra.,Clorindione
DB00398,The metabolism of Sorafenib can be increased when combined with Anakinra.,Sorafenib
DB00444,The metabolism of Teniposide can be increased when combined with Anakinra.,Teniposide
DB00530,The metabolism of Erlotinib can be increased when combined with Anakinra.,Erlotinib
DB00541,The metabolism of Vincristine can be increased when combined with Anakinra.,Vincristine
DB00619,The metabolism of Imatinib can be increased when combined with Anakinra.,Imatinib
DB00773,The metabolism of Etoposide can be increased when combined with Anakinra.,Etoposide
DB01248,The metabolism of Docetaxel can be increased when combined with Anakinra.,Docetaxel
DB01268,The metabolism of Sunitinib can be increased when combined with Anakinra.,Sunitinib
DB06626,The metabolism of Axitinib can be increased when combined with Anakinra.,Axitinib
DB08865,The metabolism of Crizotinib can be increased when combined with Anakinra.,Crizotinib
DB08901,The metabolism of Ponatinib can be increased when combined with Anakinra.,Ponatinib
DB12483,The metabolism of Copanlisib can be increased when combined with Anakinra.,Copanlisib
DB00188,The metabolism of Bortezomib can be increased when combined with Anakinra.,Bortezomib
DB00363,The metabolism of Clozapine can be increased when combined with Anakinra.,Clozapine
DB01181,The metabolism of Ifosfamide can be increased when combined with Anakinra.,Ifosfamide
DB05109,The metabolism of Trabectedin can be increased when combined with Anakinra.,Trabectedin
DB12147,The metabolism of Erdafitinib can be increased when combined with Anakinra.,Erdafitinib
DB13874,The metabolism of Enasidenib can be increased when combined with Anakinra.,Enasidenib
DB06589,The metabolism of Pazopanib can be increased when combined with Anakinra.,Pazopanib
DB05239,The metabolism of Cobimetinib can be increased when combined with Anakinra.,Cobimetinib
DB09063,The metabolism of Ceritinib can be increased when combined with Anakinra.,Ceritinib
DB11963,The metabolism of Dacomitinib can be increased when combined with Anakinra.,Dacomitinib
DB12015,The metabolism of Alpelisib can be increased when combined with Anakinra.,Alpelisib
DB00309,The metabolism of Vindesine can be increased when combined with Anakinra.,Vindesine
DB00361,The metabolism of Vinorelbine can be increased when combined with Anakinra.,Vinorelbine
DB00570,The metabolism of Vinblastine can be increased when combined with Anakinra.,Vinblastine
DB00694,The metabolism of Daunorubicin can be increased when combined with Anakinra.,Daunorubicin
DB00987,The metabolism of Cytarabine can be increased when combined with Anakinra.,Cytarabine
DB00997,The metabolism of Doxorubicin can be increased when combined with Anakinra.,Doxorubicin
DB01108,The metabolism of Trilostane can be increased when combined with Anakinra.,Trilostane
DB04572,The metabolism of Thiotepa can be increased when combined with Anakinra.,Thiotepa
DB04845,The metabolism of Ixabepilone can be increased when combined with Anakinra.,Ixabepilone
DB04868,The metabolism of Nilotinib can be increased when combined with Anakinra.,Nilotinib
DB06603,The metabolism of Panobinostat can be increased when combined with Anakinra.,Panobinostat
DB06616,The metabolism of Bosutinib can be increased when combined with Anakinra.,Bosutinib
DB08870,The metabolism of Brentuximab vedotin can be increased when combined with Anakinra.,Brentuximab vedotin
DB08877,The metabolism of Ruxolitinib can be increased when combined with Anakinra.,Ruxolitinib
DB09073,The metabolism of Palbociclib can be increased when combined with Anakinra.,Palbociclib
DB08912,The metabolism of Dabrafenib can be increased when combined with Anakinra.,Dabrafenib
DB12267,The metabolism of Brigatinib can be increased when combined with Anakinra.,Brigatinib
DB11718,The metabolism of Encorafenib can be increased when combined with Anakinra.,Encorafenib
DB00563,The metabolism of Methotrexate can be increased when combined with Anakinra.,Methotrexate
DB05294,The metabolism of Vandetanib can be increased when combined with Anakinra.,Vandetanib
DB05812,The metabolism of Abiraterone can be increased when combined with Anakinra.,Abiraterone
DB08881,The metabolism of Vemurafenib can be increased when combined with Anakinra.,Vemurafenib
DB11363,The metabolism of Alectinib can be increased when combined with Anakinra.,Alectinib
DB11581,The metabolism of Venetoclax can be increased when combined with Anakinra.,Venetoclax
DB11641,The metabolism of Vinflunine can be increased when combined with Anakinra.,Vinflunine
DB11703,The metabolism of Acalabrutinib can be increased when combined with Anakinra.,Acalabrutinib
DB15035,The metabolism of Zanubrutinib can be increased when combined with Anakinra.,Zanubrutinib
DB00248,The metabolism of Cabergoline can be increased when combined with Anakinra.,Cabergoline
DB06595,The metabolism of Midostaurin can be increased when combined with Anakinra.,Midostaurin
DB09143,The metabolism of Sonidegib can be increased when combined with Anakinra.,Sonidegib
DB11828,The metabolism of Neratinib can be increased when combined with Anakinra.,Neratinib
DB11986,The metabolism of Entrectinib can be increased when combined with Anakinra.,Entrectinib
DB12978,The metabolism of Pexidartinib can be increased when combined with Anakinra.,Pexidartinib
DB14568,The metabolism of Ivosidenib can be increased when combined with Anakinra.,Ivosidenib
DB09054,The metabolism of Idelalisib can be increased when combined with Anakinra.,Idelalisib
DB09570,The metabolism of Ixazomib can be increased when combined with Anakinra.,Ixazomib
DB00199,The metabolism of Erythromycin can be increased when combined with Anakinra.,Erythromycin
DB00246,The metabolism of Ziprasidone can be increased when combined with Anakinra.,Ziprasidone
DB00439,The metabolism of Cerivastatin can be increased when combined with Anakinra.,Cerivastatin
DB00499,The metabolism of Flutamide can be increased when combined with Anakinra.,Flutamide
DB00528,The metabolism of Lercanidipine can be increased when combined with Anakinra.,Lercanidipine
DB00571,The metabolism of Propranolol can be increased when combined with Anakinra.,Propranolol
DB00588,The metabolism of Fluticasone propionate can be increased when combined with Anakinra.,Fluticasone propionate
DB00608,The metabolism of Chloroquine can be increased when combined with Anakinra.,Chloroquine
DB00688,The metabolism of Mycophenolate mofetil can be increased when combined with Anakinra.,Mycophenolate mofetil
DB00717,The metabolism of Norethisterone can be increased when combined with Anakinra.,Norethisterone
DB00738,The metabolism of Pentamidine can be increased when combined with Anakinra.,Pentamidine
DB00741,The metabolism of Hydrocortisone can be increased when combined with Anakinra.,Hydrocortisone
DB00762,The metabolism of Irinotecan can be increased when combined with Anakinra.,Irinotecan
DB00822,The metabolism of Disulfiram can be increased when combined with Anakinra.,Disulfiram
DB00834,The metabolism of Mifepristone can be increased when combined with Anakinra.,Mifepristone
DB00938,The metabolism of Salmeterol can be increased when combined with Anakinra.,Salmeterol
DB00962,The metabolism of Zaleplon can be increased when combined with Anakinra.,Zaleplon
DB00976,The metabolism of Telithromycin can be increased when combined with Anakinra.,Telithromycin
DB01054,The metabolism of Nitrendipine can be increased when combined with Anakinra.,Nitrendipine
DB01058,The metabolism of Praziquantel can be increased when combined with Anakinra.,Praziquantel
DB01062,The metabolism of Oxybutynin can be increased when combined with Anakinra.,Oxybutynin
DB01076,The metabolism of Atorvastatin can be increased when combined with Anakinra.,Atorvastatin
DB01103,The metabolism of Quinacrine can be increased when combined with Anakinra.,Quinacrine
DB01115,The metabolism of Nifedipine can be increased when combined with Anakinra.,Nifedipine
DB01126,The metabolism of Dutasteride can be increased when combined with Anakinra.,Dutasteride
DB01166,The metabolism of Cilostazol can be increased when combined with Anakinra.,Cilostazol
DB01184,The metabolism of Domperidone can be increased when combined with Anakinra.,Domperidone
DB01211,The metabolism of Clarithromycin can be increased when combined with Anakinra.,Clarithromycin
DB01216,The metabolism of Finasteride can be increased when combined with Anakinra.,Finasteride
DB01218,The metabolism of Halofantrine can be increased when combined with Anakinra.,Halofantrine
DB05521,The metabolism of Telaprevir can be increased when combined with Anakinra.,Telaprevir
DB05773,The metabolism of Trastuzumab emtansine can be increased when combined with Anakinra.,Trastuzumab emtansine
DB06267,The metabolism of Udenafil can be increased when combined with Anakinra.,Udenafil
DB06335,The metabolism of Saxagliptin can be increased when combined with Anakinra.,Saxagliptin
DB06403,The metabolism of Ambrisentan can be increased when combined with Anakinra.,Ambrisentan
DB06419,The metabolism of Cethromycin can be increased when combined with Anakinra.,Cethromycin
DB06772,The metabolism of Cabazitaxel can be increased when combined with Anakinra.,Cabazitaxel
DB06789,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Anakinra.,Hydroxyprogesterone caproate
DB08820,The metabolism of Ivacaftor can be increased when combined with Anakinra.,Ivacaftor
DB08873,The metabolism of Boceprevir can be increased when combined with Anakinra.,Boceprevir
DB08883,The metabolism of Perampanel can be increased when combined with Anakinra.,Perampanel
DB08906,The metabolism of Fluticasone furoate can be increased when combined with Anakinra.,Fluticasone furoate
DB09065,The metabolism of Cobicistat can be increased when combined with Anakinra.,Cobicistat
DB09074,The metabolism of Olaparib can be increased when combined with Anakinra.,Olaparib
DB09102,The metabolism of Daclatasvir can be increased when combined with Anakinra.,Daclatasvir
DB09231,The metabolism of Benidipine can be increased when combined with Anakinra.,Benidipine
DB09297,The metabolism of Paritaprevir can be increased when combined with Anakinra.,Paritaprevir
DB11574,The metabolism of Elbasvir can be increased when combined with Anakinra.,Elbasvir
DB11712,The metabolism of Tezacaftor can be increased when combined with Anakinra.,Tezacaftor
DB11737,The metabolism of Icotinib can be increased when combined with Anakinra.,Icotinib
DB12301,The metabolism of Doravirine can be increased when combined with Anakinra.,Doravirine
DB13867,The metabolism of Fluticasone can be increased when combined with Anakinra.,Fluticasone
DB14538,The metabolism of Hydrocortisone aceponate can be increased when combined with Anakinra.,Hydrocortisone aceponate
DB14539,The metabolism of Hydrocortisone acetate can be increased when combined with Anakinra.,Hydrocortisone acetate
DB14541,The metabolism of Hydrocortisone cypionate can be increased when combined with Anakinra.,Hydrocortisone cypionate
DB14542,The metabolism of Hydrocortisone phosphate can be increased when combined with Anakinra.,Hydrocortisone phosphate
DB00396,The metabolism of Progesterone can be increased when combined with Anakinra.,Progesterone
DB04856,The metabolism of Dexloxiglumide can be increased when combined with Anakinra.,Dexloxiglumide
DB04957,The metabolism of Azimilide can be increased when combined with Anakinra.,Azimilide
DB00250,The metabolism of Dapsone can be increased when combined with Anakinra.,Dapsone
DB00317,The metabolism of Gefitinib can be increased when combined with Anakinra.,Gefitinib
DB00367,The metabolism of Levonorgestrel can be increased when combined with Anakinra.,Levonorgestrel
DB00497,The metabolism of Oxycodone can be increased when combined with Anakinra.,Oxycodone
DB00620,The metabolism of Triamcinolone can be increased when combined with Anakinra.,Triamcinolone
DB00624,The metabolism of Testosterone can be increased when combined with Anakinra.,Testosterone
DB00656,The metabolism of Trazodone can be increased when combined with Anakinra.,Trazodone
DB00734,The metabolism of Risperidone can be increased when combined with Anakinra.,Risperidone
DB01114,The metabolism of Chlorpheniramine can be increased when combined with Anakinra.,Chlorpheniramine
DB01238,The metabolism of Aripiprazole can be increased when combined with Anakinra.,Aripiprazole
DB01267,The metabolism of Paliperidone can be increased when combined with Anakinra.,Paliperidone
DB04946,The metabolism of Iloperidone can be increased when combined with Anakinra.,Iloperidone
DB11915,The metabolism of Valbenazine can be increased when combined with Anakinra.,Valbenazine
DB12161,The metabolism of Deutetrabenazine can be increased when combined with Anakinra.,Deutetrabenazine
DB14185,The metabolism of Aripiprazole lauroxil can be increased when combined with Anakinra.,Aripiprazole lauroxil
DB01234,The metabolism of Dexamethasone can be increased when combined with Anakinra.,Dexamethasone
DB09237,The metabolism of Levamlodipine can be increased when combined with Anakinra.,Levamlodipine
DB11951,The metabolism of Lemborexant can be increased when combined with Anakinra.,Lemborexant
DB00557,The metabolism of Hydroxyzine can be increased when combined with Anakinra.,Hydroxyzine
DB00203,The metabolism of Sildenafil can be increased when combined with Anakinra.,Sildenafil
DB00227,The metabolism of Lovastatin can be increased when combined with Anakinra.,Lovastatin
DB00490,The metabolism of Buspirone can be increased when combined with Anakinra.,Buspirone
DB00641,The metabolism of Simvastatin can be increased when combined with Anakinra.,Simvastatin
DB00673,The metabolism of Aprepitant can be increased when combined with Anakinra.,Aprepitant
DB00820,The metabolism of Tadalafil can be increased when combined with Anakinra.,Tadalafil
DB00862,The metabolism of Vardenafil can be increased when combined with Anakinra.,Vardenafil
DB01190,The metabolism of Clindamycin can be increased when combined with Anakinra.,Clindamycin
DB00503,The metabolism of Ritonavir can be increased when combined with Anakinra.,Ritonavir
DB00224,The metabolism of Indinavir can be increased when combined with Anakinra.,Indinavir
DB00401,The metabolism of Nisoldipine can be increased when combined with Anakinra.,Nisoldipine
DB00637,The metabolism of Astemizole can be increased when combined with Anakinra.,Astemizole
DB00683,The metabolism of Midazolam can be increased when combined with Anakinra.,Midazolam
DB00700,The metabolism of Eplerenone can be increased when combined with Anakinra.,Eplerenone
DB00802,The metabolism of Alfentanil can be increased when combined with Anakinra.,Alfentanil
DB00813,The metabolism of Fentanyl can be increased when combined with Anakinra.,Fentanyl
DB00897,The metabolism of Triazolam can be increased when combined with Anakinra.,Triazolam
DB01023,The metabolism of Felodipine can be increased when combined with Anakinra.,Felodipine
DB01227,The metabolism of Levacetylmethadol can be increased when combined with Anakinra.,Levacetylmethadol
DB01232,The metabolism of Saquinavir can be increased when combined with Anakinra.,Saquinavir
DB06228,The metabolism of Rivaroxaban can be increased when combined with Anakinra.,Rivaroxaban
DB05804,The metabolism of Prasterone sulfate can be increased when combined with Anakinra.,Prasterone sulfate
DB00091,Anakinra may increase the immunosuppressive activities of Cyclosporine.,Cyclosporine
DB05676,The therapeutic efficacy of Apremilast can be decreased when used in combination with Anakinra.,Apremilast
DB14513,The serum concentration of Magnesium can be decreased when it is combined with Anakinra.,Magnesium
DB01601,The serum concentration of Anakinra can be increased when it is combined with Lopinavir.,Lopinavir
DB12530,The risk or severity of infection can be increased when Anakinra is combined with Inebilizumab.,Inebilizumab
DB12768,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Gramicidin D.,BCG vaccine
DB00266,The risk or severity of bleeding can be increased when Gramicidin D is combined with Dicoumarol.,Dicoumarol
DB00498,The risk or severity of bleeding can be increased when Gramicidin D is combined with Phenindione.,Phenindione
DB00682,The risk or severity of bleeding can be increased when Gramicidin D is combined with Warfarin.,Warfarin
DB00946,The risk or severity of bleeding can be increased when Gramicidin D is combined with Phenprocoumon.,Phenprocoumon
DB01418,The risk or severity of bleeding can be increased when Gramicidin D is combined with Acenocoumarol.,Acenocoumarol
DB03410,The risk or severity of bleeding can be increased when Gramicidin D is combined with 4-hydroxycoumarin.,4-hydroxycoumarin
DB04665,The risk or severity of bleeding can be increased when Gramicidin D is combined with Coumarin.,Coumarin
DB08496,The risk or severity of bleeding can be increased when Gramicidin D is combined with (R)-warfarin.,(R)-warfarin
DB08794,The risk or severity of bleeding can be increased when Gramicidin D is combined with Ethyl biscoumacetate.,Ethyl biscoumacetate
DB13136,The risk or severity of bleeding can be increased when Gramicidin D is combined with Fluindione.,Fluindione
DB13275,The risk or severity of bleeding can be increased when Gramicidin D is combined with Clorindione.,Clorindione
DB13347,The risk or severity of bleeding can be increased when Gramicidin D is combined with Diphenadione.,Diphenadione
DB13451,The risk or severity of bleeding can be increased when Gramicidin D is combined with Tioclomarol.,Tioclomarol
DB14055,The risk or severity of bleeding can be increased when Gramicidin D is combined with (S)-Warfarin.,(S)-Warfarin
DB14443,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Gramicidin D.,Vibrio cholerae CVD 103-HgR strain live antigen
DB00255,Diethylstilbestrol may increase the thrombogenic activities of Human immunoglobulin G.,Diethylstilbestrol
DB00269,Chlorotrianisene may increase the thrombogenic activities of Human immunoglobulin G.,Chlorotrianisene
DB00286,Conjugated estrogens may increase the thrombogenic activities of Human immunoglobulin G.,Conjugated estrogens
DB00655,Estrone may increase the thrombogenic activities of Human immunoglobulin G.,Estrone
DB00783,Estradiol may increase the thrombogenic activities of Human immunoglobulin G.,Estradiol
DB00890,Dienestrol may increase the thrombogenic activities of Human immunoglobulin G.,Dienestrol
DB00977,Ethinylestradiol may increase the thrombogenic activities of Human immunoglobulin G.,Ethinylestradiol
DB01357,Mestranol may increase the thrombogenic activities of Human immunoglobulin G.,Mestranol
DB04573,Estriol may increase the thrombogenic activities of Human immunoglobulin G.,Estriol
DB04574,Estrone sulfate may increase the thrombogenic activities of Human immunoglobulin G.,Estrone sulfate
DB04575,Quinestrol may increase the thrombogenic activities of Human immunoglobulin G.,Quinestrol
DB07931,Hexestrol may increase the thrombogenic activities of Human immunoglobulin G.,Hexestrol
DB09070,Tibolone may increase the thrombogenic activities of Human immunoglobulin G.,Tibolone
DB09317,"Synthetic Conjugated Estrogens, A may increase the thrombogenic activities of Human immunoglobulin G.","Synthetic Conjugated Estrogens, A"
DB09318,"Synthetic Conjugated Estrogens, B may increase the thrombogenic activities of Human immunoglobulin G.","Synthetic Conjugated Estrogens, B"
DB09369,Polyestradiol phosphate may increase the thrombogenic activities of Human immunoglobulin G.,Polyestradiol phosphate
DB09381,Esterified estrogens may increase the thrombogenic activities of Human immunoglobulin G.,Esterified estrogens
DB11478,Zeranol may increase the thrombogenic activities of Human immunoglobulin G.,Zeranol
DB11674,Equol may increase the thrombogenic activities of Human immunoglobulin G.,Equol
DB12487,Promestriene may increase the thrombogenic activities of Human immunoglobulin G.,Promestriene
DB13143,Methallenestril may increase the thrombogenic activities of Human immunoglobulin G.,Methallenestril
DB13386,Epimestrol may increase the thrombogenic activities of Human immunoglobulin G.,Epimestrol
DB13418,Moxestrol may increase the thrombogenic activities of Human immunoglobulin G.,Moxestrol
DB13952,Estradiol acetate may increase the thrombogenic activities of Human immunoglobulin G.,Estradiol acetate
DB13953,Estradiol benzoate may increase the thrombogenic activities of Human immunoglobulin G.,Estradiol benzoate
DB13954,Estradiol cypionate may increase the thrombogenic activities of Human immunoglobulin G.,Estradiol cypionate
DB13956,Estradiol valerate may increase the thrombogenic activities of Human immunoglobulin G.,Estradiol valerate
DB15334,Biochanin A may increase the thrombogenic activities of Human immunoglobulin G.,Biochanin A
DB15335,Formononetin may increase the thrombogenic activities of Human immunoglobulin G.,Formononetin
DB00002,The risk or severity of adverse effects can be increased when Cetuximab is combined with Human immunoglobulin G.,Cetuximab
DB00043,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Omalizumab.,Omalizumab
DB00051,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Adalimumab.,Adalimumab
DB00054,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Abciximab.,Abciximab
DB00056,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin
DB00057,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Indium In-111 satumomab pendetide.,Indium In-111 satumomab pendetide
DB00065,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Infliximab.,Infliximab
DB00072,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Trastuzumab.,Trastuzumab
DB00073,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Rituximab.,Rituximab
DB00074,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Basiliximab.,Basiliximab
DB00075,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Muromonab.,Muromonab
DB00076,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Digoxin Immune Fab (Ovine).,Digoxin Immune Fab (Ovine)
DB00078,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ibritumomab tiuxetan.,Ibritumomab tiuxetan
DB00081,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tositumomab.,Tositumomab
DB00087,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Alemtuzumab.,Alemtuzumab
DB00089,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Capromab pendetide.,Capromab pendetide
DB00095,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Efalizumab.,Efalizumab
DB00098,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Antithymocyte immunoglobulin (rabbit).,Antithymocyte immunoglobulin (rabbit)
DB00108,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Natalizumab.,Natalizumab
DB00110,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Palivizumab.,Palivizumab
DB00111,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Daclizumab.,Daclizumab
DB00112,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Bevacizumab.,Bevacizumab
DB00113,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Technetium Tc-99m arcitumomab.,Technetium Tc-99m arcitumomab
DB01257,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Eculizumab.,Eculizumab
DB01269,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Panitumumab.,Panitumumab
DB01270,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ranibizumab.,Ranibizumab
DB04901,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Galiximab.,Galiximab
DB04949,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Pexelizumab.,Pexelizumab
DB04956,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Afelimomab.,Afelimomab
DB04958,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Epratuzumab.,Epratuzumab
DB04962,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Bectumomab.,Bectumomab
DB04964,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Oregovomab.,Oregovomab
DB04988,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with IGN311.,IGN311
DB05006,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Adecatumumab.,Adecatumumab
DB05097,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Labetuzumab.,Labetuzumab
DB05101,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Matuzumab.,Matuzumab
DB05111,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Fontolizumab.,Fontolizumab
DB05136,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Bavituximab.,Bavituximab
DB05139,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with CR002.,CR002
DB05209,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Rozrolimupab.,Rozrolimupab
DB05304,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Girentuximab.,Girentuximab
DB05336,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Obiltoxaximab.,Obiltoxaximab
DB05405,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with XTL-001.,XTL-001
DB05437,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with NAV 1800.,NAV 1800
DB05459,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Briakinumab.,Briakinumab
DB05496,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Otelixizumab.,Otelixizumab
DB05545,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with AMG 108.,AMG 108
DB05550,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Iratumumab.,Iratumumab
DB05555,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Enokizumab.,Enokizumab
DB05578,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ramucirumab.,Ramucirumab
DB05595,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Farletuzumab.,Farletuzumab
DB05656,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Veltuzumab.,Veltuzumab
DB05679,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ustekinumab.,Ustekinumab
DB05773,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Trastuzumab emtansine.,Trastuzumab emtansine
DB05793,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with PRO-542.,PRO-542
DB05797,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with TNX-901.,TNX-901
DB05889,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Inotuzumab ozogamicin.,Inotuzumab ozogamicin
DB05892,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with RI 624.,RI 624
DB05915,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with MYO-029.,MYO-029
DB05916,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with CT-011.,CT-011
DB05941,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Leronlimab.,Leronlimab
DB05996,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Glembatumumab vedotin.,Glembatumumab vedotin
DB06043,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Olaratumab.,Olaratumab
DB06049,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with IPH 2101.,IPH 2101
DB06050,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with TB-402.,TB-402
DB06081,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Caplacizumab.,Caplacizumab
DB06101,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with IMC-1C11.,IMC-1C11
DB06116,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Eldelumab.,Eldelumab
DB06162,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Lumiliximab.,Lumiliximab
DB06168,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Canakinumab.,Canakinumab
DB06186,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ipilimumab.,Ipilimumab
DB06192,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Nimotuzumab.,Nimotuzumab
DB06241,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Clenoliximab.,Clenoliximab
DB06273,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tocilizumab.,Tocilizumab
DB06304,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with BIIB015.,BIIB015
DB06305,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Sonepcizumab.,Sonepcizumab
DB06310,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Motavizumab.,Motavizumab
DB06317,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Elotuzumab.,Elotuzumab
DB06318,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with AVE9633.,AVE9633
DB06322,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Carotuximab.,Carotuximab
DB06324,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with XmAb 2513.,XmAb 2513
DB06342,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Coltuximab ravtansine.,Coltuximab ravtansine
DB06343,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Teprotumumab.,Teprotumumab
DB06360,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Lucatumumab.,Lucatumumab
DB06366,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Pertuzumab.,Pertuzumab
DB06371,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Siplizumab.,Siplizumab
DB06467,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Apolizumab.,Apolizumab
DB06474,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Sibrotuzumab.,Sibrotuzumab
DB06550,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Bivatuzumab.,Bivatuzumab
DB06557,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Lerdelimumab.,Lerdelimumab
DB06599,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Lexatumumab.,Lexatumumab
DB06602,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Reslizumab.,Reslizumab
DB06606,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Teplizumab.,Teplizumab
DB06607,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Catumaxomab.,Catumaxomab
DB06612,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Mepolizumab.,Mepolizumab
DB06643,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Denosumab.,Denosumab
DB06647,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Volociximab.,Volociximab
DB06650,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ofatumumab.,Ofatumumab
DB06674,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Golimumab.,Golimumab
DB08870,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Brentuximab vedotin.,Brentuximab vedotin
DB08879,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Belimumab.,Belimumab
DB08902,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Raxibacumab.,Raxibacumab
DB08904,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Certolizumab pegol.,Certolizumab pegol
DB08935,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Obinutuzumab.,Obinutuzumab
DB09029,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Secukinumab.,Secukinumab
DB09033,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Vedolizumab.,Vedolizumab
DB09035,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Nivolumab.,Nivolumab
DB09036,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Siltuximab.,Siltuximab
DB09037,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Pembrolizumab.,Pembrolizumab
DB09045,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Dulaglutide.,Dulaglutide
DB09052,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Blinatumomab.,Blinatumomab
DB09057,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Anthrax immune globulin human.,Anthrax immune globulin human
DB09077,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Dinutuximab.,Dinutuximab
DB09105,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Asfotase alfa.,Asfotase alfa
DB09264,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Idarucizumab.,Idarucizumab
DB09302,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Alirocumab.,Alirocumab
DB09303,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Evolocumab.,Evolocumab
DB09312,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Antilymphocyte immunoglobulin (horse).,Antilymphocyte immunoglobulin (horse)
DB09331,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Daratumumab.,Daratumumab
DB09559,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Necitumumab.,Necitumumab
DB11569,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ixekizumab.,Ixekizumab
DB11580,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ravulizumab.,Ravulizumab
DB11595,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Atezolizumab.,Atezolizumab
DB11604,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tetanus Immune Globulin.,Tetanus Immune Globulin
DB11608,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Eftrenonacog alfa.,Eftrenonacog alfa
DB11621,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Human Varicella-Zoster Immune Globulin.,Human Varicella-Zoster Immune Globulin
DB11646,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Conatumumab.,Conatumumab
DB11657,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tabalumab.,Tabalumab
DB11680,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ficlatuzumab.,Ficlatuzumab
DB11685,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Figitumumab.,Figitumumab
DB11714,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Durvalumab.,Durvalumab
DB11715,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Bapineuzumab.,Bapineuzumab
DB11731,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Depatuxizumab mafodotin.,Depatuxizumab mafodotin
DB11746,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Onartuzumab.,Onartuzumab
DB11756,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Solanezumab.,Solanezumab
DB11767,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Sarilumab.,Sarilumab
DB11771,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tremelimumab.,Tremelimumab
DB11776,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Brodalumab.,Brodalumab
DB11803,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Sirukumab.,Sirukumab
DB11826,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Lampalizumab.,Lampalizumab
DB11834,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Guselkumab.,Guselkumab
DB11840,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Dalotuzumab.,Dalotuzumab
DB11849,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Emibetuzumab.,Emibetuzumab
DB11850,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ublituximab.,Ublituximab
DB11856,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ligelizumab.,Ligelizumab
DB11857,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Seribantumab.,Seribantumab
DB11862,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Landogrozumab.,Landogrozumab
DB11866,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Romosozumab.,Romosozumab
DB11884,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Vadastuximab Talirine.,Vadastuximab Talirine
DB11914,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Lebrikizumab.,Lebrikizumab
DB11930,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Varlilumab.,Varlilumab
DB11945,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Avelumab.,Avelumab
DB11959,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Crenezumab.,Crenezumab
DB11972,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Rilotumumab.,Rilotumumab
DB11976,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Anifrolumab.,Anifrolumab
DB11988,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ocrelizumab.,Ocrelizumab
DB12023,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Benralizumab.,Benralizumab
DB12034,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Gantenerumab.,Gantenerumab
DB12053,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Visilizumab.,Visilizumab
DB12077,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Urelumab.,Urelumab
DB12089,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Lorvotuzumab mertansine.,Lorvotuzumab mertansine
DB12090,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Patritumab.,Patritumab
DB12102,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Fulranumab.,Fulranumab
DB12104,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tarextumab.,Tarextumab
DB12118,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Sotatercept.,Sotatercept
DB12119,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Gevokizumab.,Gevokizumab
DB12142,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Duligotuzumab.,Duligotuzumab
DB12152,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Simtuzumab.,Simtuzumab
DB12157,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Fasinumab.,Fasinumab
DB12159,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Dupilumab.,Dupilumab
DB12169,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tralokinumab.,Tralokinumab
DB12189,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Etrolizumab.,Etrolizumab
DB12202,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Zalutumumab.,Zalutumumab
DB12205,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ganitumab.,Ganitumab
DB12213,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Etaracizumab.,Etaracizumab
DB12240,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Polatuzumab vedotin.,Polatuzumab vedotin
DB12246,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Inclacumab.,Inclacumab
DB12250,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Cixutumumab.,Cixutumumab
DB12261,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ascrinvacumab.,Ascrinvacumab
DB12274,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Aducanumab.,Aducanumab
DB12281,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Luspatercept.,Luspatercept
DB12296,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with GS-5745.,GS-5745
DB12317,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Vanucizumab.,Vanucizumab
DB12331,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Labetuzumab govitecan.,Labetuzumab govitecan
DB12335,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tanezumab.,Tanezumab
DB12342,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ensituximab.,Ensituximab
DB12344,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Fezakinumab.,Fezakinumab
DB12363,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Dusigitumab.,Dusigitumab
DB12396,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Fresolimumab.,Fresolimumab
DB12413,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Indusatumab vedotin.,Indusatumab vedotin
DB12456,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Bococizumab.,Bococizumab
DB12489,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Mirvetuximab Soravtansine.,Mirvetuximab Soravtansine
DB12498,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Mogamulizumab.,Mogamulizumab
DB12520,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Plozalizumab.,Plozalizumab
DB12530,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Inebilizumab.,Inebilizumab
DB12534,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Mavrilimumab.,Mavrilimumab
DB12560,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Blosozumab.,Blosozumab
DB12584,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Bimagrumab.,Bimagrumab
DB12589,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Dacetuzumab.,Dacetuzumab
DB12609,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tovetumab.,Tovetumab
DB12683,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Lumretuzumab.,Lumretuzumab
DB12698,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ibalizumab.,Ibalizumab
DB12701,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Intetumumab.,Intetumumab
DB12718,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Carlumab.,Carlumab
DB12734,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Demcizumab.,Demcizumab
DB12773,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Sifalimumab.,Sifalimumab
DB12775,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Abituzumab.,Abituzumab
DB12797,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ecromeximab.,Ecromeximab
DB12807,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Naptumomab Estafenatox.,Naptumomab Estafenatox
DB12815,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Crotedumab.,Crotedumab
DB12820,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Concizumab.,Concizumab
DB12826,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Depatuxizumab.,Depatuxizumab
DB12844,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Rontalizumab.,Rontalizumab
DB12845,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Amatuximab.,Amatuximab
DB12849,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Clazakizumab.,Clazakizumab
DB12891,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ozanezumab.,Ozanezumab
DB12893,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Sacituzumab govitecan.,Sacituzumab govitecan
DB12917,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Bimekizumab.,Bimekizumab
DB12943,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Milatuzumab.,Milatuzumab
DB12976,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Robatumumab.,Robatumumab
DB13017,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Rovalpituzumab Tesirine.,Rovalpituzumab Tesirine
DB13037,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Namilumab.,Namilumab
DB13045,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Racotumomab.,Racotumomab
DB13073,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tregalizumab.,Tregalizumab
DB13127,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Olokizumab.,Olokizumab
DB13140,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Bezlotoxumab.,Bezlotoxumab
DB13375,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Edrecolomab.,Edrecolomab
DB13535,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Nebacumab.,Nebacumab
DB13886,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Human cytomegalovirus immune globulin.,Human cytomegalovirus immune globulin
DB13923,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Emicizumab.,Emicizumab
DB13976,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Sulesomab.,Sulesomab
DB13979,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Besilesomab.,Besilesomab
DB14004,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tildrakizumab.,Tildrakizumab
DB14012,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Burosumab.,Burosumab
DB14039,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Erenumab.,Erenumab
DB14040,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Eptinezumab.,Eptinezumab
DB14041,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Fremanezumab.,Fremanezumab
DB14042,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Galcanezumab.,Galcanezumab
DB14211,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Fanolesomab.,Fanolesomab
DB14580,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Lecanemab.,Lecanemab
DB14597,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Lanadelumab.,Lanadelumab
DB14707,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Cemiplimab.,Cemiplimab
DB14724,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Emapalumab.,Emapalumab
DB14762,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Risankizumab.,Risankizumab
DB14776,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Camrelizumab.,Camrelizumab
DB14778,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Setrusumab.,Setrusumab
DB14784,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Gancotamab.,Gancotamab
DB14809,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Anetumab ravtansine.,Anetumab ravtansine
DB14811,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Isatuximab.,Isatuximab
DB14824,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Icrucumab.,Icrucumab
DB14843,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Codrituzumab.,Codrituzumab
DB14864,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Brolucizumab.,Brolucizumab
DB14871,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Xentuzumab.,Xentuzumab
DB14877,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Lintuzumab.,Lintuzumab
DB14891,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Vobarilizumab.,Vobarilizumab
DB14897,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Parsatuzumab.,Parsatuzumab
DB14905,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Emactuzumab.,Emactuzumab
DB14907,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Bevacizumab zirconium Zr-89.,Bevacizumab zirconium Zr-89
DB14908,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Refanezumab.,Refanezumab
DB14919,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Rozanolixizumab.,Rozanolixizumab
DB14947,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Bermekimab.,Bermekimab
DB14952,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Pamrevlumab.,Pamrevlumab
DB14959,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Opicinumab.,Opicinumab
DB14962,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Trastuzumab deruxtecan.,Trastuzumab deruxtecan
DB14967,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Margetuximab.,Margetuximab
DB14988,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Dalantercept.,Dalantercept
DB14997,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Pateclizumab.,Pateclizumab
DB15014,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Gremubamab.,Gremubamab
DB15022,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Apomab.,Apomab
DB15044,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tafasitamab.,Tafasitamab
DB15045,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ipafricept.,Ipafricept
DB15076,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Abrilumab.,Abrilumab
DB15089,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Frovocimab.,Frovocimab
DB15090,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tezepelumab.,Tezepelumab
DB15101,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tigatuzumab.,Tigatuzumab
DB15104,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Telisotuzumab vedotin.,Telisotuzumab vedotin
DB15113,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Utomilumab.,Utomilumab
DB15118,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Zolbetuximab.,Zolbetuximab
DB15135,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ponezumab.,Ponezumab
DB15160,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Asunercept.,Asunercept
DB15172,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Suvratoxumab.,Suvratoxumab
DB15225,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Mitazalimab.,Mitazalimab
DB15252,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Nemolizumab.,Nemolizumab
DB15253,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Bleselumab.,Bleselumab
DB15277,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Gedivumab.,Gedivumab
DB15336,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Valanafusp alfa.,Valanafusp alfa
DB15349,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Sofituzumab vedotin.,Sofituzumab vedotin
DB15354,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Evinacumab.,Evinacumab
DB15363,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Istiratumab.,Istiratumab
DB15383,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Pidilizumab.,Pidilizumab
DB15397,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with GMA-161.,GMA-161
DB15409,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ladiratuzumab vedotin.,Ladiratuzumab vedotin
DB15415,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tomaralimab.,Tomaralimab
DB15428,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Vesencumab.,Vesencumab
DB15432,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Pinatuzumab vedotin.,Pinatuzumab vedotin
DB15441,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Lulizumab pegol.,Lulizumab pegol
DB15443,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Lorukafusp alfa.,Lorukafusp alfa
DB15453,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Naratuximab emtansine.,Naratuximab emtansine
DB15559,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Zenocutuzumab.,Zenocutuzumab
DB15595,"The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Human immunoglobulin G.","Ebola Zaire vaccine (live, attenuated)"
DB06605,Apixaban may increase the anticoagulant activities of Anistreplase.,Apixaban
DB06695,Dabigatran etexilate may increase the anticoagulant activities of Anistreplase.,Dabigatran etexilate
DB01254,The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Anistreplase.,Dasatinib
DB01609,The risk or severity of gastrointestinal bleeding can be increased when Anistreplase is combined with Deferasirox.,Deferasirox
DB01586,The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Ursodeoxycholic acid.,Ursodeoxycholic acid
DB02123,The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Glycochenodeoxycholic Acid.,Glycochenodeoxycholic Acid
DB02659,The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Cholic Acid.,Cholic Acid
DB02691,The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Glycocholic acid.,Glycocholic acid
DB03619,The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Deoxycholic acid.,Deoxycholic acid
DB04348,The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Taurocholic acid.,Taurocholic acid
DB05990,The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Obeticholic acid.,Obeticholic acid
DB06777,The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Chenodeoxycholic acid.,Chenodeoxycholic acid
DB08833,The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Taurochenodeoxycholic acid.,Taurochenodeoxycholic acid
DB08834,The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Tauroursodeoxycholic acid.,Tauroursodeoxycholic acid
DB08857,The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Bamet-UD2.,Bamet-UD2
DB11622,The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Dehydrocholic acid.,Dehydrocholic acid
DB11789,The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Hyodeoxycholic Acid.,Hyodeoxycholic Acid
DB09075,The risk or severity of bleeding can be increased when Edoxaban is combined with Anistreplase.,Edoxaban
DB09053,The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with Anistreplase.,Ibrutinib
DB08935,The risk or severity of bleeding and hemorrhage can be increased when Anistreplase is combined with Obinutuzumab.,Obinutuzumab
DB06228,Anistreplase may increase the anticoagulant activities of Rivaroxaban.,Rivaroxaban
DB06206,The risk or severity of bleeding and hemorrhage can be increased when Anistreplase is combined with Sugammadex.,Sugammadex
DB09070,Tibolone may increase the anticoagulant activities of Anistreplase.,Tibolone
DB00932,The risk or severity of bleeding and hemorrhage can be increased when Tipranavir is combined with Anistreplase.,Tipranavir
DB00013,Urokinase may increase the anticoagulant activities of Anistreplase.,Urokinase
DB00163,Vitamin E may increase the anticoagulant activities of Anistreplase.,Vitamin E
DB09030,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Anistreplase.,Vorapaxar
DB06692,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Aprotinin.,Aprotinin
DB01381,The therapeutic efficacy of Anistreplase can be increased when used in combination with Ginkgo biloba.,Ginkgo biloba
DB01181,The risk or severity of bleeding can be increased when Ifosfamide is combined with Anistreplase.,Ifosfamide
DB00468,The therapeutic efficacy of Anistreplase can be increased when used in combination with Quinine.,Quinine
DB00908,The therapeutic efficacy of Anistreplase can be increased when used in combination with Quinidine.,Quinidine
DB00675,The risk or severity of bleeding can be increased when Tamoxifen is combined with Anistreplase.,Tamoxifen
DB00539,The risk or severity of bleeding can be increased when Toremifene is combined with Anistreplase.,Toremifene
DB00806,The therapeutic efficacy of Anistreplase can be increased when used in combination with Pentoxifylline.,Pentoxifylline
DB00686,Pentosan polysulfate may increase the anticoagulant activities of Anistreplase.,Pentosan polysulfate
DB00583,The therapeutic efficacy of Anistreplase can be increased when used in combination with Levocarnitine.,Levocarnitine
DB00255,Diethylstilbestrol may decrease the anticoagulant activities of Anistreplase.,Diethylstilbestrol
DB00269,Chlorotrianisene may decrease the anticoagulant activities of Anistreplase.,Chlorotrianisene
DB00286,Conjugated estrogens may decrease the anticoagulant activities of Anistreplase.,Conjugated estrogens
DB00783,Estradiol may decrease the anticoagulant activities of Anistreplase.,Estradiol
DB00977,Ethinylestradiol may decrease the anticoagulant activities of Anistreplase.,Ethinylestradiol
DB01357,Mestranol may decrease the anticoagulant activities of Anistreplase.,Mestranol
DB04573,Estriol may decrease the anticoagulant activities of Anistreplase.,Estriol
DB04574,Estrone sulfate may decrease the anticoagulant activities of Anistreplase.,Estrone sulfate
DB04575,Quinestrol may decrease the anticoagulant activities of Anistreplase.,Quinestrol
DB07931,Hexestrol may decrease the anticoagulant activities of Anistreplase.,Hexestrol
DB09317,"Synthetic Conjugated Estrogens, A may decrease the anticoagulant activities of Anistreplase.","Synthetic Conjugated Estrogens, A"
DB09318,"Synthetic Conjugated Estrogens, B may decrease the anticoagulant activities of Anistreplase.","Synthetic Conjugated Estrogens, B"
DB09369,Polyestradiol phosphate may decrease the anticoagulant activities of Anistreplase.,Polyestradiol phosphate
DB09381,Esterified estrogens may decrease the anticoagulant activities of Anistreplase.,Esterified estrogens
DB11478,Zeranol may decrease the anticoagulant activities of Anistreplase.,Zeranol
DB11674,Equol may decrease the anticoagulant activities of Anistreplase.,Equol
DB12487,Promestriene may decrease the anticoagulant activities of Anistreplase.,Promestriene
DB13143,Methallenestril may decrease the anticoagulant activities of Anistreplase.,Methallenestril
DB13386,Epimestrol may decrease the anticoagulant activities of Anistreplase.,Epimestrol
DB13418,Moxestrol may decrease the anticoagulant activities of Anistreplase.,Moxestrol
DB13952,Estradiol acetate may decrease the anticoagulant activities of Anistreplase.,Estradiol acetate
DB13953,Estradiol benzoate may decrease the anticoagulant activities of Anistreplase.,Estradiol benzoate
DB13954,Estradiol cypionate may decrease the anticoagulant activities of Anistreplase.,Estradiol cypionate
DB13956,Estradiol valerate may decrease the anticoagulant activities of Anistreplase.,Estradiol valerate
DB15334,Biochanin A may decrease the anticoagulant activities of Anistreplase.,Biochanin A
DB15335,Formononetin may decrease the anticoagulant activities of Anistreplase.,Formononetin
DB00159,The risk or severity of bleeding and hemorrhage can be increased when Icosapent is combined with Anistreplase.,Icosapent
DB00244,The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Anistreplase.,Mesalazine
DB00328,The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Anistreplase.,Indomethacin
DB00461,The risk or severity of bleeding and hemorrhage can be increased when Nabumetone is combined with Anistreplase.,Nabumetone
DB00465,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Anistreplase.,Ketorolac
DB00469,The risk or severity of bleeding and hemorrhage can be increased when Tenoxicam is combined with Anistreplase.,Tenoxicam
DB00482,The risk or severity of bleeding and hemorrhage can be increased when Celecoxib is combined with Anistreplase.,Celecoxib
DB00500,The risk or severity of bleeding and hemorrhage can be increased when Tolmetin is combined with Anistreplase.,Tolmetin
DB00533,The risk or severity of bleeding and hemorrhage can be increased when Rofecoxib is combined with Anistreplase.,Rofecoxib
DB00554,The risk or severity of bleeding and hemorrhage can be increased when Piroxicam is combined with Anistreplase.,Piroxicam
DB00573,The risk or severity of bleeding and hemorrhage can be increased when Fenoprofen is combined with Anistreplase.,Fenoprofen
DB00580,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Anistreplase.,Valdecoxib
DB00586,The risk or severity of bleeding and hemorrhage can be increased when Diclofenac is combined with Anistreplase.,Diclofenac
DB00605,The risk or severity of bleeding and hemorrhage can be increased when Sulindac is combined with Anistreplase.,Sulindac
DB00712,The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen is combined with Anistreplase.,Flurbiprofen
DB00749,The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Anistreplase.,Etodolac
DB00784,The risk or severity of bleeding and hemorrhage can be increased when Mefenamic acid is combined with Anistreplase.,Mefenamic acid
DB00788,The risk or severity of bleeding and hemorrhage can be increased when Naproxen is combined with Anistreplase.,Naproxen
DB00795,The risk or severity of bleeding and hemorrhage can be increased when Sulfasalazine is combined with Anistreplase.,Sulfasalazine
DB00812,The risk or severity of bleeding and hemorrhage can be increased when Phenylbutazone is combined with Anistreplase.,Phenylbutazone
DB00814,The risk or severity of bleeding and hemorrhage can be increased when Meloxicam is combined with Anistreplase.,Meloxicam
DB00821,The risk or severity of bleeding and hemorrhage can be increased when Carprofen is combined with Anistreplase.,Carprofen
DB00861,The risk or severity of bleeding and hemorrhage can be increased when Diflunisal is combined with Anistreplase.,Diflunisal
DB00936,The risk or severity of bleeding and hemorrhage can be increased when Salicylic acid is combined with Anistreplase.,Salicylic acid
DB00939,The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Anistreplase.,Meclofenamic acid
DB00991,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Anistreplase.,Oxaprozin
DB01009,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Anistreplase.,Ketoprofen
DB01014,The risk or severity of bleeding and hemorrhage can be increased when Balsalazide is combined with Anistreplase.,Balsalazide
DB01250,The risk or severity of bleeding and hemorrhage can be increased when Olsalazine is combined with Anistreplase.,Olsalazine
DB01283,The risk or severity of bleeding and hemorrhage can be increased when Lumiracoxib is combined with Anistreplase.,Lumiracoxib
DB01397,The risk or severity of bleeding and hemorrhage can be increased when Magnesium salicylate is combined with Anistreplase.,Magnesium salicylate
DB01399,The risk or severity of bleeding and hemorrhage can be increased when Salsalate is combined with Anistreplase.,Salsalate
DB01401,The risk or severity of bleeding and hemorrhage can be increased when Choline magnesium trisalicylate is combined with Anistreplase.,Choline magnesium trisalicylate
DB01419,The risk or severity of bleeding and hemorrhage can be increased when Antrafenine is combined with Anistreplase.,Antrafenine
DB01424,The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Anistreplase.,Aminophenazone
DB01435,The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Anistreplase.,Antipyrine
DB01600,The risk or severity of bleeding and hemorrhage can be increased when Tiaprofenic acid is combined with Anistreplase.,Tiaprofenic acid
DB01628,The risk or severity of bleeding and hemorrhage can be increased when Etoricoxib is combined with Anistreplase.,Etoricoxib
DB02224,The risk or severity of bleeding and hemorrhage can be increased when Taxifolin is combined with Anistreplase.,Taxifolin
DB03585,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Anistreplase.,Oxyphenbutazone
DB04552,The risk or severity of bleeding and hemorrhage can be increased when Niflumic acid is combined with Anistreplase.,Niflumic acid
DB04725,The risk or severity of bleeding and hemorrhage can be increased when Licofelone is combined with Anistreplase.,Licofelone
DB04812,The risk or severity of bleeding and hemorrhage can be increased when Benoxaprofen is combined with Anistreplase.,Benoxaprofen
DB04817,The risk or severity of bleeding and hemorrhage can be increased when Metamizole is combined with Anistreplase.,Metamizole
DB04828,The risk or severity of bleeding and hemorrhage can be increased when Zomepirac is combined with Anistreplase.,Zomepirac
DB05095,The risk or severity of bleeding and hemorrhage can be increased when Cimicoxib is combined with Anistreplase.,Cimicoxib
DB06725,The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is combined with Anistreplase.,Lornoxicam
DB06736,The risk or severity of bleeding and hemorrhage can be increased when Aceclofenac is combined with Anistreplase.,Aceclofenac
DB06737,The risk or severity of bleeding and hemorrhage can be increased when Zaltoprofen is combined with Anistreplase.,Zaltoprofen
DB07402,The risk or severity of bleeding and hemorrhage can be increased when Azapropazone is combined with Anistreplase.,Azapropazone
DB07477,The risk or severity of bleeding and hemorrhage can be increased when Felbinac is combined with Anistreplase.,Felbinac
DB08439,The risk or severity of bleeding and hemorrhage can be increased when Parecoxib is combined with Anistreplase.,Parecoxib
DB08797,The risk or severity of bleeding and hemorrhage can be increased when Salicylamide is combined with Anistreplase.,Salicylamide
DB08940,The risk or severity of bleeding and hemorrhage can be increased when Kebuzone is combined with Anistreplase.,Kebuzone
DB08942,The risk or severity of bleeding and hemorrhage can be increased when Isoxicam is combined with Anistreplase.,Isoxicam
DB08951,The risk or severity of bleeding and hemorrhage can be increased when Indoprofen is combined with Anistreplase.,Indoprofen
DB08955,The risk or severity of bleeding and hemorrhage can be increased when Ibuproxam is combined with Anistreplase.,Ibuproxam
DB08976,The risk or severity of bleeding and hemorrhage can be increased when Floctafenine is combined with Anistreplase.,Floctafenine
DB08981,The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Anistreplase.,Fenbufen
DB08984,The risk or severity of bleeding and hemorrhage can be increased when Etofenamate is combined with Anistreplase.,Etofenamate
DB08991,The risk or severity of bleeding and hemorrhage can be increased when Epirizole is combined with Anistreplase.,Epirizole
DB09084,The risk or severity of bleeding and hemorrhage can be increased when Benzydamine is combined with Anistreplase.,Benzydamine
DB09212,The risk or severity of bleeding and hemorrhage can be increased when Loxoprofen is combined with Anistreplase.,Loxoprofen
DB09214,The risk or severity of bleeding and hemorrhage can be increased when Dexketoprofen is combined with Anistreplase.,Dexketoprofen
DB09215,The risk or severity of bleeding and hemorrhage can be increased when Droxicam is combined with Anistreplase.,Droxicam
DB09216,The risk or severity of bleeding and hemorrhage can be increased when Tolfenamic acid is combined with Anistreplase.,Tolfenamic acid
DB09217,The risk or severity of bleeding and hemorrhage can be increased when Firocoxib is combined with Anistreplase.,Firocoxib
DB09218,The risk or severity of bleeding and hemorrhage can be increased when Clonixin is combined with Anistreplase.,Clonixin
DB09285,The risk or severity of bleeding and hemorrhage can be increased when Morniflumate is combined with Anistreplase.,Morniflumate
DB09288,The risk or severity of bleeding and hemorrhage can be increased when Propacetamol is combined with Anistreplase.,Propacetamol
DB09295,The risk or severity of bleeding and hemorrhage can be increased when Talniflumate is combined with Anistreplase.,Talniflumate
DB11455,The risk or severity of bleeding and hemorrhage can be increased when Robenacoxib is combined with Anistreplase.,Robenacoxib
DB11466,The risk or severity of bleeding and hemorrhage can be increased when Tepoxalin is combined with Anistreplase.,Tepoxalin
DB11518,The risk or severity of bleeding and hemorrhage can be increased when Flunixin is combined with Anistreplase.,Flunixin
DB12399,The risk or severity of bleeding and hemorrhage can be increased when Polmacoxib is combined with Anistreplase.,Polmacoxib
DB12480,The risk or severity of bleeding and hemorrhage can be increased when Betulinic Acid is combined with Anistreplase.,Betulinic Acid
DB12610,The risk or severity of bleeding and hemorrhage can be increased when Ebselen is combined with Anistreplase.,Ebselen
DB13001,The risk or severity of bleeding and hemorrhage can be increased when Tinoridine is combined with Anistreplase.,Tinoridine
DB13167,The risk or severity of bleeding and hemorrhage can be increased when Alclofenac is combined with Anistreplase.,Alclofenac
DB13217,The risk or severity of bleeding and hemorrhage can be increased when Fentiazac is combined with Anistreplase.,Fentiazac
DB13232,The risk or severity of bleeding and hemorrhage can be increased when Suxibuzone is combined with Anistreplase.,Suxibuzone
DB13286,The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with Anistreplase.,Bumadizone
DB13314,The risk or severity of bleeding and hemorrhage can be increased when Alminoprofen is combined with Anistreplase.,Alminoprofen
DB13317,The risk or severity of bleeding and hemorrhage can be increased when Flunoxaprofen is combined with Anistreplase.,Flunoxaprofen
DB13364,The risk or severity of bleeding and hemorrhage can be increased when Feprazone is combined with Anistreplase.,Feprazone
DB13371,The risk or severity of bleeding and hemorrhage can be increased when Difenpiramide is combined with Anistreplase.,Difenpiramide
DB13407,The risk or severity of bleeding and hemorrhage can be increased when Nifenazone is combined with Anistreplase.,Nifenazone
DB13432,The risk or severity of bleeding and hemorrhage can be increased when Lonazolac is combined with Anistreplase.,Lonazolac
DB13481,The risk or severity of bleeding and hemorrhage can be increased when Tenidap is combined with Anistreplase.,Tenidap
DB13501,The risk or severity of bleeding and hemorrhage can be increased when Bendazac is combined with Anistreplase.,Bendazac
DB13514,The risk or severity of bleeding and hemorrhage can be increased when Pranoprofen is combined with Anistreplase.,Pranoprofen
DB13524,The risk or severity of bleeding and hemorrhage can be increased when Propyphenazone is combined with Anistreplase.,Propyphenazone
DB13527,The risk or severity of bleeding and hemorrhage can be increased when Proglumetacin is combined with Anistreplase.,Proglumetacin
DB13538,The risk or severity of bleeding and hemorrhage can be increased when Guacetisal is combined with Anistreplase.,Guacetisal
DB13544,The risk or severity of bleeding and hemorrhage can be increased when Ethenzamide is combined with Anistreplase.,Ethenzamide
DB13612,The risk or severity of bleeding and hemorrhage can be increased when Carbaspirin calcium is combined with Anistreplase.,Carbaspirin calcium
DB13629,The risk or severity of bleeding and hemorrhage can be increased when Mofebutazone is combined with Anistreplase.,Mofebutazone
DB13649,The risk or severity of bleeding and hemorrhage can be increased when Proquazone is combined with Anistreplase.,Proquazone
DB13657,The risk or severity of bleeding and hemorrhage can be increased when Benorilate is combined with Anistreplase.,Benorilate
DB13722,The risk or severity of bleeding and hemorrhage can be increased when Pirprofen is combined with Anistreplase.,Pirprofen
DB13860,The risk or severity of bleeding and hemorrhage can be increased when Imidazole salicylate is combined with Anistreplase.,Imidazole salicylate
DB14059,The risk or severity of bleeding and hemorrhage can be increased when SC-236 is combined with Anistreplase.,SC-236
DB14060,The risk or severity of bleeding and hemorrhage can be increased when NS-398 is combined with Anistreplase.,NS-398
DB14938,The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen axetil is combined with Anistreplase.,Flurbiprofen axetil
DB04865,The risk or severity of bleeding can be increased when Anistreplase is combined with Omacetaxine mepesuccinate.,Omacetaxine mepesuccinate
DB11133,Omega-3 fatty acids may increase the anticoagulant activities of Anistreplase.,Omega-3 fatty acids
DB00081,The risk or severity of bleeding and hemorrhage can be increased when Anistreplase is combined with Tositumomab.,Tositumomab
DB09211,The risk or severity of adverse effects can be increased when Limaprost is combined with Anistreplase.,Limaprost
DB00048,The risk or severity of adverse effects can be increased when Anistreplase is combined with Collagenase clostridium histolyticum.,Collagenase clostridium histolyticum
DB00389,Carbimazole may increase the anticoagulant activities of Anistreplase.,Carbimazole
DB00550,Propylthiouracil may increase the anticoagulant activities of Anistreplase.,Propylthiouracil
DB00763,Methimazole may increase the anticoagulant activities of Anistreplase.,Methimazole
DB03374,"3,5-Diiodotyrosine may increase the anticoagulant activities of Anistreplase.","3,5-Diiodotyrosine"
DB06715,Potassium Iodide may increase the anticoagulant activities of Anistreplase.,Potassium Iodide
DB07637,Dibromotyrosine may increase the anticoagulant activities of Anistreplase.,Dibromotyrosine
DB09418,Potassium perchlorate may increase the anticoagulant activities of Anistreplase.,Potassium perchlorate
DB13644,Methylthiouracil may increase the anticoagulant activities of Anistreplase.,Methylthiouracil
DB13804,Benzylthiouracil may increase the anticoagulant activities of Anistreplase.,Benzylthiouracil
DB00834,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Mifepristone.,Mifepristone
DB04066,The therapeutic efficacy of Anistreplase can be decreased when used in combination with p-Coumaric acid.,p-Coumaric acid
DB04682,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Octylphenoxy polyethoxyethanol.,Octylphenoxy polyethoxyethanol
DB05830,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Trestolone.,Trestolone
DB06266,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Lonidamine.,Lonidamine
DB08867,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Ulipristal.,Ulipristal
DB09401,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Isosorbide.,Isosorbide
DB11507,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cloprostenol.,Cloprostenol
DB12025,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Triptolide.,Triptolide
DB13044,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Gossypol.,Gossypol
DB13310,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Ormeloxifene.,Ormeloxifene
DB00294,Etonogestrel may decrease the anticoagulant activities of Anistreplase.,Etonogestrel
DB00304,Desogestrel may decrease the anticoagulant activities of Anistreplase.,Desogestrel
DB00351,Megestrol acetate may decrease the anticoagulant activities of Anistreplase.,Megestrol acetate
DB00367,Levonorgestrel may decrease the anticoagulant activities of Anistreplase.,Levonorgestrel
DB00378,Dydrogesterone may decrease the anticoagulant activities of Anistreplase.,Dydrogesterone
DB00396,Progesterone may decrease the anticoagulant activities of Anistreplase.,Progesterone
DB00603,Medroxyprogesterone acetate may decrease the anticoagulant activities of Anistreplase.,Medroxyprogesterone acetate
DB00717,Norethisterone may decrease the anticoagulant activities of Anistreplase.,Norethisterone
DB00823,Ethynodiol diacetate may decrease the anticoagulant activities of Anistreplase.,Ethynodiol diacetate
DB00957,Norgestimate may decrease the anticoagulant activities of Anistreplase.,Norgestimate
DB01395,Drospirenone may decrease the anticoagulant activities of Anistreplase.,Drospirenone
DB01431,Allylestrenol may decrease the anticoagulant activities of Anistreplase.,Allylestrenol
DB04839,Cyproterone acetate may decrease the anticoagulant activities of Anistreplase.,Cyproterone acetate
DB06713,Norelgestromin may decrease the anticoagulant activities of Anistreplase.,Norelgestromin
DB06730,Gestodene may decrease the anticoagulant activities of Anistreplase.,Gestodene
DB06789,Hydroxyprogesterone caproate may decrease the anticoagulant activities of Anistreplase.,Hydroxyprogesterone caproate
DB09123,Dienogest may decrease the anticoagulant activities of Anistreplase.,Dienogest
DB09124,Medrogestone may decrease the anticoagulant activities of Anistreplase.,Medrogestone
DB09371,Norethynodrel may decrease the anticoagulant activities of Anistreplase.,Norethynodrel
DB09389,Norgestrel may decrease the anticoagulant activities of Anistreplase.,Norgestrel
DB11372,Altrenogest may decrease the anticoagulant activities of Anistreplase.,Altrenogest
DB11619,Gestrinone may decrease the anticoagulant activities of Anistreplase.,Gestrinone
DB11636,Nomegestrol may decrease the anticoagulant activities of Anistreplase.,Nomegestrol
DB12474,Lynestrenol may decrease the anticoagulant activities of Anistreplase.,Lynestrenol
DB13230,Gestonorone may decrease the anticoagulant activities of Anistreplase.,Gestonorone
DB13528,Chlormadinone may decrease the anticoagulant activities of Anistreplase.,Chlormadinone
DB13533,Methylestrenolone may decrease the anticoagulant activities of Anistreplase.,Methylestrenolone
DB13563,Norgestrienone may decrease the anticoagulant activities of Anistreplase.,Norgestrienone
DB13602,Promegestone may decrease the anticoagulant activities of Anistreplase.,Promegestone
DB13685,Quingestanol may decrease the anticoagulant activities of Anistreplase.,Quingestanol
DB13857,Demegestone may decrease the anticoagulant activities of Anistreplase.,Demegestone
DB13866,Etynodiol may decrease the anticoagulant activities of Anistreplase.,Etynodiol
DB13981,Nomegestrol acetate may decrease the anticoagulant activities of Anistreplase.,Nomegestrol acetate
DB14570,Hydroxyprogesterone may decrease the anticoagulant activities of Anistreplase.,Hydroxyprogesterone
DB14678,Norethindrone enanthate may decrease the anticoagulant activities of Anistreplase.,Norethindrone enanthate
DB14679,Quingestanol acetate may decrease the anticoagulant activities of Anistreplase.,Quingestanol acetate
DB00233,The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Anistreplase.,Aminosalicylic acid
DB01294,The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Anistreplase.,Bismuth subsalicylate
DB06251,The risk or severity of bleeding can be increased when Dersalazine is combined with Anistreplase.,Dersalazine
DB06807,The risk or severity of bleeding can be increased when Phenyl aminosalicylate is combined with Anistreplase.,Phenyl aminosalicylate
DB09543,The risk or severity of bleeding can be increased when Methyl salicylate is combined with Anistreplase.,Methyl salicylate
DB11079,The risk or severity of bleeding can be increased when Trolamine salicylate is combined with Anistreplase.,Trolamine salicylate
DB13509,The risk or severity of bleeding can be increased when Aloxiprin is combined with Anistreplase.,Aloxiprin
DB14006,The risk or severity of bleeding can be increased when Choline salicylate is combined with Anistreplase.,Choline salicylate
DB14026,The risk or severity of bleeding can be increased when Thiosalicylic acid is combined with Anistreplase.,Thiosalicylic acid
DB00054,The risk or severity of bleeding can be increased when Abciximab is combined with Anistreplase.,Abciximab
DB00063,The risk or severity of bleeding can be increased when Eptifibatide is combined with Anistreplase.,Eptifibatide
DB00208,The risk or severity of bleeding can be increased when Ticlopidine is combined with Anistreplase.,Ticlopidine
DB00261,The risk or severity of bleeding can be increased when Anagrelide is combined with Anistreplase.,Anagrelide
DB00758,The risk or severity of bleeding can be increased when Clopidogrel is combined with Anistreplase.,Clopidogrel
DB00775,The risk or severity of bleeding can be increased when Tirofiban is combined with Anistreplase.,Tirofiban
DB00975,The risk or severity of bleeding can be increased when Dipyridamole is combined with Anistreplase.,Dipyridamole
DB01088,The risk or severity of bleeding can be increased when Iloprost is combined with Anistreplase.,Iloprost
DB01138,The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Anistreplase.,Sulfinpyrazone
DB01166,The risk or severity of bleeding can be increased when Cilostazol is combined with Anistreplase.,Cilostazol
DB01207,The risk or severity of bleeding can be increased when Ridogrel is combined with Anistreplase.,Ridogrel
DB01236,The risk or severity of bleeding can be increased when Sevoflurane is combined with Anistreplase.,Sevoflurane
DB01240,The risk or severity of bleeding can be increased when Epoprostenol is combined with Anistreplase.,Epoprostenol
DB02709,The risk or severity of bleeding can be increased when Resveratrol is combined with Anistreplase.,Resveratrol
DB04743,The risk or severity of bleeding can be increased when Nimesulide is combined with Anistreplase.,Nimesulide
DB04905,The risk or severity of bleeding can be increased when Tesmilifene is combined with Anistreplase.,Tesmilifene
DB04932,The risk or severity of bleeding can be increased when Defibrotide is combined with Anistreplase.,Defibrotide
DB05229,The risk or severity of bleeding can be increased when Beraprost is combined with Anistreplase.,Beraprost
DB05266,The risk or severity of bleeding can be increased when Ibudilast is combined with Anistreplase.,Ibudilast
DB05767,The risk or severity of bleeding can be increased when Andrographolide is combined with Anistreplase.,Andrographolide
DB06081,The risk or severity of bleeding can be increased when Caplacizumab is combined with Anistreplase.,Caplacizumab
DB06209,The risk or severity of bleeding can be increased when Prasugrel is combined with Anistreplase.,Prasugrel
DB06441,The risk or severity of bleeding can be increased when Cangrelor is combined with Anistreplase.,Cangrelor
DB07615,The risk or severity of bleeding can be increased when Tranilast is combined with Anistreplase.,Tranilast
DB08814,The risk or severity of bleeding can be increased when Triflusal is combined with Anistreplase.,Triflusal
DB08816,The risk or severity of bleeding can be increased when Ticagrelor is combined with Anistreplase.,Ticagrelor
DB08887,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Anistreplase.,Icosapent ethyl
DB09283,The risk or severity of bleeding can be increased when Trapidil is combined with Anistreplase.,Trapidil
DB12092,The risk or severity of bleeding can be increased when Naftopidil is combined with Anistreplase.,Naftopidil
DB12163,The risk or severity of bleeding can be increased when Sarpogrelate is combined with Anistreplase.,Sarpogrelate
DB12321,The risk or severity of bleeding can be increased when Ifetroban is combined with Anistreplase.,Ifetroban
DB12445,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Anistreplase.,Nitroaspirin
DB12465,The risk or severity of bleeding can be increased when Ketanserin is combined with Anistreplase.,Ketanserin
DB12545,The risk or severity of bleeding can be increased when Indobufen is combined with Anistreplase.,Indobufen
DB12749,The risk or severity of bleeding can be increased when Butylphthalide is combined with Anistreplase.,Butylphthalide
DB12771,The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Anistreplase.,Hydroxytyrosol
DB13036,The risk or severity of bleeding can be increased when Ramatroban is combined with Anistreplase.,Ramatroban
DB13327,The risk or severity of bleeding can be increased when Picotamide is combined with Anistreplase.,Picotamide
DB13367,The risk or severity of bleeding can be increased when Cloricromen is combined with Anistreplase.,Cloricromen
DB13400,The risk or severity of bleeding can be increased when Linsidomine is combined with Anistreplase.,Linsidomine
DB13510,The risk or severity of bleeding can be increased when Buflomedil is combined with Anistreplase.,Buflomedil
DB13929,The risk or severity of bleeding can be increased when Relcovaptan is combined with Anistreplase.,Relcovaptan
DB00374,The risk or severity of adverse effects can be increased when Anistreplase is combined with Treprostinil.,Treprostinil
DB03404,Hemin may increase the anticoagulant activities of Anistreplase.,Hemin
DB13783,The risk or severity of bleeding and hemorrhage can be increased when Acemetacin is combined with Anistreplase.,Acemetacin
DB00624,Testosterone may increase the anticoagulant activities of Anistreplase.,Testosterone
DB01420,Testosterone propionate may increase the anticoagulant activities of Anistreplase.,Testosterone propionate
DB01481,1-Testosterone may increase the anticoagulant activities of Anistreplase.,1-Testosterone
DB01485,4-Hydroxytestosterone may increase the anticoagulant activities of Anistreplase.,4-Hydroxytestosterone
DB01510,Dehydrochloromethyltestosterone may increase the anticoagulant activities of Anistreplase.,Dehydrochloromethyltestosterone
DB01541,Boldenone may increase the anticoagulant activities of Anistreplase.,Boldenone
DB01543,18-methyl-19-nortestosterone may increase the anticoagulant activities of Anistreplase.,18-methyl-19-nortestosterone
DB01564,Calusterone may increase the anticoagulant activities of Anistreplase.,Calusterone
DB01569,Formebolone may increase the anticoagulant activities of Anistreplase.,Formebolone
DB01572,Methyl-1-testosterone may increase the anticoagulant activities of Anistreplase.,Methyl-1-testosterone
DB02901,Stanolone may increase the anticoagulant activities of Anistreplase.,Stanolone
DB07447,5beta-dihydrotestosterone may increase the anticoagulant activities of Anistreplase.,5beta-dihydrotestosterone
DB08619,Testosterone succinate may increase the anticoagulant activities of Anistreplase.,Testosterone succinate
DB11429,Mibolerone may increase the anticoagulant activities of Anistreplase.,Mibolerone
DB13943,Testosterone cypionate may increase the anticoagulant activities of Anistreplase.,Testosterone cypionate
DB13944,Testosterone enanthate may increase the anticoagulant activities of Anistreplase.,Testosterone enanthate
DB13946,Testosterone undecanoate may increase the anticoagulant activities of Anistreplase.,Testosterone undecanoate
DB13947,Testosterone enantate benzilic acid hydrazone may increase the anticoagulant activities of Anistreplase.,Testosterone enantate benzilic acid hydrazone
DB13951,Stanolone acetate may increase the anticoagulant activities of Anistreplase.,Stanolone acetate
DB13958,Trestolone acetate may increase the anticoagulant activities of Anistreplase.,Trestolone acetate
DB14093,"(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Anistreplase.","(1,2,6,7-3H)Testosterone"
DB14655,Drostanolone propionate may increase the anticoagulant activities of Anistreplase.,Drostanolone propionate
DB11051,The risk or severity of adverse effects can be increased when Anistreplase is combined with Azficel-T.,Azficel-T
DB09568,The therapeutic efficacy of Anistreplase can be increased when used in combination with Omega-3-carboxylic acids.,Omega-3-carboxylic acids
DB00258,The therapeutic efficacy of Calcium acetate can be decreased when used in combination with Anistreplase.,Calcium acetate
DB01164,The therapeutic efficacy of Calcium chloride can be decreased when used in combination with Anistreplase.,Calcium chloride
DB01373,The therapeutic efficacy of Calcium can be decreased when used in combination with Anistreplase.,Calcium
DB11126,The therapeutic efficacy of Calcium gluconate can be decreased when used in combination with Anistreplase.,Calcium gluconate
DB11608,The therapeutic efficacy of Eftrenonacog alfa can be decreased when used in combination with Anistreplase.,Eftrenonacog alfa
DB13884,The therapeutic efficacy of Albutrepenonacog alfa can be decreased when used in combination with Anistreplase.,Albutrepenonacog alfa
DB13923,The therapeutic efficacy of Emicizumab can be decreased when used in combination with Anistreplase.,Emicizumab
DB14738,The therapeutic efficacy of Turoctocog alfa pegol can be decreased when used in combination with Anistreplase.,Turoctocog alfa pegol
DB00025,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Anistreplase.","Antihemophilic factor, human recombinant"
DB00036,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Anistreplase.,Coagulation factor VIIa Recombinant Human
DB00100,The therapeutic efficacy of Coagulation Factor IX (Recombinant) can be decreased when used in combination with Anistreplase.,Coagulation Factor IX (Recombinant)
DB01783,The therapeutic efficacy of Pantothenic acid can be decreased when used in combination with Anistreplase.,Pantothenic acid
DB01942,The therapeutic efficacy of Formic acid can be decreased when used in combination with Anistreplase.,Formic acid
DB02261,The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Anistreplase.,Platelet Activating Factor
DB06724,The therapeutic efficacy of Calcium carbonate can be decreased when used in combination with Anistreplase.,Calcium carbonate
DB09109,The therapeutic efficacy of Turoctocog alfa can be decreased when used in combination with Anistreplase.,Turoctocog alfa
DB09222,The therapeutic efficacy of Fibrinogen human can be decreased when used in combination with Anistreplase.,Fibrinogen human
DB09310,The therapeutic efficacy of Catridecacog can be decreased when used in combination with Anistreplase.,Catridecacog
DB09329,"The therapeutic efficacy of Antihemophilic Factor (Recombinant), PEGylated can be decreased when used in combination with Anistreplase.","Antihemophilic Factor (Recombinant), PEGylated"
DB11093,The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Anistreplase.,Calcium citrate
DB11168,The therapeutic efficacy of Calcium threonate can be decreased when used in combination with Anistreplase.,Calcium threonate
DB11311,The therapeutic efficacy of Prothrombin can be decreased when used in combination with Anistreplase.,Prothrombin
DB11330,The therapeutic efficacy of Factor IX Complex (Human) can be decreased when used in combination with Anistreplase.,Factor IX Complex (Human)
DB11348,The therapeutic efficacy of Calcium Phosphate can be decreased when used in combination with Anistreplase.,Calcium Phosphate
DB11606,The therapeutic efficacy of Susoctocog alfa can be decreased when used in combination with Anistreplase.,Susoctocog alfa
DB11668,The therapeutic efficacy of Rusalatide acetate can be decreased when used in combination with Anistreplase.,Rusalatide acetate
DB12409,The therapeutic efficacy of Vatreptacog alfa can be decreased when used in combination with Anistreplase.,Vatreptacog alfa
DB12909,The therapeutic efficacy of Factor XIII (human) can be decreased when used in combination with Anistreplase.,Factor XIII (human)
DB13133,The therapeutic efficacy of Von Willebrand Factor Human can be decreased when used in combination with Anistreplase.,Von Willebrand Factor Human
DB13148,The therapeutic efficacy of Coagulation factor X human can be decreased when used in combination with Anistreplase.,Coagulation factor X human
DB13150,The therapeutic efficacy of Coagulation factor VII human can be decreased when used in combination with Anistreplase.,Coagulation factor VII human
DB13151,The therapeutic efficacy of Anti-inhibitor coagulant complex can be decreased when used in combination with Anistreplase.,Anti-inhibitor coagulant complex
DB13152,The therapeutic efficacy of Coagulation Factor IX Human can be decreased when used in combination with Anistreplase.,Coagulation Factor IX Human
DB13192,The therapeutic efficacy of Antihemophilic factor human can be decreased when used in combination with Anistreplase.,Antihemophilic factor human
DB13197,The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Anistreplase.,Kallidinogenase
DB13201,The therapeutic efficacy of Trenonacog alfa can be decreased when used in combination with Anistreplase.,Trenonacog alfa
DB13933,The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Anistreplase.,Nonacog beta pegol
DB13999,The therapeutic efficacy of Moroctocog alfa can be decreased when used in combination with Anistreplase.,Moroctocog alfa
DB14473,The therapeutic efficacy of Beroctocog alfa can be decreased when used in combination with Anistreplase.,Beroctocog alfa
DB14562,The therapeutic efficacy of Andexanet alfa can be decreased when used in combination with Anistreplase.,Andexanet alfa
DB14577,The therapeutic efficacy of Calcium cation can be decreased when used in combination with Anistreplase.,Calcium cation
DB14700,The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Anistreplase.,Damoctocog alfa pegol
DB00176,The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Anistreplase.,Fluvoxamine
DB00215,The risk or severity of hemorrhage can be increased when Citalopram is combined with Anistreplase.,Citalopram
DB00472,The risk or severity of hemorrhage can be increased when Fluoxetine is combined with Anistreplase.,Fluoxetine
DB00715,The risk or severity of hemorrhage can be increased when Paroxetine is combined with Anistreplase.,Paroxetine
DB01149,The risk or severity of hemorrhage can be increased when Nefazodone is combined with Anistreplase.,Nefazodone
DB04832,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Anistreplase.,Zimelidine
DB04884,The risk or severity of hemorrhage can be increased when Dapoxetine is combined with Anistreplase.,Dapoxetine
DB06731,The risk or severity of hemorrhage can be increased when Seproxetine is combined with Anistreplase.,Seproxetine
DB08953,The risk or severity of hemorrhage can be increased when Indalpine is combined with Anistreplase.,Indalpine
DB12693,The risk or severity of hemorrhage can be increased when Ritanserin is combined with Anistreplase.,Ritanserin
DB13233,The risk or severity of hemorrhage can be increased when Alaproclate is combined with Anistreplase.,Alaproclate
DB00476,The risk or severity of hemorrhage can be increased when Duloxetine is combined with Anistreplase.,Duloxetine
DB01105,The risk or severity of hemorrhage can be increased when Sibutramine is combined with Anistreplase.,Sibutramine
DB04896,The risk or severity of hemorrhage can be increased when Milnacipran is combined with Anistreplase.,Milnacipran
DB06700,The risk or severity of hemorrhage can be increased when Desvenlafaxine is combined with Anistreplase.,Desvenlafaxine
DB08918,The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Anistreplase.,Levomilnacipran
DB00285,Venlafaxine may increase the antiplatelet activities of Anistreplase.,Venlafaxine
DB00182,The risk or severity of bleeding and hemorrhage can be increased when Amphetamine is combined with Anistreplase.,Amphetamine
DB00601,The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Anistreplase.,Linezolid
DB00614,The risk or severity of bleeding and hemorrhage can be increased when Furazolidone is combined with Anistreplase.,Furazolidone
DB00721,The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Anistreplase.,Procaine
DB00752,The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Anistreplase.,Tranylcypromine
DB00780,The risk or severity of bleeding and hemorrhage can be increased when Phenelzine is combined with Anistreplase.,Phenelzine
DB00805,The risk or severity of bleeding and hemorrhage can be increased when Minaprine is combined with Anistreplase.,Minaprine
DB01037,The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Anistreplase.,Selegiline
DB01168,The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Anistreplase.,Procarbazine
DB01171,The risk or severity of bleeding and hemorrhage can be increased when Moclobemide is combined with Anistreplase.,Moclobemide
DB01247,The risk or severity of bleeding and hemorrhage can be increased when Isocarboxazid is combined with Anistreplase.,Isocarboxazid
DB01367,The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Anistreplase.,Rasagiline
DB01626,The risk or severity of bleeding and hemorrhage can be increased when Pargyline is combined with Anistreplase.,Pargyline
DB04017,The risk or severity of bleeding and hemorrhage can be increased when Clorgiline is combined with Anistreplase.,Clorgiline
DB04818,The risk or severity of bleeding and hemorrhage can be increased when Iproniazid is combined with Anistreplase.,Iproniazid
DB04820,The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Anistreplase.,Nialamide
DB06654,The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Anistreplase.,Safinamide
DB08550,"The risk or severity of bleeding and hemorrhage can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Anistreplase.","7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline"
DB09241,The risk or severity of bleeding and hemorrhage can be increased when Methylene blue is combined with Anistreplase.,Methylene blue
DB09243,The risk or severity of bleeding and hemorrhage can be increased when Hydracarbazine is combined with Anistreplase.,Hydracarbazine
DB09244,The risk or severity of bleeding and hemorrhage can be increased when Pirlindole is combined with Anistreplase.,Pirlindole
DB09245,The risk or severity of bleeding and hemorrhage can be increased when Toloxatone is combined with Anistreplase.,Toloxatone
DB09246,The risk or severity of bleeding and hemorrhage can be increased when Benmoxin is combined with Anistreplase.,Benmoxin
DB09248,The risk or severity of bleeding and hemorrhage can be increased when Mebanazine is combined with Anistreplase.,Mebanazine
DB09249,The risk or severity of bleeding and hemorrhage can be increased when Octamoxin is combined with Anistreplase.,Octamoxin
DB09250,The risk or severity of bleeding and hemorrhage can be increased when Pheniprazine is combined with Anistreplase.,Pheniprazine
DB09251,The risk or severity of bleeding and hemorrhage can be increased when Phenoxypropazine is combined with Anistreplase.,Phenoxypropazine
DB09252,The risk or severity of bleeding and hemorrhage can be increased when Pivhydrazine is combined with Anistreplase.,Pivhydrazine
DB09253,The risk or severity of bleeding and hemorrhage can be increased when Safrazine is combined with Anistreplase.,Safrazine
DB09254,The risk or severity of bleeding and hemorrhage can be increased when Caroxazone is combined with Anistreplase.,Caroxazone
DB13875,The risk or severity of bleeding and hemorrhage can be increased when Harmaline is combined with Anistreplase.,Harmaline
DB13876,The risk or severity of bleeding and hemorrhage can be increased when Brofaromine is combined with Anistreplase.,Brofaromine
DB00006,The risk or severity of bleeding can be increased when Bivalirudin is combined with Anistreplase.,Bivalirudin
DB00266,The risk or severity of bleeding can be increased when Dicoumarol is combined with Anistreplase.,Dicoumarol
DB00278,The risk or severity of bleeding can be increased when Argatroban is combined with Anistreplase.,Argatroban
DB00407,The risk or severity of bleeding can be increased when Ardeparin is combined with Anistreplase.,Ardeparin
DB00498,The risk or severity of bleeding can be increased when Phenindione is combined with Anistreplase.,Phenindione
DB00569,The risk or severity of bleeding can be increased when Fondaparinux is combined with Anistreplase.,Fondaparinux
DB00682,The risk or severity of bleeding can be increased when Warfarin is combined with Anistreplase.,Warfarin
DB00946,The risk or severity of bleeding can be increased when Phenprocoumon is combined with Anistreplase.,Phenprocoumon
DB00974,The risk or severity of bleeding can be increased when Edetic acid is combined with Anistreplase.,Edetic acid
DB01109,The risk or severity of bleeding can be increased when Heparin is combined with Anistreplase.,Heparin
DB01225,The risk or severity of bleeding can be increased when Enoxaparin is combined with Anistreplase.,Enoxaparin
DB01418,The risk or severity of bleeding can be increased when Acenocoumarol is combined with Anistreplase.,Acenocoumarol
DB04898,The risk or severity of bleeding can be increased when Ximelagatran is combined with Anistreplase.,Ximelagatran
DB05099,The risk or severity of bleeding can be increased when Ancrod is combined with Anistreplase.,Ancrod
DB06271,The risk or severity of bleeding can be increased when Sulodexide is combined with Anistreplase.,Sulodexide
DB06406,The risk or severity of bleeding can be increased when Idraparinux is combined with Anistreplase.,Idraparinux
DB06635,The risk or severity of bleeding can be increased when Otamixaban is combined with Anistreplase.,Otamixaban
DB06754,The risk or severity of bleeding can be increased when Danaparoid is combined with Anistreplase.,Danaparoid
DB06779,The risk or severity of bleeding can be increased when Dalteparin is combined with Anistreplase.,Dalteparin
DB07767,The risk or severity of bleeding can be increased when Ferulic acid is combined with Anistreplase.,Ferulic acid
DB08794,The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Anistreplase.,Ethyl biscoumacetate
DB08813,The risk or severity of bleeding can be increased when Nadroparin is combined with Anistreplase.,Nadroparin
DB09255,The risk or severity of bleeding can be increased when Dextran is combined with Anistreplase.,Dextran
DB09259,The risk or severity of bleeding can be increased when Reviparin is combined with Anistreplase.,Reviparin
DB09261,The risk or severity of bleeding can be increased when Certoparin is combined with Anistreplase.,Certoparin
DB11095,The risk or severity of bleeding can be increased when Desirudin is combined with Anistreplase.,Desirudin
DB11268,The risk or severity of bleeding can be increased when Protocatechualdehyde is combined with Anistreplase.,Protocatechualdehyde
DB11312,The risk or severity of bleeding can be increased when Protein C is combined with Anistreplase.,Protein C
DB11598,The risk or severity of bleeding can be increased when Antithrombin III human is combined with Anistreplase.,Antithrombin III human
DB11984,The risk or severity of bleeding can be increased when Letaxaban is combined with Anistreplase.,Letaxaban
DB12289,The risk or severity of bleeding can be increased when Darexaban is combined with Anistreplase.,Darexaban
DB12598,The risk or severity of bleeding can be increased when Nafamostat is combined with Anistreplase.,Nafamostat
DB12831,The risk or severity of bleeding can be increased when Gabexate is combined with Anistreplase.,Gabexate
DB13124,The risk or severity of bleeding can be increased when Troxerutin is combined with Anistreplase.,Troxerutin
DB13136,The risk or severity of bleeding can be increased when Fluindione is combined with Anistreplase.,Fluindione
DB13149,The risk or severity of bleeding can be increased when Protein S human is combined with Anistreplase.,Protein S human
DB13616,The risk or severity of bleeding can be increased when Melagatran is combined with Anistreplase.,Melagatran
DB09125,The risk or severity of bleeding can be increased when Potassium citrate is combined with Anistreplase.,Potassium citrate
DB09154,The risk or severity of bleeding can be increased when Sodium citrate is combined with Anistreplase.,Sodium citrate
DB00031,The risk or severity of bleeding can be increased when Tenecteplase is combined with Anistreplase.,Tenecteplase
DB00055,The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Anistreplase.,Drotrecogin alfa
DB06822,The risk or severity of bleeding can be increased when Tinzaparin is combined with Anistreplase.,Tinzaparin
DB13199,The risk or severity of bleeding can be increased when Brinase is combined with Anistreplase.,Brinase
DB13646,The risk or severity of bleeding can be increased when Saruplase is combined with Anistreplase.,Saruplase
DB00086,The risk or severity of bleeding can be increased when Streptokinase is combined with Anistreplase.,Streptokinase
DB04925,The risk or severity of bleeding can be increased when Desmoteplase is combined with Anistreplase.,Desmoteplase
DB05254,The risk or severity of bleeding can be increased when Fibrinolysin is combined with Anistreplase.,Fibrinolysin
DB06543,The risk or severity of bleeding can be increased when Astaxanthin is combined with Anistreplase.,Astaxanthin
DB08994,The risk or severity of bleeding can be increased when Ditazole is combined with Anistreplase.,Ditazole
DB09258,The risk or severity of bleeding can be increased when Bemiparin is combined with Anistreplase.,Bemiparin
DB09260,The risk or severity of bleeding can be increased when Parnaparin is combined with Anistreplase.,Parnaparin
DB13275,The risk or severity of bleeding can be increased when Clorindione is combined with Anistreplase.,Clorindione
DB13347,The risk or severity of bleeding can be increased when Diphenadione is combined with Anistreplase.,Diphenadione
DB13451,The risk or severity of bleeding can be increased when Tioclomarol is combined with Anistreplase.,Tioclomarol
DB00001,The risk or severity of bleeding can be increased when Lepirudin is combined with Anistreplase.,Lepirudin
DB00009,The risk or severity of bleeding can be increased when Alteplase is combined with Anistreplase.,Alteplase
DB00015,The risk or severity of bleeding can be increased when Reteplase is combined with Anistreplase.,Reteplase
DB14094,The risk or severity of bleeding can be increased when Anistreplase is combined with Tocopherylquinone.,Tocopherylquinone
DB06679,The risk or severity of bleeding can be increased when Anistreplase is combined with Amediplase.,Amediplase
DB03410,The risk or severity of bleeding can be increased when Anistreplase is combined with 4-hydroxycoumarin.,4-hydroxycoumarin
DB08496,The risk or severity of bleeding can be increased when Anistreplase is combined with (R)-warfarin.,(R)-warfarin
DB14055,The risk or severity of bleeding can be increased when Anistreplase is combined with (S)-Warfarin.,(S)-Warfarin
DB12364,The risk or severity of bleeding can be increased when Anistreplase is combined with Betrixaban.,Betrixaban
DB14598,The risk or severity of bleeding can be increased when Anistreplase is combined with Edetate calcium disodium anhydrous.,Edetate calcium disodium anhydrous
DB11154,The risk or severity of bleeding can be increased when Anistreplase is combined with Zinc citrate.,Zinc citrate
DB11166,The risk or severity of bleeding can be increased when Anistreplase is combined with Antithrombin Alfa.,Antithrombin Alfa
DB04665,The risk or severity of bleeding can be increased when Anistreplase is combined with Coumarin.,Coumarin
DB14726,The risk or severity of bleeding can be increased when Anistreplase is combined with Dabigatran.,Dabigatran
DB06294,The risk or severity of bleeding can be increased when Anistreplase is combined with Semuloparin.,Semuloparin
DB12726,The risk or severity of bleeding can be increased when Anistreplase is combined with Monteplase.,Monteplase
DB00177,The risk or severity of angioedema can be increased when Anistreplase is combined with Valsartan.,Valsartan
DB00178,The risk or severity of angioedema can be increased when Anistreplase is combined with Ramipril.,Ramipril
DB00230,The risk or severity of angioedema can be increased when Anistreplase is combined with Pregabalin.,Pregabalin
DB00492,The risk or severity of angioedema can be increased when Anistreplase is combined with Fosinopril.,Fosinopril
DB00519,The risk or severity of angioedema can be increased when Anistreplase is combined with Trandolapril.,Trandolapril
DB00542,The risk or severity of angioedema can be increased when Anistreplase is combined with Benazepril.,Benazepril
DB00584,The risk or severity of angioedema can be increased when Anistreplase is combined with Enalapril.,Enalapril
DB00678,The risk or severity of angioedema can be increased when Anistreplase is combined with Losartan.,Losartan
DB00691,The risk or severity of angioedema can be increased when Anistreplase is combined with Moexipril.,Moexipril
DB00722,The risk or severity of angioedema can be increased when Anistreplase is combined with Lisinopril.,Lisinopril
DB00790,The risk or severity of angioedema can be increased when Anistreplase is combined with Perindopril.,Perindopril
DB00876,The risk or severity of angioedema can be increased when Anistreplase is combined with Eprosartan.,Eprosartan
DB00877,The risk or severity of angioedema can be increased when Anistreplase is combined with Sirolimus.,Sirolimus
DB00881,The risk or severity of angioedema can be increased when Anistreplase is combined with Quinapril.,Quinapril
DB00886,The risk or severity of angioedema can be increased when Anistreplase is combined with Omapatrilat.,Omapatrilat
DB00966,The risk or severity of angioedema can be increased when Anistreplase is combined with Telmisartan.,Telmisartan
DB01050,The risk or severity of angioedema can be increased when Anistreplase is combined with Ibuprofen.,Ibuprofen
DB01180,The risk or severity of angioedema can be increased when Anistreplase is combined with Rescinnamine.,Rescinnamine
DB01197,The risk or severity of angioedema can be increased when Anistreplase is combined with Captopril.,Captopril
DB01261,The risk or severity of angioedema can be increased when Anistreplase is combined with Sitagliptin.,Sitagliptin
DB01340,The risk or severity of angioedema can be increased when Anistreplase is combined with Cilazapril.,Cilazapril
DB01342,The risk or severity of angioedema can be increased when Anistreplase is combined with Forasartan.,Forasartan
DB01347,The risk or severity of angioedema can be increased when Anistreplase is combined with Saprisartan.,Saprisartan
DB01348,The risk or severity of angioedema can be increased when Anistreplase is combined with Spirapril.,Spirapril
DB04876,The risk or severity of angioedema can be increased when Anistreplase is combined with Vildagliptin.,Vildagliptin
DB06011,The risk or severity of angioedema can be increased when Anistreplase is combined with AMG-222.,AMG-222
DB06127,The risk or severity of angioedema can be increased when Anistreplase is combined with Bisegliptin.,Bisegliptin
DB06196,The risk or severity of angioedema can be increased when Anistreplase is combined with Icatibant.,Icatibant
DB06203,The risk or severity of angioedema can be increased when Anistreplase is combined with Alogliptin.,Alogliptin
DB06245,The risk or severity of angioedema can be increased when Anistreplase is combined with Lanoteplase.,Lanoteplase
DB06287,The risk or severity of angioedema can be increased when Anistreplase is combined with Temsirolimus.,Temsirolimus
DB06335,The risk or severity of angioedema can be increased when Anistreplase is combined with Saxagliptin.,Saxagliptin
DB08382,The risk or severity of angioedema can be increased when Anistreplase is combined with Gosogliptin.,Gosogliptin
DB08822,The risk or severity of angioedema can be increased when Anistreplase is combined with Azilsartan medoxomil.,Azilsartan medoxomil
DB08836,The risk or severity of angioedema can be increased when Anistreplase is combined with Temocapril.,Temocapril
DB08882,The risk or severity of angioedema can be increased when Anistreplase is combined with Linagliptin.,Linagliptin
DB09292,The risk or severity of angioedema can be increased when Anistreplase is combined with Sacubitril.,Sacubitril
DB09477,The risk or severity of angioedema can be increased when Anistreplase is combined with Enalaprilat.,Enalaprilat
DB11723,The risk or severity of angioedema can be increased when Anistreplase is combined with Dutogliptin.,Dutogliptin
DB11783,The risk or severity of angioedema can be increased when Anistreplase is combined with Imidapril.,Imidapril
DB11950,The risk or severity of angioedema can be increased when Anistreplase is combined with Teneligliptin.,Teneligliptin
DB11992,The risk or severity of angioedema can be increased when Anistreplase is combined with Omarigliptin.,Omarigliptin
DB12268,The risk or severity of angioedema can be increased when Anistreplase is combined with Carmegliptin.,Carmegliptin
DB12412,The risk or severity of angioedema can be increased when Anistreplase is combined with Gemigliptin.,Gemigliptin
DB12417,The risk or severity of angioedema can be increased when Anistreplase is combined with Anagliptin.,Anagliptin
DB12625,The risk or severity of angioedema can be increased when Anistreplase is combined with Evogliptin.,Evogliptin
DB13166,The risk or severity of angioedema can be increased when Anistreplase is combined with Zofenopril.,Zofenopril
DB13312,The risk or severity of angioedema can be increased when Anistreplase is combined with Delapril.,Delapril
DB14125,The risk or severity of angioedema can be increased when Anistreplase is combined with Benazeprilat.,Benazeprilat
DB14207,The risk or severity of angioedema can be increased when Anistreplase is combined with Fosinoprilat.,Fosinoprilat
DB14208,The risk or severity of angioedema can be increased when Anistreplase is combined with Ramiprilat.,Ramiprilat
DB14209,The risk or severity of angioedema can be increased when Anistreplase is combined with Trandolaprilat.,Trandolaprilat
DB14210,The risk or severity of angioedema can be increased when Anistreplase is combined with Moexiprilat.,Moexiprilat
DB14213,The risk or severity of angioedema can be increased when Anistreplase is combined with Perindoprilat.,Perindoprilat
DB14217,The risk or severity of angioedema can be increased when Anistreplase is combined with Quinaprilat.,Quinaprilat
DB14231,The risk or severity of angioedema can be increased when Anistreplase is combined with Quinoline Yellow WS.,Quinoline Yellow WS
DB00203,The risk or severity of hemorrhage can be increased when Anistreplase is combined with Sildenafil.,Sildenafil
DB00008,The risk or severity of bleeding can be increased when Anistreplase is combined with Peginterferon alfa-2a.,Peginterferon alfa-2a
DB00011,The risk or severity of bleeding can be increased when Anistreplase is combined with Interferon alfa-n1.,Interferon alfa-n1
DB00018,The risk or severity of bleeding can be increased when Anistreplase is combined with Interferon alfa-n3.,Interferon alfa-n3
DB00022,The risk or severity of bleeding can be increased when Anistreplase is combined with Peginterferon alfa-2b.,Peginterferon alfa-2b
DB00033,The risk or severity of bleeding can be increased when Anistreplase is combined with Interferon gamma-1b.,Interferon gamma-1b
DB00034,"The risk or severity of bleeding can be increased when Anistreplase is combined with Interferon alfa-2a, Recombinant.","Interferon alfa-2a, Recombinant"
DB00041,The risk or severity of bleeding can be increased when Anistreplase is combined with Aldesleukin.,Aldesleukin
DB00056,The risk or severity of bleeding can be increased when Anistreplase is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin
DB00068,The risk or severity of bleeding can be increased when Anistreplase is combined with Interferon beta-1b.,Interferon beta-1b
DB00069,The risk or severity of bleeding can be increased when Anistreplase is combined with Interferon alfacon-1.,Interferon alfacon-1
DB00073,The risk or severity of bleeding can be increased when Anistreplase is combined with Rituximab.,Rituximab
DB00078,The risk or severity of bleeding can be increased when Anistreplase is combined with Ibritumomab tiuxetan.,Ibritumomab tiuxetan
DB00087,The risk or severity of bleeding can be increased when Anistreplase is combined with Alemtuzumab.,Alemtuzumab
DB00105,The risk or severity of bleeding can be increased when Anistreplase is combined with Interferon alfa-2b.,Interferon alfa-2b
DB00120,The risk or severity of bleeding can be increased when Anistreplase is combined with Phenylalanine.,Phenylalanine
DB00188,The risk or severity of bleeding can be increased when Anistreplase is combined with Bortezomib.,Bortezomib
DB00242,The risk or severity of bleeding can be increased when Anistreplase is combined with Cladribine.,Cladribine
DB00262,The risk or severity of bleeding can be increased when Anistreplase is combined with Carmustine.,Carmustine
DB00276,The risk or severity of bleeding can be increased when Anistreplase is combined with Amsacrine.,Amsacrine
DB00291,The risk or severity of bleeding can be increased when Anistreplase is combined with Chlorambucil.,Chlorambucil
DB00293,The risk or severity of bleeding can be increased when Anistreplase is combined with Raltitrexed.,Raltitrexed
DB00305,The risk or severity of bleeding can be increased when Anistreplase is combined with Mitomycin.,Mitomycin
DB00307,The risk or severity of bleeding can be increased when Anistreplase is combined with Bexarotene.,Bexarotene
DB00309,The risk or severity of bleeding can be increased when Anistreplase is combined with Vindesine.,Vindesine
DB00322,The risk or severity of bleeding can be increased when Anistreplase is combined with Floxuridine.,Floxuridine
DB00352,The risk or severity of bleeding can be increased when Anistreplase is combined with Tioguanine.,Tioguanine
DB00361,The risk or severity of bleeding can be increased when Anistreplase is combined with Vinorelbine.,Vinorelbine
DB00380,The risk or severity of bleeding can be increased when Anistreplase is combined with Dexrazoxane.,Dexrazoxane
DB00398,The risk or severity of bleeding can be increased when Anistreplase is combined with Sorafenib.,Sorafenib
DB00428,The risk or severity of bleeding can be increased when Anistreplase is combined with Streptozocin.,Streptozocin
DB00441,The risk or severity of bleeding can be increased when Anistreplase is combined with Gemcitabine.,Gemcitabine
DB00444,The risk or severity of bleeding can be increased when Anistreplase is combined with Teniposide.,Teniposide
DB00445,The risk or severity of bleeding can be increased when Anistreplase is combined with Epirubicin.,Epirubicin
DB00446,The risk or severity of bleeding can be increased when Anistreplase is combined with Chloramphenicol.,Chloramphenicol
DB00480,The risk or severity of bleeding can be increased when Anistreplase is combined with Lenalidomide.,Lenalidomide
DB00488,The risk or severity of bleeding can be increased when Anistreplase is combined with Altretamine.,Altretamine
DB00495,The risk or severity of bleeding can be increased when Anistreplase is combined with Zidovudine.,Zidovudine
DB00515,The risk or severity of bleeding can be increased when Anistreplase is combined with Cisplatin.,Cisplatin
DB00526,The risk or severity of bleeding can be increased when Anistreplase is combined with Oxaliplatin.,Oxaliplatin
DB00531,The risk or severity of bleeding can be increased when Anistreplase is combined with Cyclophosphamide.,Cyclophosphamide
DB00544,The risk or severity of bleeding can be increased when Anistreplase is combined with Fluorouracil.,Fluorouracil
DB00552,The risk or severity of bleeding can be increased when Anistreplase is combined with Pentostatin.,Pentostatin
DB00563,The risk or severity of bleeding can be increased when Anistreplase is combined with Methotrexate.,Methotrexate
DB00564,The risk or severity of bleeding can be increased when Anistreplase is combined with Carbamazepine.,Carbamazepine
DB00570,The risk or severity of bleeding can be increased when Anistreplase is combined with Vinblastine.,Vinblastine
DB00619,The risk or severity of bleeding can be increased when Anistreplase is combined with Imatinib.,Imatinib
DB00631,The risk or severity of bleeding can be increased when Anistreplase is combined with Clofarabine.,Clofarabine
DB00642,The risk or severity of bleeding can be increased when Anistreplase is combined with Pemetrexed.,Pemetrexed
DB00694,The risk or severity of bleeding can be increased when Anistreplase is combined with Daunorubicin.,Daunorubicin
DB00762,The risk or severity of bleeding can be increased when Anistreplase is combined with Irinotecan.,Irinotecan
DB00773,The risk or severity of bleeding can be increased when Anistreplase is combined with Etoposide.,Etoposide
DB00851,The risk or severity of bleeding can be increased when Anistreplase is combined with Dacarbazine.,Dacarbazine
DB00853,The risk or severity of bleeding can be increased when Anistreplase is combined with Temozolomide.,Temozolomide
DB00859,The risk or severity of bleeding can be increased when Anistreplase is combined with Penicillamine.,Penicillamine
DB00864,The risk or severity of bleeding can be increased when Anistreplase is combined with Tacrolimus.,Tacrolimus
DB00888,The risk or severity of bleeding can be increased when Anistreplase is combined with Mechlorethamine.,Mechlorethamine
DB00928,The risk or severity of bleeding can be increased when Anistreplase is combined with Azacitidine.,Azacitidine
DB00958,The risk or severity of bleeding can be increased when Anistreplase is combined with Carboplatin.,Carboplatin
DB00970,The risk or severity of bleeding can be increased when Anistreplase is combined with Dactinomycin.,Dactinomycin
DB00987,The risk or severity of bleeding can be increased when Anistreplase is combined with Cytarabine.,Cytarabine
DB00997,The risk or severity of bleeding can be increased when Anistreplase is combined with Doxorubicin.,Doxorubicin
DB01005,The risk or severity of bleeding can be increased when Anistreplase is combined with Hydroxyurea.,Hydroxyurea
DB01008,The risk or severity of bleeding can be increased when Anistreplase is combined with Busulfan.,Busulfan
DB01030,The risk or severity of bleeding can be increased when Anistreplase is combined with Topotecan.,Topotecan
DB01033,The risk or severity of bleeding can be increased when Anistreplase is combined with Mercaptopurine.,Mercaptopurine
DB01041,The risk or severity of bleeding can be increased when Anistreplase is combined with Thalidomide.,Thalidomide
DB01042,The risk or severity of bleeding can be increased when Anistreplase is combined with Melphalan.,Melphalan
DB01073,The risk or severity of bleeding can be increased when Anistreplase is combined with Fludarabine.,Fludarabine
DB01099,The risk or severity of bleeding can be increased when Anistreplase is combined with Flucytosine.,Flucytosine
DB01101,The risk or severity of bleeding can be increased when Anistreplase is combined with Capecitabine.,Capecitabine
DB01169,The risk or severity of bleeding can be increased when Anistreplase is combined with Arsenic trioxide.,Arsenic trioxide
DB01177,The risk or severity of bleeding can be increased when Anistreplase is combined with Idarubicin.,Idarubicin
DB01204,The risk or severity of bleeding can be increased when Anistreplase is combined with Mitoxantrone.,Mitoxantrone
DB01206,The risk or severity of bleeding can be increased when Anistreplase is combined with Lomustine.,Lomustine
DB01229,The risk or severity of bleeding can be increased when Anistreplase is combined with Paclitaxel.,Paclitaxel
DB01248,The risk or severity of bleeding can be increased when Anistreplase is combined with Docetaxel.,Docetaxel
DB01262,The risk or severity of bleeding can be increased when Anistreplase is combined with Decitabine.,Decitabine
DB01280,The risk or severity of bleeding can be increased when Anistreplase is combined with Nelarabine.,Nelarabine
DB01590,The risk or severity of bleeding can be increased when Anistreplase is combined with Everolimus.,Everolimus
DB02546,The risk or severity of bleeding can be increased when Anistreplase is combined with Vorinostat.,Vorinostat
DB04572,The risk or severity of bleeding can be increased when Anistreplase is combined with Thiotepa.,Thiotepa
DB04845,The risk or severity of bleeding can be increased when Anistreplase is combined with Ixabepilone.,Ixabepilone
DB04868,The risk or severity of bleeding can be increased when Anistreplase is combined with Nilotinib.,Nilotinib
DB05015,The risk or severity of bleeding can be increased when Anistreplase is combined with Belinostat.,Belinostat
DB05109,The risk or severity of bleeding can be increased when Anistreplase is combined with Trabectedin.,Trabectedin
DB05258,The risk or severity of bleeding can be increased when Anistreplase is combined with Interferon alfa.,Interferon alfa
DB05472,The risk or severity of bleeding can be increased when Anistreplase is combined with omega interferon.,omega interferon
DB05773,The risk or severity of bleeding can be increased when Anistreplase is combined with Trastuzumab emtansine.,Trastuzumab emtansine
DB06616,The risk or severity of bleeding can be increased when Anistreplase is combined with Bosutinib.,Bosutinib
DB06769,The risk or severity of bleeding can be increased when Anistreplase is combined with Bendamustine.,Bendamustine
DB06772,The risk or severity of bleeding can be increased when Anistreplase is combined with Cabazitaxel.,Cabazitaxel
DB08871,The risk or severity of bleeding can be increased when Anistreplase is combined with Eribulin.,Eribulin
DB08877,The risk or severity of bleeding can be increased when Anistreplase is combined with Ruxolitinib.,Ruxolitinib
DB08889,The risk or severity of bleeding can be increased when Anistreplase is combined with Carfilzomib.,Carfilzomib
DB08895,The risk or severity of bleeding can be increased when Anistreplase is combined with Tofacitinib.,Tofacitinib
DB08901,The risk or severity of bleeding can be increased when Anistreplase is combined with Ponatinib.,Ponatinib
DB08910,The risk or severity of bleeding can be increased when Anistreplase is combined with Pomalidomide.,Pomalidomide
DB09042,The risk or severity of bleeding can be increased when Anistreplase is combined with Tedizolid phosphate.,Tedizolid phosphate
DB09052,The risk or severity of bleeding can be increased when Anistreplase is combined with Blinatumomab.,Blinatumomab
DB09073,The risk or severity of bleeding can be increased when Anistreplase is combined with Palbociclib.,Palbociclib
DB09074,The risk or severity of bleeding can be increased when Anistreplase is combined with Olaparib.,Olaparib
DB09077,The risk or severity of bleeding can be increased when Anistreplase is combined with Dinutuximab.,Dinutuximab
DB09122,The risk or severity of bleeding can be increased when Anistreplase is combined with Peginterferon beta-1a.,Peginterferon beta-1a
DB12814,The risk or severity of bleeding can be increased when Anistreplase is combined with Cepeginterferon alfa-2B.,Cepeginterferon alfa-2B
DB00229,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefotiam.,Cefotiam
DB00267,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefmenoxime.,Cefmenoxime
DB00274,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefmetazole.,Cefmetazole
DB00430,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefpiramide.,Cefpiramide
DB00438,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Ceftazidime.,Ceftazidime
DB00447,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Loracarbef.,Loracarbef
DB00456,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefalotin.,Cefalotin
DB00493,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefotaxime.,Cefotaxime
DB00535,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefdinir.,Cefdinir
DB00567,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cephalexin.,Cephalexin
DB00671,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefixime.,Cefixime
DB00689,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cephaloglycin.,Cephaloglycin
DB00833,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefaclor.,Cefaclor
DB00923,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Ceforanide.,Ceforanide
DB01066,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefditoren.,Cefditoren
DB01112,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefuroxime.,Cefuroxime
DB01139,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefapirin.,Cefapirin
DB01140,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefadroxil.,Cefadroxil
DB01150,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefprozil.,Cefprozil
DB01212,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Ceftriaxone.,Ceftriaxone
DB01326,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefamandole.,Cefamandole
DB01327,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefazolin.,Cefazolin
DB01328,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefonicid.,Cefonicid
DB01329,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefoperazone.,Cefoperazone
DB01330,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefotetan.,Cefotetan
DB01331,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefoxitin.,Cefoxitin
DB01332,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Ceftizoxime.,Ceftizoxime
DB01333,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefradine.,Cefradine
DB01413,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefepime.,Cefepime
DB01414,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefacetrile.,Cefacetrile
DB01415,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Ceftibuten.,Ceftibuten
DB01416,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefpodoxime.,Cefpodoxime
DB04570,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Latamoxef.,Latamoxef
DB04918,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Ceftobiprole.,Ceftobiprole
DB06590,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Ceftaroline fosamil.,Ceftaroline fosamil
DB09008,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefaloridine.,Cefaloridine
DB09050,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Ceftolozane.,Ceftolozane
DB09062,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefminox.,Cefminox
DB11367,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefroxadine.,Cefroxadine
DB11935,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Flomoxef.,Flomoxef
DB13266,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefatrizine.,Cefatrizine
DB13461,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefcapene.,Cefcapene
DB13470,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefodizime.,Cefodizime
DB13499,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefsulodin.,Cefsulodin
DB13504,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefetamet.,Cefetamet
DB13638,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefbuperazone.,Cefbuperazone
DB13667,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefozopran.,Cefozopran
DB13682,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefpirome.,Cefpirome
DB13778,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefazedone.,Cefazedone
DB13821,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Ceftezole.,Ceftezole
DB14725,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefamandole nafate.,Cefamandole nafate
DB00254,The risk or severity of bleeding can be increased when Doxycycline is combined with Anistreplase.,Doxycycline
DB00207,The risk or severity of adverse effects can be increased when Azithromycin is combined with Anistreplase.,Azithromycin
DB09539,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Anistreplase.,Omega-3-acid ethyl esters
DB00945,Acetylsalicylic acid may increase the anticoagulant activities of Anistreplase.,Acetylsalicylic acid
DB01606,The risk or severity of bleeding can be increased when Tazobactam is combined with Anistreplase.,Tazobactam
DB00199,The risk or severity of bleeding can be increased when Erythromycin is combined with Anistreplase.,Erythromycin
DB00656,The risk or severity of bleeding can be increased when Trazodone is combined with Anistreplase.,Trazodone
DB00620,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Triamcinolone.,Triamcinolone
DB09079,The risk or severity of bleeding can be increased when Anistreplase is combined with Nintedanib.,Nintedanib
DB01175,The risk or severity of bleeding can be increased when Escitalopram is combined with Anistreplase.,Escitalopram
DB01104,The risk or severity of bleeding can be increased when Sertraline is combined with Anistreplase.,Sertraline
DB00232,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Methyclothiazide.,Methyclothiazide
DB00436,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Bendroflumethiazide.,Bendroflumethiazide
DB00562,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Benzthiazide.,Benzthiazide
DB00606,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cyclothiazide.,Cyclothiazide
DB00774,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Hydroflumethiazide.,Hydroflumethiazide
DB00880,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Chlorothiazide.,Chlorothiazide
DB00999,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Hydrochlorothiazide.,Hydrochlorothiazide
DB01021,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Trichlormethiazide.,Trichlormethiazide
DB01324,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Polythiazide.,Polythiazide
DB13430,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Mebutizide.,Mebutizide
DB13532,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cyclopenthiazide.,Cyclopenthiazide
DB06655,Liraglutide may increase the hypoglycemic activities of Insulin human.,Liraglutide
DB09046,Metreleptin may increase the hypoglycemic activities of Insulin human.,Metreleptin
DB00082,The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Insulin human.,Pegvisomant
DB01132,The risk or severity of adverse effects can be increased when Pioglitazone is combined with Insulin human.,Pioglitazone
DB01278,Pramlintide may increase the hypoglycemic activities of Insulin human.,Pramlintide
DB00412,The risk or severity of congestive heart failure can be increased when Insulin human is combined with Rosiglitazone.,Rosiglitazone
DB00166,The risk or severity of hypoglycemia can be increased when Lipoic acid is combined with Insulin human.,Lipoic acid
DB00974,Edetic acid may increase the hypoglycemic activities of Insulin human.,Edetic acid
DB00187,Esmolol may increase the hypoglycemic activities of Insulin human.,Esmolol
DB00218,The therapeutic efficacy of Insulin human can be increased when used in combination with Moxifloxacin.,Moxifloxacin
DB00365,The therapeutic efficacy of Insulin human can be increased when used in combination with Grepafloxacin.,Grepafloxacin
DB00467,The therapeutic efficacy of Insulin human can be increased when used in combination with Enoxacin.,Enoxacin
DB00487,The therapeutic efficacy of Insulin human can be increased when used in combination with Pefloxacin.,Pefloxacin
DB00537,The therapeutic efficacy of Insulin human can be increased when used in combination with Ciprofloxacin.,Ciprofloxacin
DB00685,The therapeutic efficacy of Insulin human can be increased when used in combination with Trovafloxacin.,Trovafloxacin
DB00779,The therapeutic efficacy of Insulin human can be increased when used in combination with Nalidixic acid.,Nalidixic acid
DB00817,The therapeutic efficacy of Insulin human can be increased when used in combination with Rosoxacin.,Rosoxacin
DB00827,The therapeutic efficacy of Insulin human can be increased when used in combination with Cinoxacin.,Cinoxacin
DB00978,The therapeutic efficacy of Insulin human can be increased when used in combination with Lomefloxacin.,Lomefloxacin
DB01044,The therapeutic efficacy of Insulin human can be increased when used in combination with Gatifloxacin.,Gatifloxacin
DB01059,The therapeutic efficacy of Insulin human can be increased when used in combination with Norfloxacin.,Norfloxacin
DB01137,The therapeutic efficacy of Insulin human can be increased when used in combination with Levofloxacin.,Levofloxacin
DB01155,The therapeutic efficacy of Insulin human can be increased when used in combination with Gemifloxacin.,Gemifloxacin
DB01165,The therapeutic efficacy of Insulin human can be increased when used in combination with Ofloxacin.,Ofloxacin
DB01208,The therapeutic efficacy of Insulin human can be increased when used in combination with Sparfloxacin.,Sparfloxacin
DB01405,The therapeutic efficacy of Insulin human can be increased when used in combination with Temafloxacin.,Temafloxacin
DB04576,The therapeutic efficacy of Insulin human can be increased when used in combination with Fleroxacin.,Fleroxacin
DB05488,The therapeutic efficacy of Insulin human can be increased when used in combination with Technetium Tc-99m ciprofloxacin.,Technetium Tc-99m ciprofloxacin
DB06160,The therapeutic efficacy of Insulin human can be increased when used in combination with Garenoxacin.,Garenoxacin
DB06600,The therapeutic efficacy of Insulin human can be increased when used in combination with Nemonoxacin.,Nemonoxacin
DB08972,The therapeutic efficacy of Insulin human can be increased when used in combination with Flumequine.,Flumequine
DB11404,The therapeutic efficacy of Insulin human can be increased when used in combination with Enrofloxacin.,Enrofloxacin
DB11443,The therapeutic efficacy of Insulin human can be increased when used in combination with Orbifloxacin.,Orbifloxacin
DB11491,The therapeutic efficacy of Insulin human can be increased when used in combination with Sarafloxacin.,Sarafloxacin
DB11511,The therapeutic efficacy of Insulin human can be increased when used in combination with Difloxacin.,Difloxacin
DB11774,The therapeutic efficacy of Insulin human can be increased when used in combination with Pazufloxacin.,Pazufloxacin
DB11892,The therapeutic efficacy of Insulin human can be increased when used in combination with Prulifloxacin.,Prulifloxacin
DB11943,The therapeutic efficacy of Insulin human can be increased when used in combination with Delafloxacin.,Delafloxacin
DB13261,The therapeutic efficacy of Insulin human can be increased when used in combination with Sitafloxacin.,Sitafloxacin
DB13627,The therapeutic efficacy of Insulin human can be increased when used in combination with Oxolinic acid.,Oxolinic acid
DB13772,The therapeutic efficacy of Insulin human can be increased when used in combination with Rufloxacin.,Rufloxacin
DB13823,The therapeutic efficacy of Insulin human can be increased when used in combination with Pipemidic acid.,Pipemidic acid
DB00232,The therapeutic efficacy of Insulin human can be decreased when used in combination with Methyclothiazide.,Methyclothiazide
DB00310,The therapeutic efficacy of Insulin human can be decreased when used in combination with Chlorthalidone.,Chlorthalidone
DB00436,The therapeutic efficacy of Insulin human can be decreased when used in combination with Bendroflumethiazide.,Bendroflumethiazide
DB00524,The therapeutic efficacy of Insulin human can be decreased when used in combination with Metolazone.,Metolazone
DB00562,The therapeutic efficacy of Insulin human can be decreased when used in combination with Benzthiazide.,Benzthiazide
DB00774,The therapeutic efficacy of Insulin human can be decreased when used in combination with Hydroflumethiazide.,Hydroflumethiazide
DB00808,The therapeutic efficacy of Insulin human can be decreased when used in combination with Indapamide.,Indapamide
DB00880,The therapeutic efficacy of Insulin human can be decreased when used in combination with Chlorothiazide.,Chlorothiazide
DB00999,The therapeutic efficacy of Insulin human can be decreased when used in combination with Hydrochlorothiazide.,Hydrochlorothiazide
DB01021,The therapeutic efficacy of Insulin human can be decreased when used in combination with Trichlormethiazide.,Trichlormethiazide
DB01324,The therapeutic efficacy of Insulin human can be decreased when used in combination with Polythiazide.,Polythiazide
DB01325,The therapeutic efficacy of Insulin human can be decreased when used in combination with Quinethazone.,Quinethazone
DB13532,The therapeutic efficacy of Insulin human can be decreased when used in combination with Cyclopenthiazide.,Cyclopenthiazide
DB13989,The therapeutic efficacy of Insulin human can be decreased when used in combination with Epitizide.,Epitizide
DB00344,Protriptyline may decrease the hypoglycemic activities of Insulin human.,Protriptyline
DB00543,Amoxapine may decrease the hypoglycemic activities of Insulin human.,Amoxapine
DB00726,Trimipramine may decrease the hypoglycemic activities of Insulin human.,Trimipramine
DB04836,Amineptine may decrease the hypoglycemic activities of Insulin human.,Amineptine
DB08996,Dimetacrine may decrease the hypoglycemic activities of Insulin human.,Dimetacrine
DB09016,Butriptyline may decrease the hypoglycemic activities of Insulin human.,Butriptyline
DB09167,Dosulepin may decrease the hypoglycemic activities of Insulin human.,Dosulepin
DB09289,Tianeptine may decrease the hypoglycemic activities of Insulin human.,Tianeptine
DB09307,Oxaprotiline may decrease the hypoglycemic activities of Insulin human.,Oxaprotiline
DB12930,Opipramol may decrease the hypoglycemic activities of Insulin human.,Opipramol
DB13114,Amitriptylinoxide may decrease the hypoglycemic activities of Insulin human.,Amitriptylinoxide
DB13225,Dibenzepin may decrease the hypoglycemic activities of Insulin human.,Dibenzepin
DB13246,Quinupramine may decrease the hypoglycemic activities of Insulin human.,Quinupramine
DB13384,Melitracen may decrease the hypoglycemic activities of Insulin human.,Melitracen
DB13411,Lofepramine may decrease the hypoglycemic activities of Insulin human.,Lofepramine
DB13496,Iprindole may decrease the hypoglycemic activities of Insulin human.,Iprindole
DB13782,Imipramine oxide may decrease the hypoglycemic activities of Insulin human.,Imipramine oxide
DB06292,Dapagliflozin may increase the hypoglycemic activities of Insulin human.,Dapagliflozin
DB08907,Canagliflozin may increase the hypoglycemic activities of Insulin human.,Canagliflozin
DB00007,The therapeutic efficacy of Insulin human can be decreased when used in combination with Leuprolide.,Leuprolide
DB00014,The therapeutic efficacy of Insulin human can be decreased when used in combination with Goserelin.,Goserelin
DB00104,The therapeutic efficacy of Insulin human can be decreased when used in combination with Octreotide.,Octreotide
DB00220,The therapeutic efficacy of Insulin human can be decreased when used in combination with Nelfinavir.,Nelfinavir
DB00224,The therapeutic efficacy of Insulin human can be decreased when used in combination with Indinavir.,Indinavir
DB00246,The therapeutic efficacy of Insulin human can be decreased when used in combination with Ziprasidone.,Ziprasidone
DB00294,The therapeutic efficacy of Insulin human can be decreased when used in combination with Etonogestrel.,Etonogestrel
DB00304,The therapeutic efficacy of Insulin human can be decreased when used in combination with Desogestrel.,Desogestrel
DB00334,The therapeutic efficacy of Insulin human can be decreased when used in combination with Olanzapine.,Olanzapine
DB00351,The therapeutic efficacy of Insulin human can be decreased when used in combination with Megestrol acetate.,Megestrol acetate
DB00363,The therapeutic efficacy of Insulin human can be decreased when used in combination with Clozapine.,Clozapine
DB00367,The therapeutic efficacy of Insulin human can be decreased when used in combination with Levonorgestrel.,Levonorgestrel
DB00396,The therapeutic efficacy of Insulin human can be decreased when used in combination with Progesterone.,Progesterone
DB00477,The therapeutic efficacy of Insulin human can be decreased when used in combination with Chlorpromazine.,Chlorpromazine
DB00502,The therapeutic efficacy of Insulin human can be decreased when used in combination with Haloperidol.,Haloperidol
DB00503,The therapeutic efficacy of Insulin human can be decreased when used in combination with Ritonavir.,Ritonavir
DB00592,The therapeutic efficacy of Insulin human can be decreased when used in combination with Piperazine.,Piperazine
DB00603,The therapeutic efficacy of Insulin human can be decreased when used in combination with Medroxyprogesterone acetate.,Medroxyprogesterone acetate
DB00627,The therapeutic efficacy of Insulin human can be decreased when used in combination with Niacin.,Niacin
DB00668,The therapeutic efficacy of Insulin human can be decreased when used in combination with Epinephrine.,Epinephrine
DB00717,The therapeutic efficacy of Insulin human can be decreased when used in combination with Norethisterone.,Norethisterone
DB00734,The therapeutic efficacy of Insulin human can be decreased when used in combination with Risperidone.,Risperidone
DB00738,The therapeutic efficacy of Insulin human can be decreased when used in combination with Pentamidine.,Pentamidine
DB00823,The therapeutic efficacy of Insulin human can be decreased when used in combination with Ethynodiol diacetate.,Ethynodiol diacetate
DB00852,The therapeutic efficacy of Insulin human can be decreased when used in combination with Pseudoephedrine.,Pseudoephedrine
DB00864,The therapeutic efficacy of Insulin human can be decreased when used in combination with Tacrolimus.,Tacrolimus
DB00877,The therapeutic efficacy of Insulin human can be decreased when used in combination with Sirolimus.,Sirolimus
DB00903,The therapeutic efficacy of Insulin human can be decreased when used in combination with Etacrynic acid.,Etacrynic acid
DB00932,The therapeutic efficacy of Insulin human can be decreased when used in combination with Tipranavir.,Tipranavir
DB00957,The therapeutic efficacy of Insulin human can be decreased when used in combination with Norgestimate.,Norgestimate
DB00977,The therapeutic efficacy of Insulin human can be decreased when used in combination with Ethinylestradiol.,Ethinylestradiol
DB01072,The therapeutic efficacy of Insulin human can be decreased when used in combination with Atazanavir.,Atazanavir
DB01169,The therapeutic efficacy of Insulin human can be decreased when used in combination with Arsenic trioxide.,Arsenic trioxide
DB01224,The therapeutic efficacy of Insulin human can be decreased when used in combination with Quetiapine.,Quetiapine
DB01232,The therapeutic efficacy of Insulin human can be decreased when used in combination with Saquinavir.,Saquinavir
DB01238,The therapeutic efficacy of Insulin human can be decreased when used in combination with Aripiprazole.,Aripiprazole
DB01267,The therapeutic efficacy of Insulin human can be decreased when used in combination with Paliperidone.,Paliperidone
DB01319,The therapeutic efficacy of Insulin human can be decreased when used in combination with Fosamprenavir.,Fosamprenavir
DB01323,The therapeutic efficacy of Insulin human can be decreased when used in combination with St. John's Wort.,St. John's Wort
DB01357,The therapeutic efficacy of Insulin human can be decreased when used in combination with Mestranol.,Mestranol
DB01363,The therapeutic efficacy of Insulin human can be decreased when used in combination with Ephedra sinica root.,Ephedra sinica root
DB01395,The therapeutic efficacy of Insulin human can be decreased when used in combination with Drospirenone.,Drospirenone
DB01403,The therapeutic efficacy of Insulin human can be decreased when used in combination with Methotrimeprazine.,Methotrimeprazine
DB01406,The therapeutic efficacy of Insulin human can be decreased when used in combination with Danazol.,Danazol
DB01590,The therapeutic efficacy of Insulin human can be decreased when used in combination with Everolimus.,Everolimus
DB01601,The therapeutic efficacy of Insulin human can be decreased when used in combination with Lopinavir.,Lopinavir
DB01621,The therapeutic efficacy of Insulin human can be decreased when used in combination with Pipotiazine.,Pipotiazine
DB02546,The therapeutic efficacy of Insulin human can be decreased when used in combination with Vorinostat.,Vorinostat
DB04574,The therapeutic efficacy of Insulin human can be decreased when used in combination with Estrone sulfate.,Estrone sulfate
DB04839,The therapeutic efficacy of Insulin human can be decreased when used in combination with Cyproterone acetate.,Cyproterone acetate
DB04868,The therapeutic efficacy of Insulin human can be decreased when used in combination with Nilotinib.,Nilotinib
DB04946,The therapeutic efficacy of Insulin human can be decreased when used in combination with Iloperidone.,Iloperidone
DB06216,The therapeutic efficacy of Insulin human can be decreased when used in combination with Asenapine.,Asenapine
DB06287,The therapeutic efficacy of Insulin human can be decreased when used in combination with Temsirolimus.,Temsirolimus
DB06663,The therapeutic efficacy of Insulin human can be decreased when used in combination with Pasireotide.,Pasireotide
DB06719,The therapeutic efficacy of Insulin human can be decreased when used in combination with Buserelin.,Buserelin
DB06788,The therapeutic efficacy of Insulin human can be decreased when used in combination with Histrelin.,Histrelin
DB06789,The therapeutic efficacy of Insulin human can be decreased when used in combination with Hydroxyprogesterone caproate.,Hydroxyprogesterone caproate
DB06791,The therapeutic efficacy of Insulin human can be decreased when used in combination with Lanreotide.,Lanreotide
DB06825,The therapeutic efficacy of Insulin human can be decreased when used in combination with Triptorelin.,Triptorelin
DB08815,The therapeutic efficacy of Insulin human can be decreased when used in combination with Lurasidone.,Lurasidone
DB08912,The therapeutic efficacy of Insulin human can be decreased when used in combination with Dabrafenib.,Dabrafenib
DB09009,The therapeutic efficacy of Insulin human can be decreased when used in combination with Articaine.,Articaine
DB09063,The therapeutic efficacy of Insulin human can be decreased when used in combination with Ceritinib.,Ceritinib
DB09123,The therapeutic efficacy of Insulin human can be decreased when used in combination with Dienogest.,Dienogest
DB09128,The therapeutic efficacy of Insulin human can be decreased when used in combination with Brexpiprazole.,Brexpiprazole
DB06343,The therapeutic efficacy of Insulin human can be decreased when used in combination with Teprotumumab.,Teprotumumab
DB00621,Oxandrolone may increase the hypoglycemic activities of Insulin human.,Oxandrolone
DB00624,Testosterone may increase the hypoglycemic activities of Insulin human.,Testosterone
DB00984,Nandrolone phenpropionate may increase the hypoglycemic activities of Insulin human.,Nandrolone phenpropionate
DB01185,Fluoxymesterone may increase the hypoglycemic activities of Insulin human.,Fluoxymesterone
DB01420,Testosterone propionate may increase the hypoglycemic activities of Insulin human.,Testosterone propionate
DB02901,Stanolone may increase the hypoglycemic activities of Insulin human.,Stanolone
DB06412,Oxymetholone may increase the hypoglycemic activities of Insulin human.,Oxymetholone
DB06710,Methyltestosterone may increase the hypoglycemic activities of Insulin human.,Methyltestosterone
DB06718,Stanozolol may increase the hypoglycemic activities of Insulin human.,Stanozolol
DB08804,Nandrolone decanoate may increase the hypoglycemic activities of Insulin human.,Nandrolone decanoate
DB12461,GLPG-0492 may increase the hypoglycemic activities of Insulin human.,GLPG-0492
DB13169,Nandrolone may increase the hypoglycemic activities of Insulin human.,Nandrolone
DB13587,Mesterolone may increase the hypoglycemic activities of Insulin human.,Mesterolone
DB13943,Testosterone cypionate may increase the hypoglycemic activities of Insulin human.,Testosterone cypionate
DB13944,Testosterone enanthate may increase the hypoglycemic activities of Insulin human.,Testosterone enanthate
DB00215,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Citalopram.,Citalopram
DB00230,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Pregabalin.,Pregabalin
DB00285,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Venlafaxine.,Venlafaxine
DB00328,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Indomethacin.,Indomethacin
DB01104,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Sertraline.,Sertraline
DB01149,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Nefazodone.,Nefazodone
DB01175,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Escitalopram.,Escitalopram
DB04832,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Zimelidine.,Zimelidine
DB04884,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Dapoxetine.,Dapoxetine
DB04896,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Milnacipran.,Milnacipran
DB06700,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Desvenlafaxine.,Desvenlafaxine
DB08918,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Levomilnacipran.,Levomilnacipran
DB08953,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Indalpine.,Indalpine
DB09270,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Ubidecarenone.,Ubidecarenone
DB12693,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Ritanserin.,Ritanserin
DB13233,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Alaproclate.,Alaproclate
DB13358,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Cibenzoline.,Cibenzoline
DB14025,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Clinafloxacin.,Clinafloxacin
DB09038,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Empagliflozin.,Empagliflozin
DB00233,Aminosalicylic acid may increase the hypoglycemic activities of Insulin human.,Aminosalicylic acid
DB00244,Mesalazine may increase the hypoglycemic activities of Insulin human.,Mesalazine
DB00795,Sulfasalazine may increase the hypoglycemic activities of Insulin human.,Sulfasalazine
DB00861,Diflunisal may increase the hypoglycemic activities of Insulin human.,Diflunisal
DB00936,Salicylic acid may increase the hypoglycemic activities of Insulin human.,Salicylic acid
DB01014,Balsalazide may increase the hypoglycemic activities of Insulin human.,Balsalazide
DB01250,Olsalazine may increase the hypoglycemic activities of Insulin human.,Olsalazine
DB01294,Bismuth subsalicylate may increase the hypoglycemic activities of Insulin human.,Bismuth subsalicylate
DB06251,Dersalazine may increase the hypoglycemic activities of Insulin human.,Dersalazine
DB06807,Phenyl aminosalicylate may increase the hypoglycemic activities of Insulin human.,Phenyl aminosalicylate
DB09543,Methyl salicylate may increase the hypoglycemic activities of Insulin human.,Methyl salicylate
DB11079,Trolamine salicylate may increase the hypoglycemic activities of Insulin human.,Trolamine salicylate
DB12445,Nitroaspirin may increase the hypoglycemic activities of Insulin human.,Nitroaspirin
DB13509,Aloxiprin may increase the hypoglycemic activities of Insulin human.,Aloxiprin
DB13538,Guacetisal may increase the hypoglycemic activities of Insulin human.,Guacetisal
DB13612,Carbaspirin calcium may increase the hypoglycemic activities of Insulin human.,Carbaspirin calcium
DB14006,Choline salicylate may increase the hypoglycemic activities of Insulin human.,Choline salicylate
DB14026,Thiosalicylic acid may increase the hypoglycemic activities of Insulin human.,Thiosalicylic acid
DB01261,Sitagliptin may increase the hypoglycemic activities of Insulin human.,Sitagliptin
DB04876,Vildagliptin may increase the hypoglycemic activities of Insulin human.,Vildagliptin
DB06011,AMG-222 may increase the hypoglycemic activities of Insulin human.,AMG-222
DB06127,Bisegliptin may increase the hypoglycemic activities of Insulin human.,Bisegliptin
DB06203,Alogliptin may increase the hypoglycemic activities of Insulin human.,Alogliptin
DB06335,Saxagliptin may increase the hypoglycemic activities of Insulin human.,Saxagliptin
DB08382,Gosogliptin may increase the hypoglycemic activities of Insulin human.,Gosogliptin
DB08882,Linagliptin may increase the hypoglycemic activities of Insulin human.,Linagliptin
DB11723,Dutogliptin may increase the hypoglycemic activities of Insulin human.,Dutogliptin
DB11950,Teneligliptin may increase the hypoglycemic activities of Insulin human.,Teneligliptin
DB11992,Omarigliptin may increase the hypoglycemic activities of Insulin human.,Omarigliptin
DB12268,Carmegliptin may increase the hypoglycemic activities of Insulin human.,Carmegliptin
DB12412,Gemigliptin may increase the hypoglycemic activities of Insulin human.,Gemigliptin
DB12417,Anagliptin may increase the hypoglycemic activities of Insulin human.,Anagliptin
DB12625,Evogliptin may increase the hypoglycemic activities of Insulin human.,Evogliptin
DB01276,Exenatide may increase the hypoglycemic activities of Insulin human.,Exenatide
DB09043,Albiglutide may increase the hypoglycemic activities of Insulin human.,Albiglutide
DB09045,Dulaglutide may increase the hypoglycemic activities of Insulin human.,Dulaglutide
DB09265,Lixisenatide may increase the hypoglycemic activities of Insulin human.,Lixisenatide
DB13928,Semaglutide may increase the hypoglycemic activities of Insulin human.,Semaglutide
DB14027,Taspoglutide may increase the hypoglycemic activities of Insulin human.,Taspoglutide
DB00752,Tranylcypromine may increase the hypoglycemic activities of Insulin human.,Tranylcypromine
DB00780,Phenelzine may increase the hypoglycemic activities of Insulin human.,Phenelzine
DB01171,Moclobemide may increase the hypoglycemic activities of Insulin human.,Moclobemide
DB01247,Isocarboxazid may increase the hypoglycemic activities of Insulin human.,Isocarboxazid
DB01626,Pargyline may increase the hypoglycemic activities of Insulin human.,Pargyline
DB00805,Minaprine may increase the hypoglycemic activities of Insulin human.,Minaprine
DB04818,Iproniazid may increase the hypoglycemic activities of Insulin human.,Iproniazid
DB04820,Nialamide may increase the hypoglycemic activities of Insulin human.,Nialamide
DB09244,Pirlindole may increase the hypoglycemic activities of Insulin human.,Pirlindole
DB09245,Toloxatone may increase the hypoglycemic activities of Insulin human.,Toloxatone
DB09243,Hydracarbazine may increase the hypoglycemic activities of Insulin human.,Hydracarbazine
DB09241,Methylene blue may increase the hypoglycemic activities of Insulin human.,Methylene blue
DB09246,Benmoxin may increase the hypoglycemic activities of Insulin human.,Benmoxin
DB09248,Mebanazine may increase the hypoglycemic activities of Insulin human.,Mebanazine
DB09249,Octamoxin may increase the hypoglycemic activities of Insulin human.,Octamoxin
DB09250,Pheniprazine may increase the hypoglycemic activities of Insulin human.,Pheniprazine
DB09251,Phenoxypropazine may increase the hypoglycemic activities of Insulin human.,Phenoxypropazine
DB09252,Pivhydrazine may increase the hypoglycemic activities of Insulin human.,Pivhydrazine
DB09253,Safrazine may increase the hypoglycemic activities of Insulin human.,Safrazine
DB09254,Caroxazone may increase the hypoglycemic activities of Insulin human.,Caroxazone
DB00614,Furazolidone may increase the hypoglycemic activities of Insulin human.,Furazolidone
DB08550,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypoglycemic activities of Insulin human.","7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline"
DB13875,Harmaline may increase the hypoglycemic activities of Insulin human.,Harmaline
DB13876,Brofaromine may increase the hypoglycemic activities of Insulin human.,Brofaromine
DB00721,Procaine may increase the hypoglycemic activities of Insulin human.,Procaine
DB00182,Amphetamine may increase the hypoglycemic activities of Insulin human.,Amphetamine
DB01168,Procarbazine may increase the hypoglycemic activities of Insulin human.,Procarbazine
DB00601,Linezolid may increase the hypoglycemic activities of Insulin human.,Linezolid
DB06654,Safinamide may increase the hypoglycemic activities of Insulin human.,Safinamide
DB04017,Clorgiline may increase the hypoglycemic activities of Insulin human.,Clorgiline
DB11827,The therapeutic efficacy of Insulin human can be increased when used in combination with Ertugliflozin.,Ertugliflozin
DB00203,The therapeutic efficacy of Insulin human can be increased when used in combination with Sildenafil.,Sildenafil
DB00214,The therapeutic efficacy of Insulin human can be increased when used in combination with Torasemide.,Torasemide
DB00263,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfisoxazole.,Sulfisoxazole
DB00311,The therapeutic efficacy of Insulin human can be increased when used in combination with Ethoxzolamide.,Ethoxzolamide
DB00359,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfadiazine.,Sulfadiazine
DB00482,The therapeutic efficacy of Insulin human can be increased when used in combination with Celecoxib.,Celecoxib
DB00559,The therapeutic efficacy of Insulin human can be increased when used in combination with Bosentan.,Bosentan
DB00576,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfamethizole.,Sulfamethizole
DB00606,The therapeutic efficacy of Insulin human can be increased when used in combination with Cyclothiazide.,Cyclothiazide
DB00664,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfametopyrazine.,Sulfametopyrazine
DB00669,The therapeutic efficacy of Insulin human can be increased when used in combination with Sumatriptan.,Sumatriptan
DB00695,The therapeutic efficacy of Insulin human can be increased when used in combination with Furosemide.,Furosemide
DB00706,The therapeutic efficacy of Insulin human can be increased when used in combination with Tamsulosin.,Tamsulosin
DB00819,The therapeutic efficacy of Insulin human can be increased when used in combination with Acetazolamide.,Acetazolamide
DB00887,The therapeutic efficacy of Insulin human can be increased when used in combination with Bumetanide.,Bumetanide
DB00891,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfapyridine.,Sulfapyridine
DB00909,The therapeutic efficacy of Insulin human can be increased when used in combination with Zonisamide.,Zonisamide
DB01015,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfamethoxazole.,Sulfamethoxazole
DB01032,The therapeutic efficacy of Insulin human can be increased when used in combination with Probenecid.,Probenecid
DB01098,The therapeutic efficacy of Insulin human can be increased when used in combination with Rosuvastatin.,Rosuvastatin
DB01119,The therapeutic efficacy of Insulin human can be increased when used in combination with Diazoxide.,Diazoxide
DB01144,The therapeutic efficacy of Insulin human can be increased when used in combination with Diclofenamide.,Diclofenamide
DB01264,The therapeutic efficacy of Insulin human can be increased when used in combination with Darunavir.,Darunavir
DB01298,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfacytine.,Sulfacytine
DB01299,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfadoxine.,Sulfadoxine
DB01382,The therapeutic efficacy of Insulin human can be increased when used in combination with Glymidine.,Glymidine
DB01581,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfamerazine.,Sulfamerazine
DB01582,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfamethazine.,Sulfamethazine
DB02925,The therapeutic efficacy of Insulin human can be increased when used in combination with Piretanide.,Piretanide
DB04707,The therapeutic efficacy of Insulin human can be increased when used in combination with Hydroxyfasudil.,Hydroxyfasudil
DB06150,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfadimethoxine.,Sulfadimethoxine
DB06290,The therapeutic efficacy of Insulin human can be increased when used in combination with Simeprevir.,Simeprevir
DB06729,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfaphenazole.,Sulfaphenazole
DB06821,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfameter.,Sulfameter
DB07996,The therapeutic efficacy of Insulin human can be increased when used in combination with 5-(2-methylpiperazine-1-sulfonyl)isoquinoline.,5-(2-methylpiperazine-1-sulfonyl)isoquinoline
DB08162,The therapeutic efficacy of Insulin human can be increased when used in combination with Fasudil.,Fasudil
DB08798,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfamoxole.,Sulfamoxole
DB08881,The therapeutic efficacy of Insulin human can be increased when used in combination with Vemurafenib.,Vemurafenib
DB08961,The therapeutic efficacy of Insulin human can be increased when used in combination with Azosemide.,Azosemide
DB11389,The therapeutic efficacy of Insulin human can be increased when used in combination with Clorsulon.,Clorsulon
DB11461,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfachlorpyridazine.,Sulfachlorpyridazine
DB11462,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfaethoxypyridazine.,Sulfaethoxypyridazine
DB11463,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfanitran.,Sulfanitran
DB11464,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfaquinoxaline.,Sulfaquinoxaline
DB12051,The therapeutic efficacy of Insulin human can be increased when used in combination with Setrobuvir.,Setrobuvir
DB12921,The therapeutic efficacy of Insulin human can be increased when used in combination with Chlorsulfaquinoxaline.,Chlorsulfaquinoxaline
DB13214,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfadicramide.,Sulfadicramide
DB13248,The therapeutic efficacy of Insulin human can be increased when used in combination with Phthalylsulfathiazole.,Phthalylsulfathiazole
DB13283,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfaisodimidine.,Sulfaisodimidine
DB13284,The therapeutic efficacy of Insulin human can be increased when used in combination with Meticrane.,Meticrane
DB13320,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfaperin.,Sulfaperin
DB13405,The therapeutic efficacy of Insulin human can be increased when used in combination with Mefruside.,Mefruside
DB13430,The therapeutic efficacy of Insulin human can be increased when used in combination with Mebutizide.,Mebutizide
DB13485,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfametomidine.,Sulfametomidine
DB13547,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfatolamide.,Sulfatolamide
DB13556,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfamazone.,Sulfamazone
DB13580,The therapeutic efficacy of Insulin human can be increased when used in combination with Succinylsulfathiazole.,Succinylsulfathiazole
DB13617,The therapeutic efficacy of Insulin human can be increased when used in combination with Clorexolone.,Clorexolone
DB13663,The therapeutic efficacy of Insulin human can be increased when used in combination with Clofenamide.,Clofenamide
DB13699,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfathiourea.,Sulfathiourea
DB13708,The therapeutic efficacy of Insulin human can be increased when used in combination with Fenquizone.,Fenquizone
DB13726,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfaguanidine.,Sulfaguanidine
DB13773,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfamethoxypyridazine.,Sulfamethoxypyridazine
DB13792,The therapeutic efficacy of Insulin human can be increased when used in combination with Clopamide.,Clopamide
DB13803,The therapeutic efficacy of Insulin human can be increased when used in combination with Xipamide.,Xipamide
DB14033,The therapeutic efficacy of Insulin human can be increased when used in combination with Acetyl sulfisoxazole.,Acetyl sulfisoxazole
DB14708,The therapeutic efficacy of Insulin human can be increased when used in combination with Tosylchloramide.,Tosylchloramide
DB00703,The therapeutic efficacy of Insulin human can be increased when used in combination with Methazolamide.,Methazolamide
DB06370,The therapeutic efficacy of Insulin human can be increased when used in combination with Indisulam.,Indisulam
DB00176,The metabolism of Fluvoxamine can be increased when combined with Insulin human.,Fluvoxamine
DB00184,The metabolism of Nicotine can be increased when combined with Insulin human.,Nicotine
DB00188,The metabolism of Bortezomib can be increased when combined with Insulin human.,Bortezomib
DB00201,The metabolism of Caffeine can be increased when combined with Insulin human.,Caffeine
DB00261,The metabolism of Anagrelide can be increased when combined with Insulin human.,Anagrelide
DB00262,The metabolism of Carmustine can be increased when combined with Insulin human.,Carmustine
DB00281,The metabolism of Lidocaine can be increased when combined with Insulin human.,Lidocaine
DB00286,The metabolism of Conjugated estrogens can be increased when combined with Insulin human.,Conjugated estrogens
DB00296,The metabolism of Ropivacaine can be increased when combined with Insulin human.,Ropivacaine
DB00315,The metabolism of Zolmitriptan can be increased when combined with Insulin human.,Zolmitriptan
DB00316,The metabolism of Acetaminophen can be increased when combined with Insulin human.,Acetaminophen
DB00356,The metabolism of Chlorzoxazone can be increased when combined with Insulin human.,Chlorzoxazone
DB00370,The metabolism of Mirtazapine can be increased when combined with Insulin human.,Mirtazapine
DB00379,The metabolism of Mexiletine can be increased when combined with Insulin human.,Mexiletine
DB00382,The metabolism of Tacrine can be increased when combined with Insulin human.,Tacrine
DB00384,The metabolism of Triamterene can be increased when combined with Insulin human.,Triamterene
DB00420,The metabolism of Promazine can be increased when combined with Insulin human.,Promazine
DB00425,The metabolism of Zolpidem can be increased when combined with Insulin human.,Zolpidem
DB00442,The metabolism of Entecavir can be increased when combined with Insulin human.,Entecavir
DB00461,The metabolism of Nabumetone can be increased when combined with Insulin human.,Nabumetone
DB00472,The metabolism of Fluoxetine can be increased when combined with Insulin human.,Fluoxetine
DB00476,The metabolism of Duloxetine can be increased when combined with Insulin human.,Duloxetine
DB00499,The metabolism of Flutamide can be increased when combined with Insulin human.,Flutamide
DB00518,The metabolism of Albendazole can be increased when combined with Insulin human.,Albendazole
DB00533,The metabolism of Rofecoxib can be increased when combined with Insulin human.,Rofecoxib
DB00544,The metabolism of Fluorouracil can be increased when combined with Insulin human.,Fluorouracil
DB00568,The metabolism of Cinnarizine can be increased when combined with Insulin human.,Cinnarizine
DB00586,The metabolism of Diclofenac can be increased when combined with Insulin human.,Diclofenac
DB00619,The metabolism of Imatinib can be increased when combined with Insulin human.,Imatinib
DB00629,The metabolism of Guanabenz can be increased when combined with Insulin human.,Guanabenz
DB00642,The metabolism of Pemetrexed can be increased when combined with Insulin human.,Pemetrexed
DB00661,The metabolism of Verapamil can be increased when combined with Insulin human.,Verapamil
DB00715,The metabolism of Paroxetine can be increased when combined with Insulin human.,Paroxetine
DB00730,The metabolism of Thiabendazole can be increased when combined with Insulin human.,Thiabendazole
DB00740,The metabolism of Riluzole can be increased when combined with Insulin human.,Riluzole
DB00744,The metabolism of Zileuton can be increased when combined with Insulin human.,Zileuton
DB00758,The metabolism of Clopidogrel can be increased when combined with Insulin human.,Clopidogrel
DB00787,The metabolism of Acyclovir can be increased when combined with Insulin human.,Acyclovir
DB00788,The metabolism of Naproxen can be increased when combined with Insulin human.,Naproxen
DB00806,The metabolism of Pentoxifylline can be increased when combined with Insulin human.,Pentoxifylline
DB00831,The metabolism of Trifluoperazine can be increased when combined with Insulin human.,Trifluoperazine
DB00850,The metabolism of Perphenazine can be increased when combined with Insulin human.,Perphenazine
DB00857,The metabolism of Terbinafine can be increased when combined with Insulin human.,Terbinafine
DB00863,The metabolism of Ranitidine can be increased when combined with Insulin human.,Ranitidine
DB00898,The metabolism of Ethanol can be increased when combined with Insulin human.,Ethanol
DB00934,The metabolism of Maprotiline can be increased when combined with Insulin human.,Maprotiline
DB00969,The metabolism of Alosetron can be increased when combined with Insulin human.,Alosetron
DB00980,The metabolism of Ramelteon can be increased when combined with Insulin human.,Ramelteon
DB00993,The metabolism of Azathioprine can be increased when combined with Insulin human.,Azathioprine
DB00998,The metabolism of Frovatriptan can be increased when combined with Insulin human.,Frovatriptan
DB01002,The metabolism of Levobupivacaine can be increased when combined with Insulin human.,Levobupivacaine
DB01012,The metabolism of Cinacalcet can be increased when combined with Insulin human.,Cinacalcet
DB01037,The metabolism of Selegiline can be increased when combined with Insulin human.,Selegiline
DB01056,The metabolism of Tocainide can be increased when combined with Insulin human.,Tocainide
DB01058,The metabolism of Praziquantel can be increased when combined with Insulin human.,Praziquantel
DB01065,The metabolism of Melatonin can be increased when combined with Insulin human.,Melatonin
DB01087,The metabolism of Primaquine can be increased when combined with Insulin human.,Primaquine
DB01094,The metabolism of Hesperetin can be increased when combined with Insulin human.,Hesperetin
DB01097,The metabolism of Leflunomide can be increased when combined with Insulin human.,Leflunomide
DB01166,The metabolism of Cilostazol can be increased when combined with Insulin human.,Cilostazol
DB01184,The metabolism of Domperidone can be increased when combined with Insulin human.,Domperidone
DB01191,The metabolism of Dexfenfluramine can be increased when combined with Insulin human.,Dexfenfluramine
DB01303,The metabolism of Oxtriphylline can be increased when combined with Insulin human.,Oxtriphylline
DB01367,The metabolism of Rasagiline can be increased when combined with Insulin human.,Rasagiline
DB01412,The metabolism of Theobromine can be increased when combined with Insulin human.,Theobromine
DB01424,The metabolism of Aminophenazone can be increased when combined with Insulin human.,Aminophenazone
DB01435,The metabolism of Antipyrine can be increased when combined with Insulin human.,Antipyrine
DB01482,The metabolism of Fenethylline can be increased when combined with Insulin human.,Fenethylline
DB01558,The metabolism of Bromazepam can be increased when combined with Insulin human.,Bromazepam
DB01623,The metabolism of Thiothixene can be increased when combined with Insulin human.,Thiothixene
DB01628,The metabolism of Etoricoxib can be increased when combined with Insulin human.,Etoricoxib
DB01645,The metabolism of Genistein can be increased when combined with Insulin human.,Genistein
DB01667,The metabolism of 8-azaguanine can be increased when combined with Insulin human.,8-azaguanine
DB02134,The metabolism of Xanthine can be increased when combined with Insulin human.,Xanthine
DB02489,The metabolism of 9-Methylguanine can be increased when combined with Insulin human.,9-Methylguanine
DB02568,The metabolism of Peldesine can be increased when combined with Insulin human.,Peldesine
DB02709,The metabolism of Resveratrol can be increased when combined with Insulin human.,Resveratrol
DB03783,The metabolism of Phenacetin can be increased when combined with Insulin human.,Phenacetin
DB04076,The metabolism of Hypoxanthine can be increased when combined with Insulin human.,Hypoxanthine
DB04356,The metabolism of 9-Deazaguanine can be increased when combined with Insulin human.,9-Deazaguanine
DB04841,The metabolism of Flunarizine can be increased when combined with Insulin human.,Flunarizine
DB04871,The metabolism of Lorcaserin can be increased when combined with Insulin human.,Lorcaserin
DB04948,The metabolism of Lofexidine can be increased when combined with Insulin human.,Lofexidine
DB04951,The metabolism of Pirfenidone can be increased when combined with Insulin human.,Pirfenidone
DB05676,The metabolism of Apremilast can be increased when combined with Insulin human.,Apremilast
DB06148,The metabolism of Mianserin can be increased when combined with Insulin human.,Mianserin
DB06210,The metabolism of Eltrombopag can be increased when combined with Insulin human.,Eltrombopag
DB06235,The metabolism of Vadimezan can be increased when combined with Insulin human.,Vadimezan
DB06479,The metabolism of Propentofylline can be increased when combined with Insulin human.,Propentofylline
DB06589,The metabolism of Pazopanib can be increased when combined with Insulin human.,Pazopanib
DB06594,The metabolism of Agomelatine can be increased when combined with Insulin human.,Agomelatine
DB06626,The metabolism of Axitinib can be increased when combined with Insulin human.,Axitinib
DB06769,The metabolism of Bendamustine can be increased when combined with Insulin human.,Bendamustine
DB06770,The metabolism of Benzyl alcohol can be increased when combined with Insulin human.,Benzyl alcohol
DB06774,The metabolism of Capsaicin can be increased when combined with Insulin human.,Capsaicin
DB08496,The metabolism of (R)-warfarin can be increased when combined with Insulin human.,(R)-warfarin
DB08883,The metabolism of Perampanel can be increased when combined with Insulin human.,Perampanel
DB09071,The metabolism of Tasimelteon can be increased when combined with Insulin human.,Tasimelteon
DB09118,The metabolism of Stiripentol can be increased when combined with Insulin human.,Stiripentol
DB09225,The metabolism of Zotepine can be increased when combined with Insulin human.,Zotepine
DB09273,The metabolism of Doxofylline can be increased when combined with Insulin human.,Doxofylline
DB09288,The metabolism of Propacetamol can be increased when combined with Insulin human.,Propacetamol
DB09290,The metabolism of Ramosetron can be increased when combined with Insulin human.,Ramosetron
DB11919,The metabolism of 6-O-benzylguanine can be increased when combined with Insulin human.,6-O-benzylguanine
DB11967,The metabolism of Binimetinib can be increased when combined with Insulin human.,Binimetinib
DB12026,The metabolism of Voxilaprevir can be increased when combined with Insulin human.,Voxilaprevir
DB12245,The metabolism of Triclabendazole can be increased when combined with Insulin human.,Triclabendazole
DB12332,The metabolism of Rucaparib can be increased when combined with Insulin human.,Rucaparib
DB12406,The metabolism of Lisofylline can be increased when combined with Insulin human.,Lisofylline
DB12531,The metabolism of Lobucavir can be increased when combined with Insulin human.,Lobucavir
DB12926,The metabolism of Cafedrine can be increased when combined with Insulin human.,Cafedrine
DB12927,The metabolism of Theodrenaline can be increased when combined with Insulin human.,Theodrenaline
DB12945,The metabolism of Dihydralazine can be increased when combined with Insulin human.,Dihydralazine
DB13203,The metabolism of Bamifylline can be increased when combined with Insulin human.,Bamifylline
DB13449,The metabolism of Proxyphylline can be increased when combined with Insulin human.,Proxyphylline
DB13573,The metabolism of Acefylline can be increased when combined with Insulin human.,Acefylline
DB13592,The metabolism of Etamiphylline can be increased when combined with Insulin human.,Etamiphylline
DB13634,The metabolism of Pentifylline can be increased when combined with Insulin human.,Pentifylline
DB13812,The metabolism of Bufylline can be increased when combined with Insulin human.,Bufylline
DB13952,The metabolism of Estradiol acetate can be increased when combined with Insulin human.,Estradiol acetate
DB13953,The metabolism of Estradiol benzoate can be increased when combined with Insulin human.,Estradiol benzoate
DB13954,The metabolism of Estradiol cypionate can be increased when combined with Insulin human.,Estradiol cypionate
DB13955,The metabolism of Estradiol dienanthate can be increased when combined with Insulin human.,Estradiol dienanthate
DB13956,The metabolism of Estradiol valerate can be increased when combined with Insulin human.,Estradiol valerate
DB14018,The metabolism of Bromotheophylline can be increased when combined with Insulin human.,Bromotheophylline
DB14132,The metabolism of 8-chlorotheophylline can be increased when combined with Insulin human.,8-chlorotheophylline
DB01115,The metabolism of Nifedipine can be increased when combined with Insulin human.,Nifedipine
DB11757,The metabolism of Istradefylline can be increased when combined with Insulin human.,Istradefylline
DB00972,The metabolism of Azelastine can be increased when combined with Insulin human.,Azelastine
DB00625,The metabolism of Efavirenz can be increased when combined with Insulin human.,Efavirenz
DB04889,The metabolism of Bicifadine can be increased when combined with Insulin human.,Bicifadine
DB05708,The metabolism of GTS-21 can be increased when combined with Insulin human.,GTS-21
DB01195,The metabolism of Flecainide can be increased when combined with Insulin human.,Flecainide
DB00783,The metabolism of Estradiol can be increased when combined with Insulin human.,Estradiol
DB00321,The metabolism of Amitriptyline can be increased when combined with Insulin human.,Amitriptyline
DB00458,The metabolism of Imipramine can be increased when combined with Insulin human.,Imipramine
DB01142,The metabolism of Doxepin can be increased when combined with Insulin human.,Doxepin
DB00532,The metabolism of Mephenytoin can be increased when combined with Insulin human.,Mephenytoin
DB00540,The metabolism of Nortriptyline can be increased when combined with Insulin human.,Nortriptyline
DB00575,The metabolism of Clonidine can be increased when combined with Insulin human.,Clonidine
DB00924,The metabolism of Cyclobenzaprine can be increased when combined with Insulin human.,Cyclobenzaprine
DB01151,The metabolism of Desipramine can be increased when combined with Insulin human.,Desipramine
DB01242,The metabolism of Clomipramine can be increased when combined with Insulin human.,Clomipramine
DB11689,The metabolism of Selumetinib can be increased when combined with Insulin human.,Selumetinib
DB00277,The metabolism of Theophylline can be increased when combined with Insulin human.,Theophylline
DB00398,The metabolism of Sorafenib can be increased when combined with Insulin human.,Sorafenib
DB00530,The metabolism of Erlotinib can be increased when combined with Insulin human.,Erlotinib
DB00564,The metabolism of Carbamazepine can be increased when combined with Insulin human.,Carbamazepine
DB00682,The metabolism of Warfarin can be increased when combined with Insulin human.,Warfarin
DB00697,The metabolism of Tizanidine can be increased when combined with Insulin human.,Tizanidine
DB00773,The metabolism of Etoposide can be increased when combined with Insulin human.,Etoposide
DB00851,The metabolism of Dacarbazine can be increased when combined with Insulin human.,Dacarbazine
DB01100,The metabolism of Pimozide can be increased when combined with Insulin human.,Pimozide
DB01223,The metabolism of Aminophylline can be increased when combined with Insulin human.,Aminophylline
DB01254,The metabolism of Dasatinib can be increased when combined with Insulin human.,Dasatinib
DB01418,The metabolism of Acenocoumarol can be increased when combined with Insulin human.,Acenocoumarol
DB08910,The metabolism of Pomalidomide can be increased when combined with Insulin human.,Pomalidomide
DB09256,The metabolism of Tegafur can be increased when combined with Insulin human.,Tegafur
DB13874,The metabolism of Enasidenib can be increased when combined with Insulin human.,Enasidenib
DB00675,The metabolism of Tamoxifen can be increased when combined with Insulin human.,Tamoxifen
DB00046,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Insulin lispro.,Insulin lispro
DB00047,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Insulin glargine.,Insulin glargine
DB00071,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Insulin pork.,Insulin pork
DB00197,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Troglitazone.,Troglitazone
DB00222,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Glimepiride.,Glimepiride
DB00280,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Disopyramide.,Disopyramide
DB00284,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Acarbose.,Acarbose
DB00414,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Acetohexamide.,Acetohexamide
DB00468,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Quinine.,Quinine
DB00491,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Miglitol.,Miglitol
DB00672,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Chlorpropamide.,Chlorpropamide
DB00731,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Nateglinide.,Nateglinide
DB00834,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Mifepristone.,Mifepristone
DB00839,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Tolazamide.,Tolazamide
DB00912,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Repaglinide.,Repaglinide
DB00914,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Phenformin.,Phenformin
DB01016,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Glyburide.,Glyburide
DB01067,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Glipizide.,Glipizide
DB01120,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Gliclazide.,Gliclazide
DB01124,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Tolbutamide.,Tolbutamide
DB01200,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Bromocriptine.,Bromocriptine
DB01251,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Gliquidone.,Gliquidone
DB01252,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Mitiglinide.,Mitiglinide
DB01268,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Sunitinib.,Sunitinib
DB01277,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Mecasermin.,Mecasermin
DB01289,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Glisoxepide.,Glisoxepide
DB01306,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Insulin aspart.,Insulin aspart
DB01307,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Insulin detemir.,Insulin detemir
DB01309,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Insulin glulisine.,Insulin glulisine
DB01700,The risk or severity of hypoglycemia can be increased when Insulin human is combined with AICA ribonucleotide.,AICA ribonucleotide
DB04830,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Buformin.,Buformin
DB04878,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Voglibose.,Voglibose
DB05115,The risk or severity of hypoglycemia can be increased when Insulin human is combined with NN344.,NN344
DB05819,The risk or severity of hypoglycemia can be increased when Insulin human is combined with NBI-6024.,NBI-6024
DB08962,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Glibornuride.,Glibornuride
DB09022,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Benfluorex.,Benfluorex
DB09198,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Lobeglitazone.,Lobeglitazone
DB09199,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Netoglitazone.,Netoglitazone
DB09200,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Rivoglitazone.,Rivoglitazone
DB09201,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Ciglitazone.,Ciglitazone
DB09456,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Insulin beef.,Insulin beef
DB09564,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Insulin degludec.,Insulin degludec
DB11567,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Insulin peglispro.,Insulin peglispro
DB11568,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Insulin tregopil.,Insulin tregopil
DB11698,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Ipragliflozin.,Ipragliflozin
DB11780,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Allicin.,Allicin
DB11824,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Tofogliflozin.,Tofogliflozin
DB11898,"The risk or severity of hypoglycemia can be increased when Insulin human is combined with 2,4-thiazolidinedione.","2,4-thiazolidinedione"
DB12713,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Sotagliflozin.,Sotagliflozin
DB12781,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Balaglitazone.,Balaglitazone
DB12935,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Remogliflozin etabonate.,Remogliflozin etabonate
DB13406,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Carbutamide.,Carbutamide
DB13446,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Guar gum.,Guar gum
DB13675,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Metahexamide.,Metahexamide
DB14035,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Englitazone.,Englitazone
DB15171,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Tirzepatide.,Tirzepatide
DB15217,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Gastric inhibitory polypeptide.,Gastric inhibitory polypeptide
DB00270,The risk or severity of hypoglycemia can be increased when Isradipine is combined with Insulin human.,Isradipine
DB00343,The risk or severity of hypoglycemia can be increased when Diltiazem is combined with Insulin human.,Diltiazem
DB00347,The risk or severity of hypoglycemia can be increased when Trimethadione is combined with Insulin human.,Trimethadione
DB00381,The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Insulin human.,Amlodipine
DB00393,The risk or severity of hypoglycemia can be increased when Nimodipine is combined with Insulin human.,Nimodipine
DB00401,The risk or severity of hypoglycemia can be increased when Nisoldipine is combined with Insulin human.,Nisoldipine
DB00528,The risk or severity of hypoglycemia can be increased when Lercanidipine is combined with Insulin human.,Lercanidipine
DB00555,The risk or severity of hypoglycemia can be increased when Lamotrigine is combined with Insulin human.,Lamotrigine
DB00593,The risk or severity of hypoglycemia can be increased when Ethosuximide is combined with Insulin human.,Ethosuximide
DB00622,The risk or severity of hypoglycemia can be increased when Nicardipine is combined with Insulin human.,Nicardipine
DB00653,The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Insulin human.,Magnesium sulfate
DB00836,The risk or severity of hypoglycemia can be increased when Loperamide is combined with Insulin human.,Loperamide
DB01054,The risk or severity of hypoglycemia can be increased when Nitrendipine is combined with Insulin human.,Nitrendipine
DB01074,The risk or severity of hypoglycemia can be increased when Perhexiline is combined with Insulin human.,Perhexiline
DB01244,The risk or severity of hypoglycemia can be increased when Bepridil is combined with Insulin human.,Bepridil
DB01388,The risk or severity of hypoglycemia can be increased when Mibefradil is combined with Insulin human.,Mibefradil
DB04743,The risk or severity of hypoglycemia can be increased when Nimesulide is combined with Insulin human.,Nimesulide
DB04825,The risk or severity of hypoglycemia can be increased when Prenylamine is combined with Insulin human.,Prenylamine
DB04838,The risk or severity of hypoglycemia can be increased when Cyclandelate is combined with Insulin human.,Cyclandelate
DB04842,The risk or severity of hypoglycemia can be increased when Fluspirilene is combined with Insulin human.,Fluspirilene
DB04920,The risk or severity of hypoglycemia can be increased when Clevidipine is combined with Insulin human.,Clevidipine
DB05246,The risk or severity of hypoglycemia can be increased when Methsuximide is combined with Insulin human.,Methsuximide
DB05885,The risk or severity of hypoglycemia can be increased when Seletracetam is combined with Insulin human.,Seletracetam
DB06152,The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Insulin human.,Nylidrin
DB06283,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Insulin human.,Ziconotide
DB06446,The risk or severity of hypoglycemia can be increased when Dotarizine is combined with Insulin human.,Dotarizine
DB06694,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Insulin human.,Xylometazoline
DB06712,The risk or severity of hypoglycemia can be increased when Nilvadipine is combined with Insulin human.,Nilvadipine
DB07615,The risk or severity of hypoglycemia can be increased when Tranilast is combined with Insulin human.,Tranilast
DB08838,The risk or severity of hypoglycemia can be increased when Agmatine is combined with Insulin human.,Agmatine
DB08980,The risk or severity of hypoglycemia can be increased when Fendiline is combined with Insulin human.,Fendiline
DB08992,The risk or severity of hypoglycemia can be increased when Eperisone is combined with Insulin human.,Eperisone
DB09089,The risk or severity of hypoglycemia can be increased when Trimebutine is combined with Insulin human.,Trimebutine
DB09090,The risk or severity of hypoglycemia can be increased when Pinaverium is combined with Insulin human.,Pinaverium
DB09216,The risk or severity of hypoglycemia can be increased when Tolfenamic acid is combined with Insulin human.,Tolfenamic acid
DB09227,The risk or severity of hypoglycemia can be increased when Barnidipine is combined with Insulin human.,Barnidipine
DB09229,The risk or severity of hypoglycemia can be increased when Aranidipine is combined with Insulin human.,Aranidipine
DB09230,The risk or severity of hypoglycemia can be increased when Azelnidipine is combined with Insulin human.,Azelnidipine
DB09231,The risk or severity of hypoglycemia can be increased when Benidipine is combined with Insulin human.,Benidipine
DB09232,The risk or severity of hypoglycemia can be increased when Cilnidipine is combined with Insulin human.,Cilnidipine
DB09234,The risk or severity of hypoglycemia can be increased when Darodipine is combined with Insulin human.,Darodipine
DB09235,The risk or severity of hypoglycemia can be increased when Efonidipine is combined with Insulin human.,Efonidipine
DB09236,The risk or severity of hypoglycemia can be increased when Lacidipine is combined with Insulin human.,Lacidipine
DB09238,The risk or severity of hypoglycemia can be increased when Manidipine is combined with Insulin human.,Manidipine
DB09239,The risk or severity of hypoglycemia can be increased when Niguldipine is combined with Insulin human.,Niguldipine
DB09240,The risk or severity of hypoglycemia can be increased when Niludipine is combined with Insulin human.,Niludipine
DB11960,The risk or severity of hypoglycemia can be increased when Carboxyamidotriazole is combined with Insulin human.,Carboxyamidotriazole
DB12092,The risk or severity of hypoglycemia can be increased when Naftopidil is combined with Insulin human.,Naftopidil
DB12093,The risk or severity of hypoglycemia can be increased when Tetrahydropalmatine is combined with Insulin human.,Tetrahydropalmatine
DB12131,The risk or severity of hypoglycemia can be increased when Vinpocetine is combined with Insulin human.,Vinpocetine
DB12923,The risk or severity of hypoglycemia can be increased when Gallopamil is combined with Insulin human.,Gallopamil
DB13488,The risk or severity of hypoglycemia can be increased when Bencyclane is combined with Insulin human.,Bencyclane
DB13500,The risk or severity of hypoglycemia can be increased when Otilonium is combined with Insulin human.,Otilonium
DB13725,The risk or severity of hypoglycemia can be increased when Terodiline is combined with Insulin human.,Terodiline
DB13766,The risk or severity of hypoglycemia can be increased when Lidoflazine is combined with Insulin human.,Lidoflazine
DB13791,The risk or severity of hypoglycemia can be increased when Penfluridol is combined with Insulin human.,Penfluridol
DB13835,The risk or severity of hypoglycemia can be increased when Caroverine is combined with Insulin human.,Caroverine
DB13950,The risk or severity of hypoglycemia can be increased when WIN 55212-2 is combined with Insulin human.,WIN 55212-2
DB13961,The risk or severity of hypoglycemia can be increased when Fish oil is combined with Insulin human.,Fish oil
DB14063,The risk or severity of hypoglycemia can be increased when Dexverapamil is combined with Insulin human.,Dexverapamil
DB14064,The risk or severity of hypoglycemia can be increased when Emopamil is combined with Insulin human.,Emopamil
DB14065,The risk or severity of hypoglycemia can be increased when Lomerizine is combined with Insulin human.,Lomerizine
DB14066,The risk or severity of hypoglycemia can be increased when Tetrandrine is combined with Insulin human.,Tetrandrine
DB14068,The risk or severity of hypoglycemia can be increased when Dexniguldipine is combined with Insulin human.,Dexniguldipine
DB01023,The risk or severity of hypoglycemia can be increased when Felodipine is combined with Insulin human.,Felodipine
DB01118,The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Insulin human.,Amiodarone
DB00191,The therapeutic efficacy of Insulin human can be increased when used in combination with Phentermine.,Phentermine
DB00268,The metabolism of Ropinirole can be increased when combined with Insulin human.,Ropinirole
DB13074,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Insulin human.,Macimorelin
DB00279,The therapeutic efficacy of Insulin human can be decreased when used in combination with Liothyronine.,Liothyronine
DB00331,The risk or severity of adverse effects can be increased when Insulin human is combined with Metformin.,Metformin
DB00542,The risk or severity of hypoglycemia can be increased when Benazepril is combined with Insulin human.,Benazepril
DB13946,The risk or severity of adverse effects can be increased when Testosterone undecanoate is combined with Insulin human.,Testosterone undecanoate
DB00945,The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Insulin human.,Acetylsalicylic acid
DB00181,The therapeutic efficacy of Insulin human can be decreased when used in combination with Baclofen.,Baclofen
DB00489,The risk or severity of hypoglycemia can be increased when Sotalol is combined with Insulin human.,Sotalol
DB00196,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Fluconazole.,Fluconazole
DB00040,The therapeutic efficacy of Insulin human can be decreased when used in combination with Glucagon.,Glucagon
DB00264,The therapeutic efficacy of Insulin human can be increased when used in combination with Metoprolol.,Metoprolol
DB00335,The therapeutic efficacy of Insulin human can be increased when used in combination with Atenolol.,Atenolol
DB00373,The therapeutic efficacy of Insulin human can be increased when used in combination with Timolol.,Timolol
DB00598,The therapeutic efficacy of Insulin human can be increased when used in combination with Labetalol.,Labetalol
DB00612,The therapeutic efficacy of Insulin human can be increased when used in combination with Bisoprolol.,Bisoprolol
DB00866,The therapeutic efficacy of Insulin human can be increased when used in combination with Alprenolol.,Alprenolol
DB00960,The therapeutic efficacy of Insulin human can be increased when used in combination with Pindolol.,Pindolol
DB01193,The therapeutic efficacy of Insulin human can be increased when used in combination with Acebutolol.,Acebutolol
DB01203,The therapeutic efficacy of Insulin human can be increased when used in combination with Nadolol.,Nadolol
DB01295,The therapeutic efficacy of Insulin human can be increased when used in combination with Bevantolol.,Bevantolol
DB01297,The therapeutic efficacy of Insulin human can be increased when used in combination with Practolol.,Practolol
DB01359,The therapeutic efficacy of Insulin human can be increased when used in combination with Penbutolol.,Penbutolol
DB01580,The therapeutic efficacy of Insulin human can be increased when used in combination with Oxprenolol.,Oxprenolol
DB03322,The therapeutic efficacy of Insulin human can be increased when used in combination with Dexpropranolol.,Dexpropranolol
DB04846,The therapeutic efficacy of Insulin human can be increased when used in combination with Celiprolol.,Celiprolol
DB04861,The therapeutic efficacy of Insulin human can be increased when used in combination with Nebivolol.,Nebivolol
DB06726,The therapeutic efficacy of Insulin human can be increased when used in combination with Bufuralol.,Bufuralol
DB08807,The therapeutic efficacy of Insulin human can be increased when used in combination with Bopindolol.,Bopindolol
DB08808,The therapeutic efficacy of Insulin human can be increased when used in combination with Bupranolol.,Bupranolol
DB08952,The therapeutic efficacy of Insulin human can be increased when used in combination with Indenolol.,Indenolol
DB09013,The therapeutic efficacy of Insulin human can be increased when used in combination with Befunolol.,Befunolol
DB09204,The therapeutic efficacy of Insulin human can be increased when used in combination with Arotinolol.,Arotinolol
DB09351,The therapeutic efficacy of Insulin human can be increased when used in combination with Levobetaxolol.,Levobetaxolol
DB11770,The therapeutic efficacy of Insulin human can be increased when used in combination with Talinolol.,Talinolol
DB11785,The therapeutic efficacy of Insulin human can be increased when used in combination with Anisodamine.,Anisodamine
DB12212,The therapeutic efficacy of Insulin human can be increased when used in combination with Landiolol.,Landiolol
DB12752,The therapeutic efficacy of Insulin human can be increased when used in combination with Bucindolol.,Bucindolol
DB13443,The therapeutic efficacy of Insulin human can be increased when used in combination with Esatenolol.,Esatenolol
DB13508,The therapeutic efficacy of Insulin human can be increased when used in combination with Cloranolol.,Cloranolol
DB13530,The therapeutic efficacy of Insulin human can be increased when used in combination with Mepindolol.,Mepindolol
DB13757,The therapeutic efficacy of Insulin human can be increased when used in combination with Epanolol.,Epanolol
DB13775,The therapeutic efficacy of Insulin human can be increased when used in combination with Tertatolol.,Tertatolol
DB00195,The therapeutic efficacy of Betaxolol can be increased when used in combination with Insulin human.,Betaxolol
DB00571,The therapeutic efficacy of Propranolol can be increased when used in combination with Insulin human.,Propranolol
DB01136,The therapeutic efficacy of Carvedilol can be increased when used in combination with Insulin human.,Carvedilol
DB01182,The therapeutic efficacy of Propafenone can be increased when used in combination with Insulin human.,Propafenone
DB01611,The therapeutic efficacy of Insulin human can be increased when used in combination with Hydroxychloroquine.,Hydroxychloroquine
DB01233,The therapeutic efficacy of Metoclopramide can be increased when used in combination with Insulin human.,Metoclopramide
DB00394,The risk or severity of hyperglycemia can be increased when Beclomethasone dipropionate is combined with Insulin human.,Beclomethasone dipropionate
DB00443,The risk or severity of hyperglycemia can be increased when Betamethasone is combined with Insulin human.,Betamethasone
DB00620,The risk or severity of hyperglycemia can be increased when Triamcinolone is combined with Insulin human.,Triamcinolone
DB00635,The risk or severity of hyperglycemia can be increased when Prednisone is combined with Insulin human.,Prednisone
DB00687,The risk or severity of hyperglycemia can be increased when Fludrocortisone is combined with Insulin human.,Fludrocortisone
DB00741,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Insulin human.,Hydrocortisone
DB00764,The risk or severity of hyperglycemia can be increased when Mometasone is combined with Insulin human.,Mometasone
DB00860,The risk or severity of hyperglycemia can be increased when Prednisolone is combined with Insulin human.,Prednisolone
DB00959,The risk or severity of hyperglycemia can be increased when Methylprednisolone is combined with Insulin human.,Methylprednisolone
DB01234,The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Insulin human.,Dexamethasone
DB01285,The risk or severity of hyperglycemia can be increased when Corticotropin is combined with Insulin human.,Corticotropin
DB01380,The risk or severity of hyperglycemia can be increased when Cortisone acetate is combined with Insulin human.,Cortisone acetate
DB01384,The risk or severity of hyperglycemia can be increased when Paramethasone is combined with Insulin human.,Paramethasone
DB01410,The risk or severity of hyperglycemia can be increased when Ciclesonide is combined with Insulin human.,Ciclesonide
DB08906,The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Insulin human.,Fluticasone furoate
DB08970,The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Insulin human.,Fluprednidene
DB08971,The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Insulin human.,Fluocortolone
DB09383,The risk or severity of hyperglycemia can be increased when Meprednisone is combined with Insulin human.,Meprednisone
DB11487,The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Insulin human.,Dexamethasone isonicotinate
DB11750,The risk or severity of hyperglycemia can be increased when Clobetasol is combined with Insulin human.,Clobetasol
DB11921,The risk or severity of hyperglycemia can be increased when Deflazacort is combined with Insulin human.,Deflazacort
DB13003,The risk or severity of hyperglycemia can be increased when Cortivazol is combined with Insulin human.,Cortivazol
DB13208,The risk or severity of hyperglycemia can be increased when Prednylidene is combined with Insulin human.,Prednylidene
DB13843,The risk or severity of hyperglycemia can be increased when Cloprednol is combined with Insulin human.,Cloprednol
DB13867,The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Insulin human.,Fluticasone
DB14512,The risk or severity of hyperglycemia can be increased when Mometasone furoate is combined with Insulin human.,Mometasone furoate
DB00180,The risk or severity of hyperglycemia can be increased when Flunisolide is combined with Insulin human.,Flunisolide
DB01108,The risk or severity of hyperglycemia can be increased when Trilostane is combined with Insulin human.,Trilostane
DB01222,The risk or severity of hyperglycemia can be increased when Budesonide is combined with Insulin human.,Budesonide
DB04630,The risk or severity of hyperglycemia can be increased when Aldosterone is combined with Insulin human.,Aldosterone
DB09378,The risk or severity of hyperglycemia can be increased when Fluprednisolone is combined with Insulin human.,Fluprednisolone
DB11529,The risk or severity of hyperglycemia can be increased when Melengestrol is combined with Insulin human.,Melengestrol
DB14681,The risk or severity of hyperglycemia can be increased when Cortisone is combined with Insulin human.,Cortisone
DB00223,The risk or severity of hyperglycemia can be increased when Diflorasone is combined with Insulin human.,Diflorasone
DB00240,The risk or severity of hyperglycemia can be increased when Alclometasone is combined with Insulin human.,Alclometasone
DB00253,The risk or severity of hyperglycemia can be increased when Medrysone is combined with Insulin human.,Medrysone
DB00288,The risk or severity of hyperglycemia can be increased when Amcinonide is combined with Insulin human.,Amcinonide
DB00324,The risk or severity of hyperglycemia can be increased when Fluorometholone is combined with Insulin human.,Fluorometholone
DB00547,The risk or severity of hyperglycemia can be increased when Desoximetasone is combined with Insulin human.,Desoximetasone
DB00588,The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Insulin human.,Fluticasone propionate
DB00591,The risk or severity of hyperglycemia can be increased when Fluocinolone acetonide is combined with Insulin human.,Fluocinolone acetonide
DB00596,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Insulin human.,Ulobetasol
DB00663,The risk or severity of hyperglycemia can be increased when Flumethasone is combined with Insulin human.,Flumethasone
DB00838,The risk or severity of hyperglycemia can be increased when Clocortolone is combined with Insulin human.,Clocortolone
DB00846,The risk or severity of hyperglycemia can be increased when Flurandrenolide is combined with Insulin human.,Flurandrenolide
DB14596,The risk or severity of hyperglycemia can be increased when Loteprednol etabonate is combined with Insulin human.,Loteprednol etabonate
DB00896,The risk or severity of hyperglycemia can be increased when Rimexolone is combined with Insulin human.,Rimexolone
DB01013,The risk or severity of hyperglycemia can be increased when Clobetasol propionate is combined with Insulin human.,Clobetasol propionate
DB01047,The risk or severity of hyperglycemia can be increased when Fluocinonide is combined with Insulin human.,Fluocinonide
DB01130,The risk or severity of hyperglycemia can be increased when Prednicarbate is combined with Insulin human.,Prednicarbate
DB01260,The risk or severity of hyperglycemia can be increased when Desonide is combined with Insulin human.,Desonide
DB06781,The risk or severity of hyperglycemia can be increased when Difluprednate is combined with Insulin human.,Difluprednate
DB06786,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Insulin human.,Halcinonide
DB09091,The risk or severity of hyperglycemia can be increased when Tixocortol is combined with Insulin human.,Tixocortol
DB09095,The risk or severity of hyperglycemia can be increased when Difluocortolone is combined with Insulin human.,Difluocortolone
DB13158,The risk or severity of hyperglycemia can be increased when Clobetasone is combined with Insulin human.,Clobetasone
DB13223,The risk or severity of hyperglycemia can be increased when Fluocortin is combined with Insulin human.,Fluocortin
DB13491,The risk or severity of hyperglycemia can be increased when Fluperolone is combined with Insulin human.,Fluperolone
DB13664,The risk or severity of hyperglycemia can be increased when Formocortal is combined with Insulin human.,Formocortal
DB13728,The risk or severity of hyperglycemia can be increased when Halometasone is combined with Insulin human.,Halometasone
DB13856,The risk or severity of hyperglycemia can be increased when Fluclorolone is combined with Insulin human.,Fluclorolone
DB14538,The risk or severity of hyperglycemia can be increased when Hydrocortisone aceponate is combined with Insulin human.,Hydrocortisone aceponate
DB14539,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Insulin human.,Hydrocortisone acetate
DB14540,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Insulin human.,Hydrocortisone butyrate
DB14541,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Insulin human.,Hydrocortisone cypionate
DB14543,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Insulin human.,Hydrocortisone probutate
DB14544,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Insulin human.,Hydrocortisone valerate
DB14545,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Insulin human.,Hydrocortisone succinate
DB00873,The risk or severity of hyperglycemia can be increased when Loteprednol is combined with Insulin human.,Loteprednol
DB14631,The risk or severity of hyperglycemia can be increased when Prednisolone phosphate is combined with Insulin human.,Prednisolone phosphate
DB14633,The risk or severity of hyperglycemia can be increased when Prednisolone hemisuccinate is combined with Insulin human.,Prednisolone hemisuccinate
DB14634,The risk or severity of hyperglycemia can be increased when Fluprednidene acetate is combined with Insulin human.,Fluprednidene acetate
DB14643,The risk or severity of hyperglycemia can be increased when Methylprednisolone aceponate is combined with Insulin human.,Methylprednisolone aceponate
DB14644,The risk or severity of hyperglycemia can be increased when Methylprednisolone hemisuccinate is combined with Insulin human.,Methylprednisolone hemisuccinate
DB14646,The risk or severity of hyperglycemia can be increased when Prednisone acetate is combined with Insulin human.,Prednisone acetate
DB14652,The risk or severity of hyperglycemia can be increased when Clocortolone acetate is combined with Insulin human.,Clocortolone acetate
DB14659,The risk or severity of hyperglycemia can be increased when Melengestrol acetate is combined with Insulin human.,Melengestrol acetate
DB14669,The risk or severity of hyperglycemia can be increased when Betamethasone phosphate is combined with Insulin human.,Betamethasone phosphate
DB15566,The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Insulin human.,Prednisolone acetate
DB00451,The therapeutic efficacy of Insulin human can be decreased when used in combination with Levothyroxine.,Levothyroxine
DB00024,Thyrotropin alfa may decrease the hypoglycemic activities of Insulin human.,Thyrotropin alfa
DB01583,Liotrix may decrease the hypoglycemic activities of Insulin human.,Liotrix
DB03604,Tiratricol may decrease the hypoglycemic activities of Insulin human.,Tiratricol
DB09100,"Thyroid, porcine may decrease the hypoglycemic activities of Insulin human.","Thyroid, porcine"
DB06605,Apixaban may increase the anticoagulant activities of Tenecteplase.,Apixaban
DB06695,Dabigatran etexilate may increase the anticoagulant activities of Tenecteplase.,Dabigatran etexilate
DB01254,The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Tenecteplase.,Dasatinib
DB01609,The risk or severity of gastrointestinal bleeding can be increased when Tenecteplase is combined with Deferasirox.,Deferasirox
DB01586,The risk or severity of bleeding and bruising can be increased when Tenecteplase is combined with Ursodeoxycholic acid.,Ursodeoxycholic acid
DB02123,The risk or severity of bleeding and bruising can be increased when Tenecteplase is combined with Glycochenodeoxycholic Acid.,Glycochenodeoxycholic Acid
DB02659,The risk or severity of bleeding and bruising can be increased when Tenecteplase is combined with Cholic Acid.,Cholic Acid
DB02691,The risk or severity of bleeding and bruising can be increased when Tenecteplase is combined with Glycocholic acid.,Glycocholic acid
DB03619,The risk or severity of bleeding and bruising can be increased when Tenecteplase is combined with Deoxycholic acid.,Deoxycholic acid
DB04348,The risk or severity of bleeding and bruising can be increased when Tenecteplase is combined with Taurocholic acid.,Taurocholic acid
DB05990,The risk or severity of bleeding and bruising can be increased when Tenecteplase is combined with Obeticholic acid.,Obeticholic acid
DB06777,The risk or severity of bleeding and bruising can be increased when Tenecteplase is combined with Chenodeoxycholic acid.,Chenodeoxycholic acid
DB08833,The risk or severity of bleeding and bruising can be increased when Tenecteplase is combined with Taurochenodeoxycholic acid.,Taurochenodeoxycholic acid
DB08834,The risk or severity of bleeding and bruising can be increased when Tenecteplase is combined with Tauroursodeoxycholic acid.,Tauroursodeoxycholic acid
DB08857,The risk or severity of bleeding and bruising can be increased when Tenecteplase is combined with Bamet-UD2.,Bamet-UD2
DB11622,The risk or severity of bleeding and bruising can be increased when Tenecteplase is combined with Dehydrocholic acid.,Dehydrocholic acid
DB11789,The risk or severity of bleeding and bruising can be increased when Tenecteplase is combined with Hyodeoxycholic Acid.,Hyodeoxycholic Acid
DB09075,The risk or severity of bleeding can be increased when Edoxaban is combined with Tenecteplase.,Edoxaban
DB09053,The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with Tenecteplase.,Ibrutinib
DB08935,The risk or severity of bleeding and hemorrhage can be increased when Tenecteplase is combined with Obinutuzumab.,Obinutuzumab
DB06228,Tenecteplase may increase the anticoagulant activities of Rivaroxaban.,Rivaroxaban
DB06206,The risk or severity of bleeding and hemorrhage can be increased when Tenecteplase is combined with Sugammadex.,Sugammadex
DB09070,Tibolone may increase the anticoagulant activities of Tenecteplase.,Tibolone
DB00932,The risk or severity of bleeding and hemorrhage can be increased when Tipranavir is combined with Tenecteplase.,Tipranavir
DB00013,Urokinase may increase the anticoagulant activities of Tenecteplase.,Urokinase
DB00163,Vitamin E may increase the anticoagulant activities of Tenecteplase.,Vitamin E
DB09030,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Tenecteplase.,Vorapaxar
DB06692,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Aprotinin.,Aprotinin
DB01381,The therapeutic efficacy of Tenecteplase can be increased when used in combination with Ginkgo biloba.,Ginkgo biloba
DB01181,The risk or severity of bleeding can be increased when Ifosfamide is combined with Tenecteplase.,Ifosfamide
DB00468,The therapeutic efficacy of Tenecteplase can be increased when used in combination with Quinine.,Quinine
DB00908,The therapeutic efficacy of Tenecteplase can be increased when used in combination with Quinidine.,Quinidine
DB00675,The risk or severity of bleeding can be increased when Tamoxifen is combined with Tenecteplase.,Tamoxifen
DB00539,The risk or severity of bleeding can be increased when Toremifene is combined with Tenecteplase.,Toremifene
DB00806,The therapeutic efficacy of Tenecteplase can be increased when used in combination with Pentoxifylline.,Pentoxifylline
DB00686,Pentosan polysulfate may increase the anticoagulant activities of Tenecteplase.,Pentosan polysulfate
DB00583,The therapeutic efficacy of Tenecteplase can be increased when used in combination with Levocarnitine.,Levocarnitine
DB00255,Diethylstilbestrol may decrease the anticoagulant activities of Tenecteplase.,Diethylstilbestrol
DB00269,Chlorotrianisene may decrease the anticoagulant activities of Tenecteplase.,Chlorotrianisene
DB00286,Conjugated estrogens may decrease the anticoagulant activities of Tenecteplase.,Conjugated estrogens
DB00783,Estradiol may decrease the anticoagulant activities of Tenecteplase.,Estradiol
DB00977,Ethinylestradiol may decrease the anticoagulant activities of Tenecteplase.,Ethinylestradiol
DB01357,Mestranol may decrease the anticoagulant activities of Tenecteplase.,Mestranol
DB04573,Estriol may decrease the anticoagulant activities of Tenecteplase.,Estriol
DB04574,Estrone sulfate may decrease the anticoagulant activities of Tenecteplase.,Estrone sulfate
DB04575,Quinestrol may decrease the anticoagulant activities of Tenecteplase.,Quinestrol
DB07931,Hexestrol may decrease the anticoagulant activities of Tenecteplase.,Hexestrol
DB09317,"Synthetic Conjugated Estrogens, A may decrease the anticoagulant activities of Tenecteplase.","Synthetic Conjugated Estrogens, A"
DB09318,"Synthetic Conjugated Estrogens, B may decrease the anticoagulant activities of Tenecteplase.","Synthetic Conjugated Estrogens, B"
DB09369,Polyestradiol phosphate may decrease the anticoagulant activities of Tenecteplase.,Polyestradiol phosphate
DB09381,Esterified estrogens may decrease the anticoagulant activities of Tenecteplase.,Esterified estrogens
DB11478,Zeranol may decrease the anticoagulant activities of Tenecteplase.,Zeranol
DB11674,Equol may decrease the anticoagulant activities of Tenecteplase.,Equol
DB12487,Promestriene may decrease the anticoagulant activities of Tenecteplase.,Promestriene
DB13143,Methallenestril may decrease the anticoagulant activities of Tenecteplase.,Methallenestril
DB13386,Epimestrol may decrease the anticoagulant activities of Tenecteplase.,Epimestrol
DB13418,Moxestrol may decrease the anticoagulant activities of Tenecteplase.,Moxestrol
DB13952,Estradiol acetate may decrease the anticoagulant activities of Tenecteplase.,Estradiol acetate
DB13953,Estradiol benzoate may decrease the anticoagulant activities of Tenecteplase.,Estradiol benzoate
DB13954,Estradiol cypionate may decrease the anticoagulant activities of Tenecteplase.,Estradiol cypionate
DB13956,Estradiol valerate may decrease the anticoagulant activities of Tenecteplase.,Estradiol valerate
DB15334,Biochanin A may decrease the anticoagulant activities of Tenecteplase.,Biochanin A
DB15335,Formononetin may decrease the anticoagulant activities of Tenecteplase.,Formononetin
DB00159,The risk or severity of bleeding and hemorrhage can be increased when Icosapent is combined with Tenecteplase.,Icosapent
DB00244,The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Tenecteplase.,Mesalazine
DB00328,The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Tenecteplase.,Indomethacin
DB00461,The risk or severity of bleeding and hemorrhage can be increased when Nabumetone is combined with Tenecteplase.,Nabumetone
DB00465,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Tenecteplase.,Ketorolac
DB00469,The risk or severity of bleeding and hemorrhage can be increased when Tenoxicam is combined with Tenecteplase.,Tenoxicam
DB00482,The risk or severity of bleeding and hemorrhage can be increased when Celecoxib is combined with Tenecteplase.,Celecoxib
DB00500,The risk or severity of bleeding and hemorrhage can be increased when Tolmetin is combined with Tenecteplase.,Tolmetin
DB00533,The risk or severity of bleeding and hemorrhage can be increased when Rofecoxib is combined with Tenecteplase.,Rofecoxib
DB00554,The risk or severity of bleeding and hemorrhage can be increased when Piroxicam is combined with Tenecteplase.,Piroxicam
DB00573,The risk or severity of bleeding and hemorrhage can be increased when Fenoprofen is combined with Tenecteplase.,Fenoprofen
DB00580,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Tenecteplase.,Valdecoxib
DB00586,The risk or severity of bleeding and hemorrhage can be increased when Diclofenac is combined with Tenecteplase.,Diclofenac
DB00605,The risk or severity of bleeding and hemorrhage can be increased when Sulindac is combined with Tenecteplase.,Sulindac
DB00712,The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen is combined with Tenecteplase.,Flurbiprofen
DB00749,The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Tenecteplase.,Etodolac
DB00784,The risk or severity of bleeding and hemorrhage can be increased when Mefenamic acid is combined with Tenecteplase.,Mefenamic acid
DB00788,The risk or severity of bleeding and hemorrhage can be increased when Naproxen is combined with Tenecteplase.,Naproxen
DB00795,The risk or severity of bleeding and hemorrhage can be increased when Sulfasalazine is combined with Tenecteplase.,Sulfasalazine
DB00812,The risk or severity of bleeding and hemorrhage can be increased when Phenylbutazone is combined with Tenecteplase.,Phenylbutazone
DB00814,The risk or severity of bleeding and hemorrhage can be increased when Meloxicam is combined with Tenecteplase.,Meloxicam
DB00821,The risk or severity of bleeding and hemorrhage can be increased when Carprofen is combined with Tenecteplase.,Carprofen
DB00861,The risk or severity of bleeding and hemorrhage can be increased when Diflunisal is combined with Tenecteplase.,Diflunisal
DB00936,The risk or severity of bleeding and hemorrhage can be increased when Salicylic acid is combined with Tenecteplase.,Salicylic acid
DB00939,The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Tenecteplase.,Meclofenamic acid
DB00991,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Tenecteplase.,Oxaprozin
DB01009,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Tenecteplase.,Ketoprofen
DB01014,The risk or severity of bleeding and hemorrhage can be increased when Balsalazide is combined with Tenecteplase.,Balsalazide
DB01250,The risk or severity of bleeding and hemorrhage can be increased when Olsalazine is combined with Tenecteplase.,Olsalazine
DB01283,The risk or severity of bleeding and hemorrhage can be increased when Lumiracoxib is combined with Tenecteplase.,Lumiracoxib
DB01397,The risk or severity of bleeding and hemorrhage can be increased when Magnesium salicylate is combined with Tenecteplase.,Magnesium salicylate
DB01399,The risk or severity of bleeding and hemorrhage can be increased when Salsalate is combined with Tenecteplase.,Salsalate
DB01401,The risk or severity of bleeding and hemorrhage can be increased when Choline magnesium trisalicylate is combined with Tenecteplase.,Choline magnesium trisalicylate
DB01419,The risk or severity of bleeding and hemorrhage can be increased when Antrafenine is combined with Tenecteplase.,Antrafenine
DB01424,The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Tenecteplase.,Aminophenazone
DB01435,The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Tenecteplase.,Antipyrine
DB01600,The risk or severity of bleeding and hemorrhage can be increased when Tiaprofenic acid is combined with Tenecteplase.,Tiaprofenic acid
DB01628,The risk or severity of bleeding and hemorrhage can be increased when Etoricoxib is combined with Tenecteplase.,Etoricoxib
DB02224,The risk or severity of bleeding and hemorrhage can be increased when Taxifolin is combined with Tenecteplase.,Taxifolin
DB03585,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Tenecteplase.,Oxyphenbutazone
DB04552,The risk or severity of bleeding and hemorrhage can be increased when Niflumic acid is combined with Tenecteplase.,Niflumic acid
DB04725,The risk or severity of bleeding and hemorrhage can be increased when Licofelone is combined with Tenecteplase.,Licofelone
DB04812,The risk or severity of bleeding and hemorrhage can be increased when Benoxaprofen is combined with Tenecteplase.,Benoxaprofen
DB04817,The risk or severity of bleeding and hemorrhage can be increased when Metamizole is combined with Tenecteplase.,Metamizole
DB04828,The risk or severity of bleeding and hemorrhage can be increased when Zomepirac is combined with Tenecteplase.,Zomepirac
DB05095,The risk or severity of bleeding and hemorrhage can be increased when Cimicoxib is combined with Tenecteplase.,Cimicoxib
DB06725,The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is combined with Tenecteplase.,Lornoxicam
DB06736,The risk or severity of bleeding and hemorrhage can be increased when Aceclofenac is combined with Tenecteplase.,Aceclofenac
DB06737,The risk or severity of bleeding and hemorrhage can be increased when Zaltoprofen is combined with Tenecteplase.,Zaltoprofen
DB07402,The risk or severity of bleeding and hemorrhage can be increased when Azapropazone is combined with Tenecteplase.,Azapropazone
DB07477,The risk or severity of bleeding and hemorrhage can be increased when Felbinac is combined with Tenecteplase.,Felbinac
DB08439,The risk or severity of bleeding and hemorrhage can be increased when Parecoxib is combined with Tenecteplase.,Parecoxib
DB08797,The risk or severity of bleeding and hemorrhage can be increased when Salicylamide is combined with Tenecteplase.,Salicylamide
DB08940,The risk or severity of bleeding and hemorrhage can be increased when Kebuzone is combined with Tenecteplase.,Kebuzone
DB08942,The risk or severity of bleeding and hemorrhage can be increased when Isoxicam is combined with Tenecteplase.,Isoxicam
DB08951,The risk or severity of bleeding and hemorrhage can be increased when Indoprofen is combined with Tenecteplase.,Indoprofen
DB08955,The risk or severity of bleeding and hemorrhage can be increased when Ibuproxam is combined with Tenecteplase.,Ibuproxam
DB08976,The risk or severity of bleeding and hemorrhage can be increased when Floctafenine is combined with Tenecteplase.,Floctafenine
DB08981,The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Tenecteplase.,Fenbufen
DB08984,The risk or severity of bleeding and hemorrhage can be increased when Etofenamate is combined with Tenecteplase.,Etofenamate
DB08991,The risk or severity of bleeding and hemorrhage can be increased when Epirizole is combined with Tenecteplase.,Epirizole
DB09084,The risk or severity of bleeding and hemorrhage can be increased when Benzydamine is combined with Tenecteplase.,Benzydamine
DB09212,The risk or severity of bleeding and hemorrhage can be increased when Loxoprofen is combined with Tenecteplase.,Loxoprofen
DB09214,The risk or severity of bleeding and hemorrhage can be increased when Dexketoprofen is combined with Tenecteplase.,Dexketoprofen
DB09215,The risk or severity of bleeding and hemorrhage can be increased when Droxicam is combined with Tenecteplase.,Droxicam
DB09216,The risk or severity of bleeding and hemorrhage can be increased when Tolfenamic acid is combined with Tenecteplase.,Tolfenamic acid
DB09217,The risk or severity of bleeding and hemorrhage can be increased when Firocoxib is combined with Tenecteplase.,Firocoxib
DB09218,The risk or severity of bleeding and hemorrhage can be increased when Clonixin is combined with Tenecteplase.,Clonixin
DB09285,The risk or severity of bleeding and hemorrhage can be increased when Morniflumate is combined with Tenecteplase.,Morniflumate
DB09288,The risk or severity of bleeding and hemorrhage can be increased when Propacetamol is combined with Tenecteplase.,Propacetamol
DB09295,The risk or severity of bleeding and hemorrhage can be increased when Talniflumate is combined with Tenecteplase.,Talniflumate
DB11455,The risk or severity of bleeding and hemorrhage can be increased when Robenacoxib is combined with Tenecteplase.,Robenacoxib
DB11466,The risk or severity of bleeding and hemorrhage can be increased when Tepoxalin is combined with Tenecteplase.,Tepoxalin
DB11518,The risk or severity of bleeding and hemorrhage can be increased when Flunixin is combined with Tenecteplase.,Flunixin
DB12399,The risk or severity of bleeding and hemorrhage can be increased when Polmacoxib is combined with Tenecteplase.,Polmacoxib
DB12480,The risk or severity of bleeding and hemorrhage can be increased when Betulinic Acid is combined with Tenecteplase.,Betulinic Acid
DB12610,The risk or severity of bleeding and hemorrhage can be increased when Ebselen is combined with Tenecteplase.,Ebselen
DB13001,The risk or severity of bleeding and hemorrhage can be increased when Tinoridine is combined with Tenecteplase.,Tinoridine
DB13167,The risk or severity of bleeding and hemorrhage can be increased when Alclofenac is combined with Tenecteplase.,Alclofenac
DB13217,The risk or severity of bleeding and hemorrhage can be increased when Fentiazac is combined with Tenecteplase.,Fentiazac
DB13232,The risk or severity of bleeding and hemorrhage can be increased when Suxibuzone is combined with Tenecteplase.,Suxibuzone
DB13286,The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with Tenecteplase.,Bumadizone
DB13314,The risk or severity of bleeding and hemorrhage can be increased when Alminoprofen is combined with Tenecteplase.,Alminoprofen
DB13317,The risk or severity of bleeding and hemorrhage can be increased when Flunoxaprofen is combined with Tenecteplase.,Flunoxaprofen
DB13364,The risk or severity of bleeding and hemorrhage can be increased when Feprazone is combined with Tenecteplase.,Feprazone
DB13371,The risk or severity of bleeding and hemorrhage can be increased when Difenpiramide is combined with Tenecteplase.,Difenpiramide
DB13407,The risk or severity of bleeding and hemorrhage can be increased when Nifenazone is combined with Tenecteplase.,Nifenazone
DB13432,The risk or severity of bleeding and hemorrhage can be increased when Lonazolac is combined with Tenecteplase.,Lonazolac
DB13481,The risk or severity of bleeding and hemorrhage can be increased when Tenidap is combined with Tenecteplase.,Tenidap
DB13501,The risk or severity of bleeding and hemorrhage can be increased when Bendazac is combined with Tenecteplase.,Bendazac
DB13514,The risk or severity of bleeding and hemorrhage can be increased when Pranoprofen is combined with Tenecteplase.,Pranoprofen
DB13524,The risk or severity of bleeding and hemorrhage can be increased when Propyphenazone is combined with Tenecteplase.,Propyphenazone
DB13527,The risk or severity of bleeding and hemorrhage can be increased when Proglumetacin is combined with Tenecteplase.,Proglumetacin
DB13538,The risk or severity of bleeding and hemorrhage can be increased when Guacetisal is combined with Tenecteplase.,Guacetisal
DB13544,The risk or severity of bleeding and hemorrhage can be increased when Ethenzamide is combined with Tenecteplase.,Ethenzamide
DB13612,The risk or severity of bleeding and hemorrhage can be increased when Carbaspirin calcium is combined with Tenecteplase.,Carbaspirin calcium
DB13629,The risk or severity of bleeding and hemorrhage can be increased when Mofebutazone is combined with Tenecteplase.,Mofebutazone
DB13649,The risk or severity of bleeding and hemorrhage can be increased when Proquazone is combined with Tenecteplase.,Proquazone
DB13657,The risk or severity of bleeding and hemorrhage can be increased when Benorilate is combined with Tenecteplase.,Benorilate
DB13722,The risk or severity of bleeding and hemorrhage can be increased when Pirprofen is combined with Tenecteplase.,Pirprofen
DB13860,The risk or severity of bleeding and hemorrhage can be increased when Imidazole salicylate is combined with Tenecteplase.,Imidazole salicylate
DB14059,The risk or severity of bleeding and hemorrhage can be increased when SC-236 is combined with Tenecteplase.,SC-236
DB14060,The risk or severity of bleeding and hemorrhage can be increased when NS-398 is combined with Tenecteplase.,NS-398
DB14938,The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen axetil is combined with Tenecteplase.,Flurbiprofen axetil
DB04865,The risk or severity of bleeding can be increased when Tenecteplase is combined with Omacetaxine mepesuccinate.,Omacetaxine mepesuccinate
DB11133,Omega-3 fatty acids may increase the anticoagulant activities of Tenecteplase.,Omega-3 fatty acids
DB00081,The risk or severity of bleeding and hemorrhage can be increased when Tenecteplase is combined with Tositumomab.,Tositumomab
DB09211,The risk or severity of adverse effects can be increased when Limaprost is combined with Tenecteplase.,Limaprost
DB00048,The risk or severity of adverse effects can be increased when Tenecteplase is combined with Collagenase clostridium histolyticum.,Collagenase clostridium histolyticum
DB00389,Carbimazole may increase the anticoagulant activities of Tenecteplase.,Carbimazole
DB00550,Propylthiouracil may increase the anticoagulant activities of Tenecteplase.,Propylthiouracil
DB00763,Methimazole may increase the anticoagulant activities of Tenecteplase.,Methimazole
DB03374,"3,5-Diiodotyrosine may increase the anticoagulant activities of Tenecteplase.","3,5-Diiodotyrosine"
DB06715,Potassium Iodide may increase the anticoagulant activities of Tenecteplase.,Potassium Iodide
DB07637,Dibromotyrosine may increase the anticoagulant activities of Tenecteplase.,Dibromotyrosine
DB09418,Potassium perchlorate may increase the anticoagulant activities of Tenecteplase.,Potassium perchlorate
DB13644,Methylthiouracil may increase the anticoagulant activities of Tenecteplase.,Methylthiouracil
DB13804,Benzylthiouracil may increase the anticoagulant activities of Tenecteplase.,Benzylthiouracil
DB00834,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Mifepristone.,Mifepristone
DB04066,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with p-Coumaric acid.,p-Coumaric acid
DB04682,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Octylphenoxy polyethoxyethanol.,Octylphenoxy polyethoxyethanol
DB05830,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Trestolone.,Trestolone
DB06266,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Lonidamine.,Lonidamine
DB08867,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Ulipristal.,Ulipristal
DB09401,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Isosorbide.,Isosorbide
DB11507,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cloprostenol.,Cloprostenol
DB12025,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Triptolide.,Triptolide
DB13044,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Gossypol.,Gossypol
DB13310,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Ormeloxifene.,Ormeloxifene
DB00294,Etonogestrel may decrease the anticoagulant activities of Tenecteplase.,Etonogestrel
DB00304,Desogestrel may decrease the anticoagulant activities of Tenecteplase.,Desogestrel
DB00351,Megestrol acetate may decrease the anticoagulant activities of Tenecteplase.,Megestrol acetate
DB00367,Levonorgestrel may decrease the anticoagulant activities of Tenecteplase.,Levonorgestrel
DB00378,Dydrogesterone may decrease the anticoagulant activities of Tenecteplase.,Dydrogesterone
DB00396,Progesterone may decrease the anticoagulant activities of Tenecteplase.,Progesterone
DB00603,Medroxyprogesterone acetate may decrease the anticoagulant activities of Tenecteplase.,Medroxyprogesterone acetate
DB00717,Norethisterone may decrease the anticoagulant activities of Tenecteplase.,Norethisterone
DB00823,Ethynodiol diacetate may decrease the anticoagulant activities of Tenecteplase.,Ethynodiol diacetate
DB00957,Norgestimate may decrease the anticoagulant activities of Tenecteplase.,Norgestimate
DB01395,Drospirenone may decrease the anticoagulant activities of Tenecteplase.,Drospirenone
DB01431,Allylestrenol may decrease the anticoagulant activities of Tenecteplase.,Allylestrenol
DB04839,Cyproterone acetate may decrease the anticoagulant activities of Tenecteplase.,Cyproterone acetate
DB06713,Norelgestromin may decrease the anticoagulant activities of Tenecteplase.,Norelgestromin
DB06730,Gestodene may decrease the anticoagulant activities of Tenecteplase.,Gestodene
DB06789,Hydroxyprogesterone caproate may decrease the anticoagulant activities of Tenecteplase.,Hydroxyprogesterone caproate
DB09123,Dienogest may decrease the anticoagulant activities of Tenecteplase.,Dienogest
DB09124,Medrogestone may decrease the anticoagulant activities of Tenecteplase.,Medrogestone
DB09371,Norethynodrel may decrease the anticoagulant activities of Tenecteplase.,Norethynodrel
DB09389,Norgestrel may decrease the anticoagulant activities of Tenecteplase.,Norgestrel
DB11372,Altrenogest may decrease the anticoagulant activities of Tenecteplase.,Altrenogest
DB11619,Gestrinone may decrease the anticoagulant activities of Tenecteplase.,Gestrinone
DB11636,Nomegestrol may decrease the anticoagulant activities of Tenecteplase.,Nomegestrol
DB12474,Lynestrenol may decrease the anticoagulant activities of Tenecteplase.,Lynestrenol
DB13230,Gestonorone may decrease the anticoagulant activities of Tenecteplase.,Gestonorone
DB13528,Chlormadinone may decrease the anticoagulant activities of Tenecteplase.,Chlormadinone
DB13533,Methylestrenolone may decrease the anticoagulant activities of Tenecteplase.,Methylestrenolone
DB13563,Norgestrienone may decrease the anticoagulant activities of Tenecteplase.,Norgestrienone
DB13602,Promegestone may decrease the anticoagulant activities of Tenecteplase.,Promegestone
DB13685,Quingestanol may decrease the anticoagulant activities of Tenecteplase.,Quingestanol
DB13857,Demegestone may decrease the anticoagulant activities of Tenecteplase.,Demegestone
DB13866,Etynodiol may decrease the anticoagulant activities of Tenecteplase.,Etynodiol
DB13981,Nomegestrol acetate may decrease the anticoagulant activities of Tenecteplase.,Nomegestrol acetate
DB14570,Hydroxyprogesterone may decrease the anticoagulant activities of Tenecteplase.,Hydroxyprogesterone
DB14678,Norethindrone enanthate may decrease the anticoagulant activities of Tenecteplase.,Norethindrone enanthate
DB14679,Quingestanol acetate may decrease the anticoagulant activities of Tenecteplase.,Quingestanol acetate
DB00233,The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Tenecteplase.,Aminosalicylic acid
DB01294,The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Tenecteplase.,Bismuth subsalicylate
DB06251,The risk or severity of bleeding can be increased when Dersalazine is combined with Tenecteplase.,Dersalazine
DB06807,The risk or severity of bleeding can be increased when Phenyl aminosalicylate is combined with Tenecteplase.,Phenyl aminosalicylate
DB09543,The risk or severity of bleeding can be increased when Methyl salicylate is combined with Tenecteplase.,Methyl salicylate
DB11079,The risk or severity of bleeding can be increased when Trolamine salicylate is combined with Tenecteplase.,Trolamine salicylate
DB13509,The risk or severity of bleeding can be increased when Aloxiprin is combined with Tenecteplase.,Aloxiprin
DB14006,The risk or severity of bleeding can be increased when Choline salicylate is combined with Tenecteplase.,Choline salicylate
DB14026,The risk or severity of bleeding can be increased when Thiosalicylic acid is combined with Tenecteplase.,Thiosalicylic acid
DB00054,The risk or severity of bleeding can be increased when Abciximab is combined with Tenecteplase.,Abciximab
DB00063,The risk or severity of bleeding can be increased when Eptifibatide is combined with Tenecteplase.,Eptifibatide
DB00208,The risk or severity of bleeding can be increased when Ticlopidine is combined with Tenecteplase.,Ticlopidine
DB00261,The risk or severity of bleeding can be increased when Anagrelide is combined with Tenecteplase.,Anagrelide
DB00758,The risk or severity of bleeding can be increased when Clopidogrel is combined with Tenecteplase.,Clopidogrel
DB00775,The risk or severity of bleeding can be increased when Tirofiban is combined with Tenecteplase.,Tirofiban
DB00975,The risk or severity of bleeding can be increased when Dipyridamole is combined with Tenecteplase.,Dipyridamole
DB01088,The risk or severity of bleeding can be increased when Iloprost is combined with Tenecteplase.,Iloprost
DB01138,The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Tenecteplase.,Sulfinpyrazone
DB01166,The risk or severity of bleeding can be increased when Cilostazol is combined with Tenecteplase.,Cilostazol
DB01207,The risk or severity of bleeding can be increased when Ridogrel is combined with Tenecteplase.,Ridogrel
DB01236,The risk or severity of bleeding can be increased when Sevoflurane is combined with Tenecteplase.,Sevoflurane
DB01240,The risk or severity of bleeding can be increased when Epoprostenol is combined with Tenecteplase.,Epoprostenol
DB02709,The risk or severity of bleeding can be increased when Resveratrol is combined with Tenecteplase.,Resveratrol
DB04743,The risk or severity of bleeding can be increased when Nimesulide is combined with Tenecteplase.,Nimesulide
DB04905,The risk or severity of bleeding can be increased when Tesmilifene is combined with Tenecteplase.,Tesmilifene
DB04932,The risk or severity of bleeding can be increased when Defibrotide is combined with Tenecteplase.,Defibrotide
DB05229,The risk or severity of bleeding can be increased when Beraprost is combined with Tenecteplase.,Beraprost
DB05266,The risk or severity of bleeding can be increased when Ibudilast is combined with Tenecteplase.,Ibudilast
DB05767,The risk or severity of bleeding can be increased when Andrographolide is combined with Tenecteplase.,Andrographolide
DB06081,The risk or severity of bleeding can be increased when Caplacizumab is combined with Tenecteplase.,Caplacizumab
DB06209,The risk or severity of bleeding can be increased when Prasugrel is combined with Tenecteplase.,Prasugrel
DB06441,The risk or severity of bleeding can be increased when Cangrelor is combined with Tenecteplase.,Cangrelor
DB07615,The risk or severity of bleeding can be increased when Tranilast is combined with Tenecteplase.,Tranilast
DB08814,The risk or severity of bleeding can be increased when Triflusal is combined with Tenecteplase.,Triflusal
DB08816,The risk or severity of bleeding can be increased when Ticagrelor is combined with Tenecteplase.,Ticagrelor
DB08887,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Tenecteplase.,Icosapent ethyl
DB09283,The risk or severity of bleeding can be increased when Trapidil is combined with Tenecteplase.,Trapidil
DB12092,The risk or severity of bleeding can be increased when Naftopidil is combined with Tenecteplase.,Naftopidil
DB12163,The risk or severity of bleeding can be increased when Sarpogrelate is combined with Tenecteplase.,Sarpogrelate
DB12321,The risk or severity of bleeding can be increased when Ifetroban is combined with Tenecteplase.,Ifetroban
DB12445,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Tenecteplase.,Nitroaspirin
DB12465,The risk or severity of bleeding can be increased when Ketanserin is combined with Tenecteplase.,Ketanserin
DB12545,The risk or severity of bleeding can be increased when Indobufen is combined with Tenecteplase.,Indobufen
DB12749,The risk or severity of bleeding can be increased when Butylphthalide is combined with Tenecteplase.,Butylphthalide
DB12771,The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Tenecteplase.,Hydroxytyrosol
DB13036,The risk or severity of bleeding can be increased when Ramatroban is combined with Tenecteplase.,Ramatroban
DB13327,The risk or severity of bleeding can be increased when Picotamide is combined with Tenecteplase.,Picotamide
DB13367,The risk or severity of bleeding can be increased when Cloricromen is combined with Tenecteplase.,Cloricromen
DB13400,The risk or severity of bleeding can be increased when Linsidomine is combined with Tenecteplase.,Linsidomine
DB13510,The risk or severity of bleeding can be increased when Buflomedil is combined with Tenecteplase.,Buflomedil
DB13929,The risk or severity of bleeding can be increased when Relcovaptan is combined with Tenecteplase.,Relcovaptan
DB00374,The risk or severity of adverse effects can be increased when Tenecteplase is combined with Treprostinil.,Treprostinil
DB03404,Hemin may increase the anticoagulant activities of Tenecteplase.,Hemin
DB13783,The risk or severity of bleeding and hemorrhage can be increased when Acemetacin is combined with Tenecteplase.,Acemetacin
DB00624,Testosterone may increase the anticoagulant activities of Tenecteplase.,Testosterone
DB01420,Testosterone propionate may increase the anticoagulant activities of Tenecteplase.,Testosterone propionate
DB01481,1-Testosterone may increase the anticoagulant activities of Tenecteplase.,1-Testosterone
DB01485,4-Hydroxytestosterone may increase the anticoagulant activities of Tenecteplase.,4-Hydroxytestosterone
DB01510,Dehydrochloromethyltestosterone may increase the anticoagulant activities of Tenecteplase.,Dehydrochloromethyltestosterone
DB01541,Boldenone may increase the anticoagulant activities of Tenecteplase.,Boldenone
DB01543,18-methyl-19-nortestosterone may increase the anticoagulant activities of Tenecteplase.,18-methyl-19-nortestosterone
DB01564,Calusterone may increase the anticoagulant activities of Tenecteplase.,Calusterone
DB01569,Formebolone may increase the anticoagulant activities of Tenecteplase.,Formebolone
DB01572,Methyl-1-testosterone may increase the anticoagulant activities of Tenecteplase.,Methyl-1-testosterone
DB02901,Stanolone may increase the anticoagulant activities of Tenecteplase.,Stanolone
DB07447,5beta-dihydrotestosterone may increase the anticoagulant activities of Tenecteplase.,5beta-dihydrotestosterone
DB08619,Testosterone succinate may increase the anticoagulant activities of Tenecteplase.,Testosterone succinate
DB11429,Mibolerone may increase the anticoagulant activities of Tenecteplase.,Mibolerone
DB13943,Testosterone cypionate may increase the anticoagulant activities of Tenecteplase.,Testosterone cypionate
DB13944,Testosterone enanthate may increase the anticoagulant activities of Tenecteplase.,Testosterone enanthate
DB13946,Testosterone undecanoate may increase the anticoagulant activities of Tenecteplase.,Testosterone undecanoate
DB13947,Testosterone enantate benzilic acid hydrazone may increase the anticoagulant activities of Tenecteplase.,Testosterone enantate benzilic acid hydrazone
DB13951,Stanolone acetate may increase the anticoagulant activities of Tenecteplase.,Stanolone acetate
DB13958,Trestolone acetate may increase the anticoagulant activities of Tenecteplase.,Trestolone acetate
DB14093,"(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Tenecteplase.","(1,2,6,7-3H)Testosterone"
DB14655,Drostanolone propionate may increase the anticoagulant activities of Tenecteplase.,Drostanolone propionate
DB11051,The risk or severity of adverse effects can be increased when Tenecteplase is combined with Azficel-T.,Azficel-T
DB09568,The therapeutic efficacy of Tenecteplase can be increased when used in combination with Omega-3-carboxylic acids.,Omega-3-carboxylic acids
DB00258,The therapeutic efficacy of Calcium acetate can be decreased when used in combination with Tenecteplase.,Calcium acetate
DB01164,The therapeutic efficacy of Calcium chloride can be decreased when used in combination with Tenecteplase.,Calcium chloride
DB01373,The therapeutic efficacy of Calcium can be decreased when used in combination with Tenecteplase.,Calcium
DB11126,The therapeutic efficacy of Calcium gluconate can be decreased when used in combination with Tenecteplase.,Calcium gluconate
DB11608,The therapeutic efficacy of Eftrenonacog alfa can be decreased when used in combination with Tenecteplase.,Eftrenonacog alfa
DB13884,The therapeutic efficacy of Albutrepenonacog alfa can be decreased when used in combination with Tenecteplase.,Albutrepenonacog alfa
DB13923,The therapeutic efficacy of Emicizumab can be decreased when used in combination with Tenecteplase.,Emicizumab
DB14738,The therapeutic efficacy of Turoctocog alfa pegol can be decreased when used in combination with Tenecteplase.,Turoctocog alfa pegol
DB00025,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Tenecteplase.","Antihemophilic factor, human recombinant"
DB00036,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Tenecteplase.,Coagulation factor VIIa Recombinant Human
DB00100,The therapeutic efficacy of Coagulation Factor IX (Recombinant) can be decreased when used in combination with Tenecteplase.,Coagulation Factor IX (Recombinant)
DB01783,The therapeutic efficacy of Pantothenic acid can be decreased when used in combination with Tenecteplase.,Pantothenic acid
DB01942,The therapeutic efficacy of Formic acid can be decreased when used in combination with Tenecteplase.,Formic acid
DB02261,The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Tenecteplase.,Platelet Activating Factor
DB06724,The therapeutic efficacy of Calcium carbonate can be decreased when used in combination with Tenecteplase.,Calcium carbonate
DB09109,The therapeutic efficacy of Turoctocog alfa can be decreased when used in combination with Tenecteplase.,Turoctocog alfa
DB09222,The therapeutic efficacy of Fibrinogen human can be decreased when used in combination with Tenecteplase.,Fibrinogen human
DB09310,The therapeutic efficacy of Catridecacog can be decreased when used in combination with Tenecteplase.,Catridecacog
DB09329,"The therapeutic efficacy of Antihemophilic Factor (Recombinant), PEGylated can be decreased when used in combination with Tenecteplase.","Antihemophilic Factor (Recombinant), PEGylated"
DB11093,The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Tenecteplase.,Calcium citrate
DB11168,The therapeutic efficacy of Calcium threonate can be decreased when used in combination with Tenecteplase.,Calcium threonate
DB11311,The therapeutic efficacy of Prothrombin can be decreased when used in combination with Tenecteplase.,Prothrombin
DB11330,The therapeutic efficacy of Factor IX Complex (Human) can be decreased when used in combination with Tenecteplase.,Factor IX Complex (Human)
DB11348,The therapeutic efficacy of Calcium Phosphate can be decreased when used in combination with Tenecteplase.,Calcium Phosphate
DB11606,The therapeutic efficacy of Susoctocog alfa can be decreased when used in combination with Tenecteplase.,Susoctocog alfa
DB11668,The therapeutic efficacy of Rusalatide acetate can be decreased when used in combination with Tenecteplase.,Rusalatide acetate
DB12409,The therapeutic efficacy of Vatreptacog alfa can be decreased when used in combination with Tenecteplase.,Vatreptacog alfa
DB12909,The therapeutic efficacy of Factor XIII (human) can be decreased when used in combination with Tenecteplase.,Factor XIII (human)
DB13133,The therapeutic efficacy of Von Willebrand Factor Human can be decreased when used in combination with Tenecteplase.,Von Willebrand Factor Human
DB13148,The therapeutic efficacy of Coagulation factor X human can be decreased when used in combination with Tenecteplase.,Coagulation factor X human
DB13150,The therapeutic efficacy of Coagulation factor VII human can be decreased when used in combination with Tenecteplase.,Coagulation factor VII human
DB13151,The therapeutic efficacy of Anti-inhibitor coagulant complex can be decreased when used in combination with Tenecteplase.,Anti-inhibitor coagulant complex
DB13152,The therapeutic efficacy of Coagulation Factor IX Human can be decreased when used in combination with Tenecteplase.,Coagulation Factor IX Human
DB13192,The therapeutic efficacy of Antihemophilic factor human can be decreased when used in combination with Tenecteplase.,Antihemophilic factor human
DB13197,The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Tenecteplase.,Kallidinogenase
DB13201,The therapeutic efficacy of Trenonacog alfa can be decreased when used in combination with Tenecteplase.,Trenonacog alfa
DB13933,The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Tenecteplase.,Nonacog beta pegol
DB13999,The therapeutic efficacy of Moroctocog alfa can be decreased when used in combination with Tenecteplase.,Moroctocog alfa
DB14473,The therapeutic efficacy of Beroctocog alfa can be decreased when used in combination with Tenecteplase.,Beroctocog alfa
DB14562,The therapeutic efficacy of Andexanet alfa can be decreased when used in combination with Tenecteplase.,Andexanet alfa
DB14577,The therapeutic efficacy of Calcium cation can be decreased when used in combination with Tenecteplase.,Calcium cation
DB14700,The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Tenecteplase.,Damoctocog alfa pegol
DB00176,The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Tenecteplase.,Fluvoxamine
DB00215,The risk or severity of hemorrhage can be increased when Citalopram is combined with Tenecteplase.,Citalopram
DB00472,The risk or severity of hemorrhage can be increased when Fluoxetine is combined with Tenecteplase.,Fluoxetine
DB00715,The risk or severity of hemorrhage can be increased when Paroxetine is combined with Tenecteplase.,Paroxetine
DB01149,The risk or severity of hemorrhage can be increased when Nefazodone is combined with Tenecteplase.,Nefazodone
DB04832,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Tenecteplase.,Zimelidine
DB04884,The risk or severity of hemorrhage can be increased when Dapoxetine is combined with Tenecteplase.,Dapoxetine
DB06731,The risk or severity of hemorrhage can be increased when Seproxetine is combined with Tenecteplase.,Seproxetine
DB08953,The risk or severity of hemorrhage can be increased when Indalpine is combined with Tenecteplase.,Indalpine
DB12693,The risk or severity of hemorrhage can be increased when Ritanserin is combined with Tenecteplase.,Ritanserin
DB13233,The risk or severity of hemorrhage can be increased when Alaproclate is combined with Tenecteplase.,Alaproclate
DB00476,The risk or severity of hemorrhage can be increased when Duloxetine is combined with Tenecteplase.,Duloxetine
DB01105,The risk or severity of hemorrhage can be increased when Sibutramine is combined with Tenecteplase.,Sibutramine
DB04896,The risk or severity of hemorrhage can be increased when Milnacipran is combined with Tenecteplase.,Milnacipran
DB06700,The risk or severity of hemorrhage can be increased when Desvenlafaxine is combined with Tenecteplase.,Desvenlafaxine
DB08918,The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Tenecteplase.,Levomilnacipran
DB00285,Venlafaxine may increase the antiplatelet activities of Tenecteplase.,Venlafaxine
DB00182,The risk or severity of bleeding and hemorrhage can be increased when Amphetamine is combined with Tenecteplase.,Amphetamine
DB00601,The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Tenecteplase.,Linezolid
DB00614,The risk or severity of bleeding and hemorrhage can be increased when Furazolidone is combined with Tenecteplase.,Furazolidone
DB00721,The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Tenecteplase.,Procaine
DB00752,The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Tenecteplase.,Tranylcypromine
DB00780,The risk or severity of bleeding and hemorrhage can be increased when Phenelzine is combined with Tenecteplase.,Phenelzine
DB00805,The risk or severity of bleeding and hemorrhage can be increased when Minaprine is combined with Tenecteplase.,Minaprine
DB01037,The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Tenecteplase.,Selegiline
DB01168,The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Tenecteplase.,Procarbazine
DB01171,The risk or severity of bleeding and hemorrhage can be increased when Moclobemide is combined with Tenecteplase.,Moclobemide
DB01247,The risk or severity of bleeding and hemorrhage can be increased when Isocarboxazid is combined with Tenecteplase.,Isocarboxazid
DB01367,The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Tenecteplase.,Rasagiline
DB01626,The risk or severity of bleeding and hemorrhage can be increased when Pargyline is combined with Tenecteplase.,Pargyline
DB04017,The risk or severity of bleeding and hemorrhage can be increased when Clorgiline is combined with Tenecteplase.,Clorgiline
DB04818,The risk or severity of bleeding and hemorrhage can be increased when Iproniazid is combined with Tenecteplase.,Iproniazid
DB04820,The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Tenecteplase.,Nialamide
DB06654,The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Tenecteplase.,Safinamide
DB08550,"The risk or severity of bleeding and hemorrhage can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Tenecteplase.","7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline"
DB09241,The risk or severity of bleeding and hemorrhage can be increased when Methylene blue is combined with Tenecteplase.,Methylene blue
DB09243,The risk or severity of bleeding and hemorrhage can be increased when Hydracarbazine is combined with Tenecteplase.,Hydracarbazine
DB09244,The risk or severity of bleeding and hemorrhage can be increased when Pirlindole is combined with Tenecteplase.,Pirlindole
DB09245,The risk or severity of bleeding and hemorrhage can be increased when Toloxatone is combined with Tenecteplase.,Toloxatone
DB09246,The risk or severity of bleeding and hemorrhage can be increased when Benmoxin is combined with Tenecteplase.,Benmoxin
DB09248,The risk or severity of bleeding and hemorrhage can be increased when Mebanazine is combined with Tenecteplase.,Mebanazine
DB09249,The risk or severity of bleeding and hemorrhage can be increased when Octamoxin is combined with Tenecteplase.,Octamoxin
DB09250,The risk or severity of bleeding and hemorrhage can be increased when Pheniprazine is combined with Tenecteplase.,Pheniprazine
DB09251,The risk or severity of bleeding and hemorrhage can be increased when Phenoxypropazine is combined with Tenecteplase.,Phenoxypropazine
DB09252,The risk or severity of bleeding and hemorrhage can be increased when Pivhydrazine is combined with Tenecteplase.,Pivhydrazine
DB09253,The risk or severity of bleeding and hemorrhage can be increased when Safrazine is combined with Tenecteplase.,Safrazine
DB09254,The risk or severity of bleeding and hemorrhage can be increased when Caroxazone is combined with Tenecteplase.,Caroxazone
DB13875,The risk or severity of bleeding and hemorrhage can be increased when Harmaline is combined with Tenecteplase.,Harmaline
DB13876,The risk or severity of bleeding and hemorrhage can be increased when Brofaromine is combined with Tenecteplase.,Brofaromine
DB00006,The risk or severity of bleeding can be increased when Bivalirudin is combined with Tenecteplase.,Bivalirudin
DB00266,The risk or severity of bleeding can be increased when Dicoumarol is combined with Tenecteplase.,Dicoumarol
DB00278,The risk or severity of bleeding can be increased when Argatroban is combined with Tenecteplase.,Argatroban
DB00407,The risk or severity of bleeding can be increased when Ardeparin is combined with Tenecteplase.,Ardeparin
DB00498,The risk or severity of bleeding can be increased when Phenindione is combined with Tenecteplase.,Phenindione
DB00569,The risk or severity of bleeding can be increased when Fondaparinux is combined with Tenecteplase.,Fondaparinux
DB00682,The risk or severity of bleeding can be increased when Warfarin is combined with Tenecteplase.,Warfarin
DB00946,The risk or severity of bleeding can be increased when Phenprocoumon is combined with Tenecteplase.,Phenprocoumon
DB00974,The risk or severity of bleeding can be increased when Edetic acid is combined with Tenecteplase.,Edetic acid
DB01109,The risk or severity of bleeding can be increased when Heparin is combined with Tenecteplase.,Heparin
DB01225,The risk or severity of bleeding can be increased when Enoxaparin is combined with Tenecteplase.,Enoxaparin
DB01418,The risk or severity of bleeding can be increased when Acenocoumarol is combined with Tenecteplase.,Acenocoumarol
DB04898,The risk or severity of bleeding can be increased when Ximelagatran is combined with Tenecteplase.,Ximelagatran
DB05099,The risk or severity of bleeding can be increased when Ancrod is combined with Tenecteplase.,Ancrod
DB06271,The risk or severity of bleeding can be increased when Sulodexide is combined with Tenecteplase.,Sulodexide
DB06406,The risk or severity of bleeding can be increased when Idraparinux is combined with Tenecteplase.,Idraparinux
DB06635,The risk or severity of bleeding can be increased when Otamixaban is combined with Tenecteplase.,Otamixaban
DB06754,The risk or severity of bleeding can be increased when Danaparoid is combined with Tenecteplase.,Danaparoid
DB06779,The risk or severity of bleeding can be increased when Dalteparin is combined with Tenecteplase.,Dalteparin
DB07767,The risk or severity of bleeding can be increased when Ferulic acid is combined with Tenecteplase.,Ferulic acid
DB08794,The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Tenecteplase.,Ethyl biscoumacetate
DB08813,The risk or severity of bleeding can be increased when Nadroparin is combined with Tenecteplase.,Nadroparin
DB09255,The risk or severity of bleeding can be increased when Dextran is combined with Tenecteplase.,Dextran
DB09259,The risk or severity of bleeding can be increased when Reviparin is combined with Tenecteplase.,Reviparin
DB09261,The risk or severity of bleeding can be increased when Certoparin is combined with Tenecteplase.,Certoparin
DB11095,The risk or severity of bleeding can be increased when Desirudin is combined with Tenecteplase.,Desirudin
DB11268,The risk or severity of bleeding can be increased when Protocatechualdehyde is combined with Tenecteplase.,Protocatechualdehyde
DB11312,The risk or severity of bleeding can be increased when Protein C is combined with Tenecteplase.,Protein C
DB11598,The risk or severity of bleeding can be increased when Antithrombin III human is combined with Tenecteplase.,Antithrombin III human
DB11984,The risk or severity of bleeding can be increased when Letaxaban is combined with Tenecteplase.,Letaxaban
DB12289,The risk or severity of bleeding can be increased when Darexaban is combined with Tenecteplase.,Darexaban
DB12598,The risk or severity of bleeding can be increased when Nafamostat is combined with Tenecteplase.,Nafamostat
DB12831,The risk or severity of bleeding can be increased when Gabexate is combined with Tenecteplase.,Gabexate
DB13124,The risk or severity of bleeding can be increased when Troxerutin is combined with Tenecteplase.,Troxerutin
DB13136,The risk or severity of bleeding can be increased when Fluindione is combined with Tenecteplase.,Fluindione
DB13149,The risk or severity of bleeding can be increased when Protein S human is combined with Tenecteplase.,Protein S human
DB13616,The risk or severity of bleeding can be increased when Melagatran is combined with Tenecteplase.,Melagatran
DB09125,The risk or severity of bleeding can be increased when Potassium citrate is combined with Tenecteplase.,Potassium citrate
DB09154,The risk or severity of bleeding can be increased when Sodium citrate is combined with Tenecteplase.,Sodium citrate
DB00055,The risk or severity of bleeding can be increased when Tenecteplase is combined with Drotrecogin alfa.,Drotrecogin alfa
DB06822,The risk or severity of bleeding can be increased when Tenecteplase is combined with Tinzaparin.,Tinzaparin
DB13199,The risk or severity of bleeding can be increased when Tenecteplase is combined with Brinase.,Brinase
DB13646,The risk or severity of bleeding can be increased when Tenecteplase is combined with Saruplase.,Saruplase
DB00086,The risk or severity of bleeding can be increased when Tenecteplase is combined with Streptokinase.,Streptokinase
DB04925,The risk or severity of bleeding can be increased when Tenecteplase is combined with Desmoteplase.,Desmoteplase
DB05254,The risk or severity of bleeding can be increased when Tenecteplase is combined with Fibrinolysin.,Fibrinolysin
DB06543,The risk or severity of bleeding can be increased when Tenecteplase is combined with Astaxanthin.,Astaxanthin
DB08994,The risk or severity of bleeding can be increased when Tenecteplase is combined with Ditazole.,Ditazole
DB09258,The risk or severity of bleeding can be increased when Tenecteplase is combined with Bemiparin.,Bemiparin
DB09260,The risk or severity of bleeding can be increased when Tenecteplase is combined with Parnaparin.,Parnaparin
DB13275,The risk or severity of bleeding can be increased when Tenecteplase is combined with Clorindione.,Clorindione
DB13347,The risk or severity of bleeding can be increased when Tenecteplase is combined with Diphenadione.,Diphenadione
DB13451,The risk or severity of bleeding can be increased when Tenecteplase is combined with Tioclomarol.,Tioclomarol
DB00001,The risk or severity of bleeding can be increased when Tenecteplase is combined with Lepirudin.,Lepirudin
DB00009,The risk or severity of bleeding can be increased when Tenecteplase is combined with Alteplase.,Alteplase
DB00015,The risk or severity of bleeding can be increased when Tenecteplase is combined with Reteplase.,Reteplase
DB00029,The risk or severity of bleeding can be increased when Tenecteplase is combined with Anistreplase.,Anistreplase
DB14094,The risk or severity of bleeding can be increased when Tenecteplase is combined with Tocopherylquinone.,Tocopherylquinone
DB06679,The risk or severity of bleeding can be increased when Tenecteplase is combined with Amediplase.,Amediplase
DB03410,The risk or severity of bleeding can be increased when Tenecteplase is combined with 4-hydroxycoumarin.,4-hydroxycoumarin
DB08496,The risk or severity of bleeding can be increased when Tenecteplase is combined with (R)-warfarin.,(R)-warfarin
DB14055,The risk or severity of bleeding can be increased when Tenecteplase is combined with (S)-Warfarin.,(S)-Warfarin
DB12364,The risk or severity of bleeding can be increased when Tenecteplase is combined with Betrixaban.,Betrixaban
DB14598,The risk or severity of bleeding can be increased when Tenecteplase is combined with Edetate calcium disodium anhydrous.,Edetate calcium disodium anhydrous
DB11154,The risk or severity of bleeding can be increased when Tenecteplase is combined with Zinc citrate.,Zinc citrate
DB11166,The risk or severity of bleeding can be increased when Tenecteplase is combined with Antithrombin Alfa.,Antithrombin Alfa
DB04665,The risk or severity of bleeding can be increased when Tenecteplase is combined with Coumarin.,Coumarin
DB14726,The risk or severity of bleeding can be increased when Tenecteplase is combined with Dabigatran.,Dabigatran
DB06294,The risk or severity of bleeding can be increased when Tenecteplase is combined with Semuloparin.,Semuloparin
DB12726,The risk or severity of bleeding can be increased when Tenecteplase is combined with Monteplase.,Monteplase
DB00177,The risk or severity of angioedema can be increased when Tenecteplase is combined with Valsartan.,Valsartan
DB00178,The risk or severity of angioedema can be increased when Tenecteplase is combined with Ramipril.,Ramipril
DB00230,The risk or severity of angioedema can be increased when Tenecteplase is combined with Pregabalin.,Pregabalin
DB00492,The risk or severity of angioedema can be increased when Tenecteplase is combined with Fosinopril.,Fosinopril
DB00519,The risk or severity of angioedema can be increased when Tenecteplase is combined with Trandolapril.,Trandolapril
DB00542,The risk or severity of angioedema can be increased when Tenecteplase is combined with Benazepril.,Benazepril
DB00584,The risk or severity of angioedema can be increased when Tenecteplase is combined with Enalapril.,Enalapril
DB00678,The risk or severity of angioedema can be increased when Tenecteplase is combined with Losartan.,Losartan
DB00691,The risk or severity of angioedema can be increased when Tenecteplase is combined with Moexipril.,Moexipril
DB00722,The risk or severity of angioedema can be increased when Tenecteplase is combined with Lisinopril.,Lisinopril
DB00790,The risk or severity of angioedema can be increased when Tenecteplase is combined with Perindopril.,Perindopril
DB00876,The risk or severity of angioedema can be increased when Tenecteplase is combined with Eprosartan.,Eprosartan
DB00877,The risk or severity of angioedema can be increased when Tenecteplase is combined with Sirolimus.,Sirolimus
DB00881,The risk or severity of angioedema can be increased when Tenecteplase is combined with Quinapril.,Quinapril
DB00886,The risk or severity of angioedema can be increased when Tenecteplase is combined with Omapatrilat.,Omapatrilat
DB00966,The risk or severity of angioedema can be increased when Tenecteplase is combined with Telmisartan.,Telmisartan
DB01050,The risk or severity of angioedema can be increased when Tenecteplase is combined with Ibuprofen.,Ibuprofen
DB01180,The risk or severity of angioedema can be increased when Tenecteplase is combined with Rescinnamine.,Rescinnamine
DB01197,The risk or severity of angioedema can be increased when Tenecteplase is combined with Captopril.,Captopril
DB01261,The risk or severity of angioedema can be increased when Tenecteplase is combined with Sitagliptin.,Sitagliptin
DB01340,The risk or severity of angioedema can be increased when Tenecteplase is combined with Cilazapril.,Cilazapril
DB01342,The risk or severity of angioedema can be increased when Tenecteplase is combined with Forasartan.,Forasartan
DB01347,The risk or severity of angioedema can be increased when Tenecteplase is combined with Saprisartan.,Saprisartan
DB01348,The risk or severity of angioedema can be increased when Tenecteplase is combined with Spirapril.,Spirapril
DB04876,The risk or severity of angioedema can be increased when Tenecteplase is combined with Vildagliptin.,Vildagliptin
DB06011,The risk or severity of angioedema can be increased when Tenecteplase is combined with AMG-222.,AMG-222
DB06127,The risk or severity of angioedema can be increased when Tenecteplase is combined with Bisegliptin.,Bisegliptin
DB06196,The risk or severity of angioedema can be increased when Tenecteplase is combined with Icatibant.,Icatibant
DB06203,The risk or severity of angioedema can be increased when Tenecteplase is combined with Alogliptin.,Alogliptin
DB06245,The risk or severity of angioedema can be increased when Tenecteplase is combined with Lanoteplase.,Lanoteplase
DB06287,The risk or severity of angioedema can be increased when Tenecteplase is combined with Temsirolimus.,Temsirolimus
DB06335,The risk or severity of angioedema can be increased when Tenecteplase is combined with Saxagliptin.,Saxagliptin
DB08382,The risk or severity of angioedema can be increased when Tenecteplase is combined with Gosogliptin.,Gosogliptin
DB08822,The risk or severity of angioedema can be increased when Tenecteplase is combined with Azilsartan medoxomil.,Azilsartan medoxomil
DB08836,The risk or severity of angioedema can be increased when Tenecteplase is combined with Temocapril.,Temocapril
DB08882,The risk or severity of angioedema can be increased when Tenecteplase is combined with Linagliptin.,Linagliptin
DB09292,The risk or severity of angioedema can be increased when Tenecteplase is combined with Sacubitril.,Sacubitril
DB09477,The risk or severity of angioedema can be increased when Tenecteplase is combined with Enalaprilat.,Enalaprilat
DB11723,The risk or severity of angioedema can be increased when Tenecteplase is combined with Dutogliptin.,Dutogliptin
DB11783,The risk or severity of angioedema can be increased when Tenecteplase is combined with Imidapril.,Imidapril
DB11950,The risk or severity of angioedema can be increased when Tenecteplase is combined with Teneligliptin.,Teneligliptin
DB11992,The risk or severity of angioedema can be increased when Tenecteplase is combined with Omarigliptin.,Omarigliptin
DB12268,The risk or severity of angioedema can be increased when Tenecteplase is combined with Carmegliptin.,Carmegliptin
DB12412,The risk or severity of angioedema can be increased when Tenecteplase is combined with Gemigliptin.,Gemigliptin
DB12417,The risk or severity of angioedema can be increased when Tenecteplase is combined with Anagliptin.,Anagliptin
DB12625,The risk or severity of angioedema can be increased when Tenecteplase is combined with Evogliptin.,Evogliptin
DB13166,The risk or severity of angioedema can be increased when Tenecteplase is combined with Zofenopril.,Zofenopril
DB13312,The risk or severity of angioedema can be increased when Tenecteplase is combined with Delapril.,Delapril
DB14125,The risk or severity of angioedema can be increased when Tenecteplase is combined with Benazeprilat.,Benazeprilat
DB14207,The risk or severity of angioedema can be increased when Tenecteplase is combined with Fosinoprilat.,Fosinoprilat
DB14208,The risk or severity of angioedema can be increased when Tenecteplase is combined with Ramiprilat.,Ramiprilat
DB14209,The risk or severity of angioedema can be increased when Tenecteplase is combined with Trandolaprilat.,Trandolaprilat
DB14210,The risk or severity of angioedema can be increased when Tenecteplase is combined with Moexiprilat.,Moexiprilat
DB14213,The risk or severity of angioedema can be increased when Tenecteplase is combined with Perindoprilat.,Perindoprilat
DB14217,The risk or severity of angioedema can be increased when Tenecteplase is combined with Quinaprilat.,Quinaprilat
DB14231,The risk or severity of angioedema can be increased when Tenecteplase is combined with Quinoline Yellow WS.,Quinoline Yellow WS
DB00203,The risk or severity of hemorrhage can be increased when Tenecteplase is combined with Sildenafil.,Sildenafil
DB00008,The risk or severity of bleeding can be increased when Tenecteplase is combined with Peginterferon alfa-2a.,Peginterferon alfa-2a
DB00011,The risk or severity of bleeding can be increased when Tenecteplase is combined with Interferon alfa-n1.,Interferon alfa-n1
DB00018,The risk or severity of bleeding can be increased when Tenecteplase is combined with Interferon alfa-n3.,Interferon alfa-n3
DB00022,The risk or severity of bleeding can be increased when Tenecteplase is combined with Peginterferon alfa-2b.,Peginterferon alfa-2b
DB00033,The risk or severity of bleeding can be increased when Tenecteplase is combined with Interferon gamma-1b.,Interferon gamma-1b
DB00034,"The risk or severity of bleeding can be increased when Tenecteplase is combined with Interferon alfa-2a, Recombinant.","Interferon alfa-2a, Recombinant"
DB00041,The risk or severity of bleeding can be increased when Tenecteplase is combined with Aldesleukin.,Aldesleukin
DB00056,The risk or severity of bleeding can be increased when Tenecteplase is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin
DB00068,The risk or severity of bleeding can be increased when Tenecteplase is combined with Interferon beta-1b.,Interferon beta-1b
DB00069,The risk or severity of bleeding can be increased when Tenecteplase is combined with Interferon alfacon-1.,Interferon alfacon-1
DB00073,The risk or severity of bleeding can be increased when Tenecteplase is combined with Rituximab.,Rituximab
DB00078,The risk or severity of bleeding can be increased when Tenecteplase is combined with Ibritumomab tiuxetan.,Ibritumomab tiuxetan
DB00087,The risk or severity of bleeding can be increased when Tenecteplase is combined with Alemtuzumab.,Alemtuzumab
DB00105,The risk or severity of bleeding can be increased when Tenecteplase is combined with Interferon alfa-2b.,Interferon alfa-2b
DB00120,The risk or severity of bleeding can be increased when Tenecteplase is combined with Phenylalanine.,Phenylalanine
DB00188,The risk or severity of bleeding can be increased when Tenecteplase is combined with Bortezomib.,Bortezomib
DB00242,The risk or severity of bleeding can be increased when Tenecteplase is combined with Cladribine.,Cladribine
DB00262,The risk or severity of bleeding can be increased when Tenecteplase is combined with Carmustine.,Carmustine
DB00276,The risk or severity of bleeding can be increased when Tenecteplase is combined with Amsacrine.,Amsacrine
DB00291,The risk or severity of bleeding can be increased when Tenecteplase is combined with Chlorambucil.,Chlorambucil
DB00293,The risk or severity of bleeding can be increased when Tenecteplase is combined with Raltitrexed.,Raltitrexed
DB00305,The risk or severity of bleeding can be increased when Tenecteplase is combined with Mitomycin.,Mitomycin
DB00307,The risk or severity of bleeding can be increased when Tenecteplase is combined with Bexarotene.,Bexarotene
DB00309,The risk or severity of bleeding can be increased when Tenecteplase is combined with Vindesine.,Vindesine
DB00322,The risk or severity of bleeding can be increased when Tenecteplase is combined with Floxuridine.,Floxuridine
DB00352,The risk or severity of bleeding can be increased when Tenecteplase is combined with Tioguanine.,Tioguanine
DB00361,The risk or severity of bleeding can be increased when Tenecteplase is combined with Vinorelbine.,Vinorelbine
DB00380,The risk or severity of bleeding can be increased when Tenecteplase is combined with Dexrazoxane.,Dexrazoxane
DB00398,The risk or severity of bleeding can be increased when Tenecteplase is combined with Sorafenib.,Sorafenib
DB00428,The risk or severity of bleeding can be increased when Tenecteplase is combined with Streptozocin.,Streptozocin
DB00441,The risk or severity of bleeding can be increased when Tenecteplase is combined with Gemcitabine.,Gemcitabine
DB00444,The risk or severity of bleeding can be increased when Tenecteplase is combined with Teniposide.,Teniposide
DB00445,The risk or severity of bleeding can be increased when Tenecteplase is combined with Epirubicin.,Epirubicin
DB00446,The risk or severity of bleeding can be increased when Tenecteplase is combined with Chloramphenicol.,Chloramphenicol
DB00480,The risk or severity of bleeding can be increased when Tenecteplase is combined with Lenalidomide.,Lenalidomide
DB00488,The risk or severity of bleeding can be increased when Tenecteplase is combined with Altretamine.,Altretamine
DB00495,The risk or severity of bleeding can be increased when Tenecteplase is combined with Zidovudine.,Zidovudine
DB00515,The risk or severity of bleeding can be increased when Tenecteplase is combined with Cisplatin.,Cisplatin
DB00526,The risk or severity of bleeding can be increased when Tenecteplase is combined with Oxaliplatin.,Oxaliplatin
DB00531,The risk or severity of bleeding can be increased when Tenecteplase is combined with Cyclophosphamide.,Cyclophosphamide
DB00544,The risk or severity of bleeding can be increased when Tenecteplase is combined with Fluorouracil.,Fluorouracil
DB00552,The risk or severity of bleeding can be increased when Tenecteplase is combined with Pentostatin.,Pentostatin
DB00563,The risk or severity of bleeding can be increased when Tenecteplase is combined with Methotrexate.,Methotrexate
DB00564,The risk or severity of bleeding can be increased when Tenecteplase is combined with Carbamazepine.,Carbamazepine
DB00570,The risk or severity of bleeding can be increased when Tenecteplase is combined with Vinblastine.,Vinblastine
DB00619,The risk or severity of bleeding can be increased when Tenecteplase is combined with Imatinib.,Imatinib
DB00631,The risk or severity of bleeding can be increased when Tenecteplase is combined with Clofarabine.,Clofarabine
DB00642,The risk or severity of bleeding can be increased when Tenecteplase is combined with Pemetrexed.,Pemetrexed
DB00694,The risk or severity of bleeding can be increased when Tenecteplase is combined with Daunorubicin.,Daunorubicin
DB00762,The risk or severity of bleeding can be increased when Tenecteplase is combined with Irinotecan.,Irinotecan
DB00773,The risk or severity of bleeding can be increased when Tenecteplase is combined with Etoposide.,Etoposide
DB00851,The risk or severity of bleeding can be increased when Tenecteplase is combined with Dacarbazine.,Dacarbazine
DB00853,The risk or severity of bleeding can be increased when Tenecteplase is combined with Temozolomide.,Temozolomide
DB00859,The risk or severity of bleeding can be increased when Tenecteplase is combined with Penicillamine.,Penicillamine
DB00864,The risk or severity of bleeding can be increased when Tenecteplase is combined with Tacrolimus.,Tacrolimus
DB00888,The risk or severity of bleeding can be increased when Tenecteplase is combined with Mechlorethamine.,Mechlorethamine
DB00928,The risk or severity of bleeding can be increased when Tenecteplase is combined with Azacitidine.,Azacitidine
DB00958,The risk or severity of bleeding can be increased when Tenecteplase is combined with Carboplatin.,Carboplatin
DB00970,The risk or severity of bleeding can be increased when Tenecteplase is combined with Dactinomycin.,Dactinomycin
DB00987,The risk or severity of bleeding can be increased when Tenecteplase is combined with Cytarabine.,Cytarabine
DB00997,The risk or severity of bleeding can be increased when Tenecteplase is combined with Doxorubicin.,Doxorubicin
DB01005,The risk or severity of bleeding can be increased when Tenecteplase is combined with Hydroxyurea.,Hydroxyurea
DB01008,The risk or severity of bleeding can be increased when Tenecteplase is combined with Busulfan.,Busulfan
DB01030,The risk or severity of bleeding can be increased when Tenecteplase is combined with Topotecan.,Topotecan
DB01033,The risk or severity of bleeding can be increased when Tenecteplase is combined with Mercaptopurine.,Mercaptopurine
DB01041,The risk or severity of bleeding can be increased when Tenecteplase is combined with Thalidomide.,Thalidomide
DB01042,The risk or severity of bleeding can be increased when Tenecteplase is combined with Melphalan.,Melphalan
DB01073,The risk or severity of bleeding can be increased when Tenecteplase is combined with Fludarabine.,Fludarabine
DB01099,The risk or severity of bleeding can be increased when Tenecteplase is combined with Flucytosine.,Flucytosine
DB01101,The risk or severity of bleeding can be increased when Tenecteplase is combined with Capecitabine.,Capecitabine
DB01169,The risk or severity of bleeding can be increased when Tenecteplase is combined with Arsenic trioxide.,Arsenic trioxide
DB01177,The risk or severity of bleeding can be increased when Tenecteplase is combined with Idarubicin.,Idarubicin
DB01204,The risk or severity of bleeding can be increased when Tenecteplase is combined with Mitoxantrone.,Mitoxantrone
DB01206,The risk or severity of bleeding can be increased when Tenecteplase is combined with Lomustine.,Lomustine
DB01229,The risk or severity of bleeding can be increased when Tenecteplase is combined with Paclitaxel.,Paclitaxel
DB01248,The risk or severity of bleeding can be increased when Tenecteplase is combined with Docetaxel.,Docetaxel
DB01262,The risk or severity of bleeding can be increased when Tenecteplase is combined with Decitabine.,Decitabine
DB01280,The risk or severity of bleeding can be increased when Tenecteplase is combined with Nelarabine.,Nelarabine
DB01590,The risk or severity of bleeding can be increased when Tenecteplase is combined with Everolimus.,Everolimus
DB02546,The risk or severity of bleeding can be increased when Tenecteplase is combined with Vorinostat.,Vorinostat
DB04572,The risk or severity of bleeding can be increased when Tenecteplase is combined with Thiotepa.,Thiotepa
DB04845,The risk or severity of bleeding can be increased when Tenecteplase is combined with Ixabepilone.,Ixabepilone
DB04868,The risk or severity of bleeding can be increased when Tenecteplase is combined with Nilotinib.,Nilotinib
DB05015,The risk or severity of bleeding can be increased when Tenecteplase is combined with Belinostat.,Belinostat
DB05109,The risk or severity of bleeding can be increased when Tenecteplase is combined with Trabectedin.,Trabectedin
DB05258,The risk or severity of bleeding can be increased when Tenecteplase is combined with Interferon alfa.,Interferon alfa
DB05472,The risk or severity of bleeding can be increased when Tenecteplase is combined with omega interferon.,omega interferon
DB05773,The risk or severity of bleeding can be increased when Tenecteplase is combined with Trastuzumab emtansine.,Trastuzumab emtansine
DB06616,The risk or severity of bleeding can be increased when Tenecteplase is combined with Bosutinib.,Bosutinib
DB06769,The risk or severity of bleeding can be increased when Tenecteplase is combined with Bendamustine.,Bendamustine
DB06772,The risk or severity of bleeding can be increased when Tenecteplase is combined with Cabazitaxel.,Cabazitaxel
DB08871,The risk or severity of bleeding can be increased when Tenecteplase is combined with Eribulin.,Eribulin
DB08877,The risk or severity of bleeding can be increased when Tenecteplase is combined with Ruxolitinib.,Ruxolitinib
DB08889,The risk or severity of bleeding can be increased when Tenecteplase is combined with Carfilzomib.,Carfilzomib
DB08895,The risk or severity of bleeding can be increased when Tenecteplase is combined with Tofacitinib.,Tofacitinib
DB08901,The risk or severity of bleeding can be increased when Tenecteplase is combined with Ponatinib.,Ponatinib
DB08910,The risk or severity of bleeding can be increased when Tenecteplase is combined with Pomalidomide.,Pomalidomide
DB09042,The risk or severity of bleeding can be increased when Tenecteplase is combined with Tedizolid phosphate.,Tedizolid phosphate
DB09052,The risk or severity of bleeding can be increased when Tenecteplase is combined with Blinatumomab.,Blinatumomab
DB09073,The risk or severity of bleeding can be increased when Tenecteplase is combined with Palbociclib.,Palbociclib
DB09074,The risk or severity of bleeding can be increased when Tenecteplase is combined with Olaparib.,Olaparib
DB09077,The risk or severity of bleeding can be increased when Tenecteplase is combined with Dinutuximab.,Dinutuximab
DB09122,The risk or severity of bleeding can be increased when Tenecteplase is combined with Peginterferon beta-1a.,Peginterferon beta-1a
DB12814,The risk or severity of bleeding can be increased when Tenecteplase is combined with Cepeginterferon alfa-2B.,Cepeginterferon alfa-2B
DB00229,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefotiam.,Cefotiam
DB00267,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefmenoxime.,Cefmenoxime
DB00274,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefmetazole.,Cefmetazole
DB00430,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefpiramide.,Cefpiramide
DB00438,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Ceftazidime.,Ceftazidime
DB00447,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Loracarbef.,Loracarbef
DB00456,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefalotin.,Cefalotin
DB00493,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefotaxime.,Cefotaxime
DB00535,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefdinir.,Cefdinir
DB00567,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cephalexin.,Cephalexin
DB00671,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefixime.,Cefixime
DB00689,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cephaloglycin.,Cephaloglycin
DB00833,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefaclor.,Cefaclor
DB00923,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Ceforanide.,Ceforanide
DB01066,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefditoren.,Cefditoren
DB01112,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefuroxime.,Cefuroxime
DB01139,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefapirin.,Cefapirin
DB01140,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefadroxil.,Cefadroxil
DB01150,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefprozil.,Cefprozil
DB01212,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Ceftriaxone.,Ceftriaxone
DB01326,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefamandole.,Cefamandole
DB01327,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefazolin.,Cefazolin
DB01328,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefonicid.,Cefonicid
DB01329,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefoperazone.,Cefoperazone
DB01330,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefotetan.,Cefotetan
DB01331,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefoxitin.,Cefoxitin
DB01332,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Ceftizoxime.,Ceftizoxime
DB01333,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefradine.,Cefradine
DB01413,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefepime.,Cefepime
DB01414,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefacetrile.,Cefacetrile
DB01415,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Ceftibuten.,Ceftibuten
DB01416,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefpodoxime.,Cefpodoxime
DB04570,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Latamoxef.,Latamoxef
DB04918,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Ceftobiprole.,Ceftobiprole
DB06590,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Ceftaroline fosamil.,Ceftaroline fosamil
DB09008,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefaloridine.,Cefaloridine
DB09050,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Ceftolozane.,Ceftolozane
DB09062,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefminox.,Cefminox
DB11367,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefroxadine.,Cefroxadine
DB11935,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Flomoxef.,Flomoxef
DB13266,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefatrizine.,Cefatrizine
DB13461,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefcapene.,Cefcapene
DB13470,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefodizime.,Cefodizime
DB13499,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefsulodin.,Cefsulodin
DB13504,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefetamet.,Cefetamet
DB13638,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefbuperazone.,Cefbuperazone
DB13667,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefozopran.,Cefozopran
DB13682,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefpirome.,Cefpirome
DB13778,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefazedone.,Cefazedone
DB13821,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Ceftezole.,Ceftezole
DB14725,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefamandole nafate.,Cefamandole nafate
DB00254,The risk or severity of bleeding can be increased when Doxycycline is combined with Tenecteplase.,Doxycycline
DB00207,The risk or severity of adverse effects can be increased when Azithromycin is combined with Tenecteplase.,Azithromycin
DB09539,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Tenecteplase.,Omega-3-acid ethyl esters
DB00945,Acetylsalicylic acid may increase the anticoagulant activities of Tenecteplase.,Acetylsalicylic acid
DB01606,The risk or severity of bleeding can be increased when Tazobactam is combined with Tenecteplase.,Tazobactam
DB00727,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Nitroglycerin.,Nitroglycerin
DB00199,The risk or severity of bleeding can be increased when Erythromycin is combined with Tenecteplase.,Erythromycin
DB00656,The risk or severity of bleeding can be increased when Trazodone is combined with Tenecteplase.,Trazodone
DB00620,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Triamcinolone.,Triamcinolone
DB09079,The risk or severity of bleeding can be increased when Tenecteplase is combined with Nintedanib.,Nintedanib
DB01175,The risk or severity of bleeding can be increased when Escitalopram is combined with Tenecteplase.,Escitalopram
DB01104,The risk or severity of bleeding can be increased when Sertraline is combined with Tenecteplase.,Sertraline
DB00232,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Methyclothiazide.,Methyclothiazide
DB00436,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Bendroflumethiazide.,Bendroflumethiazide
DB00562,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Benzthiazide.,Benzthiazide
DB00606,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cyclothiazide.,Cyclothiazide
DB00774,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Hydroflumethiazide.,Hydroflumethiazide
DB00880,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Chlorothiazide.,Chlorothiazide
DB00999,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Hydrochlorothiazide.,Hydrochlorothiazide
DB01021,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Trichlormethiazide.,Trichlormethiazide
DB01324,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Polythiazide.,Polythiazide
DB13430,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Mebutizide.,Mebutizide
DB13532,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cyclopenthiazide.,Cyclopenthiazide
DB06643,The risk or severity of adverse effects can be increased when Denosumab is combined with Interferon gamma-1b.,Denosumab
DB00005,The risk or severity of adverse effects can be increased when Etanercept is combined with Interferon gamma-1b.,Etanercept
DB00008,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Interferon gamma-1b.,Peginterferon alfa-2a
DB00011,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Interferon gamma-1b.,Interferon alfa-n1
DB00018,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Interferon gamma-1b.,Interferon alfa-n3
DB00022,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Interferon gamma-1b.,Peginterferon alfa-2b
DB00026,The risk or severity of adverse effects can be increased when Anakinra is combined with Interferon gamma-1b.,Anakinra
DB00034,"The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Interferon alfa-2a, Recombinant.","Interferon alfa-2a, Recombinant"
DB00041,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Aldesleukin.,Aldesleukin
DB00051,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Adalimumab.,Adalimumab
DB00056,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin
DB00059,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Pegaspargase.,Pegaspargase
DB00065,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Infliximab.,Infliximab
DB00068,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Interferon beta-1b.,Interferon beta-1b
DB00069,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Interferon alfacon-1.,Interferon alfacon-1
DB00073,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Rituximab.,Rituximab
DB00074,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Basiliximab.,Basiliximab
DB00075,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Muromonab.,Muromonab
DB00078,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Ibritumomab tiuxetan.,Ibritumomab tiuxetan
DB00081,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Tositumomab.,Tositumomab
DB00087,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Alemtuzumab.,Alemtuzumab
DB00092,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Alefacept.,Alefacept
DB00095,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Efalizumab.,Efalizumab
DB00098,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Antithymocyte immunoglobulin (rabbit).,Antithymocyte immunoglobulin (rabbit)
DB00105,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Interferon alfa-2b.,Interferon alfa-2b
DB00111,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Daclizumab.,Daclizumab
DB00112,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Bevacizumab.,Bevacizumab
DB00120,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Phenylalanine.,Phenylalanine
DB00180,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Flunisolide.,Flunisolide
DB00188,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Bortezomib.,Bortezomib
DB00242,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Cladribine.,Cladribine
DB00262,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Carmustine.,Carmustine
DB00276,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Amsacrine.,Amsacrine
DB00290,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Bleomycin.,Bleomycin
DB00291,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Chlorambucil.,Chlorambucil
DB00293,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Raltitrexed.,Raltitrexed
DB00305,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Mitomycin.,Mitomycin
DB00307,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Bexarotene.,Bexarotene
DB00309,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Vindesine.,Vindesine
DB00322,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Floxuridine.,Floxuridine
DB00328,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Indomethacin.,Indomethacin
DB00352,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Tioguanine.,Tioguanine
DB00361,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Vinorelbine.,Vinorelbine
DB00380,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Dexrazoxane.,Dexrazoxane
DB00394,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Beclomethasone dipropionate.,Beclomethasone dipropionate
DB00398,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Sorafenib.,Sorafenib
DB00428,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Streptozocin.,Streptozocin
DB00432,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Trifluridine.,Trifluridine
DB00441,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Gemcitabine.,Gemcitabine
DB00443,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Betamethasone.,Betamethasone
DB00444,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Teniposide.,Teniposide
DB00445,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Epirubicin.,Epirubicin
DB00446,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Chloramphenicol.,Chloramphenicol
DB00480,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Lenalidomide.,Lenalidomide
DB00488,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Altretamine.,Altretamine
DB00495,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Zidovudine.,Zidovudine
DB00515,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Cisplatin.,Cisplatin
DB00526,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Oxaliplatin.,Oxaliplatin
DB00531,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Cyclophosphamide.,Cyclophosphamide
DB00541,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Vincristine.,Vincristine
DB00544,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fluorouracil.,Fluorouracil
DB00550,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Propylthiouracil.,Propylthiouracil
DB00552,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Pentostatin.,Pentostatin
DB00563,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Methotrexate.,Methotrexate
DB00564,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Carbamazepine.,Carbamazepine
DB00570,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Vinblastine.,Vinblastine
DB00588,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fluticasone propionate.,Fluticasone propionate
DB00591,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fluocinolone acetonide.,Fluocinolone acetonide
DB00601,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Linezolid.,Linezolid
DB00619,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Imatinib.,Imatinib
DB00620,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Triamcinolone.,Triamcinolone
DB00631,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Clofarabine.,Clofarabine
DB00635,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Prednisone.,Prednisone
DB00642,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Pemetrexed.,Pemetrexed
DB00687,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fludrocortisone.,Fludrocortisone
DB00688,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Mycophenolate mofetil.,Mycophenolate mofetil
DB00694,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Daunorubicin.,Daunorubicin
DB00755,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Tretinoin.,Tretinoin
DB00762,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Irinotecan.,Irinotecan
DB00763,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Methimazole.,Methimazole
DB00764,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Mometasone.,Mometasone
DB00773,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Etoposide.,Etoposide
DB00795,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Sulfasalazine.,Sulfasalazine
DB00851,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Dacarbazine.,Dacarbazine
DB00853,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Temozolomide.,Temozolomide
DB00859,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Penicillamine.,Penicillamine
DB00860,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Prednisolone.,Prednisolone
DB00877,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Sirolimus.,Sirolimus
DB00888,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Mechlorethamine.,Mechlorethamine
DB00928,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Azacitidine.,Azacitidine
DB00958,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Carboplatin.,Carboplatin
DB00959,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Methylprednisolone.,Methylprednisolone
DB00970,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Dactinomycin.,Dactinomycin
DB00987,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Cytarabine.,Cytarabine
DB00993,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Azathioprine.,Azathioprine
DB00997,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Doxorubicin.,Doxorubicin
DB01005,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Hydroxyurea.,Hydroxyurea
DB01008,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Busulfan.,Busulfan
DB01024,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Mycophenolic acid.,Mycophenolic acid
DB01030,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Topotecan.,Topotecan
DB01033,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Mercaptopurine.,Mercaptopurine
DB01041,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Thalidomide.,Thalidomide
DB01042,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Melphalan.,Melphalan
DB01073,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fludarabine.,Fludarabine
DB01099,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Flucytosine.,Flucytosine
DB01101,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Capecitabine.,Capecitabine
DB01108,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Trilostane.,Trilostane
DB01168,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Procarbazine.,Procarbazine
DB01169,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Arsenic trioxide.,Arsenic trioxide
DB01177,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Idarubicin.,Idarubicin
DB01181,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Ifosfamide.,Ifosfamide
DB01196,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Estramustine.,Estramustine
DB01204,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Mitoxantrone.,Mitoxantrone
DB01206,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Lomustine.,Lomustine
DB01222,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Budesonide.,Budesonide
DB01229,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Paclitaxel.,Paclitaxel
DB01234,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Dexamethasone.,Dexamethasone
DB01248,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Docetaxel.,Docetaxel
DB01254,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Dasatinib.,Dasatinib
DB01257,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Eculizumab.,Eculizumab
DB01262,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Decitabine.,Decitabine
DB01268,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Sunitinib.,Sunitinib
DB01280,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Nelarabine.,Nelarabine
DB01281,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Abatacept.,Abatacept
DB01285,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Corticotropin.,Corticotropin
DB01380,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Cortisone acetate.,Cortisone acetate
DB01384,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Paramethasone.,Paramethasone
DB01394,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Colchicine.,Colchicine
DB01410,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Ciclesonide.,Ciclesonide
DB01423,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Stepronin.,Stepronin
DB01590,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Everolimus.,Everolimus
DB01611,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Hydroxychloroquine.,Hydroxychloroquine
DB01816,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Castanospermine.,Castanospermine
DB02546,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Vorinostat.,Vorinostat
DB02806,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with 2-Methoxyethanol.,2-Methoxyethanol
DB03523,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Brequinar.,Brequinar
DB04572,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Thiotepa.,Thiotepa
DB04630,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Aldosterone.,Aldosterone
DB04845,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Ixabepilone.,Ixabepilone
DB04868,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Nilotinib.,Nilotinib
DB04951,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Pirfenidone.,Pirfenidone
DB04956,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Afelimomab.,Afelimomab
DB05015,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Belinostat.,Belinostat
DB05109,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Trabectedin.,Trabectedin
DB05258,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Interferon alfa.,Interferon alfa
DB05259,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Glatiramer.,Glatiramer
DB05260,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Gallium nitrate.,Gallium nitrate
DB05459,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Briakinumab.,Briakinumab
DB05472,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with omega interferon.,omega interferon
DB05676,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Apremilast.,Apremilast
DB05773,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Trastuzumab emtansine.,Trastuzumab emtansine
DB06168,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Canakinumab.,Canakinumab
DB06273,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Tocilizumab.,Tocilizumab
DB06287,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Temsirolimus.,Temsirolimus
DB06372,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Rilonacept.,Rilonacept
DB06589,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Pazopanib.,Pazopanib
DB06603,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Panobinostat.,Panobinostat
DB06612,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Mepolizumab.,Mepolizumab
DB06616,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Bosutinib.,Bosutinib
DB06662,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Abetimus.,Abetimus
DB06674,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Golimumab.,Golimumab
DB06681,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Belatacept.,Belatacept
DB06769,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Bendamustine.,Bendamustine
DB06772,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Cabazitaxel.,Cabazitaxel
DB06813,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Pralatrexate.,Pralatrexate
DB08059,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Wortmannin.,Wortmannin
DB08870,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Brentuximab vedotin.,Brentuximab vedotin
DB08871,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Eribulin.,Eribulin
DB08877,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Ruxolitinib.,Ruxolitinib
DB08879,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Belimumab.,Belimumab
DB08880,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Teriflunomide.,Teriflunomide
DB08889,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Carfilzomib.,Carfilzomib
DB08901,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Ponatinib.,Ponatinib
DB08904,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Certolizumab pegol.,Certolizumab pegol
DB08906,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fluticasone furoate.,Fluticasone furoate
DB08908,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Dimethyl fumarate.,Dimethyl fumarate
DB08910,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Pomalidomide.,Pomalidomide
DB08935,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Obinutuzumab.,Obinutuzumab
DB08970,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fluprednidene.,Fluprednidene
DB08971,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fluocortolone.,Fluocortolone
DB09029,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Secukinumab.,Secukinumab
DB09033,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Vedolizumab.,Vedolizumab
DB09036,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Siltuximab.,Siltuximab
DB09052,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Blinatumomab.,Blinatumomab
DB09053,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Ibrutinib.,Ibrutinib
DB09054,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Idelalisib.,Idelalisib
DB09073,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Palbociclib.,Palbociclib
DB09074,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Olaparib.,Olaparib
DB09077,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Dinutuximab.,Dinutuximab
DB09082,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Vilanterol.,Vilanterol
DB09091,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Tixocortol.,Tixocortol
DB09122,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Peginterferon beta-1a.,Peginterferon beta-1a
DB09312,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Antilymphocyte immunoglobulin (horse).,Antilymphocyte immunoglobulin (horse)
DB09378,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fluprednisolone.,Fluprednisolone
DB09383,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Meprednisone.,Meprednisone
DB11466,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Tepoxalin.,Tepoxalin
DB11487,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Dexamethasone isonicotinate.,Dexamethasone isonicotinate
DB11529,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Melengestrol.,Melengestrol
DB11569,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Ixekizumab.,Ixekizumab
DB11580,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Ravulizumab.,Ravulizumab
DB11616,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Pirarubicin.,Pirarubicin
DB11693,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Voclosporin.,Voclosporin
DB11708,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Peficitinib.,Peficitinib
DB11750,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Clobetasol.,Clobetasol
DB11767,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Sarilumab.,Sarilumab
DB11776,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Brodalumab.,Brodalumab
DB11803,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Sirukumab.,Sirukumab
DB11817,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Baricitinib.,Baricitinib
DB11834,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Guselkumab.,Guselkumab
DB11921,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Deflazacort.,Deflazacort
DB11988,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Ocrelizumab.,Ocrelizumab
DB12025,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Triptolide.,Triptolide
DB12371,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Siponimod.,Siponimod
DB12612,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Ozanimod.,Ozanimod
DB12617,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Mizoribine.,Mizoribine
DB12692,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Gusperimus.,Gusperimus
DB12814,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Cepeginterferon alfa-2B.,Cepeginterferon alfa-2B
DB12902,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Trofosfamide.,Trofosfamide
DB12947,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Doxifluridine.,Doxifluridine
DB12991,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Deoxyspergualin.,Deoxyspergualin
DB12996,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Acteoside.,Acteoside
DB13003,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Cortivazol.,Cortivazol
DB13014,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Hypericin.,Hypericin
DB13068,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.,9-(N-methyl-L-isoleucine)-cyclosporin A
DB13208,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Prednylidene.,Prednylidene
DB13223,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fluocortin.,Fluocortin
DB13241,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Begelomab.,Begelomab
DB13491,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fluperolone.,Fluperolone
DB13664,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Formocortal.,Formocortal
DB13728,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Halometasone.,Halometasone
DB13843,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Cloprednol.,Cloprednol
DB13856,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fluclorolone.,Fluclorolone
DB13867,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fluticasone.,Fluticasone
DB14066,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Tetrandrine.,Tetrandrine
DB14219,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Monomethyl fumarate.,Monomethyl fumarate
DB14512,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Mometasone furoate.,Mometasone furoate
DB14538,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Hydrocortisone aceponate.,Hydrocortisone aceponate
DB14539,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Hydrocortisone acetate.,Hydrocortisone acetate
DB14545,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Hydrocortisone succinate.,Hydrocortisone succinate
DB14724,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Emapalumab.,Emapalumab
DB14762,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Risankizumab.,Risankizumab
DB14919,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Rozanolixizumab.,Rozanolixizumab
DB15253,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Bleselumab.,Bleselumab
DB00108,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Natalizumab.,Natalizumab
DB00337,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Interferon gamma-1b.,Pimecrolimus
DB01656,Roflumilast may increase the immunosuppressive activities of Interferon gamma-1b.,Roflumilast
DB06688,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Interferon gamma-1b.,Sipuleucel-T
DB00363,The risk or severity of neutropenia can be increased when Interferon gamma-1b is combined with Clozapine.,Clozapine
DB00315,The metabolism of Zolmitriptan can be decreased when combined with Interferon gamma-1b.,Zolmitriptan
DB01015,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Interferon gamma-1b.,Sulfamethoxazole
DB01097,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Leflunomide.,Leflunomide
DB08895,Interferon gamma-1b may increase the immunosuppressive activities of Tofacitinib.,Tofacitinib
DB00072,Trastuzumab may increase the neutropenic activities of Interferon gamma-1b.,Trastuzumab
DB08868,Interferon gamma-1b may increase the immunosuppressive activities of Fingolimod.,Fingolimod
DB00864,Tacrolimus may increase the immunosuppressive activities of Interferon gamma-1b.,Tacrolimus
DB00201,The metabolism of Caffeine can be decreased when combined with Interferon gamma-1b.,Caffeine
DB00651,The metabolism of Dyphylline can be decreased when combined with Interferon gamma-1b.,Dyphylline
DB00806,The metabolism of Pentoxifylline can be decreased when combined with Interferon gamma-1b.,Pentoxifylline
DB01303,The metabolism of Oxtriphylline can be decreased when combined with Interferon gamma-1b.,Oxtriphylline
DB01412,The metabolism of Theobromine can be decreased when combined with Interferon gamma-1b.,Theobromine
DB01482,The metabolism of Fenethylline can be decreased when combined with Interferon gamma-1b.,Fenethylline
DB01667,The metabolism of 8-azaguanine can be decreased when combined with Interferon gamma-1b.,8-azaguanine
DB01978,"The metabolism of 7,9-Dimethylguanine can be decreased when combined with Interferon gamma-1b.","7,9-Dimethylguanine"
DB02134,The metabolism of Xanthine can be decreased when combined with Interferon gamma-1b.,Xanthine
DB02245,The metabolism of 7-Deazaguanine can be decreased when combined with Interferon gamma-1b.,7-Deazaguanine
DB02377,The metabolism of Guanine can be decreased when combined with Interferon gamma-1b.,Guanine
DB02489,The metabolism of 9-Methylguanine can be decreased when combined with Interferon gamma-1b.,9-Methylguanine
DB02568,The metabolism of Peldesine can be decreased when combined with Interferon gamma-1b.,Peldesine
DB04076,The metabolism of Hypoxanthine can be decreased when combined with Interferon gamma-1b.,Hypoxanthine
DB04356,The metabolism of 9-Deazaguanine can be decreased when combined with Interferon gamma-1b.,9-Deazaguanine
DB06479,The metabolism of Propentofylline can be decreased when combined with Interferon gamma-1b.,Propentofylline
DB06575,The metabolism of Valomaciclovir can be decreased when combined with Interferon gamma-1b.,Valomaciclovir
DB07954,The metabolism of 3-isobutyl-1-methyl-7H-xanthine can be decreased when combined with Interferon gamma-1b.,3-isobutyl-1-methyl-7H-xanthine
DB08844,The metabolism of Uric acid can be decreased when combined with Interferon gamma-1b.,Uric acid
DB09273,The metabolism of Doxofylline can be decreased when combined with Interferon gamma-1b.,Doxofylline
DB11919,The metabolism of 6-O-benzylguanine can be decreased when combined with Interferon gamma-1b.,6-O-benzylguanine
DB12406,The metabolism of Lisofylline can be decreased when combined with Interferon gamma-1b.,Lisofylline
DB12531,The metabolism of Lobucavir can be decreased when combined with Interferon gamma-1b.,Lobucavir
DB12926,The metabolism of Cafedrine can be decreased when combined with Interferon gamma-1b.,Cafedrine
DB12927,The metabolism of Theodrenaline can be decreased when combined with Interferon gamma-1b.,Theodrenaline
DB13203,The metabolism of Bamifylline can be decreased when combined with Interferon gamma-1b.,Bamifylline
DB13449,The metabolism of Proxyphylline can be decreased when combined with Interferon gamma-1b.,Proxyphylline
DB13573,The metabolism of Acefylline can be decreased when combined with Interferon gamma-1b.,Acefylline
DB13592,The metabolism of Etamiphylline can be decreased when combined with Interferon gamma-1b.,Etamiphylline
DB13634,The metabolism of Pentifylline can be decreased when combined with Interferon gamma-1b.,Pentifylline
DB13812,The metabolism of Bufylline can be decreased when combined with Interferon gamma-1b.,Bufylline
DB14018,The metabolism of Bromotheophylline can be decreased when combined with Interferon gamma-1b.,Bromotheophylline
DB14029,The metabolism of Furafylline can be decreased when combined with Interferon gamma-1b.,Furafylline
DB14132,The metabolism of 8-chlorotheophylline can be decreased when combined with Interferon gamma-1b.,8-chlorotheophylline
DB15122,The metabolism of PCS-499 can be decreased when combined with Interferon gamma-1b.,PCS-499
DB04914,The therapeutic efficacy of G17DT can be decreased when used in combination with Interferon gamma-1b.,G17DT
DB05144,The therapeutic efficacy of PEV3A can be decreased when used in combination with Interferon gamma-1b.,PEV3A
DB05325,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Interferon gamma-1b.,INGN 225
DB05374,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Interferon gamma-1b.,Rindopepimut
DB05440,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Interferon gamma-1b.,SRP 299
DB05942,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Interferon gamma-1b.,GI-5005
DB06400,The therapeutic efficacy of Vitespen can be decreased when used in combination with Interferon gamma-1b.,Vitespen
DB06584,The therapeutic efficacy of TG4010 can be decreased when used in combination with Interferon gamma-1b.,TG4010
DB09057,The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Interferon gamma-1b.,Anthrax immune globulin human
DB10062,"The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Interferon gamma-1b.","Rabies virus inactivated antigen, B"
DB10076,The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Interferon gamma-1b.,Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen
DB10276,The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Interferon gamma-1b.,Rotavirus vaccine
DB10283,"The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Interferon gamma-1b.","Rabies virus inactivated antigen, A"
DB10342,The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Interferon gamma-1b.,Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen
DB10583,The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon gamma-1b.,Clostridium tetani toxoid antigen (formaldehyde inactivated)
DB10584,The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon gamma-1b.,Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)
DB10600,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Interferon gamma-1b.,Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated)
DB10769,The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon gamma-1b.,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated)
DB10794,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon gamma-1b.,Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated)
DB10803,The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Interferon gamma-1b.,Typhoid Vi polysaccharide vaccine
DB10989,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Interferon gamma-1b.,Hepatitis A Vaccine
DB10990,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Interferon gamma-1b.,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen
DB11038,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Interferon gamma-1b.,Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated)
DB11040,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Interferon gamma-1b.,Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated)
DB11041,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Interferon gamma-1b.,Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)
DB11044,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated) can be decreased when used in combination with Interferon gamma-1b.,Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated)
DB11603,The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Interferon gamma-1b.,Human rabies virus immune globulin
DB11627,The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Interferon gamma-1b.,Hepatitis B Vaccine (Recombinant)
DB12568,The therapeutic efficacy of Tecemotide can be decreased when used in combination with Interferon gamma-1b.,Tecemotide
DB14022,The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Interferon gamma-1b.,Typhoid vaccine
DB14384,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon gamma-1b.,Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated)
DB14385,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon gamma-1b.,Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated)
DB14394,The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with Interferon gamma-1b.,Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen
DB14445,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon gamma-1b.,Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated)
DB14449,The therapeutic efficacy of Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen can be decreased when used in combination with Interferon gamma-1b.,Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen
DB14619,The therapeutic efficacy of Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated) can be decreased when used in combination with Interferon gamma-1b.,Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated)
DB14620,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Interferon gamma-1b.,Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated)
DB14711,The therapeutic efficacy of Vaccinia virus strain new york city board of health live antigen can be decreased when used in combination with Interferon gamma-1b.,Vaccinia virus strain new york city board of health live antigen
DB15274,The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Interferon gamma-1b.,Pertussis vaccine
DB15461,The therapeutic efficacy of Yersinia pestis 195/p antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon gamma-1b.,Yersinia pestis 195/p antigen (formaldehyde inactivated)
DB13924,The therapeutic efficacy of Varicella Zoster Vaccine (Recombinant) can be decreased when used in combination with Interferon gamma-1b.,Varicella Zoster Vaccine (Recombinant)
DB15483,The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Interferon gamma-1b.,Modified vaccinia ankara
DB15595,"The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Interferon gamma-1b.","Ebola Zaire vaccine (live, attenuated)"
DB00054,The risk or severity of bleeding can be increased when Abciximab is combined with Interferon gamma-1b.,Abciximab
DB00063,The risk or severity of bleeding can be increased when Eptifibatide is combined with Interferon gamma-1b.,Eptifibatide
DB00208,The risk or severity of bleeding can be increased when Ticlopidine is combined with Interferon gamma-1b.,Ticlopidine
DB00775,The risk or severity of bleeding can be increased when Tirofiban is combined with Interferon gamma-1b.,Tirofiban
DB00945,The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Interferon gamma-1b.,Acetylsalicylic acid
DB00975,The risk or severity of bleeding can be increased when Dipyridamole is combined with Interferon gamma-1b.,Dipyridamole
DB01088,The risk or severity of bleeding can be increased when Iloprost is combined with Interferon gamma-1b.,Iloprost
DB01138,The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Interferon gamma-1b.,Sulfinpyrazone
DB01207,The risk or severity of bleeding can be increased when Ridogrel is combined with Interferon gamma-1b.,Ridogrel
DB01236,The risk or severity of bleeding can be increased when Sevoflurane is combined with Interferon gamma-1b.,Sevoflurane
DB01240,The risk or severity of bleeding can be increased when Epoprostenol is combined with Interferon gamma-1b.,Epoprostenol
DB04743,The risk or severity of bleeding can be increased when Nimesulide is combined with Interferon gamma-1b.,Nimesulide
DB04905,The risk or severity of bleeding can be increased when Tesmilifene is combined with Interferon gamma-1b.,Tesmilifene
DB04932,The risk or severity of bleeding can be increased when Defibrotide is combined with Interferon gamma-1b.,Defibrotide
DB05229,The risk or severity of bleeding can be increased when Beraprost is combined with Interferon gamma-1b.,Beraprost
DB05266,The risk or severity of bleeding can be increased when Ibudilast is combined with Interferon gamma-1b.,Ibudilast
DB05767,The risk or severity of bleeding can be increased when Andrographolide is combined with Interferon gamma-1b.,Andrographolide
DB06081,The risk or severity of bleeding can be increased when Caplacizumab is combined with Interferon gamma-1b.,Caplacizumab
DB06209,The risk or severity of bleeding can be increased when Prasugrel is combined with Interferon gamma-1b.,Prasugrel
DB06441,The risk or severity of bleeding can be increased when Cangrelor is combined with Interferon gamma-1b.,Cangrelor
DB07615,The risk or severity of bleeding can be increased when Tranilast is combined with Interferon gamma-1b.,Tranilast
DB08814,The risk or severity of bleeding can be increased when Triflusal is combined with Interferon gamma-1b.,Triflusal
DB08816,The risk or severity of bleeding can be increased when Ticagrelor is combined with Interferon gamma-1b.,Ticagrelor
DB08887,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Interferon gamma-1b.,Icosapent ethyl
DB09030,The risk or severity of bleeding can be increased when Vorapaxar is combined with Interferon gamma-1b.,Vorapaxar
DB09283,The risk or severity of bleeding can be increased when Trapidil is combined with Interferon gamma-1b.,Trapidil
DB12092,The risk or severity of bleeding can be increased when Naftopidil is combined with Interferon gamma-1b.,Naftopidil
DB12163,The risk or severity of bleeding can be increased when Sarpogrelate is combined with Interferon gamma-1b.,Sarpogrelate
DB12321,The risk or severity of bleeding can be increased when Ifetroban is combined with Interferon gamma-1b.,Ifetroban
DB12445,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Interferon gamma-1b.,Nitroaspirin
DB12465,The risk or severity of bleeding can be increased when Ketanserin is combined with Interferon gamma-1b.,Ketanserin
DB12545,The risk or severity of bleeding can be increased when Indobufen is combined with Interferon gamma-1b.,Indobufen
DB12749,The risk or severity of bleeding can be increased when Butylphthalide is combined with Interferon gamma-1b.,Butylphthalide
DB12771,The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Interferon gamma-1b.,Hydroxytyrosol
DB13036,The risk or severity of bleeding can be increased when Ramatroban is combined with Interferon gamma-1b.,Ramatroban
DB13327,The risk or severity of bleeding can be increased when Picotamide is combined with Interferon gamma-1b.,Picotamide
DB13367,The risk or severity of bleeding can be increased when Cloricromen is combined with Interferon gamma-1b.,Cloricromen
DB13400,The risk or severity of bleeding can be increased when Linsidomine is combined with Interferon gamma-1b.,Linsidomine
DB13510,The risk or severity of bleeding can be increased when Buflomedil is combined with Interferon gamma-1b.,Buflomedil
DB13929,The risk or severity of bleeding can be increased when Relcovaptan is combined with Interferon gamma-1b.,Relcovaptan
DB13200,Interferon gamma-1b may increase the myelosuppressive activities of Lipegfilgrastim.,Lipegfilgrastim
DB10317,The risk or severity of infection can be increased when Rubella virus vaccine is combined with Interferon gamma-1b.,Rubella virus vaccine
DB10318,The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Interferon gamma-1b.,Varicella Zoster Vaccine (Live/attenuated)
DB10343,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Interferon gamma-1b.,Bacillus calmette-guerin substrain tice live antigen
DB10804,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Interferon gamma-1b.,Bacillus calmette-guerin substrain connaught live antigen
DB10805,The risk or severity of infection can be increased when Yellow Fever Vaccine is combined with Interferon gamma-1b.,Yellow Fever Vaccine
DB11003,The risk or severity of infection can be increased when Anthrax vaccine is combined with Interferon gamma-1b.,Anthrax vaccine
DB11050,The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Interferon gamma-1b.,Typhoid Vaccine Live
DB12386,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain danish 1331 live antigen is combined with Interferon gamma-1b.,Bacillus calmette-guerin substrain danish 1331 live antigen
DB12768,The risk or severity of infection can be increased when BCG vaccine is combined with Interferon gamma-1b.,BCG vaccine
DB14409,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Interferon gamma-1b.,Human adenovirus e serotype 4 strain cl-68578 antigen
DB14443,The risk or severity of infection can be increased when Vibrio cholerae CVD 103-HgR strain live antigen is combined with Interferon gamma-1b.,Vibrio cholerae CVD 103-HgR strain live antigen
DB14685,The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Interferon gamma-1b.,Adenovirus type 7 vaccine live
DB00039,The therapeutic efficacy of Palifermin can be decreased when used in combination with Interferon gamma-1b.,Palifermin
DB00176,The metabolism of Fluvoxamine can be decreased when combined with Interferon gamma-1b.,Fluvoxamine
DB00184,The metabolism of Nicotine can be decreased when combined with Interferon gamma-1b.,Nicotine
DB00195,The metabolism of Betaxolol can be decreased when combined with Interferon gamma-1b.,Betaxolol
DB00261,The metabolism of Anagrelide can be decreased when combined with Interferon gamma-1b.,Anagrelide
DB00280,The metabolism of Disopyramide can be decreased when combined with Interferon gamma-1b.,Disopyramide
DB00281,The metabolism of Lidocaine can be decreased when combined with Interferon gamma-1b.,Lidocaine
DB00286,The metabolism of Conjugated estrogens can be decreased when combined with Interferon gamma-1b.,Conjugated estrogens
DB00296,The metabolism of Ropivacaine can be decreased when combined with Interferon gamma-1b.,Ropivacaine
DB00316,The metabolism of Acetaminophen can be decreased when combined with Interferon gamma-1b.,Acetaminophen
DB00334,The metabolism of Olanzapine can be decreased when combined with Interferon gamma-1b.,Olanzapine
DB00356,The metabolism of Chlorzoxazone can be decreased when combined with Interferon gamma-1b.,Chlorzoxazone
DB00365,The metabolism of Grepafloxacin can be decreased when combined with Interferon gamma-1b.,Grepafloxacin
DB00370,The metabolism of Mirtazapine can be decreased when combined with Interferon gamma-1b.,Mirtazapine
DB00379,The metabolism of Mexiletine can be decreased when combined with Interferon gamma-1b.,Mexiletine
DB00382,The metabolism of Tacrine can be decreased when combined with Interferon gamma-1b.,Tacrine
DB00384,The metabolism of Triamterene can be decreased when combined with Interferon gamma-1b.,Triamterene
DB00420,The metabolism of Promazine can be decreased when combined with Interferon gamma-1b.,Promazine
DB00425,The metabolism of Zolpidem can be decreased when combined with Interferon gamma-1b.,Zolpidem
DB00442,The metabolism of Entecavir can be decreased when combined with Interferon gamma-1b.,Entecavir
DB00461,The metabolism of Nabumetone can be decreased when combined with Interferon gamma-1b.,Nabumetone
DB00468,The metabolism of Quinine can be decreased when combined with Interferon gamma-1b.,Quinine
DB00472,The metabolism of Fluoxetine can be decreased when combined with Interferon gamma-1b.,Fluoxetine
DB00476,The metabolism of Duloxetine can be decreased when combined with Interferon gamma-1b.,Duloxetine
DB00477,The metabolism of Chlorpromazine can be decreased when combined with Interferon gamma-1b.,Chlorpromazine
DB00499,The metabolism of Flutamide can be decreased when combined with Interferon gamma-1b.,Flutamide
DB00502,The metabolism of Haloperidol can be decreased when combined with Interferon gamma-1b.,Haloperidol
DB00518,The metabolism of Albendazole can be decreased when combined with Interferon gamma-1b.,Albendazole
DB00533,The metabolism of Rofecoxib can be decreased when combined with Interferon gamma-1b.,Rofecoxib
DB00568,The metabolism of Cinnarizine can be decreased when combined with Interferon gamma-1b.,Cinnarizine
DB00571,The metabolism of Propranolol can be decreased when combined with Interferon gamma-1b.,Propranolol
DB00586,The metabolism of Diclofenac can be decreased when combined with Interferon gamma-1b.,Diclofenac
DB00629,The metabolism of Guanabenz can be decreased when combined with Interferon gamma-1b.,Guanabenz
DB00661,The metabolism of Verapamil can be decreased when combined with Interferon gamma-1b.,Verapamil
DB00715,The metabolism of Paroxetine can be decreased when combined with Interferon gamma-1b.,Paroxetine
DB00730,The metabolism of Thiabendazole can be decreased when combined with Interferon gamma-1b.,Thiabendazole
DB00740,The metabolism of Riluzole can be decreased when combined with Interferon gamma-1b.,Riluzole
DB00744,The metabolism of Zileuton can be decreased when combined with Interferon gamma-1b.,Zileuton
DB00758,The metabolism of Clopidogrel can be decreased when combined with Interferon gamma-1b.,Clopidogrel
DB00783,The metabolism of Estradiol can be decreased when combined with Interferon gamma-1b.,Estradiol
DB00787,The metabolism of Acyclovir can be decreased when combined with Interferon gamma-1b.,Acyclovir
DB00788,The metabolism of Naproxen can be decreased when combined with Interferon gamma-1b.,Naproxen
DB00831,The metabolism of Trifluoperazine can be decreased when combined with Interferon gamma-1b.,Trifluoperazine
DB00850,The metabolism of Perphenazine can be decreased when combined with Interferon gamma-1b.,Perphenazine
DB00857,The metabolism of Terbinafine can be decreased when combined with Interferon gamma-1b.,Terbinafine
DB00863,The metabolism of Ranitidine can be decreased when combined with Interferon gamma-1b.,Ranitidine
DB00898,The metabolism of Ethanol can be decreased when combined with Interferon gamma-1b.,Ethanol
DB00934,The metabolism of Maprotiline can be decreased when combined with Interferon gamma-1b.,Maprotiline
DB00969,The metabolism of Alosetron can be decreased when combined with Interferon gamma-1b.,Alosetron
DB00978,The metabolism of Lomefloxacin can be decreased when combined with Interferon gamma-1b.,Lomefloxacin
DB00980,The metabolism of Ramelteon can be decreased when combined with Interferon gamma-1b.,Ramelteon
DB00998,The metabolism of Frovatriptan can be decreased when combined with Interferon gamma-1b.,Frovatriptan
DB01002,The metabolism of Levobupivacaine can be decreased when combined with Interferon gamma-1b.,Levobupivacaine
DB01012,The metabolism of Cinacalcet can be decreased when combined with Interferon gamma-1b.,Cinacalcet
DB01037,The metabolism of Selegiline can be decreased when combined with Interferon gamma-1b.,Selegiline
DB01056,The metabolism of Tocainide can be decreased when combined with Interferon gamma-1b.,Tocainide
DB01058,The metabolism of Praziquantel can be decreased when combined with Interferon gamma-1b.,Praziquantel
DB01065,The metabolism of Melatonin can be decreased when combined with Interferon gamma-1b.,Melatonin
DB01087,The metabolism of Primaquine can be decreased when combined with Interferon gamma-1b.,Primaquine
DB01094,The metabolism of Hesperetin can be decreased when combined with Interferon gamma-1b.,Hesperetin
DB01115,The metabolism of Nifedipine can be decreased when combined with Interferon gamma-1b.,Nifedipine
DB01136,The metabolism of Carvedilol can be decreased when combined with Interferon gamma-1b.,Carvedilol
DB01166,The metabolism of Cilostazol can be decreased when combined with Interferon gamma-1b.,Cilostazol
DB01182,The metabolism of Propafenone can be decreased when combined with Interferon gamma-1b.,Propafenone
DB01184,The metabolism of Domperidone can be decreased when combined with Interferon gamma-1b.,Domperidone
DB01191,The metabolism of Dexfenfluramine can be decreased when combined with Interferon gamma-1b.,Dexfenfluramine
DB01367,The metabolism of Rasagiline can be decreased when combined with Interferon gamma-1b.,Rasagiline
DB01405,The metabolism of Temafloxacin can be decreased when combined with Interferon gamma-1b.,Temafloxacin
DB01424,The metabolism of Aminophenazone can be decreased when combined with Interferon gamma-1b.,Aminophenazone
DB01435,The metabolism of Antipyrine can be decreased when combined with Interferon gamma-1b.,Antipyrine
DB01558,The metabolism of Bromazepam can be decreased when combined with Interferon gamma-1b.,Bromazepam
DB01623,The metabolism of Thiothixene can be decreased when combined with Interferon gamma-1b.,Thiothixene
DB01628,The metabolism of Etoricoxib can be decreased when combined with Interferon gamma-1b.,Etoricoxib
DB01645,The metabolism of Genistein can be decreased when combined with Interferon gamma-1b.,Genistein
DB02709,The metabolism of Resveratrol can be decreased when combined with Interferon gamma-1b.,Resveratrol
DB03783,The metabolism of Phenacetin can be decreased when combined with Interferon gamma-1b.,Phenacetin
DB04574,The metabolism of Estrone sulfate can be decreased when combined with Interferon gamma-1b.,Estrone sulfate
DB04841,The metabolism of Flunarizine can be decreased when combined with Interferon gamma-1b.,Flunarizine
DB04871,The metabolism of Lorcaserin can be decreased when combined with Interferon gamma-1b.,Lorcaserin
DB04948,The metabolism of Lofexidine can be decreased when combined with Interferon gamma-1b.,Lofexidine
DB06148,The metabolism of Mianserin can be decreased when combined with Interferon gamma-1b.,Mianserin
DB06210,The metabolism of Eltrombopag can be decreased when combined with Interferon gamma-1b.,Eltrombopag
DB06216,The metabolism of Asenapine can be decreased when combined with Interferon gamma-1b.,Asenapine
DB06235,The metabolism of Vadimezan can be decreased when combined with Interferon gamma-1b.,Vadimezan
DB06292,The metabolism of Dapagliflozin can be decreased when combined with Interferon gamma-1b.,Dapagliflozin
DB06594,The metabolism of Agomelatine can be decreased when combined with Interferon gamma-1b.,Agomelatine
DB06626,The metabolism of Axitinib can be decreased when combined with Interferon gamma-1b.,Axitinib
DB06770,The metabolism of Benzyl alcohol can be decreased when combined with Interferon gamma-1b.,Benzyl alcohol
DB06774,The metabolism of Capsaicin can be decreased when combined with Interferon gamma-1b.,Capsaicin
DB08496,The metabolism of (R)-warfarin can be decreased when combined with Interferon gamma-1b.,(R)-warfarin
DB08883,The metabolism of Perampanel can be decreased when combined with Interferon gamma-1b.,Perampanel
DB09071,The metabolism of Tasimelteon can be decreased when combined with Interferon gamma-1b.,Tasimelteon
DB09118,The metabolism of Stiripentol can be decreased when combined with Interferon gamma-1b.,Stiripentol
DB09225,The metabolism of Zotepine can be decreased when combined with Interferon gamma-1b.,Zotepine
DB09288,The metabolism of Propacetamol can be decreased when combined with Interferon gamma-1b.,Propacetamol
DB09290,The metabolism of Ramosetron can be decreased when combined with Interferon gamma-1b.,Ramosetron
DB11967,The metabolism of Binimetinib can be decreased when combined with Interferon gamma-1b.,Binimetinib
DB12026,The metabolism of Voxilaprevir can be decreased when combined with Interferon gamma-1b.,Voxilaprevir
DB12245,The metabolism of Triclabendazole can be decreased when combined with Interferon gamma-1b.,Triclabendazole
DB12332,The metabolism of Rucaparib can be decreased when combined with Interferon gamma-1b.,Rucaparib
DB12945,The metabolism of Dihydralazine can be decreased when combined with Interferon gamma-1b.,Dihydralazine
DB13952,The metabolism of Estradiol acetate can be decreased when combined with Interferon gamma-1b.,Estradiol acetate
DB13953,The metabolism of Estradiol benzoate can be decreased when combined with Interferon gamma-1b.,Estradiol benzoate
DB13954,The metabolism of Estradiol cypionate can be decreased when combined with Interferon gamma-1b.,Estradiol cypionate
DB13955,The metabolism of Estradiol dienanthate can be decreased when combined with Interferon gamma-1b.,Estradiol dienanthate
DB13956,The metabolism of Estradiol valerate can be decreased when combined with Interferon gamma-1b.,Estradiol valerate
DB11757,The metabolism of Istradefylline can be decreased when combined with Interferon gamma-1b.,Istradefylline
DB00972,The metabolism of Azelastine can be decreased when combined with Interferon gamma-1b.,Azelastine
DB00625,The metabolism of Efavirenz can be decreased when combined with Interferon gamma-1b.,Efavirenz
DB01233,The metabolism of Metoclopramide can be decreased when combined with Interferon gamma-1b.,Metoclopramide
DB04889,The metabolism of Bicifadine can be decreased when combined with Interferon gamma-1b.,Bicifadine
DB05708,The metabolism of GTS-21 can be decreased when combined with Interferon gamma-1b.,GTS-21
DB01195,The metabolism of Flecainide can be decreased when combined with Interferon gamma-1b.,Flecainide
DB00977,The metabolism of Ethinylestradiol can be decreased when combined with Interferon gamma-1b.,Ethinylestradiol
DB00321,The metabolism of Amitriptyline can be decreased when combined with Interferon gamma-1b.,Amitriptyline
DB00458,The metabolism of Imipramine can be decreased when combined with Interferon gamma-1b.,Imipramine
DB01142,The metabolism of Doxepin can be decreased when combined with Interferon gamma-1b.,Doxepin
DB00532,The metabolism of Mephenytoin can be decreased when combined with Interferon gamma-1b.,Mephenytoin
DB00540,The metabolism of Nortriptyline can be decreased when combined with Interferon gamma-1b.,Nortriptyline
DB00575,The metabolism of Clonidine can be decreased when combined with Interferon gamma-1b.,Clonidine
DB00924,The metabolism of Cyclobenzaprine can be decreased when combined with Interferon gamma-1b.,Cyclobenzaprine
DB01151,The metabolism of Desipramine can be decreased when combined with Interferon gamma-1b.,Desipramine
DB01242,The metabolism of Clomipramine can be decreased when combined with Interferon gamma-1b.,Clomipramine
DB11689,The metabolism of Selumetinib can be decreased when combined with Interferon gamma-1b.,Selumetinib
DB00277,The metabolism of Theophylline can be decreased when combined with Interferon gamma-1b.,Theophylline
DB00682,The metabolism of Warfarin can be decreased when combined with Interferon gamma-1b.,Warfarin
DB00697,The metabolism of Tizanidine can be decreased when combined with Interferon gamma-1b.,Tizanidine
DB01100,The metabolism of Pimozide can be decreased when combined with Interferon gamma-1b.,Pimozide
DB01223,The metabolism of Aminophylline can be decreased when combined with Interferon gamma-1b.,Aminophylline
DB01418,The metabolism of Acenocoumarol can be decreased when combined with Interferon gamma-1b.,Acenocoumarol
DB00530,The metabolism of Erlotinib can be decreased when combined with Interferon gamma-1b.,Erlotinib
DB09256,The metabolism of Tegafur can be decreased when combined with Interferon gamma-1b.,Tegafur
DB13874,The metabolism of Enasidenib can be decreased when combined with Interferon gamma-1b.,Enasidenib
DB00675,The metabolism of Tamoxifen can be decreased when combined with Interferon gamma-1b.,Tamoxifen
DB00001,The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon gamma-1b.,Lepirudin
DB00006,The risk or severity of bleeding can be increased when Bivalirudin is combined with Interferon gamma-1b.,Bivalirudin
DB00009,The risk or severity of bleeding can be increased when Alteplase is combined with Interferon gamma-1b.,Alteplase
DB00013,The risk or severity of bleeding can be increased when Urokinase is combined with Interferon gamma-1b.,Urokinase
DB00015,The risk or severity of bleeding can be increased when Reteplase is combined with Interferon gamma-1b.,Reteplase
DB00029,The risk or severity of bleeding can be increased when Anistreplase is combined with Interferon gamma-1b.,Anistreplase
DB00031,The risk or severity of bleeding can be increased when Tenecteplase is combined with Interferon gamma-1b.,Tenecteplase
DB00055,The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Interferon gamma-1b.,Drotrecogin alfa
DB00086,The risk or severity of bleeding can be increased when Streptokinase is combined with Interferon gamma-1b.,Streptokinase
DB00266,The risk or severity of bleeding can be increased when Dicoumarol is combined with Interferon gamma-1b.,Dicoumarol
DB00278,The risk or severity of bleeding can be increased when Argatroban is combined with Interferon gamma-1b.,Argatroban
DB00407,The risk or severity of bleeding can be increased when Ardeparin is combined with Interferon gamma-1b.,Ardeparin
DB00498,The risk or severity of bleeding can be increased when Phenindione is combined with Interferon gamma-1b.,Phenindione
DB00569,The risk or severity of bleeding can be increased when Fondaparinux is combined with Interferon gamma-1b.,Fondaparinux
DB00686,The risk or severity of bleeding can be increased when Pentosan polysulfate is combined with Interferon gamma-1b.,Pentosan polysulfate
DB00946,The risk or severity of bleeding can be increased when Phenprocoumon is combined with Interferon gamma-1b.,Phenprocoumon
DB01109,The risk or severity of bleeding can be increased when Heparin is combined with Interferon gamma-1b.,Heparin
DB01225,The risk or severity of bleeding can be increased when Enoxaparin is combined with Interferon gamma-1b.,Enoxaparin
DB03410,The risk or severity of bleeding can be increased when 4-hydroxycoumarin is combined with Interferon gamma-1b.,4-hydroxycoumarin
DB04665,The risk or severity of bleeding can be increased when Coumarin is combined with Interferon gamma-1b.,Coumarin
DB04898,The risk or severity of bleeding can be increased when Ximelagatran is combined with Interferon gamma-1b.,Ximelagatran
DB04925,The risk or severity of bleeding can be increased when Desmoteplase is combined with Interferon gamma-1b.,Desmoteplase
DB05099,The risk or severity of bleeding can be increased when Ancrod is combined with Interferon gamma-1b.,Ancrod
DB05254,The risk or severity of bleeding can be increased when Fibrinolysin is combined with Interferon gamma-1b.,Fibrinolysin
DB06228,The risk or severity of bleeding can be increased when Rivaroxaban is combined with Interferon gamma-1b.,Rivaroxaban
DB06271,The risk or severity of bleeding can be increased when Sulodexide is combined with Interferon gamma-1b.,Sulodexide
DB06294,The risk or severity of bleeding can be increased when Semuloparin is combined with Interferon gamma-1b.,Semuloparin
DB06406,The risk or severity of bleeding can be increased when Idraparinux is combined with Interferon gamma-1b.,Idraparinux
DB06543,The risk or severity of bleeding can be increased when Astaxanthin is combined with Interferon gamma-1b.,Astaxanthin
DB06605,The risk or severity of bleeding can be increased when Apixaban is combined with Interferon gamma-1b.,Apixaban
DB06635,The risk or severity of bleeding can be increased when Otamixaban is combined with Interferon gamma-1b.,Otamixaban
DB06679,The risk or severity of bleeding can be increased when Amediplase is combined with Interferon gamma-1b.,Amediplase
DB06695,The risk or severity of bleeding can be increased when Dabigatran etexilate is combined with Interferon gamma-1b.,Dabigatran etexilate
DB06754,The risk or severity of bleeding can be increased when Danaparoid is combined with Interferon gamma-1b.,Danaparoid
DB06779,The risk or severity of bleeding can be increased when Dalteparin is combined with Interferon gamma-1b.,Dalteparin
DB06822,The risk or severity of bleeding can be increased when Tinzaparin is combined with Interferon gamma-1b.,Tinzaparin
DB07767,The risk or severity of bleeding can be increased when Ferulic acid is combined with Interferon gamma-1b.,Ferulic acid
DB08794,The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Interferon gamma-1b.,Ethyl biscoumacetate
DB08813,The risk or severity of bleeding can be increased when Nadroparin is combined with Interferon gamma-1b.,Nadroparin
DB08994,The risk or severity of bleeding can be increased when Ditazole is combined with Interferon gamma-1b.,Ditazole
DB09075,The risk or severity of bleeding can be increased when Edoxaban is combined with Interferon gamma-1b.,Edoxaban
DB09125,The risk or severity of bleeding can be increased when Potassium citrate is combined with Interferon gamma-1b.,Potassium citrate
DB09154,The risk or severity of bleeding can be increased when Sodium citrate is combined with Interferon gamma-1b.,Sodium citrate
DB09255,The risk or severity of bleeding can be increased when Dextran is combined with Interferon gamma-1b.,Dextran
DB09258,The risk or severity of bleeding can be increased when Bemiparin is combined with Interferon gamma-1b.,Bemiparin
DB09259,The risk or severity of bleeding can be increased when Reviparin is combined with Interferon gamma-1b.,Reviparin
DB09260,The risk or severity of bleeding can be increased when Parnaparin is combined with Interferon gamma-1b.,Parnaparin
DB09261,The risk or severity of bleeding can be increased when Certoparin is combined with Interferon gamma-1b.,Certoparin
DB11095,The risk or severity of bleeding can be increased when Desirudin is combined with Interferon gamma-1b.,Desirudin
DB11154,The risk or severity of bleeding can be increased when Zinc citrate is combined with Interferon gamma-1b.,Zinc citrate
DB11166,The risk or severity of bleeding can be increased when Antithrombin Alfa is combined with Interferon gamma-1b.,Antithrombin Alfa
DB11312,The risk or severity of bleeding can be increased when Protein C is combined with Interferon gamma-1b.,Protein C
DB11598,The risk or severity of bleeding can be increased when Antithrombin III human is combined with Interferon gamma-1b.,Antithrombin III human
DB11984,The risk or severity of bleeding can be increased when Letaxaban is combined with Interferon gamma-1b.,Letaxaban
DB12289,The risk or severity of bleeding can be increased when Darexaban is combined with Interferon gamma-1b.,Darexaban
DB12364,The risk or severity of bleeding can be increased when Betrixaban is combined with Interferon gamma-1b.,Betrixaban
DB12598,The risk or severity of bleeding can be increased when Nafamostat is combined with Interferon gamma-1b.,Nafamostat
DB12726,The risk or severity of bleeding can be increased when Monteplase is combined with Interferon gamma-1b.,Monteplase
DB12831,The risk or severity of bleeding can be increased when Gabexate is combined with Interferon gamma-1b.,Gabexate
DB13136,The risk or severity of bleeding can be increased when Fluindione is combined with Interferon gamma-1b.,Fluindione
DB13149,The risk or severity of bleeding can be increased when Protein S human is combined with Interferon gamma-1b.,Protein S human
DB13199,The risk or severity of bleeding can be increased when Brinase is combined with Interferon gamma-1b.,Brinase
DB13275,The risk or severity of bleeding can be increased when Clorindione is combined with Interferon gamma-1b.,Clorindione
DB13347,The risk or severity of bleeding can be increased when Diphenadione is combined with Interferon gamma-1b.,Diphenadione
DB13451,The risk or severity of bleeding can be increased when Tioclomarol is combined with Interferon gamma-1b.,Tioclomarol
DB13616,The risk or severity of bleeding can be increased when Melagatran is combined with Interferon gamma-1b.,Melagatran
DB13646,The risk or severity of bleeding can be increased when Saruplase is combined with Interferon gamma-1b.,Saruplase
DB14055,The risk or severity of bleeding can be increased when (S)-Warfarin is combined with Interferon gamma-1b.,(S)-Warfarin
DB14094,The risk or severity of bleeding can be increased when Tocopherylquinone is combined with Interferon gamma-1b.,Tocopherylquinone
DB14598,The risk or severity of bleeding can be increased when Edetate calcium disodium anhydrous is combined with Interferon gamma-1b.,Edetate calcium disodium anhydrous
DB14726,The risk or severity of bleeding can be increased when Dabigatran is combined with Interferon gamma-1b.,Dabigatran
DB00232,The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Interferon gamma-1b.,Methyclothiazide
DB00436,The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Interferon gamma-1b.,Bendroflumethiazide
DB00562,The risk or severity of neutropenia and thrombocytopenia can be increased when Benzthiazide is combined with Interferon gamma-1b.,Benzthiazide
DB00606,The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclothiazide is combined with Interferon gamma-1b.,Cyclothiazide
DB00774,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Interferon gamma-1b.,Hydroflumethiazide
DB00880,The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Interferon gamma-1b.,Chlorothiazide
DB00999,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Interferon gamma-1b.,Hydrochlorothiazide
DB01021,The risk or severity of neutropenia and thrombocytopenia can be increased when Trichlormethiazide is combined with Interferon gamma-1b.,Trichlormethiazide
DB01324,The risk or severity of neutropenia and thrombocytopenia can be increased when Polythiazide is combined with Interferon gamma-1b.,Polythiazide
DB13430,The risk or severity of neutropenia and thrombocytopenia can be increased when Mebutizide is combined with Interferon gamma-1b.,Mebutizide
DB13532,The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclopenthiazide is combined with Interferon gamma-1b.,Cyclopenthiazide
DB09042,The risk or severity of myelosuppression can be increased when Interferon gamma-1b is combined with Tedizolid phosphate.,Tedizolid phosphate
DB00091,Interferon gamma-1b may increase the immunosuppressive activities of Cyclosporine.,Cyclosporine
DB00268,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Ropinirole.,Ropinirole
DB00115,The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Interferon gamma-1b.,Cyanocobalamin
DB00437,The risk or severity of adverse effects can be increased when Allopurinol is combined with Interferon gamma-1b.,Allopurinol
DB14513,The serum concentration of Magnesium can be decreased when it is combined with Interferon gamma-1b.,Magnesium
DB01601,The serum concentration of Interferon gamma-1b can be increased when it is combined with Lopinavir.,Lopinavir
DB12530,The risk or severity of infection can be increased when Interferon gamma-1b is combined with Inebilizumab.,Inebilizumab
DB06643,"The risk or severity of adverse effects can be increased when Denosumab is combined with Interferon alfa-2a, Recombinant.",Denosumab
DB00005,"The risk or severity of adverse effects can be increased when Etanercept is combined with Interferon alfa-2a, Recombinant.",Etanercept
DB00008,"The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Interferon alfa-2a, Recombinant.",Peginterferon alfa-2a
DB00011,"The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Interferon alfa-2a, Recombinant.",Interferon alfa-n1
DB00018,"The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Interferon alfa-2a, Recombinant.",Interferon alfa-n3
DB00022,"The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Interferon alfa-2a, Recombinant.",Peginterferon alfa-2b
DB00026,"The risk or severity of adverse effects can be increased when Anakinra is combined with Interferon alfa-2a, Recombinant.",Anakinra
DB00033,"The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Interferon alfa-2a, Recombinant.",Interferon gamma-1b
DB00051,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Adalimumab.",Adalimumab
DB00056,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Gemtuzumab ozogamicin.",Gemtuzumab ozogamicin
DB00059,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Pegaspargase.",Pegaspargase
DB00065,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Infliximab.",Infliximab
DB00068,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Interferon beta-1b.",Interferon beta-1b
DB00069,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Interferon alfacon-1.",Interferon alfacon-1
DB00073,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Rituximab.",Rituximab
DB00074,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Basiliximab.",Basiliximab
DB00075,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Muromonab.",Muromonab
DB00078,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Ibritumomab tiuxetan.",Ibritumomab tiuxetan
DB00081,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Tositumomab.",Tositumomab
DB00087,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Alemtuzumab.",Alemtuzumab
DB00092,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Alefacept.",Alefacept
DB00095,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Efalizumab.",Efalizumab
DB00098,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Antithymocyte immunoglobulin (rabbit).",Antithymocyte immunoglobulin (rabbit)
DB00105,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Interferon alfa-2b.",Interferon alfa-2b
DB00111,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Daclizumab.",Daclizumab
DB00112,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Bevacizumab.",Bevacizumab
DB00120,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Phenylalanine.",Phenylalanine
DB00180,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Flunisolide.",Flunisolide
DB00188,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Bortezomib.",Bortezomib
DB00242,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Cladribine.",Cladribine
DB00262,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Carmustine.",Carmustine
DB00276,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Amsacrine.",Amsacrine
DB00290,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Bleomycin.",Bleomycin
DB00291,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Chlorambucil.",Chlorambucil
DB00293,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Raltitrexed.",Raltitrexed
DB00305,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Mitomycin.",Mitomycin
DB00307,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Bexarotene.",Bexarotene
DB00309,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Vindesine.",Vindesine
DB00322,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Floxuridine.",Floxuridine
DB00328,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Indomethacin.",Indomethacin
DB00352,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Tioguanine.",Tioguanine
DB00361,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Vinorelbine.",Vinorelbine
DB00380,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Dexrazoxane.",Dexrazoxane
DB00394,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Beclomethasone dipropionate.",Beclomethasone dipropionate
DB00398,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Sorafenib.",Sorafenib
DB00428,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Streptozocin.",Streptozocin
DB00432,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Trifluridine.",Trifluridine
DB00441,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Gemcitabine.",Gemcitabine
DB00443,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Betamethasone.",Betamethasone
DB00444,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Teniposide.",Teniposide
DB00445,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Epirubicin.",Epirubicin
DB00446,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Chloramphenicol.",Chloramphenicol
DB00480,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Lenalidomide.",Lenalidomide
DB00488,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Altretamine.",Altretamine
DB00495,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Zidovudine.",Zidovudine
DB00515,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Cisplatin.",Cisplatin
DB00526,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Oxaliplatin.",Oxaliplatin
DB00531,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Cyclophosphamide.",Cyclophosphamide
DB00541,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Vincristine.",Vincristine
DB00544,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Fluorouracil.",Fluorouracil
DB00550,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Propylthiouracil.",Propylthiouracil
DB00552,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Pentostatin.",Pentostatin
DB00563,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Methotrexate.",Methotrexate
DB00564,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Carbamazepine.",Carbamazepine
DB00570,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Vinblastine.",Vinblastine
DB00588,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Fluticasone propionate.",Fluticasone propionate
DB00591,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Fluocinolone acetonide.",Fluocinolone acetonide
DB00601,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Linezolid.",Linezolid
DB00619,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Imatinib.",Imatinib
DB00620,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Triamcinolone.",Triamcinolone
DB00631,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Clofarabine.",Clofarabine
DB00635,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Prednisone.",Prednisone
DB00642,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Pemetrexed.",Pemetrexed
DB00687,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Fludrocortisone.",Fludrocortisone
DB00688,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Mycophenolate mofetil.",Mycophenolate mofetil
DB00694,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Daunorubicin.",Daunorubicin
DB00755,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Tretinoin.",Tretinoin
DB00762,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Irinotecan.",Irinotecan
DB00763,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Methimazole.",Methimazole
DB00764,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Mometasone.",Mometasone
DB00773,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Etoposide.",Etoposide
DB00795,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Sulfasalazine.",Sulfasalazine
DB00851,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Dacarbazine.",Dacarbazine
DB00853,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Temozolomide.",Temozolomide
DB00859,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Penicillamine.",Penicillamine
DB00860,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Prednisolone.",Prednisolone
DB00877,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Sirolimus.",Sirolimus
DB00888,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Mechlorethamine.",Mechlorethamine
DB00928,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Azacitidine.",Azacitidine
DB00958,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Carboplatin.",Carboplatin
DB00959,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Methylprednisolone.",Methylprednisolone
DB00970,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Dactinomycin.",Dactinomycin
DB00987,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Cytarabine.",Cytarabine
DB00993,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Azathioprine.",Azathioprine
DB00997,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Doxorubicin.",Doxorubicin
DB01005,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Hydroxyurea.",Hydroxyurea
DB01008,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Busulfan.",Busulfan
DB01024,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Mycophenolic acid.",Mycophenolic acid
DB01030,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Topotecan.",Topotecan
DB01033,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Mercaptopurine.",Mercaptopurine
DB01041,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Thalidomide.",Thalidomide
DB01042,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Melphalan.",Melphalan
DB01073,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Fludarabine.",Fludarabine
DB01099,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Flucytosine.",Flucytosine
DB01101,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Capecitabine.",Capecitabine
DB01108,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Trilostane.",Trilostane
DB01168,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Procarbazine.",Procarbazine
DB01169,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Arsenic trioxide.",Arsenic trioxide
DB01177,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Idarubicin.",Idarubicin
DB01181,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Ifosfamide.",Ifosfamide
DB01196,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Estramustine.",Estramustine
DB01204,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Mitoxantrone.",Mitoxantrone
DB01206,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Lomustine.",Lomustine
DB01222,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Budesonide.",Budesonide
DB01229,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Paclitaxel.",Paclitaxel
DB01234,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Dexamethasone.",Dexamethasone
DB01248,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Docetaxel.",Docetaxel
DB01254,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Dasatinib.",Dasatinib
DB01257,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Eculizumab.",Eculizumab
DB01262,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Decitabine.",Decitabine
DB01268,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Sunitinib.",Sunitinib
DB01280,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Nelarabine.",Nelarabine
DB01281,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Abatacept.",Abatacept
DB01285,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Corticotropin.",Corticotropin
DB01380,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Cortisone acetate.",Cortisone acetate
DB01384,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Paramethasone.",Paramethasone
DB01394,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Colchicine.",Colchicine
DB01410,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Ciclesonide.",Ciclesonide
DB01423,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Stepronin.",Stepronin
DB01590,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Everolimus.",Everolimus
DB01611,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Hydroxychloroquine.",Hydroxychloroquine
DB01816,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Castanospermine.",Castanospermine
DB02546,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Vorinostat.",Vorinostat
DB02806,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with 2-Methoxyethanol.",2-Methoxyethanol
DB03523,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Brequinar.",Brequinar
DB04572,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Thiotepa.",Thiotepa
DB04630,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Aldosterone.",Aldosterone
DB04845,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Ixabepilone.",Ixabepilone
DB04868,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Nilotinib.",Nilotinib
DB04951,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Pirfenidone.",Pirfenidone
DB04956,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Afelimomab.",Afelimomab
DB05015,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Belinostat.",Belinostat
DB05109,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Trabectedin.",Trabectedin
DB05258,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Interferon alfa.",Interferon alfa
DB05259,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Glatiramer.",Glatiramer
DB05260,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Gallium nitrate.",Gallium nitrate
DB05459,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Briakinumab.",Briakinumab
DB05472,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with omega interferon.",omega interferon
DB05676,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Apremilast.",Apremilast
DB05773,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Trastuzumab emtansine.",Trastuzumab emtansine
DB06168,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Canakinumab.",Canakinumab
DB06273,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Tocilizumab.",Tocilizumab
DB06287,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Temsirolimus.",Temsirolimus
DB06372,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Rilonacept.",Rilonacept
DB06589,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Pazopanib.",Pazopanib
DB06603,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Panobinostat.",Panobinostat
DB06612,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Mepolizumab.",Mepolizumab
DB06616,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Bosutinib.",Bosutinib
DB06662,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Abetimus.",Abetimus
DB06674,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Golimumab.",Golimumab
DB06681,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Belatacept.",Belatacept
DB06769,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Bendamustine.",Bendamustine
DB06772,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Cabazitaxel.",Cabazitaxel
DB06813,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Pralatrexate.",Pralatrexate
DB08059,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Wortmannin.",Wortmannin
DB08870,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Brentuximab vedotin.",Brentuximab vedotin
DB08871,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Eribulin.",Eribulin
DB08877,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Ruxolitinib.",Ruxolitinib
DB08879,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Belimumab.",Belimumab
DB08880,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Teriflunomide.",Teriflunomide
DB08889,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Carfilzomib.",Carfilzomib
DB08901,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Ponatinib.",Ponatinib
DB08904,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Certolizumab pegol.",Certolizumab pegol
DB08906,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Fluticasone furoate.",Fluticasone furoate
DB08908,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Dimethyl fumarate.",Dimethyl fumarate
DB08910,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Pomalidomide.",Pomalidomide
DB08935,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Obinutuzumab.",Obinutuzumab
DB08970,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Fluprednidene.",Fluprednidene
DB08971,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Fluocortolone.",Fluocortolone
DB09029,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Secukinumab.",Secukinumab
DB09033,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Vedolizumab.",Vedolizumab
DB09036,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Siltuximab.",Siltuximab
DB09052,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Blinatumomab.",Blinatumomab
DB09053,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Ibrutinib.",Ibrutinib
DB09054,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Idelalisib.",Idelalisib
DB09073,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Palbociclib.",Palbociclib
DB09074,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Olaparib.",Olaparib
DB09077,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Dinutuximab.",Dinutuximab
DB09082,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Vilanterol.",Vilanterol
DB09091,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Tixocortol.",Tixocortol
DB09122,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Peginterferon beta-1a.",Peginterferon beta-1a
DB09312,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Antilymphocyte immunoglobulin (horse).",Antilymphocyte immunoglobulin (horse)
DB09378,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Fluprednisolone.",Fluprednisolone
DB09383,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Meprednisone.",Meprednisone
DB11466,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Tepoxalin.",Tepoxalin
DB11487,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Dexamethasone isonicotinate.",Dexamethasone isonicotinate
DB11529,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Melengestrol.",Melengestrol
DB11569,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Ixekizumab.",Ixekizumab
DB11580,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Ravulizumab.",Ravulizumab
DB11616,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Pirarubicin.",Pirarubicin
DB11693,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Voclosporin.",Voclosporin
DB11708,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Peficitinib.",Peficitinib
DB11750,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Clobetasol.",Clobetasol
DB11767,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Sarilumab.",Sarilumab
DB11776,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Brodalumab.",Brodalumab
DB11803,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Sirukumab.",Sirukumab
DB11817,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Baricitinib.",Baricitinib
DB11834,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Guselkumab.",Guselkumab
DB11921,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Deflazacort.",Deflazacort
DB11988,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Ocrelizumab.",Ocrelizumab
DB12025,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Triptolide.",Triptolide
DB12371,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Siponimod.",Siponimod
DB12612,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Ozanimod.",Ozanimod
DB12617,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Mizoribine.",Mizoribine
DB12692,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Gusperimus.",Gusperimus
DB12814,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Cepeginterferon alfa-2B.",Cepeginterferon alfa-2B
DB12902,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Trofosfamide.",Trofosfamide
DB12947,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Doxifluridine.",Doxifluridine
DB12991,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Deoxyspergualin.",Deoxyspergualin
DB12996,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Acteoside.",Acteoside
DB13003,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Cortivazol.",Cortivazol
DB13014,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Hypericin.",Hypericin
DB13068,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.",9-(N-methyl-L-isoleucine)-cyclosporin A
DB13208,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Prednylidene.",Prednylidene
DB13223,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Fluocortin.",Fluocortin
DB13241,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Begelomab.",Begelomab
DB13491,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Fluperolone.",Fluperolone
DB13664,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Formocortal.",Formocortal
DB13728,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Halometasone.",Halometasone
DB13843,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Cloprednol.",Cloprednol
DB13856,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Fluclorolone.",Fluclorolone
DB13867,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Fluticasone.",Fluticasone
DB14066,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Tetrandrine.",Tetrandrine
DB14219,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Monomethyl fumarate.",Monomethyl fumarate
DB14512,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Mometasone furoate.",Mometasone furoate
DB14538,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Hydrocortisone aceponate.",Hydrocortisone aceponate
DB14539,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Hydrocortisone acetate.",Hydrocortisone acetate
DB14545,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Hydrocortisone succinate.",Hydrocortisone succinate
DB14724,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Emapalumab.",Emapalumab
DB14762,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Risankizumab.",Risankizumab
DB14919,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Rozanolixizumab.",Rozanolixizumab
DB15253,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Bleselumab.",Bleselumab
DB00108,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Natalizumab.",Natalizumab
DB00337,"The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Interferon alfa-2a, Recombinant.",Pimecrolimus
DB01656,"Roflumilast may increase the immunosuppressive activities of Interferon alfa-2a, Recombinant.",Roflumilast
DB06688,"The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Sipuleucel-T
DB00041,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Aldesleukin.",Aldesleukin
DB00363,"The risk or severity of neutropenia can be increased when Interferon alfa-2a, Recombinant is combined with Clozapine.",Clozapine
DB00333,"The serum concentration of Methadone can be increased when it is combined with Interferon alfa-2a, Recombinant.",Methadone
DB00811,"The risk or severity of anemia can be increased when Interferon alfa-2a, Recombinant is combined with Ribavirin.",Ribavirin
DB00315,"The metabolism of Zolmitriptan can be decreased when combined with Interferon alfa-2a, Recombinant.",Zolmitriptan
DB01015,"The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Interferon alfa-2a, Recombinant.",Sulfamethoxazole
DB01265,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Telbivudine.",Telbivudine
DB01097,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Leflunomide.",Leflunomide
DB08895,"Interferon alfa-2a, Recombinant may increase the immunosuppressive activities of Tofacitinib.",Tofacitinib
DB00072,"Trastuzumab may increase the neutropenic activities of Interferon alfa-2a, Recombinant.",Trastuzumab
DB08868,"Interferon alfa-2a, Recombinant may increase the immunosuppressive activities of Fingolimod.",Fingolimod
DB00864,"Tacrolimus may increase the immunosuppressive activities of Interferon alfa-2a, Recombinant.",Tacrolimus
DB00201,"The metabolism of Caffeine can be decreased when combined with Interferon alfa-2a, Recombinant.",Caffeine
DB00651,"The metabolism of Dyphylline can be decreased when combined with Interferon alfa-2a, Recombinant.",Dyphylline
DB00806,"The metabolism of Pentoxifylline can be decreased when combined with Interferon alfa-2a, Recombinant.",Pentoxifylline
DB01303,"The metabolism of Oxtriphylline can be decreased when combined with Interferon alfa-2a, Recombinant.",Oxtriphylline
DB01412,"The metabolism of Theobromine can be decreased when combined with Interferon alfa-2a, Recombinant.",Theobromine
DB01482,"The metabolism of Fenethylline can be decreased when combined with Interferon alfa-2a, Recombinant.",Fenethylline
DB01667,"The metabolism of 8-azaguanine can be decreased when combined with Interferon alfa-2a, Recombinant.",8-azaguanine
DB01978,"The metabolism of 7,9-Dimethylguanine can be decreased when combined with Interferon alfa-2a, Recombinant.","7,9-Dimethylguanine"
DB02134,"The metabolism of Xanthine can be decreased when combined with Interferon alfa-2a, Recombinant.",Xanthine
DB02245,"The metabolism of 7-Deazaguanine can be decreased when combined with Interferon alfa-2a, Recombinant.",7-Deazaguanine
DB02377,"The metabolism of Guanine can be decreased when combined with Interferon alfa-2a, Recombinant.",Guanine
DB02489,"The metabolism of 9-Methylguanine can be decreased when combined with Interferon alfa-2a, Recombinant.",9-Methylguanine
DB02568,"The metabolism of Peldesine can be decreased when combined with Interferon alfa-2a, Recombinant.",Peldesine
DB04076,"The metabolism of Hypoxanthine can be decreased when combined with Interferon alfa-2a, Recombinant.",Hypoxanthine
DB04356,"The metabolism of 9-Deazaguanine can be decreased when combined with Interferon alfa-2a, Recombinant.",9-Deazaguanine
DB06479,"The metabolism of Propentofylline can be decreased when combined with Interferon alfa-2a, Recombinant.",Propentofylline
DB06575,"The metabolism of Valomaciclovir can be decreased when combined with Interferon alfa-2a, Recombinant.",Valomaciclovir
DB07954,"The metabolism of 3-isobutyl-1-methyl-7H-xanthine can be decreased when combined with Interferon alfa-2a, Recombinant.",3-isobutyl-1-methyl-7H-xanthine
DB08844,"The metabolism of Uric acid can be decreased when combined with Interferon alfa-2a, Recombinant.",Uric acid
DB09273,"The metabolism of Doxofylline can be decreased when combined with Interferon alfa-2a, Recombinant.",Doxofylline
DB11919,"The metabolism of 6-O-benzylguanine can be decreased when combined with Interferon alfa-2a, Recombinant.",6-O-benzylguanine
DB12406,"The metabolism of Lisofylline can be decreased when combined with Interferon alfa-2a, Recombinant.",Lisofylline
DB12531,"The metabolism of Lobucavir can be decreased when combined with Interferon alfa-2a, Recombinant.",Lobucavir
DB12926,"The metabolism of Cafedrine can be decreased when combined with Interferon alfa-2a, Recombinant.",Cafedrine
DB12927,"The metabolism of Theodrenaline can be decreased when combined with Interferon alfa-2a, Recombinant.",Theodrenaline
DB13203,"The metabolism of Bamifylline can be decreased when combined with Interferon alfa-2a, Recombinant.",Bamifylline
DB13449,"The metabolism of Proxyphylline can be decreased when combined with Interferon alfa-2a, Recombinant.",Proxyphylline
DB13573,"The metabolism of Acefylline can be decreased when combined with Interferon alfa-2a, Recombinant.",Acefylline
DB13592,"The metabolism of Etamiphylline can be decreased when combined with Interferon alfa-2a, Recombinant.",Etamiphylline
DB13634,"The metabolism of Pentifylline can be decreased when combined with Interferon alfa-2a, Recombinant.",Pentifylline
DB13812,"The metabolism of Bufylline can be decreased when combined with Interferon alfa-2a, Recombinant.",Bufylline
DB14018,"The metabolism of Bromotheophylline can be decreased when combined with Interferon alfa-2a, Recombinant.",Bromotheophylline
DB14029,"The metabolism of Furafylline can be decreased when combined with Interferon alfa-2a, Recombinant.",Furafylline
DB14132,"The metabolism of 8-chlorotheophylline can be decreased when combined with Interferon alfa-2a, Recombinant.",8-chlorotheophylline
DB15122,"The metabolism of PCS-499 can be decreased when combined with Interferon alfa-2a, Recombinant.",PCS-499
DB04914,"The therapeutic efficacy of G17DT can be decreased when used in combination with Interferon alfa-2a, Recombinant.",G17DT
DB05144,"The therapeutic efficacy of PEV3A can be decreased when used in combination with Interferon alfa-2a, Recombinant.",PEV3A
DB05325,"The therapeutic efficacy of INGN 225 can be decreased when used in combination with Interferon alfa-2a, Recombinant.",INGN 225
DB05374,"The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Rindopepimut
DB05440,"The therapeutic efficacy of SRP 299 can be decreased when used in combination with Interferon alfa-2a, Recombinant.",SRP 299
DB05942,"The therapeutic efficacy of GI-5005 can be decreased when used in combination with Interferon alfa-2a, Recombinant.",GI-5005
DB06400,"The therapeutic efficacy of Vitespen can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Vitespen
DB06584,"The therapeutic efficacy of TG4010 can be decreased when used in combination with Interferon alfa-2a, Recombinant.",TG4010
DB09057,"The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Anthrax immune globulin human
DB10062,"The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Interferon alfa-2a, Recombinant.","Rabies virus inactivated antigen, B"
DB10076,"The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen
DB10276,"The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Rotavirus vaccine
DB10283,"The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Interferon alfa-2a, Recombinant.","Rabies virus inactivated antigen, A"
DB10342,"The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen
DB10583,"The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Clostridium tetani toxoid antigen (formaldehyde inactivated)
DB10584,"The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)
DB10600,"The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated)
DB10769,"The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated)
DB10794,"The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated)
DB10803,"The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Typhoid Vi polysaccharide vaccine
DB10989,"The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Hepatitis A Vaccine
DB10990,"The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen
DB11038,"The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated)
DB11040,"The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated)
DB11041,"The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)
DB11044,"The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated)
DB11603,"The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Human rabies virus immune globulin
DB11627,"The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Hepatitis B Vaccine (Recombinant)
DB12568,"The therapeutic efficacy of Tecemotide can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Tecemotide
DB14022,"The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Typhoid vaccine
DB14384,"The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated)
DB14385,"The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated)
DB14394,"The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen
DB14445,"The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated)
DB14449,"The therapeutic efficacy of Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen
DB14619,"The therapeutic efficacy of Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated)
DB14620,"The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated)
DB14711,"The therapeutic efficacy of Vaccinia virus strain new york city board of health live antigen can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Vaccinia virus strain new york city board of health live antigen
DB15274,"The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Pertussis vaccine
DB15461,"The therapeutic efficacy of Yersinia pestis 195/p antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Yersinia pestis 195/p antigen (formaldehyde inactivated)
DB13924,"The therapeutic efficacy of Varicella Zoster Vaccine (Recombinant) can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Varicella Zoster Vaccine (Recombinant)
DB15483,"The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Modified vaccinia ankara
DB15595,"The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Interferon alfa-2a, Recombinant.","Ebola Zaire vaccine (live, attenuated)"
DB00054,"The risk or severity of bleeding can be increased when Abciximab is combined with Interferon alfa-2a, Recombinant.",Abciximab
DB00063,"The risk or severity of bleeding can be increased when Eptifibatide is combined with Interferon alfa-2a, Recombinant.",Eptifibatide
DB00208,"The risk or severity of bleeding can be increased when Ticlopidine is combined with Interferon alfa-2a, Recombinant.",Ticlopidine
DB00775,"The risk or severity of bleeding can be increased when Tirofiban is combined with Interferon alfa-2a, Recombinant.",Tirofiban
DB00945,"The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Interferon alfa-2a, Recombinant.",Acetylsalicylic acid
DB00975,"The risk or severity of bleeding can be increased when Dipyridamole is combined with Interferon alfa-2a, Recombinant.",Dipyridamole
DB01088,"The risk or severity of bleeding can be increased when Iloprost is combined with Interferon alfa-2a, Recombinant.",Iloprost
DB01138,"The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Interferon alfa-2a, Recombinant.",Sulfinpyrazone
DB01207,"The risk or severity of bleeding can be increased when Ridogrel is combined with Interferon alfa-2a, Recombinant.",Ridogrel
DB01236,"The risk or severity of bleeding can be increased when Sevoflurane is combined with Interferon alfa-2a, Recombinant.",Sevoflurane
DB01240,"The risk or severity of bleeding can be increased when Epoprostenol is combined with Interferon alfa-2a, Recombinant.",Epoprostenol
DB04743,"The risk or severity of bleeding can be increased when Nimesulide is combined with Interferon alfa-2a, Recombinant.",Nimesulide
DB04905,"The risk or severity of bleeding can be increased when Tesmilifene is combined with Interferon alfa-2a, Recombinant.",Tesmilifene
DB04932,"The risk or severity of bleeding can be increased when Defibrotide is combined with Interferon alfa-2a, Recombinant.",Defibrotide
DB05229,"The risk or severity of bleeding can be increased when Beraprost is combined with Interferon alfa-2a, Recombinant.",Beraprost
DB05266,"The risk or severity of bleeding can be increased when Ibudilast is combined with Interferon alfa-2a, Recombinant.",Ibudilast
DB05767,"The risk or severity of bleeding can be increased when Andrographolide is combined with Interferon alfa-2a, Recombinant.",Andrographolide
DB06081,"The risk or severity of bleeding can be increased when Caplacizumab is combined with Interferon alfa-2a, Recombinant.",Caplacizumab
DB06209,"The risk or severity of bleeding can be increased when Prasugrel is combined with Interferon alfa-2a, Recombinant.",Prasugrel
DB06441,"The risk or severity of bleeding can be increased when Cangrelor is combined with Interferon alfa-2a, Recombinant.",Cangrelor
DB07615,"The risk or severity of bleeding can be increased when Tranilast is combined with Interferon alfa-2a, Recombinant.",Tranilast
DB08814,"The risk or severity of bleeding can be increased when Triflusal is combined with Interferon alfa-2a, Recombinant.",Triflusal
DB08816,"The risk or severity of bleeding can be increased when Ticagrelor is combined with Interferon alfa-2a, Recombinant.",Ticagrelor
DB08887,"The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Interferon alfa-2a, Recombinant.",Icosapent ethyl
DB09030,"The risk or severity of bleeding can be increased when Vorapaxar is combined with Interferon alfa-2a, Recombinant.",Vorapaxar
DB09283,"The risk or severity of bleeding can be increased when Trapidil is combined with Interferon alfa-2a, Recombinant.",Trapidil
DB12092,"The risk or severity of bleeding can be increased when Naftopidil is combined with Interferon alfa-2a, Recombinant.",Naftopidil
DB12163,"The risk or severity of bleeding can be increased when Sarpogrelate is combined with Interferon alfa-2a, Recombinant.",Sarpogrelate
DB12321,"The risk or severity of bleeding can be increased when Ifetroban is combined with Interferon alfa-2a, Recombinant.",Ifetroban
DB12445,"The risk or severity of bleeding can be increased when Nitroaspirin is combined with Interferon alfa-2a, Recombinant.",Nitroaspirin
DB12465,"The risk or severity of bleeding can be increased when Ketanserin is combined with Interferon alfa-2a, Recombinant.",Ketanserin
DB12545,"The risk or severity of bleeding can be increased when Indobufen is combined with Interferon alfa-2a, Recombinant.",Indobufen
DB12749,"The risk or severity of bleeding can be increased when Butylphthalide is combined with Interferon alfa-2a, Recombinant.",Butylphthalide
DB12771,"The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Interferon alfa-2a, Recombinant.",Hydroxytyrosol
DB13036,"The risk or severity of bleeding can be increased when Ramatroban is combined with Interferon alfa-2a, Recombinant.",Ramatroban
DB13327,"The risk or severity of bleeding can be increased when Picotamide is combined with Interferon alfa-2a, Recombinant.",Picotamide
DB13367,"The risk or severity of bleeding can be increased when Cloricromen is combined with Interferon alfa-2a, Recombinant.",Cloricromen
DB13400,"The risk or severity of bleeding can be increased when Linsidomine is combined with Interferon alfa-2a, Recombinant.",Linsidomine
DB13510,"The risk or severity of bleeding can be increased when Buflomedil is combined with Interferon alfa-2a, Recombinant.",Buflomedil
DB13929,"The risk or severity of bleeding can be increased when Relcovaptan is combined with Interferon alfa-2a, Recombinant.",Relcovaptan
DB13200,"Interferon alfa-2a, Recombinant may increase the myelosuppressive activities of Lipegfilgrastim.",Lipegfilgrastim
DB10317,"The risk or severity of infection can be increased when Rubella virus vaccine is combined with Interferon alfa-2a, Recombinant.",Rubella virus vaccine
DB10318,"The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Interferon alfa-2a, Recombinant.",Varicella Zoster Vaccine (Live/attenuated)
DB10343,"The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Interferon alfa-2a, Recombinant.",Bacillus calmette-guerin substrain tice live antigen
DB10804,"The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Interferon alfa-2a, Recombinant.",Bacillus calmette-guerin substrain connaught live antigen
DB10805,"The risk or severity of infection can be increased when Yellow Fever Vaccine is combined with Interferon alfa-2a, Recombinant.",Yellow Fever Vaccine
DB11003,"The risk or severity of infection can be increased when Anthrax vaccine is combined with Interferon alfa-2a, Recombinant.",Anthrax vaccine
DB11050,"The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Interferon alfa-2a, Recombinant.",Typhoid Vaccine Live
DB12386,"The risk or severity of infection can be increased when Bacillus calmette-guerin substrain danish 1331 live antigen is combined with Interferon alfa-2a, Recombinant.",Bacillus calmette-guerin substrain danish 1331 live antigen
DB12768,"The risk or severity of infection can be increased when BCG vaccine is combined with Interferon alfa-2a, Recombinant.",BCG vaccine
DB14409,"The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Interferon alfa-2a, Recombinant.",Human adenovirus e serotype 4 strain cl-68578 antigen
DB14443,"The risk or severity of infection can be increased when Vibrio cholerae CVD 103-HgR strain live antigen is combined with Interferon alfa-2a, Recombinant.",Vibrio cholerae CVD 103-HgR strain live antigen
DB14685,"The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Interferon alfa-2a, Recombinant.",Adenovirus type 7 vaccine live
DB00039,"The therapeutic efficacy of Palifermin can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Palifermin
DB00176,"The metabolism of Fluvoxamine can be decreased when combined with Interferon alfa-2a, Recombinant.",Fluvoxamine
DB00184,"The metabolism of Nicotine can be decreased when combined with Interferon alfa-2a, Recombinant.",Nicotine
DB00195,"The metabolism of Betaxolol can be decreased when combined with Interferon alfa-2a, Recombinant.",Betaxolol
DB00261,"The metabolism of Anagrelide can be decreased when combined with Interferon alfa-2a, Recombinant.",Anagrelide
DB00280,"The metabolism of Disopyramide can be decreased when combined with Interferon alfa-2a, Recombinant.",Disopyramide
DB00281,"The metabolism of Lidocaine can be decreased when combined with Interferon alfa-2a, Recombinant.",Lidocaine
DB00286,"The metabolism of Conjugated estrogens can be decreased when combined with Interferon alfa-2a, Recombinant.",Conjugated estrogens
DB00296,"The metabolism of Ropivacaine can be decreased when combined with Interferon alfa-2a, Recombinant.",Ropivacaine
DB00316,"The metabolism of Acetaminophen can be decreased when combined with Interferon alfa-2a, Recombinant.",Acetaminophen
DB00334,"The metabolism of Olanzapine can be decreased when combined with Interferon alfa-2a, Recombinant.",Olanzapine
DB00356,"The metabolism of Chlorzoxazone can be decreased when combined with Interferon alfa-2a, Recombinant.",Chlorzoxazone
DB00365,"The metabolism of Grepafloxacin can be decreased when combined with Interferon alfa-2a, Recombinant.",Grepafloxacin
DB00370,"The metabolism of Mirtazapine can be decreased when combined with Interferon alfa-2a, Recombinant.",Mirtazapine
DB00379,"The metabolism of Mexiletine can be decreased when combined with Interferon alfa-2a, Recombinant.",Mexiletine
DB00382,"The metabolism of Tacrine can be decreased when combined with Interferon alfa-2a, Recombinant.",Tacrine
DB00384,"The metabolism of Triamterene can be decreased when combined with Interferon alfa-2a, Recombinant.",Triamterene
DB00420,"The metabolism of Promazine can be decreased when combined with Interferon alfa-2a, Recombinant.",Promazine
DB00425,"The metabolism of Zolpidem can be decreased when combined with Interferon alfa-2a, Recombinant.",Zolpidem
DB00442,"The metabolism of Entecavir can be decreased when combined with Interferon alfa-2a, Recombinant.",Entecavir
DB00461,"The metabolism of Nabumetone can be decreased when combined with Interferon alfa-2a, Recombinant.",Nabumetone
DB00468,"The metabolism of Quinine can be decreased when combined with Interferon alfa-2a, Recombinant.",Quinine
DB00472,"The metabolism of Fluoxetine can be decreased when combined with Interferon alfa-2a, Recombinant.",Fluoxetine
DB00476,"The metabolism of Duloxetine can be decreased when combined with Interferon alfa-2a, Recombinant.",Duloxetine
DB00477,"The metabolism of Chlorpromazine can be decreased when combined with Interferon alfa-2a, Recombinant.",Chlorpromazine
DB00499,"The metabolism of Flutamide can be decreased when combined with Interferon alfa-2a, Recombinant.",Flutamide
DB00502,"The metabolism of Haloperidol can be decreased when combined with Interferon alfa-2a, Recombinant.",Haloperidol
DB00518,"The metabolism of Albendazole can be decreased when combined with Interferon alfa-2a, Recombinant.",Albendazole
DB00533,"The metabolism of Rofecoxib can be decreased when combined with Interferon alfa-2a, Recombinant.",Rofecoxib
DB00568,"The metabolism of Cinnarizine can be decreased when combined with Interferon alfa-2a, Recombinant.",Cinnarizine
DB00571,"The metabolism of Propranolol can be decreased when combined with Interferon alfa-2a, Recombinant.",Propranolol
DB00586,"The metabolism of Diclofenac can be decreased when combined with Interferon alfa-2a, Recombinant.",Diclofenac
DB00629,"The metabolism of Guanabenz can be decreased when combined with Interferon alfa-2a, Recombinant.",Guanabenz
DB00661,"The metabolism of Verapamil can be decreased when combined with Interferon alfa-2a, Recombinant.",Verapamil
DB00715,"The metabolism of Paroxetine can be decreased when combined with Interferon alfa-2a, Recombinant.",Paroxetine
DB00730,"The metabolism of Thiabendazole can be decreased when combined with Interferon alfa-2a, Recombinant.",Thiabendazole
DB00740,"The metabolism of Riluzole can be decreased when combined with Interferon alfa-2a, Recombinant.",Riluzole
DB00744,"The metabolism of Zileuton can be decreased when combined with Interferon alfa-2a, Recombinant.",Zileuton
DB00758,"The metabolism of Clopidogrel can be decreased when combined with Interferon alfa-2a, Recombinant.",Clopidogrel
DB00783,"The metabolism of Estradiol can be decreased when combined with Interferon alfa-2a, Recombinant.",Estradiol
DB00787,"The metabolism of Acyclovir can be decreased when combined with Interferon alfa-2a, Recombinant.",Acyclovir
DB00788,"The metabolism of Naproxen can be decreased when combined with Interferon alfa-2a, Recombinant.",Naproxen
DB00831,"The metabolism of Trifluoperazine can be decreased when combined with Interferon alfa-2a, Recombinant.",Trifluoperazine
DB00850,"The metabolism of Perphenazine can be decreased when combined with Interferon alfa-2a, Recombinant.",Perphenazine
DB00857,"The metabolism of Terbinafine can be decreased when combined with Interferon alfa-2a, Recombinant.",Terbinafine
DB00863,"The metabolism of Ranitidine can be decreased when combined with Interferon alfa-2a, Recombinant.",Ranitidine
DB00898,"The metabolism of Ethanol can be decreased when combined with Interferon alfa-2a, Recombinant.",Ethanol
DB00934,"The metabolism of Maprotiline can be decreased when combined with Interferon alfa-2a, Recombinant.",Maprotiline
DB00969,"The metabolism of Alosetron can be decreased when combined with Interferon alfa-2a, Recombinant.",Alosetron
DB00978,"The metabolism of Lomefloxacin can be decreased when combined with Interferon alfa-2a, Recombinant.",Lomefloxacin
DB00980,"The metabolism of Ramelteon can be decreased when combined with Interferon alfa-2a, Recombinant.",Ramelteon
DB00998,"The metabolism of Frovatriptan can be decreased when combined with Interferon alfa-2a, Recombinant.",Frovatriptan
DB01002,"The metabolism of Levobupivacaine can be decreased when combined with Interferon alfa-2a, Recombinant.",Levobupivacaine
DB01012,"The metabolism of Cinacalcet can be decreased when combined with Interferon alfa-2a, Recombinant.",Cinacalcet
DB01037,"The metabolism of Selegiline can be decreased when combined with Interferon alfa-2a, Recombinant.",Selegiline
DB01056,"The metabolism of Tocainide can be decreased when combined with Interferon alfa-2a, Recombinant.",Tocainide
DB01058,"The metabolism of Praziquantel can be decreased when combined with Interferon alfa-2a, Recombinant.",Praziquantel
DB01065,"The metabolism of Melatonin can be decreased when combined with Interferon alfa-2a, Recombinant.",Melatonin
DB01087,"The metabolism of Primaquine can be decreased when combined with Interferon alfa-2a, Recombinant.",Primaquine
DB01094,"The metabolism of Hesperetin can be decreased when combined with Interferon alfa-2a, Recombinant.",Hesperetin
DB01115,"The metabolism of Nifedipine can be decreased when combined with Interferon alfa-2a, Recombinant.",Nifedipine
DB01136,"The metabolism of Carvedilol can be decreased when combined with Interferon alfa-2a, Recombinant.",Carvedilol
DB01166,"The metabolism of Cilostazol can be decreased when combined with Interferon alfa-2a, Recombinant.",Cilostazol
DB01182,"The metabolism of Propafenone can be decreased when combined with Interferon alfa-2a, Recombinant.",Propafenone
DB01184,"The metabolism of Domperidone can be decreased when combined with Interferon alfa-2a, Recombinant.",Domperidone
DB01191,"The metabolism of Dexfenfluramine can be decreased when combined with Interferon alfa-2a, Recombinant.",Dexfenfluramine
DB01367,"The metabolism of Rasagiline can be decreased when combined with Interferon alfa-2a, Recombinant.",Rasagiline
DB01405,"The metabolism of Temafloxacin can be decreased when combined with Interferon alfa-2a, Recombinant.",Temafloxacin
DB01424,"The metabolism of Aminophenazone can be decreased when combined with Interferon alfa-2a, Recombinant.",Aminophenazone
DB01435,"The metabolism of Antipyrine can be decreased when combined with Interferon alfa-2a, Recombinant.",Antipyrine
DB01558,"The metabolism of Bromazepam can be decreased when combined with Interferon alfa-2a, Recombinant.",Bromazepam
DB01623,"The metabolism of Thiothixene can be decreased when combined with Interferon alfa-2a, Recombinant.",Thiothixene
DB01628,"The metabolism of Etoricoxib can be decreased when combined with Interferon alfa-2a, Recombinant.",Etoricoxib
DB01645,"The metabolism of Genistein can be decreased when combined with Interferon alfa-2a, Recombinant.",Genistein
DB02709,"The metabolism of Resveratrol can be decreased when combined with Interferon alfa-2a, Recombinant.",Resveratrol
DB03783,"The metabolism of Phenacetin can be decreased when combined with Interferon alfa-2a, Recombinant.",Phenacetin
DB04574,"The metabolism of Estrone sulfate can be decreased when combined with Interferon alfa-2a, Recombinant.",Estrone sulfate
DB04841,"The metabolism of Flunarizine can be decreased when combined with Interferon alfa-2a, Recombinant.",Flunarizine
DB04871,"The metabolism of Lorcaserin can be decreased when combined with Interferon alfa-2a, Recombinant.",Lorcaserin
DB04948,"The metabolism of Lofexidine can be decreased when combined with Interferon alfa-2a, Recombinant.",Lofexidine
DB06148,"The metabolism of Mianserin can be decreased when combined with Interferon alfa-2a, Recombinant.",Mianserin
DB06210,"The metabolism of Eltrombopag can be decreased when combined with Interferon alfa-2a, Recombinant.",Eltrombopag
DB06216,"The metabolism of Asenapine can be decreased when combined with Interferon alfa-2a, Recombinant.",Asenapine
DB06235,"The metabolism of Vadimezan can be decreased when combined with Interferon alfa-2a, Recombinant.",Vadimezan
DB06292,"The metabolism of Dapagliflozin can be decreased when combined with Interferon alfa-2a, Recombinant.",Dapagliflozin
DB06594,"The metabolism of Agomelatine can be decreased when combined with Interferon alfa-2a, Recombinant.",Agomelatine
DB06626,"The metabolism of Axitinib can be decreased when combined with Interferon alfa-2a, Recombinant.",Axitinib
DB06770,"The metabolism of Benzyl alcohol can be decreased when combined with Interferon alfa-2a, Recombinant.",Benzyl alcohol
DB06774,"The metabolism of Capsaicin can be decreased when combined with Interferon alfa-2a, Recombinant.",Capsaicin
DB08496,"The metabolism of (R)-warfarin can be decreased when combined with Interferon alfa-2a, Recombinant.",(R)-warfarin
DB08883,"The metabolism of Perampanel can be decreased when combined with Interferon alfa-2a, Recombinant.",Perampanel
DB09071,"The metabolism of Tasimelteon can be decreased when combined with Interferon alfa-2a, Recombinant.",Tasimelteon
DB09118,"The metabolism of Stiripentol can be decreased when combined with Interferon alfa-2a, Recombinant.",Stiripentol
DB09225,"The metabolism of Zotepine can be decreased when combined with Interferon alfa-2a, Recombinant.",Zotepine
DB09288,"The metabolism of Propacetamol can be decreased when combined with Interferon alfa-2a, Recombinant.",Propacetamol
DB09290,"The metabolism of Ramosetron can be decreased when combined with Interferon alfa-2a, Recombinant.",Ramosetron
DB11967,"The metabolism of Binimetinib can be decreased when combined with Interferon alfa-2a, Recombinant.",Binimetinib
DB12026,"The metabolism of Voxilaprevir can be decreased when combined with Interferon alfa-2a, Recombinant.",Voxilaprevir
DB12245,"The metabolism of Triclabendazole can be decreased when combined with Interferon alfa-2a, Recombinant.",Triclabendazole
DB12332,"The metabolism of Rucaparib can be decreased when combined with Interferon alfa-2a, Recombinant.",Rucaparib
DB12945,"The metabolism of Dihydralazine can be decreased when combined with Interferon alfa-2a, Recombinant.",Dihydralazine
DB13952,"The metabolism of Estradiol acetate can be decreased when combined with Interferon alfa-2a, Recombinant.",Estradiol acetate
DB13953,"The metabolism of Estradiol benzoate can be decreased when combined with Interferon alfa-2a, Recombinant.",Estradiol benzoate
DB13954,"The metabolism of Estradiol cypionate can be decreased when combined with Interferon alfa-2a, Recombinant.",Estradiol cypionate
DB13955,"The metabolism of Estradiol dienanthate can be decreased when combined with Interferon alfa-2a, Recombinant.",Estradiol dienanthate
DB13956,"The metabolism of Estradiol valerate can be decreased when combined with Interferon alfa-2a, Recombinant.",Estradiol valerate
DB11757,"The metabolism of Istradefylline can be decreased when combined with Interferon alfa-2a, Recombinant.",Istradefylline
DB00972,"The metabolism of Azelastine can be decreased when combined with Interferon alfa-2a, Recombinant.",Azelastine
DB00625,"The metabolism of Efavirenz can be decreased when combined with Interferon alfa-2a, Recombinant.",Efavirenz
DB01233,"The metabolism of Metoclopramide can be decreased when combined with Interferon alfa-2a, Recombinant.",Metoclopramide
DB04889,"The metabolism of Bicifadine can be decreased when combined with Interferon alfa-2a, Recombinant.",Bicifadine
DB05708,"The metabolism of GTS-21 can be decreased when combined with Interferon alfa-2a, Recombinant.",GTS-21
DB01195,"The metabolism of Flecainide can be decreased when combined with Interferon alfa-2a, Recombinant.",Flecainide
DB00977,"The metabolism of Ethinylestradiol can be decreased when combined with Interferon alfa-2a, Recombinant.",Ethinylestradiol
DB00321,"The metabolism of Amitriptyline can be decreased when combined with Interferon alfa-2a, Recombinant.",Amitriptyline
DB00458,"The metabolism of Imipramine can be decreased when combined with Interferon alfa-2a, Recombinant.",Imipramine
DB01142,"The metabolism of Doxepin can be decreased when combined with Interferon alfa-2a, Recombinant.",Doxepin
DB00532,"The metabolism of Mephenytoin can be decreased when combined with Interferon alfa-2a, Recombinant.",Mephenytoin
DB00540,"The metabolism of Nortriptyline can be decreased when combined with Interferon alfa-2a, Recombinant.",Nortriptyline
DB00575,"The metabolism of Clonidine can be decreased when combined with Interferon alfa-2a, Recombinant.",Clonidine
DB00924,"The metabolism of Cyclobenzaprine can be decreased when combined with Interferon alfa-2a, Recombinant.",Cyclobenzaprine
DB01151,"The metabolism of Desipramine can be decreased when combined with Interferon alfa-2a, Recombinant.",Desipramine
DB01242,"The metabolism of Clomipramine can be decreased when combined with Interferon alfa-2a, Recombinant.",Clomipramine
DB11689,"The metabolism of Selumetinib can be decreased when combined with Interferon alfa-2a, Recombinant.",Selumetinib
DB00277,"The metabolism of Theophylline can be decreased when combined with Interferon alfa-2a, Recombinant.",Theophylline
DB00682,"The metabolism of Warfarin can be decreased when combined with Interferon alfa-2a, Recombinant.",Warfarin
DB00697,"The metabolism of Tizanidine can be decreased when combined with Interferon alfa-2a, Recombinant.",Tizanidine
DB01100,"The metabolism of Pimozide can be decreased when combined with Interferon alfa-2a, Recombinant.",Pimozide
DB01223,"The metabolism of Aminophylline can be decreased when combined with Interferon alfa-2a, Recombinant.",Aminophylline
DB01418,"The metabolism of Acenocoumarol can be decreased when combined with Interferon alfa-2a, Recombinant.",Acenocoumarol
DB00530,"The metabolism of Erlotinib can be decreased when combined with Interferon alfa-2a, Recombinant.",Erlotinib
DB09256,"The metabolism of Tegafur can be decreased when combined with Interferon alfa-2a, Recombinant.",Tegafur
DB13874,"The metabolism of Enasidenib can be decreased when combined with Interferon alfa-2a, Recombinant.",Enasidenib
DB00675,"The metabolism of Tamoxifen can be decreased when combined with Interferon alfa-2a, Recombinant.",Tamoxifen
DB00001,"The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon alfa-2a, Recombinant.",Lepirudin
DB00006,"The risk or severity of bleeding can be increased when Bivalirudin is combined with Interferon alfa-2a, Recombinant.",Bivalirudin
DB00009,"The risk or severity of bleeding can be increased when Alteplase is combined with Interferon alfa-2a, Recombinant.",Alteplase
DB00013,"The risk or severity of bleeding can be increased when Urokinase is combined with Interferon alfa-2a, Recombinant.",Urokinase
DB00015,"The risk or severity of bleeding can be increased when Reteplase is combined with Interferon alfa-2a, Recombinant.",Reteplase
DB00029,"The risk or severity of bleeding can be increased when Anistreplase is combined with Interferon alfa-2a, Recombinant.",Anistreplase
DB00031,"The risk or severity of bleeding can be increased when Tenecteplase is combined with Interferon alfa-2a, Recombinant.",Tenecteplase
DB00055,"The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Interferon alfa-2a, Recombinant.",Drotrecogin alfa
DB00086,"The risk or severity of bleeding can be increased when Streptokinase is combined with Interferon alfa-2a, Recombinant.",Streptokinase
DB00266,"The risk or severity of bleeding can be increased when Dicoumarol is combined with Interferon alfa-2a, Recombinant.",Dicoumarol
DB00278,"The risk or severity of bleeding can be increased when Argatroban is combined with Interferon alfa-2a, Recombinant.",Argatroban
DB00407,"The risk or severity of bleeding can be increased when Ardeparin is combined with Interferon alfa-2a, Recombinant.",Ardeparin
DB00498,"The risk or severity of bleeding can be increased when Phenindione is combined with Interferon alfa-2a, Recombinant.",Phenindione
DB00569,"The risk or severity of bleeding can be increased when Fondaparinux is combined with Interferon alfa-2a, Recombinant.",Fondaparinux
DB00686,"The risk or severity of bleeding can be increased when Pentosan polysulfate is combined with Interferon alfa-2a, Recombinant.",Pentosan polysulfate
DB00946,"The risk or severity of bleeding can be increased when Phenprocoumon is combined with Interferon alfa-2a, Recombinant.",Phenprocoumon
DB01109,"The risk or severity of bleeding can be increased when Heparin is combined with Interferon alfa-2a, Recombinant.",Heparin
DB01225,"The risk or severity of bleeding can be increased when Enoxaparin is combined with Interferon alfa-2a, Recombinant.",Enoxaparin
DB03410,"The risk or severity of bleeding can be increased when 4-hydroxycoumarin is combined with Interferon alfa-2a, Recombinant.",4-hydroxycoumarin
DB04665,"The risk or severity of bleeding can be increased when Coumarin is combined with Interferon alfa-2a, Recombinant.",Coumarin
DB04898,"The risk or severity of bleeding can be increased when Ximelagatran is combined with Interferon alfa-2a, Recombinant.",Ximelagatran
DB04925,"The risk or severity of bleeding can be increased when Desmoteplase is combined with Interferon alfa-2a, Recombinant.",Desmoteplase
DB05099,"The risk or severity of bleeding can be increased when Ancrod is combined with Interferon alfa-2a, Recombinant.",Ancrod
DB05254,"The risk or severity of bleeding can be increased when Fibrinolysin is combined with Interferon alfa-2a, Recombinant.",Fibrinolysin
DB06228,"The risk or severity of bleeding can be increased when Rivaroxaban is combined with Interferon alfa-2a, Recombinant.",Rivaroxaban
DB06271,"The risk or severity of bleeding can be increased when Sulodexide is combined with Interferon alfa-2a, Recombinant.",Sulodexide
DB06294,"The risk or severity of bleeding can be increased when Semuloparin is combined with Interferon alfa-2a, Recombinant.",Semuloparin
DB06406,"The risk or severity of bleeding can be increased when Idraparinux is combined with Interferon alfa-2a, Recombinant.",Idraparinux
DB06543,"The risk or severity of bleeding can be increased when Astaxanthin is combined with Interferon alfa-2a, Recombinant.",Astaxanthin
DB06605,"The risk or severity of bleeding can be increased when Apixaban is combined with Interferon alfa-2a, Recombinant.",Apixaban
DB06635,"The risk or severity of bleeding can be increased when Otamixaban is combined with Interferon alfa-2a, Recombinant.",Otamixaban
DB06679,"The risk or severity of bleeding can be increased when Amediplase is combined with Interferon alfa-2a, Recombinant.",Amediplase
DB06695,"The risk or severity of bleeding can be increased when Dabigatran etexilate is combined with Interferon alfa-2a, Recombinant.",Dabigatran etexilate
DB06754,"The risk or severity of bleeding can be increased when Danaparoid is combined with Interferon alfa-2a, Recombinant.",Danaparoid
DB06779,"The risk or severity of bleeding can be increased when Dalteparin is combined with Interferon alfa-2a, Recombinant.",Dalteparin
DB06822,"The risk or severity of bleeding can be increased when Tinzaparin is combined with Interferon alfa-2a, Recombinant.",Tinzaparin
DB07767,"The risk or severity of bleeding can be increased when Ferulic acid is combined with Interferon alfa-2a, Recombinant.",Ferulic acid
DB08794,"The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Interferon alfa-2a, Recombinant.",Ethyl biscoumacetate
DB08813,"The risk or severity of bleeding can be increased when Nadroparin is combined with Interferon alfa-2a, Recombinant.",Nadroparin
DB08994,"The risk or severity of bleeding can be increased when Ditazole is combined with Interferon alfa-2a, Recombinant.",Ditazole
DB09075,"The risk or severity of bleeding can be increased when Edoxaban is combined with Interferon alfa-2a, Recombinant.",Edoxaban
DB09125,"The risk or severity of bleeding can be increased when Potassium citrate is combined with Interferon alfa-2a, Recombinant.",Potassium citrate
DB09154,"The risk or severity of bleeding can be increased when Sodium citrate is combined with Interferon alfa-2a, Recombinant.",Sodium citrate
DB09255,"The risk or severity of bleeding can be increased when Dextran is combined with Interferon alfa-2a, Recombinant.",Dextran
DB09258,"The risk or severity of bleeding can be increased when Bemiparin is combined with Interferon alfa-2a, Recombinant.",Bemiparin
DB09259,"The risk or severity of bleeding can be increased when Reviparin is combined with Interferon alfa-2a, Recombinant.",Reviparin
DB09260,"The risk or severity of bleeding can be increased when Parnaparin is combined with Interferon alfa-2a, Recombinant.",Parnaparin
DB09261,"The risk or severity of bleeding can be increased when Certoparin is combined with Interferon alfa-2a, Recombinant.",Certoparin
DB11095,"The risk or severity of bleeding can be increased when Desirudin is combined with Interferon alfa-2a, Recombinant.",Desirudin
DB11154,"The risk or severity of bleeding can be increased when Zinc citrate is combined with Interferon alfa-2a, Recombinant.",Zinc citrate
DB11166,"The risk or severity of bleeding can be increased when Antithrombin Alfa is combined with Interferon alfa-2a, Recombinant.",Antithrombin Alfa
DB11312,"The risk or severity of bleeding can be increased when Protein C is combined with Interferon alfa-2a, Recombinant.",Protein C
DB11598,"The risk or severity of bleeding can be increased when Antithrombin III human is combined with Interferon alfa-2a, Recombinant.",Antithrombin III human
DB11984,"The risk or severity of bleeding can be increased when Letaxaban is combined with Interferon alfa-2a, Recombinant.",Letaxaban
DB12289,"The risk or severity of bleeding can be increased when Darexaban is combined with Interferon alfa-2a, Recombinant.",Darexaban
DB12364,"The risk or severity of bleeding can be increased when Betrixaban is combined with Interferon alfa-2a, Recombinant.",Betrixaban
DB12598,"The risk or severity of bleeding can be increased when Nafamostat is combined with Interferon alfa-2a, Recombinant.",Nafamostat
DB12726,"The risk or severity of bleeding can be increased when Monteplase is combined with Interferon alfa-2a, Recombinant.",Monteplase
DB12831,"The risk or severity of bleeding can be increased when Gabexate is combined with Interferon alfa-2a, Recombinant.",Gabexate
DB13136,"The risk or severity of bleeding can be increased when Fluindione is combined with Interferon alfa-2a, Recombinant.",Fluindione
DB13149,"The risk or severity of bleeding can be increased when Protein S human is combined with Interferon alfa-2a, Recombinant.",Protein S human
DB13199,"The risk or severity of bleeding can be increased when Brinase is combined with Interferon alfa-2a, Recombinant.",Brinase
DB13275,"The risk or severity of bleeding can be increased when Clorindione is combined with Interferon alfa-2a, Recombinant.",Clorindione
DB13347,"The risk or severity of bleeding can be increased when Diphenadione is combined with Interferon alfa-2a, Recombinant.",Diphenadione
DB13451,"The risk or severity of bleeding can be increased when Tioclomarol is combined with Interferon alfa-2a, Recombinant.",Tioclomarol
DB13616,"The risk or severity of bleeding can be increased when Melagatran is combined with Interferon alfa-2a, Recombinant.",Melagatran
DB13646,"The risk or severity of bleeding can be increased when Saruplase is combined with Interferon alfa-2a, Recombinant.",Saruplase
DB14055,"The risk or severity of bleeding can be increased when (S)-Warfarin is combined with Interferon alfa-2a, Recombinant.",(S)-Warfarin
DB14094,"The risk or severity of bleeding can be increased when Tocopherylquinone is combined with Interferon alfa-2a, Recombinant.",Tocopherylquinone
DB14598,"The risk or severity of bleeding can be increased when Edetate calcium disodium anhydrous is combined with Interferon alfa-2a, Recombinant.",Edetate calcium disodium anhydrous
DB14726,"The risk or severity of bleeding can be increased when Dabigatran is combined with Interferon alfa-2a, Recombinant.",Dabigatran
DB00232,"The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Interferon alfa-2a, Recombinant.",Methyclothiazide
DB00436,"The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Interferon alfa-2a, Recombinant.",Bendroflumethiazide
DB00562,"The risk or severity of neutropenia and thrombocytopenia can be increased when Benzthiazide is combined with Interferon alfa-2a, Recombinant.",Benzthiazide
DB00606,"The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclothiazide is combined with Interferon alfa-2a, Recombinant.",Cyclothiazide
DB00774,"The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Interferon alfa-2a, Recombinant.",Hydroflumethiazide
DB00880,"The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Interferon alfa-2a, Recombinant.",Chlorothiazide
DB00999,"The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Interferon alfa-2a, Recombinant.",Hydrochlorothiazide
DB01021,"The risk or severity of neutropenia and thrombocytopenia can be increased when Trichlormethiazide is combined with Interferon alfa-2a, Recombinant.",Trichlormethiazide
DB01324,"The risk or severity of neutropenia and thrombocytopenia can be increased when Polythiazide is combined with Interferon alfa-2a, Recombinant.",Polythiazide
DB13430,"The risk or severity of neutropenia and thrombocytopenia can be increased when Mebutizide is combined with Interferon alfa-2a, Recombinant.",Mebutizide
DB13532,"The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclopenthiazide is combined with Interferon alfa-2a, Recombinant.",Cyclopenthiazide
DB09042,"The risk or severity of myelosuppression can be increased when Interferon alfa-2a, Recombinant is combined with Tedizolid phosphate.",Tedizolid phosphate
DB00091,"Interferon alfa-2a, Recombinant may increase the immunosuppressive activities of Cyclosporine.",Cyclosporine
DB00268,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Ropinirole.",Ropinirole
DB00115,"The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Interferon alfa-2a, Recombinant.",Cyanocobalamin
DB00437,"The risk or severity of adverse effects can be increased when Allopurinol is combined with Interferon alfa-2a, Recombinant.",Allopurinol
DB14513,"The serum concentration of Magnesium can be decreased when it is combined with Interferon alfa-2a, Recombinant.",Magnesium
DB01601,"The serum concentration of Interferon alfa-2a, Recombinant can be increased when it is combined with Lopinavir.",Lopinavir
DB12530,"The risk or severity of infection can be increased when Interferon alfa-2a, Recombinant is combined with Inebilizumab.",Inebilizumab
DB00564,The risk or severity of adverse effects can be increased when Carbamazepine is combined with Desmopressin.,Carbamazepine
DB00477,The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Desmopressin.,Chlorpromazine
DB00618,The therapeutic efficacy of Desmopressin can be decreased when used in combination with Demeclocycline.,Demeclocycline
DB00555,The risk or severity of adverse effects can be increased when Lamotrigine is combined with Desmopressin.,Lamotrigine
DB01356,The therapeutic efficacy of Desmopressin can be decreased when used in combination with Lithium cation.,Lithium cation
DB14507,The therapeutic efficacy of Desmopressin can be decreased when used in combination with Lithium citrate.,Lithium citrate
DB14509,The therapeutic efficacy of Desmopressin can be decreased when used in combination with Lithium carbonate.,Lithium carbonate
DB14506,The therapeutic efficacy of Lithium hydroxide can be decreased when used in combination with Desmopressin.,Lithium hydroxide
DB06212,The therapeutic efficacy of Desmopressin can be decreased when used in combination with Tolvaptan.,Tolvaptan
DB00176,The risk or severity of hyponatremia can be increased when Fluvoxamine is combined with Desmopressin.,Fluvoxamine
DB00215,The risk or severity of hyponatremia can be increased when Citalopram is combined with Desmopressin.,Citalopram
DB00472,The risk or severity of hyponatremia can be increased when Fluoxetine is combined with Desmopressin.,Fluoxetine
DB00476,The risk or severity of hyponatremia can be increased when Duloxetine is combined with Desmopressin.,Duloxetine
DB00656,The risk or severity of hyponatremia can be increased when Trazodone is combined with Desmopressin.,Trazodone
DB00715,The risk or severity of hyponatremia can be increased when Paroxetine is combined with Desmopressin.,Paroxetine
DB01104,The risk or severity of hyponatremia can be increased when Sertraline is combined with Desmopressin.,Sertraline
DB01105,The risk or severity of hyponatremia can be increased when Sibutramine is combined with Desmopressin.,Sibutramine
DB01149,The risk or severity of hyponatremia can be increased when Nefazodone is combined with Desmopressin.,Nefazodone
DB01175,The risk or severity of hyponatremia can be increased when Escitalopram is combined with Desmopressin.,Escitalopram
DB04832,The risk or severity of hyponatremia can be increased when Zimelidine is combined with Desmopressin.,Zimelidine
DB04884,The risk or severity of hyponatremia can be increased when Dapoxetine is combined with Desmopressin.,Dapoxetine
DB04896,The risk or severity of hyponatremia can be increased when Milnacipran is combined with Desmopressin.,Milnacipran
DB06700,The risk or severity of hyponatremia can be increased when Desvenlafaxine is combined with Desmopressin.,Desvenlafaxine
DB06731,The risk or severity of hyponatremia can be increased when Seproxetine is combined with Desmopressin.,Seproxetine
DB08918,The risk or severity of hyponatremia can be increased when Levomilnacipran is combined with Desmopressin.,Levomilnacipran
DB08953,The risk or severity of hyponatremia can be increased when Indalpine is combined with Desmopressin.,Indalpine
DB12693,The risk or severity of hyponatremia can be increased when Ritanserin is combined with Desmopressin.,Ritanserin
DB13233,The risk or severity of hyponatremia can be increased when Alaproclate is combined with Desmopressin.,Alaproclate
DB00177,Desmopressin may decrease the antihypertensive activities of Valsartan.,Valsartan
DB00178,Desmopressin may decrease the antihypertensive activities of Ramipril.,Ramipril
DB00187,Desmopressin may decrease the antihypertensive activities of Esmolol.,Esmolol
DB00195,Desmopressin may decrease the antihypertensive activities of Betaxolol.,Betaxolol
DB00212,Desmopressin may decrease the antihypertensive activities of Remikiren.,Remikiren
DB00226,Desmopressin may decrease the antihypertensive activities of Guanadrel.,Guanadrel
DB00275,Desmopressin may decrease the antihypertensive activities of Olmesartan.,Olmesartan
DB00335,Desmopressin may decrease the antihypertensive activities of Atenolol.,Atenolol
DB00343,Desmopressin may decrease the antihypertensive activities of Diltiazem.,Diltiazem
DB00350,Desmopressin may decrease the antihypertensive activities of Minoxidil.,Minoxidil
DB00374,Desmopressin may decrease the antihypertensive activities of Treprostinil.,Treprostinil
DB00381,Desmopressin may decrease the antihypertensive activities of Amlodipine.,Amlodipine
DB00393,Desmopressin may decrease the antihypertensive activities of Nimodipine.,Nimodipine
DB00457,Desmopressin may decrease the antihypertensive activities of Prazosin.,Prazosin
DB00519,Desmopressin may decrease the antihypertensive activities of Trandolapril.,Trandolapril
DB00528,Desmopressin may decrease the antihypertensive activities of Lercanidipine.,Lercanidipine
DB00542,Desmopressin may decrease the antihypertensive activities of Benazepril.,Benazepril
DB00559,Desmopressin may decrease the antihypertensive activities of Bosentan.,Bosentan
DB00584,Desmopressin may decrease the antihypertensive activities of Enalapril.,Enalapril
DB00590,Desmopressin may decrease the antihypertensive activities of Doxazosin.,Doxazosin
DB00616,Desmopressin may decrease the antihypertensive activities of Candoxatril.,Candoxatril
DB00622,Desmopressin may decrease the antihypertensive activities of Nicardipine.,Nicardipine
DB00678,Desmopressin may decrease the antihypertensive activities of Losartan.,Losartan
DB00691,Desmopressin may decrease the antihypertensive activities of Moexipril.,Moexipril
DB00727,Desmopressin may decrease the antihypertensive activities of Nitroglycerin.,Nitroglycerin
DB00765,Desmopressin may decrease the antihypertensive activities of Metyrosine.,Metyrosine
DB00785,Desmopressin may decrease the antihypertensive activities of Cryptenamine.,Cryptenamine
DB00796,Desmopressin may decrease the antihypertensive activities of Candesartan cilexetil.,Candesartan cilexetil
DB00866,Desmopressin may decrease the antihypertensive activities of Alprenolol.,Alprenolol
DB00876,Desmopressin may decrease the antihypertensive activities of Eprosartan.,Eprosartan
DB00881,Desmopressin may decrease the antihypertensive activities of Quinapril.,Quinapril
DB00966,Desmopressin may decrease the antihypertensive activities of Telmisartan.,Telmisartan
DB01023,Desmopressin may decrease the antihypertensive activities of Felodipine.,Felodipine
DB01029,Desmopressin may decrease the antihypertensive activities of Irbesartan.,Irbesartan
DB01054,Desmopressin may decrease the antihypertensive activities of Nitrendipine.,Nitrendipine
DB01089,Desmopressin may decrease the antihypertensive activities of Deserpidine.,Deserpidine
DB01090,Desmopressin may decrease the antihypertensive activities of Pentolinium.,Pentolinium
DB01116,Desmopressin may decrease the antihypertensive activities of Trimethaphan.,Trimethaphan
DB01136,Desmopressin may decrease the antihypertensive activities of Carvedilol.,Carvedilol
DB01158,Desmopressin may decrease the antihypertensive activities of Bretylium.,Bretylium
DB01162,Desmopressin may decrease the antihypertensive activities of Terazosin.,Terazosin
DB01193,Desmopressin may decrease the antihypertensive activities of Acebutolol.,Acebutolol
DB01197,Desmopressin may decrease the antihypertensive activities of Captopril.,Captopril
DB01244,Desmopressin may decrease the antihypertensive activities of Bepridil.,Bepridil
DB01295,Desmopressin may decrease the antihypertensive activities of Bevantolol.,Bevantolol
DB01297,Desmopressin may decrease the antihypertensive activities of Practolol.,Practolol
DB01340,Desmopressin may decrease the antihypertensive activities of Cilazapril.,Cilazapril
DB01347,Desmopressin may decrease the antihypertensive activities of Saprisartan.,Saprisartan
DB01348,Desmopressin may decrease the antihypertensive activities of Spirapril.,Spirapril
DB01388,Desmopressin may decrease the antihypertensive activities of Mibefradil.,Mibefradil
DB01580,Desmopressin may decrease the antihypertensive activities of Oxprenolol.,Oxprenolol
DB03322,Desmopressin may decrease the antihypertensive activities of Dexpropranolol.,Dexpropranolol
DB04840,Desmopressin may decrease the antihypertensive activities of Debrisoquine.,Debrisoquine
DB04846,Desmopressin may decrease the antihypertensive activities of Celiprolol.,Celiprolol
DB04861,Desmopressin may decrease the antihypertensive activities of Nebivolol.,Nebivolol
DB06268,Desmopressin may decrease the antihypertensive activities of Sitaxentan.,Sitaxentan
DB06403,Desmopressin may decrease the antihypertensive activities of Ambrisentan.,Ambrisentan
DB06445,Desmopressin may decrease the antihypertensive activities of Diethylnorspermine.,Diethylnorspermine
DB06712,Desmopressin may decrease the antihypertensive activities of Nilvadipine.,Nilvadipine
DB06762,Desmopressin may decrease the antihypertensive activities of Pinacidil.,Pinacidil
DB07767,Desmopressin may decrease the antihypertensive activities of Ferulic acid.,Ferulic acid
DB08808,Desmopressin may decrease the antihypertensive activities of Bupranolol.,Bupranolol
DB08836,Desmopressin may decrease the antihypertensive activities of Temocapril.,Temocapril
DB08931,Desmopressin may decrease the antihypertensive activities of Riociguat.,Riociguat
DB08952,Desmopressin may decrease the antihypertensive activities of Indenolol.,Indenolol
DB08960,Desmopressin may decrease the antihypertensive activities of Hexamethonium.,Hexamethonium
DB09026,Desmopressin may decrease the antihypertensive activities of Aliskiren.,Aliskiren
DB09206,Desmopressin may decrease the antihypertensive activities of Trimazosin.,Trimazosin
DB09236,Desmopressin may decrease the antihypertensive activities of Lacidipine.,Lacidipine
DB09238,Desmopressin may decrease the antihypertensive activities of Manidipine.,Manidipine
DB09239,Desmopressin may decrease the antihypertensive activities of Niguldipine.,Niguldipine
DB09363,Desmopressin may decrease the antihypertensive activities of Rauwolfia serpentina root.,Rauwolfia serpentina root
DB11362,Desmopressin may decrease the antihypertensive activities of Selexipag.,Selexipag
DB11720,Desmopressin may decrease the antihypertensive activities of Angiotensin 1-7.,Angiotensin 1-7
DB11770,Desmopressin may decrease the antihypertensive activities of Talinolol.,Talinolol
DB11783,Desmopressin may decrease the antihypertensive activities of Imidapril.,Imidapril
DB12054,Desmopressin may decrease the antihypertensive activities of BQ-123.,BQ-123
DB12093,Desmopressin may decrease the antihypertensive activities of Tetrahydropalmatine.,Tetrahydropalmatine
DB12212,Desmopressin may decrease the antihypertensive activities of Landiolol.,Landiolol
DB12465,Desmopressin may decrease the antihypertensive activities of Ketanserin.,Ketanserin
DB12945,Desmopressin may decrease the antihypertensive activities of Dihydralazine.,Dihydralazine
DB13166,Desmopressin may decrease the antihypertensive activities of Zofenopril.,Zofenopril
DB13211,Desmopressin may decrease the antihypertensive activities of Guanoxan.,Guanoxan
DB13312,Desmopressin may decrease the antihypertensive activities of Delapril.,Delapril
DB13374,Desmopressin may decrease the antihypertensive activities of Vincamine.,Vincamine
DB13400,Desmopressin may decrease the antihypertensive activities of Linsidomine.,Linsidomine
DB13410,Desmopressin may decrease the antihypertensive activities of Guanoxabenz.,Guanoxabenz
DB13429,Desmopressin may decrease the antihypertensive activities of Tolonidine.,Tolonidine
DB13435,Desmopressin may decrease the antihypertensive activities of Endralazine.,Endralazine
DB13443,Desmopressin may decrease the antihypertensive activities of Esatenolol.,Esatenolol
DB13452,Desmopressin may decrease the antihypertensive activities of Cadralazine.,Cadralazine
DB13508,Desmopressin may decrease the antihypertensive activities of Cloranolol.,Cloranolol
DB13575,Desmopressin may decrease the antihypertensive activities of Bietaserpine.,Bietaserpine
DB13604,Desmopressin may decrease the antihypertensive activities of Guanazodine.,Guanazodine
DB13631,Desmopressin may decrease the antihypertensive activities of Methoserpidine.,Methoserpidine
DB13757,Desmopressin may decrease the antihypertensive activities of Epanolol.,Epanolol
DB13779,Desmopressin may decrease the antihypertensive activities of Guanoclor.,Guanoclor
DB13919,Desmopressin may decrease the antihypertensive activities of Candesartan.,Candesartan
DB14068,Desmopressin may decrease the antihypertensive activities of Dexniguldipine.,Dexniguldipine
DB14094,Desmopressin may decrease the antihypertensive activities of Tocopherylquinone.,Tocopherylquinone
DB14125,Desmopressin may decrease the antihypertensive activities of Benazeprilat.,Benazeprilat
DB14207,Desmopressin may decrease the antihypertensive activities of Fosinoprilat.,Fosinoprilat
DB14208,Desmopressin may decrease the antihypertensive activities of Ramiprilat.,Ramiprilat
DB14213,Desmopressin may decrease the antihypertensive activities of Perindoprilat.,Perindoprilat
DB14217,Desmopressin may decrease the antihypertensive activities of Quinaprilat.,Quinaprilat
DB00193,The risk or severity of hyponatremia can be increased when Tramadol is combined with Desmopressin.,Tramadol
DB00295,The risk or severity of hyponatremia can be increased when Morphine is combined with Desmopressin.,Morphine
DB00318,The risk or severity of hyponatremia can be increased when Codeine is combined with Desmopressin.,Codeine
DB00327,The risk or severity of hyponatremia can be increased when Hydromorphone is combined with Desmopressin.,Hydromorphone
DB00333,The risk or severity of hyponatremia can be increased when Methadone is combined with Desmopressin.,Methadone
DB00454,The risk or severity of hyponatremia can be increased when Meperidine is combined with Desmopressin.,Meperidine
DB00497,The risk or severity of hyponatremia can be increased when Oxycodone is combined with Desmopressin.,Oxycodone
DB00611,The risk or severity of hyponatremia can be increased when Butorphanol is combined with Desmopressin.,Butorphanol
DB00647,The risk or severity of hyponatremia can be increased when Dextropropoxyphene is combined with Desmopressin.,Dextropropoxyphene
DB00652,The risk or severity of hyponatremia can be increased when Pentazocine is combined with Desmopressin.,Pentazocine
DB00704,The risk or severity of hyponatremia can be increased when Naltrexone is combined with Desmopressin.,Naltrexone
DB00708,The risk or severity of hyponatremia can be increased when Sufentanil is combined with Desmopressin.,Sufentanil
DB00802,The risk or severity of hyponatremia can be increased when Alfentanil is combined with Desmopressin.,Alfentanil
DB00813,The risk or severity of hyponatremia can be increased when Fentanyl is combined with Desmopressin.,Fentanyl
DB00844,The risk or severity of hyponatremia can be increased when Nalbuphine is combined with Desmopressin.,Nalbuphine
DB00854,The risk or severity of hyponatremia can be increased when Levorphanol is combined with Desmopressin.,Levorphanol
DB00899,The risk or severity of hyponatremia can be increased when Remifentanil is combined with Desmopressin.,Remifentanil
DB00921,The risk or severity of hyponatremia can be increased when Buprenorphine is combined with Desmopressin.,Buprenorphine
DB00956,The risk or severity of hyponatremia can be increased when Hydrocodone is combined with Desmopressin.,Hydrocodone
DB01081,The risk or severity of hyponatremia can be increased when Diphenoxylate is combined with Desmopressin.,Diphenoxylate
DB01192,The risk or severity of hyponatremia can be increased when Oxymorphone is combined with Desmopressin.,Oxymorphone
DB01209,The risk or severity of hyponatremia can be increased when Dezocine is combined with Desmopressin.,Dezocine
DB01227,The risk or severity of hyponatremia can be increased when Levacetylmethadol is combined with Desmopressin.,Levacetylmethadol
DB01433,The risk or severity of hyponatremia can be increased when Methadyl acetate is combined with Desmopressin.,Methadyl acetate
DB01450,The risk or severity of hyponatremia can be increased when Dihydroetorphine is combined with Desmopressin.,Dihydroetorphine
DB01452,The risk or severity of hyponatremia can be increased when Diamorphine is combined with Desmopressin.,Diamorphine
DB01459,The risk or severity of hyponatremia can be increased when Bezitramide is combined with Desmopressin.,Bezitramide
DB01466,The risk or severity of hyponatremia can be increased when Ethylmorphine is combined with Desmopressin.,Ethylmorphine
DB01497,The risk or severity of hyponatremia can be increased when Etorphine is combined with Desmopressin.,Etorphine
DB01529,The risk or severity of hyponatremia can be increased when Dextromoramide is combined with Desmopressin.,Dextromoramide
DB01531,The risk or severity of hyponatremia can be increased when Desomorphine is combined with Desmopressin.,Desomorphine
DB01535,The risk or severity of hyponatremia can be increased when Carfentanil is combined with Desmopressin.,Carfentanil
DB01551,The risk or severity of hyponatremia can be increased when Dihydrocodeine is combined with Desmopressin.,Dihydrocodeine
DB01555,The risk or severity of hyponatremia can be increased when Alphacetylmethadol is combined with Desmopressin.,Alphacetylmethadol
DB01565,The risk or severity of hyponatremia can be increased when Dihydromorphine is combined with Desmopressin.,Dihydromorphine
DB06204,The risk or severity of hyponatremia can be increased when Tapentadol is combined with Desmopressin.,Tapentadol
DB06738,The risk or severity of hyponatremia can be increased when Ketobemidone is combined with Desmopressin.,Ketobemidone
DB08861,The risk or severity of hyponatremia can be increased when DPDPE is combined with Desmopressin.,DPDPE
DB09174,The risk or severity of hyponatremia can be increased when Lofentanil is combined with Desmopressin.,Lofentanil
DB09272,The risk or severity of hyponatremia can be increased when Eluxadoline is combined with Desmopressin.,Eluxadoline
DB11130,The risk or severity of hyponatremia can be increased when Opium is combined with Desmopressin.,Opium
DB11609,The risk or severity of hyponatremia can be increased when Normethadone is combined with Desmopressin.,Normethadone
DB12492,The risk or severity of hyponatremia can be increased when Piritramide is combined with Desmopressin.,Piritramide
DB13160,The risk or severity of hyponatremia can be increased when Alphaprodine is combined with Desmopressin.,Alphaprodine
DB13454,The risk or severity of hyponatremia can be increased when Nicomorphine is combined with Desmopressin.,Nicomorphine
DB13478,The risk or severity of hyponatremia can be increased when Meptazinol is combined with Desmopressin.,Meptazinol
DB13605,The risk or severity of hyponatremia can be increased when Phenoperidine is combined with Desmopressin.,Phenoperidine
DB13606,The risk or severity of hyponatremia can be increased when Phenazocine is combined with Desmopressin.,Phenazocine
DB13787,The risk or severity of hyponatremia can be increased when Tilidine is combined with Desmopressin.,Tilidine
DB15360,"The risk or severity of hyponatremia can be increased when Carfentanil, C-11 is combined with Desmopressin.","Carfentanil, C-11"
DB15465,The risk or severity of hyponatremia can be increased when Benzhydrocodone is combined with Desmopressin.,Benzhydrocodone
DB00191,The risk or severity of hypertension can be increased when Desmopressin is combined with Phentermine.,Phentermine
DB00211,The risk or severity of hypertension can be increased when Desmopressin is combined with Midodrine.,Midodrine
DB00216,The risk or severity of hypertension can be increased when Desmopressin is combined with Eletriptan.,Eletriptan
DB00217,The risk or severity of hypertension can be increased when Desmopressin is combined with Bethanidine.,Bethanidine
DB00221,The risk or severity of hypertension can be increased when Desmopressin is combined with Isoetharine.,Isoetharine
DB00246,The risk or severity of hypertension can be increased when Desmopressin is combined with Ziprasidone.,Ziprasidone
DB00247,The risk or severity of hypertension can be increased when Desmopressin is combined with Methysergide.,Methysergide
DB00248,The risk or severity of hypertension can be increased when Desmopressin is combined with Cabergoline.,Cabergoline
DB00315,The risk or severity of hypertension can be increased when Desmopressin is combined with Zolmitriptan.,Zolmitriptan
DB00320,The risk or severity of hypertension can be increased when Desmopressin is combined with Dihydroergotamine.,Dihydroergotamine
DB00353,The risk or severity of hypertension can be increased when Desmopressin is combined with Methylergometrine.,Methylergometrine
DB00368,The risk or severity of hypertension can be increased when Desmopressin is combined with Norepinephrine.,Norepinephrine
DB00370,The risk or severity of hypertension can be increased when Desmopressin is combined with Mirtazapine.,Mirtazapine
DB00388,The risk or severity of hypertension can be increased when Desmopressin is combined with Phenylephrine.,Phenylephrine
DB00397,The risk or severity of hypertension can be increased when Desmopressin is combined with Phenylpropanolamine.,Phenylpropanolamine
DB00420,The risk or severity of hypertension can be increased when Desmopressin is combined with Promazine.,Promazine
DB00450,The risk or severity of hypertension can be increased when Desmopressin is combined with Droperidol.,Droperidol
DB00561,The risk or severity of hypertension can be increased when Desmopressin is combined with Doxapram.,Doxapram
DB00572,The risk or severity of hypertension can be increased when Desmopressin is combined with Atropine.,Atropine
DB00575,The risk or severity of hypertension can be increased when Desmopressin is combined with Clonidine.,Clonidine
DB00589,The risk or severity of hypertension can be increased when Desmopressin is combined with Lisuride.,Lisuride
DB00601,The risk or severity of hypertension can be increased when Desmopressin is combined with Linezolid.,Linezolid
DB00610,The risk or severity of hypertension can be increased when Desmopressin is combined with Metaraminol.,Metaraminol
DB00614,The risk or severity of hypertension can be increased when Desmopressin is combined with Furazolidone.,Furazolidone
DB00629,The risk or severity of hypertension can be increased when Desmopressin is combined with Guanabenz.,Guanabenz
DB00668,The risk or severity of hypertension can be increased when Desmopressin is combined with Epinephrine.,Epinephrine
DB00679,The risk or severity of hypertension can be increased when Desmopressin is combined with Thioridazine.,Thioridazine
DB00696,The risk or severity of hypertension can be increased when Desmopressin is combined with Ergotamine.,Ergotamine
DB00699,The risk or severity of hypertension can be increased when Desmopressin is combined with Nicergoline.,Nicergoline
DB00723,The risk or severity of hypertension can be increased when Desmopressin is combined with Methoxamine.,Methoxamine
DB00734,The risk or severity of hypertension can be increased when Desmopressin is combined with Risperidone.,Risperidone
DB00752,The risk or severity of hypertension can be increased when Desmopressin is combined with Tranylcypromine.,Tranylcypromine
DB00753,The risk or severity of hypertension can be increased when Desmopressin is combined with Isoflurane.,Isoflurane
DB00777,The risk or severity of hypertension can be increased when Desmopressin is combined with Propiomazine.,Propiomazine
DB00797,The risk or severity of hypertension can be increased when Desmopressin is combined with Tolazoline.,Tolazoline
DB00805,The risk or severity of hypertension can be increased when Desmopressin is combined with Minaprine.,Minaprine
DB00816,The risk or severity of hypertension can be increased when Desmopressin is combined with Orciprenaline.,Orciprenaline
DB00818,The risk or severity of hypertension can be increased when Desmopressin is combined with Propofol.,Propofol
DB00830,The risk or severity of hypertension can be increased when Desmopressin is combined with Phenmetrazine.,Phenmetrazine
DB00831,The risk or severity of hypertension can be increased when Desmopressin is combined with Trifluoperazine.,Trifluoperazine
DB00852,The risk or severity of hypertension can be increased when Desmopressin is combined with Pseudoephedrine.,Pseudoephedrine
DB00865,The risk or severity of hypertension can be increased when Desmopressin is combined with Benzphetamine.,Benzphetamine
DB00867,The risk or severity of hypertension can be increased when Desmopressin is combined with Ritodrine.,Ritodrine
DB00875,The risk or severity of hypertension can be increased when Desmopressin is combined with Flupentixol.,Flupentixol
DB00886,The risk or severity of hypertension can be increased when Desmopressin is combined with Omapatrilat.,Omapatrilat
DB00901,The risk or severity of hypertension can be increased when Desmopressin is combined with Bitolterol.,Bitolterol
DB00925,The risk or severity of hypertension can be increased when Desmopressin is combined with Phenoxybenzamine.,Phenoxybenzamine
DB00935,The risk or severity of hypertension can be increased when Desmopressin is combined with Oxymetazoline.,Oxymetazoline
DB00937,The risk or severity of hypertension can be increased when Desmopressin is combined with Diethylpropion.,Diethylpropion
DB00938,The risk or severity of hypertension can be increased when Desmopressin is combined with Salmeterol.,Salmeterol
DB00952,The risk or severity of hypertension can be increased when Desmopressin is combined with Naratriptan.,Naratriptan
DB00983,The risk or severity of hypertension can be increased when Desmopressin is combined with Formoterol.,Formoterol
DB00998,The risk or severity of hypertension can be increased when Desmopressin is combined with Frovatriptan.,Frovatriptan
DB01028,The risk or severity of hypertension can be increased when Desmopressin is combined with Methoxyflurane.,Methoxyflurane
DB01037,The risk or severity of hypertension can be increased when Desmopressin is combined with Selegiline.,Selegiline
DB01049,The risk or severity of hypertension can be increased when Desmopressin is combined with Ergoloid mesylate.,Ergoloid mesylate
DB01064,The risk or severity of hypertension can be increased when Desmopressin is combined with Isoprenaline.,Isoprenaline
DB01102,The risk or severity of hypertension can be increased when Desmopressin is combined with Arbutamine.,Arbutamine
DB01126,The risk or severity of hypertension can be increased when Desmopressin is combined with Dutasteride.,Dutasteride
DB01159,The risk or severity of hypertension can be increased when Desmopressin is combined with Halothane.,Halothane
DB01171,The risk or severity of hypertension can be increased when Desmopressin is combined with Moclobemide.,Moclobemide
DB01180,The risk or severity of hypertension can be increased when Desmopressin is combined with Rescinnamine.,Rescinnamine
DB01182,The risk or severity of hypertension can be increased when Desmopressin is combined with Propafenone.,Propafenone
DB01186,The risk or severity of hypertension can be increased when Desmopressin is combined with Pergolide.,Pergolide
DB01189,The risk or severity of hypertension can be increased when Desmopressin is combined with Desflurane.,Desflurane
DB01200,The risk or severity of hypertension can be increased when Desmopressin is combined with Bromocriptine.,Bromocriptine
DB01216,The risk or severity of hypertension can be increased when Desmopressin is combined with Finasteride.,Finasteride
DB01236,The risk or severity of hypertension can be increased when Desmopressin is combined with Sevoflurane.,Sevoflurane
DB01238,The risk or severity of hypertension can be increased when Desmopressin is combined with Aripiprazole.,Aripiprazole
DB01247,The risk or severity of hypertension can be increased when Desmopressin is combined with Isocarboxazid.,Isocarboxazid
DB01253,The risk or severity of hypertension can be increased when Desmopressin is combined with Ergometrine.,Ergometrine
DB01255,The risk or severity of hypertension can be increased when Desmopressin is combined with Lisdexamfetamine.,Lisdexamfetamine
DB01288,The risk or severity of hypertension can be increased when Desmopressin is combined with Fenoterol.,Fenoterol
DB01291,The risk or severity of hypertension can be increased when Desmopressin is combined with Pirbuterol.,Pirbuterol
DB01363,The risk or severity of hypertension can be increased when Desmopressin is combined with Ephedra sinica root.,Ephedra sinica root
DB01364,The risk or severity of hypertension can be increased when Desmopressin is combined with Ephedrine.,Ephedrine
DB01365,The risk or severity of hypertension can be increased when Desmopressin is combined with Mephentermine.,Mephentermine
DB01366,The risk or severity of hypertension can be increased when Desmopressin is combined with Procaterol.,Procaterol
DB01392,The risk or severity of hypertension can be increased when Desmopressin is combined with Yohimbine.,Yohimbine
DB01403,The risk or severity of hypertension can be increased when Desmopressin is combined with Methotrimeprazine.,Methotrimeprazine
DB01407,The risk or severity of hypertension can be increased when Desmopressin is combined with Clenbuterol.,Clenbuterol
DB01408,The risk or severity of hypertension can be increased when Desmopressin is combined with Bambuterol.,Bambuterol
DB01442,The risk or severity of hypertension can be increased when Desmopressin is combined with MMDA.,MMDA
DB01454,The risk or severity of hypertension can be increased when Desmopressin is combined with Midomafetamine.,Midomafetamine
DB01467,"The risk or severity of hypertension can be increased when Desmopressin is combined with 2,5-Dimethoxy-4-ethylamphetamine.","2,5-Dimethoxy-4-ethylamphetamine"
DB01472,The risk or severity of hypertension can be increased when Desmopressin is combined with 4-Methoxyamphetamine.,4-Methoxyamphetamine
DB01484,"The risk or severity of hypertension can be increased when Desmopressin is combined with 4-Bromo-2,5-dimethoxyamphetamine.","4-Bromo-2,5-dimethoxyamphetamine"
DB01509,The risk or severity of hypertension can be increased when Desmopressin is combined with Tenamfetamine.,Tenamfetamine
DB01556,The risk or severity of hypertension can be increased when Desmopressin is combined with Chlorphentermine.,Chlorphentermine
DB01576,The risk or severity of hypertension can be increased when Desmopressin is combined with Dextroamphetamine.,Dextroamphetamine
DB01579,The risk or severity of hypertension can be increased when Desmopressin is combined with Phendimetrazine.,Phendimetrazine
DB01591,The risk or severity of hypertension can be increased when Desmopressin is combined with Solifenacin.,Solifenacin
DB01608,The risk or severity of hypertension can be increased when Desmopressin is combined with Periciazine.,Periciazine
DB01614,The risk or severity of hypertension can be increased when Desmopressin is combined with Acepromazine.,Acepromazine
DB01622,The risk or severity of hypertension can be increased when Desmopressin is combined with Thioproperazine.,Thioproperazine
DB01624,The risk or severity of hypertension can be increased when Desmopressin is combined with Zuclopenthixol.,Zuclopenthixol
DB01626,The risk or severity of hypertension can be increased when Desmopressin is combined with Pargyline.,Pargyline
DB02032,The risk or severity of hypertension can be increased when Desmopressin is combined with Epicaptopril.,Epicaptopril
DB04017,The risk or severity of hypertension can be increased when Desmopressin is combined with Clorgiline.,Clorgiline
DB04581,The risk or severity of hypertension can be increased when Desmopressin is combined with 1-benzylimidazole.,1-benzylimidazole
DB04818,The risk or severity of hypertension can be increased when Desmopressin is combined with Iproniazid.,Iproniazid
DB04820,The risk or severity of hypertension can be increased when Desmopressin is combined with Nialamide.,Nialamide
DB04829,The risk or severity of hypertension can be increased when Desmopressin is combined with Lysergic acid diethylamide.,Lysergic acid diethylamide
DB04855,The risk or severity of hypertension can be increased when Desmopressin is combined with Dronedarone.,Dronedarone
DB04908,The risk or severity of hypertension can be increased when Desmopressin is combined with Flibanserin.,Flibanserin
DB04946,The risk or severity of hypertension can be increased when Desmopressin is combined with Iloperidone.,Iloperidone
DB05039,The risk or severity of hypertension can be increased when Desmopressin is combined with Indacaterol.,Indacaterol
DB05271,The risk or severity of hypertension can be increased when Desmopressin is combined with Rotigotine.,Rotigotine
DB05395,The risk or severity of hypertension can be increased when Desmopressin is combined with Amibegron.,Amibegron
DB05562,The risk or severity of hypertension can be increased when Desmopressin is combined with Naluzotan.,Naluzotan
DB06016,The risk or severity of hypertension can be increased when Desmopressin is combined with Cariprazine.,Cariprazine
DB06148,The risk or severity of hypertension can be increased when Desmopressin is combined with Mianserin.,Mianserin
DB06152,The risk or severity of hypertension can be increased when Desmopressin is combined with Nylidrin.,Nylidrin
DB06153,The risk or severity of hypertension can be increased when Desmopressin is combined with Pizotifen.,Pizotifen
DB06190,The risk or severity of hypertension can be increased when Desmopressin is combined with Solabegron.,Solabegron
DB06216,The risk or severity of hypertension can be increased when Desmopressin is combined with Asenapine.,Asenapine
DB06654,The risk or severity of hypertension can be increased when Desmopressin is combined with Safinamide.,Safinamide
DB06678,The risk or severity of hypertension can be increased when Desmopressin is combined with Esmirtazapine.,Esmirtazapine
DB06684,The risk or severity of hypertension can be increased when Desmopressin is combined with Vilazodone.,Vilazodone
DB06690,The risk or severity of hypertension can be increased when Desmopressin is combined with Nitrous oxide.,Nitrous oxide
DB06694,The risk or severity of hypertension can be increased when Desmopressin is combined with Xylometazoline.,Xylometazoline
DB06701,The risk or severity of hypertension can be increased when Desmopressin is combined with Dexmethylphenidate.,Dexmethylphenidate
DB06706,The risk or severity of hypertension can be increased when Desmopressin is combined with Isometheptene.,Isometheptene
DB06707,The risk or severity of hypertension can be increased when Desmopressin is combined with Levonordefrin.,Levonordefrin
DB06711,The risk or severity of hypertension can be increased when Desmopressin is combined with Naphazoline.,Naphazoline
DB06763,The risk or severity of hypertension can be increased when Desmopressin is combined with Saralasin.,Saralasin
DB06764,The risk or severity of hypertension can be increased when Desmopressin is combined with Tetryzoline.,Tetryzoline
DB08810,The risk or severity of hypertension can be increased when Desmopressin is combined with Cinitapride.,Cinitapride
DB08815,The risk or severity of hypertension can be increased when Desmopressin is combined with Lurasidone.,Lurasidone
DB08841,The risk or severity of hypertension can be increased when Desmopressin is combined with Tyramine.,Tyramine
DB08925,The risk or severity of hypertension can be increased when Desmopressin is combined with Adrafinil.,Adrafinil
DB08941,The risk or severity of hypertension can be increased when Desmopressin is combined with Isoxsuprine.,Isoxsuprine
DB08950,The risk or severity of hypertension can be increased when Desmopressin is combined with Indoramin.,Indoramin
DB08954,The risk or severity of hypertension can be increased when Desmopressin is combined with Ifenprodil.,Ifenprodil
DB08957,The risk or severity of hypertension can be increased when Desmopressin is combined with Hexoprenaline.,Hexoprenaline
DB08985,The risk or severity of hypertension can be increased when Desmopressin is combined with Etilefrine.,Etilefrine
DB09061,The risk or severity of hypertension can be increased when Desmopressin is combined with Cannabidiol.,Cannabidiol
DB09080,The risk or severity of hypertension can be increased when Desmopressin is combined with Olodaterol.,Olodaterol
DB09128,The risk or severity of hypertension can be increased when Desmopressin is combined with Brexpiprazole.,Brexpiprazole
DB09202,The risk or severity of hypertension can be increased when Desmopressin is combined with Cirazoline.,Cirazoline
DB09203,The risk or severity of hypertension can be increased when Desmopressin is combined with Synephrine.,Synephrine
DB09242,The risk or severity of hypertension can be increased when Desmopressin is combined with Moxonidine.,Moxonidine
DB09243,The risk or severity of hypertension can be increased when Desmopressin is combined with Hydracarbazine.,Hydracarbazine
DB09246,The risk or severity of hypertension can be increased when Desmopressin is combined with Benmoxin.,Benmoxin
DB09248,The risk or severity of hypertension can be increased when Desmopressin is combined with Mebanazine.,Mebanazine
DB09249,The risk or severity of hypertension can be increased when Desmopressin is combined with Octamoxin.,Octamoxin
DB09250,The risk or severity of hypertension can be increased when Desmopressin is combined with Pheniprazine.,Pheniprazine
DB09251,The risk or severity of hypertension can be increased when Desmopressin is combined with Phenoxypropazine.,Phenoxypropazine
DB09252,The risk or severity of hypertension can be increased when Desmopressin is combined with Pivhydrazine.,Pivhydrazine
DB09253,The risk or severity of hypertension can be increased when Desmopressin is combined with Safrazine.,Safrazine
DB09254,The risk or severity of hypertension can be increased when Desmopressin is combined with Caroxazone.,Caroxazone
DB09273,The risk or severity of hypertension can be increased when Desmopressin is combined with Doxofylline.,Doxofylline
DB09480,The risk or severity of hypertension can be increased when Desmopressin is combined with Iofetamine I-123.,Iofetamine I-123
DB11124,The risk or severity of hypertension can be increased when Desmopressin is combined with Racepinephrine.,Racepinephrine
DB11273,The risk or severity of hypertension can be increased when Desmopressin is combined with Dihydroergocornine.,Dihydroergocornine
DB11373,The risk or severity of hypertension can be increased when Desmopressin is combined with Amitraz.,Amitraz
DB11428,The risk or severity of hypertension can be increased when Desmopressin is combined with Medetomidine.,Medetomidine
DB11477,The risk or severity of hypertension can be increased when Desmopressin is combined with Xylazine.,Xylazine
DB11481,The risk or severity of hypertension can be increased when Desmopressin is combined with Atipamezole.,Atipamezole
DB11541,The risk or severity of hypertension can be increased when Desmopressin is combined with Ractopamine.,Ractopamine
DB11543,The risk or severity of hypertension can be increased when Desmopressin is combined with Romifidine.,Romifidine
DB11556,The risk or severity of hypertension can be increased when Desmopressin is combined with Detomidine.,Detomidine
DB11738,The risk or severity of hypertension can be increased when Desmopressin is combined with Rilmenidine.,Rilmenidine
DB11755,The risk or severity of hypertension can be increased when Desmopressin is combined with Tetrahydrocannabivarin.,Tetrahydrocannabivarin
DB11785,The risk or severity of hypertension can be increased when Desmopressin is combined with Anisodamine.,Anisodamine
DB11871,The risk or severity of hypertension can be increased when Desmopressin is combined with PF-00610355.,PF-00610355
DB12080,The risk or severity of hypertension can be increased when Desmopressin is combined with Ritobegron.,Ritobegron
DB12092,The risk or severity of hypertension can be increased when Desmopressin is combined with Naftopidil.,Naftopidil
DB12100,The risk or severity of hypertension can be increased when Desmopressin is combined with Abediterol.,Abediterol
DB12248,The risk or severity of hypertension can be increased when Desmopressin is combined with Tulobuterol.,Tulobuterol
DB12313,The risk or severity of hypertension can be increased when Desmopressin is combined with Dopexamine.,Dopexamine
DB12361,The risk or severity of hypertension can be increased when Desmopressin is combined with Piclozotan.,Piclozotan
DB12371,The risk or severity of hypertension can be increased when Desmopressin is combined with Siponimod.,Siponimod
DB12551,The risk or severity of hypertension can be increased when Desmopressin is combined with Idazoxan.,Idazoxan
DB12661,The risk or severity of hypertension can be increased when Desmopressin is combined with Urapidil.,Urapidil
DB12779,The risk or severity of hypertension can be increased when Desmopressin is combined with Higenamine.,Higenamine
DB12846,The risk or severity of hypertension can be increased when Desmopressin is combined with Reproterol.,Reproterol
DB12927,The risk or severity of hypertension can be increased when Desmopressin is combined with Theodrenaline.,Theodrenaline
DB13064,The risk or severity of hypertension can be increased when Desmopressin is combined with Tramazoline.,Tramazoline
DB13108,The risk or severity of hypertension can be increased when Desmopressin is combined with Mephedrone.,Mephedrone
DB13251,The risk or severity of hypertension can be increased when Desmopressin is combined with Octopamine.,Octopamine
DB13323,The risk or severity of hypertension can be increased when Desmopressin is combined with Trichloroethylene.,Trichloroethylene
DB13341,The risk or severity of hypertension can be increased when Desmopressin is combined with Fenozolone.,Fenozolone
DB13345,The risk or severity of hypertension can be increased when Desmopressin is combined with Dihydroergocristine.,Dihydroergocristine
DB13378,The risk or severity of hypertension can be increased when Desmopressin is combined with Norfenefrine.,Norfenefrine
DB13385,The risk or severity of hypertension can be increased when Desmopressin is combined with Dihydroergocryptine.,Dihydroergocryptine
DB13398,The risk or severity of hypertension can be increased when Desmopressin is combined with Oxyfedrine.,Oxyfedrine
DB13399,The risk or severity of hypertension can be increased when Desmopressin is combined with Terguride.,Terguride
DB13453,The risk or severity of hypertension can be increased when Desmopressin is combined with Xenon.,Xenon
DB13510,The risk or severity of hypertension can be increased when Desmopressin is combined with Buflomedil.,Buflomedil
DB13520,The risk or severity of hypertension can be increased when Desmopressin is combined with Metergoline.,Metergoline
DB13559,The risk or severity of hypertension can be increased when Desmopressin is combined with Rimiterol.,Rimiterol
DB13598,The risk or severity of hypertension can be increased when Desmopressin is combined with Diethyl ether.,Diethyl ether
DB13624,The risk or severity of hypertension can be increased when Desmopressin is combined with Methoxyphenamine.,Methoxyphenamine
DB13692,The risk or severity of hypertension can be increased when Desmopressin is combined with Tretoquinol.,Tretoquinol
DB13703,The risk or severity of hypertension can be increased when Desmopressin is combined with Gepefrine.,Gepefrine
DB13777,The risk or severity of hypertension can be increased when Desmopressin is combined with Prenalterol.,Prenalterol
DB13781,The risk or severity of hypertension can be increased when Desmopressin is combined with Xamoterol.,Xamoterol
DB13852,The risk or severity of hypertension can be increased when Desmopressin is combined with Mefenorex.,Mefenorex
DB13875,The risk or severity of hypertension can be increased when Desmopressin is combined with Harmaline.,Harmaline
DB13917,The risk or severity of hypertension can be increased when Desmopressin is combined with Deoxyepinephrine.,Deoxyepinephrine
DB13940,"The risk or severity of hypertension can be increased when Desmopressin is combined with 2,5-Dimethoxy-4-ethylthioamphetamine.","2,5-Dimethoxy-4-ethylthioamphetamine"
DB14010,"The risk or severity of hypertension can be increased when Desmopressin is combined with 5-methoxy-N,N-dimethyltryptamine.","5-methoxy-N,N-dimethyltryptamine"
DB14185,The risk or severity of hypertension can be increased when Desmopressin is combined with Aripiprazole lauroxil.,Aripiprazole lauroxil
DB14231,The risk or severity of hypertension can be increased when Desmopressin is combined with Quinoline Yellow WS.,Quinoline Yellow WS
DB15685,The risk or severity of hypertension can be increased when Desmopressin is combined with Selpercatinib.,Selpercatinib
DB00321,The risk or severity of hyponatremia and water intoxication can be increased when Amitriptyline is combined with Desmopressin.,Amitriptyline
DB00344,The risk or severity of hyponatremia and water intoxication can be increased when Protriptyline is combined with Desmopressin.,Protriptyline
DB00458,The risk or severity of hyponatremia and water intoxication can be increased when Imipramine is combined with Desmopressin.,Imipramine
DB00540,The risk or severity of hyponatremia and water intoxication can be increased when Nortriptyline is combined with Desmopressin.,Nortriptyline
DB00543,The risk or severity of hyponatremia and water intoxication can be increased when Amoxapine is combined with Desmopressin.,Amoxapine
DB00726,The risk or severity of hyponatremia and water intoxication can be increased when Trimipramine is combined with Desmopressin.,Trimipramine
DB01142,The risk or severity of hyponatremia and water intoxication can be increased when Doxepin is combined with Desmopressin.,Doxepin
DB01151,The risk or severity of hyponatremia and water intoxication can be increased when Desipramine is combined with Desmopressin.,Desipramine
DB01242,The risk or severity of hyponatremia and water intoxication can be increased when Clomipramine is combined with Desmopressin.,Clomipramine
DB04836,The risk or severity of hyponatremia and water intoxication can be increased when Amineptine is combined with Desmopressin.,Amineptine
DB08996,The risk or severity of hyponatremia and water intoxication can be increased when Dimetacrine is combined with Desmopressin.,Dimetacrine
DB09016,The risk or severity of hyponatremia and water intoxication can be increased when Butriptyline is combined with Desmopressin.,Butriptyline
DB09167,The risk or severity of hyponatremia and water intoxication can be increased when Dosulepin is combined with Desmopressin.,Dosulepin
DB09289,The risk or severity of hyponatremia and water intoxication can be increased when Tianeptine is combined with Desmopressin.,Tianeptine
DB09307,The risk or severity of hyponatremia and water intoxication can be increased when Oxaprotiline is combined with Desmopressin.,Oxaprotiline
DB12930,The risk or severity of hyponatremia and water intoxication can be increased when Opipramol is combined with Desmopressin.,Opipramol
DB13114,The risk or severity of hyponatremia and water intoxication can be increased when Amitriptylinoxide is combined with Desmopressin.,Amitriptylinoxide
DB13225,The risk or severity of hyponatremia and water intoxication can be increased when Dibenzepin is combined with Desmopressin.,Dibenzepin
DB13246,The risk or severity of hyponatremia and water intoxication can be increased when Quinupramine is combined with Desmopressin.,Quinupramine
DB13384,The risk or severity of hyponatremia and water intoxication can be increased when Melitracen is combined with Desmopressin.,Melitracen
DB13411,The risk or severity of hyponatremia and water intoxication can be increased when Lofepramine is combined with Desmopressin.,Lofepramine
DB13496,The risk or severity of hyponatremia and water intoxication can be increased when Iprindole is combined with Desmopressin.,Iprindole
DB13782,The risk or severity of hyponatremia and water intoxication can be increased when Imipramine oxide is combined with Desmopressin.,Imipramine oxide
DB00159,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Icosapent is combined with Desmopressin.",Icosapent
DB00244,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Mesalazine is combined with Desmopressin.",Mesalazine
DB00328,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Indomethacin is combined with Desmopressin.",Indomethacin
DB00461,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Nabumetone is combined with Desmopressin.",Nabumetone
DB00465,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Ketorolac is combined with Desmopressin.",Ketorolac
DB00469,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Tenoxicam is combined with Desmopressin.",Tenoxicam
DB00482,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Celecoxib is combined with Desmopressin.",Celecoxib
DB00500,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Tolmetin is combined with Desmopressin.",Tolmetin
DB00533,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Rofecoxib is combined with Desmopressin.",Rofecoxib
DB00554,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Piroxicam is combined with Desmopressin.",Piroxicam
DB00573,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Fenoprofen is combined with Desmopressin.",Fenoprofen
DB00580,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Valdecoxib is combined with Desmopressin.",Valdecoxib
DB00586,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Diclofenac is combined with Desmopressin.",Diclofenac
DB00605,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Sulindac is combined with Desmopressin.",Sulindac
DB00712,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Flurbiprofen is combined with Desmopressin.",Flurbiprofen
DB00749,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Etodolac is combined with Desmopressin.",Etodolac
DB00784,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Mefenamic acid is combined with Desmopressin.",Mefenamic acid
DB00788,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Naproxen is combined with Desmopressin.",Naproxen
DB00795,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Sulfasalazine is combined with Desmopressin.",Sulfasalazine
DB00812,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Phenylbutazone is combined with Desmopressin.",Phenylbutazone
DB00814,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Meloxicam is combined with Desmopressin.",Meloxicam
DB00821,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Carprofen is combined with Desmopressin.",Carprofen
DB00861,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Diflunisal is combined with Desmopressin.",Diflunisal
DB00936,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Salicylic acid is combined with Desmopressin.",Salicylic acid
DB00939,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Meclofenamic acid is combined with Desmopressin.",Meclofenamic acid
DB00945,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Acetylsalicylic acid is combined with Desmopressin.",Acetylsalicylic acid
DB00991,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Oxaprozin is combined with Desmopressin.",Oxaprozin
DB01009,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Ketoprofen is combined with Desmopressin.",Ketoprofen
DB01014,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Balsalazide is combined with Desmopressin.",Balsalazide
DB01050,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Ibuprofen is combined with Desmopressin.",Ibuprofen
DB01250,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Olsalazine is combined with Desmopressin.",Olsalazine
DB01283,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Lumiracoxib is combined with Desmopressin.",Lumiracoxib
DB01397,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Magnesium salicylate is combined with Desmopressin.",Magnesium salicylate
DB01399,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Salsalate is combined with Desmopressin.",Salsalate
DB01401,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Choline magnesium trisalicylate is combined with Desmopressin.",Choline magnesium trisalicylate
DB01419,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Antrafenine is combined with Desmopressin.",Antrafenine
DB01424,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Aminophenazone is combined with Desmopressin.",Aminophenazone
DB01435,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Antipyrine is combined with Desmopressin.",Antipyrine
DB01600,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Tiaprofenic acid is combined with Desmopressin.",Tiaprofenic acid
DB01628,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Etoricoxib is combined with Desmopressin.",Etoricoxib
DB02224,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Taxifolin is combined with Desmopressin.",Taxifolin
DB03585,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Oxyphenbutazone is combined with Desmopressin.",Oxyphenbutazone
DB04552,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Niflumic acid is combined with Desmopressin.",Niflumic acid
DB04725,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Licofelone is combined with Desmopressin.",Licofelone
DB04743,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Nimesulide is combined with Desmopressin.",Nimesulide
DB04812,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Benoxaprofen is combined with Desmopressin.",Benoxaprofen
DB04817,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Metamizole is combined with Desmopressin.",Metamizole
DB04828,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Zomepirac is combined with Desmopressin.",Zomepirac
DB05095,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Cimicoxib is combined with Desmopressin.",Cimicoxib
DB06725,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Lornoxicam is combined with Desmopressin.",Lornoxicam
DB06736,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Aceclofenac is combined with Desmopressin.",Aceclofenac
DB06737,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Zaltoprofen is combined with Desmopressin.",Zaltoprofen
DB07402,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Azapropazone is combined with Desmopressin.",Azapropazone
DB07477,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Felbinac is combined with Desmopressin.",Felbinac
DB08439,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Parecoxib is combined with Desmopressin.",Parecoxib
DB08797,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Salicylamide is combined with Desmopressin.",Salicylamide
DB08940,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Kebuzone is combined with Desmopressin.",Kebuzone
DB08942,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Isoxicam is combined with Desmopressin.",Isoxicam
DB08951,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Indoprofen is combined with Desmopressin.",Indoprofen
DB08955,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Ibuproxam is combined with Desmopressin.",Ibuproxam
DB08976,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Floctafenine is combined with Desmopressin.",Floctafenine
DB08981,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Fenbufen is combined with Desmopressin.",Fenbufen
DB08984,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Etofenamate is combined with Desmopressin.",Etofenamate
DB08991,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Epirizole is combined with Desmopressin.",Epirizole
DB09084,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Benzydamine is combined with Desmopressin.",Benzydamine
DB09212,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Loxoprofen is combined with Desmopressin.",Loxoprofen
DB09213,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Dexibuprofen is combined with Desmopressin.",Dexibuprofen
DB09214,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Dexketoprofen is combined with Desmopressin.",Dexketoprofen
DB09215,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Droxicam is combined with Desmopressin.",Droxicam
DB09216,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Tolfenamic acid is combined with Desmopressin.",Tolfenamic acid
DB09217,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Firocoxib is combined with Desmopressin.",Firocoxib
DB09218,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Clonixin is combined with Desmopressin.",Clonixin
DB09285,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Morniflumate is combined with Desmopressin.",Morniflumate
DB09288,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Propacetamol is combined with Desmopressin.",Propacetamol
DB09295,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Talniflumate is combined with Desmopressin.",Talniflumate
DB11455,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Robenacoxib is combined with Desmopressin.",Robenacoxib
DB11466,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Tepoxalin is combined with Desmopressin.",Tepoxalin
DB11518,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Flunixin is combined with Desmopressin.",Flunixin
DB12399,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Polmacoxib is combined with Desmopressin.",Polmacoxib
DB12445,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Nitroaspirin is combined with Desmopressin.",Nitroaspirin
DB12480,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Betulinic Acid is combined with Desmopressin.",Betulinic Acid
DB12545,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Indobufen is combined with Desmopressin.",Indobufen
DB12610,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Ebselen is combined with Desmopressin.",Ebselen
DB13001,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Tinoridine is combined with Desmopressin.",Tinoridine
DB13167,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Alclofenac is combined with Desmopressin.",Alclofenac
DB13217,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Fentiazac is combined with Desmopressin.",Fentiazac
DB13232,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Suxibuzone is combined with Desmopressin.",Suxibuzone
DB13286,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Bumadizone is combined with Desmopressin.",Bumadizone
DB13314,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Alminoprofen is combined with Desmopressin.",Alminoprofen
DB13317,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Flunoxaprofen is combined with Desmopressin.",Flunoxaprofen
DB13364,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Feprazone is combined with Desmopressin.",Feprazone
DB13371,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Difenpiramide is combined with Desmopressin.",Difenpiramide
DB13407,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Nifenazone is combined with Desmopressin.",Nifenazone
DB13432,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Lonazolac is combined with Desmopressin.",Lonazolac
DB13481,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Tenidap is combined with Desmopressin.",Tenidap
DB13501,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Bendazac is combined with Desmopressin.",Bendazac
DB13514,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Pranoprofen is combined with Desmopressin.",Pranoprofen
DB13524,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Propyphenazone is combined with Desmopressin.",Propyphenazone
DB13527,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Proglumetacin is combined with Desmopressin.",Proglumetacin
DB13538,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Guacetisal is combined with Desmopressin.",Guacetisal
DB13544,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Ethenzamide is combined with Desmopressin.",Ethenzamide
DB13612,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Carbaspirin calcium is combined with Desmopressin.",Carbaspirin calcium
DB13629,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Mofebutazone is combined with Desmopressin.",Mofebutazone
DB13649,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Proquazone is combined with Desmopressin.",Proquazone
DB13657,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Benorilate is combined with Desmopressin.",Benorilate
DB13722,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Pirprofen is combined with Desmopressin.",Pirprofen
DB13783,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Acemetacin is combined with Desmopressin.",Acemetacin
DB13860,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Imidazole salicylate is combined with Desmopressin.",Imidazole salicylate
DB14059,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when SC-236 is combined with Desmopressin.",SC-236
DB14060,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when NS-398 is combined with Desmopressin.",NS-398
DB14938,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Flurbiprofen axetil is combined with Desmopressin.",Flurbiprofen axetil
DB00091,Cyclosporine may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cyclosporine
DB00229,Cefotiam may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefotiam
DB00267,Cefmenoxime may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefmenoxime
DB00274,Cefmetazole may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefmetazole
DB00282,Pamidronic acid may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Pamidronic acid
DB00300,Tenofovir disoproxil may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Tenofovir disoproxil
DB00369,Cidofovir may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cidofovir
DB00384,Triamterene may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Triamterene
DB00430,Cefpiramide may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefpiramide
DB00438,Ceftazidime may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Ceftazidime
DB00447,Loracarbef may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Loracarbef
DB00456,Cefalotin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefalotin
DB00493,Cefotaxime may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefotaxime
DB00529,Foscarnet may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Foscarnet
DB00563,Methotrexate may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Methotrexate
DB00567,Cephalexin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cephalexin
DB00577,Valaciclovir may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Valaciclovir
DB00626,Bacitracin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Bacitracin
DB00681,Amphotericin B may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Amphotericin B
DB00689,Cephaloglycin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cephaloglycin
DB00718,Adefovir dipivoxil may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Adefovir dipivoxil
DB00738,Pentamidine may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Pentamidine
DB00742,Mannitol may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Mannitol
DB00787,Acyclovir may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Acyclovir
DB00833,Cefaclor may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefaclor
DB00864,Tacrolimus may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Tacrolimus
DB00903,Etacrynic acid may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Etacrynic acid
DB00923,Ceforanide may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Ceforanide
DB00958,Carboplatin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Carboplatin
DB00999,Hydrochlorothiazide may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Hydrochlorothiazide
DB01066,Cefditoren may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefditoren
DB01072,Atazanavir may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Atazanavir
DB01111,Colistimethate may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Colistimethate
DB01112,Cefuroxime may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefuroxime
DB01139,Cefapirin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefapirin
DB01140,Cefadroxil may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefadroxil
DB01150,Cefprozil may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefprozil
DB01212,Ceftriaxone may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Ceftriaxone
DB01326,Cefamandole may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefamandole
DB01327,Cefazolin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefazolin
DB01328,Cefonicid may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefonicid
DB01329,Cefoperazone may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefoperazone
DB01330,Cefotetan may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefotetan
DB01331,Cefoxitin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefoxitin
DB01332,Ceftizoxime may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Ceftizoxime
DB01333,Cefradine may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefradine
DB01413,Cefepime may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefepime
DB01414,Cefacetrile may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefacetrile
DB01415,Ceftibuten may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Ceftibuten
DB01416,Cefpodoxime may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefpodoxime
DB01601,Lopinavir may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Lopinavir
DB02247,Hydrolyzed Cephalothin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Hydrolyzed Cephalothin
DB03450,Cephalothin Group may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cephalothin Group
DB04570,Latamoxef may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Latamoxef
DB04918,Ceftobiprole may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Ceftobiprole
DB06590,Ceftaroline fosamil may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Ceftaroline fosamil
DB09008,Cefaloridine may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefaloridine
DB09062,Cefminox may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefminox
DB09299,Tenofovir alafenamide may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Tenofovir alafenamide
DB11367,Cefroxadine may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefroxadine
DB11935,Flomoxef may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Flomoxef
DB12151,Brincidofovir may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Brincidofovir
DB13266,Cefatrizine may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefatrizine
DB13461,Cefcapene may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefcapene
DB13470,Cefodizime may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefodizime
DB13499,Cefsulodin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefsulodin
DB13504,Cefetamet may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefetamet
DB13638,Cefbuperazone may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefbuperazone
DB13667,Cefozopran may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefozopran
DB13682,Cefpirome may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefpirome
DB13778,Cefazedone may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Cefazedone
DB13821,Ceftezole may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Ceftezole
DB13868,Adefovir may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Adefovir
DB14126,Tenofovir may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Tenofovir
DB14713,Inotersen may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Inotersen
DB01438,Phenazopyridine may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Phenazopyridine
DB15066,Givosiran may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Givosiran
DB00007,Leuprolide may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Leuprolide
DB00014,Goserelin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Goserelin
DB00017,Salmon calcitonin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Salmon calcitonin
DB00041,Desmopressin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Aldesleukin
DB00080,Desmopressin may decrease the excretion rate of Daptomycin which could result in a higher serum level.,Daptomycin
DB00081,Desmopressin may decrease the excretion rate of Tositumomab which could result in a higher serum level.,Tositumomab
DB00115,Desmopressin may decrease the excretion rate of Cyanocobalamin which could result in a higher serum level.,Cyanocobalamin
DB00158,Desmopressin may decrease the excretion rate of Folic acid which could result in a higher serum level.,Folic acid
DB00165,Desmopressin may decrease the excretion rate of Pyridoxine which could result in a higher serum level.,Pyridoxine
DB00181,Desmopressin may decrease the excretion rate of Baclofen which could result in a higher serum level.,Baclofen
DB00182,Desmopressin may decrease the excretion rate of Amphetamine which could result in a higher serum level.,Amphetamine
DB00185,Desmopressin may decrease the excretion rate of Cevimeline which could result in a higher serum level.,Cevimeline
DB00186,Desmopressin may decrease the excretion rate of Lorazepam which could result in a higher serum level.,Lorazepam
DB00190,Desmopressin may decrease the excretion rate of Carbidopa which could result in a higher serum level.,Carbidopa
DB00196,Desmopressin may decrease the excretion rate of Fluconazole which could result in a higher serum level.,Fluconazole
DB00198,Desmopressin may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,Oseltamivir
DB00200,Desmopressin may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,Hydroxocobalamin
DB00206,Desmopressin may decrease the excretion rate of Reserpine which could result in a higher serum level.,Reserpine
DB00208,Desmopressin may decrease the excretion rate of Ticlopidine which could result in a higher serum level.,Ticlopidine
DB00213,Desmopressin may decrease the excretion rate of Pantoprazole which could result in a higher serum level.,Pantoprazole
DB00225,Desmopressin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,Gadodiamide
DB00230,Desmopressin may decrease the excretion rate of Pregabalin which could result in a higher serum level.,Pregabalin
DB00231,Desmopressin may decrease the excretion rate of Temazepam which could result in a higher serum level.,Temazepam
DB00235,Desmopressin may decrease the excretion rate of Milrinone which could result in a higher serum level.,Milrinone
DB00237,Desmopressin may decrease the excretion rate of Butabarbital which could result in a higher serum level.,Butabarbital
DB00243,Desmopressin may decrease the excretion rate of Ranolazine which could result in a higher serum level.,Ranolazine
DB00245,Desmopressin may decrease the excretion rate of Benzatropine which could result in a higher serum level.,Benzatropine
DB00254,Desmopressin may decrease the excretion rate of Doxycycline which could result in a higher serum level.,Doxycycline
DB00262,Desmopressin may decrease the excretion rate of Carmustine which could result in a higher serum level.,Carmustine
DB00264,Desmopressin may decrease the excretion rate of Metoprolol which could result in a higher serum level.,Metoprolol
DB00270,Desmopressin may decrease the excretion rate of Isradipine which could result in a higher serum level.,Isradipine
DB00271,Desmopressin may decrease the excretion rate of Diatrizoate which could result in a higher serum level.,Diatrizoate
DB00273,Desmopressin may decrease the excretion rate of Topiramate which could result in a higher serum level.,Topiramate
DB00279,Desmopressin may decrease the excretion rate of Liothyronine which could result in a higher serum level.,Liothyronine
DB00280,Desmopressin may decrease the excretion rate of Disopyramide which could result in a higher serum level.,Disopyramide
DB00284,Desmopressin may decrease the excretion rate of Acarbose which could result in a higher serum level.,Acarbose
DB00285,Desmopressin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,Venlafaxine
DB00286,Desmopressin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.,Conjugated estrogens
DB00289,Desmopressin may decrease the excretion rate of Atomoxetine which could result in a higher serum level.,Atomoxetine
DB00290,Desmopressin may decrease the excretion rate of Bleomycin which could result in a higher serum level.,Bleomycin
DB00292,Desmopressin may decrease the excretion rate of Etomidate which could result in a higher serum level.,Etomidate
DB00294,Desmopressin may decrease the excretion rate of Etonogestrel which could result in a higher serum level.,Etonogestrel
DB00296,Desmopressin may decrease the excretion rate of Ropivacaine which could result in a higher serum level.,Ropivacaine
DB00303,Desmopressin may decrease the excretion rate of Ertapenem which could result in a higher serum level.,Ertapenem
DB00308,Desmopressin may decrease the excretion rate of Ibutilide which could result in a higher serum level.,Ibutilide
DB00312,Desmopressin may decrease the excretion rate of Pentobarbital which could result in a higher serum level.,Pentobarbital
DB00316,Desmopressin may decrease the excretion rate of Acetaminophen which could result in a higher serum level.,Acetaminophen
DB00319,Desmopressin may decrease the excretion rate of Piperacillin which could result in a higher serum level.,Piperacillin
DB00322,Desmopressin may decrease the excretion rate of Floxuridine which could result in a higher serum level.,Floxuridine
DB00323,Desmopressin may decrease the excretion rate of Tolcapone which could result in a higher serum level.,Tolcapone
DB00325,Desmopressin may decrease the excretion rate of Nitroprusside which could result in a higher serum level.,Nitroprusside
DB00330,Desmopressin may decrease the excretion rate of Ethambutol which could result in a higher serum level.,Ethambutol
DB00331,Desmopressin may decrease the excretion rate of Metformin which could result in a higher serum level.,Metformin
DB00339,Desmopressin may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.,Pyrazinamide
DB00341,Desmopressin may decrease the excretion rate of Cetirizine which could result in a higher serum level.,Cetirizine
DB00349,Desmopressin may decrease the excretion rate of Clobazam which could result in a higher serum level.,Clobazam
DB00351,Desmopressin may decrease the excretion rate of Megestrol acetate which could result in a higher serum level.,Megestrol acetate
DB00355,Desmopressin may decrease the excretion rate of Aztreonam which could result in a higher serum level.,Aztreonam
DB00356,Desmopressin may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.,Chlorzoxazone
DB00359,Desmopressin may decrease the excretion rate of Sulfadiazine which could result in a higher serum level.,Sulfadiazine
DB00363,Desmopressin may decrease the excretion rate of Clozapine which could result in a higher serum level.,Clozapine
DB00364,Desmopressin may decrease the excretion rate of Sucralfate which could result in a higher serum level.,Sucralfate
DB00372,Desmopressin may decrease the excretion rate of Thiethylperazine which could result in a higher serum level.,Thiethylperazine
DB00373,Desmopressin may decrease the excretion rate of Timolol which could result in a higher serum level.,Timolol
DB00377,Desmopressin may decrease the excretion rate of Palonosetron which could result in a higher serum level.,Palonosetron
DB00380,Desmopressin may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.,Dexrazoxane
DB00398,Desmopressin may decrease the excretion rate of Sorafenib which could result in a higher serum level.,Sorafenib
DB00401,Desmopressin may decrease the excretion rate of Nisoldipine which could result in a higher serum level.,Nisoldipine
DB00402,Desmopressin may decrease the excretion rate of Eszopiclone which could result in a higher serum level.,Eszopiclone
DB00404,Desmopressin may decrease the excretion rate of Alprazolam which could result in a higher serum level.,Alprazolam
DB00412,Desmopressin may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.,Rosiglitazone
DB00413,Desmopressin may decrease the excretion rate of Pramipexole which could result in a higher serum level.,Pramipexole
DB00415,Desmopressin may decrease the excretion rate of Ampicillin which could result in a higher serum level.,Ampicillin
DB00418,Desmopressin may decrease the excretion rate of Secobarbital which could result in a higher serum level.,Secobarbital
DB00422,Desmopressin may decrease the excretion rate of Methylphenidate which could result in a higher serum level.,Methylphenidate
DB00432,Desmopressin may decrease the excretion rate of Trifluridine which could result in a higher serum level.,Trifluridine
DB00435,Desmopressin may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.,Nitric Oxide
DB00437,Desmopressin may decrease the excretion rate of Allopurinol which could result in a higher serum level.,Allopurinol
DB00440,Desmopressin may decrease the excretion rate of Trimethoprim which could result in a higher serum level.,Trimethoprim
DB00441,Desmopressin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,Gemcitabine
DB00480,Desmopressin may decrease the excretion rate of Lenalidomide which could result in a higher serum level.,Lenalidomide
DB00490,Desmopressin may decrease the excretion rate of Buspirone which could result in a higher serum level.,Buspirone
DB00492,Desmopressin may decrease the excretion rate of Fosinopril which could result in a higher serum level.,Fosinopril
DB00499,Desmopressin may decrease the excretion rate of Flutamide which could result in a higher serum level.,Flutamide
DB00501,Desmopressin may decrease the excretion rate of Cimetidine which could result in a higher serum level.,Cimetidine
DB00502,Desmopressin may decrease the excretion rate of Haloperidol which could result in a higher serum level.,Haloperidol
DB00535,Desmopressin may decrease the excretion rate of Cefdinir which could result in a higher serum level.,Cefdinir
DB00537,Desmopressin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.,Ciprofloxacin
DB00548,Desmopressin may decrease the excretion rate of Azelaic acid which could result in a higher serum level.,Azelaic acid
DB00553,Desmopressin may decrease the excretion rate of Methoxsalen which could result in a higher serum level.,Methoxsalen
DB00558,Desmopressin may decrease the excretion rate of Zanamivir which could result in a higher serum level.,Zanamivir
DB00569,Desmopressin may decrease the excretion rate of Fondaparinux which could result in a higher serum level.,Fondaparinux
DB00571,Desmopressin may decrease the excretion rate of Propranolol which could result in a higher serum level.,Propranolol
DB00583,Desmopressin may decrease the excretion rate of Levocarnitine which could result in a higher serum level.,Levocarnitine
DB00591,Desmopressin may decrease the excretion rate of Fluocinolone acetonide which could result in a higher serum level.,Fluocinolone acetonide
DB00597,Desmopressin may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,Gadoteridol
DB00598,Desmopressin may decrease the excretion rate of Labetalol which could result in a higher serum level.,Labetalol
DB00603,Desmopressin may decrease the excretion rate of Medroxyprogesterone acetate which could result in a higher serum level.,Medroxyprogesterone acetate
DB00608,Desmopressin may decrease the excretion rate of Chloroquine which could result in a higher serum level.,Chloroquine
DB00612,Desmopressin may decrease the excretion rate of Bisoprolol which could result in a higher serum level.,Bisoprolol
DB00624,Desmopressin may decrease the excretion rate of Testosterone which could result in a higher serum level.,Testosterone
DB00628,Desmopressin may decrease the excretion rate of Clorazepic acid which could result in a higher serum level.,Clorazepic acid
DB00631,Desmopressin may decrease the excretion rate of Clofarabine which could result in a higher serum level.,Clofarabine
DB00633,Desmopressin may decrease the excretion rate of Dexmedetomidine which could result in a higher serum level.,Dexmedetomidine
DB00635,Desmopressin may decrease the excretion rate of Prednisone which could result in a higher serum level.,Prednisone
DB00651,Desmopressin may decrease the excretion rate of Dyphylline which could result in a higher serum level.,Dyphylline
DB00657,Desmopressin may decrease the excretion rate of Mecamylamine which could result in a higher serum level.,Mecamylamine
DB00660,Desmopressin may decrease the excretion rate of Metaxalone which could result in a higher serum level.,Metaxalone
DB00661,Desmopressin may decrease the excretion rate of Verapamil which could result in a higher serum level.,Verapamil
DB00665,Desmopressin may decrease the excretion rate of Nilutamide which could result in a higher serum level.,Nilutamide
DB00669,Desmopressin may decrease the excretion rate of Sumatriptan which could result in a higher serum level.,Sumatriptan
DB00672,Desmopressin may decrease the excretion rate of Chlorpropamide which could result in a higher serum level.,Chlorpropamide
DB00683,Desmopressin may decrease the excretion rate of Midazolam which could result in a higher serum level.,Midazolam
DB00688,Desmopressin may decrease the excretion rate of Mycophenolate mofetil which could result in a higher serum level.,Mycophenolate mofetil
DB00690,Desmopressin may decrease the excretion rate of Flurazepam which could result in a higher serum level.,Flurazepam
DB00692,Desmopressin may decrease the excretion rate of Phentolamine which could result in a higher serum level.,Phentolamine
DB00698,Desmopressin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.,Nitrofurantoin
DB00706,Desmopressin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.,Tamsulosin
DB00709,Desmopressin may decrease the excretion rate of Lamivudine which could result in a higher serum level.,Lamivudine
DB00713,Desmopressin may decrease the excretion rate of Oxacillin which could result in a higher serum level.,Oxacillin
DB00716,Desmopressin may decrease the excretion rate of Nedocromil which could result in a higher serum level.,Nedocromil
DB00722,Desmopressin may decrease the excretion rate of Lisinopril which could result in a higher serum level.,Lisinopril
DB00730,Desmopressin may decrease the excretion rate of Thiabendazole which could result in a higher serum level.,Thiabendazole
DB00731,Desmopressin may decrease the excretion rate of Nateglinide which could result in a higher serum level.,Nateglinide
DB00733,Desmopressin may decrease the excretion rate of Pralidoxime which could result in a higher serum level.,Pralidoxime
DB00743,Desmopressin may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,Gadobenic acid
DB00759,Desmopressin may decrease the excretion rate of Tetracycline which could result in a higher serum level.,Tetracycline
DB00760,Desmopressin may decrease the excretion rate of Meropenem which could result in a higher serum level.,Meropenem
DB00761,Desmopressin may decrease the excretion rate of Potassium chloride which could result in a higher serum level.,Potassium chloride
DB00763,Desmopressin may decrease the excretion rate of Methimazole which could result in a higher serum level.,Methimazole
DB00775,Desmopressin may decrease the excretion rate of Tirofiban which could result in a higher serum level.,Tirofiban
DB00780,Desmopressin may decrease the excretion rate of Phenelzine which could result in a higher serum level.,Phenelzine
DB00782,Desmopressin may decrease the excretion rate of Propantheline which could result in a higher serum level.,Propantheline
DB00783,Desmopressin may decrease the excretion rate of Estradiol which could result in a higher serum level.,Estradiol
DB00789,Desmopressin may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,Gadopentetic acid
DB00790,Desmopressin may decrease the excretion rate of Perindopril which could result in a higher serum level.,Perindopril
DB00800,Desmopressin may decrease the excretion rate of Fenoldopam which could result in a higher serum level.,Fenoldopam
DB00804,Desmopressin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.,Dicyclomine
DB00806,Desmopressin may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.,Pentoxifylline
DB00811,Desmopressin may decrease the excretion rate of Ribavirin which could result in a higher serum level.,Ribavirin
DB00820,Desmopressin may decrease the excretion rate of Tadalafil which could result in a higher serum level.,Tadalafil
DB00828,Desmopressin may decrease the excretion rate of Fosfomycin which could result in a higher serum level.,Fosfomycin
DB00829,Desmopressin may decrease the excretion rate of Diazepam which could result in a higher serum level.,Diazepam
DB00839,Desmopressin may decrease the excretion rate of Tolazamide which could result in a higher serum level.,Tolazamide
DB00841,Desmopressin may decrease the excretion rate of Dobutamine which could result in a higher serum level.,Dobutamine
DB00842,Desmopressin may decrease the excretion rate of Oxazepam which could result in a higher serum level.,Oxazepam
DB00851,Desmopressin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.,Dacarbazine
DB00853,Desmopressin may decrease the excretion rate of Temozolomide which could result in a higher serum level.,Temozolomide
DB00863,Desmopressin may decrease the excretion rate of Ranitidine which could result in a higher serum level.,Ranitidine
DB00871,Desmopressin may decrease the excretion rate of Terbutaline which could result in a higher serum level.,Terbutaline
DB00894,Desmopressin may decrease the excretion rate of Testolactone which could result in a higher serum level.,Testolactone
DB00897,Desmopressin may decrease the excretion rate of Triazolam which could result in a higher serum level.,Triazolam
DB00900,Desmopressin may decrease the excretion rate of Didanosine which could result in a higher serum level.,Didanosine
DB00911,Desmopressin may decrease the excretion rate of Tinidazole which could result in a higher serum level.,Tinidazole
DB00915,Desmopressin may decrease the excretion rate of Amantadine which could result in a higher serum level.,Amantadine
DB00918,Desmopressin may decrease the excretion rate of Almotriptan which could result in a higher serum level.,Almotriptan
DB00928,Desmopressin may decrease the excretion rate of Azacitidine which could result in a higher serum level.,Azacitidine
DB00934,Desmopressin may decrease the excretion rate of Maprotiline which could result in a higher serum level.,Maprotiline
DB00951,Desmopressin may decrease the excretion rate of Isoniazid which could result in a higher serum level.,Isoniazid
DB00953,Desmopressin may decrease the excretion rate of Rizatriptan which could result in a higher serum level.,Rizatriptan
DB00960,Desmopressin may decrease the excretion rate of Pindolol which could result in a higher serum level.,Pindolol
DB00961,Desmopressin may decrease the excretion rate of Mepivacaine which could result in a higher serum level.,Mepivacaine
DB00962,Desmopressin may decrease the excretion rate of Zaleplon which could result in a higher serum level.,Zaleplon
DB00968,Desmopressin may decrease the excretion rate of Methyldopa which could result in a higher serum level.,Methyldopa
DB00980,Desmopressin may decrease the excretion rate of Ramelteon which could result in a higher serum level.,Ramelteon
DB00988,Desmopressin may decrease the excretion rate of Dopamine which could result in a higher serum level.,Dopamine
DB00993,Desmopressin may decrease the excretion rate of Azathioprine which could result in a higher serum level.,Azathioprine
DB00995,Desmopressin may decrease the excretion rate of Auranofin which could result in a higher serum level.,Auranofin
DB01001,Desmopressin may decrease the excretion rate of Salbutamol which could result in a higher serum level.,Salbutamol
DB01002,Desmopressin may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.,Levobupivacaine
DB01004,Desmopressin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,Ganciclovir
DB01010,Desmopressin may decrease the excretion rate of Edrophonium which could result in a higher serum level.,Edrophonium
DB01011,Desmopressin may decrease the excretion rate of Metyrapone which could result in a higher serum level.,Metyrapone
DB01015,Desmopressin may decrease the excretion rate of Sulfamethoxazole which could result in a higher serum level.,Sulfamethoxazole
DB01018,Desmopressin may decrease the excretion rate of Guanfacine which could result in a higher serum level.,Guanfacine
DB01020,Desmopressin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.,Isosorbide mononitrate
DB01022,Desmopressin may decrease the excretion rate of Phylloquinone which could result in a higher serum level.,Phylloquinone
DB01024,Desmopressin may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.,Mycophenolic acid
DB01030,Desmopressin may decrease the excretion rate of Topotecan which could result in a higher serum level.,Topotecan
DB01032,Desmopressin may decrease the excretion rate of Probenecid which could result in a higher serum level.,Probenecid
DB01036,Desmopressin may decrease the excretion rate of Tolterodine which could result in a higher serum level.,Tolterodine
DB01039,Desmopressin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.,Fenofibrate
DB01043,Desmopressin may decrease the excretion rate of Memantine which could result in a higher serum level.,Memantine
DB01046,Desmopressin may decrease the excretion rate of Lubiprostone which could result in a higher serum level.,Lubiprostone
DB01048,Desmopressin may decrease the excretion rate of Abacavir which could result in a higher serum level.,Abacavir
DB01060,Desmopressin may decrease the excretion rate of Amoxicillin which could result in a higher serum level.,Amoxicillin
DB01067,Desmopressin may decrease the excretion rate of Glipizide which could result in a higher serum level.,Glipizide
DB01068,Desmopressin may decrease the excretion rate of Clonazepam which could result in a higher serum level.,Clonazepam
DB01069,Desmopressin may decrease the excretion rate of Promethazine which could result in a higher serum level.,Promethazine
DB01093,Desmopressin may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.,Dimethyl sulfoxide
DB01099,Desmopressin may decrease the excretion rate of Flucytosine which could result in a higher serum level.,Flucytosine
DB01101,Desmopressin may decrease the excretion rate of Capecitabine which could result in a higher serum level.,Capecitabine
DB01115,Desmopressin may decrease the excretion rate of Nifedipine which could result in a higher serum level.,Nifedipine
DB01124,Desmopressin may decrease the excretion rate of Tolbutamide which could result in a higher serum level.,Tolbutamide
DB01129,Desmopressin may decrease the excretion rate of Rabeprazole which could result in a higher serum level.,Rabeprazole
DB01133,Desmopressin may decrease the excretion rate of Tiludronic acid which could result in a higher serum level.,Tiludronic acid
DB01135,Desmopressin may decrease the excretion rate of Doxacurium which could result in a higher serum level.,Doxacurium
DB01137,Desmopressin may decrease the excretion rate of Levofloxacin which could result in a higher serum level.,Levofloxacin
DB01148,Desmopressin may decrease the excretion rate of Flavoxate which could result in a higher serum level.,Flavoxate
DB01156,Desmopressin may decrease the excretion rate of Bupropion which could result in a higher serum level.,Bupropion
DB01157,Desmopressin may decrease the excretion rate of Trimetrexate which could result in a higher serum level.,Trimetrexate
DB01166,Desmopressin may decrease the excretion rate of Cilostazol which could result in a higher serum level.,Cilostazol
DB01169,Desmopressin may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.,Arsenic trioxide
DB01170,Desmopressin may decrease the excretion rate of Guanethidine which could result in a higher serum level.,Guanethidine
DB01181,Desmopressin may decrease the excretion rate of Ifosfamide which could result in a higher serum level.,Ifosfamide
DB01203,Desmopressin may decrease the excretion rate of Nadolol which could result in a higher serum level.,Nadolol
DB01205,Desmopressin may decrease the excretion rate of Flumazenil which could result in a higher serum level.,Flumazenil
DB01213,Desmopressin may decrease the excretion rate of Fomepizole which could result in a higher serum level.,Fomepizole
DB01215,Desmopressin may decrease the excretion rate of Estazolam which could result in a higher serum level.,Estazolam
DB01221,Desmopressin may decrease the excretion rate of Ketamine which could result in a higher serum level.,Ketamine
DB01222,Desmopressin may decrease the excretion rate of Budesonide which could result in a higher serum level.,Budesonide
DB01224,Desmopressin may decrease the excretion rate of Quetiapine which could result in a higher serum level.,Quetiapine
DB01233,Desmopressin may decrease the excretion rate of Metoclopramide which could result in a higher serum level.,Metoclopramide
DB01240,Desmopressin may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,Epoprostenol
DB01241,Desmopressin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,Gemfibrozil
DB01249,Desmopressin may decrease the excretion rate of Iodixanol which could result in a higher serum level.,Iodixanol
DB01261,Desmopressin may decrease the excretion rate of Sitagliptin which could result in a higher serum level.,Sitagliptin
DB01267,Desmopressin may decrease the excretion rate of Paliperidone which could result in a higher serum level.,Paliperidone
DB01273,Desmopressin may decrease the excretion rate of Varenicline which could result in a higher serum level.,Varenicline
DB01274,Desmopressin may decrease the excretion rate of Arformoterol which could result in a higher serum level.,Arformoterol
DB01275,Desmopressin may decrease the excretion rate of Hydralazine which could result in a higher serum level.,Hydralazine
DB01359,Desmopressin may decrease the excretion rate of Penbutolol which could result in a higher serum level.,Penbutolol
DB01367,Desmopressin may decrease the excretion rate of Rasagiline which could result in a higher serum level.,Rasagiline
DB01394,Desmopressin may decrease the excretion rate of Colchicine which could result in a higher serum level.,Colchicine
DB01409,Desmopressin may decrease the excretion rate of Tiotropium which could result in a higher serum level.,Tiotropium
DB01420,Desmopressin may decrease the excretion rate of Testosterone propionate which could result in a higher serum level.,Testosterone propionate
DB01427,Desmopressin may decrease the excretion rate of Amrinone which could result in a higher serum level.,Amrinone
DB01428,Desmopressin may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,Oxybenzone
DB01431,Desmopressin may decrease the excretion rate of Allylestrenol which could result in a higher serum level.,Allylestrenol
DB01550,Desmopressin may decrease the excretion rate of Fenproporex which could result in a higher serum level.,Fenproporex
DB01558,Desmopressin may decrease the excretion rate of Bromazepam which could result in a higher serum level.,Bromazepam
DB01563,Desmopressin may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.,Chloral hydrate
DB01577,Desmopressin may decrease the excretion rate of Metamfetamine which could result in a higher serum level.,Metamfetamine
DB01587,Desmopressin may decrease the excretion rate of Ketazolam which could result in a higher serum level.,Ketazolam
DB01610,Desmopressin may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,Valganciclovir
DB01638,Desmopressin may decrease the excretion rate of Sorbitol which could result in a higher serum level.,Sorbitol
DB01656,Desmopressin may decrease the excretion rate of Roflumilast which could result in a higher serum level.,Roflumilast
DB01685,Desmopressin may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,Topiroxostat
DB04574,Desmopressin may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.,Estrone sulfate
DB04871,Desmopressin may decrease the excretion rate of Lorcaserin which could result in a higher serum level.,Lorcaserin
DB04895,Desmopressin may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,Pegaptanib
DB04920,Desmopressin may decrease the excretion rate of Clevidipine which could result in a higher serum level.,Clevidipine
DB04948,Desmopressin may decrease the excretion rate of Lofexidine which could result in a higher serum level.,Lofexidine
DB04953,Desmopressin may decrease the excretion rate of Ezogabine which could result in a higher serum level.,Ezogabine
DB05018,Desmopressin may decrease the excretion rate of Migalastat which could result in a higher serum level.,Migalastat
DB05541,Desmopressin may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,Brivaracetam
DB05676,Desmopressin may decrease the excretion rate of Apremilast which could result in a higher serum level.,Apremilast
DB06154,Desmopressin may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,Pentaerythritol tetranitrate
DB06186,Desmopressin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,Ipilimumab
DB06196,Desmopressin may decrease the excretion rate of Icatibant which could result in a higher serum level.,Icatibant
DB06203,Desmopressin may decrease the excretion rate of Alogliptin which could result in a higher serum level.,Alogliptin
DB06209,Desmopressin may decrease the excretion rate of Prasugrel which could result in a higher serum level.,Prasugrel
DB06211,Desmopressin may decrease the excretion rate of Doripenem which could result in a higher serum level.,Doripenem
DB06228,Desmopressin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.,Rivaroxaban
DB06230,Desmopressin may decrease the excretion rate of Nalmefene which could result in a higher serum level.,Nalmefene
DB06262,Desmopressin may decrease the excretion rate of Droxidopa which could result in a higher serum level.,Droxidopa
DB06282,Desmopressin may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,Levocetirizine
DB06335,Desmopressin may decrease the excretion rate of Saxagliptin which could result in a higher serum level.,Saxagliptin
DB06402,Desmopressin may decrease the excretion rate of Telavancin which could result in a higher serum level.,Telavancin
DB06480,Desmopressin may decrease the excretion rate of Prucalopride which could result in a higher serum level.,Prucalopride
DB06623,Desmopressin may decrease the excretion rate of Flupirtine which could result in a higher serum level.,Flupirtine
DB06637,Desmopressin may decrease the excretion rate of Dalfampridine which could result in a higher serum level.,Dalfampridine
DB06695,Desmopressin may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.,Dabigatran etexilate
DB06702,Desmopressin may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,Fesoterodine
DB06705,Desmopressin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,Gadofosveset trisodium
DB06710,Desmopressin may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,Methyltestosterone
DB06767,Desmopressin may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.,Ammonium chloride
DB06782,Desmopressin may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,Dimercaprol
DB06796,Desmopressin may decrease the excretion rate of Mangafodipir which could result in a higher serum level.,Mangafodipir
DB06800,Desmopressin may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,Methylnaltrexone
DB06809,Desmopressin may decrease the excretion rate of Plerixafor which could result in a higher serum level.,Plerixafor
DB06813,Desmopressin may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,Pralatrexate
DB06823,Desmopressin may decrease the excretion rate of Tiopronin which could result in a higher serum level.,Tiopronin
DB06824,Desmopressin may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,Triethylenetetramine
DB08824,Desmopressin may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.,Ioflupane I-123
DB08826,Desmopressin may decrease the excretion rate of Deferiprone which could result in a higher serum level.,Deferiprone
DB08840,Desmopressin may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,N-methylnicotinamide
DB08872,Desmopressin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,Gabapentin enacarbil
DB08877,Desmopressin may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,Ruxolitinib
DB08893,Desmopressin may decrease the excretion rate of Mirabegron which could result in a higher serum level.,Mirabegron
DB08894,Desmopressin may decrease the excretion rate of Peginesatide which could result in a higher serum level.,Peginesatide
DB08897,Desmopressin may decrease the excretion rate of Aclidinium which could result in a higher serum level.,Aclidinium
DB08899,Desmopressin may decrease the excretion rate of Enzalutamide which could result in a higher serum level.,Enzalutamide
DB08900,Desmopressin may decrease the excretion rate of Teduglutide which could result in a higher serum level.,Teduglutide
DB08904,Desmopressin may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,Certolizumab pegol
DB08905,Desmopressin may decrease the excretion rate of Formestane which could result in a higher serum level.,Formestane
DB08909,Desmopressin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,Glycerol phenylbutyrate
DB08910,Desmopressin may decrease the excretion rate of Pomalidomide which could result in a higher serum level.,Pomalidomide
DB08911,Desmopressin may decrease the excretion rate of Trametinib which could result in a higher serum level.,Trametinib
DB08932,Desmopressin may decrease the excretion rate of Macitentan which could result in a higher serum level.,Macitentan
DB08934,Desmopressin may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,Sofosbuvir
DB08964,Desmopressin may decrease the excretion rate of Gemeprost which could result in a higher serum level.,Gemeprost
DB09027,Desmopressin may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,Ledipasvir
DB09050,Desmopressin may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,Ceftolozane
DB09066,Desmopressin may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,Corifollitropin alfa
DB09068,Desmopressin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,Vortioxetine
DB09071,Desmopressin may decrease the excretion rate of Tasimelteon which could result in a higher serum level.,Tasimelteon
DB09075,Desmopressin may decrease the excretion rate of Edoxaban which could result in a higher serum level.,Edoxaban
DB09081,Desmopressin may decrease the excretion rate of Idebenone which could result in a higher serum level.,Idebenone
DB09082,Desmopressin may decrease the excretion rate of Vilanterol which could result in a higher serum level.,Vilanterol
DB09089,Desmopressin may decrease the excretion rate of Trimebutine which could result in a higher serum level.,Trimebutine
DB09091,Desmopressin may decrease the excretion rate of Tixocortol which could result in a higher serum level.,Tixocortol
DB09103,Desmopressin may decrease the excretion rate of Ancestim which could result in a higher serum level.,Ancestim
DB09104,Desmopressin may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.,Magnesium hydroxide
DB09106,Desmopressin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,Hydroxyethyl Starch
DB09111,Desmopressin may decrease the excretion rate of Pentastarch which could result in a higher serum level.,Pentastarch
DB09118,Desmopressin may decrease the excretion rate of Stiripentol which could result in a higher serum level.,Stiripentol
DB09121,Desmopressin may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.,Aurothioglucose
DB09123,Desmopressin may decrease the excretion rate of Dienogest which could result in a higher serum level.,Dienogest
DB09129,Desmopressin may decrease the excretion rate of Chromic chloride which could result in a higher serum level.,Chromic chloride
DB09132,Desmopressin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,Gadoteric acid
DB09133,Desmopressin may decrease the excretion rate of Iothalamic acid which could result in a higher serum level.,Iothalamic acid
DB09134,Desmopressin may decrease the excretion rate of Ioversol which could result in a higher serum level.,Ioversol
DB09135,Desmopressin may decrease the excretion rate of Ioxilan which could result in a higher serum level.,Ioxilan
DB09136,Desmopressin may decrease the excretion rate of Isosulfan blue which could result in a higher serum level.,Isosulfan blue
DB09137,Desmopressin may decrease the excretion rate of Technetium Tc-99m mebrofenin which could result in a higher serum level.,Technetium Tc-99m mebrofenin
DB09139,Desmopressin may decrease the excretion rate of Technetium Tc-99m oxidronate which could result in a higher serum level.,Technetium Tc-99m oxidronate
DB09148,Desmopressin may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.,Florbetaben (18F)
DB09149,Desmopressin may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.,Florbetapir (18F)
DB09156,Desmopressin may decrease the excretion rate of Iopromide which could result in a higher serum level.,Iopromide
DB09163,Desmopressin may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.,Technetium Tc-99m exametazime
DB09165,Desmopressin may decrease the excretion rate of Technetium Tc-99m pyrophosphate which could result in a higher serum level.,Technetium Tc-99m pyrophosphate
DB09185,Desmopressin may decrease the excretion rate of Viloxazine which could result in a higher serum level.,Viloxazine
DB09194,Desmopressin may decrease the excretion rate of Etoperidone which could result in a higher serum level.,Etoperidone
DB09195,Desmopressin may decrease the excretion rate of Lorpiprazole which could result in a higher serum level.,Lorpiprazole
DB09204,Desmopressin may decrease the excretion rate of Arotinolol which could result in a higher serum level.,Arotinolol
DB09205,Desmopressin may decrease the excretion rate of Moxisylyte which could result in a higher serum level.,Moxisylyte
DB09209,Desmopressin may decrease the excretion rate of Pholcodine which could result in a higher serum level.,Pholcodine
DB09210,Desmopressin may decrease the excretion rate of Piracetam which could result in a higher serum level.,Piracetam
DB09219,Desmopressin may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,Bisoxatin
DB09220,Desmopressin may decrease the excretion rate of Nicorandil which could result in a higher serum level.,Nicorandil
DB09223,Desmopressin may decrease the excretion rate of Blonanserin which could result in a higher serum level.,Blonanserin
DB09224,Desmopressin may decrease the excretion rate of Melperone which could result in a higher serum level.,Melperone
DB09241,Desmopressin may decrease the excretion rate of Methylene blue which could result in a higher serum level.,Methylene blue
DB09244,Desmopressin may decrease the excretion rate of Pirlindole which could result in a higher serum level.,Pirlindole
DB09245,Desmopressin may decrease the excretion rate of Toloxatone which could result in a higher serum level.,Toloxatone
DB09255,Desmopressin may decrease the excretion rate of Dextran which could result in a higher serum level.,Dextran
DB09256,Desmopressin may decrease the excretion rate of Tegafur which could result in a higher serum level.,Tegafur
DB09257,Desmopressin may decrease the excretion rate of Gimeracil which could result in a higher serum level.,Gimeracil
DB09262,Desmopressin may decrease the excretion rate of Imidafenacin which could result in a higher serum level.,Imidafenacin
DB09264,Desmopressin may decrease the excretion rate of Idarucizumab which could result in a higher serum level.,Idarucizumab
DB09265,Desmopressin may decrease the excretion rate of Lixisenatide which could result in a higher serum level.,Lixisenatide
DB09268,Desmopressin may decrease the excretion rate of Picosulfuric acid which could result in a higher serum level.,Picosulfuric acid
DB09276,Desmopressin may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.,Sodium aurothiomalate
DB09277,Desmopressin may decrease the excretion rate of Choline C 11 which could result in a higher serum level.,Choline C 11
DB09281,Desmopressin may decrease the excretion rate of Magnesium trisilicate which could result in a higher serum level.,Magnesium trisilicate
DB09292,Desmopressin may decrease the excretion rate of Sacubitril which could result in a higher serum level.,Sacubitril
DB09301,Desmopressin may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.,Chondroitin sulfate
DB09317,"Desmopressin may decrease the excretion rate of Synthetic Conjugated Estrogens, A which could result in a higher serum level.","Synthetic Conjugated Estrogens, A"
DB09318,"Desmopressin may decrease the excretion rate of Synthetic Conjugated Estrogens, B which could result in a higher serum level.","Synthetic Conjugated Estrogens, B"
DB09320,Desmopressin may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.,Procaine benzylpenicillin
DB09324,Desmopressin may decrease the excretion rate of Sulbactam which could result in a higher serum level.,Sulbactam
DB09325,Desmopressin may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.,Sodium fluoride
DB09329,"Desmopressin may decrease the excretion rate of Antihemophilic Factor (Recombinant), PEGylated which could result in a higher serum level.","Antihemophilic Factor (Recombinant), PEGylated"
DB09344,Desmopressin may decrease the excretion rate of Invert sugar which could result in a higher serum level.,Invert sugar
DB09357,Desmopressin may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.,Dexpanthenol
DB09394,Desmopressin may decrease the excretion rate of Phosphoric acid which could result in a higher serum level.,Phosphoric acid
DB09395,Desmopressin may decrease the excretion rate of Sodium acetate which could result in a higher serum level.,Sodium acetate
DB09407,Desmopressin may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.,Magnesium chloride
DB09418,Desmopressin may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.,Potassium perchlorate
DB09472,Desmopressin may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.,Sodium sulfate
DB09477,Desmopressin may decrease the excretion rate of Enalaprilat which could result in a higher serum level.,Enalaprilat
DB09481,Desmopressin may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.,Magnesium carbonate
DB09488,Desmopressin may decrease the excretion rate of Acrivastine which could result in a higher serum level.,Acrivastine
DB09496,Desmopressin may decrease the excretion rate of Octinoxate which could result in a higher serum level.,Octinoxate
DB09502,Desmopressin may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.,Fludeoxyglucose (18F)
DB09546,Desmopressin may decrease the excretion rate of Iobenguane sulfate I-123 which could result in a higher serum level.,Iobenguane sulfate I-123
DB09570,Desmopressin may decrease the excretion rate of Ixazomib which could result in a higher serum level.,Ixazomib
DB11077,Desmopressin may decrease the excretion rate of Polyethylene glycol 400 which could result in a higher serum level.,Polyethylene glycol 400
DB11090,Desmopressin may decrease the excretion rate of Potassium nitrate which could result in a higher serum level.,Potassium nitrate
DB11098,Desmopressin may decrease the excretion rate of Potassium bicarbonate which could result in a higher serum level.,Potassium bicarbonate
DB11102,Desmopressin may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,N-acetyltyrosine
DB11114,Desmopressin may decrease the excretion rate of Eucalyptus oil which could result in a higher serum level.,Eucalyptus oil
DB11127,Desmopressin may decrease the excretion rate of Selenious acid which could result in a higher serum level.,Selenious acid
DB11135,Desmopressin may decrease the excretion rate of Selenium which could result in a higher serum level.,Selenium
DB11136,Desmopressin may decrease the excretion rate of Chromium which could result in a higher serum level.,Chromium
DB11145,Desmopressin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,Oxyquinoline
DB11156,Desmopressin may decrease the excretion rate of Pyrantel which could result in a higher serum level.,Pyrantel
DB11164,Desmopressin may decrease the excretion rate of Bicisate which could result in a higher serum level.,Bicisate
DB11251,Desmopressin may decrease the excretion rate of Tocopherol which could result in a higher serum level.,Tocopherol
DB11278,Desmopressin may decrease the excretion rate of DL-Methylephedrine which could result in a higher serum level.,DL-Methylephedrine
DB11328,Desmopressin may decrease the excretion rate of Tetradecyl hydrogen sulfate (ester) which could result in a higher serum level.,Tetradecyl hydrogen sulfate (ester)
DB11338,Desmopressin may decrease the excretion rate of Clove oil which could result in a higher serum level.,Clove oil
DB11358,Desmopressin may decrease the excretion rate of Evening primrose oil which could result in a higher serum level.,Evening primrose oil
DB11364,Desmopressin may decrease the excretion rate of Pidotimod which could result in a higher serum level.,Pidotimod
DB11560,Desmopressin may decrease the excretion rate of Lesinurad which could result in a higher serum level.,Lesinurad
DB11577,Desmopressin may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.,Indigotindisulfonic acid
DB11587,Desmopressin may decrease the excretion rate of Etafedrine which could result in a higher serum level.,Etafedrine
DB11598,Desmopressin may decrease the excretion rate of Antithrombin III human which could result in a higher serum level.,Antithrombin III human
DB11642,Desmopressin may decrease the excretion rate of Pitolisant which could result in a higher serum level.,Pitolisant
DB11691,Desmopressin may decrease the excretion rate of Naldemedine which could result in a higher serum level.,Naldemedine
DB11699,Desmopressin may decrease the excretion rate of Tropisetron which could result in a higher serum level.,Tropisetron
DB11817,Desmopressin may decrease the excretion rate of Baricitinib which could result in a higher serum level.,Baricitinib
DB11901,Desmopressin may decrease the excretion rate of Apalutamide which could result in a higher serum level.,Apalutamide
DB11915,Desmopressin may decrease the excretion rate of Valbenazine which could result in a higher serum level.,Valbenazine
DB11943,Desmopressin may decrease the excretion rate of Delafloxacin which could result in a higher serum level.,Delafloxacin
DB11989,Desmopressin may decrease the excretion rate of Benznidazole which could result in a higher serum level.,Benznidazole
DB12007,Desmopressin may decrease the excretion rate of Isoflavone which could result in a higher serum level.,Isoflavone
DB12107,Desmopressin may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,Vaborbactam
DB12161,Desmopressin may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.,Deutetrabenazine
DB12278,Desmopressin may decrease the excretion rate of Propiverine which could result in a higher serum level.,Propiverine
DB12783,Desmopressin may decrease the excretion rate of Benserazide which could result in a higher serum level.,Benserazide
DB13025,Desmopressin may decrease the excretion rate of Tiapride which could result in a higher serum level.,Tiapride
DB13139,Desmopressin may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,Levosalbutamol
DB13156,Desmopressin may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.,Inosine pranobex
DB13178,Desmopressin may decrease the excretion rate of Inositol which could result in a higher serum level.,Inositol
DB13185,Desmopressin may decrease the excretion rate of Oxabolone cipionate which could result in a higher serum level.,Oxabolone cipionate
DB13191,Desmopressin may decrease the excretion rate of Phosphocreatine which could result in a higher serum level.,Phosphocreatine
DB13269,Desmopressin may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.,Dichlorobenzyl alcohol
DB13293,Desmopressin may decrease the excretion rate of Ipecac which could result in a higher serum level.,Ipecac
DB13595,Desmopressin may decrease the excretion rate of Almasilate which could result in a higher serum level.,Almasilate
DB13873,Desmopressin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.,Fenofibric acid
DB13884,Desmopressin may decrease the excretion rate of Albutrepenonacog alfa which could result in a higher serum level.,Albutrepenonacog alfa
DB13909,Desmopressin may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,Bismuth subgallate
DB13943,Desmopressin may decrease the excretion rate of Testosterone cypionate which could result in a higher serum level.,Testosterone cypionate
DB13944,Desmopressin may decrease the excretion rate of Testosterone enanthate which could result in a higher serum level.,Testosterone enanthate
DB13952,Desmopressin may decrease the excretion rate of Estradiol acetate which could result in a higher serum level.,Estradiol acetate
DB13954,Desmopressin may decrease the excretion rate of Estradiol cypionate which could result in a higher serum level.,Estradiol cypionate
DB13955,Desmopressin may decrease the excretion rate of Estradiol dienanthate which could result in a higher serum level.,Estradiol dienanthate
DB13956,Desmopressin may decrease the excretion rate of Estradiol valerate which could result in a higher serum level.,Estradiol valerate
DB13967,Desmopressin may decrease the excretion rate of Patent Blue which could result in a higher serum level.,Patent Blue
DB14006,Desmopressin may decrease the excretion rate of Choline salicylate which could result in a higher serum level.,Choline salicylate
DB14007,Desmopressin may decrease the excretion rate of Pentetic acid which could result in a higher serum level.,Pentetic acid
DB14498,Desmopressin may decrease the excretion rate of Potassium acetate which could result in a higher serum level.,Potassium acetate
DB14499,Desmopressin may decrease the excretion rate of Potassium sulfate which could result in a higher serum level.,Potassium sulfate
DB14526,Desmopressin may decrease the excretion rate of Chromic citrate which could result in a higher serum level.,Chromic citrate
DB14527,Desmopressin may decrease the excretion rate of Chromic nitrate which could result in a higher serum level.,Chromic nitrate
DB14528,Desmopressin may decrease the excretion rate of Chromium gluconate which could result in a higher serum level.,Chromium gluconate
DB14529,Desmopressin may decrease the excretion rate of Chromium nicotinate which could result in a higher serum level.,Chromium nicotinate
DB14530,Desmopressin may decrease the excretion rate of Chromous sulfate which could result in a higher serum level.,Chromous sulfate
DB06815,Desmopressin may decrease the excretion rate of Pyrithione which could result in a higher serum level.,Pyrithione
DB11121,Desmopressin may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.,Chloroxylenol
DB01183,Desmopressin may decrease the excretion rate of Naloxone which could result in a higher serum level.,Naloxone
DB11085,Desmopressin may decrease the excretion rate of Resorcinol which could result in a higher serum level.,Resorcinol
DB15593,Desmopressin may decrease the excretion rate of Golodirsen which could result in a higher serum level.,Golodirsen
DB00879,Desmopressin may decrease the excretion rate of Emtricitabine which could result in a higher serum level.,Emtricitabine
DB00452,Framycetin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Framycetin
DB00479,Amikacin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Amikacin
DB00684,Tobramycin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Tobramycin
DB00798,Gentamicin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Gentamicin
DB00955,Netilmicin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Netilmicin
DB00994,Neomycin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Neomycin
DB01082,Streptomycin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Streptomycin
DB01172,Kanamycin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Kanamycin
DB01421,Paromomycin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Paromomycin
DB03615,Ribostamycin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Ribostamycin
DB04263,Geneticin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Geneticin
DB04626,Apramycin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Apramycin
DB04729,Gentamicin C1a may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Gentamicin C1a
DB04808,Neamine may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Neamine
DB06696,Arbekacin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Arbekacin
DB08437,Puromycin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Puromycin
DB11512,Dihydrostreptomycin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Dihydrostreptomycin
DB11520,Hygromycin B may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Hygromycin B
DB12604,Sisomicin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Sisomicin
DB13270,Dibekacin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Dibekacin
DB13274,Micronomicin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Micronomicin
DB13540,Isepamicin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Isepamicin
DB13673,Bekanamycin may decrease the excretion rate of Desmopressin which could result in a higher serum level.,Bekanamycin
DB00552,Desmopressin may decrease the excretion rate of Pentostatin which could result in a higher serum level.,Pentostatin
DB13145,Desmopressin may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,Nedaplatin
DB00314,Desmopressin may decrease the excretion rate of Capreomycin which could result in a higher serum level.,Capreomycin
DB00390,Desmopressin may decrease the excretion rate of Digoxin which could result in a higher serum level.,Digoxin
DB00512,Desmopressin may decrease the excretion rate of Vancomycin which could result in a higher serum level.,Vancomycin
DB00515,Desmopressin may decrease the excretion rate of Cisplatin which could result in a higher serum level.,Cisplatin
DB00642,Desmopressin may decrease the excretion rate of Pemetrexed which could result in a higher serum level.,Pemetrexed
DB00682,Desmopressin may decrease the excretion rate of Warfarin which could result in a higher serum level.,Warfarin
DB00908,Desmopressin may decrease the excretion rate of Quinidine which could result in a higher serum level.,Quinidine
DB00982,Desmopressin may decrease the excretion rate of Isotretinoin which could result in a higher serum level.,Isotretinoin
DB01035,Desmopressin may decrease the excretion rate of Procainamide which could result in a higher serum level.,Procainamide
DB12615,Desmopressin may decrease the excretion rate of Plazomicin which could result in a higher serum level.,Plazomicin
DB13316,Desmopressin may increase the excretion rate of Ibopamine which could result in a lower serum level and potentially a reduction in efficacy.,Ibopamine
DB00524,Desmopressin may increase the excretion rate of Metolazone which could result in a lower serum level and potentially a reduction in efficacy.,Metolazone
DB00695,Desmopressin may increase the excretion rate of Furosemide which could result in a lower serum level and potentially a reduction in efficacy.,Furosemide
DB00808,Desmopressin may increase the excretion rate of Indapamide which could result in a lower serum level and potentially a reduction in efficacy.,Indapamide
DB00887,Desmopressin may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.,Bumetanide
DB00909,Desmopressin may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy.,Zonisamide
DB08907,Desmopressin may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.,Canagliflozin
DB09338,Desmopressin may increase the excretion rate of Mersalyl which could result in a lower serum level and potentially a reduction in efficacy.,Mersalyl
DB00214,Torasemide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Torasemide
DB00232,Methyclothiazide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Methyclothiazide
DB00310,Chlorthalidone may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Chlorthalidone
DB00311,Ethoxzolamide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Ethoxzolamide
DB00421,Spironolactone may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Spironolactone
DB00436,Bendroflumethiazide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Bendroflumethiazide
DB00562,Benzthiazide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Benzthiazide
DB00594,Amiloride may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Amiloride
DB00606,Cyclothiazide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Cyclothiazide
DB00700,Eplerenone may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Eplerenone
DB00703,Methazolamide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Methazolamide
DB00774,Hydroflumethiazide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Hydroflumethiazide
DB00819,Acetazolamide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Acetazolamide
DB00872,Conivaptan may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Conivaptan
DB00880,Chlorothiazide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Chlorothiazide
DB01021,Trichlormethiazide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Trichlormethiazide
DB01119,Diazoxide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Diazoxide
DB01144,Diclofenamide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Diclofenamide
DB01324,Polythiazide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Polythiazide
DB01325,Quinethazone may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Quinethazone
DB01395,Drospirenone may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Drospirenone
DB01412,Theobromine may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Theobromine
DB02925,Piretanide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Piretanide
DB04831,Tienilic acid may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Tienilic acid
DB05034,Ularitide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Ularitide
DB06292,Dapagliflozin may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Dapagliflozin
DB06370,Indisulam may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Indisulam
DB08961,Azosemide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Azosemide
DB09015,Canrenoic acid may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Canrenoic acid
DB09125,Potassium citrate may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Potassium citrate
DB09235,Efonidipine may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Efonidipine
DB09401,Isosorbide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Isosorbide
DB11827,Ertugliflozin may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Ertugliflozin
DB12221,Canrenone may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Canrenone
DB12670,Rolofylline may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Rolofylline
DB12704,Spiradoline may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Spiradoline
DB12766,Cicletanine may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Cicletanine
DB13284,Meticrane may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Meticrane
DB13405,Mefruside may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Mefruside
DB13430,Mebutizide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Mebutizide
DB13532,Cyclopenthiazide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Cyclopenthiazide
DB13617,Clorexolone may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Clorexolone
DB13663,Clofenamide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Clofenamide
DB13708,Fenquizone may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Fenquizone
DB13792,Clopamide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Clopamide
DB13801,Muzolimine may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Muzolimine
DB13803,Xipamide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Xipamide
DB13989,Epitizide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Epitizide
DB14018,Bromotheophylline may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Bromotheophylline
DB14500,Potassium may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.,Potassium
DB11823,The risk or severity of hypertension can be increased when Esketamine is combined with Desmopressin.,Esketamine
DB14754,The risk or severity of hypertension can be increased when Solriamfetol is combined with Desmopressin.,Solriamfetol
DB13946,Testosterone undecanoate may increase the hypertensive activities of Desmopressin.,Testosterone undecanoate
DB09310,Catridecacog may increase the thrombogenic activities of Coagulation factor VIIa Recombinant Human.,Catridecacog
DB00513,The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Coagulation factor VIIa Recombinant Human.,Aminocaproic acid
DB00058,Alpha-1-proteinase inhibitor may increase the thrombogenic activities of Coagulation factor VIIa Recombinant Human.,Alpha-1-proteinase inhibitor
DB00170,Menadione may increase the thrombogenic activities of Coagulation factor VIIa Recombinant Human.,Menadione
DB00302,Tranexamic acid may increase the thrombogenic activities of Coagulation factor VIIa Recombinant Human.,Tranexamic acid
DB06692,Aprotinin may increase the thrombogenic activities of Coagulation factor VIIa Recombinant Human.,Aprotinin
DB11091,Hydrogen peroxide may increase the thrombogenic activities of Coagulation factor VIIa Recombinant Human.,Hydrogen peroxide
DB13244,Aminomethylbenzoic acid may increase the thrombogenic activities of Coagulation factor VIIa Recombinant Human.,Aminomethylbenzoic acid
DB13729,Camostat may increase the thrombogenic activities of Coagulation factor VIIa Recombinant Human.,Camostat
DB12726,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Monteplase.,Monteplase
DB00001,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Lepirudin.,Lepirudin
DB00006,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Bivalirudin.,Bivalirudin
DB00009,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Alteplase.,Alteplase
DB00013,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Urokinase.,Urokinase
DB00015,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Reteplase.,Reteplase
DB00029,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Anistreplase.,Anistreplase
DB00031,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Tenecteplase.,Tenecteplase
DB00054,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Abciximab.,Abciximab
DB00055,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Drotrecogin alfa.,Drotrecogin alfa
DB00086,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Streptokinase.,Streptokinase
DB00266,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Dicoumarol.,Dicoumarol
DB00278,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Argatroban.,Argatroban
DB00407,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Ardeparin.,Ardeparin
DB00498,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Phenindione.,Phenindione
DB00569,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Fondaparinux.,Fondaparinux
DB00682,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Warfarin.,Warfarin
DB00686,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Pentosan polysulfate.,Pentosan polysulfate
DB00945,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Acetylsalicylic acid.,Acetylsalicylic acid
DB00946,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Phenprocoumon.,Phenprocoumon
DB00975,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Dipyridamole.,Dipyridamole
DB01088,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Iloprost.,Iloprost
DB01109,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Heparin.,Heparin
DB01225,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Enoxaparin.,Enoxaparin
DB01240,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Epoprostenol.,Epoprostenol
DB01418,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Acenocoumarol.,Acenocoumarol
DB03410,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with 4-hydroxycoumarin.,4-hydroxycoumarin
DB04665,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Coumarin.,Coumarin
DB04898,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Ximelagatran.,Ximelagatran
DB04925,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Desmoteplase.,Desmoteplase
DB04932,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Defibrotide.,Defibrotide
DB05099,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Ancrod.,Ancrod
DB05229,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Beraprost.,Beraprost
DB05254,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Fibrinolysin.,Fibrinolysin
DB06209,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Prasugrel.,Prasugrel
DB06228,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Rivaroxaban.,Rivaroxaban
DB06271,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Sulodexide.,Sulodexide
DB06406,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Idraparinux.,Idraparinux
DB06441,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Cangrelor.,Cangrelor
DB06543,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Astaxanthin.,Astaxanthin
DB06605,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Apixaban.,Apixaban
DB06635,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Otamixaban.,Otamixaban
DB06679,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Amediplase.,Amediplase
DB06695,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Dabigatran etexilate.,Dabigatran etexilate
DB06754,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Danaparoid.,Danaparoid
DB06779,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Dalteparin.,Dalteparin
DB06822,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Tinzaparin.,Tinzaparin
DB07767,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Ferulic acid.,Ferulic acid
DB08496,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with (R)-warfarin.,(R)-warfarin
DB08794,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Ethyl biscoumacetate.,Ethyl biscoumacetate
DB08813,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Nadroparin.,Nadroparin
DB08814,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Triflusal.,Triflusal
DB08816,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Ticagrelor.,Ticagrelor
DB08994,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Ditazole.,Ditazole
DB09030,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Vorapaxar.,Vorapaxar
DB09075,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Edoxaban.,Edoxaban
DB09125,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Potassium citrate.,Potassium citrate
DB09154,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Sodium citrate.,Sodium citrate
DB09255,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Dextran.,Dextran
DB09258,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Bemiparin.,Bemiparin
DB09259,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Reviparin.,Reviparin
DB09260,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Parnaparin.,Parnaparin
DB09261,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Certoparin.,Certoparin
DB11095,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Desirudin.,Desirudin
DB11154,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Zinc citrate.,Zinc citrate
DB11166,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Antithrombin Alfa.,Antithrombin Alfa
DB11312,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Protein C.,Protein C
DB11598,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Antithrombin III human.,Antithrombin III human
DB11984,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Letaxaban.,Letaxaban
DB12289,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Darexaban.,Darexaban
DB12364,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Betrixaban.,Betrixaban
DB12598,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Nafamostat.,Nafamostat
DB12831,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Gabexate.,Gabexate
DB13136,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Fluindione.,Fluindione
DB13149,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Protein S human.,Protein S human
DB13199,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Brinase.,Brinase
DB13275,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Clorindione.,Clorindione
DB13347,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Diphenadione.,Diphenadione
DB13451,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Tioclomarol.,Tioclomarol
DB13616,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Melagatran.,Melagatran
DB13646,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Saruplase.,Saruplase
DB14055,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with (S)-Warfarin.,(S)-Warfarin
DB14094,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Tocopherylquinone.,Tocopherylquinone
DB14598,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Edetate calcium disodium anhydrous.,Edetate calcium disodium anhydrous
DB14726,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Dabigatran.,Dabigatran
DB06294,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Semuloparin.,Semuloparin
DB00407,The serum concentration of Palifermin can be increased when it is combined with Ardeparin.,Ardeparin
DB01109,The serum concentration of Palifermin can be increased when it is combined with Heparin.,Heparin
DB01225,The serum concentration of Palifermin can be increased when it is combined with Enoxaparin.,Enoxaparin
DB06271,The serum concentration of Palifermin can be increased when it is combined with Sulodexide.,Sulodexide
DB06294,The serum concentration of Palifermin can be increased when it is combined with Semuloparin.,Semuloparin
DB06754,The serum concentration of Palifermin can be increased when it is combined with Danaparoid.,Danaparoid
DB06779,The serum concentration of Palifermin can be increased when it is combined with Dalteparin.,Dalteparin
DB06822,The serum concentration of Palifermin can be increased when it is combined with Tinzaparin.,Tinzaparin
DB08813,The serum concentration of Palifermin can be increased when it is combined with Nadroparin.,Nadroparin
DB09258,The serum concentration of Palifermin can be increased when it is combined with Bemiparin.,Bemiparin
DB09259,The serum concentration of Palifermin can be increased when it is combined with Reviparin.,Reviparin
DB09260,The serum concentration of Palifermin can be increased when it is combined with Parnaparin.,Parnaparin
DB09261,The serum concentration of Palifermin can be increased when it is combined with Certoparin.,Certoparin
DB00008,The therapeutic efficacy of Palifermin can be decreased when used in combination with Peginterferon alfa-2a.,Peginterferon alfa-2a
DB00011,The therapeutic efficacy of Palifermin can be decreased when used in combination with Interferon alfa-n1.,Interferon alfa-n1
DB00018,The therapeutic efficacy of Palifermin can be decreased when used in combination with Interferon alfa-n3.,Interferon alfa-n3
DB00022,The therapeutic efficacy of Palifermin can be decreased when used in combination with Peginterferon alfa-2b.,Peginterferon alfa-2b
DB00033,The therapeutic efficacy of Palifermin can be decreased when used in combination with Interferon gamma-1b.,Interferon gamma-1b
DB00034,"The therapeutic efficacy of Palifermin can be decreased when used in combination with Interferon alfa-2a, Recombinant.","Interferon alfa-2a, Recombinant"
DB00041,The therapeutic efficacy of Palifermin can be decreased when used in combination with Aldesleukin.,Aldesleukin
DB00056,The therapeutic efficacy of Palifermin can be decreased when used in combination with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin
DB00068,The therapeutic efficacy of Palifermin can be decreased when used in combination with Interferon beta-1b.,Interferon beta-1b
DB00069,The therapeutic efficacy of Palifermin can be decreased when used in combination with Interferon alfacon-1.,Interferon alfacon-1
DB00073,The therapeutic efficacy of Palifermin can be decreased when used in combination with Rituximab.,Rituximab
DB00078,The therapeutic efficacy of Palifermin can be decreased when used in combination with Ibritumomab tiuxetan.,Ibritumomab tiuxetan
DB00081,The therapeutic efficacy of Palifermin can be decreased when used in combination with Tositumomab.,Tositumomab
DB00087,The therapeutic efficacy of Palifermin can be decreased when used in combination with Alemtuzumab.,Alemtuzumab
DB00105,The therapeutic efficacy of Palifermin can be decreased when used in combination with Interferon alfa-2b.,Interferon alfa-2b
DB00120,The therapeutic efficacy of Palifermin can be decreased when used in combination with Phenylalanine.,Phenylalanine
DB00188,The therapeutic efficacy of Palifermin can be decreased when used in combination with Bortezomib.,Bortezomib
DB00242,The therapeutic efficacy of Palifermin can be decreased when used in combination with Cladribine.,Cladribine
DB00262,The therapeutic efficacy of Palifermin can be decreased when used in combination with Carmustine.,Carmustine
DB00276,The therapeutic efficacy of Palifermin can be decreased when used in combination with Amsacrine.,Amsacrine
DB00291,The therapeutic efficacy of Palifermin can be decreased when used in combination with Chlorambucil.,Chlorambucil
DB00293,The therapeutic efficacy of Palifermin can be decreased when used in combination with Raltitrexed.,Raltitrexed
DB00305,The therapeutic efficacy of Palifermin can be decreased when used in combination with Mitomycin.,Mitomycin
DB00307,The therapeutic efficacy of Palifermin can be decreased when used in combination with Bexarotene.,Bexarotene
DB00309,The therapeutic efficacy of Palifermin can be decreased when used in combination with Vindesine.,Vindesine
DB00322,The therapeutic efficacy of Palifermin can be decreased when used in combination with Floxuridine.,Floxuridine
DB00328,The therapeutic efficacy of Palifermin can be decreased when used in combination with Indomethacin.,Indomethacin
DB00352,The therapeutic efficacy of Palifermin can be decreased when used in combination with Tioguanine.,Tioguanine
DB00361,The therapeutic efficacy of Palifermin can be decreased when used in combination with Vinorelbine.,Vinorelbine
DB00380,The therapeutic efficacy of Palifermin can be decreased when used in combination with Dexrazoxane.,Dexrazoxane
DB00398,The therapeutic efficacy of Palifermin can be decreased when used in combination with Sorafenib.,Sorafenib
DB00428,The therapeutic efficacy of Palifermin can be decreased when used in combination with Streptozocin.,Streptozocin
DB00441,The therapeutic efficacy of Palifermin can be decreased when used in combination with Gemcitabine.,Gemcitabine
DB00444,The therapeutic efficacy of Palifermin can be decreased when used in combination with Teniposide.,Teniposide
DB00445,The therapeutic efficacy of Palifermin can be decreased when used in combination with Epirubicin.,Epirubicin
DB00446,The therapeutic efficacy of Palifermin can be decreased when used in combination with Chloramphenicol.,Chloramphenicol
DB00480,The therapeutic efficacy of Palifermin can be decreased when used in combination with Lenalidomide.,Lenalidomide
DB00488,The therapeutic efficacy of Palifermin can be decreased when used in combination with Altretamine.,Altretamine
DB00495,The therapeutic efficacy of Palifermin can be decreased when used in combination with Zidovudine.,Zidovudine
DB00515,The therapeutic efficacy of Palifermin can be decreased when used in combination with Cisplatin.,Cisplatin
DB00526,The therapeutic efficacy of Palifermin can be decreased when used in combination with Oxaliplatin.,Oxaliplatin
DB00531,The therapeutic efficacy of Palifermin can be decreased when used in combination with Cyclophosphamide.,Cyclophosphamide
DB00544,The therapeutic efficacy of Palifermin can be decreased when used in combination with Fluorouracil.,Fluorouracil
DB00550,The therapeutic efficacy of Palifermin can be decreased when used in combination with Propylthiouracil.,Propylthiouracil
DB00552,The therapeutic efficacy of Palifermin can be decreased when used in combination with Pentostatin.,Pentostatin
DB00563,The therapeutic efficacy of Palifermin can be decreased when used in combination with Methotrexate.,Methotrexate
DB00564,The therapeutic efficacy of Palifermin can be decreased when used in combination with Carbamazepine.,Carbamazepine
DB00570,The therapeutic efficacy of Palifermin can be decreased when used in combination with Vinblastine.,Vinblastine
DB00601,The therapeutic efficacy of Palifermin can be decreased when used in combination with Linezolid.,Linezolid
DB00619,The therapeutic efficacy of Palifermin can be decreased when used in combination with Imatinib.,Imatinib
DB00631,The therapeutic efficacy of Palifermin can be decreased when used in combination with Clofarabine.,Clofarabine
DB00642,The therapeutic efficacy of Palifermin can be decreased when used in combination with Pemetrexed.,Pemetrexed
DB00694,The therapeutic efficacy of Palifermin can be decreased when used in combination with Daunorubicin.,Daunorubicin
DB00762,The therapeutic efficacy of Palifermin can be decreased when used in combination with Irinotecan.,Irinotecan
DB00763,The therapeutic efficacy of Palifermin can be decreased when used in combination with Methimazole.,Methimazole
DB00773,The therapeutic efficacy of Palifermin can be decreased when used in combination with Etoposide.,Etoposide
DB00851,The therapeutic efficacy of Palifermin can be decreased when used in combination with Dacarbazine.,Dacarbazine
DB00853,The therapeutic efficacy of Palifermin can be decreased when used in combination with Temozolomide.,Temozolomide
DB00859,The therapeutic efficacy of Palifermin can be decreased when used in combination with Penicillamine.,Penicillamine
DB00864,The therapeutic efficacy of Palifermin can be decreased when used in combination with Tacrolimus.,Tacrolimus
DB00877,The therapeutic efficacy of Palifermin can be decreased when used in combination with Sirolimus.,Sirolimus
DB00888,The therapeutic efficacy of Palifermin can be decreased when used in combination with Mechlorethamine.,Mechlorethamine
DB00928,The therapeutic efficacy of Palifermin can be decreased when used in combination with Azacitidine.,Azacitidine
DB00958,The therapeutic efficacy of Palifermin can be decreased when used in combination with Carboplatin.,Carboplatin
DB00970,The therapeutic efficacy of Palifermin can be decreased when used in combination with Dactinomycin.,Dactinomycin
DB00987,The therapeutic efficacy of Palifermin can be decreased when used in combination with Cytarabine.,Cytarabine
DB00997,The therapeutic efficacy of Palifermin can be decreased when used in combination with Doxorubicin.,Doxorubicin
DB01005,The therapeutic efficacy of Palifermin can be decreased when used in combination with Hydroxyurea.,Hydroxyurea
DB01008,The therapeutic efficacy of Palifermin can be decreased when used in combination with Busulfan.,Busulfan
DB01030,The therapeutic efficacy of Palifermin can be decreased when used in combination with Topotecan.,Topotecan
DB01033,The therapeutic efficacy of Palifermin can be decreased when used in combination with Mercaptopurine.,Mercaptopurine
DB01041,The therapeutic efficacy of Palifermin can be decreased when used in combination with Thalidomide.,Thalidomide
DB01042,The therapeutic efficacy of Palifermin can be decreased when used in combination with Melphalan.,Melphalan
DB01073,The therapeutic efficacy of Palifermin can be decreased when used in combination with Fludarabine.,Fludarabine
DB01099,The therapeutic efficacy of Palifermin can be decreased when used in combination with Flucytosine.,Flucytosine
DB01101,The therapeutic efficacy of Palifermin can be decreased when used in combination with Capecitabine.,Capecitabine
DB01168,The therapeutic efficacy of Palifermin can be decreased when used in combination with Procarbazine.,Procarbazine
DB01169,The therapeutic efficacy of Palifermin can be decreased when used in combination with Arsenic trioxide.,Arsenic trioxide
DB01177,The therapeutic efficacy of Palifermin can be decreased when used in combination with Idarubicin.,Idarubicin
DB01181,The therapeutic efficacy of Palifermin can be decreased when used in combination with Ifosfamide.,Ifosfamide
DB01204,The therapeutic efficacy of Palifermin can be decreased when used in combination with Mitoxantrone.,Mitoxantrone
DB01206,The therapeutic efficacy of Palifermin can be decreased when used in combination with Lomustine.,Lomustine
DB01229,The therapeutic efficacy of Palifermin can be decreased when used in combination with Paclitaxel.,Paclitaxel
DB01248,The therapeutic efficacy of Palifermin can be decreased when used in combination with Docetaxel.,Docetaxel
DB01254,The therapeutic efficacy of Palifermin can be decreased when used in combination with Dasatinib.,Dasatinib
DB01262,The therapeutic efficacy of Palifermin can be decreased when used in combination with Decitabine.,Decitabine
DB01280,The therapeutic efficacy of Palifermin can be decreased when used in combination with Nelarabine.,Nelarabine
DB01590,The therapeutic efficacy of Palifermin can be decreased when used in combination with Everolimus.,Everolimus
DB02546,The therapeutic efficacy of Palifermin can be decreased when used in combination with Vorinostat.,Vorinostat
DB04572,The therapeutic efficacy of Palifermin can be decreased when used in combination with Thiotepa.,Thiotepa
DB04845,The therapeutic efficacy of Palifermin can be decreased when used in combination with Ixabepilone.,Ixabepilone
DB04868,The therapeutic efficacy of Palifermin can be decreased when used in combination with Nilotinib.,Nilotinib
DB05015,The therapeutic efficacy of Palifermin can be decreased when used in combination with Belinostat.,Belinostat
DB05109,The therapeutic efficacy of Palifermin can be decreased when used in combination with Trabectedin.,Trabectedin
DB05258,The therapeutic efficacy of Palifermin can be decreased when used in combination with Interferon alfa.,Interferon alfa
DB05472,The therapeutic efficacy of Palifermin can be decreased when used in combination with omega interferon.,omega interferon
DB05773,The therapeutic efficacy of Palifermin can be decreased when used in combination with Trastuzumab emtansine.,Trastuzumab emtansine
DB06287,The therapeutic efficacy of Palifermin can be decreased when used in combination with Temsirolimus.,Temsirolimus
DB06616,The therapeutic efficacy of Palifermin can be decreased when used in combination with Bosutinib.,Bosutinib
DB06769,The therapeutic efficacy of Palifermin can be decreased when used in combination with Bendamustine.,Bendamustine
DB06772,The therapeutic efficacy of Palifermin can be decreased when used in combination with Cabazitaxel.,Cabazitaxel
DB08871,The therapeutic efficacy of Palifermin can be decreased when used in combination with Eribulin.,Eribulin
DB08877,The therapeutic efficacy of Palifermin can be decreased when used in combination with Ruxolitinib.,Ruxolitinib
DB08889,The therapeutic efficacy of Palifermin can be decreased when used in combination with Carfilzomib.,Carfilzomib
DB08895,The therapeutic efficacy of Palifermin can be decreased when used in combination with Tofacitinib.,Tofacitinib
DB08901,The therapeutic efficacy of Palifermin can be decreased when used in combination with Ponatinib.,Ponatinib
DB08910,The therapeutic efficacy of Palifermin can be decreased when used in combination with Pomalidomide.,Pomalidomide
DB08935,The therapeutic efficacy of Palifermin can be decreased when used in combination with Obinutuzumab.,Obinutuzumab
DB09042,The therapeutic efficacy of Palifermin can be decreased when used in combination with Tedizolid phosphate.,Tedizolid phosphate
DB09052,The therapeutic efficacy of Palifermin can be decreased when used in combination with Blinatumomab.,Blinatumomab
DB09053,The therapeutic efficacy of Palifermin can be decreased when used in combination with Ibrutinib.,Ibrutinib
DB09073,The therapeutic efficacy of Palifermin can be decreased when used in combination with Palbociclib.,Palbociclib
DB09074,The therapeutic efficacy of Palifermin can be decreased when used in combination with Olaparib.,Olaparib
DB09077,The therapeutic efficacy of Palifermin can be decreased when used in combination with Dinutuximab.,Dinutuximab
DB09122,The therapeutic efficacy of Palifermin can be decreased when used in combination with Peginterferon beta-1a.,Peginterferon beta-1a
DB12814,The therapeutic efficacy of Palifermin can be decreased when used in combination with Cepeginterferon alfa-2B.,Cepeginterferon alfa-2B
DB00193,Tramadol may increase the gastrointestinal motility reducing activities of Glucagon.,Tramadol
DB00209,Trospium may increase the gastrointestinal motility reducing activities of Glucagon.,Trospium
DB00219,Oxyphenonium may increase the gastrointestinal motility reducing activities of Glucagon.,Oxyphenonium
DB00245,Benzatropine may increase the gastrointestinal motility reducing activities of Glucagon.,Benzatropine
DB00246,Ziprasidone may increase the gastrointestinal motility reducing activities of Glucagon.,Ziprasidone
DB00280,Disopyramide may increase the gastrointestinal motility reducing activities of Glucagon.,Disopyramide
DB00321,Amitriptyline may increase the gastrointestinal motility reducing activities of Glucagon.,Amitriptyline
DB00332,Ipratropium may increase the gastrointestinal motility reducing activities of Glucagon.,Ipratropium
DB00334,Olanzapine may increase the gastrointestinal motility reducing activities of Glucagon.,Olanzapine
DB00340,Metixene may increase the gastrointestinal motility reducing activities of Glucagon.,Metixene
DB00342,Terfenadine may increase the gastrointestinal motility reducing activities of Glucagon.,Terfenadine
DB00354,Buclizine may increase the gastrointestinal motility reducing activities of Glucagon.,Buclizine
DB00363,Clozapine may increase the gastrointestinal motility reducing activities of Glucagon.,Clozapine
DB00366,Doxylamine may increase the gastrointestinal motility reducing activities of Glucagon.,Doxylamine
DB00376,Trihexyphenidyl may increase the gastrointestinal motility reducing activities of Glucagon.,Trihexyphenidyl
DB00383,Oxyphencyclimine may increase the gastrointestinal motility reducing activities of Glucagon.,Oxyphencyclimine
DB00387,Procyclidine may increase the gastrointestinal motility reducing activities of Glucagon.,Procyclidine
DB00392,Profenamine may increase the gastrointestinal motility reducing activities of Glucagon.,Profenamine
DB00420,Promazine may increase the gastrointestinal motility reducing activities of Glucagon.,Promazine
DB00424,Hyoscyamine may increase the gastrointestinal motility reducing activities of Glucagon.,Hyoscyamine
DB00434,Cyproheptadine may increase the gastrointestinal motility reducing activities of Glucagon.,Cyproheptadine
DB00458,Imipramine may increase the gastrointestinal motility reducing activities of Glucagon.,Imipramine
DB00462,Methscopolamine bromide may increase the gastrointestinal motility reducing activities of Glucagon.,Methscopolamine bromide
DB00477,Chlorpromazine may increase the gastrointestinal motility reducing activities of Glucagon.,Chlorpromazine
DB00483,Gallamine triethiodide may increase the gastrointestinal motility reducing activities of Glucagon.,Gallamine triethiodide
DB00496,Darifenacin may increase the gastrointestinal motility reducing activities of Glucagon.,Darifenacin
DB00505,Tridihexethyl may increase the gastrointestinal motility reducing activities of Glucagon.,Tridihexethyl
DB00508,Triflupromazine may increase the gastrointestinal motility reducing activities of Glucagon.,Triflupromazine
DB00517,Anisotropine methylbromide may increase the gastrointestinal motility reducing activities of Glucagon.,Anisotropine methylbromide
DB00540,Nortriptyline may increase the gastrointestinal motility reducing activities of Glucagon.,Nortriptyline
DB00543,Amoxapine may increase the gastrointestinal motility reducing activities of Glucagon.,Amoxapine
DB00555,Lamotrigine may increase the gastrointestinal motility reducing activities of Glucagon.,Lamotrigine
DB00572,Atropine may increase the gastrointestinal motility reducing activities of Glucagon.,Atropine
DB00622,Nicardipine may increase the gastrointestinal motility reducing activities of Glucagon.,Nicardipine
DB00670,Pirenzepine may increase the gastrointestinal motility reducing activities of Glucagon.,Pirenzepine
DB00715,Paroxetine may increase the gastrointestinal motility reducing activities of Glucagon.,Paroxetine
DB00725,Homatropine methylbromide may increase the gastrointestinal motility reducing activities of Glucagon.,Homatropine methylbromide
DB00728,Rocuronium may increase the gastrointestinal motility reducing activities of Glucagon.,Rocuronium
DB00747,Scopolamine may increase the gastrointestinal motility reducing activities of Glucagon.,Scopolamine
DB00767,Benzquinamide may increase the gastrointestinal motility reducing activities of Glucagon.,Benzquinamide
DB00771,Clidinium may increase the gastrointestinal motility reducing activities of Glucagon.,Clidinium
DB00777,Propiomazine may increase the gastrointestinal motility reducing activities of Glucagon.,Propiomazine
DB00782,Propantheline may increase the gastrointestinal motility reducing activities of Glucagon.,Propantheline
DB00804,Dicyclomine may increase the gastrointestinal motility reducing activities of Glucagon.,Dicyclomine
DB00810,Biperiden may increase the gastrointestinal motility reducing activities of Glucagon.,Biperiden
DB00835,Brompheniramine may increase the gastrointestinal motility reducing activities of Glucagon.,Brompheniramine
DB00875,Flupentixol may increase the gastrointestinal motility reducing activities of Glucagon.,Flupentixol
DB00907,Cocaine may increase the gastrointestinal motility reducing activities of Glucagon.,Cocaine
DB00908,Quinidine may increase the gastrointestinal motility reducing activities of Glucagon.,Quinidine
DB00934,Maprotiline may increase the gastrointestinal motility reducing activities of Glucagon.,Maprotiline
DB00940,Methantheline may increase the gastrointestinal motility reducing activities of Glucagon.,Methantheline
DB00942,Cycrimine may increase the gastrointestinal motility reducing activities of Glucagon.,Cycrimine
DB00986,Glycopyrronium may increase the gastrointestinal motility reducing activities of Glucagon.,Glycopyrronium
DB01036,Tolterodine may increase the gastrointestinal motility reducing activities of Glucagon.,Tolterodine
DB01062,Oxybutynin may increase the gastrointestinal motility reducing activities of Glucagon.,Oxybutynin
DB01069,Promethazine may increase the gastrointestinal motility reducing activities of Glucagon.,Promethazine
DB01075,Diphenhydramine may increase the gastrointestinal motility reducing activities of Glucagon.,Diphenhydramine
DB01135,Doxacurium may increase the gastrointestinal motility reducing activities of Glucagon.,Doxacurium
DB01142,Doxepin may increase the gastrointestinal motility reducing activities of Glucagon.,Doxepin
DB01148,Flavoxate may increase the gastrointestinal motility reducing activities of Glucagon.,Flavoxate
DB01151,Desipramine may increase the gastrointestinal motility reducing activities of Glucagon.,Desipramine
DB01173,Orphenadrine may increase the gastrointestinal motility reducing activities of Glucagon.,Orphenadrine
DB01175,Escitalopram may increase the gastrointestinal motility reducing activities of Glucagon.,Escitalopram
DB01224,Quetiapine may increase the gastrointestinal motility reducing activities of Glucagon.,Quetiapine
DB01226,Mivacurium may increase the gastrointestinal motility reducing activities of Glucagon.,Mivacurium
DB01231,Diphenidol may increase the gastrointestinal motility reducing activities of Glucagon.,Diphenidol
DB01238,Aripiprazole may increase the gastrointestinal motility reducing activities of Glucagon.,Aripiprazole
DB01239,Chlorprothixene may increase the gastrointestinal motility reducing activities of Glucagon.,Chlorprothixene
DB01336,Metocurine may increase the gastrointestinal motility reducing activities of Glucagon.,Metocurine
DB01337,Pancuronium may increase the gastrointestinal motility reducing activities of Glucagon.,Pancuronium
DB01338,Pipecuronium may increase the gastrointestinal motility reducing activities of Glucagon.,Pipecuronium
DB01403,Methotrimeprazine may increase the gastrointestinal motility reducing activities of Glucagon.,Methotrimeprazine
DB01409,Tiotropium may increase the gastrointestinal motility reducing activities of Glucagon.,Tiotropium
DB01591,Solifenacin may increase the gastrointestinal motility reducing activities of Glucagon.,Solifenacin
DB01625,Isopropamide may increase the gastrointestinal motility reducing activities of Glucagon.,Isopropamide
DB04834,Rapacuronium may increase the gastrointestinal motility reducing activities of Glucagon.,Rapacuronium
DB04843,Mepenzolate may increase the gastrointestinal motility reducing activities of Glucagon.,Mepenzolate
DB06153,Pizotifen may increase the gastrointestinal motility reducing activities of Glucagon.,Pizotifen
DB06702,Fesoterodine may increase the gastrointestinal motility reducing activities of Glucagon.,Fesoterodine
DB06787,Hexocyclium may increase the gastrointestinal motility reducing activities of Glucagon.,Hexocyclium
DB08801,Dimetindene may increase the gastrointestinal motility reducing activities of Glucagon.,Dimetindene
DB08897,Aclidinium may increase the gastrointestinal motility reducing activities of Glucagon.,Aclidinium
DB08997,Dexetimide may increase the gastrointestinal motility reducing activities of Glucagon.,Dexetimide
DB09007,Chlorphenoxamine may increase the gastrointestinal motility reducing activities of Glucagon.,Chlorphenoxamine
DB09023,Benactyzine may increase the gastrointestinal motility reducing activities of Glucagon.,Benactyzine
DB09076,Umeclidinium may increase the gastrointestinal motility reducing activities of Glucagon.,Umeclidinium
DB09089,Trimebutine may increase the gastrointestinal motility reducing activities of Glucagon.,Trimebutine
DB09167,Dosulepin may increase the gastrointestinal motility reducing activities of Glucagon.,Dosulepin
DB09262,Imidafenacin may increase the gastrointestinal motility reducing activities of Glucagon.,Imidafenacin
DB09300,Butylscopolamine may increase the gastrointestinal motility reducing activities of Glucagon.,Butylscopolamine
DB11235,Thonzylamine may increase the gastrointestinal motility reducing activities of Glucagon.,Thonzylamine
DB11315,Methscopolamine may increase the gastrointestinal motility reducing activities of Glucagon.,Methscopolamine
DB11855,Revefenacin may increase the gastrointestinal motility reducing activities of Glucagon.,Revefenacin
DB12086,Oxitropium may increase the gastrointestinal motility reducing activities of Glucagon.,Oxitropium
DB12278,Propiverine may increase the gastrointestinal motility reducing activities of Glucagon.,Propiverine
DB12526,Batefenterol may increase the gastrointestinal motility reducing activities of Glucagon.,Batefenterol
DB12554,Mebeverine may increase the gastrointestinal motility reducing activities of Glucagon.,Mebeverine
DB13252,Tropatepine may increase the gastrointestinal motility reducing activities of Glucagon.,Tropatepine
DB13254,Prifinium may increase the gastrointestinal motility reducing activities of Glucagon.,Prifinium
DB13351,Piperidolate may increase the gastrointestinal motility reducing activities of Glucagon.,Piperidolate
DB13369,Benzilone may increase the gastrointestinal motility reducing activities of Glucagon.,Benzilone
DB13380,Difemerine may increase the gastrointestinal motility reducing activities of Glucagon.,Difemerine
DB13413,Phenglutarimide may increase the gastrointestinal motility reducing activities of Glucagon.,Phenglutarimide
DB13448,Mazaticol may increase the gastrointestinal motility reducing activities of Glucagon.,Mazaticol
DB13468,Etybenzatropine may increase the gastrointestinal motility reducing activities of Glucagon.,Etybenzatropine
DB13500,Otilonium may increase the gastrointestinal motility reducing activities of Glucagon.,Otilonium
DB13505,Emepronium may increase the gastrointestinal motility reducing activities of Glucagon.,Emepronium
DB13507,Poldine may increase the gastrointestinal motility reducing activities of Glucagon.,Poldine
DB13542,Bevonium may increase the gastrointestinal motility reducing activities of Glucagon.,Bevonium
DB13581,Rociverine may increase the gastrointestinal motility reducing activities of Glucagon.,Rociverine
DB13619,Bornaprine may increase the gastrointestinal motility reducing activities of Glucagon.,Bornaprine
DB13636,Etanautine may increase the gastrointestinal motility reducing activities of Glucagon.,Etanautine
DB13666,Tiemonium iodide may increase the gastrointestinal motility reducing activities of Glucagon.,Tiemonium iodide
DB13678,Dihexyverine may increase the gastrointestinal motility reducing activities of Glucagon.,Dihexyverine
DB13695,Penthienate may increase the gastrointestinal motility reducing activities of Glucagon.,Penthienate
DB13720,Diphemanil may increase the gastrointestinal motility reducing activities of Glucagon.,Diphemanil
DB13738,Camylofin may increase the gastrointestinal motility reducing activities of Glucagon.,Camylofin
DB13759,Fenpiverinium may increase the gastrointestinal motility reducing activities of Glucagon.,Fenpiverinium
DB13769,Emetonium iodide may increase the gastrointestinal motility reducing activities of Glucagon.,Emetonium iodide
DB13844,Pipenzolate may increase the gastrointestinal motility reducing activities of Glucagon.,Pipenzolate
DB13850,Timepidium may increase the gastrointestinal motility reducing activities of Glucagon.,Timepidium
DB00328,The therapeutic efficacy of Glucagon can be decreased when used in combination with Indomethacin.,Indomethacin
DB00266,The therapeutic efficacy of Dicoumarol can be increased when used in combination with Glucagon.,Dicoumarol
DB00498,The therapeutic efficacy of Phenindione can be increased when used in combination with Glucagon.,Phenindione
DB00682,The therapeutic efficacy of Warfarin can be increased when used in combination with Glucagon.,Warfarin
DB00946,The therapeutic efficacy of Phenprocoumon can be increased when used in combination with Glucagon.,Phenprocoumon
DB01418,The therapeutic efficacy of Acenocoumarol can be increased when used in combination with Glucagon.,Acenocoumarol
DB03410,The therapeutic efficacy of 4-hydroxycoumarin can be increased when used in combination with Glucagon.,4-hydroxycoumarin
DB04665,The therapeutic efficacy of Coumarin can be increased when used in combination with Glucagon.,Coumarin
DB08496,The therapeutic efficacy of (R)-warfarin can be increased when used in combination with Glucagon.,(R)-warfarin
DB08794,The therapeutic efficacy of Ethyl biscoumacetate can be increased when used in combination with Glucagon.,Ethyl biscoumacetate
DB13136,The therapeutic efficacy of Fluindione can be increased when used in combination with Glucagon.,Fluindione
DB13275,The therapeutic efficacy of Clorindione can be increased when used in combination with Glucagon.,Clorindione
DB13347,The therapeutic efficacy of Diphenadione can be increased when used in combination with Glucagon.,Diphenadione
DB13451,The therapeutic efficacy of Tioclomarol can be increased when used in combination with Glucagon.,Tioclomarol
DB14055,The therapeutic efficacy of (S)-Warfarin can be increased when used in combination with Glucagon.,(S)-Warfarin
DB00187,The therapeutic efficacy of Esmolol can be decreased when used in combination with Glucagon.,Esmolol
DB00195,The therapeutic efficacy of Betaxolol can be decreased when used in combination with Glucagon.,Betaxolol
DB00264,The therapeutic efficacy of Metoprolol can be decreased when used in combination with Glucagon.,Metoprolol
DB00335,The therapeutic efficacy of Atenolol can be decreased when used in combination with Glucagon.,Atenolol
DB00373,The therapeutic efficacy of Timolol can be decreased when used in combination with Glucagon.,Timolol
DB00489,The therapeutic efficacy of Sotalol can be decreased when used in combination with Glucagon.,Sotalol
DB00571,The therapeutic efficacy of Propranolol can be decreased when used in combination with Glucagon.,Propranolol
DB00598,The therapeutic efficacy of Labetalol can be decreased when used in combination with Glucagon.,Labetalol
DB00612,The therapeutic efficacy of Bisoprolol can be decreased when used in combination with Glucagon.,Bisoprolol
DB00866,The therapeutic efficacy of Alprenolol can be decreased when used in combination with Glucagon.,Alprenolol
DB00960,The therapeutic efficacy of Pindolol can be decreased when used in combination with Glucagon.,Pindolol
DB01136,The therapeutic efficacy of Carvedilol can be decreased when used in combination with Glucagon.,Carvedilol
DB01182,The therapeutic efficacy of Propafenone can be decreased when used in combination with Glucagon.,Propafenone
DB01193,The therapeutic efficacy of Acebutolol can be decreased when used in combination with Glucagon.,Acebutolol
DB01203,The therapeutic efficacy of Nadolol can be decreased when used in combination with Glucagon.,Nadolol
DB01295,The therapeutic efficacy of Bevantolol can be decreased when used in combination with Glucagon.,Bevantolol
DB01297,The therapeutic efficacy of Practolol can be decreased when used in combination with Glucagon.,Practolol
DB01359,The therapeutic efficacy of Penbutolol can be decreased when used in combination with Glucagon.,Penbutolol
DB01580,The therapeutic efficacy of Oxprenolol can be decreased when used in combination with Glucagon.,Oxprenolol
DB03322,The therapeutic efficacy of Dexpropranolol can be decreased when used in combination with Glucagon.,Dexpropranolol
DB04846,The therapeutic efficacy of Celiprolol can be decreased when used in combination with Glucagon.,Celiprolol
DB04861,The therapeutic efficacy of Nebivolol can be decreased when used in combination with Glucagon.,Nebivolol
DB06726,The therapeutic efficacy of Bufuralol can be decreased when used in combination with Glucagon.,Bufuralol
DB08807,The therapeutic efficacy of Bopindolol can be decreased when used in combination with Glucagon.,Bopindolol
DB08808,The therapeutic efficacy of Bupranolol can be decreased when used in combination with Glucagon.,Bupranolol
DB08952,The therapeutic efficacy of Indenolol can be decreased when used in combination with Glucagon.,Indenolol
DB09013,The therapeutic efficacy of Befunolol can be decreased when used in combination with Glucagon.,Befunolol
DB09204,The therapeutic efficacy of Arotinolol can be decreased when used in combination with Glucagon.,Arotinolol
DB09351,The therapeutic efficacy of Levobetaxolol can be decreased when used in combination with Glucagon.,Levobetaxolol
DB11770,The therapeutic efficacy of Talinolol can be decreased when used in combination with Glucagon.,Talinolol
DB11785,The therapeutic efficacy of Anisodamine can be decreased when used in combination with Glucagon.,Anisodamine
DB12212,The therapeutic efficacy of Landiolol can be decreased when used in combination with Glucagon.,Landiolol
DB12752,The therapeutic efficacy of Bucindolol can be decreased when used in combination with Glucagon.,Bucindolol
DB13443,The therapeutic efficacy of Esatenolol can be decreased when used in combination with Glucagon.,Esatenolol
DB13508,The therapeutic efficacy of Cloranolol can be decreased when used in combination with Glucagon.,Cloranolol
DB13530,The therapeutic efficacy of Mepindolol can be decreased when used in combination with Glucagon.,Mepindolol
DB13757,The therapeutic efficacy of Epanolol can be decreased when used in combination with Glucagon.,Epanolol
DB13775,The therapeutic efficacy of Tertatolol can be decreased when used in combination with Glucagon.,Tertatolol
DB00030,The therapeutic efficacy of Insulin human can be decreased when used in combination with Glucagon.,Insulin human
DB00046,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Glucagon.,Insulin lispro
DB00047,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Glucagon.,Insulin glargine
DB00071,The therapeutic efficacy of Insulin pork can be decreased when used in combination with Glucagon.,Insulin pork
DB01306,The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Glucagon.,Insulin aspart
DB01307,The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Glucagon.,Insulin detemir
DB01309,The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Glucagon.,Insulin glulisine
DB05115,The therapeutic efficacy of NN344 can be decreased when used in combination with Glucagon.,NN344
DB09456,The therapeutic efficacy of Insulin beef can be decreased when used in combination with Glucagon.,Insulin beef
DB09564,The therapeutic efficacy of Insulin degludec can be decreased when used in combination with Glucagon.,Insulin degludec
DB11567,The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Glucagon.,Insulin peglispro
DB11568,The therapeutic efficacy of Insulin tregopil can be decreased when used in combination with Glucagon.,Insulin tregopil
DB11564,The therapeutic efficacy of Insulin argine can be decreased when used in combination with Glucagon.,Insulin argine
DB14513,The serum concentration of Magnesium can be increased when it is combined with Glucagon.,Magnesium
DB06643,The risk or severity of adverse effects can be increased when Denosumab is combined with Aldesleukin.,Denosumab
DB00005,The risk or severity of adverse effects can be increased when Etanercept is combined with Aldesleukin.,Etanercept
DB00011,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Aldesleukin.,Interferon alfa-n1
DB00026,The risk or severity of adverse effects can be increased when Anakinra is combined with Aldesleukin.,Anakinra
DB00033,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Aldesleukin.,Interferon gamma-1b
DB00051,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Adalimumab.,Adalimumab
DB00056,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin
DB00059,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Pegaspargase.,Pegaspargase
DB00065,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Infliximab.,Infliximab
DB00068,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Interferon beta-1b.,Interferon beta-1b
DB00073,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Rituximab.,Rituximab
DB00074,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Basiliximab.,Basiliximab
DB00075,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Muromonab.,Muromonab
DB00078,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Ibritumomab tiuxetan.,Ibritumomab tiuxetan
DB00081,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Tositumomab.,Tositumomab
DB00087,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Alemtuzumab.,Alemtuzumab
DB00092,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Alefacept.,Alefacept
DB00095,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Efalizumab.,Efalizumab
DB00098,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Antithymocyte immunoglobulin (rabbit).,Antithymocyte immunoglobulin (rabbit)
DB00111,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Daclizumab.,Daclizumab
DB00112,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Bevacizumab.,Bevacizumab
DB00120,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Phenylalanine.,Phenylalanine
DB00180,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Flunisolide.,Flunisolide
DB00242,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Cladribine.,Cladribine
DB00262,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Carmustine.,Carmustine
DB00276,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Amsacrine.,Amsacrine
DB00290,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Bleomycin.,Bleomycin
DB00291,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Chlorambucil.,Chlorambucil
DB00293,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Raltitrexed.,Raltitrexed
DB00305,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Mitomycin.,Mitomycin
DB00307,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Bexarotene.,Bexarotene
DB00322,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Floxuridine.,Floxuridine
DB00328,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Indomethacin.,Indomethacin
DB00352,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Tioguanine.,Tioguanine
DB00380,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Dexrazoxane.,Dexrazoxane
DB00428,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Streptozocin.,Streptozocin
DB00432,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Trifluridine.,Trifluridine
DB00441,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Gemcitabine.,Gemcitabine
DB00445,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Epirubicin.,Epirubicin
DB00446,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Chloramphenicol.,Chloramphenicol
DB00480,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Lenalidomide.,Lenalidomide
DB00488,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Altretamine.,Altretamine
DB00495,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Zidovudine.,Zidovudine
DB00515,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Cisplatin.,Cisplatin
DB00526,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Oxaliplatin.,Oxaliplatin
DB00531,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Cyclophosphamide.,Cyclophosphamide
DB00544,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Fluorouracil.,Fluorouracil
DB00552,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Pentostatin.,Pentostatin
DB00588,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Fluticasone propionate.,Fluticasone propionate
DB00591,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Fluocinolone acetonide.,Fluocinolone acetonide
DB00601,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Linezolid.,Linezolid
DB00631,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Clofarabine.,Clofarabine
DB00642,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Pemetrexed.,Pemetrexed
DB00687,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Fludrocortisone.,Fludrocortisone
DB00688,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Mycophenolate mofetil.,Mycophenolate mofetil
DB00755,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Tretinoin.,Tretinoin
DB00762,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Irinotecan.,Irinotecan
DB00795,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Sulfasalazine.,Sulfasalazine
DB00851,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Dacarbazine.,Dacarbazine
DB00853,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Temozolomide.,Temozolomide
DB00859,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Penicillamine.,Penicillamine
DB00860,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Prednisolone.,Prednisolone
DB00888,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Mechlorethamine.,Mechlorethamine
DB00928,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Azacitidine.,Azacitidine
DB00958,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Carboplatin.,Carboplatin
DB00959,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Methylprednisolone.,Methylprednisolone
DB00970,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Dactinomycin.,Dactinomycin
DB00993,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Azathioprine.,Azathioprine
DB01005,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Hydroxyurea.,Hydroxyurea
DB01024,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Mycophenolic acid.,Mycophenolic acid
DB01030,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Topotecan.,Topotecan
DB01033,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Mercaptopurine.,Mercaptopurine
DB01041,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Thalidomide.,Thalidomide
DB01042,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Melphalan.,Melphalan
DB01073,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Fludarabine.,Fludarabine
DB01099,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Flucytosine.,Flucytosine
DB01101,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Capecitabine.,Capecitabine
DB01168,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Procarbazine.,Procarbazine
DB01169,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Arsenic trioxide.,Arsenic trioxide
DB01177,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Idarubicin.,Idarubicin
DB01196,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Estramustine.,Estramustine
DB01204,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Mitoxantrone.,Mitoxantrone
DB01206,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Lomustine.,Lomustine
DB01234,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Dexamethasone.,Dexamethasone
DB01257,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Eculizumab.,Eculizumab
DB01262,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Decitabine.,Decitabine
DB01280,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Nelarabine.,Nelarabine
DB01281,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Abatacept.,Abatacept
DB01285,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Corticotropin.,Corticotropin
DB01423,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Stepronin.,Stepronin
DB01611,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Hydroxychloroquine.,Hydroxychloroquine
DB01816,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Castanospermine.,Castanospermine
DB02546,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Vorinostat.,Vorinostat
DB02806,The risk or severity of adverse effects can be increased when Aldesleukin is combined with 2-Methoxyethanol.,2-Methoxyethanol
DB03523,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Brequinar.,Brequinar
DB04630,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Aldosterone.,Aldosterone
DB04951,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Pirfenidone.,Pirfenidone
DB04956,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Afelimomab.,Afelimomab
DB05258,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Interferon alfa.,Interferon alfa
DB05259,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Glatiramer.,Glatiramer
DB05260,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Gallium nitrate.,Gallium nitrate
DB05459,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Briakinumab.,Briakinumab
DB05472,The risk or severity of adverse effects can be increased when Aldesleukin is combined with omega interferon.,omega interferon
DB05676,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Apremilast.,Apremilast
DB05773,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Trastuzumab emtansine.,Trastuzumab emtansine
DB06168,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Canakinumab.,Canakinumab
DB06273,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Tocilizumab.,Tocilizumab
DB06372,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Rilonacept.,Rilonacept
DB06612,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Mepolizumab.,Mepolizumab
DB06662,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Abetimus.,Abetimus
DB06674,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Golimumab.,Golimumab
DB06681,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Belatacept.,Belatacept
DB06769,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Bendamustine.,Bendamustine
DB06772,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Cabazitaxel.,Cabazitaxel
DB06813,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Pralatrexate.,Pralatrexate
DB08059,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Wortmannin.,Wortmannin
DB08871,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Eribulin.,Eribulin
DB08879,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Belimumab.,Belimumab
DB08880,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Teriflunomide.,Teriflunomide
DB08889,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Carfilzomib.,Carfilzomib
DB08904,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Certolizumab pegol.,Certolizumab pegol
DB08908,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Dimethyl fumarate.,Dimethyl fumarate
DB08910,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Pomalidomide.,Pomalidomide
DB08935,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Obinutuzumab.,Obinutuzumab
DB09029,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Secukinumab.,Secukinumab
DB09033,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Vedolizumab.,Vedolizumab
DB09036,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Siltuximab.,Siltuximab
DB09052,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Blinatumomab.,Blinatumomab
DB09074,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Olaparib.,Olaparib
DB09077,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Dinutuximab.,Dinutuximab
DB09082,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Vilanterol.,Vilanterol
DB09091,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Tixocortol.,Tixocortol
DB09122,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Peginterferon beta-1a.,Peginterferon beta-1a
DB09312,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Antilymphocyte immunoglobulin (horse).,Antilymphocyte immunoglobulin (horse)
DB09378,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Fluprednisolone.,Fluprednisolone
DB11466,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Tepoxalin.,Tepoxalin
DB11529,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Melengestrol.,Melengestrol
DB11569,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Ixekizumab.,Ixekizumab
DB11580,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Ravulizumab.,Ravulizumab
DB11616,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Pirarubicin.,Pirarubicin
DB11693,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Voclosporin.,Voclosporin
DB11708,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Peficitinib.,Peficitinib
DB11767,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Sarilumab.,Sarilumab
DB11776,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Brodalumab.,Brodalumab
DB11803,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Sirukumab.,Sirukumab
DB11817,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Baricitinib.,Baricitinib
DB11834,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Guselkumab.,Guselkumab
DB12025,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Triptolide.,Triptolide
DB12612,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Ozanimod.,Ozanimod
DB12617,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Mizoribine.,Mizoribine
DB12692,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Gusperimus.,Gusperimus
DB12814,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Cepeginterferon alfa-2B.,Cepeginterferon alfa-2B
DB12902,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Trofosfamide.,Trofosfamide
DB12947,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Doxifluridine.,Doxifluridine
DB12991,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Deoxyspergualin.,Deoxyspergualin
DB12996,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Acteoside.,Acteoside
DB13014,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Hypericin.,Hypericin
DB13068,The risk or severity of adverse effects can be increased when Aldesleukin is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.,9-(N-methyl-L-isoleucine)-cyclosporin A
DB13223,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Fluocortin.,Fluocortin
DB13241,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Begelomab.,Begelomab
DB13491,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Fluperolone.,Fluperolone
DB13664,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Formocortal.,Formocortal
DB13856,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Fluclorolone.,Fluclorolone
DB14066,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Tetrandrine.,Tetrandrine
DB14219,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Monomethyl fumarate.,Monomethyl fumarate
DB14538,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Hydrocortisone aceponate.,Hydrocortisone aceponate
DB14539,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Hydrocortisone acetate.,Hydrocortisone acetate
DB14545,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Hydrocortisone succinate.,Hydrocortisone succinate
DB14724,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Emapalumab.,Emapalumab
DB14762,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Risankizumab.,Risankizumab
DB14919,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Rozanolixizumab.,Rozanolixizumab
DB15253,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Bleselumab.,Bleselumab
DB01222,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Budesonide.,Budesonide
DB12371,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Siponimod.,Siponimod
DB00108,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Natalizumab.,Natalizumab
DB00337,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Aldesleukin.,Pimecrolimus
DB01656,Roflumilast may increase the immunosuppressive activities of Aldesleukin.,Roflumilast
DB06688,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Aldesleukin.,Sipuleucel-T
DB00008,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Aldesleukin.,Peginterferon alfa-2a
DB00018,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Aldesleukin.,Interferon alfa-n3
DB00022,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Aldesleukin.,Peginterferon alfa-2b
DB00034,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Aldesleukin.","Interferon alfa-2a, Recombinant"
DB00069,The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Aldesleukin.,Interferon alfacon-1
DB00105,The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Aldesleukin.,Interferon alfa-2b
DB00363,The risk or severity of neutropenia can be increased when Aldesleukin is combined with Clozapine.,Clozapine
DB08894,The risk or severity of Thrombosis can be increased when Aldesleukin is combined with Peginesatide.,Peginesatide
DB00012,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Aldesleukin.,Darbepoetin alfa
DB00016,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Aldesleukin.,Erythropoietin
DB09107,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Aldesleukin.,Methoxy polyethylene glycol-epoetin beta
DB00476,The risk or severity of orthostatic hypotension and syncope can be increased when Aldesleukin is combined with Duloxetine.,Duloxetine
DB01235,The risk or severity of hypotension and orthostatic hypotension can be increased when Aldesleukin is combined with Levodopa.,Levodopa
DB00734,Aldesleukin may increase the hypotensive activities of Risperidone.,Risperidone
DB09039,The metabolism of Eliglustat can be decreased when combined with Aldesleukin.,Eliglustat
DB09053,The metabolism of Ibrutinib can be decreased when combined with Aldesleukin.,Ibrutinib
DB01166,The metabolism of Cilostazol can be decreased when combined with Aldesleukin.,Cilostazol
DB01394,The metabolism of Colchicine can be decreased when combined with Aldesleukin.,Colchicine
DB00813,The metabolism of Fentanyl can be decreased when combined with Aldesleukin.,Fentanyl
DB04946,The metabolism of Iloperidone can be decreased when combined with Aldesleukin.,Iloperidone
DB01256,The metabolism of Retapamulin can be decreased when combined with Aldesleukin.,Retapamulin
DB08895,The metabolism of Tofacitinib can be decreased when combined with Aldesleukin.,Tofacitinib
DB00862,The metabolism of Vardenafil can be decreased when combined with Aldesleukin.,Vardenafil
DB00402,The metabolism of Eszopiclone can be decreased when combined with Aldesleukin.,Eszopiclone
DB01198,The metabolism of Zopiclone can be decreased when combined with Aldesleukin.,Zopiclone
DB00394,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Beclomethasone dipropionate.,Beclomethasone dipropionate
DB00443,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Betamethasone.,Betamethasone
DB00620,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Triamcinolone.,Triamcinolone
DB00635,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Prednisone.,Prednisone
DB00764,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Mometasone.,Mometasone
DB01380,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Cortisone acetate.,Cortisone acetate
DB01384,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Paramethasone.,Paramethasone
DB01410,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Ciclesonide.,Ciclesonide
DB08906,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Fluticasone furoate.,Fluticasone furoate
DB08970,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Fluprednidene.,Fluprednidene
DB08971,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Fluocortolone.,Fluocortolone
DB09383,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Meprednisone.,Meprednisone
DB11487,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Dexamethasone isonicotinate.,Dexamethasone isonicotinate
DB11750,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Clobetasol.,Clobetasol
DB11921,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Deflazacort.,Deflazacort
DB13003,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Cortivazol.,Cortivazol
DB13208,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Prednylidene.,Prednylidene
DB13728,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Halometasone.,Halometasone
DB13843,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Cloprednol.,Cloprednol
DB13867,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Fluticasone.,Fluticasone
DB14512,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Mometasone furoate.,Mometasone furoate
DB14631,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Prednisolone phosphate.,Prednisolone phosphate
DB14633,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Prednisolone hemisuccinate.,Prednisolone hemisuccinate
DB14634,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Fluprednidene acetate.,Fluprednidene acetate
DB14644,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Methylprednisolone hemisuccinate.,Methylprednisolone hemisuccinate
DB14646,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Prednisone acetate.,Prednisone acetate
DB14652,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Clocortolone acetate.,Clocortolone acetate
DB14659,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Melengestrol acetate.,Melengestrol acetate
DB14669,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Betamethasone phosphate.,Betamethasone phosphate
DB14681,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Cortisone.,Cortisone
DB00227,The metabolism of Lovastatin can be decreased when combined with Aldesleukin.,Lovastatin
DB00271,The risk of a hypersensitivity reaction to Diatrizoate is increased when it is combined with Aldesleukin.,Diatrizoate
DB00965,The risk of a hypersensitivity reaction to Ethiodized oil is increased when it is combined with Aldesleukin.,Ethiodized oil
DB01249,The risk of a hypersensitivity reaction to Iodixanol is increased when it is combined with Aldesleukin.,Iodixanol
DB01362,The risk of a hypersensitivity reaction to Iohexol is increased when it is combined with Aldesleukin.,Iohexol
DB04711,The risk of a hypersensitivity reaction to Iodipamide is increased when it is combined with Aldesleukin.,Iodipamide
DB08947,The risk of a hypersensitivity reaction to Iopamidol is increased when it is combined with Aldesleukin.,Iopamidol
DB09134,The risk of a hypersensitivity reaction to Ioversol is increased when it is combined with Aldesleukin.,Ioversol
DB09135,The risk of a hypersensitivity reaction to Ioxilan is increased when it is combined with Aldesleukin.,Ioxilan
DB09156,The risk of a hypersensitivity reaction to Iopromide is increased when it is combined with Aldesleukin.,Iopromide
DB00346,The metabolism of Alfuzosin can be decreased when combined with Aldesleukin.,Alfuzosin
DB00404,The metabolism of Alprazolam can be decreased when combined with Aldesleukin.,Alprazolam
DB00682,The serum concentration of Warfarin can be increased when it is combined with Aldesleukin.,Warfarin
DB01418,The serum concentration of Acenocoumarol can be increased when it is combined with Aldesleukin.,Acenocoumarol
DB08496,The serum concentration of (R)-warfarin can be increased when it is combined with Aldesleukin.,(R)-warfarin
DB08735,"The serum concentration of R,S-Warfarin alcohol can be increased when it is combined with Aldesleukin.","R,S-Warfarin alcohol"
DB08736,"The serum concentration of S,R-Warfarin alcohol can be increased when it is combined with Aldesleukin.","S,R-Warfarin alcohol"
DB14055,The serum concentration of (S)-Warfarin can be increased when it is combined with Aldesleukin.,(S)-Warfarin
DB00683,The serum concentration of Midazolam can be increased when it is combined with Aldesleukin.,Midazolam
DB00864,The serum concentration of Tacrolimus can be increased when it is combined with Aldesleukin.,Tacrolimus
DB01015,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Aldesleukin.,Sulfamethoxazole
DB01076,The metabolism of Atorvastatin can be decreased when combined with Aldesleukin.,Atorvastatin
DB01097,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Leflunomide.,Leflunomide
DB00072,Trastuzumab may increase the neutropenic activities of Aldesleukin.,Trastuzumab
DB08868,Aldesleukin may increase the immunosuppressive activities of Fingolimod.,Fingolimod
DB09220,Nicorandil may increase the hypotensive activities of Aldesleukin.,Nicorandil
DB00614,Furazolidone may increase the orthostatic hypotensive activities of Aldesleukin.,Furazolidone
DB00721,Procaine may increase the orthostatic hypotensive activities of Aldesleukin.,Procaine
DB00752,Tranylcypromine may increase the orthostatic hypotensive activities of Aldesleukin.,Tranylcypromine
DB00780,Phenelzine may increase the orthostatic hypotensive activities of Aldesleukin.,Phenelzine
DB00805,Minaprine may increase the orthostatic hypotensive activities of Aldesleukin.,Minaprine
DB01037,Selegiline may increase the orthostatic hypotensive activities of Aldesleukin.,Selegiline
DB01171,Moclobemide may increase the orthostatic hypotensive activities of Aldesleukin.,Moclobemide
DB01247,Isocarboxazid may increase the orthostatic hypotensive activities of Aldesleukin.,Isocarboxazid
DB01367,Rasagiline may increase the orthostatic hypotensive activities of Aldesleukin.,Rasagiline
DB01626,Pargyline may increase the orthostatic hypotensive activities of Aldesleukin.,Pargyline
DB04017,Clorgiline may increase the orthostatic hypotensive activities of Aldesleukin.,Clorgiline
DB04818,Iproniazid may increase the orthostatic hypotensive activities of Aldesleukin.,Iproniazid
DB04820,Nialamide may increase the orthostatic hypotensive activities of Aldesleukin.,Nialamide
DB06654,Safinamide may increase the orthostatic hypotensive activities of Aldesleukin.,Safinamide
DB08550,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the orthostatic hypotensive activities of Aldesleukin.","7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline"
DB09241,Methylene blue may increase the orthostatic hypotensive activities of Aldesleukin.,Methylene blue
DB09243,Hydracarbazine may increase the orthostatic hypotensive activities of Aldesleukin.,Hydracarbazine
DB09244,Pirlindole may increase the orthostatic hypotensive activities of Aldesleukin.,Pirlindole
DB09245,Toloxatone may increase the orthostatic hypotensive activities of Aldesleukin.,Toloxatone
DB09246,Benmoxin may increase the orthostatic hypotensive activities of Aldesleukin.,Benmoxin
DB09248,Mebanazine may increase the orthostatic hypotensive activities of Aldesleukin.,Mebanazine
DB09249,Octamoxin may increase the orthostatic hypotensive activities of Aldesleukin.,Octamoxin
DB09250,Pheniprazine may increase the orthostatic hypotensive activities of Aldesleukin.,Pheniprazine
DB09251,Phenoxypropazine may increase the orthostatic hypotensive activities of Aldesleukin.,Phenoxypropazine
DB09252,Pivhydrazine may increase the orthostatic hypotensive activities of Aldesleukin.,Pivhydrazine
DB09253,Safrazine may increase the orthostatic hypotensive activities of Aldesleukin.,Safrazine
DB09254,Caroxazone may increase the orthostatic hypotensive activities of Aldesleukin.,Caroxazone
DB13875,Harmaline may increase the orthostatic hypotensive activities of Aldesleukin.,Harmaline
DB13876,Brofaromine may increase the orthostatic hypotensive activities of Aldesleukin.,Brofaromine
DB00182,Aldesleukin may increase the orthostatic hypotensive activities of Amphetamine.,Amphetamine
DB00241,Butalbital may increase the hypotensive activities of Aldesleukin.,Butalbital
DB00312,Pentobarbital may increase the hypotensive activities of Aldesleukin.,Pentobarbital
DB00418,Secobarbital may increase the hypotensive activities of Aldesleukin.,Secobarbital
DB00474,Methohexital may increase the hypotensive activities of Aldesleukin.,Methohexital
DB00599,Thiopental may increase the hypotensive activities of Aldesleukin.,Thiopental
DB00794,Primidone may increase the hypotensive activities of Aldesleukin.,Primidone
DB00849,Methylphenobarbital may increase the hypotensive activities of Aldesleukin.,Methylphenobarbital
DB01154,Thiamylal may increase the hypotensive activities of Aldesleukin.,Thiamylal
DB01174,Phenobarbital may increase the hypotensive activities of Aldesleukin.,Phenobarbital
DB01351,Amobarbital may increase the hypotensive activities of Aldesleukin.,Amobarbital
DB01355,Hexobarbital may increase the hypotensive activities of Aldesleukin.,Hexobarbital
DB01483,Barbital may increase the hypotensive activities of Aldesleukin.,Barbital
DB09001,Barbexaclone may increase the hypotensive activities of Aldesleukin.,Barbexaclone
DB00237,Aldesleukin may increase the hypotensive activities of Butabarbital.,Butabarbital
DB00086,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Streptokinase.,Streptokinase
DB00268,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Ropinirole.,Ropinirole
DB00334,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Olanzapine.,Olanzapine
DB00486,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Nabilone.,Nabilone
DB00489,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Sotalol.,Sotalol
DB00679,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Thioridazine.,Thioridazine
DB00697,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Tizanidine.,Tizanidine
DB00714,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Apomorphine.,Apomorphine
DB00818,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Propofol.,Propofol
DB00899,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Remifentanil.,Remifentanil
DB00922,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Levosimendan.,Levosimendan
DB01113,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Papaverine.,Papaverine
DB01143,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Amifostine.,Amifostine
DB01189,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Desflurane.,Desflurane
DB01282,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Carbetocin.,Carbetocin
DB01612,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Amyl Nitrite.,Amyl Nitrite
DB04899,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Nesiritide.,Nesiritide
DB08822,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Azilsartan medoxomil.,Azilsartan medoxomil
DB08941,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Isoxsuprine.,Isoxsuprine
DB09112,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Nitrous acid.,Nitrous acid
DB09279,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Fimasartan.,Fimasartan
DB09286,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Pipamperone.,Pipamperone
DB00177,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Valsartan.,Valsartan
DB00178,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Ramipril.,Ramipril
DB00187,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Esmolol.,Esmolol
DB00195,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Betaxolol.,Betaxolol
DB00275,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Olmesartan.,Olmesartan
DB00335,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Atenolol.,Atenolol
DB00350,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Minoxidil.,Minoxidil
DB00457,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Prazosin.,Prazosin
DB00519,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Trandolapril.,Trandolapril
DB00542,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Benazepril.,Benazepril
DB00691,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Moexipril.,Moexipril
DB00727,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Nitroglycerin.,Nitroglycerin
DB00796,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Candesartan cilexetil.,Candesartan cilexetil
DB00797,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Tolazoline.,Tolazoline
DB00876,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Eprosartan.,Eprosartan
DB00881,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Quinapril.,Quinapril
DB00925,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Phenoxybenzamine.,Phenoxybenzamine
DB00966,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Telmisartan.,Telmisartan
DB01029,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Irbesartan.,Irbesartan
DB01158,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Bretylium.,Bretylium
DB01162,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Terazosin.,Terazosin
DB01193,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Acebutolol.,Acebutolol
DB01197,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Captopril.,Captopril
DB01340,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Cilazapril.,Cilazapril
DB01580,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Oxprenolol.,Oxprenolol
DB08950,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Indoramin.,Indoramin
DB09242,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Moxonidine.,Moxonidine
DB11783,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Imidapril.,Imidapril
DB00584,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Enalapril.,Enalapril
DB00343,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Diltiazem.,Diltiazem
DB00381,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Amlodipine.,Amlodipine
DB00393,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Nimodipine.,Nimodipine
DB00528,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Lercanidipine.,Lercanidipine
DB00622,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Nicardipine.,Nicardipine
DB00678,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Losartan.,Losartan
DB01054,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Nitrendipine.,Nitrendipine
DB01244,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Bepridil.,Bepridil
DB04861,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Nebivolol.,Nebivolol
DB08931,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Riociguat.,Riociguat
DB09026,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Aliskiren.,Aliskiren
DB00295,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Morphine.,Morphine
DB00297,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Bupivacaine.,Bupivacaine
DB00708,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Sufentanil.,Sufentanil
DB00883,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Isosorbide dinitrate.,Isosorbide dinitrate
DB05271,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Rotigotine.,Rotigotine
DB09227,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Barnidipine.,Barnidipine
DB09232,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Cilnidipine.,Cilnidipine
DB00401,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Nisoldipine.,Nisoldipine
DB00575,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Clonidine.,Clonidine
DB01023,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Felodipine.,Felodipine
DB01200,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Bromocriptine.,Bromocriptine
DB01242,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Clomipramine.,Clomipramine
DB09038,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Empagliflozin.,Empagliflozin
DB04914,The therapeutic efficacy of G17DT can be decreased when used in combination with Aldesleukin.,G17DT
DB05144,The therapeutic efficacy of PEV3A can be decreased when used in combination with Aldesleukin.,PEV3A
DB05325,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Aldesleukin.,INGN 225
DB05374,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Aldesleukin.,Rindopepimut
DB05440,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Aldesleukin.,SRP 299
DB05942,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Aldesleukin.,GI-5005
DB06400,The therapeutic efficacy of Vitespen can be decreased when used in combination with Aldesleukin.,Vitespen
DB06584,The therapeutic efficacy of TG4010 can be decreased when used in combination with Aldesleukin.,TG4010
DB09057,The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Aldesleukin.,Anthrax immune globulin human
DB10062,"The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Aldesleukin.","Rabies virus inactivated antigen, B"
DB10076,The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Aldesleukin.,Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen
DB10276,The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Aldesleukin.,Rotavirus vaccine
DB10283,"The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Aldesleukin.","Rabies virus inactivated antigen, A"
DB10342,The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Aldesleukin.,Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen
DB10583,The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Aldesleukin.,Clostridium tetani toxoid antigen (formaldehyde inactivated)
DB10584,The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Aldesleukin.,Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)
DB10600,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Aldesleukin.,Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated)
DB10769,The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Aldesleukin.,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated)
DB10794,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) can be decreased when used in combination with Aldesleukin.,Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated)
DB10803,The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Aldesleukin.,Typhoid Vi polysaccharide vaccine
DB10989,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Aldesleukin.,Hepatitis A Vaccine
DB10990,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Aldesleukin.,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen
DB11038,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Aldesleukin.,Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated)
DB11040,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Aldesleukin.,Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated)
DB11041,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Aldesleukin.,Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)
DB11044,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated) can be decreased when used in combination with Aldesleukin.,Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated)
DB11603,The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Aldesleukin.,Human rabies virus immune globulin
DB11627,The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Aldesleukin.,Hepatitis B Vaccine (Recombinant)
DB12568,The therapeutic efficacy of Tecemotide can be decreased when used in combination with Aldesleukin.,Tecemotide
DB14022,The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Aldesleukin.,Typhoid vaccine
DB14384,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Aldesleukin.,Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated)
DB14385,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Aldesleukin.,Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated)
DB14394,The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with Aldesleukin.,Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen
DB14445,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) can be decreased when used in combination with Aldesleukin.,Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated)
DB14449,The therapeutic efficacy of Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen can be decreased when used in combination with Aldesleukin.,Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen
DB14619,The therapeutic efficacy of Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated) can be decreased when used in combination with Aldesleukin.,Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated)
DB14620,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Aldesleukin.,Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated)
DB14711,The therapeutic efficacy of Vaccinia virus strain new york city board of health live antigen can be decreased when used in combination with Aldesleukin.,Vaccinia virus strain new york city board of health live antigen
DB15274,The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Aldesleukin.,Pertussis vaccine
DB15461,The therapeutic efficacy of Yersinia pestis 195/p antigen (formaldehyde inactivated) can be decreased when used in combination with Aldesleukin.,Yersinia pestis 195/p antigen (formaldehyde inactivated)
DB13924,The therapeutic efficacy of Varicella Zoster Vaccine (Recombinant) can be decreased when used in combination with Aldesleukin.,Varicella Zoster Vaccine (Recombinant)
DB15483,The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Aldesleukin.,Modified vaccinia ankara
DB15595,"The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Aldesleukin.","Ebola Zaire vaccine (live, attenuated)"
DB00054,The risk or severity of bleeding can be increased when Abciximab is combined with Aldesleukin.,Abciximab
DB00063,The risk or severity of bleeding can be increased when Eptifibatide is combined with Aldesleukin.,Eptifibatide
DB00261,The risk or severity of bleeding can be increased when Anagrelide is combined with Aldesleukin.,Anagrelide
DB00975,The risk or severity of bleeding can be increased when Dipyridamole is combined with Aldesleukin.,Dipyridamole
DB01088,The risk or severity of bleeding can be increased when Iloprost is combined with Aldesleukin.,Iloprost
DB01207,The risk or severity of bleeding can be increased when Ridogrel is combined with Aldesleukin.,Ridogrel
DB02709,The risk or severity of bleeding can be increased when Resveratrol is combined with Aldesleukin.,Resveratrol
DB04932,The risk or severity of bleeding can be increased when Defibrotide is combined with Aldesleukin.,Defibrotide
DB05229,The risk or severity of bleeding can be increased when Beraprost is combined with Aldesleukin.,Beraprost
DB05266,The risk or severity of bleeding can be increased when Ibudilast is combined with Aldesleukin.,Ibudilast
DB05767,The risk or severity of bleeding can be increased when Andrographolide is combined with Aldesleukin.,Andrographolide
DB06081,The risk or severity of bleeding can be increased when Caplacizumab is combined with Aldesleukin.,Caplacizumab
DB06441,The risk or severity of bleeding can be increased when Cangrelor is combined with Aldesleukin.,Cangrelor
DB08814,The risk or severity of bleeding can be increased when Triflusal is combined with Aldesleukin.,Triflusal
DB08887,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Aldesleukin.,Icosapent ethyl
DB09283,The risk or severity of bleeding can be increased when Trapidil is combined with Aldesleukin.,Trapidil
DB12163,The risk or severity of bleeding can be increased when Sarpogrelate is combined with Aldesleukin.,Sarpogrelate
DB12321,The risk or severity of bleeding can be increased when Ifetroban is combined with Aldesleukin.,Ifetroban
DB12749,The risk or severity of bleeding can be increased when Butylphthalide is combined with Aldesleukin.,Butylphthalide
DB12771,The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Aldesleukin.,Hydroxytyrosol
DB13036,The risk or severity of bleeding can be increased when Ramatroban is combined with Aldesleukin.,Ramatroban
DB13327,The risk or severity of bleeding can be increased when Picotamide is combined with Aldesleukin.,Picotamide
DB13367,The risk or severity of bleeding can be increased when Cloricromen is combined with Aldesleukin.,Cloricromen
DB13510,The risk or severity of bleeding can be increased when Buflomedil is combined with Aldesleukin.,Buflomedil
DB13929,The risk or severity of bleeding can be increased when Relcovaptan is combined with Aldesleukin.,Relcovaptan
DB12465,The risk or severity of bleeding can be increased when Aldesleukin is combined with Ketanserin.,Ketanserin
DB13400,The risk or severity of bleeding can be increased when Aldesleukin is combined with Linsidomine.,Linsidomine
DB12092,The risk or severity of bleeding can be increased when Aldesleukin is combined with Naftopidil.,Naftopidil
DB00758,The risk or severity of bleeding can be increased when Clopidogrel is combined with Aldesleukin.,Clopidogrel
DB01138,The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Aldesleukin.,Sulfinpyrazone
DB04905,The risk or severity of bleeding can be increased when Tesmilifene is combined with Aldesleukin.,Tesmilifene
DB07615,The risk or severity of bleeding can be increased when Tranilast is combined with Aldesleukin.,Tranilast
DB08816,The risk or severity of bleeding can be increased when Ticagrelor is combined with Aldesleukin.,Ticagrelor
DB09236,Aldesleukin may increase the hypotensive activities of Lacidipine.,Lacidipine
DB00898,Ethanol may increase the hypotensive activities of Aldesleukin.,Ethanol
DB11988,Ocrelizumab may increase the immunosuppressive activities of Aldesleukin.,Ocrelizumab
DB13200,Aldesleukin may increase the myelosuppressive activities of Lipegfilgrastim.,Lipegfilgrastim
DB10317,The risk or severity of infection can be increased when Rubella virus vaccine is combined with Aldesleukin.,Rubella virus vaccine
DB10318,The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Aldesleukin.,Varicella Zoster Vaccine (Live/attenuated)
DB10343,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Aldesleukin.,Bacillus calmette-guerin substrain tice live antigen
DB10804,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Aldesleukin.,Bacillus calmette-guerin substrain connaught live antigen
DB10805,The risk or severity of infection can be increased when Yellow Fever Vaccine is combined with Aldesleukin.,Yellow Fever Vaccine
DB11003,The risk or severity of infection can be increased when Anthrax vaccine is combined with Aldesleukin.,Anthrax vaccine
DB11050,The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Aldesleukin.,Typhoid Vaccine Live
DB12386,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain danish 1331 live antigen is combined with Aldesleukin.,Bacillus calmette-guerin substrain danish 1331 live antigen
DB12768,The risk or severity of infection can be increased when BCG vaccine is combined with Aldesleukin.,BCG vaccine
DB14409,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Aldesleukin.,Human adenovirus e serotype 4 strain cl-68578 antigen
DB14443,The risk or severity of infection can be increased when Vibrio cholerae CVD 103-HgR strain live antigen is combined with Aldesleukin.,Vibrio cholerae CVD 103-HgR strain live antigen
DB14685,The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Aldesleukin.,Adenovirus type 7 vaccine live
DB01238,The metabolism of Aripiprazole can be decreased when combined with Aldesleukin.,Aripiprazole
DB14185,The metabolism of Aripiprazole lauroxil can be decreased when combined with Aldesleukin.,Aripiprazole lauroxil
DB00039,The therapeutic efficacy of Palifermin can be decreased when used in combination with Aldesleukin.,Palifermin
DB00159,Icosapent may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Icosapent
DB00229,Cefotiam may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefotiam
DB00244,Mesalazine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Mesalazine
DB00267,Cefmenoxime may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefmenoxime
DB00274,Cefmetazole may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefmetazole
DB00282,Pamidronic acid may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Pamidronic acid
DB00300,Tenofovir disoproxil may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Tenofovir disoproxil
DB00369,Cidofovir may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cidofovir
DB00384,Triamterene may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Triamterene
DB00430,Cefpiramide may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefpiramide
DB00438,Ceftazidime may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Ceftazidime
DB00447,Loracarbef may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Loracarbef
DB00456,Cefalotin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefalotin
DB00461,Nabumetone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Nabumetone
DB00465,Ketorolac may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Ketorolac
DB00469,Tenoxicam may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Tenoxicam
DB00482,Celecoxib may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Celecoxib
DB00493,Cefotaxime may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefotaxime
DB00500,Tolmetin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Tolmetin
DB00529,Foscarnet may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Foscarnet
DB00533,Rofecoxib may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Rofecoxib
DB00554,Piroxicam may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Piroxicam
DB00567,Cephalexin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cephalexin
DB00573,Fenoprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Fenoprofen
DB00577,Valaciclovir may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Valaciclovir
DB00580,Valdecoxib may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Valdecoxib
DB00586,Diclofenac may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Diclofenac
DB00605,Sulindac may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Sulindac
DB00626,Bacitracin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Bacitracin
DB00681,Amphotericin B may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Amphotericin B
DB00689,Cephaloglycin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cephaloglycin
DB00712,Flurbiprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Flurbiprofen
DB00718,Adefovir dipivoxil may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Adefovir dipivoxil
DB00738,Pentamidine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Pentamidine
DB00742,Mannitol may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Mannitol
DB00749,Etodolac may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Etodolac
DB00784,Mefenamic acid may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Mefenamic acid
DB00787,Acyclovir may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Acyclovir
DB00788,Naproxen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Naproxen
DB00812,Phenylbutazone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Phenylbutazone
DB00814,Meloxicam may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Meloxicam
DB00821,Carprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Carprofen
DB00833,Cefaclor may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefaclor
DB00861,Diflunisal may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Diflunisal
DB00903,Etacrynic acid may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Etacrynic acid
DB00923,Ceforanide may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Ceforanide
DB00936,Salicylic acid may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Salicylic acid
DB00939,Meclofenamic acid may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Meclofenamic acid
DB00945,Acetylsalicylic acid may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Acetylsalicylic acid
DB00991,Oxaprozin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Oxaprozin
DB00999,Hydrochlorothiazide may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Hydrochlorothiazide
DB01009,Ketoprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Ketoprofen
DB01014,Balsalazide may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Balsalazide
DB01050,Ibuprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Ibuprofen
DB01066,Cefditoren may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefditoren
DB01072,Atazanavir may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Atazanavir
DB01111,Colistimethate may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Colistimethate
DB01112,Cefuroxime may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefuroxime
DB01139,Cefapirin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefapirin
DB01140,Cefadroxil may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefadroxil
DB01150,Cefprozil may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefprozil
DB01212,Ceftriaxone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Ceftriaxone
DB01250,Olsalazine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Olsalazine
DB01283,Lumiracoxib may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Lumiracoxib
DB01326,Cefamandole may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefamandole
DB01327,Cefazolin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefazolin
DB01328,Cefonicid may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefonicid
DB01329,Cefoperazone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefoperazone
DB01330,Cefotetan may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefotetan
DB01331,Cefoxitin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefoxitin
DB01332,Ceftizoxime may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Ceftizoxime
DB01333,Cefradine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefradine
DB01397,Magnesium salicylate may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Magnesium salicylate
DB01399,Salsalate may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Salsalate
DB01401,Choline magnesium trisalicylate may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Choline magnesium trisalicylate
DB01413,Cefepime may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefepime
DB01414,Cefacetrile may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefacetrile
DB01415,Ceftibuten may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Ceftibuten
DB01416,Cefpodoxime may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefpodoxime
DB01419,Antrafenine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Antrafenine
DB01424,Aminophenazone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Aminophenazone
DB01435,Antipyrine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Antipyrine
DB01600,Tiaprofenic acid may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Tiaprofenic acid
DB01628,Etoricoxib may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Etoricoxib
DB02247,Hydrolyzed Cephalothin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Hydrolyzed Cephalothin
DB03450,Cephalothin Group may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cephalothin Group
DB03585,Oxyphenbutazone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Oxyphenbutazone
DB04552,Niflumic acid may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Niflumic acid
DB04570,Latamoxef may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Latamoxef
DB04743,Nimesulide may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Nimesulide
DB04812,Benoxaprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Benoxaprofen
DB04817,Metamizole may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Metamizole
DB04828,Zomepirac may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Zomepirac
DB04918,Ceftobiprole may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Ceftobiprole
DB05095,Cimicoxib may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cimicoxib
DB06590,Ceftaroline fosamil may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Ceftaroline fosamil
DB06725,Lornoxicam may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Lornoxicam
DB06736,Aceclofenac may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Aceclofenac
DB06737,Zaltoprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Zaltoprofen
DB07402,Azapropazone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Azapropazone
DB07477,Felbinac may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Felbinac
DB08439,Parecoxib may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Parecoxib
DB08797,Salicylamide may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Salicylamide
DB08940,Kebuzone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Kebuzone
DB08942,Isoxicam may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Isoxicam
DB08951,Indoprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Indoprofen
DB08955,Ibuproxam may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Ibuproxam
DB08976,Floctafenine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Floctafenine
DB08981,Fenbufen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Fenbufen
DB08984,Etofenamate may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Etofenamate
DB08991,Epirizole may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Epirizole
DB09008,Cefaloridine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefaloridine
DB09062,Cefminox may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefminox
DB09084,Benzydamine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Benzydamine
DB09212,Loxoprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Loxoprofen
DB09213,Dexibuprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Dexibuprofen
DB09214,Dexketoprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Dexketoprofen
DB09215,Droxicam may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Droxicam
DB09216,Tolfenamic acid may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Tolfenamic acid
DB09217,Firocoxib may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Firocoxib
DB09218,Clonixin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Clonixin
DB09285,Morniflumate may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Morniflumate
DB09295,Talniflumate may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Talniflumate
DB09299,Tenofovir alafenamide may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Tenofovir alafenamide
DB11367,Cefroxadine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefroxadine
DB11455,Robenacoxib may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Robenacoxib
DB11518,Flunixin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Flunixin
DB11935,Flomoxef may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Flomoxef
DB12151,Brincidofovir may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Brincidofovir
DB12445,Nitroaspirin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Nitroaspirin
DB12545,Indobufen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Indobufen
DB13001,Tinoridine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Tinoridine
DB13167,Alclofenac may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Alclofenac
DB13217,Fentiazac may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Fentiazac
DB13232,Suxibuzone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Suxibuzone
DB13266,Cefatrizine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefatrizine
DB13286,Bumadizone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Bumadizone
DB13314,Alminoprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Alminoprofen
DB13317,Flunoxaprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Flunoxaprofen
DB13364,Feprazone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Feprazone
DB13371,Difenpiramide may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Difenpiramide
DB13407,Nifenazone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Nifenazone
DB13432,Lonazolac may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Lonazolac
DB13461,Cefcapene may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefcapene
DB13470,Cefodizime may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefodizime
DB13481,Tenidap may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Tenidap
DB13499,Cefsulodin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefsulodin
DB13501,Bendazac may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Bendazac
DB13504,Cefetamet may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefetamet
DB13514,Pranoprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Pranoprofen
DB13524,Propyphenazone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Propyphenazone
DB13527,Proglumetacin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Proglumetacin
DB13538,Guacetisal may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Guacetisal
DB13544,Ethenzamide may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Ethenzamide
DB13612,Carbaspirin calcium may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Carbaspirin calcium
DB13629,Mofebutazone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Mofebutazone
DB13638,Cefbuperazone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefbuperazone
DB13649,Proquazone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Proquazone
DB13657,Benorilate may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Benorilate
DB13667,Cefozopran may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefozopran
DB13682,Cefpirome may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefpirome
DB13722,Pirprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Pirprofen
DB13778,Cefazedone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Cefazedone
DB13783,Acemetacin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Acemetacin
DB13821,Ceftezole may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Ceftezole
DB13860,Imidazole salicylate may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Imidazole salicylate
DB13868,Adefovir may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Adefovir
DB14059,SC-236 may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,SC-236
DB14060,NS-398 may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,NS-398
DB14126,Tenofovir may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Tenofovir
DB14713,Inotersen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Inotersen
DB01438,Phenazopyridine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Phenazopyridine
DB15066,Givosiran may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Givosiran
DB01356,Lithium cation may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Lithium cation
DB14507,Lithium citrate may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Lithium citrate
DB00007,Leuprolide may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Leuprolide
DB00014,Goserelin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Goserelin
DB00035,Desmopressin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Desmopressin
DB00080,Aldesleukin may decrease the excretion rate of Daptomycin which could result in a higher serum level.,Daptomycin
DB00158,Aldesleukin may decrease the excretion rate of Folic acid which could result in a higher serum level.,Folic acid
DB00165,Aldesleukin may decrease the excretion rate of Pyridoxine which could result in a higher serum level.,Pyridoxine
DB00176,Aldesleukin may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.,Fluvoxamine
DB00181,Aldesleukin may decrease the excretion rate of Baclofen which could result in a higher serum level.,Baclofen
DB00185,Aldesleukin may decrease the excretion rate of Cevimeline which could result in a higher serum level.,Cevimeline
DB00190,Aldesleukin may decrease the excretion rate of Carbidopa which could result in a higher serum level.,Carbidopa
DB00196,Aldesleukin may decrease the excretion rate of Fluconazole which could result in a higher serum level.,Fluconazole
DB00198,Aldesleukin may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,Oseltamivir
DB00200,Aldesleukin may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,Hydroxocobalamin
DB00206,Aldesleukin may decrease the excretion rate of Reserpine which could result in a higher serum level.,Reserpine
DB00213,Aldesleukin may decrease the excretion rate of Pantoprazole which could result in a higher serum level.,Pantoprazole
DB00225,Aldesleukin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,Gadodiamide
DB00230,Aldesleukin may decrease the excretion rate of Pregabalin which could result in a higher serum level.,Pregabalin
DB00231,Aldesleukin may decrease the excretion rate of Temazepam which could result in a higher serum level.,Temazepam
DB00235,Aldesleukin may decrease the excretion rate of Milrinone which could result in a higher serum level.,Milrinone
DB00243,Aldesleukin may decrease the excretion rate of Ranolazine which could result in a higher serum level.,Ranolazine
DB00245,Aldesleukin may decrease the excretion rate of Benzatropine which could result in a higher serum level.,Benzatropine
DB00254,Aldesleukin may decrease the excretion rate of Doxycycline which could result in a higher serum level.,Doxycycline
DB00270,Aldesleukin may decrease the excretion rate of Isradipine which could result in a higher serum level.,Isradipine
DB00273,Aldesleukin may decrease the excretion rate of Topiramate which could result in a higher serum level.,Topiramate
DB00280,Aldesleukin may decrease the excretion rate of Disopyramide which could result in a higher serum level.,Disopyramide
DB00284,Aldesleukin may decrease the excretion rate of Acarbose which could result in a higher serum level.,Acarbose
DB00285,Aldesleukin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,Venlafaxine
DB00286,Aldesleukin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.,Conjugated estrogens
DB00289,Aldesleukin may decrease the excretion rate of Atomoxetine which could result in a higher serum level.,Atomoxetine
DB00292,Aldesleukin may decrease the excretion rate of Etomidate which could result in a higher serum level.,Etomidate
DB00294,Aldesleukin may decrease the excretion rate of Etonogestrel which could result in a higher serum level.,Etonogestrel
DB00296,Aldesleukin may decrease the excretion rate of Ropivacaine which could result in a higher serum level.,Ropivacaine
DB00303,Aldesleukin may decrease the excretion rate of Ertapenem which could result in a higher serum level.,Ertapenem
DB00308,Aldesleukin may decrease the excretion rate of Ibutilide which could result in a higher serum level.,Ibutilide
DB00319,Aldesleukin may decrease the excretion rate of Piperacillin which could result in a higher serum level.,Piperacillin
DB00323,Aldesleukin may decrease the excretion rate of Tolcapone which could result in a higher serum level.,Tolcapone
DB00325,Aldesleukin may decrease the excretion rate of Nitroprusside which could result in a higher serum level.,Nitroprusside
DB00327,Aldesleukin may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,Hydromorphone
DB00330,Aldesleukin may decrease the excretion rate of Ethambutol which could result in a higher serum level.,Ethambutol
DB00331,Aldesleukin may decrease the excretion rate of Metformin which could result in a higher serum level.,Metformin
DB00333,Aldesleukin may decrease the excretion rate of Methadone which could result in a higher serum level.,Methadone
DB00339,Aldesleukin may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.,Pyrazinamide
DB00341,Aldesleukin may decrease the excretion rate of Cetirizine which could result in a higher serum level.,Cetirizine
DB00349,Aldesleukin may decrease the excretion rate of Clobazam which could result in a higher serum level.,Clobazam
DB00351,Aldesleukin may decrease the excretion rate of Megestrol acetate which could result in a higher serum level.,Megestrol acetate
DB00355,Aldesleukin may decrease the excretion rate of Aztreonam which could result in a higher serum level.,Aztreonam
DB00359,Aldesleukin may decrease the excretion rate of Sulfadiazine which could result in a higher serum level.,Sulfadiazine
DB00364,Aldesleukin may decrease the excretion rate of Sucralfate which could result in a higher serum level.,Sucralfate
DB00372,Aldesleukin may decrease the excretion rate of Thiethylperazine which could result in a higher serum level.,Thiethylperazine
DB00373,Aldesleukin may decrease the excretion rate of Timolol which could result in a higher serum level.,Timolol
DB00377,Aldesleukin may decrease the excretion rate of Palonosetron which could result in a higher serum level.,Palonosetron
DB00412,Aldesleukin may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.,Rosiglitazone
DB00413,Aldesleukin may decrease the excretion rate of Pramipexole which could result in a higher serum level.,Pramipexole
DB00415,Aldesleukin may decrease the excretion rate of Ampicillin which could result in a higher serum level.,Ampicillin
DB00422,Aldesleukin may decrease the excretion rate of Methylphenidate which could result in a higher serum level.,Methylphenidate
DB00435,Aldesleukin may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.,Nitric Oxide
DB00440,Aldesleukin may decrease the excretion rate of Trimethoprim which could result in a higher serum level.,Trimethoprim
DB00492,Aldesleukin may decrease the excretion rate of Fosinopril which could result in a higher serum level.,Fosinopril
DB00499,Aldesleukin may decrease the excretion rate of Flutamide which could result in a higher serum level.,Flutamide
DB00535,Aldesleukin may decrease the excretion rate of Cefdinir which could result in a higher serum level.,Cefdinir
DB00537,Aldesleukin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.,Ciprofloxacin
DB00548,Aldesleukin may decrease the excretion rate of Azelaic acid which could result in a higher serum level.,Azelaic acid
DB00553,Aldesleukin may decrease the excretion rate of Methoxsalen which could result in a higher serum level.,Methoxsalen
DB00555,Aldesleukin may decrease the excretion rate of Lamotrigine which could result in a higher serum level.,Lamotrigine
DB00558,Aldesleukin may decrease the excretion rate of Zanamivir which could result in a higher serum level.,Zanamivir
DB00569,Aldesleukin may decrease the excretion rate of Fondaparinux which could result in a higher serum level.,Fondaparinux
DB00571,Aldesleukin may decrease the excretion rate of Propranolol which could result in a higher serum level.,Propranolol
DB00583,Aldesleukin may decrease the excretion rate of Levocarnitine which could result in a higher serum level.,Levocarnitine
DB00597,Aldesleukin may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,Gadoteridol
DB00598,Aldesleukin may decrease the excretion rate of Labetalol which could result in a higher serum level.,Labetalol
DB00603,Aldesleukin may decrease the excretion rate of Medroxyprogesterone acetate which could result in a higher serum level.,Medroxyprogesterone acetate
DB00608,Aldesleukin may decrease the excretion rate of Chloroquine which could result in a higher serum level.,Chloroquine
DB00612,Aldesleukin may decrease the excretion rate of Bisoprolol which could result in a higher serum level.,Bisoprolol
DB00624,Aldesleukin may decrease the excretion rate of Testosterone which could result in a higher serum level.,Testosterone
DB00628,Aldesleukin may decrease the excretion rate of Clorazepic acid which could result in a higher serum level.,Clorazepic acid
DB00633,Aldesleukin may decrease the excretion rate of Dexmedetomidine which could result in a higher serum level.,Dexmedetomidine
DB00651,Aldesleukin may decrease the excretion rate of Dyphylline which could result in a higher serum level.,Dyphylline
DB00657,Aldesleukin may decrease the excretion rate of Mecamylamine which could result in a higher serum level.,Mecamylamine
DB00660,Aldesleukin may decrease the excretion rate of Metaxalone which could result in a higher serum level.,Metaxalone
DB00661,Aldesleukin may decrease the excretion rate of Verapamil which could result in a higher serum level.,Verapamil
DB00665,Aldesleukin may decrease the excretion rate of Nilutamide which could result in a higher serum level.,Nilutamide
DB00669,Aldesleukin may decrease the excretion rate of Sumatriptan which could result in a higher serum level.,Sumatriptan
DB00672,Aldesleukin may decrease the excretion rate of Chlorpropamide which could result in a higher serum level.,Chlorpropamide
DB00690,Aldesleukin may decrease the excretion rate of Flurazepam which could result in a higher serum level.,Flurazepam
DB00692,Aldesleukin may decrease the excretion rate of Phentolamine which could result in a higher serum level.,Phentolamine
DB00698,Aldesleukin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.,Nitrofurantoin
DB00706,Aldesleukin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.,Tamsulosin
DB00709,Aldesleukin may decrease the excretion rate of Lamivudine which could result in a higher serum level.,Lamivudine
DB00713,Aldesleukin may decrease the excretion rate of Oxacillin which could result in a higher serum level.,Oxacillin
DB00716,Aldesleukin may decrease the excretion rate of Nedocromil which could result in a higher serum level.,Nedocromil
DB00722,Aldesleukin may decrease the excretion rate of Lisinopril which could result in a higher serum level.,Lisinopril
DB00730,Aldesleukin may decrease the excretion rate of Thiabendazole which could result in a higher serum level.,Thiabendazole
DB00731,Aldesleukin may decrease the excretion rate of Nateglinide which could result in a higher serum level.,Nateglinide
DB00733,Aldesleukin may decrease the excretion rate of Pralidoxime which could result in a higher serum level.,Pralidoxime
DB00743,Aldesleukin may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,Gadobenic acid
DB00759,Aldesleukin may decrease the excretion rate of Tetracycline which could result in a higher serum level.,Tetracycline
DB00760,Aldesleukin may decrease the excretion rate of Meropenem which could result in a higher serum level.,Meropenem
DB00761,Aldesleukin may decrease the excretion rate of Potassium chloride which could result in a higher serum level.,Potassium chloride
DB00775,Aldesleukin may decrease the excretion rate of Tirofiban which could result in a higher serum level.,Tirofiban
DB00782,Aldesleukin may decrease the excretion rate of Propantheline which could result in a higher serum level.,Propantheline
DB00783,Aldesleukin may decrease the excretion rate of Estradiol which could result in a higher serum level.,Estradiol
DB00789,Aldesleukin may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,Gadopentetic acid
DB00790,Aldesleukin may decrease the excretion rate of Perindopril which could result in a higher serum level.,Perindopril
DB00800,Aldesleukin may decrease the excretion rate of Fenoldopam which could result in a higher serum level.,Fenoldopam
DB00804,Aldesleukin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.,Dicyclomine
DB00806,Aldesleukin may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.,Pentoxifylline
DB00811,Aldesleukin may decrease the excretion rate of Ribavirin which could result in a higher serum level.,Ribavirin
DB00828,Aldesleukin may decrease the excretion rate of Fosfomycin which could result in a higher serum level.,Fosfomycin
DB00829,Aldesleukin may decrease the excretion rate of Diazepam which could result in a higher serum level.,Diazepam
DB00839,Aldesleukin may decrease the excretion rate of Tolazamide which could result in a higher serum level.,Tolazamide
DB00841,Aldesleukin may decrease the excretion rate of Dobutamine which could result in a higher serum level.,Dobutamine
DB00842,Aldesleukin may decrease the excretion rate of Oxazepam which could result in a higher serum level.,Oxazepam
DB00863,Aldesleukin may decrease the excretion rate of Ranitidine which could result in a higher serum level.,Ranitidine
DB00871,Aldesleukin may decrease the excretion rate of Terbutaline which could result in a higher serum level.,Terbutaline
DB00894,Aldesleukin may decrease the excretion rate of Testolactone which could result in a higher serum level.,Testolactone
DB00900,Aldesleukin may decrease the excretion rate of Didanosine which could result in a higher serum level.,Didanosine
DB00911,Aldesleukin may decrease the excretion rate of Tinidazole which could result in a higher serum level.,Tinidazole
DB00915,Aldesleukin may decrease the excretion rate of Amantadine which could result in a higher serum level.,Amantadine
DB00918,Aldesleukin may decrease the excretion rate of Almotriptan which could result in a higher serum level.,Almotriptan
DB00934,Aldesleukin may decrease the excretion rate of Maprotiline which could result in a higher serum level.,Maprotiline
DB00951,Aldesleukin may decrease the excretion rate of Isoniazid which could result in a higher serum level.,Isoniazid
DB00953,Aldesleukin may decrease the excretion rate of Rizatriptan which could result in a higher serum level.,Rizatriptan
DB00960,Aldesleukin may decrease the excretion rate of Pindolol which could result in a higher serum level.,Pindolol
DB00961,Aldesleukin may decrease the excretion rate of Mepivacaine which could result in a higher serum level.,Mepivacaine
DB00962,Aldesleukin may decrease the excretion rate of Zaleplon which could result in a higher serum level.,Zaleplon
DB00968,Aldesleukin may decrease the excretion rate of Methyldopa which could result in a higher serum level.,Methyldopa
DB00980,Aldesleukin may decrease the excretion rate of Ramelteon which could result in a higher serum level.,Ramelteon
DB00988,Aldesleukin may decrease the excretion rate of Dopamine which could result in a higher serum level.,Dopamine
DB00995,Aldesleukin may decrease the excretion rate of Auranofin which could result in a higher serum level.,Auranofin
DB01001,Aldesleukin may decrease the excretion rate of Salbutamol which could result in a higher serum level.,Salbutamol
DB01002,Aldesleukin may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.,Levobupivacaine
DB01004,Aldesleukin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,Ganciclovir
DB01010,Aldesleukin may decrease the excretion rate of Edrophonium which could result in a higher serum level.,Edrophonium
DB01011,Aldesleukin may decrease the excretion rate of Metyrapone which could result in a higher serum level.,Metyrapone
DB01018,Aldesleukin may decrease the excretion rate of Guanfacine which could result in a higher serum level.,Guanfacine
DB01020,Aldesleukin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.,Isosorbide mononitrate
DB01022,Aldesleukin may decrease the excretion rate of Phylloquinone which could result in a higher serum level.,Phylloquinone
DB01032,Aldesleukin may decrease the excretion rate of Probenecid which could result in a higher serum level.,Probenecid
DB01036,Aldesleukin may decrease the excretion rate of Tolterodine which could result in a higher serum level.,Tolterodine
DB01043,Aldesleukin may decrease the excretion rate of Memantine which could result in a higher serum level.,Memantine
DB01046,Aldesleukin may decrease the excretion rate of Lubiprostone which could result in a higher serum level.,Lubiprostone
DB01048,Aldesleukin may decrease the excretion rate of Abacavir which could result in a higher serum level.,Abacavir
DB01060,Aldesleukin may decrease the excretion rate of Amoxicillin which could result in a higher serum level.,Amoxicillin
DB01067,Aldesleukin may decrease the excretion rate of Glipizide which could result in a higher serum level.,Glipizide
DB01068,Aldesleukin may decrease the excretion rate of Clonazepam which could result in a higher serum level.,Clonazepam
DB01069,Aldesleukin may decrease the excretion rate of Promethazine which could result in a higher serum level.,Promethazine
DB01093,Aldesleukin may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.,Dimethyl sulfoxide
DB01105,Aldesleukin may decrease the excretion rate of Sibutramine which could result in a higher serum level.,Sibutramine
DB01115,Aldesleukin may decrease the excretion rate of Nifedipine which could result in a higher serum level.,Nifedipine
DB01124,Aldesleukin may decrease the excretion rate of Tolbutamide which could result in a higher serum level.,Tolbutamide
DB01129,Aldesleukin may decrease the excretion rate of Rabeprazole which could result in a higher serum level.,Rabeprazole
DB01133,Aldesleukin may decrease the excretion rate of Tiludronic acid which could result in a higher serum level.,Tiludronic acid
DB01135,Aldesleukin may decrease the excretion rate of Doxacurium which could result in a higher serum level.,Doxacurium
DB01137,Aldesleukin may decrease the excretion rate of Levofloxacin which could result in a higher serum level.,Levofloxacin
DB01148,Aldesleukin may decrease the excretion rate of Flavoxate which could result in a higher serum level.,Flavoxate
DB01149,Aldesleukin may decrease the excretion rate of Nefazodone which could result in a higher serum level.,Nefazodone
DB01156,Aldesleukin may decrease the excretion rate of Bupropion which could result in a higher serum level.,Bupropion
DB01157,Aldesleukin may decrease the excretion rate of Trimetrexate which could result in a higher serum level.,Trimetrexate
DB01170,Aldesleukin may decrease the excretion rate of Guanethidine which could result in a higher serum level.,Guanethidine
DB01183,Aldesleukin may decrease the excretion rate of Naloxone which could result in a higher serum level.,Naloxone
DB01203,Aldesleukin may decrease the excretion rate of Nadolol which could result in a higher serum level.,Nadolol
DB01205,Aldesleukin may decrease the excretion rate of Flumazenil which could result in a higher serum level.,Flumazenil
DB01213,Aldesleukin may decrease the excretion rate of Fomepizole which could result in a higher serum level.,Fomepizole
DB01215,Aldesleukin may decrease the excretion rate of Estazolam which could result in a higher serum level.,Estazolam
DB01221,Aldesleukin may decrease the excretion rate of Ketamine which could result in a higher serum level.,Ketamine
DB01233,Aldesleukin may decrease the excretion rate of Metoclopramide which could result in a higher serum level.,Metoclopramide
DB01240,Aldesleukin may decrease the excretion rate of Epoprostenol which could result in a higher serum level.,Epoprostenol
DB01241,Aldesleukin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,Gemfibrozil
DB01261,Aldesleukin may decrease the excretion rate of Sitagliptin which could result in a higher serum level.,Sitagliptin
DB01267,Aldesleukin may decrease the excretion rate of Paliperidone which could result in a higher serum level.,Paliperidone
DB01273,Aldesleukin may decrease the excretion rate of Varenicline which could result in a higher serum level.,Varenicline
DB01274,Aldesleukin may decrease the excretion rate of Arformoterol which could result in a higher serum level.,Arformoterol
DB01275,Aldesleukin may decrease the excretion rate of Hydralazine which could result in a higher serum level.,Hydralazine
DB01359,Aldesleukin may decrease the excretion rate of Penbutolol which could result in a higher serum level.,Penbutolol
DB01409,Aldesleukin may decrease the excretion rate of Tiotropium which could result in a higher serum level.,Tiotropium
DB01420,Aldesleukin may decrease the excretion rate of Testosterone propionate which could result in a higher serum level.,Testosterone propionate
DB01427,Aldesleukin may decrease the excretion rate of Amrinone which could result in a higher serum level.,Amrinone
DB01428,Aldesleukin may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,Oxybenzone
DB01550,Aldesleukin may decrease the excretion rate of Fenproporex which could result in a higher serum level.,Fenproporex
DB01558,Aldesleukin may decrease the excretion rate of Bromazepam which could result in a higher serum level.,Bromazepam
DB01563,Aldesleukin may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.,Chloral hydrate
DB01577,Aldesleukin may decrease the excretion rate of Metamfetamine which could result in a higher serum level.,Metamfetamine
DB01587,Aldesleukin may decrease the excretion rate of Ketazolam which could result in a higher serum level.,Ketazolam
DB01610,Aldesleukin may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,Valganciclovir
DB01638,Aldesleukin may decrease the excretion rate of Sorbitol which could result in a higher serum level.,Sorbitol
DB01685,Aldesleukin may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,Topiroxostat
DB04574,Aldesleukin may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.,Estrone sulfate
DB04871,Aldesleukin may decrease the excretion rate of Lorcaserin which could result in a higher serum level.,Lorcaserin
DB04895,Aldesleukin may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,Pegaptanib
DB04896,Aldesleukin may decrease the excretion rate of Milnacipran which could result in a higher serum level.,Milnacipran
DB04920,Aldesleukin may decrease the excretion rate of Clevidipine which could result in a higher serum level.,Clevidipine
DB04948,Aldesleukin may decrease the excretion rate of Lofexidine which could result in a higher serum level.,Lofexidine
DB04953,Aldesleukin may decrease the excretion rate of Ezogabine which could result in a higher serum level.,Ezogabine
DB05018,Aldesleukin may decrease the excretion rate of Migalastat which could result in a higher serum level.,Migalastat
DB05541,Aldesleukin may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,Brivaracetam
DB06154,Aldesleukin may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,Pentaerythritol tetranitrate
DB06186,Aldesleukin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,Ipilimumab
DB06196,Aldesleukin may decrease the excretion rate of Icatibant which could result in a higher serum level.,Icatibant
DB06203,Aldesleukin may decrease the excretion rate of Alogliptin which could result in a higher serum level.,Alogliptin
DB06209,Aldesleukin may decrease the excretion rate of Prasugrel which could result in a higher serum level.,Prasugrel
DB06211,Aldesleukin may decrease the excretion rate of Doripenem which could result in a higher serum level.,Doripenem
DB06230,Aldesleukin may decrease the excretion rate of Nalmefene which could result in a higher serum level.,Nalmefene
DB06262,Aldesleukin may decrease the excretion rate of Droxidopa which could result in a higher serum level.,Droxidopa
DB06282,Aldesleukin may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,Levocetirizine
DB06335,Aldesleukin may decrease the excretion rate of Saxagliptin which could result in a higher serum level.,Saxagliptin
DB06402,Aldesleukin may decrease the excretion rate of Telavancin which could result in a higher serum level.,Telavancin
DB06623,Aldesleukin may decrease the excretion rate of Flupirtine which could result in a higher serum level.,Flupirtine
DB06637,Aldesleukin may decrease the excretion rate of Dalfampridine which could result in a higher serum level.,Dalfampridine
DB06695,Aldesleukin may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.,Dabigatran etexilate
DB06700,Aldesleukin may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.,Desvenlafaxine
DB06702,Aldesleukin may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,Fesoterodine
DB06705,Aldesleukin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,Gadofosveset trisodium
DB06710,Aldesleukin may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,Methyltestosterone
DB06767,Aldesleukin may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.,Ammonium chloride
DB06782,Aldesleukin may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,Dimercaprol
DB06796,Aldesleukin may decrease the excretion rate of Mangafodipir which could result in a higher serum level.,Mangafodipir
DB06800,Aldesleukin may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,Methylnaltrexone
DB06809,Aldesleukin may decrease the excretion rate of Plerixafor which could result in a higher serum level.,Plerixafor
DB06823,Aldesleukin may decrease the excretion rate of Tiopronin which could result in a higher serum level.,Tiopronin
DB06824,Aldesleukin may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,Triethylenetetramine
DB08824,Aldesleukin may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.,Ioflupane I-123
DB08826,Aldesleukin may decrease the excretion rate of Deferiprone which could result in a higher serum level.,Deferiprone
DB08840,Aldesleukin may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,N-methylnicotinamide
DB08872,Aldesleukin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,Gabapentin enacarbil
DB08893,Aldesleukin may decrease the excretion rate of Mirabegron which could result in a higher serum level.,Mirabegron
DB08897,Aldesleukin may decrease the excretion rate of Aclidinium which could result in a higher serum level.,Aclidinium
DB08899,Aldesleukin may decrease the excretion rate of Enzalutamide which could result in a higher serum level.,Enzalutamide
DB08900,Aldesleukin may decrease the excretion rate of Teduglutide which could result in a higher serum level.,Teduglutide
DB08905,Aldesleukin may decrease the excretion rate of Formestane which could result in a higher serum level.,Formestane
DB08909,Aldesleukin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,Glycerol phenylbutyrate
DB08911,Aldesleukin may decrease the excretion rate of Trametinib which could result in a higher serum level.,Trametinib
DB08918,Aldesleukin may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.,Levomilnacipran
DB08932,Aldesleukin may decrease the excretion rate of Macitentan which could result in a higher serum level.,Macitentan
DB08934,Aldesleukin may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.,Sofosbuvir
DB08964,Aldesleukin may decrease the excretion rate of Gemeprost which could result in a higher serum level.,Gemeprost
DB09027,Aldesleukin may decrease the excretion rate of Ledipasvir which could result in a higher serum level.,Ledipasvir
DB09050,Aldesleukin may decrease the excretion rate of Ceftolozane which could result in a higher serum level.,Ceftolozane
DB09066,Aldesleukin may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.,Corifollitropin alfa
DB09068,Aldesleukin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,Vortioxetine
DB09075,Aldesleukin may decrease the excretion rate of Edoxaban which could result in a higher serum level.,Edoxaban
DB09081,Aldesleukin may decrease the excretion rate of Idebenone which could result in a higher serum level.,Idebenone
DB09089,Aldesleukin may decrease the excretion rate of Trimebutine which could result in a higher serum level.,Trimebutine
DB09103,Aldesleukin may decrease the excretion rate of Ancestim which could result in a higher serum level.,Ancestim
DB09104,Aldesleukin may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.,Magnesium hydroxide
DB09106,Aldesleukin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,Hydroxyethyl Starch
DB09111,Aldesleukin may decrease the excretion rate of Pentastarch which could result in a higher serum level.,Pentastarch
DB09118,Aldesleukin may decrease the excretion rate of Stiripentol which could result in a higher serum level.,Stiripentol
DB09121,Aldesleukin may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.,Aurothioglucose
DB09123,Aldesleukin may decrease the excretion rate of Dienogest which could result in a higher serum level.,Dienogest
DB09129,Aldesleukin may decrease the excretion rate of Chromic chloride which could result in a higher serum level.,Chromic chloride
DB09132,Aldesleukin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,Gadoteric acid
DB09133,Aldesleukin may decrease the excretion rate of Iothalamic acid which could result in a higher serum level.,Iothalamic acid
DB09136,Aldesleukin may decrease the excretion rate of Isosulfan blue which could result in a higher serum level.,Isosulfan blue
DB09137,Aldesleukin may decrease the excretion rate of Technetium Tc-99m mebrofenin which could result in a higher serum level.,Technetium Tc-99m mebrofenin
DB09139,Aldesleukin may decrease the excretion rate of Technetium Tc-99m oxidronate which could result in a higher serum level.,Technetium Tc-99m oxidronate
DB09148,Aldesleukin may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.,Florbetaben (18F)
DB09149,Aldesleukin may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.,Florbetapir (18F)
DB09163,Aldesleukin may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.,Technetium Tc-99m exametazime
DB09165,Aldesleukin may decrease the excretion rate of Technetium Tc-99m pyrophosphate which could result in a higher serum level.,Technetium Tc-99m pyrophosphate
DB09185,Aldesleukin may decrease the excretion rate of Viloxazine which could result in a higher serum level.,Viloxazine
DB09194,Aldesleukin may decrease the excretion rate of Etoperidone which could result in a higher serum level.,Etoperidone
DB09195,Aldesleukin may decrease the excretion rate of Lorpiprazole which could result in a higher serum level.,Lorpiprazole
DB09204,Aldesleukin may decrease the excretion rate of Arotinolol which could result in a higher serum level.,Arotinolol
DB09205,Aldesleukin may decrease the excretion rate of Moxisylyte which could result in a higher serum level.,Moxisylyte
DB09209,Aldesleukin may decrease the excretion rate of Pholcodine which could result in a higher serum level.,Pholcodine
DB09210,Aldesleukin may decrease the excretion rate of Piracetam which could result in a higher serum level.,Piracetam
DB09219,Aldesleukin may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,Bisoxatin
DB09223,Aldesleukin may decrease the excretion rate of Blonanserin which could result in a higher serum level.,Blonanserin
DB09224,Aldesleukin may decrease the excretion rate of Melperone which could result in a higher serum level.,Melperone
DB09255,Aldesleukin may decrease the excretion rate of Dextran which could result in a higher serum level.,Dextran
DB09256,Aldesleukin may decrease the excretion rate of Tegafur which could result in a higher serum level.,Tegafur
DB09257,Aldesleukin may decrease the excretion rate of Gimeracil which could result in a higher serum level.,Gimeracil
DB09262,Aldesleukin may decrease the excretion rate of Imidafenacin which could result in a higher serum level.,Imidafenacin
DB09264,Aldesleukin may decrease the excretion rate of Idarucizumab which could result in a higher serum level.,Idarucizumab
DB09265,Aldesleukin may decrease the excretion rate of Lixisenatide which could result in a higher serum level.,Lixisenatide
DB09268,Aldesleukin may decrease the excretion rate of Picosulfuric acid which could result in a higher serum level.,Picosulfuric acid
DB09276,Aldesleukin may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.,Sodium aurothiomalate
DB09277,Aldesleukin may decrease the excretion rate of Choline C 11 which could result in a higher serum level.,Choline C 11
DB09281,Aldesleukin may decrease the excretion rate of Magnesium trisilicate which could result in a higher serum level.,Magnesium trisilicate
DB09292,Aldesleukin may decrease the excretion rate of Sacubitril which could result in a higher serum level.,Sacubitril
DB09301,Aldesleukin may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.,Chondroitin sulfate
DB09317,"Aldesleukin may decrease the excretion rate of Synthetic Conjugated Estrogens, A which could result in a higher serum level.","Synthetic Conjugated Estrogens, A"
DB09318,"Aldesleukin may decrease the excretion rate of Synthetic Conjugated Estrogens, B which could result in a higher serum level.","Synthetic Conjugated Estrogens, B"
DB09320,Aldesleukin may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.,Procaine benzylpenicillin
DB09324,Aldesleukin may decrease the excretion rate of Sulbactam which could result in a higher serum level.,Sulbactam
DB09325,Aldesleukin may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.,Sodium fluoride
DB09329,"Aldesleukin may decrease the excretion rate of Antihemophilic Factor (Recombinant), PEGylated which could result in a higher serum level.","Antihemophilic Factor (Recombinant), PEGylated"
DB09344,Aldesleukin may decrease the excretion rate of Invert sugar which could result in a higher serum level.,Invert sugar
DB09357,Aldesleukin may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.,Dexpanthenol
DB09394,Aldesleukin may decrease the excretion rate of Phosphoric acid which could result in a higher serum level.,Phosphoric acid
DB09395,Aldesleukin may decrease the excretion rate of Sodium acetate which could result in a higher serum level.,Sodium acetate
DB09407,Aldesleukin may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.,Magnesium chloride
DB09472,Aldesleukin may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.,Sodium sulfate
DB09477,Aldesleukin may decrease the excretion rate of Enalaprilat which could result in a higher serum level.,Enalaprilat
DB09481,Aldesleukin may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.,Magnesium carbonate
DB09488,Aldesleukin may decrease the excretion rate of Acrivastine which could result in a higher serum level.,Acrivastine
DB09496,Aldesleukin may decrease the excretion rate of Octinoxate which could result in a higher serum level.,Octinoxate
DB09502,Aldesleukin may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.,Fludeoxyglucose (18F)
DB09546,Aldesleukin may decrease the excretion rate of Iobenguane sulfate I-123 which could result in a higher serum level.,Iobenguane sulfate I-123
DB11077,Aldesleukin may decrease the excretion rate of Polyethylene glycol 400 which could result in a higher serum level.,Polyethylene glycol 400
DB11090,Aldesleukin may decrease the excretion rate of Potassium nitrate which could result in a higher serum level.,Potassium nitrate
DB11098,Aldesleukin may decrease the excretion rate of Potassium bicarbonate which could result in a higher serum level.,Potassium bicarbonate
DB11102,Aldesleukin may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.,N-acetyltyrosine
DB11114,Aldesleukin may decrease the excretion rate of Eucalyptus oil which could result in a higher serum level.,Eucalyptus oil
DB11127,Aldesleukin may decrease the excretion rate of Selenious acid which could result in a higher serum level.,Selenious acid
DB11130,Aldesleukin may decrease the excretion rate of Opium which could result in a higher serum level.,Opium
DB11135,Aldesleukin may decrease the excretion rate of Selenium which could result in a higher serum level.,Selenium
DB11136,Aldesleukin may decrease the excretion rate of Chromium which could result in a higher serum level.,Chromium
DB11145,Aldesleukin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,Oxyquinoline
DB11156,Aldesleukin may decrease the excretion rate of Pyrantel which could result in a higher serum level.,Pyrantel
DB11164,Aldesleukin may decrease the excretion rate of Bicisate which could result in a higher serum level.,Bicisate
DB11251,Aldesleukin may decrease the excretion rate of Tocopherol which could result in a higher serum level.,Tocopherol
DB11278,Aldesleukin may decrease the excretion rate of DL-Methylephedrine which could result in a higher serum level.,DL-Methylephedrine
DB11328,Aldesleukin may decrease the excretion rate of Tetradecyl hydrogen sulfate (ester) which could result in a higher serum level.,Tetradecyl hydrogen sulfate (ester)
DB11338,Aldesleukin may decrease the excretion rate of Clove oil which could result in a higher serum level.,Clove oil
DB11358,Aldesleukin may decrease the excretion rate of Evening primrose oil which could result in a higher serum level.,Evening primrose oil
DB11364,Aldesleukin may decrease the excretion rate of Pidotimod which could result in a higher serum level.,Pidotimod
DB11560,Aldesleukin may decrease the excretion rate of Lesinurad which could result in a higher serum level.,Lesinurad
DB11577,Aldesleukin may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.,Indigotindisulfonic acid
DB11587,Aldesleukin may decrease the excretion rate of Etafedrine which could result in a higher serum level.,Etafedrine
DB11598,Aldesleukin may decrease the excretion rate of Antithrombin III human which could result in a higher serum level.,Antithrombin III human
DB11642,Aldesleukin may decrease the excretion rate of Pitolisant which could result in a higher serum level.,Pitolisant
DB11691,Aldesleukin may decrease the excretion rate of Naldemedine which could result in a higher serum level.,Naldemedine
DB11699,Aldesleukin may decrease the excretion rate of Tropisetron which could result in a higher serum level.,Tropisetron
DB11901,Aldesleukin may decrease the excretion rate of Apalutamide which could result in a higher serum level.,Apalutamide
DB11915,Aldesleukin may decrease the excretion rate of Valbenazine which could result in a higher serum level.,Valbenazine
DB11943,Aldesleukin may decrease the excretion rate of Delafloxacin which could result in a higher serum level.,Delafloxacin
DB11989,Aldesleukin may decrease the excretion rate of Benznidazole which could result in a higher serum level.,Benznidazole
DB12007,Aldesleukin may decrease the excretion rate of Isoflavone which could result in a higher serum level.,Isoflavone
DB12107,Aldesleukin may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,Vaborbactam
DB12161,Aldesleukin may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.,Deutetrabenazine
DB12278,Aldesleukin may decrease the excretion rate of Propiverine which could result in a higher serum level.,Propiverine
DB12783,Aldesleukin may decrease the excretion rate of Benserazide which could result in a higher serum level.,Benserazide
DB13025,Aldesleukin may decrease the excretion rate of Tiapride which could result in a higher serum level.,Tiapride
DB13139,Aldesleukin may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,Levosalbutamol
DB13156,Aldesleukin may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.,Inosine pranobex
DB13178,Aldesleukin may decrease the excretion rate of Inositol which could result in a higher serum level.,Inositol
DB13185,Aldesleukin may decrease the excretion rate of Oxabolone cipionate which could result in a higher serum level.,Oxabolone cipionate
DB13191,Aldesleukin may decrease the excretion rate of Phosphocreatine which could result in a higher serum level.,Phosphocreatine
DB13269,Aldesleukin may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.,Dichlorobenzyl alcohol
DB13293,Aldesleukin may decrease the excretion rate of Ipecac which could result in a higher serum level.,Ipecac
DB13595,Aldesleukin may decrease the excretion rate of Almasilate which could result in a higher serum level.,Almasilate
DB13873,Aldesleukin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.,Fenofibric acid
DB13884,Aldesleukin may decrease the excretion rate of Albutrepenonacog alfa which could result in a higher serum level.,Albutrepenonacog alfa
DB13909,Aldesleukin may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,Bismuth subgallate
DB13943,Aldesleukin may decrease the excretion rate of Testosterone cypionate which could result in a higher serum level.,Testosterone cypionate
DB13944,Aldesleukin may decrease the excretion rate of Testosterone enanthate which could result in a higher serum level.,Testosterone enanthate
DB13946,Aldesleukin may decrease the excretion rate of Testosterone undecanoate which could result in a higher serum level.,Testosterone undecanoate
DB13952,Aldesleukin may decrease the excretion rate of Estradiol acetate which could result in a higher serum level.,Estradiol acetate
DB13954,Aldesleukin may decrease the excretion rate of Estradiol cypionate which could result in a higher serum level.,Estradiol cypionate
DB13955,Aldesleukin may decrease the excretion rate of Estradiol dienanthate which could result in a higher serum level.,Estradiol dienanthate
DB13956,Aldesleukin may decrease the excretion rate of Estradiol valerate which could result in a higher serum level.,Estradiol valerate
DB13967,Aldesleukin may decrease the excretion rate of Patent Blue which could result in a higher serum level.,Patent Blue
DB14006,Aldesleukin may decrease the excretion rate of Choline salicylate which could result in a higher serum level.,Choline salicylate
DB14007,Aldesleukin may decrease the excretion rate of Pentetic acid which could result in a higher serum level.,Pentetic acid
DB14498,Aldesleukin may decrease the excretion rate of Potassium acetate which could result in a higher serum level.,Potassium acetate
DB14499,Aldesleukin may decrease the excretion rate of Potassium sulfate which could result in a higher serum level.,Potassium sulfate
DB14526,Aldesleukin may decrease the excretion rate of Chromic citrate which could result in a higher serum level.,Chromic citrate
DB14527,Aldesleukin may decrease the excretion rate of Chromic nitrate which could result in a higher serum level.,Chromic nitrate
DB14528,Aldesleukin may decrease the excretion rate of Chromium gluconate which could result in a higher serum level.,Chromium gluconate
DB14529,Aldesleukin may decrease the excretion rate of Chromium nicotinate which could result in a higher serum level.,Chromium nicotinate
DB14530,Aldesleukin may decrease the excretion rate of Chromous sulfate which could result in a higher serum level.,Chromous sulfate
DB14754,Aldesleukin may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,Solriamfetol
DB06815,Aldesleukin may decrease the excretion rate of Pyrithione which could result in a higher serum level.,Pyrithione
DB11121,Aldesleukin may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.,Chloroxylenol
DB11085,Aldesleukin may decrease the excretion rate of Resorcinol which could result in a higher serum level.,Resorcinol
DB01224,Aldesleukin may decrease the excretion rate of Quetiapine which could result in a higher serum level.,Quetiapine
DB00501,Aldesleukin may decrease the excretion rate of Cimetidine which could result in a higher serum level.,Cimetidine
DB15593,Aldesleukin may decrease the excretion rate of Golodirsen which could result in a higher serum level.,Golodirsen
DB00321,Aldesleukin may decrease the excretion rate of Amitriptyline which could result in a higher serum level.,Amitriptyline
DB00458,Aldesleukin may decrease the excretion rate of Imipramine which could result in a higher serum level.,Imipramine
DB00490,Aldesleukin may decrease the excretion rate of Buspirone which could result in a higher serum level.,Buspirone
DB00820,Aldesleukin may decrease the excretion rate of Tadalafil which could result in a higher serum level.,Tadalafil
DB01142,Aldesleukin may decrease the excretion rate of Doxepin which could result in a higher serum level.,Doxepin
DB00318,Aldesleukin may decrease the excretion rate of Codeine which could result in a higher serum level.,Codeine
DB00879,Aldesleukin may decrease the excretion rate of Emtricitabine which could result in a higher serum level.,Emtricitabine
DB00897,Aldesleukin may decrease the excretion rate of Triazolam which could result in a higher serum level.,Triazolam
DB06228,Aldesleukin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.,Rivaroxaban
DB08996,Aldesleukin may decrease the excretion rate of Dimetacrine which could result in a higher serum level.,Dimetacrine
DB14506,Aldesleukin may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level.,Lithium hydroxide
DB00452,Framycetin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Framycetin
DB00479,Amikacin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Amikacin
DB00684,Tobramycin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Tobramycin
DB00798,Gentamicin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Gentamicin
DB00955,Netilmicin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Netilmicin
DB00994,Neomycin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Neomycin
DB01082,Streptomycin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Streptomycin
DB01172,Kanamycin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Kanamycin
DB01421,Paromomycin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Paromomycin
DB03615,Ribostamycin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Ribostamycin
DB04263,Geneticin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Geneticin
DB04626,Apramycin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Apramycin
DB04729,Gentamicin C1a may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Gentamicin C1a
DB04808,Neamine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Neamine
DB06696,Arbekacin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Arbekacin
DB08437,Puromycin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Puromycin
DB11512,Dihydrostreptomycin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Dihydrostreptomycin
DB11520,Hygromycin B may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Hygromycin B
DB12604,Sisomicin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Sisomicin
DB13270,Dibekacin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Dibekacin
DB13274,Micronomicin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Micronomicin
DB13540,Isepamicin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Isepamicin
DB13673,Bekanamycin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.,Bekanamycin
DB13145,Aldesleukin may decrease the excretion rate of Nedaplatin which could result in a higher serum level.,Nedaplatin
DB00314,Aldesleukin may decrease the excretion rate of Capreomycin which could result in a higher serum level.,Capreomycin
DB00390,Aldesleukin may decrease the excretion rate of Digoxin which could result in a higher serum level.,Digoxin
DB00512,Aldesleukin may decrease the excretion rate of Vancomycin which could result in a higher serum level.,Vancomycin
DB00982,Aldesleukin may decrease the excretion rate of Isotretinoin which could result in a higher serum level.,Isotretinoin
DB01035,Aldesleukin may decrease the excretion rate of Procainamide which could result in a higher serum level.,Procainamide
DB12615,Aldesleukin may decrease the excretion rate of Plazomicin which could result in a higher serum level.,Plazomicin
DB14509,Aldesleukin may decrease the excretion rate of Lithium carbonate which could result in a higher serum level.,Lithium carbonate
DB00232,Aldesleukin may increase the excretion rate of Methyclothiazide which could result in a lower serum level and potentially a reduction in efficacy.,Methyclothiazide
DB00421,Aldesleukin may increase the excretion rate of Spironolactone which could result in a lower serum level and potentially a reduction in efficacy.,Spironolactone
DB00594,Aldesleukin may increase the excretion rate of Amiloride which could result in a lower serum level and potentially a reduction in efficacy.,Amiloride
DB00703,Aldesleukin may increase the excretion rate of Methazolamide which could result in a lower serum level and potentially a reduction in efficacy.,Methazolamide
DB01144,Aldesleukin may increase the excretion rate of Diclofenamide which could result in a lower serum level and potentially a reduction in efficacy.,Diclofenamide
DB09125,Potassium citrate may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Potassium citrate
DB00562,Benzthiazide may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Benzthiazide
DB13430,Mebutizide may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Mebutizide
DB00214,Aldesleukin may increase the excretion rate of Torasemide which could result in a lower serum level and potentially a reduction in efficacy.,Torasemide
DB00310,Aldesleukin may increase the excretion rate of Chlorthalidone which could result in a lower serum level and potentially a reduction in efficacy.,Chlorthalidone
DB00436,Aldesleukin may increase the excretion rate of Bendroflumethiazide which could result in a lower serum level and potentially a reduction in efficacy.,Bendroflumethiazide
DB00606,Aldesleukin may increase the excretion rate of Cyclothiazide which could result in a lower serum level and potentially a reduction in efficacy.,Cyclothiazide
DB00774,Aldesleukin may increase the excretion rate of Hydroflumethiazide which could result in a lower serum level and potentially a reduction in efficacy.,Hydroflumethiazide
DB00880,Aldesleukin may increase the excretion rate of Chlorothiazide which could result in a lower serum level and potentially a reduction in efficacy.,Chlorothiazide
DB01021,Aldesleukin may increase the excretion rate of Trichlormethiazide which could result in a lower serum level and potentially a reduction in efficacy.,Trichlormethiazide
DB01119,Aldesleukin may increase the excretion rate of Diazoxide which could result in a lower serum level and potentially a reduction in efficacy.,Diazoxide
DB01324,Aldesleukin may increase the excretion rate of Polythiazide which could result in a lower serum level and potentially a reduction in efficacy.,Polythiazide
DB04831,Aldesleukin may increase the excretion rate of Tienilic acid which could result in a lower serum level and potentially a reduction in efficacy.,Tienilic acid
DB12766,Aldesleukin may increase the excretion rate of Cicletanine which could result in a lower serum level and potentially a reduction in efficacy.,Cicletanine
DB13532,Aldesleukin may increase the excretion rate of Cyclopenthiazide which could result in a lower serum level and potentially a reduction in efficacy.,Cyclopenthiazide
DB13801,Aldesleukin may increase the excretion rate of Muzolimine which could result in a lower serum level and potentially a reduction in efficacy.,Muzolimine
DB13803,Aldesleukin may increase the excretion rate of Xipamide which could result in a lower serum level and potentially a reduction in efficacy.,Xipamide
DB00524,Aldesleukin may increase the excretion rate of Metolazone which could result in a lower serum level and potentially a reduction in efficacy.,Metolazone
DB00695,Aldesleukin may increase the excretion rate of Furosemide which could result in a lower serum level and potentially a reduction in efficacy.,Furosemide
DB00808,Aldesleukin may increase the excretion rate of Indapamide which could result in a lower serum level and potentially a reduction in efficacy.,Indapamide
DB00887,Aldesleukin may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.,Bumetanide
DB00909,Aldesleukin may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy.,Zonisamide
DB08907,Aldesleukin may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.,Canagliflozin
DB09338,Aldesleukin may increase the excretion rate of Mersalyl which could result in a lower serum level and potentially a reduction in efficacy.,Mersalyl
DB00311,Ethoxzolamide may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Ethoxzolamide
DB00819,Acetazolamide may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Acetazolamide
DB01325,Quinethazone may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Quinethazone
DB01412,Theobromine may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Theobromine
DB02925,Piretanide may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Piretanide
DB05034,Ularitide may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Ularitide
DB06370,Indisulam may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Indisulam
DB08961,Azosemide may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Azosemide
DB09015,Canrenoic acid may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Canrenoic acid
DB09401,Isosorbide may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Isosorbide
DB11827,Ertugliflozin may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Ertugliflozin
DB12221,Canrenone may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Canrenone
DB12670,Rolofylline may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Rolofylline
DB12704,Spiradoline may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Spiradoline
DB13284,Meticrane may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Meticrane
DB13316,Ibopamine may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Ibopamine
DB13405,Mefruside may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Mefruside
DB13617,Clorexolone may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Clorexolone
DB13663,Clofenamide may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Clofenamide
DB13708,Fenquizone may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Fenquizone
DB13792,Clopamide may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Clopamide
DB13989,Epitizide may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Epitizide
DB14018,Bromotheophylline may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Bromotheophylline
DB14500,Potassium may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Potassium
DB09235,Aldesleukin may increase the excretion rate of Efonidipine which could result in a lower serum level and potentially a reduction in efficacy.,Efonidipine
DB06292,Dapagliflozin may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Dapagliflozin
DB00700,Aldesleukin may increase the excretion rate of Eplerenone which could result in a lower serum level and potentially a reduction in efficacy.,Eplerenone
DB00872,Aldesleukin may increase the excretion rate of Conivaptan which could result in a lower serum level and potentially a reduction in efficacy.,Conivaptan
DB06212,Tolvaptan may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.,Tolvaptan
DB00228,The metabolism of Enflurane can be decreased when combined with Aldesleukin.,Enflurane
DB00347,The metabolism of Trimethadione can be decreased when combined with Aldesleukin.,Trimethadione
DB00753,The metabolism of Isoflurane can be decreased when combined with Aldesleukin.,Isoflurane
DB01028,The metabolism of Methoxyflurane can be decreased when combined with Aldesleukin.,Methoxyflurane
DB01159,The metabolism of Halothane can be decreased when combined with Aldesleukin.,Halothane
DB01236,The metabolism of Sevoflurane can be decreased when combined with Aldesleukin.,Sevoflurane
DB06712,The metabolism of Nilvadipine can be decreased when combined with Aldesleukin.,Nilvadipine
DB06728,The metabolism of Aniline can be decreased when combined with Aldesleukin.,Aniline
DB06770,The metabolism of Benzyl alcohol can be decreased when combined with Aldesleukin.,Benzyl alcohol
DB00356,The metabolism of Chlorzoxazone can be decreased when combined with Aldesleukin.,Chlorzoxazone
DB00949,The metabolism of Felbamate can be decreased when combined with Aldesleukin.,Felbamate
DB01136,The metabolism of Carvedilol can be decreased when combined with Aldesleukin.,Carvedilol
DB06119,The metabolism of Cenobamate can be decreased when combined with Aldesleukin.,Cenobamate
DB00252,The metabolism of Phenytoin can be decreased when combined with Aldesleukin.,Phenytoin
DB00593,The metabolism of Ethosuximide can be decreased when combined with Aldesleukin.,Ethosuximide
DB11689,The metabolism of Selumetinib can be decreased when combined with Aldesleukin.,Selumetinib
DB00908,The metabolism of Quinidine can be decreased when combined with Aldesleukin.,Quinidine
DB00001,The risk or severity of bleeding can be increased when Lepirudin is combined with Aldesleukin.,Lepirudin
DB00006,The risk or severity of bleeding can be increased when Bivalirudin is combined with Aldesleukin.,Bivalirudin
DB00009,The risk or severity of bleeding can be increased when Alteplase is combined with Aldesleukin.,Alteplase
DB00013,The risk or severity of bleeding can be increased when Urokinase is combined with Aldesleukin.,Urokinase
DB00015,The risk or severity of bleeding can be increased when Reteplase is combined with Aldesleukin.,Reteplase
DB00029,The risk or severity of bleeding can be increased when Anistreplase is combined with Aldesleukin.,Anistreplase
DB00031,The risk or severity of bleeding can be increased when Tenecteplase is combined with Aldesleukin.,Tenecteplase
DB00055,The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Aldesleukin.,Drotrecogin alfa
DB00266,The risk or severity of bleeding can be increased when Dicoumarol is combined with Aldesleukin.,Dicoumarol
DB00407,The risk or severity of bleeding can be increased when Ardeparin is combined with Aldesleukin.,Ardeparin
DB00498,The risk or severity of bleeding can be increased when Phenindione is combined with Aldesleukin.,Phenindione
DB00686,The risk or severity of bleeding can be increased when Pentosan polysulfate is combined with Aldesleukin.,Pentosan polysulfate
DB01109,The risk or severity of bleeding can be increased when Heparin is combined with Aldesleukin.,Heparin
DB01225,The risk or severity of bleeding can be increased when Enoxaparin is combined with Aldesleukin.,Enoxaparin
DB04665,The risk or severity of bleeding can be increased when Coumarin is combined with Aldesleukin.,Coumarin
DB04898,The risk or severity of bleeding can be increased when Ximelagatran is combined with Aldesleukin.,Ximelagatran
DB04925,The risk or severity of bleeding can be increased when Desmoteplase is combined with Aldesleukin.,Desmoteplase
DB05099,The risk or severity of bleeding can be increased when Ancrod is combined with Aldesleukin.,Ancrod
DB05254,The risk or severity of bleeding can be increased when Fibrinolysin is combined with Aldesleukin.,Fibrinolysin
DB06271,The risk or severity of bleeding can be increased when Sulodexide is combined with Aldesleukin.,Sulodexide
DB06294,The risk or severity of bleeding can be increased when Semuloparin is combined with Aldesleukin.,Semuloparin
DB06406,The risk or severity of bleeding can be increased when Idraparinux is combined with Aldesleukin.,Idraparinux
DB06543,The risk or severity of bleeding can be increased when Astaxanthin is combined with Aldesleukin.,Astaxanthin
DB06635,The risk or severity of bleeding can be increased when Otamixaban is combined with Aldesleukin.,Otamixaban
DB06679,The risk or severity of bleeding can be increased when Amediplase is combined with Aldesleukin.,Amediplase
DB06754,The risk or severity of bleeding can be increased when Danaparoid is combined with Aldesleukin.,Danaparoid
DB06779,The risk or severity of bleeding can be increased when Dalteparin is combined with Aldesleukin.,Dalteparin
DB06822,The risk or severity of bleeding can be increased when Tinzaparin is combined with Aldesleukin.,Tinzaparin
DB08813,The risk or severity of bleeding can be increased when Nadroparin is combined with Aldesleukin.,Nadroparin
DB08994,The risk or severity of bleeding can be increased when Ditazole is combined with Aldesleukin.,Ditazole
DB09154,The risk or severity of bleeding can be increased when Sodium citrate is combined with Aldesleukin.,Sodium citrate
DB09258,The risk or severity of bleeding can be increased when Bemiparin is combined with Aldesleukin.,Bemiparin
DB09259,The risk or severity of bleeding can be increased when Reviparin is combined with Aldesleukin.,Reviparin
DB09260,The risk or severity of bleeding can be increased when Parnaparin is combined with Aldesleukin.,Parnaparin
DB09261,The risk or severity of bleeding can be increased when Certoparin is combined with Aldesleukin.,Certoparin
DB11095,The risk or severity of bleeding can be increased when Desirudin is combined with Aldesleukin.,Desirudin
DB11154,The risk or severity of bleeding can be increased when Zinc citrate is combined with Aldesleukin.,Zinc citrate
DB11166,The risk or severity of bleeding can be increased when Antithrombin Alfa is combined with Aldesleukin.,Antithrombin Alfa
DB11312,The risk or severity of bleeding can be increased when Protein C is combined with Aldesleukin.,Protein C
DB11984,The risk or severity of bleeding can be increased when Letaxaban is combined with Aldesleukin.,Letaxaban
DB12289,The risk or severity of bleeding can be increased when Darexaban is combined with Aldesleukin.,Darexaban
DB12364,The risk or severity of bleeding can be increased when Betrixaban is combined with Aldesleukin.,Betrixaban
DB12598,The risk or severity of bleeding can be increased when Nafamostat is combined with Aldesleukin.,Nafamostat
DB12726,The risk or severity of bleeding can be increased when Monteplase is combined with Aldesleukin.,Monteplase
DB12831,The risk or severity of bleeding can be increased when Gabexate is combined with Aldesleukin.,Gabexate
DB13149,The risk or severity of bleeding can be increased when Protein S human is combined with Aldesleukin.,Protein S human
DB13199,The risk or severity of bleeding can be increased when Brinase is combined with Aldesleukin.,Brinase
DB13451,The risk or severity of bleeding can be increased when Tioclomarol is combined with Aldesleukin.,Tioclomarol
DB13616,The risk or severity of bleeding can be increased when Melagatran is combined with Aldesleukin.,Melagatran
DB13646,The risk or severity of bleeding can be increased when Saruplase is combined with Aldesleukin.,Saruplase
DB14598,The risk or severity of bleeding can be increased when Edetate calcium disodium anhydrous is combined with Aldesleukin.,Edetate calcium disodium anhydrous
DB14726,The risk or severity of bleeding can be increased when Dabigatran is combined with Aldesleukin.,Dabigatran
DB07767,The risk or severity of bleeding can be increased when Aldesleukin is combined with Ferulic acid.,Ferulic acid
DB14094,The risk or severity of bleeding can be increased when Aldesleukin is combined with Tocopherylquinone.,Tocopherylquinone
DB00278,The risk or severity of bleeding can be increased when Argatroban is combined with Aldesleukin.,Argatroban
DB06605,The risk or severity of bleeding can be increased when Apixaban is combined with Aldesleukin.,Apixaban
DB08794,The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Aldesleukin.,Ethyl biscoumacetate
DB13347,The risk or severity of bleeding can be increased when Diphenadione is combined with Aldesleukin.,Diphenadione
DB09042,The risk or severity of myelosuppression can be increased when Aldesleukin is combined with Tedizolid phosphate.,Tedizolid phosphate
DB06480,The metabolism of Prucalopride can be decreased when combined with Aldesleukin.,Prucalopride
DB00091,Aldesleukin may increase the immunosuppressive activities of Cyclosporine.,Cyclosporine
DB00115,The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Aldesleukin.,Cyanocobalamin
DB00017,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Aldesleukin.,Salmon calcitonin
DB00024,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Aldesleukin.,Thyrotropin alfa
DB00066,The therapeutic efficacy of Follitropin can be decreased when used in combination with Aldesleukin.,Follitropin
DB00279,The therapeutic efficacy of Liothyronine can be decreased when used in combination with Aldesleukin.,Liothyronine
DB00389,The therapeutic efficacy of Carbimazole can be decreased when used in combination with Aldesleukin.,Carbimazole
DB00451,The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Aldesleukin.,Levothyroxine
DB00550,The therapeutic efficacy of Propylthiouracil can be decreased when used in combination with Aldesleukin.,Propylthiouracil
DB00763,The therapeutic efficacy of Methimazole can be decreased when used in combination with Aldesleukin.,Methimazole
DB01583,The therapeutic efficacy of Liotrix can be decreased when used in combination with Aldesleukin.,Liotrix
DB03374,"The therapeutic efficacy of 3,5-Diiodotyrosine can be decreased when used in combination with Aldesleukin.","3,5-Diiodotyrosine"
DB03604,The therapeutic efficacy of Tiratricol can be decreased when used in combination with Aldesleukin.,Tiratricol
DB05084,The therapeutic efficacy of Abaloparatide can be decreased when used in combination with Aldesleukin.,Abaloparatide
DB05829,The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Aldesleukin.,Parathyroid hormone
DB06285,The therapeutic efficacy of Teriparatide can be decreased when used in combination with Aldesleukin.,Teriparatide
DB06715,The therapeutic efficacy of Potassium Iodide can be decreased when used in combination with Aldesleukin.,Potassium Iodide
DB07637,The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with Aldesleukin.,Dibromotyrosine
DB09100,"The therapeutic efficacy of Thyroid, porcine can be decreased when used in combination with Aldesleukin.","Thyroid, porcine"
DB09418,The therapeutic efficacy of Potassium perchlorate can be decreased when used in combination with Aldesleukin.,Potassium perchlorate
DB09421,The therapeutic efficacy of Protirelin can be decreased when used in combination with Aldesleukin.,Protirelin
DB12629,"The therapeutic efficacy of 3,5-diiodothyropropionic acid can be decreased when used in combination with Aldesleukin.","3,5-diiodothyropropionic acid"
DB13644,The therapeutic efficacy of Methylthiouracil can be decreased when used in combination with Aldesleukin.,Methylthiouracil
DB13742,The therapeutic efficacy of Elcatonin can be decreased when used in combination with Aldesleukin.,Elcatonin
DB13804,The therapeutic efficacy of Benzylthiouracil can be decreased when used in combination with Aldesleukin.,Benzylthiouracil
DB15263,The therapeutic efficacy of Thyrotropin can be decreased when used in combination with Aldesleukin.,Thyrotropin
DB00437,The risk or severity of adverse effects can be increased when Allopurinol is combined with Aldesleukin.,Allopurinol
DB00316,Aldesleukin may increase the hepatotoxic activities of Acetaminophen.,Acetaminophen
DB09288,Aldesleukin may increase the hepatotoxic activities of Propacetamol.,Propacetamol
DB00212,Aldesleukin may increase the hypotensive activities of Remikiren.,Remikiren
DB00217,Aldesleukin may increase the hypotensive activities of Bethanidine.,Bethanidine
DB00226,Aldesleukin may increase the hypotensive activities of Guanadrel.,Guanadrel
DB00374,Aldesleukin may increase the hypotensive activities of Treprostinil.,Treprostinil
DB00616,Aldesleukin may increase the hypotensive activities of Candoxatril.,Candoxatril
DB00629,Aldesleukin may increase the hypotensive activities of Guanabenz.,Guanabenz
DB00765,Aldesleukin may increase the hypotensive activities of Metyrosine.,Metyrosine
DB00785,Aldesleukin may increase the hypotensive activities of Cryptenamine.,Cryptenamine
DB00866,Aldesleukin may increase the hypotensive activities of Alprenolol.,Alprenolol
DB00886,Aldesleukin may increase the hypotensive activities of Omapatrilat.,Omapatrilat
DB01089,Aldesleukin may increase the hypotensive activities of Deserpidine.,Deserpidine
DB01090,Aldesleukin may increase the hypotensive activities of Pentolinium.,Pentolinium
DB01116,Aldesleukin may increase the hypotensive activities of Trimethaphan.,Trimethaphan
DB01180,Aldesleukin may increase the hypotensive activities of Rescinnamine.,Rescinnamine
DB01295,Aldesleukin may increase the hypotensive activities of Bevantolol.,Bevantolol
DB01297,Aldesleukin may increase the hypotensive activities of Practolol.,Practolol
DB01347,Aldesleukin may increase the hypotensive activities of Saprisartan.,Saprisartan
DB01348,Aldesleukin may increase the hypotensive activities of Spirapril.,Spirapril
DB03322,Aldesleukin may increase the hypotensive activities of Dexpropranolol.,Dexpropranolol
DB04840,Aldesleukin may increase the hypotensive activities of Debrisoquine.,Debrisoquine
DB04846,Aldesleukin may increase the hypotensive activities of Celiprolol.,Celiprolol
DB06268,Aldesleukin may increase the hypotensive activities of Sitaxentan.,Sitaxentan
DB06445,Aldesleukin may increase the hypotensive activities of Diethylnorspermine.,Diethylnorspermine
DB08808,Aldesleukin may increase the hypotensive activities of Bupranolol.,Bupranolol
DB08836,Aldesleukin may increase the hypotensive activities of Temocapril.,Temocapril
DB08952,Aldesleukin may increase the hypotensive activities of Indenolol.,Indenolol
DB08960,Aldesleukin may increase the hypotensive activities of Hexamethonium.,Hexamethonium
DB09206,Aldesleukin may increase the hypotensive activities of Trimazosin.,Trimazosin
DB09363,Aldesleukin may increase the hypotensive activities of Rauwolfia serpentina root.,Rauwolfia serpentina root
DB11720,Aldesleukin may increase the hypotensive activities of Angiotensin 1-7.,Angiotensin 1-7
DB11738,Aldesleukin may increase the hypotensive activities of Rilmenidine.,Rilmenidine
DB11770,Aldesleukin may increase the hypotensive activities of Talinolol.,Talinolol
DB12054,Aldesleukin may increase the hypotensive activities of BQ-123.,BQ-123
DB12212,Aldesleukin may increase the hypotensive activities of Landiolol.,Landiolol
DB12661,Aldesleukin may increase the hypotensive activities of Urapidil.,Urapidil
DB12945,Aldesleukin may increase the hypotensive activities of Dihydralazine.,Dihydralazine
DB13166,Aldesleukin may increase the hypotensive activities of Zofenopril.,Zofenopril
DB13211,Aldesleukin may increase the hypotensive activities of Guanoxan.,Guanoxan
DB13312,Aldesleukin may increase the hypotensive activities of Delapril.,Delapril
DB13374,Aldesleukin may increase the hypotensive activities of Vincamine.,Vincamine
DB13410,Aldesleukin may increase the hypotensive activities of Guanoxabenz.,Guanoxabenz
DB13429,Aldesleukin may increase the hypotensive activities of Tolonidine.,Tolonidine
DB13435,Aldesleukin may increase the hypotensive activities of Endralazine.,Endralazine
DB13443,Aldesleukin may increase the hypotensive activities of Esatenolol.,Esatenolol
DB13452,Aldesleukin may increase the hypotensive activities of Cadralazine.,Cadralazine
DB13508,Aldesleukin may increase the hypotensive activities of Cloranolol.,Cloranolol
DB13575,Aldesleukin may increase the hypotensive activities of Bietaserpine.,Bietaserpine
DB13604,Aldesleukin may increase the hypotensive activities of Guanazodine.,Guanazodine
DB13631,Aldesleukin may increase the hypotensive activities of Methoserpidine.,Methoserpidine
DB13757,Aldesleukin may increase the hypotensive activities of Epanolol.,Epanolol
DB13779,Aldesleukin may increase the hypotensive activities of Guanoclor.,Guanoclor
DB13919,Aldesleukin may increase the hypotensive activities of Candesartan.,Candesartan
DB14125,Aldesleukin may increase the hypotensive activities of Benazeprilat.,Benazeprilat
DB14207,Aldesleukin may increase the hypotensive activities of Fosinoprilat.,Fosinoprilat
DB14208,Aldesleukin may increase the hypotensive activities of Ramiprilat.,Ramiprilat
DB14213,Aldesleukin may increase the hypotensive activities of Perindoprilat.,Perindoprilat
DB14217,Aldesleukin may increase the hypotensive activities of Quinaprilat.,Quinaprilat
DB00559,Aldesleukin may increase the hypotensive activities of Bosentan.,Bosentan
DB01388,Aldesleukin may increase the hypotensive activities of Mibefradil.,Mibefradil
DB06403,Aldesleukin may increase the hypotensive activities of Ambrisentan.,Ambrisentan
DB06762,Aldesleukin may increase the hypotensive activities of Pinacidil.,Pinacidil
DB09238,Aldesleukin may increase the hypotensive activities of Manidipine.,Manidipine
DB09239,Aldesleukin may increase the hypotensive activities of Niguldipine.,Niguldipine
DB11362,Aldesleukin may increase the hypotensive activities of Selexipag.,Selexipag
DB12093,Aldesleukin may increase the hypotensive activities of Tetrahydropalmatine.,Tetrahydropalmatine
DB14068,Aldesleukin may increase the hypotensive activities of Dexniguldipine.,Dexniguldipine
DB14975,The serum concentration of Voxelotor can be increased when it is combined with Aldesleukin.,Voxelotor
DB09237,The serum concentration of Levamlodipine can be increased when it is combined with Aldesleukin.,Levamlodipine
DB00193,The metabolism of Tramadol can be decreased when combined with Aldesleukin.,Tramadol
DB14513,The serum concentration of Magnesium can be decreased when it is combined with Aldesleukin.,Magnesium
DB01601,The serum concentration of Aldesleukin can be increased when it is combined with Lopinavir.,Lopinavir
DB00502,The serum concentration of Haloperidol can be increased when it is combined with Aldesleukin.,Haloperidol
DB12530,The risk or severity of infection can be increased when Aldesleukin is combined with Inebilizumab.,Inebilizumab
DB00186,The metabolism of Lorazepam can be decreased when combined with Aldesleukin.,Lorazepam
DB00208,The metabolism of Ticlopidine can be decreased when combined with Aldesleukin.,Ticlopidine
DB00264,The metabolism of Metoprolol can be decreased when combined with Aldesleukin.,Metoprolol
DB00477,The metabolism of Chlorpromazine can be decreased when combined with Aldesleukin.,Chlorpromazine
DB01039,The metabolism of Fenofibrate can be decreased when combined with Aldesleukin.,Fenofibrate
DB01431,The metabolism of Allylestrenol can be decreased when combined with Aldesleukin.,Allylestrenol
DB09071,The metabolism of Tasimelteon can be decreased when combined with Aldesleukin.,Tasimelteon
DB00191,The metabolism of Phentermine can be decreased when combined with Aldesleukin.,Phentermine
DB00207,The metabolism of Azithromycin can be decreased when combined with Aldesleukin.,Azithromycin
DB00246,The metabolism of Ziprasidone can be decreased when combined with Aldesleukin.,Ziprasidone
DB00426,The metabolism of Famciclovir can be decreased when combined with Aldesleukin.,Famciclovir
DB00433,The metabolism of Prochlorperazine can be decreased when combined with Aldesleukin.,Prochlorperazine
DB00518,The metabolism of Albendazole can be decreased when combined with Aldesleukin.,Albendazole
DB00590,The metabolism of Doxazosin can be decreased when combined with Aldesleukin.,Doxazosin
DB00717,The metabolism of Norethisterone can be decreased when combined with Aldesleukin.,Norethisterone
DB01098,The metabolism of Rosuvastatin can be decreased when combined with Aldesleukin.,Rosuvastatin
DB01323,The metabolism of St. John's Wort can be decreased when combined with Aldesleukin.,St. John's Wort
DB01395,The metabolism of Drospirenone can be decreased when combined with Aldesleukin.,Drospirenone
DB01411,The metabolism of Pranlukast can be decreased when combined with Aldesleukin.,Pranlukast
DB01624,The metabolism of Zuclopenthixol can be decreased when combined with Aldesleukin.,Zuclopenthixol
DB06201,The metabolism of Rufinamide can be decreased when combined with Aldesleukin.,Rufinamide
DB06218,The metabolism of Lacosamide can be decreased when combined with Aldesleukin.,Lacosamide
DB08882,The metabolism of Linagliptin can be decreased when combined with Aldesleukin.,Linagliptin
DB09030,The metabolism of Vorapaxar can be decreased when combined with Aldesleukin.,Vorapaxar
DB09034,The metabolism of Suvorexant can be decreased when combined with Aldesleukin.,Suvorexant
DB09048,The metabolism of Netupitant can be decreased when combined with Aldesleukin.,Netupitant
DB09079,The metabolism of Nintedanib can be decreased when combined with Aldesleukin.,Nintedanib
DB09330,The metabolism of Osimertinib can be decreased when combined with Aldesleukin.,Osimertinib
DB11094,The metabolism of Vitamin D can be decreased when combined with Aldesleukin.,Vitamin D
DB11273,The metabolism of Dihydroergocornine can be decreased when combined with Aldesleukin.,Dihydroergocornine
DB11730,The metabolism of Ribociclib can be decreased when combined with Aldesleukin.,Ribociclib
DB11952,The metabolism of Duvelisib can be decreased when combined with Aldesleukin.,Duvelisib
DB12141,The metabolism of Gilteritinib can be decreased when combined with Aldesleukin.,Gilteritinib
DB12515,The metabolism of 9-aminocamptothecin can be decreased when combined with Aldesleukin.,9-aminocamptothecin
DB12952,The metabolism of Methylprednisone can be decreased when combined with Aldesleukin.,Methylprednisone
DB13345,The metabolism of Dihydroergocristine can be decreased when combined with Aldesleukin.,Dihydroergocristine
DB13385,The metabolism of Dihydroergocryptine can be decreased when combined with Aldesleukin.,Dihydroergocryptine
DB14009,The metabolism of Medical Cannabis can be decreased when combined with Aldesleukin.,Medical Cannabis
DB00549,The metabolism of Zafirlukast can be decreased when combined with Aldesleukin.,Zafirlukast
DB15444,The metabolism of Elexacaftor can be decreased when combined with Aldesleukin.,Elexacaftor
DB12887,The metabolism of Tazemetostat can be decreased when combined with Aldesleukin.,Tazemetostat
DB06717,The metabolism of Fosaprepitant can be decreased when combined with Aldesleukin.,Fosaprepitant
DB12825,The metabolism of Lefamulin can be decreased when combined with Aldesleukin.,Lefamulin
DB01151,The metabolism of Desipramine can be decreased when combined with Aldesleukin.,Desipramine
DB00454,The metabolism of Meperidine can be decreased when combined with Aldesleukin.,Meperidine
DB00247,The metabolism of Methysergide can be decreased when combined with Aldesleukin.,Methysergide
DB00637,The metabolism of Astemizole can be decreased when combined with Aldesleukin.,Astemizole
DB08827,The metabolism of Lomitapide can be decreased when combined with Aldesleukin.,Lomitapide
DB11742,The metabolism of Ebastine can be decreased when combined with Aldesleukin.,Ebastine
DB00188,The metabolism of Bortezomib can be decreased when combined with Aldesleukin.,Bortezomib
DB00309,The metabolism of Vindesine can be decreased when combined with Aldesleukin.,Vindesine
DB00361,The metabolism of Vinorelbine can be decreased when combined with Aldesleukin.,Vinorelbine
DB00398,The metabolism of Sorafenib can be decreased when combined with Aldesleukin.,Sorafenib
DB00444,The metabolism of Teniposide can be decreased when combined with Aldesleukin.,Teniposide
DB00541,The metabolism of Vincristine can be decreased when combined with Aldesleukin.,Vincristine
DB00563,The metabolism of Methotrexate can be decreased when combined with Aldesleukin.,Methotrexate
DB00570,The metabolism of Vinblastine can be decreased when combined with Aldesleukin.,Vinblastine
DB00619,The metabolism of Imatinib can be decreased when combined with Aldesleukin.,Imatinib
DB00694,The metabolism of Daunorubicin can be decreased when combined with Aldesleukin.,Daunorubicin
DB00773,The metabolism of Etoposide can be decreased when combined with Aldesleukin.,Etoposide
DB00987,The metabolism of Cytarabine can be decreased when combined with Aldesleukin.,Cytarabine
DB00997,The metabolism of Doxorubicin can be decreased when combined with Aldesleukin.,Doxorubicin
DB01108,The metabolism of Trilostane can be decreased when combined with Aldesleukin.,Trilostane
DB01181,The metabolism of Ifosfamide can be decreased when combined with Aldesleukin.,Ifosfamide
DB01248,The metabolism of Docetaxel can be decreased when combined with Aldesleukin.,Docetaxel
DB01268,The metabolism of Sunitinib can be decreased when combined with Aldesleukin.,Sunitinib
DB04572,The metabolism of Thiotepa can be decreased when combined with Aldesleukin.,Thiotepa
DB04845,The metabolism of Ixabepilone can be decreased when combined with Aldesleukin.,Ixabepilone
DB04868,The metabolism of Nilotinib can be decreased when combined with Aldesleukin.,Nilotinib
DB05015,The metabolism of Belinostat can be decreased when combined with Aldesleukin.,Belinostat
DB05109,The metabolism of Trabectedin can be decreased when combined with Aldesleukin.,Trabectedin
DB06589,The metabolism of Pazopanib can be decreased when combined with Aldesleukin.,Pazopanib
DB06603,The metabolism of Panobinostat can be decreased when combined with Aldesleukin.,Panobinostat
DB06616,The metabolism of Bosutinib can be decreased when combined with Aldesleukin.,Bosutinib
DB08870,The metabolism of Brentuximab vedotin can be decreased when combined with Aldesleukin.,Brentuximab vedotin
DB08877,The metabolism of Ruxolitinib can be decreased when combined with Aldesleukin.,Ruxolitinib
DB08901,The metabolism of Ponatinib can be decreased when combined with Aldesleukin.,Ponatinib
DB09054,The metabolism of Idelalisib can be decreased when combined with Aldesleukin.,Idelalisib
DB09073,The metabolism of Palbociclib can be decreased when combined with Aldesleukin.,Palbociclib
DB09570,The metabolism of Ixazomib can be decreased when combined with Aldesleukin.,Ixazomib
DB00564,The metabolism of Carbamazepine can be decreased when combined with Aldesleukin.,Carbamazepine
DB00204,The metabolism of Dofetilide can be decreased when combined with Aldesleukin.,Dofetilide
DB00277,The metabolism of Theophylline can be decreased when combined with Aldesleukin.,Theophylline
DB00342,The metabolism of Terfenadine can be decreased when combined with Aldesleukin.,Terfenadine
DB00604,The metabolism of Cisapride can be decreased when combined with Aldesleukin.,Cisapride
DB00877,The metabolism of Sirolimus can be decreased when combined with Aldesleukin.,Sirolimus
DB00946,The metabolism of Phenprocoumon can be decreased when combined with Aldesleukin.,Phenprocoumon
DB01008,The metabolism of Busulfan can be decreased when combined with Aldesleukin.,Busulfan
DB01100,The metabolism of Pimozide can be decreased when combined with Aldesleukin.,Pimozide
DB01118,The metabolism of Amiodarone can be decreased when combined with Aldesleukin.,Amiodarone
DB01223,The metabolism of Aminophylline can be decreased when combined with Aldesleukin.,Aminophylline
DB01229,The metabolism of Paclitaxel can be decreased when combined with Aldesleukin.,Paclitaxel
DB01254,The metabolism of Dasatinib can be decreased when combined with Aldesleukin.,Dasatinib
DB01320,The metabolism of Fosphenytoin can be decreased when combined with Aldesleukin.,Fosphenytoin
DB01396,The metabolism of Digitoxin can be decreased when combined with Aldesleukin.,Digitoxin
DB01590,The metabolism of Everolimus can be decreased when combined with Aldesleukin.,Everolimus
DB03410,The metabolism of 4-hydroxycoumarin can be decreased when combined with Aldesleukin.,4-hydroxycoumarin
DB04855,The metabolism of Dronedarone can be decreased when combined with Aldesleukin.,Dronedarone
DB05239,The metabolism of Cobimetinib can be decreased when combined with Aldesleukin.,Cobimetinib
DB06287,The metabolism of Temsirolimus can be decreased when combined with Aldesleukin.,Temsirolimus
DB09063,The metabolism of Ceritinib can be decreased when combined with Aldesleukin.,Ceritinib
DB09289,The metabolism of Tianeptine can be decreased when combined with Aldesleukin.,Tianeptine
DB11633,The metabolism of Isavuconazole can be decreased when combined with Aldesleukin.,Isavuconazole
DB11963,The metabolism of Dacomitinib can be decreased when combined with Aldesleukin.,Dacomitinib
DB12015,The metabolism of Alpelisib can be decreased when combined with Aldesleukin.,Alpelisib
DB13136,The metabolism of Fluindione can be decreased when combined with Aldesleukin.,Fluindione
DB13275,The metabolism of Clorindione can be decreased when combined with Aldesleukin.,Clorindione
DB00675,The metabolism of Tamoxifen can be decreased when combined with Aldesleukin.,Tamoxifen
DB05294,The metabolism of Vandetanib can be decreased when combined with Aldesleukin.,Vandetanib
DB05812,The metabolism of Abiraterone can be decreased when combined with Aldesleukin.,Abiraterone
DB08881,The metabolism of Vemurafenib can be decreased when combined with Aldesleukin.,Vemurafenib
DB11363,The metabolism of Alectinib can be decreased when combined with Aldesleukin.,Alectinib
DB11581,The metabolism of Venetoclax can be decreased when combined with Aldesleukin.,Venetoclax
DB11641,The metabolism of Vinflunine can be decreased when combined with Aldesleukin.,Vinflunine
DB11703,The metabolism of Acalabrutinib can be decreased when combined with Aldesleukin.,Acalabrutinib
DB13874,The metabolism of Enasidenib can be decreased when combined with Aldesleukin.,Enasidenib
DB15035,The metabolism of Zanubrutinib can be decreased when combined with Aldesleukin.,Zanubrutinib
DB00248,The metabolism of Cabergoline can be decreased when combined with Aldesleukin.,Cabergoline
DB00530,The metabolism of Erlotinib can be decreased when combined with Aldesleukin.,Erlotinib
DB06595,The metabolism of Midostaurin can be decreased when combined with Aldesleukin.,Midostaurin
DB06626,The metabolism of Axitinib can be decreased when combined with Aldesleukin.,Axitinib
DB08865,The metabolism of Crizotinib can be decreased when combined with Aldesleukin.,Crizotinib
DB08912,The metabolism of Dabrafenib can be decreased when combined with Aldesleukin.,Dabrafenib
DB09143,The metabolism of Sonidegib can be decreased when combined with Aldesleukin.,Sonidegib
DB11718,The metabolism of Encorafenib can be decreased when combined with Aldesleukin.,Encorafenib
DB11828,The metabolism of Neratinib can be decreased when combined with Aldesleukin.,Neratinib
DB12147,The metabolism of Erdafitinib can be decreased when combined with Aldesleukin.,Erdafitinib
DB12267,The metabolism of Brigatinib can be decreased when combined with Aldesleukin.,Brigatinib
DB12483,The metabolism of Copanlisib can be decreased when combined with Aldesleukin.,Copanlisib
DB12978,The metabolism of Pexidartinib can be decreased when combined with Aldesleukin.,Pexidartinib
DB14568,The metabolism of Ivosidenib can be decreased when combined with Aldesleukin.,Ivosidenib
DB11986,The metabolism of Entrectinib can be decreased when combined with Aldesleukin.,Entrectinib
DB00921,Botulinum Toxin Type B may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,Buprenorphine
DB00366,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Botulinum Toxin Type B.,Doxylamine
DB00470,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Botulinum Toxin Type B.,Dronabinol
DB00450,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Botulinum Toxin Type B.,Droperidol
DB00956,Botulinum Toxin Type B may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,Hydrocodone
DB00557,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Botulinum Toxin Type B.,Hydroxyzine
DB00653,The therapeutic efficacy of Botulinum Toxin Type B can be increased when used in combination with Magnesium sulfate.,Magnesium sulfate
DB01403,Botulinum Toxin Type B may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.,Methotrimeprazine
DB00765,Botulinum Toxin Type B may increase the sedative activities of Metyrosine.,Metyrosine
DB01017,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Botulinum Toxin Type B.,Minocycline
DB00370,Botulinum Toxin Type B may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.,Mirtazapine
DB00486,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Botulinum Toxin Type B.,Nabilone
DB01173,Botulinum Toxin Type B may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,Orphenadrine
DB09117,Botulinum Toxin Type B may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.,Paraldehyde
DB08883,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Botulinum Toxin Type B.,Perampanel
DB00413,Botulinum Toxin Type B may increase the sedative activities of Pramipexole.,Pramipexole
DB00268,Botulinum Toxin Type B may increase the sedative activities of Ropinirole.,Ropinirole
DB05271,Botulinum Toxin Type B may increase the sedative activities of Rotigotine.,Rotigotine
DB06201,The risk or severity of adverse effects can be increased when Rufinamide is combined with Botulinum Toxin Type B.,Rufinamide
DB09072,Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Botulinum Toxin Type B.,Sodium oxybate
DB09034,Botulinum Toxin Type B may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.,Suvorexant
DB06204,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Botulinum Toxin Type B.,Tapentadol
DB01041,Botulinum Toxin Type B may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.,Thalidomide
DB00425,Botulinum Toxin Type B may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,Zolpidem
DB00202,The therapeutic efficacy of Succinylcholine can be increased when used in combination with Botulinum Toxin Type B.,Succinylcholine
DB01245,The therapeutic efficacy of Decamethonium can be increased when used in combination with Botulinum Toxin Type B.,Decamethonium
DB11156,The therapeutic efficacy of Pyrantel can be increased when used in combination with Botulinum Toxin Type B.,Pyrantel
DB12989,The therapeutic efficacy of Neosaxitoxin can be increased when used in combination with Botulinum Toxin Type B.,Neosaxitoxin
DB00333,The risk or severity of adverse effects can be increased when Methadone is combined with Botulinum Toxin Type B.,Methadone
DB00209,The risk or severity of adverse effects can be increased when Trospium is combined with Botulinum Toxin Type B.,Trospium
DB00219,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Botulinum Toxin Type B.,Oxyphenonium
DB00237,The risk or severity of adverse effects can be increased when Butabarbital is combined with Botulinum Toxin Type B.,Butabarbital
DB00241,The risk or severity of adverse effects can be increased when Butalbital is combined with Botulinum Toxin Type B.,Butalbital
DB00245,The risk or severity of adverse effects can be increased when Benzatropine is combined with Botulinum Toxin Type B.,Benzatropine
DB00280,The risk or severity of adverse effects can be increased when Disopyramide is combined with Botulinum Toxin Type B.,Disopyramide
DB00306,The risk or severity of adverse effects can be increased when Talbutal is combined with Botulinum Toxin Type B.,Talbutal
DB00312,The risk or severity of adverse effects can be increased when Pentobarbital is combined with Botulinum Toxin Type B.,Pentobarbital
DB00321,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Botulinum Toxin Type B.,Amitriptyline
DB00332,The risk or severity of adverse effects can be increased when Ipratropium is combined with Botulinum Toxin Type B.,Ipratropium
DB00334,The risk or severity of adverse effects can be increased when Olanzapine is combined with Botulinum Toxin Type B.,Olanzapine
DB00340,The risk or severity of adverse effects can be increased when Metixene is combined with Botulinum Toxin Type B.,Metixene
DB00342,The risk or severity of adverse effects can be increased when Terfenadine is combined with Botulinum Toxin Type B.,Terfenadine
DB00354,The risk or severity of adverse effects can be increased when Buclizine is combined with Botulinum Toxin Type B.,Buclizine
DB00363,The risk or severity of adverse effects can be increased when Clozapine is combined with Botulinum Toxin Type B.,Clozapine
DB00376,The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Botulinum Toxin Type B.,Trihexyphenidyl
DB00383,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Botulinum Toxin Type B.,Oxyphencyclimine
DB00387,The risk or severity of adverse effects can be increased when Procyclidine is combined with Botulinum Toxin Type B.,Procyclidine
DB00392,The risk or severity of adverse effects can be increased when Profenamine is combined with Botulinum Toxin Type B.,Profenamine
DB00416,The risk or severity of adverse effects can be increased when Metocurine iodide is combined with Botulinum Toxin Type B.,Metocurine iodide
DB00418,The risk or severity of adverse effects can be increased when Secobarbital is combined with Botulinum Toxin Type B.,Secobarbital
DB00420,The risk or severity of adverse effects can be increased when Promazine is combined with Botulinum Toxin Type B.,Promazine
DB00424,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Botulinum Toxin Type B.,Hyoscyamine
DB00434,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Botulinum Toxin Type B.,Cyproheptadine
DB00458,The risk or severity of adverse effects can be increased when Imipramine is combined with Botulinum Toxin Type B.,Imipramine
DB00462,The risk or severity of adverse effects can be increased when Methscopolamine bromide is combined with Botulinum Toxin Type B.,Methscopolamine bromide
DB00463,The risk or severity of adverse effects can be increased when Metharbital is combined with Botulinum Toxin Type B.,Metharbital
DB00477,The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Botulinum Toxin Type B.,Chlorpromazine
DB00483,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Botulinum Toxin Type B.,Gallamine triethiodide
DB00496,The risk or severity of adverse effects can be increased when Darifenacin is combined with Botulinum Toxin Type B.,Darifenacin
DB00505,The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Botulinum Toxin Type B.,Tridihexethyl
DB00508,The risk or severity of adverse effects can be increased when Triflupromazine is combined with Botulinum Toxin Type B.,Triflupromazine
DB00514,The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Botulinum Toxin Type B.,Dextromethorphan
DB00517,The risk or severity of adverse effects can be increased when Anisotropine methylbromide is combined with Botulinum Toxin Type B.,Anisotropine methylbromide
DB00540,The risk or severity of adverse effects can be increased when Nortriptyline is combined with Botulinum Toxin Type B.,Nortriptyline
DB00543,The risk or severity of adverse effects can be increased when Amoxapine is combined with Botulinum Toxin Type B.,Amoxapine
DB00555,The risk or severity of adverse effects can be increased when Lamotrigine is combined with Botulinum Toxin Type B.,Lamotrigine
DB00565,The risk or severity of adverse effects can be increased when Cisatracurium is combined with Botulinum Toxin Type B.,Cisatracurium
DB00572,The risk or severity of adverse effects can be increased when Atropine is combined with Botulinum Toxin Type B.,Atropine
DB00599,The risk or severity of adverse effects can be increased when Thiopental is combined with Botulinum Toxin Type B.,Thiopental
DB00622,The risk or severity of adverse effects can be increased when Nicardipine is combined with Botulinum Toxin Type B.,Nicardipine
DB00657,The risk or severity of adverse effects can be increased when Mecamylamine is combined with Botulinum Toxin Type B.,Mecamylamine
DB00670,The risk or severity of adverse effects can be increased when Pirenzepine is combined with Botulinum Toxin Type B.,Pirenzepine
DB00715,The risk or severity of adverse effects can be increased when Paroxetine is combined with Botulinum Toxin Type B.,Paroxetine
DB00721,The risk or severity of adverse effects can be increased when Procaine is combined with Botulinum Toxin Type B.,Procaine
DB00725,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Botulinum Toxin Type B.,Homatropine methylbromide
DB00728,The risk or severity of adverse effects can be increased when Rocuronium is combined with Botulinum Toxin Type B.,Rocuronium
DB00732,The risk or severity of adverse effects can be increased when Atracurium besylate is combined with Botulinum Toxin Type B.,Atracurium besylate
DB00747,The risk or severity of adverse effects can be increased when Scopolamine is combined with Botulinum Toxin Type B.,Scopolamine
DB00753,The risk or severity of adverse effects can be increased when Isoflurane is combined with Botulinum Toxin Type B.,Isoflurane
DB00767,The risk or severity of adverse effects can be increased when Benzquinamide is combined with Botulinum Toxin Type B.,Benzquinamide
DB00771,The risk or severity of adverse effects can be increased when Clidinium is combined with Botulinum Toxin Type B.,Clidinium
DB00777,The risk or severity of adverse effects can be increased when Propiomazine is combined with Botulinum Toxin Type B.,Propiomazine
DB00782,The risk or severity of adverse effects can be increased when Propantheline is combined with Botulinum Toxin Type B.,Propantheline
DB00794,The risk or severity of adverse effects can be increased when Primidone is combined with Botulinum Toxin Type B.,Primidone
DB00804,The risk or severity of adverse effects can be increased when Dicyclomine is combined with Botulinum Toxin Type B.,Dicyclomine
DB00810,The risk or severity of adverse effects can be increased when Biperiden is combined with Botulinum Toxin Type B.,Biperiden
DB00835,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Botulinum Toxin Type B.,Brompheniramine
DB00849,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Botulinum Toxin Type B.,Methylphenobarbital
DB00875,The risk or severity of adverse effects can be increased when Flupentixol is combined with Botulinum Toxin Type B.,Flupentixol
DB00907,The risk or severity of adverse effects can be increased when Cocaine is combined with Botulinum Toxin Type B.,Cocaine
DB00908,The risk or severity of adverse effects can be increased when Quinidine is combined with Botulinum Toxin Type B.,Quinidine
DB00915,The risk or severity of adverse effects can be increased when Amantadine is combined with Botulinum Toxin Type B.,Amantadine
DB00934,The risk or severity of adverse effects can be increased when Maprotiline is combined with Botulinum Toxin Type B.,Maprotiline
DB00940,The risk or severity of adverse effects can be increased when Methantheline is combined with Botulinum Toxin Type B.,Methantheline
DB00941,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Botulinum Toxin Type B.,Hexafluronium
DB00942,The risk or severity of adverse effects can be increased when Cycrimine is combined with Botulinum Toxin Type B.,Cycrimine
DB00967,The risk or severity of adverse effects can be increased when Desloratadine is combined with Botulinum Toxin Type B.,Desloratadine
DB00986,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Botulinum Toxin Type B.,Glycopyrronium
DB01036,The risk or severity of adverse effects can be increased when Tolterodine is combined with Botulinum Toxin Type B.,Tolterodine
DB01062,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Botulinum Toxin Type B.,Oxybutynin
DB01069,The risk or severity of adverse effects can be increased when Promethazine is combined with Botulinum Toxin Type B.,Promethazine
DB01075,The risk or severity of adverse effects can be increased when Diphenhydramine is combined with Botulinum Toxin Type B.,Diphenhydramine
DB01090,The risk or severity of adverse effects can be increased when Pentolinium is combined with Botulinum Toxin Type B.,Pentolinium
DB01116,The risk or severity of adverse effects can be increased when Trimethaphan is combined with Botulinum Toxin Type B.,Trimethaphan
DB01135,The risk or severity of adverse effects can be increased when Doxacurium is combined with Botulinum Toxin Type B.,Doxacurium
DB01142,The risk or severity of adverse effects can be increased when Doxepin is combined with Botulinum Toxin Type B.,Doxepin
DB01148,The risk or severity of adverse effects can be increased when Flavoxate is combined with Botulinum Toxin Type B.,Flavoxate
DB01151,The risk or severity of adverse effects can be increased when Desipramine is combined with Botulinum Toxin Type B.,Desipramine
DB01161,The risk or severity of adverse effects can be increased when Chloroprocaine is combined with Botulinum Toxin Type B.,Chloroprocaine
DB01174,The risk or severity of adverse effects can be increased when Phenobarbital is combined with Botulinum Toxin Type B.,Phenobarbital
DB01175,The risk or severity of adverse effects can be increased when Escitalopram is combined with Botulinum Toxin Type B.,Escitalopram
DB01199,The risk or severity of adverse effects can be increased when Tubocurarine is combined with Botulinum Toxin Type B.,Tubocurarine
DB01224,The risk or severity of adverse effects can be increased when Quetiapine is combined with Botulinum Toxin Type B.,Quetiapine
DB01226,The risk or severity of adverse effects can be increased when Mivacurium is combined with Botulinum Toxin Type B.,Mivacurium
DB01227,The risk or severity of adverse effects can be increased when Levacetylmethadol is combined with Botulinum Toxin Type B.,Levacetylmethadol
DB01231,The risk or severity of adverse effects can be increased when Diphenidol is combined with Botulinum Toxin Type B.,Diphenidol
DB01238,The risk or severity of adverse effects can be increased when Aripiprazole is combined with Botulinum Toxin Type B.,Aripiprazole
DB01239,The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Botulinum Toxin Type B.,Chlorprothixene
DB01288,The risk or severity of adverse effects can be increased when Fenoterol is combined with Botulinum Toxin Type B.,Fenoterol
DB01336,The risk or severity of adverse effects can be increased when Metocurine is combined with Botulinum Toxin Type B.,Metocurine
DB01337,The risk or severity of adverse effects can be increased when Pancuronium is combined with Botulinum Toxin Type B.,Pancuronium
DB01338,The risk or severity of adverse effects can be increased when Pipecuronium is combined with Botulinum Toxin Type B.,Pipecuronium
DB01339,The risk or severity of adverse effects can be increased when Vecuronium is combined with Botulinum Toxin Type B.,Vecuronium
DB01351,The risk or severity of adverse effects can be increased when Amobarbital is combined with Botulinum Toxin Type B.,Amobarbital
DB01352,The risk or severity of adverse effects can be increased when Aprobarbital is combined with Botulinum Toxin Type B.,Aprobarbital
DB01353,The risk or severity of adverse effects can be increased when Butobarbital is combined with Botulinum Toxin Type B.,Butobarbital
DB01354,The risk or severity of adverse effects can be increased when Heptabarbital is combined with Botulinum Toxin Type B.,Heptabarbital
DB01355,The risk or severity of adverse effects can be increased when Hexobarbital is combined with Botulinum Toxin Type B.,Hexobarbital
DB01409,The risk or severity of adverse effects can be increased when Tiotropium is combined with Botulinum Toxin Type B.,Tiotropium
DB01483,The risk or severity of adverse effects can be increased when Barbital is combined with Botulinum Toxin Type B.,Barbital
DB01496,"The risk or severity of adverse effects can be increased when Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione is combined with Botulinum Toxin Type B.","Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione"
DB01591,The risk or severity of adverse effects can be increased when Solifenacin is combined with Botulinum Toxin Type B.,Solifenacin
DB01625,The risk or severity of adverse effects can be increased when Isopropamide is combined with Botulinum Toxin Type B.,Isopropamide
DB04834,The risk or severity of adverse effects can be increased when Rapacuronium is combined with Botulinum Toxin Type B.,Rapacuronium
DB04843,The risk or severity of adverse effects can be increased when Mepenzolate is combined with Botulinum Toxin Type B.,Mepenzolate
DB05710,The risk or severity of adverse effects can be increased when Gantacurium is combined with Botulinum Toxin Type B.,Gantacurium
DB06153,The risk or severity of adverse effects can be increased when Pizotifen is combined with Botulinum Toxin Type B.,Pizotifen
DB06702,The risk or severity of adverse effects can be increased when Fesoterodine is combined with Botulinum Toxin Type B.,Fesoterodine
DB06787,The risk or severity of adverse effects can be increased when Hexocyclium is combined with Botulinum Toxin Type B.,Hexocyclium
DB08801,The risk or severity of adverse effects can be increased when Dimetindene is combined with Botulinum Toxin Type B.,Dimetindene
DB08838,The risk or severity of adverse effects can be increased when Agmatine is combined with Botulinum Toxin Type B.,Agmatine
DB08897,The risk or severity of adverse effects can be increased when Aclidinium is combined with Botulinum Toxin Type B.,Aclidinium
DB08960,The risk or severity of adverse effects can be increased when Hexamethonium is combined with Botulinum Toxin Type B.,Hexamethonium
DB08997,The risk or severity of adverse effects can be increased when Dexetimide is combined with Botulinum Toxin Type B.,Dexetimide
DB09007,The risk or severity of adverse effects can be increased when Chlorphenoxamine is combined with Botulinum Toxin Type B.,Chlorphenoxamine
DB09023,The risk or severity of adverse effects can be increased when Benactyzine is combined with Botulinum Toxin Type B.,Benactyzine
DB09076,The risk or severity of adverse effects can be increased when Umeclidinium is combined with Botulinum Toxin Type B.,Umeclidinium
DB09089,The risk or severity of adverse effects can be increased when Trimebutine is combined with Botulinum Toxin Type B.,Trimebutine
DB09167,The risk or severity of adverse effects can be increased when Dosulepin is combined with Botulinum Toxin Type B.,Dosulepin
DB09262,The risk or severity of adverse effects can be increased when Imidafenacin is combined with Botulinum Toxin Type B.,Imidafenacin
DB09300,The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Botulinum Toxin Type B.,Butylscopolamine
DB11235,The risk or severity of adverse effects can be increased when Thonzylamine is combined with Botulinum Toxin Type B.,Thonzylamine
DB11315,The risk or severity of adverse effects can be increased when Methscopolamine is combined with Botulinum Toxin Type B.,Methscopolamine
DB11855,The risk or severity of adverse effects can be increased when Revefenacin is combined with Botulinum Toxin Type B.,Revefenacin
DB12086,The risk or severity of adverse effects can be increased when Oxitropium is combined with Botulinum Toxin Type B.,Oxitropium
DB12278,The risk or severity of adverse effects can be increased when Propiverine is combined with Botulinum Toxin Type B.,Propiverine
DB12526,The risk or severity of adverse effects can be increased when Batefenterol is combined with Botulinum Toxin Type B.,Batefenterol
DB12554,The risk or severity of adverse effects can be increased when Mebeverine is combined with Botulinum Toxin Type B.,Mebeverine
DB13252,The risk or severity of adverse effects can be increased when Tropatepine is combined with Botulinum Toxin Type B.,Tropatepine
DB13254,The risk or severity of adverse effects can be increased when Prifinium is combined with Botulinum Toxin Type B.,Prifinium
DB13295,The risk or severity of adverse effects can be increased when Atracurium is combined with Botulinum Toxin Type B.,Atracurium
DB13351,The risk or severity of adverse effects can be increased when Piperidolate is combined with Botulinum Toxin Type B.,Piperidolate
DB13369,The risk or severity of adverse effects can be increased when Benzilone is combined with Botulinum Toxin Type B.,Benzilone
DB13380,The risk or severity of adverse effects can be increased when Difemerine is combined with Botulinum Toxin Type B.,Difemerine
DB13413,The risk or severity of adverse effects can be increased when Phenglutarimide is combined with Botulinum Toxin Type B.,Phenglutarimide
DB13448,The risk or severity of adverse effects can be increased when Mazaticol is combined with Botulinum Toxin Type B.,Mazaticol
DB13468,The risk or severity of adverse effects can be increased when Etybenzatropine is combined with Botulinum Toxin Type B.,Etybenzatropine
DB13500,The risk or severity of adverse effects can be increased when Otilonium is combined with Botulinum Toxin Type B.,Otilonium
DB13505,The risk or severity of adverse effects can be increased when Emepronium is combined with Botulinum Toxin Type B.,Emepronium
DB13507,The risk or severity of adverse effects can be increased when Poldine is combined with Botulinum Toxin Type B.,Poldine
DB13542,The risk or severity of adverse effects can be increased when Bevonium is combined with Botulinum Toxin Type B.,Bevonium
DB13581,The risk or severity of adverse effects can be increased when Rociverine is combined with Botulinum Toxin Type B.,Rociverine
DB13584,The risk or severity of adverse effects can be increased when Gallamine is combined with Botulinum Toxin Type B.,Gallamine
DB13619,The risk or severity of adverse effects can be increased when Bornaprine is combined with Botulinum Toxin Type B.,Bornaprine
DB13636,The risk or severity of adverse effects can be increased when Etanautine is combined with Botulinum Toxin Type B.,Etanautine
DB13648,The risk or severity of adverse effects can be increased when Alcuronium is combined with Botulinum Toxin Type B.,Alcuronium
DB13666,The risk or severity of adverse effects can be increased when Tiemonium iodide is combined with Botulinum Toxin Type B.,Tiemonium iodide
DB13678,The risk or severity of adverse effects can be increased when Dihexyverine is combined with Botulinum Toxin Type B.,Dihexyverine
DB13695,The risk or severity of adverse effects can be increased when Penthienate is combined with Botulinum Toxin Type B.,Penthienate
DB13720,The risk or severity of adverse effects can be increased when Diphemanil is combined with Botulinum Toxin Type B.,Diphemanil
DB13738,The risk or severity of adverse effects can be increased when Camylofin is combined with Botulinum Toxin Type B.,Camylofin
DB13759,The risk or severity of adverse effects can be increased when Fenpiverinium is combined with Botulinum Toxin Type B.,Fenpiverinium
DB13769,The risk or severity of adverse effects can be increased when Emetonium iodide is combined with Botulinum Toxin Type B.,Emetonium iodide
DB13844,The risk or severity of adverse effects can be increased when Pipenzolate is combined with Botulinum Toxin Type B.,Pipenzolate
DB13850,The risk or severity of adverse effects can be increased when Timepidium is combined with Botulinum Toxin Type B.,Timepidium
DB00898,Botulinum Toxin Type B may increase the central nervous system depressant (CNS depressant) activities of Ethanol.,Ethanol
DB00972,Botulinum Toxin Type B may increase the central nervous system depressant (CNS depressant) activities of Azelastine.,Azelastine
DB00484,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Botulinum Toxin Type B.,Brimonidine
DB00176,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fluvoxamine.,Fluvoxamine
DB00215,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Citalopram.,Citalopram
DB00476,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Duloxetine.,Duloxetine
DB00656,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Trazodone.,Trazodone
DB01104,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Sertraline.,Sertraline
DB01105,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Sibutramine.,Sibutramine
DB01149,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Nefazodone.,Nefazodone
DB04832,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Zimelidine.,Zimelidine
DB04884,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dapoxetine.,Dapoxetine
DB04896,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Milnacipran.,Milnacipran
DB06700,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Desvenlafaxine.,Desvenlafaxine
DB06731,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Seproxetine.,Seproxetine
DB08918,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Levomilnacipran.,Levomilnacipran
DB08953,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Indalpine.,Indalpine
DB12693,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ritanserin.,Ritanserin
DB13233,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Alaproclate.,Alaproclate
DB01198,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Zopiclone.,Zopiclone
DB00150,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tryptophan.,Tryptophan
DB00181,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Baclofen.,Baclofen
DB00182,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Amphetamine.,Amphetamine
DB00186,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lorazepam.,Lorazepam
DB00189,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ethchlorvynol.,Ethchlorvynol
DB00206,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Reserpine.,Reserpine
DB00216,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Eletriptan.,Eletriptan
DB00228,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Enflurane.,Enflurane
DB00231,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Temazepam.,Temazepam
DB00234,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Reboxetine.,Reboxetine
DB00247,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Methysergide.,Methysergide
DB00248,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cabergoline.,Cabergoline
DB00252,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Phenytoin.,Phenytoin
DB00273,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Topiramate.,Topiramate
DB00283,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Clemastine.,Clemastine
DB00285,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Venlafaxine.,Venlafaxine
DB00289,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Atomoxetine.,Atomoxetine
DB00292,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Etomidate.,Etomidate
DB00295,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Morphine.,Morphine
DB00313,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Valproic acid.,Valproic acid
DB00315,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Zolmitriptan.,Zolmitriptan
DB00318,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Codeine.,Codeine
DB00320,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dihydroergotamine.,Dihydroergotamine
DB00323,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tolcapone.,Tolcapone
DB00327,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Hydromorphone.,Hydromorphone
DB00341,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cetirizine.,Cetirizine
DB00344,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Protriptyline.,Protriptyline
DB00347,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Trimethadione.,Trimethadione
DB00349,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Clobazam.,Clobazam
DB00356,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Chlorzoxazone.,Chlorzoxazone
DB00371,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Meprobamate.,Meprobamate
DB00372,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Thiethylperazine.,Thiethylperazine
DB00377,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Palonosetron.,Palonosetron
DB00391,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Sulpiride.,Sulpiride
DB00404,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Alprazolam.,Alprazolam
DB00405,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dexbrompheniramine.,Dexbrompheniramine
DB00408,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Loxapine.,Loxapine
DB00409,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Remoxipride.,Remoxipride
DB00423,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Methocarbamol.,Methocarbamol
DB00427,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Triprolidine.,Triprolidine
DB00433,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Prochlorperazine.,Prochlorperazine
DB00454,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Meperidine.,Meperidine
DB00474,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Methohexital.,Methohexital
DB00475,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Chlordiazepoxide.,Chlordiazepoxide
DB00494,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Entacapone.,Entacapone
DB00497,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Oxycodone.,Oxycodone
DB00532,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Mephenytoin.,Mephenytoin
DB00546,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Adinazolam.,Adinazolam
DB00564,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Carbamazepine.,Carbamazepine
DB00574,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fenfluramine.,Fenfluramine
DB00579,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Mazindol.,Mazindol
DB00588,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fluticasone propionate.,Fluticasone propionate
DB00589,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lisuride.,Lisuride
DB00593,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ethosuximide.,Ethosuximide
DB00601,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Linezolid.,Linezolid
DB00604,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cisapride.,Cisapride
DB00611,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Butorphanol.,Butorphanol
DB00614,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Furazolidone.,Furazolidone
DB00617,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Paramethadione.,Paramethadione
DB00623,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fluphenazine.,Fluphenazine
DB00625,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Efavirenz.,Efavirenz
DB00628,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Clorazepic acid.,Clorazepic acid
DB00633,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dexmedetomidine.,Dexmedetomidine
DB00645,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dyclonine.,Dyclonine
DB00647,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dextropropoxyphene.,Dextropropoxyphene
DB00652,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pentazocine.,Pentazocine
DB00660,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Metaxalone.,Metaxalone
DB00662,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Trimethobenzamide.,Trimethobenzamide
DB00669,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Sumatriptan.,Sumatriptan
DB00679,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Thioridazine.,Thioridazine
DB00680,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Moricizine.,Moricizine
DB00683,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Midazolam.,Midazolam
DB00690,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Flurazepam.,Flurazepam
DB00696,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ergotamine.,Ergotamine
DB00697,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tizanidine.,Tizanidine
DB00708,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Sufentanil.,Sufentanil
DB00714,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Apomorphine.,Apomorphine
DB00726,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Trimipramine.,Trimipramine
DB00734,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Risperidone.,Risperidone
DB00737,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Meclizine.,Meclizine
DB00740,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Riluzole.,Riluzole
DB00748,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Carbinoxamine.,Carbinoxamine
DB00752,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tranylcypromine.,Tranylcypromine
DB00754,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ethotoin.,Ethotoin
DB00757,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dolasetron.,Dolasetron
DB00776,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Oxcarbazepine.,Oxcarbazepine
DB00780,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Phenelzine.,Phenelzine
DB00801,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Halazepam.,Halazepam
DB00802,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Alfentanil.,Alfentanil
DB00805,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Minaprine.,Minaprine
DB00813,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fentanyl.,Fentanyl
DB00818,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Propofol.,Propofol
DB00819,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Acetazolamide.,Acetazolamide
DB00829,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Diazepam.,Diazepam
DB00831,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Trifluoperazine.,Trifluoperazine
DB00832,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Phensuximide.,Phensuximide
DB00837,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Progabide.,Progabide
DB00842,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Oxazepam.,Oxazepam
DB00843,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Donepezil.,Donepezil
DB00844,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Nalbuphine.,Nalbuphine
DB00850,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Perphenazine.,Perphenazine
DB00854,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Levorphanol.,Levorphanol
DB00865,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Benzphetamine.,Benzphetamine
DB00866,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Alprenolol.,Alprenolol
DB00889,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Granisetron.,Granisetron
DB00897,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Triazolam.,Triazolam
DB00899,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Remifentanil.,Remifentanil
DB00904,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ondansetron.,Ondansetron
DB00906,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tiagabine.,Tiagabine
DB00909,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Zonisamide.,Zonisamide
DB00918,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Almotriptan.,Almotriptan
DB00933,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Mesoridazine.,Mesoridazine
DB00937,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Diethylpropion.,Diethylpropion
DB00949,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Felbamate.,Felbamate
DB00952,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Naratriptan.,Naratriptan
DB00953,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Rizatriptan.,Rizatriptan
DB00960,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pindolol.,Pindolol
DB00962,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Zaleplon.,Zaleplon
DB00969,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Alosetron.,Alosetron
DB00980,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ramelteon.,Ramelteon
DB00985,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dimenhydrinate.,Dimenhydrinate
DB00996,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Gabapentin.,Gabapentin
DB00998,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Frovatriptan.,Frovatriptan
DB01018,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Guanfacine.,Guanfacine
DB01028,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Methoxyflurane.,Methoxyflurane
DB01037,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Selegiline.,Selegiline
DB01049,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ergoloid mesylate.,Ergoloid mesylate
DB01063,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Acetophenazine.,Acetophenazine
DB01065,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Melatonin.,Melatonin
DB01068,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Clonazepam.,Clonazepam
DB01080,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Vigabatrin.,Vigabatrin
DB01081,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Diphenoxylate.,Diphenoxylate
DB01100,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pimozide.,Pimozide
DB01107,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Methyprylon.,Methyprylon
DB01114,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Chlorpheniramine.,Chlorpheniramine
DB01121,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Phenacemide.,Phenacemide
DB01154,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Thiamylal.,Thiamylal
DB01156,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Bupropion.,Bupropion
DB01159,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Halothane.,Halothane
DB01168,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Procarbazine.,Procarbazine
DB01171,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Moclobemide.,Moclobemide
DB01176,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cyclizine.,Cyclizine
DB01178,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Chlormezanone.,Chlormezanone
DB01186,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pergolide.,Pergolide
DB01189,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Desflurane.,Desflurane
DB01192,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Oxymorphone.,Oxymorphone
DB01200,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Bromocriptine.,Bromocriptine
DB01202,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Levetiracetam.,Levetiracetam
DB01209,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dezocine.,Dezocine
DB01215,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Estazolam.,Estazolam
DB01221,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ketamine.,Ketamine
DB01235,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Levodopa.,Levodopa
DB01236,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Sevoflurane.,Sevoflurane
DB01242,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Clomipramine.,Clomipramine
DB01246,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Alimemazine.,Alimemazine
DB01247,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Isocarboxazid.,Isocarboxazid
DB01253,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ergometrine.,Ergometrine
DB01267,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Paliperidone.,Paliperidone
DB01320,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fosphenytoin.,Fosphenytoin
DB01323,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with St. John's Wort.,St. John's Wort
DB01356,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lithium cation.,Lithium cation
DB01359,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Penbutolol.,Penbutolol
DB01367,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Rasagiline.,Rasagiline
DB01392,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Yohimbine.,Yohimbine
DB01433,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Methadyl acetate.,Methadyl acetate
DB01437,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Glutethimide.,Glutethimide
DB01440,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with gamma-Hydroxybutyric acid.,gamma-Hydroxybutyric acid
DB01442,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with MMDA.,MMDA
DB01445,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Bufotenine.,Bufotenine
DB01450,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dihydroetorphine.,Dihydroetorphine
DB01452,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Diamorphine.,Diamorphine
DB01454,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Midomafetamine.,Midomafetamine
DB01463,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fencamfamin.,Fencamfamin
DB01466,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ethylmorphine.,Ethylmorphine
DB01472,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with 4-Methoxyamphetamine.,4-Methoxyamphetamine
DB01484,"The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with 4-Bromo-2,5-dimethoxyamphetamine.","4-Bromo-2,5-dimethoxyamphetamine"
DB01488,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dimethyltryptamine.,Dimethyltryptamine
DB01489,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Camazepam.,Camazepam
DB01495,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dichloralphenazone.,Dichloralphenazone
DB01497,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Etorphine.,Etorphine
DB01501,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Difenoxin.,Difenoxin
DB01509,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tenamfetamine.,Tenamfetamine
DB01511,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Delorazepam.,Delorazepam
DB01529,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dextromoramide.,Dextromoramide
DB01531,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Desomorphine.,Desomorphine
DB01534,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Chlorhexadol.,Chlorhexadol
DB01535,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Carfentanil.,Carfentanil
DB01544,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Flunitrazepam.,Flunitrazepam
DB01545,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ethyl loflazepate.,Ethyl loflazepate
DB01547,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Drotebanol.,Drotebanol
DB01551,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dihydrocodeine.,Dihydrocodeine
DB01553,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cloxazolam.,Cloxazolam
DB01555,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Alphacetylmethadol.,Alphacetylmethadol
DB01558,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Bromazepam.,Bromazepam
DB01559,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Clotiazepam.,Clotiazepam
DB01560,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cathinone.,Cathinone
DB01563,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Chloral hydrate.,Chloral hydrate
DB01565,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dihydromorphine.,Dihydromorphine
DB01567,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fludiazepam.,Fludiazepam
DB01577,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Metamfetamine.,Metamfetamine
DB01580,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Oxprenolol.,Oxprenolol
DB01587,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ketazolam.,Ketazolam
DB01588,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Prazepam.,Prazepam
DB01589,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Quazepam.,Quazepam
DB01594,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cinolazepam.,Cinolazepam
DB01595,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Nitrazepam.,Nitrazepam
DB01608,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Periciazine.,Periciazine
DB01614,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Acepromazine.,Acepromazine
DB01615,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Aceprometazine.,Aceprometazine
DB01616,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Alverine.,Alverine
DB01618,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Molindone.,Molindone
DB01621,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pipotiazine.,Pipotiazine
DB01622,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Thioproperazine.,Thioproperazine
DB01623,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Thiothixene.,Thiothixene
DB01624,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Zuclopenthixol.,Zuclopenthixol
DB01626,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pargyline.,Pargyline
DB01954,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Rolipram.,Rolipram
DB02207,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with 7-Nitroindazole.,7-Nitroindazole
DB02234,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with S-Ethylisothiourea.,S-Ethylisothiourea
DB02852,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Domoic Acid.,Domoic Acid
DB02959,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Oxitriptan.,Oxitriptan
DB03575,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Phencyclidine.,Phencyclidine
DB04017,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Clorgiline.,Clorgiline
DB04165,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Valpromide.,Valpromide
DB04325,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Phenethylamine.,Phenethylamine
DB04599,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Aniracetam.,Aniracetam
DB04818,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Iproniazid.,Iproniazid
DB04819,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Methapyrilene.,Methapyrilene
DB04820,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Nialamide.,Nialamide
DB04821,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Nomifensine.,Nomifensine
DB04827,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Urethane.,Urethane
DB04829,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lysergic acid diethylamide.,Lysergic acid diethylamide
DB04833,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Methaqualone.,Methaqualone
DB04836,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Amineptine.,Amineptine
DB04841,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Flunarizine.,Flunarizine
DB04842,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fluspirilene.,Fluspirilene
DB04871,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lorcaserin.,Lorcaserin
DB04872,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Osanetant.,Osanetant
DB04885,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cilansetron.,Cilansetron
DB04888,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Bifeprunox.,Bifeprunox
DB04903,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pagoclone.,Pagoclone
DB04908,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Flibanserin.,Flibanserin
DB04917,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Renzapride.,Renzapride
DB04946,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Iloperidone.,Iloperidone
DB04953,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ezogabine.,Ezogabine
DB05227,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with APD791.,APD791
DB05232,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tetrodotoxin.,Tetrodotoxin
DB05246,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Methsuximide.,Methsuximide
DB05316,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pimavanserin.,Pimavanserin
DB05541,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Brivaracetam.,Brivaracetam
DB05542,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Naronapride.,Naronapride
DB05562,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Naluzotan.,Naluzotan
DB05607,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with PRX-08066.,PRX-08066
DB05687,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with BL-1020.,BL-1020
DB06016,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cariprazine.,Cariprazine
DB06077,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lumateperone.,Lumateperone
DB06109,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with YKP-1358.,YKP-1358
DB06144,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Sertindole.,Sertindole
DB06148,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Mianserin.,Mianserin
DB06216,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Asenapine.,Asenapine
DB06218,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lacosamide.,Lacosamide
DB06264,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tolperisone.,Tolperisone
DB06282,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Levocetirizine.,Levocetirizine
DB06283,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ziconotide.,Ziconotide
DB06288,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Amisulpride.,Amisulpride
DB06446,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dotarizine.,Dotarizine
DB06458,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Remacemide.,Remacemide
DB06470,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Clomethiazole.,Clomethiazole
DB06512,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Deramciclane.,Deramciclane
DB06527,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tramiprosate.,Tramiprosate
DB06529,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ocinaplon.,Ocinaplon
DB06554,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Gaboxadol.,Gaboxadol
DB06579,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Adipiplon.,Adipiplon
DB06582,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dextofisopam.,Dextofisopam
DB06594,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Agomelatine.,Agomelatine
DB06654,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Safinamide.,Safinamide
DB06660,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Saredutant.,Saredutant
DB06678,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Esmirtazapine.,Esmirtazapine
DB06684,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Vilazodone.,Vilazodone
DB06690,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Nitrous oxide.,Nitrous oxide
DB06691,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Mepyramine.,Mepyramine
DB06701,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dexmethylphenidate.,Dexmethylphenidate
DB06716,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fospropofol.,Fospropofol
DB06738,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ketobemidone.,Ketobemidone
DB06753,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Triclofos.,Triclofos
DB06770,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Benzyl alcohol.,Benzyl alcohol
DB06797,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Mebutamate.,Mebutamate
DB08059,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Wortmannin.,Wortmannin
DB08329,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Sulthiame.,Sulthiame
DB08550,"The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.","7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline"
DB08810,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cinitapride.,Cinitapride
DB08811,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tofisopam.,Tofisopam
DB08815,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lurasidone.,Lurasidone
DB08839,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Serotonin.,Serotonin
DB08861,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with DPDPE.,DPDPE
DB08872,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Gabapentin enacarbil.,Gabapentin enacarbil
DB08892,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Arbaclofen Placarbil.,Arbaclofen Placarbil
DB08910,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pomalidomide.,Pomalidomide
DB08922,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Perospirone.,Perospirone
DB08927,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Amperozide.,Amperozide
DB08954,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ifenprodil.,Ifenprodil
DB08986,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Etifoxine.,Etifoxine
DB08992,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Eperisone.,Eperisone
DB08996,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dimetacrine.,Dimetacrine
DB09000,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cyamemazine.,Cyamemazine
DB09001,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Barbexaclone.,Barbexaclone
DB09011,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Beclamide.,Beclamide
DB09014,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Captodiame.,Captodiame
DB09016,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Butriptyline.,Butriptyline
DB09017,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Brotizolam.,Brotizolam
DB09021,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Benzoctamine.,Benzoctamine
DB09068,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Vortioxetine.,Vortioxetine
DB09071,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tasimelteon.,Tasimelteon
DB09118,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Stiripentol.,Stiripentol
DB09119,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Eslicarbazepine acetate.,Eslicarbazepine acetate
DB09128,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Brexpiprazole.,Brexpiprazole
DB09166,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Etizolam.,Etizolam
DB09174,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lofentanil.,Lofentanil
DB09184,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Edivoxetine.,Edivoxetine
DB09185,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Viloxazine.,Viloxazine
DB09186,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Nisoxetine.,Nisoxetine
DB09187,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lortalamine.,Lortalamine
DB09190,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Talopram.,Talopram
DB09194,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Etoperidone.,Etoperidone
DB09223,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Blonanserin.,Blonanserin
DB09224,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Melperone.,Melperone
DB09225,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Zotepine.,Zotepine
DB09226,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Brilaroxazine.,Brilaroxazine
DB09241,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Methylene blue.,Methylene blue
DB09243,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Hydracarbazine.,Hydracarbazine
DB09244,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pirlindole.,Pirlindole
DB09245,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Toloxatone.,Toloxatone
DB09246,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Benmoxin.,Benmoxin
DB09247,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Iproclozide.,Iproclozide
DB09248,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Mebanazine.,Mebanazine
DB09249,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Octamoxin.,Octamoxin
DB09250,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pheniprazine.,Pheniprazine
DB09251,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Phenoxypropazine.,Phenoxypropazine
DB09252,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pivhydrazine.,Pivhydrazine
DB09253,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Safrazine.,Safrazine
DB09254,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Caroxazone.,Caroxazone
DB09286,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pipamperone.,Pipamperone
DB09289,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tianeptine.,Tianeptine
DB09290,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ramosetron.,Ramosetron
DB09307,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Oxaprotiline.,Oxaprotiline
DB11130,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Opium.,Opium
DB11371,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Alfaxalone.,Alfaxalone
DB11376,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Azaperone.,Azaperone
DB11400,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Doramectin.,Doramectin
DB11428,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Medetomidine.,Medetomidine
DB11477,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Xylazine.,Xylazine
DB11540,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Propiopromazine.,Propiopromazine
DB11543,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Romifidine.,Romifidine
DB11549,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tiletamine.,Tiletamine
DB11552,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tricaine.,Tricaine
DB11555,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Zolazepam.,Zolazepam
DB11556,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Detomidine.,Detomidine
DB11582,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Thiocolchicoside.,Thiocolchicoside
DB11609,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Normethadone.,Normethadone
DB11664,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Psilocybin.,Psilocybin
DB11675,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Mosapride.,Mosapride
DB11686,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Iferanserin.,Iferanserin
DB11699,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tropisetron.,Tropisetron
DB11755,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tetrahydrocannabivarin.,Tetrahydrocannabivarin
DB11859,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Brexanolone.,Brexanolone
DB11868,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Etiracetam.,Etiracetam
DB11889,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lanicemine.,Lanicemine
DB11957,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Idalopirdine.,Idalopirdine
DB12071,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Vabicaserin.,Vabicaserin
DB12093,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tetrahydropalmatine.,Tetrahydropalmatine
DB12105,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Imagabalin.,Imagabalin
DB12110,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with m-Chlorophenylpiperazine.,m-Chlorophenylpiperazine
DB12111,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with MK-212.,MK-212
DB12131,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Vinpocetine.,Vinpocetine
DB12163,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Sarpogrelate.,Sarpogrelate
DB12177,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Eplivanserin.,Eplivanserin
DB12184,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Gepirone.,Gepirone
DB12229,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cerlapirdine.,Cerlapirdine
DB12273,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ecopipam.,Ecopipam
DB12308,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Eltanolone.,Eltanolone
DB12327,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Salvinorin A.,Salvinorin A
DB12338,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Carisbamate.,Carisbamate
DB12361,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Piclozotan.,Piclozotan
DB12395,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Esreboxetine.,Esreboxetine
DB12401,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Bromperidol.,Bromperidol
DB12427,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Orvepitant.,Orvepitant
DB12465,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ketanserin.,Ketanserin
DB12492,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Piritramide.,Piritramide
DB12518,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Raclopride.,Raclopride
DB12537,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Benzodiazepine.,Benzodiazepine
DB12576,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with AZD-3043.,AZD-3043
DB12590,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Indiplon.,Indiplon
DB12661,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Urapidil.,Urapidil
DB12710,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Perazine.,Perazine
DB12725,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with TD-8954.,TD-8954
DB12833,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tandospirone.,Tandospirone
DB12867,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Benperidol.,Benperidol
DB12883,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Eltoprazine.,Eltoprazine
DB12930,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Opipramol.,Opipramol
DB12951,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pivagabine.,Pivagabine
DB12958,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Prothipendyl.,Prothipendyl
DB13014,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Hypericin.,Hypericin
DB13025,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tiapride.,Tiapride
DB13082,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Nefiracetam.,Nefiracetam
DB13099,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Valnoctamide.,Valnoctamide
DB13114,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Amitriptylinoxide.,Amitriptylinoxide
DB13160,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Alphaprodine.,Alphaprodine
DB13213,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Butaperazine.,Butaperazine
DB13219,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Medifoxamine.,Medifoxamine
DB13221,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Apronalide.,Apronalide
DB13225,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dibenzepin.,Dibenzepin
DB13234,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Propanidid.,Propanidid
DB13246,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Quinupramine.,Quinupramine
DB13253,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Proxibarbal.,Proxibarbal
DB13256,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Clothiapine.,Clothiapine
DB13273,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Sultopride.,Sultopride
DB13303,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Febarbamate.,Febarbamate
DB13323,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Trichloroethylene.,Trichloroethylene
DB13324,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tetrazepam.,Tetrazepam
DB13331,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pyrithyldione.,Pyrithyldione
DB13335,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pinazepam.,Pinazepam
DB13352,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Deanol.,Deanol
DB13354,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Phenprobamate.,Phenprobamate
DB13357,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Styramate.,Styramate
DB13362,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pheneturide.,Pheneturide
DB13370,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Bromisoval.,Bromisoval
DB13377,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Vinbarbital.,Vinbarbital
DB13382,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Chlorproethazine.,Chlorproethazine
DB13384,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Melitracen.,Melitracen
DB13396,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Neocitrullamon.,Neocitrullamon
DB13402,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Acetylglycinamide chloral hydrate.,Acetylglycinamide chloral hydrate
DB13403,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Oxypertine.,Oxypertine
DB13411,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lofepramine.,Lofepramine
DB13414,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fenyramidol.,Fenyramidol
DB13420,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Thiazinam.,Thiazinam
DB13437,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Medazepam.,Medazepam
DB13455,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Phenibut.,Phenibut
DB13457,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Oxaflozane.,Oxaflozane
DB13478,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Meptazinol.,Meptazinol
DB13496,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Iprindole.,Iprindole
DB13520,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Metergoline.,Metergoline
DB13522,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Mebicar.,Mebicar
DB13523,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Veralipride.,Veralipride
DB13534,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Gedocarnil.,Gedocarnil
DB13541,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Iprazochrome.,Iprazochrome
DB13550,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Bifemelane.,Bifemelane
DB13552,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Trifluperidol.,Trifluperidol
DB13554,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Moperone.,Moperone
DB13557,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Thiopropazate.,Thiopropazate
DB13572,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Emylcamate.,Emylcamate
DB13577,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Allobarbital.,Allobarbital
DB13588,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Naftidrofuryl.,Naftidrofuryl
DB13598,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Diethyl ether.,Diethyl ether
DB13601,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Oxiracetam.,Oxiracetam
DB13605,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Phenoperidine.,Phenoperidine
DB13606,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Phenazocine.,Phenazocine
DB13623,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fabomotizole.,Fabomotizole
DB13642,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pridinol.,Pridinol
DB13643,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Loprazolam.,Loprazolam
DB13662,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Hexapropymate.,Hexapropymate
DB13665,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fluanisone.,Fluanisone
DB13676,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Mosapramine.,Mosapramine
DB13687,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Niaprazine.,Niaprazine
DB13690,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Vinyl ether.,Vinyl ether
DB13733,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Methylpentynol.,Methylpentynol
DB13737,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cyclobarbital.,Cyclobarbital
DB13745,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fazadinium bromide.,Fazadinium bromide
DB13754,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Mephenoxalone.,Mephenoxalone
DB13770,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Vinylbital.,Vinylbital
DB13782,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Imipramine oxide.,Imipramine oxide
DB13784,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dixyrazine.,Dixyrazine
DB13787,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tilidine.,Tilidine
DB13791,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Penfluridol.,Penfluridol
DB13799,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ethadione.,Ethadione
DB13805,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Reposal.,Reposal
DB13817,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Carbromal.,Carbromal
DB13837,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Doxefazepam.,Doxefazepam
DB13841,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Clopenthixol.,Clopenthixol
DB13872,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lormetazepam.,Lormetazepam
DB13875,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Harmaline.,Harmaline
DB13876,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Brofaromine.,Brofaromine
DB13940,"The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with 2,5-Dimethoxy-4-ethylthioamphetamine.","2,5-Dimethoxy-4-ethylthioamphetamine"
DB13948,"The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine.","N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine"
DB13984,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cyclopropane.,Cyclopropane
DB13993,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with MRK-409.,MRK-409
DB14010,"The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with 5-methoxy-N,N-dimethyltryptamine.","5-methoxy-N,N-dimethyltryptamine"
DB14028,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Nordazepam.,Nordazepam
DB14050,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cannabidivarin.,Cannabidivarin
DB14185,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Aripiprazole lauroxil.,Aripiprazole lauroxil
DB14509,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lithium carbonate.,Lithium carbonate
DB14575,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Eslicarbazepine.,Eslicarbazepine
DB14651,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Perphenazine enanthate.,Perphenazine enanthate
DB14672,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Oxazepam acetate.,Oxazepam acetate
DB14715,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cinazepam.,Cinazepam
DB14718,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pyrazolam.,Pyrazolam
DB14719,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Bentazepam.,Bentazepam
DB14754,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Solriamfetol.,Solriamfetol
DB15203,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with JNJ-26489112.,JNJ-26489112
DB15360,"The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Carfentanil, C-11.","Carfentanil, C-11"
DB11951,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lemborexant.,Lemborexant
DB00230,The therapeutic efficacy of Botulinum Toxin Type B can be increased when used in combination with Pregabalin.,Pregabalin
DB04948,The therapeutic efficacy of Botulinum Toxin Type B can be increased when used in combination with Lofexidine.,Lofexidine
DB00083,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Botulinum toxin type A.,Botulinum toxin type A
DB00184,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Nicotine.,Nicotine
DB08837,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tetraethylammonium.,Tetraethylammonium
DB08999,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cyclopentamine.,Cyclopentamine
DB00091,The risk or severity of adverse effects can be increased when Cyclosporine is combined with Botulinum Toxin Type B.,Cyclosporine
DB00254,The risk or severity of adverse effects can be increased when Doxycycline is combined with Botulinum Toxin Type B.,Doxycycline
DB00256,The risk or severity of adverse effects can be increased when Lymecycline is combined with Botulinum Toxin Type B.,Lymecycline
DB00314,The risk or severity of adverse effects can be increased when Capreomycin is combined with Botulinum Toxin Type B.,Capreomycin
DB00319,The risk or severity of adverse effects can be increased when Piperacillin is combined with Botulinum Toxin Type B.,Piperacillin
DB00452,The risk or severity of adverse effects can be increased when Framycetin is combined with Botulinum Toxin Type B.,Framycetin
DB00453,The risk or severity of adverse effects can be increased when Clomocycline is combined with Botulinum Toxin Type B.,Clomocycline
DB00468,The risk or severity of adverse effects can be increased when Quinine is combined with Botulinum Toxin Type B.,Quinine
DB00512,The risk or severity of adverse effects can be increased when Vancomycin is combined with Botulinum Toxin Type B.,Vancomycin
DB00560,The risk or severity of adverse effects can be increased when Tigecycline is combined with Botulinum Toxin Type B.,Tigecycline
DB00595,The risk or severity of adverse effects can be increased when Oxytetracycline is combined with Botulinum Toxin Type B.,Oxytetracycline
DB00608,The risk or severity of adverse effects can be increased when Chloroquine is combined with Botulinum Toxin Type B.,Chloroquine
DB00618,The risk or severity of adverse effects can be increased when Demeclocycline is combined with Botulinum Toxin Type B.,Demeclocycline
DB00684,The risk or severity of adverse effects can be increased when Tobramycin is combined with Botulinum Toxin Type B.,Tobramycin
DB00759,The risk or severity of adverse effects can be increased when Tetracycline is combined with Botulinum Toxin Type B.,Tetracycline
DB00798,The risk or severity of adverse effects can be increased when Gentamicin is combined with Botulinum Toxin Type B.,Gentamicin
DB00903,The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Botulinum Toxin Type B.,Etacrynic acid
DB00931,The risk or severity of adverse effects can be increased when Metacycline is combined with Botulinum Toxin Type B.,Metacycline
DB00955,The risk or severity of adverse effects can be increased when Netilmicin is combined with Botulinum Toxin Type B.,Netilmicin
DB00994,The risk or severity of adverse effects can be increased when Neomycin is combined with Botulinum Toxin Type B.,Neomycin
DB01035,The risk or severity of adverse effects can be increased when Procainamide is combined with Botulinum Toxin Type B.,Procainamide
DB01082,The risk or severity of adverse effects can be increased when Streptomycin is combined with Botulinum Toxin Type B.,Streptomycin
DB01111,The risk or severity of adverse effects can be increased when Colistimethate is combined with Botulinum Toxin Type B.,Colistimethate
DB01172,The risk or severity of adverse effects can be increased when Kanamycin is combined with Botulinum Toxin Type B.,Kanamycin
DB01190,The risk or severity of adverse effects can be increased when Clindamycin is combined with Botulinum Toxin Type B.,Clindamycin
DB01219,The risk or severity of adverse effects can be increased when Dantrolene is combined with Botulinum Toxin Type B.,Dantrolene
DB01301,The risk or severity of adverse effects can be increased when Rolitetracycline is combined with Botulinum Toxin Type B.,Rolitetracycline
DB01377,The risk or severity of adverse effects can be increased when Magnesium oxide is combined with Botulinum Toxin Type B.,Magnesium oxide
DB01378,The risk or severity of adverse effects can be increased when Magnesium cation is combined with Botulinum Toxin Type B.,Magnesium cation
DB01421,The risk or severity of adverse effects can be increased when Paromomycin is combined with Botulinum Toxin Type B.,Paromomycin
DB01627,The risk or severity of adverse effects can be increased when Lincomycin is combined with Botulinum Toxin Type B.,Lincomycin
DB03615,The risk or severity of adverse effects can be increased when Ribostamycin is combined with Botulinum Toxin Type B.,Ribostamycin
DB04263,The risk or severity of adverse effects can be increased when Geneticin is combined with Botulinum Toxin Type B.,Geneticin
DB04626,The risk or severity of adverse effects can be increased when Apramycin is combined with Botulinum Toxin Type B.,Apramycin
DB04729,The risk or severity of adverse effects can be increased when Gentamicin C1a is combined with Botulinum Toxin Type B.,Gentamicin C1a
DB04808,The risk or severity of adverse effects can be increased when Neamine is combined with Botulinum Toxin Type B.,Neamine
DB06696,The risk or severity of adverse effects can be increased when Arbekacin is combined with Botulinum Toxin Type B.,Arbekacin
DB06827,The risk or severity of adverse effects can be increased when Viomycin is combined with Botulinum Toxin Type B.,Viomycin
DB08437,The risk or severity of adverse effects can be increased when Puromycin is combined with Botulinum Toxin Type B.,Puromycin
DB09104,The risk or severity of adverse effects can be increased when Magnesium hydroxide is combined with Botulinum Toxin Type B.,Magnesium hydroxide
DB09281,The risk or severity of adverse effects can be increased when Magnesium trisilicate is combined with Botulinum Toxin Type B.,Magnesium trisilicate
DB09407,The risk or severity of adverse effects can be increased when Magnesium chloride is combined with Botulinum Toxin Type B.,Magnesium chloride
DB09409,The risk or severity of adverse effects can be increased when Magnesium acetate tetrahydrate is combined with Botulinum Toxin Type B.,Magnesium acetate tetrahydrate
DB09481,The risk or severity of adverse effects can be increased when Magnesium carbonate is combined with Botulinum Toxin Type B.,Magnesium carbonate
DB11110,The risk or severity of adverse effects can be increased when Magnesium citrate is combined with Botulinum Toxin Type B.,Magnesium citrate
DB11189,The risk or severity of adverse effects can be increased when Magnesium glycinate is combined with Botulinum Toxin Type B.,Magnesium glycinate
DB11230,The risk or severity of adverse effects can be increased when Magnesium Aluminum Silicate is combined with Botulinum Toxin Type B.,Magnesium Aluminum Silicate
DB11512,The risk or severity of adverse effects can be increased when Dihydrostreptomycin is combined with Botulinum Toxin Type B.,Dihydrostreptomycin
DB11520,The risk or severity of adverse effects can be increased when Hygromycin B is combined with Botulinum Toxin Type B.,Hygromycin B
DB12604,The risk or severity of adverse effects can be increased when Sisomicin is combined with Botulinum Toxin Type B.,Sisomicin
DB12615,The risk or severity of adverse effects can be increased when Plazomicin is combined with Botulinum Toxin Type B.,Plazomicin
DB13249,The risk or severity of adverse effects can be increased when Magnesium silicate is combined with Botulinum Toxin Type B.,Magnesium silicate
DB13264,The risk or severity of adverse effects can be increased when Penimepicycline is combined with Botulinum Toxin Type B.,Penimepicycline
DB13270,The risk or severity of adverse effects can be increased when Dibekacin is combined with Botulinum Toxin Type B.,Dibekacin
DB13274,The risk or severity of adverse effects can be increased when Micronomicin is combined with Botulinum Toxin Type B.,Micronomicin
DB13359,The risk or severity of adverse effects can be increased when Magnesium aspartate is combined with Botulinum Toxin Type B.,Magnesium aspartate
DB13540,The risk or severity of adverse effects can be increased when Isepamicin is combined with Botulinum Toxin Type B.,Isepamicin
DB13673,The risk or severity of adverse effects can be increased when Bekanamycin is combined with Botulinum Toxin Type B.,Bekanamycin
DB13749,The risk or severity of adverse effects can be increased when Magnesium gluconate is combined with Botulinum Toxin Type B.,Magnesium gluconate
DB13786,The risk or severity of adverse effects can be increased when Magnesium orotate is combined with Botulinum Toxin Type B.,Magnesium orotate
DB13862,The risk or severity of adverse effects can be increased when Magnesium phosphate is combined with Botulinum Toxin Type B.,Magnesium phosphate
DB13996,The risk or severity of adverse effects can be increased when Magnesium acetate is combined with Botulinum Toxin Type B.,Magnesium acetate
DB05077,The risk or severity of adverse effects can be increased when SLV319 is combined with Botulinum Toxin Type B.,SLV319
DB06155,The risk or severity of adverse effects can be increased when Rimonabant is combined with Botulinum Toxin Type B.,Rimonabant
DB06624,The risk or severity of adverse effects can be increased when Taranabant is combined with Botulinum Toxin Type B.,Taranabant
DB09061,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Botulinum Toxin Type B.,Cannabidiol
DB11903,The risk or severity of adverse effects can be increased when GW842166 is combined with Botulinum Toxin Type B.,GW842166
DB12193,The risk or severity of adverse effects can be increased when Ajulemic acid is combined with Botulinum Toxin Type B.,Ajulemic acid
DB12649,The risk or severity of adverse effects can be increased when Ibipinabant is combined with Botulinum Toxin Type B.,Ibipinabant
DB13070,The risk or severity of adverse effects can be increased when Surinabant is combined with Botulinum Toxin Type B.,Surinabant
DB13950,The risk or severity of adverse effects can be increased when WIN 55212-2 is combined with Botulinum Toxin Type B.,WIN 55212-2
DB14011,The risk or severity of adverse effects can be increased when Nabiximols is combined with Botulinum Toxin Type B.,Nabiximols
DB14043,The risk or severity of adverse effects can be increased when Palmidrol is combined with Botulinum Toxin Type B.,Palmidrol
DB14737,The risk or severity of adverse effects can be increased when Cannabinol is combined with Botulinum Toxin Type B.,Cannabinol
DB11823,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Esketamine.,Esketamine
DB00395,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Botulinum Toxin Type B.,Carisoprodol
DB00704,The risk or severity of respiratory depression can be increased when Naltrexone is combined with Botulinum Toxin Type B.,Naltrexone
DB01459,The risk or severity of respiratory depression can be increased when Bezitramide is combined with Botulinum Toxin Type B.,Bezitramide
DB09272,The risk or severity of respiratory depression can be increased when Eluxadoline is combined with Botulinum Toxin Type B.,Eluxadoline
DB13454,The risk or severity of respiratory depression can be increased when Nicomorphine is combined with Botulinum Toxin Type B.,Nicomorphine
DB15465,The risk or severity of respiratory depression can be increased when Benzhydrocodone is combined with Botulinum Toxin Type B.,Benzhydrocodone
DB00402,The risk or severity of CNS depression can be increased when Botulinum Toxin Type B is combined with Eszopiclone.,Eszopiclone
DB00575,The risk or severity of sedation can be increased when Clonidine is combined with Botulinum Toxin Type B.,Clonidine
DB00924,The risk or severity of CNS depression can be increased when Botulinum Toxin Type B is combined with Cyclobenzaprine.,Cyclobenzaprine
DB01233,The risk or severity of sedation can be increased when Metoclopramide is combined with Botulinum Toxin Type B.,Metoclopramide
DB11732,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lasmiditan.,Lasmiditan
DB00193,The risk or severity of CNS depression can be increased when Tramadol is combined with Botulinum Toxin Type B.,Tramadol
DB00246,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Botulinum Toxin Type B.,Ziprasidone
DB00502,The risk or severity of CNS depression can be increased when Botulinum Toxin Type B is combined with Haloperidol.,Haloperidol
DB00472,Fluoxetine may increase the central nervous system depressant (CNS depressant) activities of Botulinum Toxin Type B.,Fluoxetine
DB00408,The therapeutic efficacy of Omalizumab can be decreased when used in combination with Loxapine.,Loxapine
DB00255,Diethylstilbestrol may increase the thrombogenic activities of Omalizumab.,Diethylstilbestrol
DB00269,Chlorotrianisene may increase the thrombogenic activities of Omalizumab.,Chlorotrianisene
DB00286,Conjugated estrogens may increase the thrombogenic activities of Omalizumab.,Conjugated estrogens
DB00655,Estrone may increase the thrombogenic activities of Omalizumab.,Estrone
DB00783,Estradiol may increase the thrombogenic activities of Omalizumab.,Estradiol
DB00890,Dienestrol may increase the thrombogenic activities of Omalizumab.,Dienestrol
DB00977,Ethinylestradiol may increase the thrombogenic activities of Omalizumab.,Ethinylestradiol
DB01357,Mestranol may increase the thrombogenic activities of Omalizumab.,Mestranol
DB04573,Estriol may increase the thrombogenic activities of Omalizumab.,Estriol
DB04574,Estrone sulfate may increase the thrombogenic activities of Omalizumab.,Estrone sulfate
DB04575,Quinestrol may increase the thrombogenic activities of Omalizumab.,Quinestrol
DB07931,Hexestrol may increase the thrombogenic activities of Omalizumab.,Hexestrol
DB09070,Tibolone may increase the thrombogenic activities of Omalizumab.,Tibolone
DB09317,"Synthetic Conjugated Estrogens, A may increase the thrombogenic activities of Omalizumab.","Synthetic Conjugated Estrogens, A"
DB09318,"Synthetic Conjugated Estrogens, B may increase the thrombogenic activities of Omalizumab.","Synthetic Conjugated Estrogens, B"
DB09369,Polyestradiol phosphate may increase the thrombogenic activities of Omalizumab.,Polyestradiol phosphate
DB09381,Esterified estrogens may increase the thrombogenic activities of Omalizumab.,Esterified estrogens
DB11478,Zeranol may increase the thrombogenic activities of Omalizumab.,Zeranol
DB11674,Equol may increase the thrombogenic activities of Omalizumab.,Equol
DB12487,Promestriene may increase the thrombogenic activities of Omalizumab.,Promestriene
DB13143,Methallenestril may increase the thrombogenic activities of Omalizumab.,Methallenestril
DB13386,Epimestrol may increase the thrombogenic activities of Omalizumab.,Epimestrol
DB13418,Moxestrol may increase the thrombogenic activities of Omalizumab.,Moxestrol
DB13952,Estradiol acetate may increase the thrombogenic activities of Omalizumab.,Estradiol acetate
DB13953,Estradiol benzoate may increase the thrombogenic activities of Omalizumab.,Estradiol benzoate
DB13954,Estradiol cypionate may increase the thrombogenic activities of Omalizumab.,Estradiol cypionate
DB13956,Estradiol valerate may increase the thrombogenic activities of Omalizumab.,Estradiol valerate
DB15334,Biochanin A may increase the thrombogenic activities of Omalizumab.,Biochanin A
DB15335,Formononetin may increase the thrombogenic activities of Omalizumab.,Formononetin
DB00002,The risk or severity of adverse effects can be increased when Cetuximab is combined with Omalizumab.,Cetuximab
DB00028,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Omalizumab.,Human immunoglobulin G
DB00051,The risk or severity of adverse effects can be increased when Omalizumab is combined with Adalimumab.,Adalimumab
DB00054,The risk or severity of adverse effects can be increased when Omalizumab is combined with Abciximab.,Abciximab
DB00056,The risk or severity of adverse effects can be increased when Omalizumab is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin
DB00057,The risk or severity of adverse effects can be increased when Omalizumab is combined with Indium In-111 satumomab pendetide.,Indium In-111 satumomab pendetide
DB00065,The risk or severity of adverse effects can be increased when Omalizumab is combined with Infliximab.,Infliximab
DB00072,The risk or severity of adverse effects can be increased when Omalizumab is combined with Trastuzumab.,Trastuzumab
DB00073,The risk or severity of adverse effects can be increased when Omalizumab is combined with Rituximab.,Rituximab
DB00074,The risk or severity of adverse effects can be increased when Omalizumab is combined with Basiliximab.,Basiliximab
DB00075,The risk or severity of adverse effects can be increased when Omalizumab is combined with Muromonab.,Muromonab
DB00076,The risk or severity of adverse effects can be increased when Omalizumab is combined with Digoxin Immune Fab (Ovine).,Digoxin Immune Fab (Ovine)
DB00078,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ibritumomab tiuxetan.,Ibritumomab tiuxetan
DB00081,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tositumomab.,Tositumomab
DB00087,The risk or severity of adverse effects can be increased when Omalizumab is combined with Alemtuzumab.,Alemtuzumab
DB00089,The risk or severity of adverse effects can be increased when Omalizumab is combined with Capromab pendetide.,Capromab pendetide
DB00095,The risk or severity of adverse effects can be increased when Omalizumab is combined with Efalizumab.,Efalizumab
DB00098,The risk or severity of adverse effects can be increased when Omalizumab is combined with Antithymocyte immunoglobulin (rabbit).,Antithymocyte immunoglobulin (rabbit)
DB00108,The risk or severity of adverse effects can be increased when Omalizumab is combined with Natalizumab.,Natalizumab
DB00110,The risk or severity of adverse effects can be increased when Omalizumab is combined with Palivizumab.,Palivizumab
DB00111,The risk or severity of adverse effects can be increased when Omalizumab is combined with Daclizumab.,Daclizumab
DB00112,The risk or severity of adverse effects can be increased when Omalizumab is combined with Bevacizumab.,Bevacizumab
DB00113,The risk or severity of adverse effects can be increased when Omalizumab is combined with Technetium Tc-99m arcitumomab.,Technetium Tc-99m arcitumomab
DB01257,The risk or severity of adverse effects can be increased when Omalizumab is combined with Eculizumab.,Eculizumab
DB01269,The risk or severity of adverse effects can be increased when Omalizumab is combined with Panitumumab.,Panitumumab
DB01270,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ranibizumab.,Ranibizumab
DB04901,The risk or severity of adverse effects can be increased when Omalizumab is combined with Galiximab.,Galiximab
DB04949,The risk or severity of adverse effects can be increased when Omalizumab is combined with Pexelizumab.,Pexelizumab
DB04956,The risk or severity of adverse effects can be increased when Omalizumab is combined with Afelimomab.,Afelimomab
DB04958,The risk or severity of adverse effects can be increased when Omalizumab is combined with Epratuzumab.,Epratuzumab
DB04962,The risk or severity of adverse effects can be increased when Omalizumab is combined with Bectumomab.,Bectumomab
DB04964,The risk or severity of adverse effects can be increased when Omalizumab is combined with Oregovomab.,Oregovomab
DB04988,The risk or severity of adverse effects can be increased when Omalizumab is combined with IGN311.,IGN311
DB05006,The risk or severity of adverse effects can be increased when Omalizumab is combined with Adecatumumab.,Adecatumumab
DB05097,The risk or severity of adverse effects can be increased when Omalizumab is combined with Labetuzumab.,Labetuzumab
DB05101,The risk or severity of adverse effects can be increased when Omalizumab is combined with Matuzumab.,Matuzumab
DB05111,The risk or severity of adverse effects can be increased when Omalizumab is combined with Fontolizumab.,Fontolizumab
DB05136,The risk or severity of adverse effects can be increased when Omalizumab is combined with Bavituximab.,Bavituximab
DB05139,The risk or severity of adverse effects can be increased when Omalizumab is combined with CR002.,CR002
DB05209,The risk or severity of adverse effects can be increased when Omalizumab is combined with Rozrolimupab.,Rozrolimupab
DB05304,The risk or severity of adverse effects can be increased when Omalizumab is combined with Girentuximab.,Girentuximab
DB05336,The risk or severity of adverse effects can be increased when Omalizumab is combined with Obiltoxaximab.,Obiltoxaximab
DB05405,The risk or severity of adverse effects can be increased when Omalizumab is combined with XTL-001.,XTL-001
DB05437,The risk or severity of adverse effects can be increased when Omalizumab is combined with NAV 1800.,NAV 1800
DB05459,The risk or severity of adverse effects can be increased when Omalizumab is combined with Briakinumab.,Briakinumab
DB05496,The risk or severity of adverse effects can be increased when Omalizumab is combined with Otelixizumab.,Otelixizumab
DB05545,The risk or severity of adverse effects can be increased when Omalizumab is combined with AMG 108.,AMG 108
DB05550,The risk or severity of adverse effects can be increased when Omalizumab is combined with Iratumumab.,Iratumumab
DB05555,The risk or severity of adverse effects can be increased when Omalizumab is combined with Enokizumab.,Enokizumab
DB05578,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ramucirumab.,Ramucirumab
DB05595,The risk or severity of adverse effects can be increased when Omalizumab is combined with Farletuzumab.,Farletuzumab
DB05656,The risk or severity of adverse effects can be increased when Omalizumab is combined with Veltuzumab.,Veltuzumab
DB05679,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ustekinumab.,Ustekinumab
DB05773,The risk or severity of adverse effects can be increased when Omalizumab is combined with Trastuzumab emtansine.,Trastuzumab emtansine
DB05793,The risk or severity of adverse effects can be increased when Omalizumab is combined with PRO-542.,PRO-542
DB05797,The risk or severity of adverse effects can be increased when Omalizumab is combined with TNX-901.,TNX-901
DB05889,The risk or severity of adverse effects can be increased when Omalizumab is combined with Inotuzumab ozogamicin.,Inotuzumab ozogamicin
DB05892,The risk or severity of adverse effects can be increased when Omalizumab is combined with RI 624.,RI 624
DB05915,The risk or severity of adverse effects can be increased when Omalizumab is combined with MYO-029.,MYO-029
DB05916,The risk or severity of adverse effects can be increased when Omalizumab is combined with CT-011.,CT-011
DB05941,The risk or severity of adverse effects can be increased when Omalizumab is combined with Leronlimab.,Leronlimab
DB05996,The risk or severity of adverse effects can be increased when Omalizumab is combined with Glembatumumab vedotin.,Glembatumumab vedotin
DB06043,The risk or severity of adverse effects can be increased when Omalizumab is combined with Olaratumab.,Olaratumab
DB06049,The risk or severity of adverse effects can be increased when Omalizumab is combined with IPH 2101.,IPH 2101
DB06050,The risk or severity of adverse effects can be increased when Omalizumab is combined with TB-402.,TB-402
DB06081,The risk or severity of adverse effects can be increased when Omalizumab is combined with Caplacizumab.,Caplacizumab
DB06101,The risk or severity of adverse effects can be increased when Omalizumab is combined with IMC-1C11.,IMC-1C11
DB06116,The risk or severity of adverse effects can be increased when Omalizumab is combined with Eldelumab.,Eldelumab
DB06162,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lumiliximab.,Lumiliximab
DB06168,The risk or severity of adverse effects can be increased when Omalizumab is combined with Canakinumab.,Canakinumab
DB06186,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ipilimumab.,Ipilimumab
DB06192,The risk or severity of adverse effects can be increased when Omalizumab is combined with Nimotuzumab.,Nimotuzumab
DB06241,The risk or severity of adverse effects can be increased when Omalizumab is combined with Clenoliximab.,Clenoliximab
DB06273,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tocilizumab.,Tocilizumab
DB06304,The risk or severity of adverse effects can be increased when Omalizumab is combined with BIIB015.,BIIB015
DB06305,The risk or severity of adverse effects can be increased when Omalizumab is combined with Sonepcizumab.,Sonepcizumab
DB06310,The risk or severity of adverse effects can be increased when Omalizumab is combined with Motavizumab.,Motavizumab
DB06317,The risk or severity of adverse effects can be increased when Omalizumab is combined with Elotuzumab.,Elotuzumab
DB06318,The risk or severity of adverse effects can be increased when Omalizumab is combined with AVE9633.,AVE9633
DB06322,The risk or severity of adverse effects can be increased when Omalizumab is combined with Carotuximab.,Carotuximab
DB06324,The risk or severity of adverse effects can be increased when Omalizumab is combined with XmAb 2513.,XmAb 2513
DB06342,The risk or severity of adverse effects can be increased when Omalizumab is combined with Coltuximab ravtansine.,Coltuximab ravtansine
DB06343,The risk or severity of adverse effects can be increased when Omalizumab is combined with Teprotumumab.,Teprotumumab
DB06360,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lucatumumab.,Lucatumumab
DB06366,The risk or severity of adverse effects can be increased when Omalizumab is combined with Pertuzumab.,Pertuzumab
DB06371,The risk or severity of adverse effects can be increased when Omalizumab is combined with Siplizumab.,Siplizumab
DB06467,The risk or severity of adverse effects can be increased when Omalizumab is combined with Apolizumab.,Apolizumab
DB06474,The risk or severity of adverse effects can be increased when Omalizumab is combined with Sibrotuzumab.,Sibrotuzumab
DB06550,The risk or severity of adverse effects can be increased when Omalizumab is combined with Bivatuzumab.,Bivatuzumab
DB06557,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lerdelimumab.,Lerdelimumab
DB06599,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lexatumumab.,Lexatumumab
DB06602,The risk or severity of adverse effects can be increased when Omalizumab is combined with Reslizumab.,Reslizumab
DB06606,The risk or severity of adverse effects can be increased when Omalizumab is combined with Teplizumab.,Teplizumab
DB06607,The risk or severity of adverse effects can be increased when Omalizumab is combined with Catumaxomab.,Catumaxomab
DB06612,The risk or severity of adverse effects can be increased when Omalizumab is combined with Mepolizumab.,Mepolizumab
DB06643,The risk or severity of adverse effects can be increased when Omalizumab is combined with Denosumab.,Denosumab
DB06647,The risk or severity of adverse effects can be increased when Omalizumab is combined with Volociximab.,Volociximab
DB06650,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ofatumumab.,Ofatumumab
DB06674,The risk or severity of adverse effects can be increased when Omalizumab is combined with Golimumab.,Golimumab
DB08870,The risk or severity of adverse effects can be increased when Omalizumab is combined with Brentuximab vedotin.,Brentuximab vedotin
DB08879,The risk or severity of adverse effects can be increased when Omalizumab is combined with Belimumab.,Belimumab
DB08902,The risk or severity of adverse effects can be increased when Omalizumab is combined with Raxibacumab.,Raxibacumab
DB08904,The risk or severity of adverse effects can be increased when Omalizumab is combined with Certolizumab pegol.,Certolizumab pegol
DB08935,The risk or severity of adverse effects can be increased when Omalizumab is combined with Obinutuzumab.,Obinutuzumab
DB09029,The risk or severity of adverse effects can be increased when Omalizumab is combined with Secukinumab.,Secukinumab
DB09033,The risk or severity of adverse effects can be increased when Omalizumab is combined with Vedolizumab.,Vedolizumab
DB09035,The risk or severity of adverse effects can be increased when Omalizumab is combined with Nivolumab.,Nivolumab
DB09036,The risk or severity of adverse effects can be increased when Omalizumab is combined with Siltuximab.,Siltuximab
DB09037,The risk or severity of adverse effects can be increased when Omalizumab is combined with Pembrolizumab.,Pembrolizumab
DB09045,The risk or severity of adverse effects can be increased when Omalizumab is combined with Dulaglutide.,Dulaglutide
DB09052,The risk or severity of adverse effects can be increased when Omalizumab is combined with Blinatumomab.,Blinatumomab
DB09057,The risk or severity of adverse effects can be increased when Omalizumab is combined with Anthrax immune globulin human.,Anthrax immune globulin human
DB09077,The risk or severity of adverse effects can be increased when Omalizumab is combined with Dinutuximab.,Dinutuximab
DB09105,The risk or severity of adverse effects can be increased when Omalizumab is combined with Asfotase alfa.,Asfotase alfa
DB09264,The risk or severity of adverse effects can be increased when Omalizumab is combined with Idarucizumab.,Idarucizumab
DB09302,The risk or severity of adverse effects can be increased when Omalizumab is combined with Alirocumab.,Alirocumab
DB09303,The risk or severity of adverse effects can be increased when Omalizumab is combined with Evolocumab.,Evolocumab
DB09312,The risk or severity of adverse effects can be increased when Omalizumab is combined with Antilymphocyte immunoglobulin (horse).,Antilymphocyte immunoglobulin (horse)
DB09331,The risk or severity of adverse effects can be increased when Omalizumab is combined with Daratumumab.,Daratumumab
DB09559,The risk or severity of adverse effects can be increased when Omalizumab is combined with Necitumumab.,Necitumumab
DB11569,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ixekizumab.,Ixekizumab
DB11580,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ravulizumab.,Ravulizumab
DB11595,The risk or severity of adverse effects can be increased when Omalizumab is combined with Atezolizumab.,Atezolizumab
DB11604,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tetanus Immune Globulin.,Tetanus Immune Globulin
DB11608,The risk or severity of adverse effects can be increased when Omalizumab is combined with Eftrenonacog alfa.,Eftrenonacog alfa
DB11621,The risk or severity of adverse effects can be increased when Omalizumab is combined with Human Varicella-Zoster Immune Globulin.,Human Varicella-Zoster Immune Globulin
DB11646,The risk or severity of adverse effects can be increased when Omalizumab is combined with Conatumumab.,Conatumumab
DB11657,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tabalumab.,Tabalumab
DB11680,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ficlatuzumab.,Ficlatuzumab
DB11685,The risk or severity of adverse effects can be increased when Omalizumab is combined with Figitumumab.,Figitumumab
DB11714,The risk or severity of adverse effects can be increased when Omalizumab is combined with Durvalumab.,Durvalumab
DB11715,The risk or severity of adverse effects can be increased when Omalizumab is combined with Bapineuzumab.,Bapineuzumab
DB11731,The risk or severity of adverse effects can be increased when Omalizumab is combined with Depatuxizumab mafodotin.,Depatuxizumab mafodotin
DB11746,The risk or severity of adverse effects can be increased when Omalizumab is combined with Onartuzumab.,Onartuzumab
DB11756,The risk or severity of adverse effects can be increased when Omalizumab is combined with Solanezumab.,Solanezumab
DB11767,The risk or severity of adverse effects can be increased when Omalizumab is combined with Sarilumab.,Sarilumab
DB11771,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tremelimumab.,Tremelimumab
DB11776,The risk or severity of adverse effects can be increased when Omalizumab is combined with Brodalumab.,Brodalumab
DB11803,The risk or severity of adverse effects can be increased when Omalizumab is combined with Sirukumab.,Sirukumab
DB11826,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lampalizumab.,Lampalizumab
DB11834,The risk or severity of adverse effects can be increased when Omalizumab is combined with Guselkumab.,Guselkumab
DB11840,The risk or severity of adverse effects can be increased when Omalizumab is combined with Dalotuzumab.,Dalotuzumab
DB11849,The risk or severity of adverse effects can be increased when Omalizumab is combined with Emibetuzumab.,Emibetuzumab
DB11850,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ublituximab.,Ublituximab
DB11856,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ligelizumab.,Ligelizumab
DB11857,The risk or severity of adverse effects can be increased when Omalizumab is combined with Seribantumab.,Seribantumab
DB11862,The risk or severity of adverse effects can be increased when Omalizumab is combined with Landogrozumab.,Landogrozumab
DB11866,The risk or severity of adverse effects can be increased when Omalizumab is combined with Romosozumab.,Romosozumab
DB11884,The risk or severity of adverse effects can be increased when Omalizumab is combined with Vadastuximab Talirine.,Vadastuximab Talirine
DB11914,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lebrikizumab.,Lebrikizumab
DB11930,The risk or severity of adverse effects can be increased when Omalizumab is combined with Varlilumab.,Varlilumab
DB11945,The risk or severity of adverse effects can be increased when Omalizumab is combined with Avelumab.,Avelumab
DB11959,The risk or severity of adverse effects can be increased when Omalizumab is combined with Crenezumab.,Crenezumab
DB11972,The risk or severity of adverse effects can be increased when Omalizumab is combined with Rilotumumab.,Rilotumumab
DB11976,The risk or severity of adverse effects can be increased when Omalizumab is combined with Anifrolumab.,Anifrolumab
DB11988,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ocrelizumab.,Ocrelizumab
DB12023,The risk or severity of adverse effects can be increased when Omalizumab is combined with Benralizumab.,Benralizumab
DB12034,The risk or severity of adverse effects can be increased when Omalizumab is combined with Gantenerumab.,Gantenerumab
DB12053,The risk or severity of adverse effects can be increased when Omalizumab is combined with Visilizumab.,Visilizumab
DB12077,The risk or severity of adverse effects can be increased when Omalizumab is combined with Urelumab.,Urelumab
DB12089,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lorvotuzumab mertansine.,Lorvotuzumab mertansine
DB12090,The risk or severity of adverse effects can be increased when Omalizumab is combined with Patritumab.,Patritumab
DB12102,The risk or severity of adverse effects can be increased when Omalizumab is combined with Fulranumab.,Fulranumab
DB12104,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tarextumab.,Tarextumab
DB12118,The risk or severity of adverse effects can be increased when Omalizumab is combined with Sotatercept.,Sotatercept
DB12119,The risk or severity of adverse effects can be increased when Omalizumab is combined with Gevokizumab.,Gevokizumab
DB12142,The risk or severity of adverse effects can be increased when Omalizumab is combined with Duligotuzumab.,Duligotuzumab
DB12152,The risk or severity of adverse effects can be increased when Omalizumab is combined with Simtuzumab.,Simtuzumab
DB12157,The risk or severity of adverse effects can be increased when Omalizumab is combined with Fasinumab.,Fasinumab
DB12159,The risk or severity of adverse effects can be increased when Omalizumab is combined with Dupilumab.,Dupilumab
DB12169,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tralokinumab.,Tralokinumab
DB12189,The risk or severity of adverse effects can be increased when Omalizumab is combined with Etrolizumab.,Etrolizumab
DB12202,The risk or severity of adverse effects can be increased when Omalizumab is combined with Zalutumumab.,Zalutumumab
DB12205,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ganitumab.,Ganitumab
DB12213,The risk or severity of adverse effects can be increased when Omalizumab is combined with Etaracizumab.,Etaracizumab
DB12240,The risk or severity of adverse effects can be increased when Omalizumab is combined with Polatuzumab vedotin.,Polatuzumab vedotin
DB12246,The risk or severity of adverse effects can be increased when Omalizumab is combined with Inclacumab.,Inclacumab
DB12250,The risk or severity of adverse effects can be increased when Omalizumab is combined with Cixutumumab.,Cixutumumab
DB12261,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ascrinvacumab.,Ascrinvacumab
DB12274,The risk or severity of adverse effects can be increased when Omalizumab is combined with Aducanumab.,Aducanumab
DB12281,The risk or severity of adverse effects can be increased when Omalizumab is combined with Luspatercept.,Luspatercept
DB12296,The risk or severity of adverse effects can be increased when Omalizumab is combined with GS-5745.,GS-5745
DB12317,The risk or severity of adverse effects can be increased when Omalizumab is combined with Vanucizumab.,Vanucizumab
DB12331,The risk or severity of adverse effects can be increased when Omalizumab is combined with Labetuzumab govitecan.,Labetuzumab govitecan
DB12335,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tanezumab.,Tanezumab
DB12342,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ensituximab.,Ensituximab
DB12344,The risk or severity of adverse effects can be increased when Omalizumab is combined with Fezakinumab.,Fezakinumab
DB12363,The risk or severity of adverse effects can be increased when Omalizumab is combined with Dusigitumab.,Dusigitumab
DB12396,The risk or severity of adverse effects can be increased when Omalizumab is combined with Fresolimumab.,Fresolimumab
DB12413,The risk or severity of adverse effects can be increased when Omalizumab is combined with Indusatumab vedotin.,Indusatumab vedotin
DB12456,The risk or severity of adverse effects can be increased when Omalizumab is combined with Bococizumab.,Bococizumab
DB12489,The risk or severity of adverse effects can be increased when Omalizumab is combined with Mirvetuximab Soravtansine.,Mirvetuximab Soravtansine
DB12498,The risk or severity of adverse effects can be increased when Omalizumab is combined with Mogamulizumab.,Mogamulizumab
DB12520,The risk or severity of adverse effects can be increased when Omalizumab is combined with Plozalizumab.,Plozalizumab
DB12530,The risk or severity of adverse effects can be increased when Omalizumab is combined with Inebilizumab.,Inebilizumab
DB12534,The risk or severity of adverse effects can be increased when Omalizumab is combined with Mavrilimumab.,Mavrilimumab
DB12560,The risk or severity of adverse effects can be increased when Omalizumab is combined with Blosozumab.,Blosozumab
DB12584,The risk or severity of adverse effects can be increased when Omalizumab is combined with Bimagrumab.,Bimagrumab
DB12589,The risk or severity of adverse effects can be increased when Omalizumab is combined with Dacetuzumab.,Dacetuzumab
DB12609,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tovetumab.,Tovetumab
DB12683,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lumretuzumab.,Lumretuzumab
DB12698,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ibalizumab.,Ibalizumab
DB12701,The risk or severity of adverse effects can be increased when Omalizumab is combined with Intetumumab.,Intetumumab
DB12718,The risk or severity of adverse effects can be increased when Omalizumab is combined with Carlumab.,Carlumab
DB12734,The risk or severity of adverse effects can be increased when Omalizumab is combined with Demcizumab.,Demcizumab
DB12773,The risk or severity of adverse effects can be increased when Omalizumab is combined with Sifalimumab.,Sifalimumab
DB12775,The risk or severity of adverse effects can be increased when Omalizumab is combined with Abituzumab.,Abituzumab
DB12797,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ecromeximab.,Ecromeximab
DB12807,The risk or severity of adverse effects can be increased when Omalizumab is combined with Naptumomab Estafenatox.,Naptumomab Estafenatox
DB12815,The risk or severity of adverse effects can be increased when Omalizumab is combined with Crotedumab.,Crotedumab
DB12820,The risk or severity of adverse effects can be increased when Omalizumab is combined with Concizumab.,Concizumab
DB12826,The risk or severity of adverse effects can be increased when Omalizumab is combined with Depatuxizumab.,Depatuxizumab
DB12844,The risk or severity of adverse effects can be increased when Omalizumab is combined with Rontalizumab.,Rontalizumab
DB12845,The risk or severity of adverse effects can be increased when Omalizumab is combined with Amatuximab.,Amatuximab
DB12849,The risk or severity of adverse effects can be increased when Omalizumab is combined with Clazakizumab.,Clazakizumab
DB12891,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ozanezumab.,Ozanezumab
DB12893,The risk or severity of adverse effects can be increased when Omalizumab is combined with Sacituzumab govitecan.,Sacituzumab govitecan
DB12917,The risk or severity of adverse effects can be increased when Omalizumab is combined with Bimekizumab.,Bimekizumab
DB12943,The risk or severity of adverse effects can be increased when Omalizumab is combined with Milatuzumab.,Milatuzumab
DB12976,The risk or severity of adverse effects can be increased when Omalizumab is combined with Robatumumab.,Robatumumab
DB13017,The risk or severity of adverse effects can be increased when Omalizumab is combined with Rovalpituzumab Tesirine.,Rovalpituzumab Tesirine
DB13037,The risk or severity of adverse effects can be increased when Omalizumab is combined with Namilumab.,Namilumab
DB13045,The risk or severity of adverse effects can be increased when Omalizumab is combined with Racotumomab.,Racotumomab
DB13073,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tregalizumab.,Tregalizumab
DB13127,The risk or severity of adverse effects can be increased when Omalizumab is combined with Olokizumab.,Olokizumab
DB13140,The risk or severity of adverse effects can be increased when Omalizumab is combined with Bezlotoxumab.,Bezlotoxumab
DB13375,The risk or severity of adverse effects can be increased when Omalizumab is combined with Edrecolomab.,Edrecolomab
DB13535,The risk or severity of adverse effects can be increased when Omalizumab is combined with Nebacumab.,Nebacumab
DB13886,The risk or severity of adverse effects can be increased when Omalizumab is combined with Human cytomegalovirus immune globulin.,Human cytomegalovirus immune globulin
DB13923,The risk or severity of adverse effects can be increased when Omalizumab is combined with Emicizumab.,Emicizumab
DB13976,The risk or severity of adverse effects can be increased when Omalizumab is combined with Sulesomab.,Sulesomab
DB13979,The risk or severity of adverse effects can be increased when Omalizumab is combined with Besilesomab.,Besilesomab
DB14004,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tildrakizumab.,Tildrakizumab
DB14012,The risk or severity of adverse effects can be increased when Omalizumab is combined with Burosumab.,Burosumab
DB14039,The risk or severity of adverse effects can be increased when Omalizumab is combined with Erenumab.,Erenumab
DB14040,The risk or severity of adverse effects can be increased when Omalizumab is combined with Eptinezumab.,Eptinezumab
DB14041,The risk or severity of adverse effects can be increased when Omalizumab is combined with Fremanezumab.,Fremanezumab
DB14042,The risk or severity of adverse effects can be increased when Omalizumab is combined with Galcanezumab.,Galcanezumab
DB14211,The risk or severity of adverse effects can be increased when Omalizumab is combined with Fanolesomab.,Fanolesomab
DB14580,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lecanemab.,Lecanemab
DB14597,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lanadelumab.,Lanadelumab
DB14707,The risk or severity of adverse effects can be increased when Omalizumab is combined with Cemiplimab.,Cemiplimab
DB14724,The risk or severity of adverse effects can be increased when Omalizumab is combined with Emapalumab.,Emapalumab
DB14762,The risk or severity of adverse effects can be increased when Omalizumab is combined with Risankizumab.,Risankizumab
DB14776,The risk or severity of adverse effects can be increased when Omalizumab is combined with Camrelizumab.,Camrelizumab
DB14778,The risk or severity of adverse effects can be increased when Omalizumab is combined with Setrusumab.,Setrusumab
DB14784,The risk or severity of adverse effects can be increased when Omalizumab is combined with Gancotamab.,Gancotamab
DB14809,The risk or severity of adverse effects can be increased when Omalizumab is combined with Anetumab ravtansine.,Anetumab ravtansine
DB14811,The risk or severity of adverse effects can be increased when Omalizumab is combined with Isatuximab.,Isatuximab
DB14824,The risk or severity of adverse effects can be increased when Omalizumab is combined with Icrucumab.,Icrucumab
DB14843,The risk or severity of adverse effects can be increased when Omalizumab is combined with Codrituzumab.,Codrituzumab
DB14864,The risk or severity of adverse effects can be increased when Omalizumab is combined with Brolucizumab.,Brolucizumab
DB14871,The risk or severity of adverse effects can be increased when Omalizumab is combined with Xentuzumab.,Xentuzumab
DB14877,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lintuzumab.,Lintuzumab
DB14891,The risk or severity of adverse effects can be increased when Omalizumab is combined with Vobarilizumab.,Vobarilizumab
DB14897,The risk or severity of adverse effects can be increased when Omalizumab is combined with Parsatuzumab.,Parsatuzumab
DB14905,The risk or severity of adverse effects can be increased when Omalizumab is combined with Emactuzumab.,Emactuzumab
DB14907,The risk or severity of adverse effects can be increased when Omalizumab is combined with Bevacizumab zirconium Zr-89.,Bevacizumab zirconium Zr-89
DB14908,The risk or severity of adverse effects can be increased when Omalizumab is combined with Refanezumab.,Refanezumab
DB14919,The risk or severity of adverse effects can be increased when Omalizumab is combined with Rozanolixizumab.,Rozanolixizumab
DB14947,The risk or severity of adverse effects can be increased when Omalizumab is combined with Bermekimab.,Bermekimab
DB14952,The risk or severity of adverse effects can be increased when Omalizumab is combined with Pamrevlumab.,Pamrevlumab
DB14959,The risk or severity of adverse effects can be increased when Omalizumab is combined with Opicinumab.,Opicinumab
DB14962,The risk or severity of adverse effects can be increased when Omalizumab is combined with Trastuzumab deruxtecan.,Trastuzumab deruxtecan
DB14967,The risk or severity of adverse effects can be increased when Omalizumab is combined with Margetuximab.,Margetuximab
DB14988,The risk or severity of adverse effects can be increased when Omalizumab is combined with Dalantercept.,Dalantercept
DB14997,The risk or severity of adverse effects can be increased when Omalizumab is combined with Pateclizumab.,Pateclizumab
DB15014,The risk or severity of adverse effects can be increased when Omalizumab is combined with Gremubamab.,Gremubamab
DB15022,The risk or severity of adverse effects can be increased when Omalizumab is combined with Apomab.,Apomab
DB15044,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tafasitamab.,Tafasitamab
DB15045,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ipafricept.,Ipafricept
DB15076,The risk or severity of adverse effects can be increased when Omalizumab is combined with Abrilumab.,Abrilumab
DB15089,The risk or severity of adverse effects can be increased when Omalizumab is combined with Frovocimab.,Frovocimab
DB15090,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tezepelumab.,Tezepelumab
DB15101,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tigatuzumab.,Tigatuzumab
DB15104,The risk or severity of adverse effects can be increased when Omalizumab is combined with Telisotuzumab vedotin.,Telisotuzumab vedotin
DB15113,The risk or severity of adverse effects can be increased when Omalizumab is combined with Utomilumab.,Utomilumab
DB15118,The risk or severity of adverse effects can be increased when Omalizumab is combined with Zolbetuximab.,Zolbetuximab
DB15135,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ponezumab.,Ponezumab
DB15160,The risk or severity of adverse effects can be increased when Omalizumab is combined with Asunercept.,Asunercept
DB15172,The risk or severity of adverse effects can be increased when Omalizumab is combined with Suvratoxumab.,Suvratoxumab
DB15225,The risk or severity of adverse effects can be increased when Omalizumab is combined with Mitazalimab.,Mitazalimab
DB15252,The risk or severity of adverse effects can be increased when Omalizumab is combined with Nemolizumab.,Nemolizumab
DB15253,The risk or severity of adverse effects can be increased when Omalizumab is combined with Bleselumab.,Bleselumab
DB15277,The risk or severity of adverse effects can be increased when Omalizumab is combined with Gedivumab.,Gedivumab
DB15336,The risk or severity of adverse effects can be increased when Omalizumab is combined with Valanafusp alfa.,Valanafusp alfa
DB15349,The risk or severity of adverse effects can be increased when Omalizumab is combined with Sofituzumab vedotin.,Sofituzumab vedotin
DB15354,The risk or severity of adverse effects can be increased when Omalizumab is combined with Evinacumab.,Evinacumab
DB15363,The risk or severity of adverse effects can be increased when Omalizumab is combined with Istiratumab.,Istiratumab
DB15383,The risk or severity of adverse effects can be increased when Omalizumab is combined with Pidilizumab.,Pidilizumab
DB15397,The risk or severity of adverse effects can be increased when Omalizumab is combined with GMA-161.,GMA-161
DB15409,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ladiratuzumab vedotin.,Ladiratuzumab vedotin
DB15415,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tomaralimab.,Tomaralimab
DB15428,The risk or severity of adverse effects can be increased when Omalizumab is combined with Vesencumab.,Vesencumab
DB15432,The risk or severity of adverse effects can be increased when Omalizumab is combined with Pinatuzumab vedotin.,Pinatuzumab vedotin
DB15441,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lulizumab pegol.,Lulizumab pegol
DB15443,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lorukafusp alfa.,Lorukafusp alfa
DB15453,The risk or severity of adverse effects can be increased when Omalizumab is combined with Naratuximab emtansine.,Naratuximab emtansine
DB15559,The risk or severity of adverse effects can be increased when Omalizumab is combined with Zenocutuzumab.,Zenocutuzumab
DB15595,"The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Omalizumab.","Ebola Zaire vaccine (live, attenuated)"
DB06655,Liraglutide may increase the hypoglycemic activities of Insulin lispro.,Liraglutide
DB09046,Metreleptin may increase the hypoglycemic activities of Insulin lispro.,Metreleptin
DB00082,The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Insulin lispro.,Pegvisomant
DB01132,The risk or severity of adverse effects can be increased when Pioglitazone is combined with Insulin lispro.,Pioglitazone
DB01278,Pramlintide may increase the hypoglycemic activities of Insulin lispro.,Pramlintide
DB00412,The risk or severity of congestive heart failure can be increased when Insulin lispro is combined with Rosiglitazone.,Rosiglitazone
DB00166,The risk or severity of hypoglycemia can be increased when Lipoic acid is combined with Insulin lispro.,Lipoic acid
DB00974,Edetic acid may increase the hypoglycemic activities of Insulin lispro.,Edetic acid
DB00187,Esmolol may increase the hypoglycemic activities of Insulin lispro.,Esmolol
DB00218,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Moxifloxacin.,Moxifloxacin
DB00365,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Grepafloxacin.,Grepafloxacin
DB00467,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Enoxacin.,Enoxacin
DB00487,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Pefloxacin.,Pefloxacin
DB00537,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Ciprofloxacin.,Ciprofloxacin
DB00685,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Trovafloxacin.,Trovafloxacin
DB00779,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Nalidixic acid.,Nalidixic acid
DB00817,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Rosoxacin.,Rosoxacin
DB00827,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Cinoxacin.,Cinoxacin
DB00978,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Lomefloxacin.,Lomefloxacin
DB01044,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Gatifloxacin.,Gatifloxacin
DB01059,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Norfloxacin.,Norfloxacin
DB01137,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Levofloxacin.,Levofloxacin
DB01155,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Gemifloxacin.,Gemifloxacin
DB01165,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Ofloxacin.,Ofloxacin
DB01208,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sparfloxacin.,Sparfloxacin
DB01405,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Temafloxacin.,Temafloxacin
DB04576,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Fleroxacin.,Fleroxacin
DB05488,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Technetium Tc-99m ciprofloxacin.,Technetium Tc-99m ciprofloxacin
DB06160,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Garenoxacin.,Garenoxacin
DB06600,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Nemonoxacin.,Nemonoxacin
DB08972,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Flumequine.,Flumequine
DB11404,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Enrofloxacin.,Enrofloxacin
DB11443,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Orbifloxacin.,Orbifloxacin
DB11491,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sarafloxacin.,Sarafloxacin
DB11511,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Difloxacin.,Difloxacin
DB11774,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Pazufloxacin.,Pazufloxacin
DB11892,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Prulifloxacin.,Prulifloxacin
DB11943,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Delafloxacin.,Delafloxacin
DB13261,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sitafloxacin.,Sitafloxacin
DB13627,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Oxolinic acid.,Oxolinic acid
DB13772,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Rufloxacin.,Rufloxacin
DB13823,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Pipemidic acid.,Pipemidic acid
DB00232,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Methyclothiazide.,Methyclothiazide
DB00310,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Chlorthalidone.,Chlorthalidone
DB00436,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Bendroflumethiazide.,Bendroflumethiazide
DB00524,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Metolazone.,Metolazone
DB00562,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Benzthiazide.,Benzthiazide
DB00774,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Hydroflumethiazide.,Hydroflumethiazide
DB00808,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Indapamide.,Indapamide
DB00880,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Chlorothiazide.,Chlorothiazide
DB00999,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Hydrochlorothiazide.,Hydrochlorothiazide
DB01021,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Trichlormethiazide.,Trichlormethiazide
DB01324,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Polythiazide.,Polythiazide
DB01325,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Quinethazone.,Quinethazone
DB13532,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Cyclopenthiazide.,Cyclopenthiazide
DB13989,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Epitizide.,Epitizide
DB00344,Protriptyline may decrease the hypoglycemic activities of Insulin lispro.,Protriptyline
DB00543,Amoxapine may decrease the hypoglycemic activities of Insulin lispro.,Amoxapine
DB00726,Trimipramine may decrease the hypoglycemic activities of Insulin lispro.,Trimipramine
DB04836,Amineptine may decrease the hypoglycemic activities of Insulin lispro.,Amineptine
DB08996,Dimetacrine may decrease the hypoglycemic activities of Insulin lispro.,Dimetacrine
DB09016,Butriptyline may decrease the hypoglycemic activities of Insulin lispro.,Butriptyline
DB09167,Dosulepin may decrease the hypoglycemic activities of Insulin lispro.,Dosulepin
DB09289,Tianeptine may decrease the hypoglycemic activities of Insulin lispro.,Tianeptine
DB09307,Oxaprotiline may decrease the hypoglycemic activities of Insulin lispro.,Oxaprotiline
DB12930,Opipramol may decrease the hypoglycemic activities of Insulin lispro.,Opipramol
DB13114,Amitriptylinoxide may decrease the hypoglycemic activities of Insulin lispro.,Amitriptylinoxide
DB13225,Dibenzepin may decrease the hypoglycemic activities of Insulin lispro.,Dibenzepin
DB13246,Quinupramine may decrease the hypoglycemic activities of Insulin lispro.,Quinupramine
DB13384,Melitracen may decrease the hypoglycemic activities of Insulin lispro.,Melitracen
DB13411,Lofepramine may decrease the hypoglycemic activities of Insulin lispro.,Lofepramine
DB13496,Iprindole may decrease the hypoglycemic activities of Insulin lispro.,Iprindole
DB13782,Imipramine oxide may decrease the hypoglycemic activities of Insulin lispro.,Imipramine oxide
DB06292,Dapagliflozin may increase the hypoglycemic activities of Insulin lispro.,Dapagliflozin
DB08907,Canagliflozin may increase the hypoglycemic activities of Insulin lispro.,Canagliflozin
DB00007,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Leuprolide.,Leuprolide
DB00014,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Goserelin.,Goserelin
DB00104,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Octreotide.,Octreotide
DB00220,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Nelfinavir.,Nelfinavir
DB00224,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Indinavir.,Indinavir
DB00246,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Ziprasidone.,Ziprasidone
DB00294,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Etonogestrel.,Etonogestrel
DB00304,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Desogestrel.,Desogestrel
DB00334,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Olanzapine.,Olanzapine
DB00351,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Megestrol acetate.,Megestrol acetate
DB00363,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Clozapine.,Clozapine
DB00367,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Levonorgestrel.,Levonorgestrel
DB00396,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Progesterone.,Progesterone
DB00477,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Chlorpromazine.,Chlorpromazine
DB00502,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Haloperidol.,Haloperidol
DB00503,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Ritonavir.,Ritonavir
DB00592,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Piperazine.,Piperazine
DB00603,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Medroxyprogesterone acetate.,Medroxyprogesterone acetate
DB00627,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Niacin.,Niacin
DB00668,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Epinephrine.,Epinephrine
DB00717,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Norethisterone.,Norethisterone
DB00734,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Risperidone.,Risperidone
DB00738,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Pentamidine.,Pentamidine
DB00823,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Ethynodiol diacetate.,Ethynodiol diacetate
DB00852,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Pseudoephedrine.,Pseudoephedrine
DB00864,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Tacrolimus.,Tacrolimus
DB00877,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Sirolimus.,Sirolimus
DB00903,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Etacrynic acid.,Etacrynic acid
DB00932,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Tipranavir.,Tipranavir
DB00957,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Norgestimate.,Norgestimate
DB00977,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Ethinylestradiol.,Ethinylestradiol
DB01072,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Atazanavir.,Atazanavir
DB01169,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Arsenic trioxide.,Arsenic trioxide
DB01224,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Quetiapine.,Quetiapine
DB01232,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Saquinavir.,Saquinavir
DB01238,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Aripiprazole.,Aripiprazole
DB01267,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Paliperidone.,Paliperidone
DB01319,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Fosamprenavir.,Fosamprenavir
DB01323,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with St. John's Wort.,St. John's Wort
DB01357,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Mestranol.,Mestranol
DB01363,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Ephedra sinica root.,Ephedra sinica root
DB01395,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Drospirenone.,Drospirenone
DB01403,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Methotrimeprazine.,Methotrimeprazine
DB01406,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Danazol.,Danazol
DB01590,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Everolimus.,Everolimus
DB01601,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Lopinavir.,Lopinavir
DB01621,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Pipotiazine.,Pipotiazine
DB02546,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Vorinostat.,Vorinostat
DB04574,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Estrone sulfate.,Estrone sulfate
DB04839,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Cyproterone acetate.,Cyproterone acetate
DB04868,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Nilotinib.,Nilotinib
DB04946,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Iloperidone.,Iloperidone
DB06216,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Asenapine.,Asenapine
DB06287,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Temsirolimus.,Temsirolimus
DB06663,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Pasireotide.,Pasireotide
DB06719,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Buserelin.,Buserelin
DB06788,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Histrelin.,Histrelin
DB06789,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Hydroxyprogesterone caproate.,Hydroxyprogesterone caproate
DB06791,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Lanreotide.,Lanreotide
DB06825,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Triptorelin.,Triptorelin
DB08815,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Lurasidone.,Lurasidone
DB08912,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Dabrafenib.,Dabrafenib
DB09009,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Articaine.,Articaine
DB09063,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Ceritinib.,Ceritinib
DB09123,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Dienogest.,Dienogest
DB09128,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Brexpiprazole.,Brexpiprazole
DB06343,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Teprotumumab.,Teprotumumab
DB00621,Oxandrolone may increase the hypoglycemic activities of Insulin lispro.,Oxandrolone
DB00624,Testosterone may increase the hypoglycemic activities of Insulin lispro.,Testosterone
DB00984,Nandrolone phenpropionate may increase the hypoglycemic activities of Insulin lispro.,Nandrolone phenpropionate
DB01185,Fluoxymesterone may increase the hypoglycemic activities of Insulin lispro.,Fluoxymesterone
DB01420,Testosterone propionate may increase the hypoglycemic activities of Insulin lispro.,Testosterone propionate
DB02901,Stanolone may increase the hypoglycemic activities of Insulin lispro.,Stanolone
DB06412,Oxymetholone may increase the hypoglycemic activities of Insulin lispro.,Oxymetholone
DB06710,Methyltestosterone may increase the hypoglycemic activities of Insulin lispro.,Methyltestosterone
DB06718,Stanozolol may increase the hypoglycemic activities of Insulin lispro.,Stanozolol
DB08804,Nandrolone decanoate may increase the hypoglycemic activities of Insulin lispro.,Nandrolone decanoate
DB12461,GLPG-0492 may increase the hypoglycemic activities of Insulin lispro.,GLPG-0492
DB13169,Nandrolone may increase the hypoglycemic activities of Insulin lispro.,Nandrolone
DB13587,Mesterolone may increase the hypoglycemic activities of Insulin lispro.,Mesterolone
DB13943,Testosterone cypionate may increase the hypoglycemic activities of Insulin lispro.,Testosterone cypionate
DB13944,Testosterone enanthate may increase the hypoglycemic activities of Insulin lispro.,Testosterone enanthate
DB00215,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Citalopram.,Citalopram
DB00230,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Pregabalin.,Pregabalin
DB00285,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Venlafaxine.,Venlafaxine
DB00328,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Indomethacin.,Indomethacin
DB01104,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Sertraline.,Sertraline
DB01149,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Nefazodone.,Nefazodone
DB01175,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Escitalopram.,Escitalopram
DB04832,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Zimelidine.,Zimelidine
DB04884,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Dapoxetine.,Dapoxetine
DB04896,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Milnacipran.,Milnacipran
DB06700,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Desvenlafaxine.,Desvenlafaxine
DB08918,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Levomilnacipran.,Levomilnacipran
DB08953,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Indalpine.,Indalpine
DB09270,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Ubidecarenone.,Ubidecarenone
DB12693,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Ritanserin.,Ritanserin
DB13233,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Alaproclate.,Alaproclate
DB13358,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Cibenzoline.,Cibenzoline
DB14025,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Clinafloxacin.,Clinafloxacin
DB09038,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Empagliflozin.,Empagliflozin
DB00233,Aminosalicylic acid may increase the hypoglycemic activities of Insulin lispro.,Aminosalicylic acid
DB00244,Mesalazine may increase the hypoglycemic activities of Insulin lispro.,Mesalazine
DB00795,Sulfasalazine may increase the hypoglycemic activities of Insulin lispro.,Sulfasalazine
DB00861,Diflunisal may increase the hypoglycemic activities of Insulin lispro.,Diflunisal
DB00936,Salicylic acid may increase the hypoglycemic activities of Insulin lispro.,Salicylic acid
DB01014,Balsalazide may increase the hypoglycemic activities of Insulin lispro.,Balsalazide
DB01250,Olsalazine may increase the hypoglycemic activities of Insulin lispro.,Olsalazine
DB01294,Bismuth subsalicylate may increase the hypoglycemic activities of Insulin lispro.,Bismuth subsalicylate
DB06251,Dersalazine may increase the hypoglycemic activities of Insulin lispro.,Dersalazine
DB06807,Phenyl aminosalicylate may increase the hypoglycemic activities of Insulin lispro.,Phenyl aminosalicylate
DB09543,Methyl salicylate may increase the hypoglycemic activities of Insulin lispro.,Methyl salicylate
DB11079,Trolamine salicylate may increase the hypoglycemic activities of Insulin lispro.,Trolamine salicylate
DB12445,Nitroaspirin may increase the hypoglycemic activities of Insulin lispro.,Nitroaspirin
DB13509,Aloxiprin may increase the hypoglycemic activities of Insulin lispro.,Aloxiprin
DB13538,Guacetisal may increase the hypoglycemic activities of Insulin lispro.,Guacetisal
DB13612,Carbaspirin calcium may increase the hypoglycemic activities of Insulin lispro.,Carbaspirin calcium
DB14006,Choline salicylate may increase the hypoglycemic activities of Insulin lispro.,Choline salicylate
DB14026,Thiosalicylic acid may increase the hypoglycemic activities of Insulin lispro.,Thiosalicylic acid
DB01261,Sitagliptin may increase the hypoglycemic activities of Insulin lispro.,Sitagliptin
DB04876,Vildagliptin may increase the hypoglycemic activities of Insulin lispro.,Vildagliptin
DB06011,AMG-222 may increase the hypoglycemic activities of Insulin lispro.,AMG-222
DB06127,Bisegliptin may increase the hypoglycemic activities of Insulin lispro.,Bisegliptin
DB06203,Alogliptin may increase the hypoglycemic activities of Insulin lispro.,Alogliptin
DB06335,Saxagliptin may increase the hypoglycemic activities of Insulin lispro.,Saxagliptin
DB08382,Gosogliptin may increase the hypoglycemic activities of Insulin lispro.,Gosogliptin
DB08882,Linagliptin may increase the hypoglycemic activities of Insulin lispro.,Linagliptin
DB11723,Dutogliptin may increase the hypoglycemic activities of Insulin lispro.,Dutogliptin
DB11950,Teneligliptin may increase the hypoglycemic activities of Insulin lispro.,Teneligliptin
DB11992,Omarigliptin may increase the hypoglycemic activities of Insulin lispro.,Omarigliptin
DB12268,Carmegliptin may increase the hypoglycemic activities of Insulin lispro.,Carmegliptin
DB12412,Gemigliptin may increase the hypoglycemic activities of Insulin lispro.,Gemigliptin
DB12417,Anagliptin may increase the hypoglycemic activities of Insulin lispro.,Anagliptin
DB12625,Evogliptin may increase the hypoglycemic activities of Insulin lispro.,Evogliptin
DB01276,Exenatide may increase the hypoglycemic activities of Insulin lispro.,Exenatide
DB09043,Albiglutide may increase the hypoglycemic activities of Insulin lispro.,Albiglutide
DB09045,Dulaglutide may increase the hypoglycemic activities of Insulin lispro.,Dulaglutide
DB09265,Lixisenatide may increase the hypoglycemic activities of Insulin lispro.,Lixisenatide
DB13928,Semaglutide may increase the hypoglycemic activities of Insulin lispro.,Semaglutide
DB14027,Taspoglutide may increase the hypoglycemic activities of Insulin lispro.,Taspoglutide
DB00752,Tranylcypromine may increase the hypoglycemic activities of Insulin lispro.,Tranylcypromine
DB00780,Phenelzine may increase the hypoglycemic activities of Insulin lispro.,Phenelzine
DB01171,Moclobemide may increase the hypoglycemic activities of Insulin lispro.,Moclobemide
DB01247,Isocarboxazid may increase the hypoglycemic activities of Insulin lispro.,Isocarboxazid
DB01626,Pargyline may increase the hypoglycemic activities of Insulin lispro.,Pargyline
DB00805,Minaprine may increase the hypoglycemic activities of Insulin lispro.,Minaprine
DB04818,Iproniazid may increase the hypoglycemic activities of Insulin lispro.,Iproniazid
DB04820,Nialamide may increase the hypoglycemic activities of Insulin lispro.,Nialamide
DB09244,Pirlindole may increase the hypoglycemic activities of Insulin lispro.,Pirlindole
DB09245,Toloxatone may increase the hypoglycemic activities of Insulin lispro.,Toloxatone
DB09243,Hydracarbazine may increase the hypoglycemic activities of Insulin lispro.,Hydracarbazine
DB09241,Methylene blue may increase the hypoglycemic activities of Insulin lispro.,Methylene blue
DB09246,Benmoxin may increase the hypoglycemic activities of Insulin lispro.,Benmoxin
DB09248,Mebanazine may increase the hypoglycemic activities of Insulin lispro.,Mebanazine
DB09249,Octamoxin may increase the hypoglycemic activities of Insulin lispro.,Octamoxin
DB09250,Pheniprazine may increase the hypoglycemic activities of Insulin lispro.,Pheniprazine
DB09251,Phenoxypropazine may increase the hypoglycemic activities of Insulin lispro.,Phenoxypropazine
DB09252,Pivhydrazine may increase the hypoglycemic activities of Insulin lispro.,Pivhydrazine
DB09253,Safrazine may increase the hypoglycemic activities of Insulin lispro.,Safrazine
DB09254,Caroxazone may increase the hypoglycemic activities of Insulin lispro.,Caroxazone
DB00614,Furazolidone may increase the hypoglycemic activities of Insulin lispro.,Furazolidone
DB08550,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypoglycemic activities of Insulin lispro.","7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline"
DB13875,Harmaline may increase the hypoglycemic activities of Insulin lispro.,Harmaline
DB13876,Brofaromine may increase the hypoglycemic activities of Insulin lispro.,Brofaromine
DB00721,Procaine may increase the hypoglycemic activities of Insulin lispro.,Procaine
DB00182,Amphetamine may increase the hypoglycemic activities of Insulin lispro.,Amphetamine
DB01168,Procarbazine may increase the hypoglycemic activities of Insulin lispro.,Procarbazine
DB00601,Linezolid may increase the hypoglycemic activities of Insulin lispro.,Linezolid
DB06654,Safinamide may increase the hypoglycemic activities of Insulin lispro.,Safinamide
DB04017,Clorgiline may increase the hypoglycemic activities of Insulin lispro.,Clorgiline
DB11827,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Ertugliflozin.,Ertugliflozin
DB00203,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sildenafil.,Sildenafil
DB00214,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Torasemide.,Torasemide
DB00263,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfisoxazole.,Sulfisoxazole
DB00311,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Ethoxzolamide.,Ethoxzolamide
DB00359,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfadiazine.,Sulfadiazine
DB00482,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Celecoxib.,Celecoxib
DB00559,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Bosentan.,Bosentan
DB00576,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfamethizole.,Sulfamethizole
DB00606,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Cyclothiazide.,Cyclothiazide
DB00664,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfametopyrazine.,Sulfametopyrazine
DB00669,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sumatriptan.,Sumatriptan
DB00695,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Furosemide.,Furosemide
DB00706,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Tamsulosin.,Tamsulosin
DB00819,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Acetazolamide.,Acetazolamide
DB00887,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Bumetanide.,Bumetanide
DB00891,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfapyridine.,Sulfapyridine
DB00909,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Zonisamide.,Zonisamide
DB01015,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfamethoxazole.,Sulfamethoxazole
DB01032,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Probenecid.,Probenecid
DB01098,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Rosuvastatin.,Rosuvastatin
DB01119,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Diazoxide.,Diazoxide
DB01144,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Diclofenamide.,Diclofenamide
DB01264,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Darunavir.,Darunavir
DB01298,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfacytine.,Sulfacytine
DB01299,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfadoxine.,Sulfadoxine
DB01382,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Glymidine.,Glymidine
DB01581,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfamerazine.,Sulfamerazine
DB01582,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfamethazine.,Sulfamethazine
DB02925,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Piretanide.,Piretanide
DB04707,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Hydroxyfasudil.,Hydroxyfasudil
DB06150,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfadimethoxine.,Sulfadimethoxine
DB06290,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Simeprevir.,Simeprevir
DB06729,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfaphenazole.,Sulfaphenazole
DB06821,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfameter.,Sulfameter
DB07996,The therapeutic efficacy of Insulin lispro can be increased when used in combination with 5-(2-methylpiperazine-1-sulfonyl)isoquinoline.,5-(2-methylpiperazine-1-sulfonyl)isoquinoline
DB08162,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Fasudil.,Fasudil
DB08798,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfamoxole.,Sulfamoxole
DB08881,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Vemurafenib.,Vemurafenib
DB08961,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Azosemide.,Azosemide
DB11389,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Clorsulon.,Clorsulon
DB11461,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfachlorpyridazine.,Sulfachlorpyridazine
DB11462,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfaethoxypyridazine.,Sulfaethoxypyridazine
DB11463,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfanitran.,Sulfanitran
DB11464,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfaquinoxaline.,Sulfaquinoxaline
DB12051,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Setrobuvir.,Setrobuvir
DB12921,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Chlorsulfaquinoxaline.,Chlorsulfaquinoxaline
DB13214,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfadicramide.,Sulfadicramide
DB13248,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Phthalylsulfathiazole.,Phthalylsulfathiazole
DB13283,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfaisodimidine.,Sulfaisodimidine
DB13284,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Meticrane.,Meticrane
DB13320,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfaperin.,Sulfaperin
DB13405,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Mefruside.,Mefruside
DB13430,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Mebutizide.,Mebutizide
DB13485,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfametomidine.,Sulfametomidine
DB13547,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfatolamide.,Sulfatolamide
DB13556,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfamazone.,Sulfamazone
DB13580,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Succinylsulfathiazole.,Succinylsulfathiazole
DB13617,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Clorexolone.,Clorexolone
DB13663,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Clofenamide.,Clofenamide
DB13699,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfathiourea.,Sulfathiourea
DB13708,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Fenquizone.,Fenquizone
DB13726,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfaguanidine.,Sulfaguanidine
DB13773,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfamethoxypyridazine.,Sulfamethoxypyridazine
DB13792,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Clopamide.,Clopamide
DB13803,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Xipamide.,Xipamide
DB14033,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Acetyl sulfisoxazole.,Acetyl sulfisoxazole
DB14708,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Tosylchloramide.,Tosylchloramide
DB00703,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Methazolamide.,Methazolamide
DB06370,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Indisulam.,Indisulam
DB00176,The metabolism of Fluvoxamine can be increased when combined with Insulin lispro.,Fluvoxamine
DB00184,The metabolism of Nicotine can be increased when combined with Insulin lispro.,Nicotine
DB00188,The metabolism of Bortezomib can be increased when combined with Insulin lispro.,Bortezomib
DB00201,The metabolism of Caffeine can be increased when combined with Insulin lispro.,Caffeine
DB00261,The metabolism of Anagrelide can be increased when combined with Insulin lispro.,Anagrelide
DB00262,The metabolism of Carmustine can be increased when combined with Insulin lispro.,Carmustine
DB00281,The metabolism of Lidocaine can be increased when combined with Insulin lispro.,Lidocaine
DB00286,The metabolism of Conjugated estrogens can be increased when combined with Insulin lispro.,Conjugated estrogens
DB00296,The metabolism of Ropivacaine can be increased when combined with Insulin lispro.,Ropivacaine
DB00315,The metabolism of Zolmitriptan can be increased when combined with Insulin lispro.,Zolmitriptan
DB00316,The metabolism of Acetaminophen can be increased when combined with Insulin lispro.,Acetaminophen
DB00356,The metabolism of Chlorzoxazone can be increased when combined with Insulin lispro.,Chlorzoxazone
DB00370,The metabolism of Mirtazapine can be increased when combined with Insulin lispro.,Mirtazapine
DB00379,The metabolism of Mexiletine can be increased when combined with Insulin lispro.,Mexiletine
DB00382,The metabolism of Tacrine can be increased when combined with Insulin lispro.,Tacrine
DB00384,The metabolism of Triamterene can be increased when combined with Insulin lispro.,Triamterene
DB00420,The metabolism of Promazine can be increased when combined with Insulin lispro.,Promazine
DB00425,The metabolism of Zolpidem can be increased when combined with Insulin lispro.,Zolpidem
DB00442,The metabolism of Entecavir can be increased when combined with Insulin lispro.,Entecavir
DB00461,The metabolism of Nabumetone can be increased when combined with Insulin lispro.,Nabumetone
DB00472,The metabolism of Fluoxetine can be increased when combined with Insulin lispro.,Fluoxetine
DB00476,The metabolism of Duloxetine can be increased when combined with Insulin lispro.,Duloxetine
DB00499,The metabolism of Flutamide can be increased when combined with Insulin lispro.,Flutamide
DB00518,The metabolism of Albendazole can be increased when combined with Insulin lispro.,Albendazole
DB00533,The metabolism of Rofecoxib can be increased when combined with Insulin lispro.,Rofecoxib
DB00544,The metabolism of Fluorouracil can be increased when combined with Insulin lispro.,Fluorouracil
DB00568,The metabolism of Cinnarizine can be increased when combined with Insulin lispro.,Cinnarizine
DB00586,The metabolism of Diclofenac can be increased when combined with Insulin lispro.,Diclofenac
DB00619,The metabolism of Imatinib can be increased when combined with Insulin lispro.,Imatinib
DB00629,The metabolism of Guanabenz can be increased when combined with Insulin lispro.,Guanabenz
DB00642,The metabolism of Pemetrexed can be increased when combined with Insulin lispro.,Pemetrexed
DB00661,The metabolism of Verapamil can be increased when combined with Insulin lispro.,Verapamil
DB00715,The metabolism of Paroxetine can be increased when combined with Insulin lispro.,Paroxetine
DB00730,The metabolism of Thiabendazole can be increased when combined with Insulin lispro.,Thiabendazole
DB00740,The metabolism of Riluzole can be increased when combined with Insulin lispro.,Riluzole
DB00744,The metabolism of Zileuton can be increased when combined with Insulin lispro.,Zileuton
DB00758,The metabolism of Clopidogrel can be increased when combined with Insulin lispro.,Clopidogrel
DB00787,The metabolism of Acyclovir can be increased when combined with Insulin lispro.,Acyclovir
DB00788,The metabolism of Naproxen can be increased when combined with Insulin lispro.,Naproxen
DB00806,The metabolism of Pentoxifylline can be increased when combined with Insulin lispro.,Pentoxifylline
DB00831,The metabolism of Trifluoperazine can be increased when combined with Insulin lispro.,Trifluoperazine
DB00850,The metabolism of Perphenazine can be increased when combined with Insulin lispro.,Perphenazine
DB00857,The metabolism of Terbinafine can be increased when combined with Insulin lispro.,Terbinafine
DB00863,The metabolism of Ranitidine can be increased when combined with Insulin lispro.,Ranitidine
DB00898,The metabolism of Ethanol can be increased when combined with Insulin lispro.,Ethanol
DB00934,The metabolism of Maprotiline can be increased when combined with Insulin lispro.,Maprotiline
DB00969,The metabolism of Alosetron can be increased when combined with Insulin lispro.,Alosetron
DB00980,The metabolism of Ramelteon can be increased when combined with Insulin lispro.,Ramelteon
DB00993,The metabolism of Azathioprine can be increased when combined with Insulin lispro.,Azathioprine
DB00998,The metabolism of Frovatriptan can be increased when combined with Insulin lispro.,Frovatriptan
DB01002,The metabolism of Levobupivacaine can be increased when combined with Insulin lispro.,Levobupivacaine
DB01012,The metabolism of Cinacalcet can be increased when combined with Insulin lispro.,Cinacalcet
DB01037,The metabolism of Selegiline can be increased when combined with Insulin lispro.,Selegiline
DB01056,The metabolism of Tocainide can be increased when combined with Insulin lispro.,Tocainide
DB01058,The metabolism of Praziquantel can be increased when combined with Insulin lispro.,Praziquantel
DB01065,The metabolism of Melatonin can be increased when combined with Insulin lispro.,Melatonin
DB01087,The metabolism of Primaquine can be increased when combined with Insulin lispro.,Primaquine
DB01094,The metabolism of Hesperetin can be increased when combined with Insulin lispro.,Hesperetin
DB01097,The metabolism of Leflunomide can be increased when combined with Insulin lispro.,Leflunomide
DB01166,The metabolism of Cilostazol can be increased when combined with Insulin lispro.,Cilostazol
DB01184,The metabolism of Domperidone can be increased when combined with Insulin lispro.,Domperidone
DB01191,The metabolism of Dexfenfluramine can be increased when combined with Insulin lispro.,Dexfenfluramine
DB01303,The metabolism of Oxtriphylline can be increased when combined with Insulin lispro.,Oxtriphylline
DB01367,The metabolism of Rasagiline can be increased when combined with Insulin lispro.,Rasagiline
DB01412,The metabolism of Theobromine can be increased when combined with Insulin lispro.,Theobromine
DB01424,The metabolism of Aminophenazone can be increased when combined with Insulin lispro.,Aminophenazone
DB01435,The metabolism of Antipyrine can be increased when combined with Insulin lispro.,Antipyrine
DB01482,The metabolism of Fenethylline can be increased when combined with Insulin lispro.,Fenethylline
DB01558,The metabolism of Bromazepam can be increased when combined with Insulin lispro.,Bromazepam
DB01623,The metabolism of Thiothixene can be increased when combined with Insulin lispro.,Thiothixene
DB01628,The metabolism of Etoricoxib can be increased when combined with Insulin lispro.,Etoricoxib
DB01645,The metabolism of Genistein can be increased when combined with Insulin lispro.,Genistein
DB01667,The metabolism of 8-azaguanine can be increased when combined with Insulin lispro.,8-azaguanine
DB02134,The metabolism of Xanthine can be increased when combined with Insulin lispro.,Xanthine
DB02489,The metabolism of 9-Methylguanine can be increased when combined with Insulin lispro.,9-Methylguanine
DB02568,The metabolism of Peldesine can be increased when combined with Insulin lispro.,Peldesine
DB02709,The metabolism of Resveratrol can be increased when combined with Insulin lispro.,Resveratrol
DB03783,The metabolism of Phenacetin can be increased when combined with Insulin lispro.,Phenacetin
DB04076,The metabolism of Hypoxanthine can be increased when combined with Insulin lispro.,Hypoxanthine
DB04356,The metabolism of 9-Deazaguanine can be increased when combined with Insulin lispro.,9-Deazaguanine
DB04841,The metabolism of Flunarizine can be increased when combined with Insulin lispro.,Flunarizine
DB04871,The metabolism of Lorcaserin can be increased when combined with Insulin lispro.,Lorcaserin
DB04948,The metabolism of Lofexidine can be increased when combined with Insulin lispro.,Lofexidine
DB04951,The metabolism of Pirfenidone can be increased when combined with Insulin lispro.,Pirfenidone
DB05676,The metabolism of Apremilast can be increased when combined with Insulin lispro.,Apremilast
DB06148,The metabolism of Mianserin can be increased when combined with Insulin lispro.,Mianserin
DB06210,The metabolism of Eltrombopag can be increased when combined with Insulin lispro.,Eltrombopag
DB06235,The metabolism of Vadimezan can be increased when combined with Insulin lispro.,Vadimezan
DB06479,The metabolism of Propentofylline can be increased when combined with Insulin lispro.,Propentofylline
DB06589,The metabolism of Pazopanib can be increased when combined with Insulin lispro.,Pazopanib
DB06594,The metabolism of Agomelatine can be increased when combined with Insulin lispro.,Agomelatine
DB06626,The metabolism of Axitinib can be increased when combined with Insulin lispro.,Axitinib
DB06769,The metabolism of Bendamustine can be increased when combined with Insulin lispro.,Bendamustine
DB06770,The metabolism of Benzyl alcohol can be increased when combined with Insulin lispro.,Benzyl alcohol
DB06774,The metabolism of Capsaicin can be increased when combined with Insulin lispro.,Capsaicin
DB08496,The metabolism of (R)-warfarin can be increased when combined with Insulin lispro.,(R)-warfarin
DB08883,The metabolism of Perampanel can be increased when combined with Insulin lispro.,Perampanel
DB09071,The metabolism of Tasimelteon can be increased when combined with Insulin lispro.,Tasimelteon
DB09118,The metabolism of Stiripentol can be increased when combined with Insulin lispro.,Stiripentol
DB09225,The metabolism of Zotepine can be increased when combined with Insulin lispro.,Zotepine
DB09273,The metabolism of Doxofylline can be increased when combined with Insulin lispro.,Doxofylline
DB09288,The metabolism of Propacetamol can be increased when combined with Insulin lispro.,Propacetamol
DB09290,The metabolism of Ramosetron can be increased when combined with Insulin lispro.,Ramosetron
DB11919,The metabolism of 6-O-benzylguanine can be increased when combined with Insulin lispro.,6-O-benzylguanine
DB11967,The metabolism of Binimetinib can be increased when combined with Insulin lispro.,Binimetinib
DB12026,The metabolism of Voxilaprevir can be increased when combined with Insulin lispro.,Voxilaprevir
DB12245,The metabolism of Triclabendazole can be increased when combined with Insulin lispro.,Triclabendazole
DB12332,The metabolism of Rucaparib can be increased when combined with Insulin lispro.,Rucaparib
DB12406,The metabolism of Lisofylline can be increased when combined with Insulin lispro.,Lisofylline
DB12531,The metabolism of Lobucavir can be increased when combined with Insulin lispro.,Lobucavir
DB12926,The metabolism of Cafedrine can be increased when combined with Insulin lispro.,Cafedrine
DB12927,The metabolism of Theodrenaline can be increased when combined with Insulin lispro.,Theodrenaline
DB12945,The metabolism of Dihydralazine can be increased when combined with Insulin lispro.,Dihydralazine
DB13203,The metabolism of Bamifylline can be increased when combined with Insulin lispro.,Bamifylline
DB13449,The metabolism of Proxyphylline can be increased when combined with Insulin lispro.,Proxyphylline
DB13573,The metabolism of Acefylline can be increased when combined with Insulin lispro.,Acefylline
DB13592,The metabolism of Etamiphylline can be increased when combined with Insulin lispro.,Etamiphylline
DB13634,The metabolism of Pentifylline can be increased when combined with Insulin lispro.,Pentifylline
DB13812,The metabolism of Bufylline can be increased when combined with Insulin lispro.,Bufylline
DB13952,The metabolism of Estradiol acetate can be increased when combined with Insulin lispro.,Estradiol acetate
DB13953,The metabolism of Estradiol benzoate can be increased when combined with Insulin lispro.,Estradiol benzoate
DB13954,The metabolism of Estradiol cypionate can be increased when combined with Insulin lispro.,Estradiol cypionate
DB13955,The metabolism of Estradiol dienanthate can be increased when combined with Insulin lispro.,Estradiol dienanthate
DB13956,The metabolism of Estradiol valerate can be increased when combined with Insulin lispro.,Estradiol valerate
DB14018,The metabolism of Bromotheophylline can be increased when combined with Insulin lispro.,Bromotheophylline
DB14132,The metabolism of 8-chlorotheophylline can be increased when combined with Insulin lispro.,8-chlorotheophylline
DB01115,The metabolism of Nifedipine can be increased when combined with Insulin lispro.,Nifedipine
DB11757,The metabolism of Istradefylline can be increased when combined with Insulin lispro.,Istradefylline
DB00972,The metabolism of Azelastine can be increased when combined with Insulin lispro.,Azelastine
DB00625,The metabolism of Efavirenz can be increased when combined with Insulin lispro.,Efavirenz
DB04889,The metabolism of Bicifadine can be increased when combined with Insulin lispro.,Bicifadine
DB05708,The metabolism of GTS-21 can be increased when combined with Insulin lispro.,GTS-21
DB01195,The metabolism of Flecainide can be increased when combined with Insulin lispro.,Flecainide
DB00783,The metabolism of Estradiol can be increased when combined with Insulin lispro.,Estradiol
DB00321,The metabolism of Amitriptyline can be increased when combined with Insulin lispro.,Amitriptyline
DB00458,The metabolism of Imipramine can be increased when combined with Insulin lispro.,Imipramine
DB01142,The metabolism of Doxepin can be increased when combined with Insulin lispro.,Doxepin
DB00532,The metabolism of Mephenytoin can be increased when combined with Insulin lispro.,Mephenytoin
DB00540,The metabolism of Nortriptyline can be increased when combined with Insulin lispro.,Nortriptyline
DB00575,The metabolism of Clonidine can be increased when combined with Insulin lispro.,Clonidine
DB00924,The metabolism of Cyclobenzaprine can be increased when combined with Insulin lispro.,Cyclobenzaprine
DB01151,The metabolism of Desipramine can be increased when combined with Insulin lispro.,Desipramine
DB01242,The metabolism of Clomipramine can be increased when combined with Insulin lispro.,Clomipramine
DB11689,The metabolism of Selumetinib can be increased when combined with Insulin lispro.,Selumetinib
DB00277,The metabolism of Theophylline can be increased when combined with Insulin lispro.,Theophylline
DB00398,The metabolism of Sorafenib can be increased when combined with Insulin lispro.,Sorafenib
DB00530,The metabolism of Erlotinib can be increased when combined with Insulin lispro.,Erlotinib
DB00564,The metabolism of Carbamazepine can be increased when combined with Insulin lispro.,Carbamazepine
DB00682,The metabolism of Warfarin can be increased when combined with Insulin lispro.,Warfarin
DB00697,The metabolism of Tizanidine can be increased when combined with Insulin lispro.,Tizanidine
DB00773,The metabolism of Etoposide can be increased when combined with Insulin lispro.,Etoposide
DB00851,The metabolism of Dacarbazine can be increased when combined with Insulin lispro.,Dacarbazine
DB01100,The metabolism of Pimozide can be increased when combined with Insulin lispro.,Pimozide
DB01223,The metabolism of Aminophylline can be increased when combined with Insulin lispro.,Aminophylline
DB01254,The metabolism of Dasatinib can be increased when combined with Insulin lispro.,Dasatinib
DB01418,The metabolism of Acenocoumarol can be increased when combined with Insulin lispro.,Acenocoumarol
DB08910,The metabolism of Pomalidomide can be increased when combined with Insulin lispro.,Pomalidomide
DB09256,The metabolism of Tegafur can be increased when combined with Insulin lispro.,Tegafur
DB13874,The metabolism of Enasidenib can be increased when combined with Insulin lispro.,Enasidenib
DB00675,The metabolism of Tamoxifen can be increased when combined with Insulin lispro.,Tamoxifen
DB00030,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Insulin lispro.,Insulin human
DB00047,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Insulin glargine.,Insulin glargine
DB00071,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Insulin pork.,Insulin pork
DB00197,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Troglitazone.,Troglitazone
DB00222,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Glimepiride.,Glimepiride
DB00280,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Disopyramide.,Disopyramide
DB00284,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Acarbose.,Acarbose
DB00414,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Acetohexamide.,Acetohexamide
DB00468,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Quinine.,Quinine
DB00491,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Miglitol.,Miglitol
DB00672,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Chlorpropamide.,Chlorpropamide
DB00731,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Nateglinide.,Nateglinide
DB00834,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Mifepristone.,Mifepristone
DB00839,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Tolazamide.,Tolazamide
DB00912,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Repaglinide.,Repaglinide
DB00914,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Phenformin.,Phenformin
DB01016,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Glyburide.,Glyburide
DB01067,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Glipizide.,Glipizide
DB01120,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Gliclazide.,Gliclazide
DB01124,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Tolbutamide.,Tolbutamide
DB01200,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Bromocriptine.,Bromocriptine
DB01251,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Gliquidone.,Gliquidone
DB01252,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Mitiglinide.,Mitiglinide
DB01268,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Sunitinib.,Sunitinib
DB01277,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Mecasermin.,Mecasermin
DB01289,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Glisoxepide.,Glisoxepide
DB01306,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Insulin aspart.,Insulin aspart
DB01307,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Insulin detemir.,Insulin detemir
DB01309,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Insulin glulisine.,Insulin glulisine
DB01700,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with AICA ribonucleotide.,AICA ribonucleotide
DB04830,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Buformin.,Buformin
DB04878,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Voglibose.,Voglibose
DB05115,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with NN344.,NN344
DB05819,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with NBI-6024.,NBI-6024
DB08962,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Glibornuride.,Glibornuride
DB09022,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Benfluorex.,Benfluorex
DB09198,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Lobeglitazone.,Lobeglitazone
DB09199,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Netoglitazone.,Netoglitazone
DB09200,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Rivoglitazone.,Rivoglitazone
DB09201,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Ciglitazone.,Ciglitazone
DB09456,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Insulin beef.,Insulin beef
DB09564,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Insulin degludec.,Insulin degludec
DB11567,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Insulin peglispro.,Insulin peglispro
DB11568,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Insulin tregopil.,Insulin tregopil
DB11698,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Ipragliflozin.,Ipragliflozin
DB11780,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Allicin.,Allicin
DB11824,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Tofogliflozin.,Tofogliflozin
DB11898,"The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with 2,4-thiazolidinedione.","2,4-thiazolidinedione"
DB12713,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Sotagliflozin.,Sotagliflozin
DB12781,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Balaglitazone.,Balaglitazone
DB12935,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Remogliflozin etabonate.,Remogliflozin etabonate
DB13406,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Carbutamide.,Carbutamide
DB13446,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Guar gum.,Guar gum
DB13675,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Metahexamide.,Metahexamide
DB14035,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Englitazone.,Englitazone
DB15171,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Tirzepatide.,Tirzepatide
DB15217,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Gastric inhibitory polypeptide.,Gastric inhibitory polypeptide
DB00270,The risk or severity of hypoglycemia can be increased when Isradipine is combined with Insulin lispro.,Isradipine
DB00343,The risk or severity of hypoglycemia can be increased when Diltiazem is combined with Insulin lispro.,Diltiazem
DB00347,The risk or severity of hypoglycemia can be increased when Trimethadione is combined with Insulin lispro.,Trimethadione
DB00381,The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Insulin lispro.,Amlodipine
DB00393,The risk or severity of hypoglycemia can be increased when Nimodipine is combined with Insulin lispro.,Nimodipine
DB00401,The risk or severity of hypoglycemia can be increased when Nisoldipine is combined with Insulin lispro.,Nisoldipine
DB00528,The risk or severity of hypoglycemia can be increased when Lercanidipine is combined with Insulin lispro.,Lercanidipine
DB00555,The risk or severity of hypoglycemia can be increased when Lamotrigine is combined with Insulin lispro.,Lamotrigine
DB00593,The risk or severity of hypoglycemia can be increased when Ethosuximide is combined with Insulin lispro.,Ethosuximide
DB00622,The risk or severity of hypoglycemia can be increased when Nicardipine is combined with Insulin lispro.,Nicardipine
DB00653,The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Insulin lispro.,Magnesium sulfate
DB00836,The risk or severity of hypoglycemia can be increased when Loperamide is combined with Insulin lispro.,Loperamide
DB01054,The risk or severity of hypoglycemia can be increased when Nitrendipine is combined with Insulin lispro.,Nitrendipine
DB01074,The risk or severity of hypoglycemia can be increased when Perhexiline is combined with Insulin lispro.,Perhexiline
DB01244,The risk or severity of hypoglycemia can be increased when Bepridil is combined with Insulin lispro.,Bepridil
DB01388,The risk or severity of hypoglycemia can be increased when Mibefradil is combined with Insulin lispro.,Mibefradil
DB04743,The risk or severity of hypoglycemia can be increased when Nimesulide is combined with Insulin lispro.,Nimesulide
DB04825,The risk or severity of hypoglycemia can be increased when Prenylamine is combined with Insulin lispro.,Prenylamine
DB04838,The risk or severity of hypoglycemia can be increased when Cyclandelate is combined with Insulin lispro.,Cyclandelate
DB04842,The risk or severity of hypoglycemia can be increased when Fluspirilene is combined with Insulin lispro.,Fluspirilene
DB04920,The risk or severity of hypoglycemia can be increased when Clevidipine is combined with Insulin lispro.,Clevidipine
DB05246,The risk or severity of hypoglycemia can be increased when Methsuximide is combined with Insulin lispro.,Methsuximide
DB05885,The risk or severity of hypoglycemia can be increased when Seletracetam is combined with Insulin lispro.,Seletracetam
DB06152,The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Insulin lispro.,Nylidrin
DB06283,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Insulin lispro.,Ziconotide
DB06446,The risk or severity of hypoglycemia can be increased when Dotarizine is combined with Insulin lispro.,Dotarizine
DB06694,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Insulin lispro.,Xylometazoline
DB06712,The risk or severity of hypoglycemia can be increased when Nilvadipine is combined with Insulin lispro.,Nilvadipine
DB07615,The risk or severity of hypoglycemia can be increased when Tranilast is combined with Insulin lispro.,Tranilast
DB08838,The risk or severity of hypoglycemia can be increased when Agmatine is combined with Insulin lispro.,Agmatine
DB08980,The risk or severity of hypoglycemia can be increased when Fendiline is combined with Insulin lispro.,Fendiline
DB08992,The risk or severity of hypoglycemia can be increased when Eperisone is combined with Insulin lispro.,Eperisone
DB09089,The risk or severity of hypoglycemia can be increased when Trimebutine is combined with Insulin lispro.,Trimebutine
DB09090,The risk or severity of hypoglycemia can be increased when Pinaverium is combined with Insulin lispro.,Pinaverium
DB09216,The risk or severity of hypoglycemia can be increased when Tolfenamic acid is combined with Insulin lispro.,Tolfenamic acid
DB09227,The risk or severity of hypoglycemia can be increased when Barnidipine is combined with Insulin lispro.,Barnidipine
DB09229,The risk or severity of hypoglycemia can be increased when Aranidipine is combined with Insulin lispro.,Aranidipine
DB09230,The risk or severity of hypoglycemia can be increased when Azelnidipine is combined with Insulin lispro.,Azelnidipine
DB09231,The risk or severity of hypoglycemia can be increased when Benidipine is combined with Insulin lispro.,Benidipine
DB09232,The risk or severity of hypoglycemia can be increased when Cilnidipine is combined with Insulin lispro.,Cilnidipine
DB09234,The risk or severity of hypoglycemia can be increased when Darodipine is combined with Insulin lispro.,Darodipine
DB09235,The risk or severity of hypoglycemia can be increased when Efonidipine is combined with Insulin lispro.,Efonidipine
DB09236,The risk or severity of hypoglycemia can be increased when Lacidipine is combined with Insulin lispro.,Lacidipine
DB09238,The risk or severity of hypoglycemia can be increased when Manidipine is combined with Insulin lispro.,Manidipine
DB09239,The risk or severity of hypoglycemia can be increased when Niguldipine is combined with Insulin lispro.,Niguldipine
DB09240,The risk or severity of hypoglycemia can be increased when Niludipine is combined with Insulin lispro.,Niludipine
DB11960,The risk or severity of hypoglycemia can be increased when Carboxyamidotriazole is combined with Insulin lispro.,Carboxyamidotriazole
DB12092,The risk or severity of hypoglycemia can be increased when Naftopidil is combined with Insulin lispro.,Naftopidil
DB12093,The risk or severity of hypoglycemia can be increased when Tetrahydropalmatine is combined with Insulin lispro.,Tetrahydropalmatine
DB12131,The risk or severity of hypoglycemia can be increased when Vinpocetine is combined with Insulin lispro.,Vinpocetine
DB12923,The risk or severity of hypoglycemia can be increased when Gallopamil is combined with Insulin lispro.,Gallopamil
DB13488,The risk or severity of hypoglycemia can be increased when Bencyclane is combined with Insulin lispro.,Bencyclane
DB13500,The risk or severity of hypoglycemia can be increased when Otilonium is combined with Insulin lispro.,Otilonium
DB13725,The risk or severity of hypoglycemia can be increased when Terodiline is combined with Insulin lispro.,Terodiline
DB13766,The risk or severity of hypoglycemia can be increased when Lidoflazine is combined with Insulin lispro.,Lidoflazine
DB13791,The risk or severity of hypoglycemia can be increased when Penfluridol is combined with Insulin lispro.,Penfluridol
DB13835,The risk or severity of hypoglycemia can be increased when Caroverine is combined with Insulin lispro.,Caroverine
DB13950,The risk or severity of hypoglycemia can be increased when WIN 55212-2 is combined with Insulin lispro.,WIN 55212-2
DB13961,The risk or severity of hypoglycemia can be increased when Fish oil is combined with Insulin lispro.,Fish oil
DB14063,The risk or severity of hypoglycemia can be increased when Dexverapamil is combined with Insulin lispro.,Dexverapamil
DB14064,The risk or severity of hypoglycemia can be increased when Emopamil is combined with Insulin lispro.,Emopamil
DB14065,The risk or severity of hypoglycemia can be increased when Lomerizine is combined with Insulin lispro.,Lomerizine
DB14066,The risk or severity of hypoglycemia can be increased when Tetrandrine is combined with Insulin lispro.,Tetrandrine
DB14068,The risk or severity of hypoglycemia can be increased when Dexniguldipine is combined with Insulin lispro.,Dexniguldipine
DB01023,The risk or severity of hypoglycemia can be increased when Felodipine is combined with Insulin lispro.,Felodipine
DB01118,The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Insulin lispro.,Amiodarone
DB00191,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Phentermine.,Phentermine
DB00268,The metabolism of Ropinirole can be increased when combined with Insulin lispro.,Ropinirole
DB13074,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Insulin lispro.,Macimorelin
DB00279,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Liothyronine.,Liothyronine
DB00331,The risk or severity of adverse effects can be increased when Insulin lispro is combined with Metformin.,Metformin
DB00542,The risk or severity of hypoglycemia can be increased when Benazepril is combined with Insulin lispro.,Benazepril
DB13946,The risk or severity of adverse effects can be increased when Testosterone undecanoate is combined with Insulin lispro.,Testosterone undecanoate
DB00945,The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Insulin lispro.,Acetylsalicylic acid
DB00181,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Baclofen.,Baclofen
DB00489,The risk or severity of hypoglycemia can be increased when Sotalol is combined with Insulin lispro.,Sotalol
DB00196,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Fluconazole.,Fluconazole
DB00040,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Glucagon.,Glucagon
DB00264,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Metoprolol.,Metoprolol
DB00335,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Atenolol.,Atenolol
DB00373,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Timolol.,Timolol
DB00598,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Labetalol.,Labetalol
DB00612,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Bisoprolol.,Bisoprolol
DB00866,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Alprenolol.,Alprenolol
DB00960,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Pindolol.,Pindolol
DB01193,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Acebutolol.,Acebutolol
DB01203,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Nadolol.,Nadolol
DB01295,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Bevantolol.,Bevantolol
DB01297,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Practolol.,Practolol
DB01359,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Penbutolol.,Penbutolol
DB01580,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Oxprenolol.,Oxprenolol
DB03322,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Dexpropranolol.,Dexpropranolol
DB04846,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Celiprolol.,Celiprolol
DB04861,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Nebivolol.,Nebivolol
DB06726,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Bufuralol.,Bufuralol
DB08807,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Bopindolol.,Bopindolol
DB08808,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Bupranolol.,Bupranolol
DB08952,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Indenolol.,Indenolol
DB09013,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Befunolol.,Befunolol
DB09204,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Arotinolol.,Arotinolol
DB09351,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Levobetaxolol.,Levobetaxolol
DB11770,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Talinolol.,Talinolol
DB11785,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Anisodamine.,Anisodamine
DB12212,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Landiolol.,Landiolol
DB12752,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Bucindolol.,Bucindolol
DB13443,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Esatenolol.,Esatenolol
DB13508,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Cloranolol.,Cloranolol
DB13530,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Mepindolol.,Mepindolol
DB13757,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Epanolol.,Epanolol
DB13775,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Tertatolol.,Tertatolol
DB00195,The therapeutic efficacy of Betaxolol can be increased when used in combination with Insulin lispro.,Betaxolol
DB00571,The therapeutic efficacy of Propranolol can be increased when used in combination with Insulin lispro.,Propranolol
DB01136,The therapeutic efficacy of Carvedilol can be increased when used in combination with Insulin lispro.,Carvedilol
DB01182,The therapeutic efficacy of Propafenone can be increased when used in combination with Insulin lispro.,Propafenone
DB01611,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Hydroxychloroquine.,Hydroxychloroquine
DB01233,The therapeutic efficacy of Metoclopramide can be increased when used in combination with Insulin lispro.,Metoclopramide
DB00394,The risk or severity of hyperglycemia can be increased when Beclomethasone dipropionate is combined with Insulin lispro.,Beclomethasone dipropionate
DB00443,The risk or severity of hyperglycemia can be increased when Betamethasone is combined with Insulin lispro.,Betamethasone
DB00620,The risk or severity of hyperglycemia can be increased when Triamcinolone is combined with Insulin lispro.,Triamcinolone
DB00635,The risk or severity of hyperglycemia can be increased when Prednisone is combined with Insulin lispro.,Prednisone
DB00687,The risk or severity of hyperglycemia can be increased when Fludrocortisone is combined with Insulin lispro.,Fludrocortisone
DB00741,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Insulin lispro.,Hydrocortisone
DB00764,The risk or severity of hyperglycemia can be increased when Mometasone is combined with Insulin lispro.,Mometasone
DB00860,The risk or severity of hyperglycemia can be increased when Prednisolone is combined with Insulin lispro.,Prednisolone
DB00959,The risk or severity of hyperglycemia can be increased when Methylprednisolone is combined with Insulin lispro.,Methylprednisolone
DB01234,The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Insulin lispro.,Dexamethasone
DB01285,The risk or severity of hyperglycemia can be increased when Corticotropin is combined with Insulin lispro.,Corticotropin
DB01380,The risk or severity of hyperglycemia can be increased when Cortisone acetate is combined with Insulin lispro.,Cortisone acetate
DB01384,The risk or severity of hyperglycemia can be increased when Paramethasone is combined with Insulin lispro.,Paramethasone
DB01410,The risk or severity of hyperglycemia can be increased when Ciclesonide is combined with Insulin lispro.,Ciclesonide
DB08906,The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Insulin lispro.,Fluticasone furoate
DB08970,The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Insulin lispro.,Fluprednidene
DB08971,The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Insulin lispro.,Fluocortolone
DB09383,The risk or severity of hyperglycemia can be increased when Meprednisone is combined with Insulin lispro.,Meprednisone
DB11487,The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Insulin lispro.,Dexamethasone isonicotinate
DB11750,The risk or severity of hyperglycemia can be increased when Clobetasol is combined with Insulin lispro.,Clobetasol
DB11921,The risk or severity of hyperglycemia can be increased when Deflazacort is combined with Insulin lispro.,Deflazacort
DB13003,The risk or severity of hyperglycemia can be increased when Cortivazol is combined with Insulin lispro.,Cortivazol
DB13208,The risk or severity of hyperglycemia can be increased when Prednylidene is combined with Insulin lispro.,Prednylidene
DB13843,The risk or severity of hyperglycemia can be increased when Cloprednol is combined with Insulin lispro.,Cloprednol
DB13867,The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Insulin lispro.,Fluticasone
DB14512,The risk or severity of hyperglycemia can be increased when Mometasone furoate is combined with Insulin lispro.,Mometasone furoate
DB00180,The risk or severity of hyperglycemia can be increased when Flunisolide is combined with Insulin lispro.,Flunisolide
DB01108,The risk or severity of hyperglycemia can be increased when Trilostane is combined with Insulin lispro.,Trilostane
DB01222,The risk or severity of hyperglycemia can be increased when Budesonide is combined with Insulin lispro.,Budesonide
DB04630,The risk or severity of hyperglycemia can be increased when Aldosterone is combined with Insulin lispro.,Aldosterone
DB09378,The risk or severity of hyperglycemia can be increased when Fluprednisolone is combined with Insulin lispro.,Fluprednisolone
DB11529,The risk or severity of hyperglycemia can be increased when Melengestrol is combined with Insulin lispro.,Melengestrol
DB14681,The risk or severity of hyperglycemia can be increased when Cortisone is combined with Insulin lispro.,Cortisone
DB00223,The risk or severity of hyperglycemia can be increased when Diflorasone is combined with Insulin lispro.,Diflorasone
DB00240,The risk or severity of hyperglycemia can be increased when Alclometasone is combined with Insulin lispro.,Alclometasone
DB00253,The risk or severity of hyperglycemia can be increased when Medrysone is combined with Insulin lispro.,Medrysone
DB00288,The risk or severity of hyperglycemia can be increased when Amcinonide is combined with Insulin lispro.,Amcinonide
DB00324,The risk or severity of hyperglycemia can be increased when Fluorometholone is combined with Insulin lispro.,Fluorometholone
DB00547,The risk or severity of hyperglycemia can be increased when Desoximetasone is combined with Insulin lispro.,Desoximetasone
DB00588,The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Insulin lispro.,Fluticasone propionate
DB00591,The risk or severity of hyperglycemia can be increased when Fluocinolone acetonide is combined with Insulin lispro.,Fluocinolone acetonide
DB00596,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Insulin lispro.,Ulobetasol
DB00663,The risk or severity of hyperglycemia can be increased when Flumethasone is combined with Insulin lispro.,Flumethasone
DB00838,The risk or severity of hyperglycemia can be increased when Clocortolone is combined with Insulin lispro.,Clocortolone
DB00846,The risk or severity of hyperglycemia can be increased when Flurandrenolide is combined with Insulin lispro.,Flurandrenolide
DB14596,The risk or severity of hyperglycemia can be increased when Loteprednol etabonate is combined with Insulin lispro.,Loteprednol etabonate
DB00896,The risk or severity of hyperglycemia can be increased when Rimexolone is combined with Insulin lispro.,Rimexolone
DB01013,The risk or severity of hyperglycemia can be increased when Clobetasol propionate is combined with Insulin lispro.,Clobetasol propionate
DB01047,The risk or severity of hyperglycemia can be increased when Fluocinonide is combined with Insulin lispro.,Fluocinonide
DB01130,The risk or severity of hyperglycemia can be increased when Prednicarbate is combined with Insulin lispro.,Prednicarbate
DB01260,The risk or severity of hyperglycemia can be increased when Desonide is combined with Insulin lispro.,Desonide
DB06781,The risk or severity of hyperglycemia can be increased when Difluprednate is combined with Insulin lispro.,Difluprednate
DB06786,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Insulin lispro.,Halcinonide
DB09091,The risk or severity of hyperglycemia can be increased when Tixocortol is combined with Insulin lispro.,Tixocortol
DB09095,The risk or severity of hyperglycemia can be increased when Difluocortolone is combined with Insulin lispro.,Difluocortolone
DB13158,The risk or severity of hyperglycemia can be increased when Clobetasone is combined with Insulin lispro.,Clobetasone
DB13223,The risk or severity of hyperglycemia can be increased when Fluocortin is combined with Insulin lispro.,Fluocortin
DB13491,The risk or severity of hyperglycemia can be increased when Fluperolone is combined with Insulin lispro.,Fluperolone
DB13664,The risk or severity of hyperglycemia can be increased when Formocortal is combined with Insulin lispro.,Formocortal
DB13728,The risk or severity of hyperglycemia can be increased when Halometasone is combined with Insulin lispro.,Halometasone
DB13856,The risk or severity of hyperglycemia can be increased when Fluclorolone is combined with Insulin lispro.,Fluclorolone
DB14538,The risk or severity of hyperglycemia can be increased when Hydrocortisone aceponate is combined with Insulin lispro.,Hydrocortisone aceponate
DB14539,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Insulin lispro.,Hydrocortisone acetate
DB14540,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Insulin lispro.,Hydrocortisone butyrate
DB14541,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Insulin lispro.,Hydrocortisone cypionate
DB14543,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Insulin lispro.,Hydrocortisone probutate
DB14544,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Insulin lispro.,Hydrocortisone valerate
DB14545,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Insulin lispro.,Hydrocortisone succinate
DB00873,The risk or severity of hyperglycemia can be increased when Loteprednol is combined with Insulin lispro.,Loteprednol
DB14631,The risk or severity of hyperglycemia can be increased when Prednisolone phosphate is combined with Insulin lispro.,Prednisolone phosphate
DB14633,The risk or severity of hyperglycemia can be increased when Prednisolone hemisuccinate is combined with Insulin lispro.,Prednisolone hemisuccinate
DB14634,The risk or severity of hyperglycemia can be increased when Fluprednidene acetate is combined with Insulin lispro.,Fluprednidene acetate
DB14643,The risk or severity of hyperglycemia can be increased when Methylprednisolone aceponate is combined with Insulin lispro.,Methylprednisolone aceponate
DB14644,The risk or severity of hyperglycemia can be increased when Methylprednisolone hemisuccinate is combined with Insulin lispro.,Methylprednisolone hemisuccinate
DB14646,The risk or severity of hyperglycemia can be increased when Prednisone acetate is combined with Insulin lispro.,Prednisone acetate
DB14652,The risk or severity of hyperglycemia can be increased when Clocortolone acetate is combined with Insulin lispro.,Clocortolone acetate
DB14659,The risk or severity of hyperglycemia can be increased when Melengestrol acetate is combined with Insulin lispro.,Melengestrol acetate
DB14669,The risk or severity of hyperglycemia can be increased when Betamethasone phosphate is combined with Insulin lispro.,Betamethasone phosphate
DB15566,The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Insulin lispro.,Prednisolone acetate
DB00451,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Levothyroxine.,Levothyroxine
DB00024,Thyrotropin alfa may decrease the hypoglycemic activities of Insulin lispro.,Thyrotropin alfa
DB01583,Liotrix may decrease the hypoglycemic activities of Insulin lispro.,Liotrix
DB03604,Tiratricol may decrease the hypoglycemic activities of Insulin lispro.,Tiratricol
DB09100,"Thyroid, porcine may decrease the hypoglycemic activities of Insulin lispro.","Thyroid, porcine"
DB06655,Liraglutide may increase the hypoglycemic activities of Insulin glargine.,Liraglutide
DB09046,Metreleptin may increase the hypoglycemic activities of Insulin glargine.,Metreleptin
DB00082,The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Insulin glargine.,Pegvisomant
DB01132,The risk or severity of adverse effects can be increased when Pioglitazone is combined with Insulin glargine.,Pioglitazone
DB01278,Pramlintide may increase the hypoglycemic activities of Insulin glargine.,Pramlintide
DB00412,The risk or severity of congestive heart failure can be increased when Insulin glargine is combined with Rosiglitazone.,Rosiglitazone
DB00166,The risk or severity of hypoglycemia can be increased when Lipoic acid is combined with Insulin glargine.,Lipoic acid
DB00974,Edetic acid may increase the hypoglycemic activities of Insulin glargine.,Edetic acid
DB00187,Esmolol may increase the hypoglycemic activities of Insulin glargine.,Esmolol
DB01044,The therapeutic efficacy of Gatifloxacin can be increased when used in combination with Insulin glargine.,Gatifloxacin
DB00218,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Moxifloxacin.,Moxifloxacin
DB00467,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Enoxacin.,Enoxacin
DB00487,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Pefloxacin.,Pefloxacin
DB00537,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Ciprofloxacin.,Ciprofloxacin
DB00685,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Trovafloxacin.,Trovafloxacin
DB00779,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Nalidixic acid.,Nalidixic acid
DB00817,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Rosoxacin.,Rosoxacin
DB00827,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Cinoxacin.,Cinoxacin
DB01059,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Norfloxacin.,Norfloxacin
DB01137,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Levofloxacin.,Levofloxacin
DB01155,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Gemifloxacin.,Gemifloxacin
DB01165,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Ofloxacin.,Ofloxacin
DB01208,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sparfloxacin.,Sparfloxacin
DB04576,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Fleroxacin.,Fleroxacin
DB05488,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Technetium Tc-99m ciprofloxacin.,Technetium Tc-99m ciprofloxacin
DB06160,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Garenoxacin.,Garenoxacin
DB06600,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Nemonoxacin.,Nemonoxacin
DB08972,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Flumequine.,Flumequine
DB11404,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Enrofloxacin.,Enrofloxacin
DB11443,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Orbifloxacin.,Orbifloxacin
DB11491,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sarafloxacin.,Sarafloxacin
DB11511,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Difloxacin.,Difloxacin
DB11774,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Pazufloxacin.,Pazufloxacin
DB11892,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Prulifloxacin.,Prulifloxacin
DB11943,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Delafloxacin.,Delafloxacin
DB13261,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sitafloxacin.,Sitafloxacin
DB13627,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Oxolinic acid.,Oxolinic acid
DB13772,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Rufloxacin.,Rufloxacin
DB13823,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Pipemidic acid.,Pipemidic acid
DB00232,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Methyclothiazide.,Methyclothiazide
DB00310,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Chlorthalidone.,Chlorthalidone
DB00436,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Bendroflumethiazide.,Bendroflumethiazide
DB00524,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Metolazone.,Metolazone
DB00562,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Benzthiazide.,Benzthiazide
DB00774,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Hydroflumethiazide.,Hydroflumethiazide
DB00808,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Indapamide.,Indapamide
DB00880,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Chlorothiazide.,Chlorothiazide
DB00999,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Hydrochlorothiazide.,Hydrochlorothiazide
DB01021,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Trichlormethiazide.,Trichlormethiazide
DB01324,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Polythiazide.,Polythiazide
DB01325,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Quinethazone.,Quinethazone
DB13532,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Cyclopenthiazide.,Cyclopenthiazide
DB13989,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Epitizide.,Epitizide
DB00344,Protriptyline may decrease the hypoglycemic activities of Insulin glargine.,Protriptyline
DB00543,Amoxapine may decrease the hypoglycemic activities of Insulin glargine.,Amoxapine
DB00726,Trimipramine may decrease the hypoglycemic activities of Insulin glargine.,Trimipramine
DB04836,Amineptine may decrease the hypoglycemic activities of Insulin glargine.,Amineptine
DB08996,Dimetacrine may decrease the hypoglycemic activities of Insulin glargine.,Dimetacrine
DB09016,Butriptyline may decrease the hypoglycemic activities of Insulin glargine.,Butriptyline
DB09167,Dosulepin may decrease the hypoglycemic activities of Insulin glargine.,Dosulepin
DB09289,Tianeptine may decrease the hypoglycemic activities of Insulin glargine.,Tianeptine
DB09307,Oxaprotiline may decrease the hypoglycemic activities of Insulin glargine.,Oxaprotiline
DB12930,Opipramol may decrease the hypoglycemic activities of Insulin glargine.,Opipramol
DB13114,Amitriptylinoxide may decrease the hypoglycemic activities of Insulin glargine.,Amitriptylinoxide
DB13225,Dibenzepin may decrease the hypoglycemic activities of Insulin glargine.,Dibenzepin
DB13246,Quinupramine may decrease the hypoglycemic activities of Insulin glargine.,Quinupramine
DB13384,Melitracen may decrease the hypoglycemic activities of Insulin glargine.,Melitracen
DB13411,Lofepramine may decrease the hypoglycemic activities of Insulin glargine.,Lofepramine
DB13496,Iprindole may decrease the hypoglycemic activities of Insulin glargine.,Iprindole
DB13782,Imipramine oxide may decrease the hypoglycemic activities of Insulin glargine.,Imipramine oxide
DB06292,Dapagliflozin may increase the hypoglycemic activities of Insulin glargine.,Dapagliflozin
DB08907,Canagliflozin may increase the hypoglycemic activities of Insulin glargine.,Canagliflozin
DB00007,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Leuprolide.,Leuprolide
DB00014,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Goserelin.,Goserelin
DB00104,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Octreotide.,Octreotide
DB00214,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Torasemide.,Torasemide
DB00220,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Nelfinavir.,Nelfinavir
DB00224,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Indinavir.,Indinavir
DB00246,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Ziprasidone.,Ziprasidone
DB00294,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Etonogestrel.,Etonogestrel
DB00304,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Desogestrel.,Desogestrel
DB00334,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Olanzapine.,Olanzapine
DB00351,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Megestrol acetate.,Megestrol acetate
DB00363,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Clozapine.,Clozapine
DB00367,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Levonorgestrel.,Levonorgestrel
DB00396,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Progesterone.,Progesterone
DB00477,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Chlorpromazine.,Chlorpromazine
DB00502,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Haloperidol.,Haloperidol
DB00503,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Ritonavir.,Ritonavir
DB00592,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Piperazine.,Piperazine
DB00603,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Medroxyprogesterone acetate.,Medroxyprogesterone acetate
DB00606,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Cyclothiazide.,Cyclothiazide
DB00627,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Niacin.,Niacin
DB00668,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Epinephrine.,Epinephrine
DB00695,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Furosemide.,Furosemide
DB00717,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Norethisterone.,Norethisterone
DB00734,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Risperidone.,Risperidone
DB00738,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Pentamidine.,Pentamidine
DB00823,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Ethynodiol diacetate.,Ethynodiol diacetate
DB00852,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Pseudoephedrine.,Pseudoephedrine
DB00864,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Tacrolimus.,Tacrolimus
DB00877,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Sirolimus.,Sirolimus
DB00887,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Bumetanide.,Bumetanide
DB00903,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Etacrynic acid.,Etacrynic acid
DB00932,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Tipranavir.,Tipranavir
DB00957,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Norgestimate.,Norgestimate
DB00977,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Ethinylestradiol.,Ethinylestradiol
DB01072,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Atazanavir.,Atazanavir
DB01119,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Diazoxide.,Diazoxide
DB01169,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Arsenic trioxide.,Arsenic trioxide
DB01224,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Quetiapine.,Quetiapine
DB01232,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Saquinavir.,Saquinavir
DB01238,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Aripiprazole.,Aripiprazole
DB01264,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Darunavir.,Darunavir
DB01267,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Paliperidone.,Paliperidone
DB01319,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Fosamprenavir.,Fosamprenavir
DB01323,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with St. John's Wort.,St. John's Wort
DB01357,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Mestranol.,Mestranol
DB01363,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Ephedra sinica root.,Ephedra sinica root
DB01395,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Drospirenone.,Drospirenone
DB01403,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Methotrimeprazine.,Methotrimeprazine
DB01406,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Danazol.,Danazol
DB01590,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Everolimus.,Everolimus
DB01601,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Lopinavir.,Lopinavir
DB01621,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Pipotiazine.,Pipotiazine
DB02546,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Vorinostat.,Vorinostat
DB04574,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Estrone sulfate.,Estrone sulfate
DB04839,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Cyproterone acetate.,Cyproterone acetate
DB04868,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Nilotinib.,Nilotinib
DB04946,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Iloperidone.,Iloperidone
DB06216,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Asenapine.,Asenapine
DB06287,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Temsirolimus.,Temsirolimus
DB06663,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Pasireotide.,Pasireotide
DB06719,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Buserelin.,Buserelin
DB06788,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Histrelin.,Histrelin
DB06789,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Hydroxyprogesterone caproate.,Hydroxyprogesterone caproate
DB06791,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Lanreotide.,Lanreotide
DB06825,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Triptorelin.,Triptorelin
DB08815,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Lurasidone.,Lurasidone
DB08912,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Dabrafenib.,Dabrafenib
DB09009,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Articaine.,Articaine
DB09063,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Ceritinib.,Ceritinib
DB09123,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Dienogest.,Dienogest
DB09128,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Brexpiprazole.,Brexpiprazole
DB13430,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Mebutizide.,Mebutizide
DB06343,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Teprotumumab.,Teprotumumab
DB00621,Oxandrolone may increase the hypoglycemic activities of Insulin glargine.,Oxandrolone
DB00624,Testosterone may increase the hypoglycemic activities of Insulin glargine.,Testosterone
DB00984,Nandrolone phenpropionate may increase the hypoglycemic activities of Insulin glargine.,Nandrolone phenpropionate
DB01185,Fluoxymesterone may increase the hypoglycemic activities of Insulin glargine.,Fluoxymesterone
DB01420,Testosterone propionate may increase the hypoglycemic activities of Insulin glargine.,Testosterone propionate
DB02901,Stanolone may increase the hypoglycemic activities of Insulin glargine.,Stanolone
DB06412,Oxymetholone may increase the hypoglycemic activities of Insulin glargine.,Oxymetholone
DB06710,Methyltestosterone may increase the hypoglycemic activities of Insulin glargine.,Methyltestosterone
DB06718,Stanozolol may increase the hypoglycemic activities of Insulin glargine.,Stanozolol
DB08804,Nandrolone decanoate may increase the hypoglycemic activities of Insulin glargine.,Nandrolone decanoate
DB12461,GLPG-0492 may increase the hypoglycemic activities of Insulin glargine.,GLPG-0492
DB13169,Nandrolone may increase the hypoglycemic activities of Insulin glargine.,Nandrolone
DB13587,Mesterolone may increase the hypoglycemic activities of Insulin glargine.,Mesterolone
DB13943,Testosterone cypionate may increase the hypoglycemic activities of Insulin glargine.,Testosterone cypionate
DB13944,Testosterone enanthate may increase the hypoglycemic activities of Insulin glargine.,Testosterone enanthate
DB00215,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Citalopram.,Citalopram
DB00230,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Pregabalin.,Pregabalin
DB00285,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Venlafaxine.,Venlafaxine
DB00328,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Indomethacin.,Indomethacin
DB01104,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Sertraline.,Sertraline
DB01149,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Nefazodone.,Nefazodone
DB01175,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Escitalopram.,Escitalopram
DB04832,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Zimelidine.,Zimelidine
DB04884,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Dapoxetine.,Dapoxetine
DB04896,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Milnacipran.,Milnacipran
DB06700,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Desvenlafaxine.,Desvenlafaxine
DB08918,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Levomilnacipran.,Levomilnacipran
DB08953,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Indalpine.,Indalpine
DB09270,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Ubidecarenone.,Ubidecarenone
DB12693,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Ritanserin.,Ritanserin
DB13233,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Alaproclate.,Alaproclate
DB13358,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Cibenzoline.,Cibenzoline
DB14025,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Clinafloxacin.,Clinafloxacin
DB09038,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Empagliflozin.,Empagliflozin
DB00233,Aminosalicylic acid may increase the hypoglycemic activities of Insulin glargine.,Aminosalicylic acid
DB00244,Mesalazine may increase the hypoglycemic activities of Insulin glargine.,Mesalazine
DB00795,Sulfasalazine may increase the hypoglycemic activities of Insulin glargine.,Sulfasalazine
DB00861,Diflunisal may increase the hypoglycemic activities of Insulin glargine.,Diflunisal
DB00936,Salicylic acid may increase the hypoglycemic activities of Insulin glargine.,Salicylic acid
DB01014,Balsalazide may increase the hypoglycemic activities of Insulin glargine.,Balsalazide
DB01250,Olsalazine may increase the hypoglycemic activities of Insulin glargine.,Olsalazine
DB01294,Bismuth subsalicylate may increase the hypoglycemic activities of Insulin glargine.,Bismuth subsalicylate
DB06251,Dersalazine may increase the hypoglycemic activities of Insulin glargine.,Dersalazine
DB06807,Phenyl aminosalicylate may increase the hypoglycemic activities of Insulin glargine.,Phenyl aminosalicylate
DB09543,Methyl salicylate may increase the hypoglycemic activities of Insulin glargine.,Methyl salicylate
DB11079,Trolamine salicylate may increase the hypoglycemic activities of Insulin glargine.,Trolamine salicylate
DB12445,Nitroaspirin may increase the hypoglycemic activities of Insulin glargine.,Nitroaspirin
DB13509,Aloxiprin may increase the hypoglycemic activities of Insulin glargine.,Aloxiprin
DB13538,Guacetisal may increase the hypoglycemic activities of Insulin glargine.,Guacetisal
DB13612,Carbaspirin calcium may increase the hypoglycemic activities of Insulin glargine.,Carbaspirin calcium
DB14006,Choline salicylate may increase the hypoglycemic activities of Insulin glargine.,Choline salicylate
DB14026,Thiosalicylic acid may increase the hypoglycemic activities of Insulin glargine.,Thiosalicylic acid
DB01261,Sitagliptin may increase the hypoglycemic activities of Insulin glargine.,Sitagliptin
DB04876,Vildagliptin may increase the hypoglycemic activities of Insulin glargine.,Vildagliptin
DB06011,AMG-222 may increase the hypoglycemic activities of Insulin glargine.,AMG-222
DB06127,Bisegliptin may increase the hypoglycemic activities of Insulin glargine.,Bisegliptin
DB06203,Alogliptin may increase the hypoglycemic activities of Insulin glargine.,Alogliptin
DB06335,Saxagliptin may increase the hypoglycemic activities of Insulin glargine.,Saxagliptin
DB08382,Gosogliptin may increase the hypoglycemic activities of Insulin glargine.,Gosogliptin
DB08882,Linagliptin may increase the hypoglycemic activities of Insulin glargine.,Linagliptin
DB11723,Dutogliptin may increase the hypoglycemic activities of Insulin glargine.,Dutogliptin
DB11950,Teneligliptin may increase the hypoglycemic activities of Insulin glargine.,Teneligliptin
DB11992,Omarigliptin may increase the hypoglycemic activities of Insulin glargine.,Omarigliptin
DB12268,Carmegliptin may increase the hypoglycemic activities of Insulin glargine.,Carmegliptin
DB12412,Gemigliptin may increase the hypoglycemic activities of Insulin glargine.,Gemigliptin
DB12417,Anagliptin may increase the hypoglycemic activities of Insulin glargine.,Anagliptin
DB12625,Evogliptin may increase the hypoglycemic activities of Insulin glargine.,Evogliptin
DB01276,Exenatide may increase the hypoglycemic activities of Insulin glargine.,Exenatide
DB09043,Albiglutide may increase the hypoglycemic activities of Insulin glargine.,Albiglutide
DB09045,Dulaglutide may increase the hypoglycemic activities of Insulin glargine.,Dulaglutide
DB13928,Semaglutide may increase the hypoglycemic activities of Insulin glargine.,Semaglutide
DB14027,Taspoglutide may increase the hypoglycemic activities of Insulin glargine.,Taspoglutide
DB00752,Tranylcypromine may increase the hypoglycemic activities of Insulin glargine.,Tranylcypromine
DB00780,Phenelzine may increase the hypoglycemic activities of Insulin glargine.,Phenelzine
DB01171,Moclobemide may increase the hypoglycemic activities of Insulin glargine.,Moclobemide
DB01247,Isocarboxazid may increase the hypoglycemic activities of Insulin glargine.,Isocarboxazid
DB01626,Pargyline may increase the hypoglycemic activities of Insulin glargine.,Pargyline
DB00805,Minaprine may increase the hypoglycemic activities of Insulin glargine.,Minaprine
DB04818,Iproniazid may increase the hypoglycemic activities of Insulin glargine.,Iproniazid
DB04820,Nialamide may increase the hypoglycemic activities of Insulin glargine.,Nialamide
DB09244,Pirlindole may increase the hypoglycemic activities of Insulin glargine.,Pirlindole
DB09245,Toloxatone may increase the hypoglycemic activities of Insulin glargine.,Toloxatone
DB09243,Hydracarbazine may increase the hypoglycemic activities of Insulin glargine.,Hydracarbazine
DB09241,Methylene blue may increase the hypoglycemic activities of Insulin glargine.,Methylene blue
DB09246,Benmoxin may increase the hypoglycemic activities of Insulin glargine.,Benmoxin
DB09248,Mebanazine may increase the hypoglycemic activities of Insulin glargine.,Mebanazine
DB09249,Octamoxin may increase the hypoglycemic activities of Insulin glargine.,Octamoxin
DB09250,Pheniprazine may increase the hypoglycemic activities of Insulin glargine.,Pheniprazine
DB09251,Phenoxypropazine may increase the hypoglycemic activities of Insulin glargine.,Phenoxypropazine
DB09252,Pivhydrazine may increase the hypoglycemic activities of Insulin glargine.,Pivhydrazine
DB09253,Safrazine may increase the hypoglycemic activities of Insulin glargine.,Safrazine
DB09254,Caroxazone may increase the hypoglycemic activities of Insulin glargine.,Caroxazone
DB00614,Furazolidone may increase the hypoglycemic activities of Insulin glargine.,Furazolidone
DB08550,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypoglycemic activities of Insulin glargine.","7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline"
DB13875,Harmaline may increase the hypoglycemic activities of Insulin glargine.,Harmaline
DB13876,Brofaromine may increase the hypoglycemic activities of Insulin glargine.,Brofaromine
DB00721,Procaine may increase the hypoglycemic activities of Insulin glargine.,Procaine
DB00182,Amphetamine may increase the hypoglycemic activities of Insulin glargine.,Amphetamine
DB01168,Procarbazine may increase the hypoglycemic activities of Insulin glargine.,Procarbazine
DB00601,Linezolid may increase the hypoglycemic activities of Insulin glargine.,Linezolid
DB06654,Safinamide may increase the hypoglycemic activities of Insulin glargine.,Safinamide
DB04017,Clorgiline may increase the hypoglycemic activities of Insulin glargine.,Clorgiline
DB11827,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Ertugliflozin.,Ertugliflozin
DB00203,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sildenafil.,Sildenafil
DB00263,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfisoxazole.,Sulfisoxazole
DB00311,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Ethoxzolamide.,Ethoxzolamide
DB00359,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfadiazine.,Sulfadiazine
DB00482,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Celecoxib.,Celecoxib
DB00559,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Bosentan.,Bosentan
DB00576,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfamethizole.,Sulfamethizole
DB00664,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfametopyrazine.,Sulfametopyrazine
DB00669,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sumatriptan.,Sumatriptan
DB00706,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Tamsulosin.,Tamsulosin
DB00819,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Acetazolamide.,Acetazolamide
DB00891,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfapyridine.,Sulfapyridine
DB00909,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Zonisamide.,Zonisamide
DB01015,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfamethoxazole.,Sulfamethoxazole
DB01032,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Probenecid.,Probenecid
DB01144,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Diclofenamide.,Diclofenamide
DB01298,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfacytine.,Sulfacytine
DB01299,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfadoxine.,Sulfadoxine
DB01382,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Glymidine.,Glymidine
DB01581,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfamerazine.,Sulfamerazine
DB01582,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfamethazine.,Sulfamethazine
DB02925,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Piretanide.,Piretanide
DB04707,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Hydroxyfasudil.,Hydroxyfasudil
DB06150,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfadimethoxine.,Sulfadimethoxine
DB06290,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Simeprevir.,Simeprevir
DB06729,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfaphenazole.,Sulfaphenazole
DB06821,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfameter.,Sulfameter
DB07996,The therapeutic efficacy of Insulin glargine can be increased when used in combination with 5-(2-methylpiperazine-1-sulfonyl)isoquinoline.,5-(2-methylpiperazine-1-sulfonyl)isoquinoline
DB08162,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Fasudil.,Fasudil
DB08798,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfamoxole.,Sulfamoxole
DB08881,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Vemurafenib.,Vemurafenib
DB08961,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Azosemide.,Azosemide
DB11389,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Clorsulon.,Clorsulon
DB11461,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfachlorpyridazine.,Sulfachlorpyridazine
DB11462,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfaethoxypyridazine.,Sulfaethoxypyridazine
DB11463,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfanitran.,Sulfanitran
DB11464,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfaquinoxaline.,Sulfaquinoxaline
DB12051,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Setrobuvir.,Setrobuvir
DB12921,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Chlorsulfaquinoxaline.,Chlorsulfaquinoxaline
DB13214,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfadicramide.,Sulfadicramide
DB13248,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Phthalylsulfathiazole.,Phthalylsulfathiazole
DB13283,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfaisodimidine.,Sulfaisodimidine
DB13284,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Meticrane.,Meticrane
DB13320,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfaperin.,Sulfaperin
DB13405,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Mefruside.,Mefruside
DB13485,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfametomidine.,Sulfametomidine
DB13547,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfatolamide.,Sulfatolamide
DB13556,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfamazone.,Sulfamazone
DB13580,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Succinylsulfathiazole.,Succinylsulfathiazole
DB13617,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Clorexolone.,Clorexolone
DB13663,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Clofenamide.,Clofenamide
DB13699,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfathiourea.,Sulfathiourea
DB13708,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Fenquizone.,Fenquizone
DB13726,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfaguanidine.,Sulfaguanidine
DB13773,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfamethoxypyridazine.,Sulfamethoxypyridazine
DB13792,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Clopamide.,Clopamide
DB13803,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Xipamide.,Xipamide
DB14033,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Acetyl sulfisoxazole.,Acetyl sulfisoxazole
DB14708,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Tosylchloramide.,Tosylchloramide
DB01098,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Rosuvastatin.,Rosuvastatin
DB00703,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Methazolamide.,Methazolamide
DB06370,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Indisulam.,Indisulam
DB00176,The metabolism of Fluvoxamine can be increased when combined with Insulin glargine.,Fluvoxamine
DB00184,The metabolism of Nicotine can be increased when combined with Insulin glargine.,Nicotine
DB00188,The metabolism of Bortezomib can be increased when combined with Insulin glargine.,Bortezomib
DB00201,The metabolism of Caffeine can be increased when combined with Insulin glargine.,Caffeine
DB00261,The metabolism of Anagrelide can be increased when combined with Insulin glargine.,Anagrelide
DB00262,The metabolism of Carmustine can be increased when combined with Insulin glargine.,Carmustine
DB00281,The metabolism of Lidocaine can be increased when combined with Insulin glargine.,Lidocaine
DB00286,The metabolism of Conjugated estrogens can be increased when combined with Insulin glargine.,Conjugated estrogens
DB00296,The metabolism of Ropivacaine can be increased when combined with Insulin glargine.,Ropivacaine
DB00315,The metabolism of Zolmitriptan can be increased when combined with Insulin glargine.,Zolmitriptan
DB00316,The metabolism of Acetaminophen can be increased when combined with Insulin glargine.,Acetaminophen
DB00356,The metabolism of Chlorzoxazone can be increased when combined with Insulin glargine.,Chlorzoxazone
DB00365,The metabolism of Grepafloxacin can be increased when combined with Insulin glargine.,Grepafloxacin
DB00370,The metabolism of Mirtazapine can be increased when combined with Insulin glargine.,Mirtazapine
DB00379,The metabolism of Mexiletine can be increased when combined with Insulin glargine.,Mexiletine
DB00382,The metabolism of Tacrine can be increased when combined with Insulin glargine.,Tacrine
DB00384,The metabolism of Triamterene can be increased when combined with Insulin glargine.,Triamterene
DB00420,The metabolism of Promazine can be increased when combined with Insulin glargine.,Promazine
DB00425,The metabolism of Zolpidem can be increased when combined with Insulin glargine.,Zolpidem
DB00442,The metabolism of Entecavir can be increased when combined with Insulin glargine.,Entecavir
DB00461,The metabolism of Nabumetone can be increased when combined with Insulin glargine.,Nabumetone
DB00472,The metabolism of Fluoxetine can be increased when combined with Insulin glargine.,Fluoxetine
DB00476,The metabolism of Duloxetine can be increased when combined with Insulin glargine.,Duloxetine
DB00499,The metabolism of Flutamide can be increased when combined with Insulin glargine.,Flutamide
DB00518,The metabolism of Albendazole can be increased when combined with Insulin glargine.,Albendazole
DB00533,The metabolism of Rofecoxib can be increased when combined with Insulin glargine.,Rofecoxib
DB00544,The metabolism of Fluorouracil can be increased when combined with Insulin glargine.,Fluorouracil
DB00568,The metabolism of Cinnarizine can be increased when combined with Insulin glargine.,Cinnarizine
DB00586,The metabolism of Diclofenac can be increased when combined with Insulin glargine.,Diclofenac
DB00619,The metabolism of Imatinib can be increased when combined with Insulin glargine.,Imatinib
DB00629,The metabolism of Guanabenz can be increased when combined with Insulin glargine.,Guanabenz
DB00642,The metabolism of Pemetrexed can be increased when combined with Insulin glargine.,Pemetrexed
DB00661,The metabolism of Verapamil can be increased when combined with Insulin glargine.,Verapamil
DB00715,The metabolism of Paroxetine can be increased when combined with Insulin glargine.,Paroxetine
DB00730,The metabolism of Thiabendazole can be increased when combined with Insulin glargine.,Thiabendazole
DB00740,The metabolism of Riluzole can be increased when combined with Insulin glargine.,Riluzole
DB00744,The metabolism of Zileuton can be increased when combined with Insulin glargine.,Zileuton
DB00758,The metabolism of Clopidogrel can be increased when combined with Insulin glargine.,Clopidogrel
DB00787,The metabolism of Acyclovir can be increased when combined with Insulin glargine.,Acyclovir
DB00788,The metabolism of Naproxen can be increased when combined with Insulin glargine.,Naproxen
DB00806,The metabolism of Pentoxifylline can be increased when combined with Insulin glargine.,Pentoxifylline
DB00831,The metabolism of Trifluoperazine can be increased when combined with Insulin glargine.,Trifluoperazine
DB00850,The metabolism of Perphenazine can be increased when combined with Insulin glargine.,Perphenazine
DB00857,The metabolism of Terbinafine can be increased when combined with Insulin glargine.,Terbinafine
DB00863,The metabolism of Ranitidine can be increased when combined with Insulin glargine.,Ranitidine
DB00898,The metabolism of Ethanol can be increased when combined with Insulin glargine.,Ethanol
DB00934,The metabolism of Maprotiline can be increased when combined with Insulin glargine.,Maprotiline
DB00969,The metabolism of Alosetron can be increased when combined with Insulin glargine.,Alosetron
DB00978,The metabolism of Lomefloxacin can be increased when combined with Insulin glargine.,Lomefloxacin
DB00980,The metabolism of Ramelteon can be increased when combined with Insulin glargine.,Ramelteon
DB00993,The metabolism of Azathioprine can be increased when combined with Insulin glargine.,Azathioprine
DB00998,The metabolism of Frovatriptan can be increased when combined with Insulin glargine.,Frovatriptan
DB01002,The metabolism of Levobupivacaine can be increased when combined with Insulin glargine.,Levobupivacaine
DB01012,The metabolism of Cinacalcet can be increased when combined with Insulin glargine.,Cinacalcet
DB01037,The metabolism of Selegiline can be increased when combined with Insulin glargine.,Selegiline
DB01056,The metabolism of Tocainide can be increased when combined with Insulin glargine.,Tocainide
DB01058,The metabolism of Praziquantel can be increased when combined with Insulin glargine.,Praziquantel
DB01065,The metabolism of Melatonin can be increased when combined with Insulin glargine.,Melatonin
DB01087,The metabolism of Primaquine can be increased when combined with Insulin glargine.,Primaquine
DB01094,The metabolism of Hesperetin can be increased when combined with Insulin glargine.,Hesperetin
DB01097,The metabolism of Leflunomide can be increased when combined with Insulin glargine.,Leflunomide
DB01166,The metabolism of Cilostazol can be increased when combined with Insulin glargine.,Cilostazol
DB01184,The metabolism of Domperidone can be increased when combined with Insulin glargine.,Domperidone
DB01191,The metabolism of Dexfenfluramine can be increased when combined with Insulin glargine.,Dexfenfluramine
DB01303,The metabolism of Oxtriphylline can be increased when combined with Insulin glargine.,Oxtriphylline
DB01367,The metabolism of Rasagiline can be increased when combined with Insulin glargine.,Rasagiline
DB01405,The metabolism of Temafloxacin can be increased when combined with Insulin glargine.,Temafloxacin
DB01412,The metabolism of Theobromine can be increased when combined with Insulin glargine.,Theobromine
DB01424,The metabolism of Aminophenazone can be increased when combined with Insulin glargine.,Aminophenazone
DB01435,The metabolism of Antipyrine can be increased when combined with Insulin glargine.,Antipyrine
DB01482,The metabolism of Fenethylline can be increased when combined with Insulin glargine.,Fenethylline
DB01558,The metabolism of Bromazepam can be increased when combined with Insulin glargine.,Bromazepam
DB01623,The metabolism of Thiothixene can be increased when combined with Insulin glargine.,Thiothixene
DB01628,The metabolism of Etoricoxib can be increased when combined with Insulin glargine.,Etoricoxib
DB01645,The metabolism of Genistein can be increased when combined with Insulin glargine.,Genistein
DB01667,The metabolism of 8-azaguanine can be increased when combined with Insulin glargine.,8-azaguanine
DB02134,The metabolism of Xanthine can be increased when combined with Insulin glargine.,Xanthine
DB02489,The metabolism of 9-Methylguanine can be increased when combined with Insulin glargine.,9-Methylguanine
DB02568,The metabolism of Peldesine can be increased when combined with Insulin glargine.,Peldesine
DB02709,The metabolism of Resveratrol can be increased when combined with Insulin glargine.,Resveratrol
DB03783,The metabolism of Phenacetin can be increased when combined with Insulin glargine.,Phenacetin
DB04076,The metabolism of Hypoxanthine can be increased when combined with Insulin glargine.,Hypoxanthine
DB04356,The metabolism of 9-Deazaguanine can be increased when combined with Insulin glargine.,9-Deazaguanine
DB04841,The metabolism of Flunarizine can be increased when combined with Insulin glargine.,Flunarizine
DB04871,The metabolism of Lorcaserin can be increased when combined with Insulin glargine.,Lorcaserin
DB04948,The metabolism of Lofexidine can be increased when combined with Insulin glargine.,Lofexidine
DB04951,The metabolism of Pirfenidone can be increased when combined with Insulin glargine.,Pirfenidone
DB05676,The metabolism of Apremilast can be increased when combined with Insulin glargine.,Apremilast
DB06148,The metabolism of Mianserin can be increased when combined with Insulin glargine.,Mianserin
DB06210,The metabolism of Eltrombopag can be increased when combined with Insulin glargine.,Eltrombopag
DB06235,The metabolism of Vadimezan can be increased when combined with Insulin glargine.,Vadimezan
DB06479,The metabolism of Propentofylline can be increased when combined with Insulin glargine.,Propentofylline
DB06589,The metabolism of Pazopanib can be increased when combined with Insulin glargine.,Pazopanib
DB06594,The metabolism of Agomelatine can be increased when combined with Insulin glargine.,Agomelatine
DB06626,The metabolism of Axitinib can be increased when combined with Insulin glargine.,Axitinib
DB06769,The metabolism of Bendamustine can be increased when combined with Insulin glargine.,Bendamustine
DB06770,The metabolism of Benzyl alcohol can be increased when combined with Insulin glargine.,Benzyl alcohol
DB06774,The metabolism of Capsaicin can be increased when combined with Insulin glargine.,Capsaicin
DB08496,The metabolism of (R)-warfarin can be increased when combined with Insulin glargine.,(R)-warfarin
DB08883,The metabolism of Perampanel can be increased when combined with Insulin glargine.,Perampanel
DB09071,The metabolism of Tasimelteon can be increased when combined with Insulin glargine.,Tasimelteon
DB09118,The metabolism of Stiripentol can be increased when combined with Insulin glargine.,Stiripentol
DB09225,The metabolism of Zotepine can be increased when combined with Insulin glargine.,Zotepine
DB09273,The metabolism of Doxofylline can be increased when combined with Insulin glargine.,Doxofylline
DB09288,The metabolism of Propacetamol can be increased when combined with Insulin glargine.,Propacetamol
DB09290,The metabolism of Ramosetron can be increased when combined with Insulin glargine.,Ramosetron
DB11919,The metabolism of 6-O-benzylguanine can be increased when combined with Insulin glargine.,6-O-benzylguanine
DB11967,The metabolism of Binimetinib can be increased when combined with Insulin glargine.,Binimetinib
DB12026,The metabolism of Voxilaprevir can be increased when combined with Insulin glargine.,Voxilaprevir
DB12245,The metabolism of Triclabendazole can be increased when combined with Insulin glargine.,Triclabendazole
DB12332,The metabolism of Rucaparib can be increased when combined with Insulin glargine.,Rucaparib
DB12406,The metabolism of Lisofylline can be increased when combined with Insulin glargine.,Lisofylline
DB12531,The metabolism of Lobucavir can be increased when combined with Insulin glargine.,Lobucavir
DB12926,The metabolism of Cafedrine can be increased when combined with Insulin glargine.,Cafedrine
DB12927,The metabolism of Theodrenaline can be increased when combined with Insulin glargine.,Theodrenaline
DB12945,The metabolism of Dihydralazine can be increased when combined with Insulin glargine.,Dihydralazine
DB13203,The metabolism of Bamifylline can be increased when combined with Insulin glargine.,Bamifylline
DB13449,The metabolism of Proxyphylline can be increased when combined with Insulin glargine.,Proxyphylline
DB13573,The metabolism of Acefylline can be increased when combined with Insulin glargine.,Acefylline
DB13592,The metabolism of Etamiphylline can be increased when combined with Insulin glargine.,Etamiphylline
DB13634,The metabolism of Pentifylline can be increased when combined with Insulin glargine.,Pentifylline
DB13812,The metabolism of Bufylline can be increased when combined with Insulin glargine.,Bufylline
DB13952,The metabolism of Estradiol acetate can be increased when combined with Insulin glargine.,Estradiol acetate
DB13953,The metabolism of Estradiol benzoate can be increased when combined with Insulin glargine.,Estradiol benzoate
DB13954,The metabolism of Estradiol cypionate can be increased when combined with Insulin glargine.,Estradiol cypionate
DB13955,The metabolism of Estradiol dienanthate can be increased when combined with Insulin glargine.,Estradiol dienanthate
DB13956,The metabolism of Estradiol valerate can be increased when combined with Insulin glargine.,Estradiol valerate
DB14018,The metabolism of Bromotheophylline can be increased when combined with Insulin glargine.,Bromotheophylline
DB14132,The metabolism of 8-chlorotheophylline can be increased when combined with Insulin glargine.,8-chlorotheophylline
DB01115,The metabolism of Nifedipine can be increased when combined with Insulin glargine.,Nifedipine
DB11757,The metabolism of Istradefylline can be increased when combined with Insulin glargine.,Istradefylline
DB00972,The metabolism of Azelastine can be increased when combined with Insulin glargine.,Azelastine
DB00625,The metabolism of Efavirenz can be increased when combined with Insulin glargine.,Efavirenz
DB04889,The metabolism of Bicifadine can be increased when combined with Insulin glargine.,Bicifadine
DB05708,The metabolism of GTS-21 can be increased when combined with Insulin glargine.,GTS-21
DB01195,The metabolism of Flecainide can be increased when combined with Insulin glargine.,Flecainide
DB00783,The metabolism of Estradiol can be increased when combined with Insulin glargine.,Estradiol
DB00321,The metabolism of Amitriptyline can be increased when combined with Insulin glargine.,Amitriptyline
DB00458,The metabolism of Imipramine can be increased when combined with Insulin glargine.,Imipramine
DB01142,The metabolism of Doxepin can be increased when combined with Insulin glargine.,Doxepin
DB00532,The metabolism of Mephenytoin can be increased when combined with Insulin glargine.,Mephenytoin
DB00540,The metabolism of Nortriptyline can be increased when combined with Insulin glargine.,Nortriptyline
DB00575,The metabolism of Clonidine can be increased when combined with Insulin glargine.,Clonidine
DB00924,The metabolism of Cyclobenzaprine can be increased when combined with Insulin glargine.,Cyclobenzaprine
DB01151,The metabolism of Desipramine can be increased when combined with Insulin glargine.,Desipramine
DB01242,The metabolism of Clomipramine can be increased when combined with Insulin glargine.,Clomipramine
DB11689,The metabolism of Selumetinib can be increased when combined with Insulin glargine.,Selumetinib
DB00277,The metabolism of Theophylline can be increased when combined with Insulin glargine.,Theophylline
DB00398,The metabolism of Sorafenib can be increased when combined with Insulin glargine.,Sorafenib
DB00530,The metabolism of Erlotinib can be increased when combined with Insulin glargine.,Erlotinib
DB00564,The metabolism of Carbamazepine can be increased when combined with Insulin glargine.,Carbamazepine
DB00682,The metabolism of Warfarin can be increased when combined with Insulin glargine.,Warfarin
DB00697,The metabolism of Tizanidine can be increased when combined with Insulin glargine.,Tizanidine
DB00773,The metabolism of Etoposide can be increased when combined with Insulin glargine.,Etoposide
DB00851,The metabolism of Dacarbazine can be increased when combined with Insulin glargine.,Dacarbazine
DB01100,The metabolism of Pimozide can be increased when combined with Insulin glargine.,Pimozide
DB01223,The metabolism of Aminophylline can be increased when combined with Insulin glargine.,Aminophylline
DB01254,The metabolism of Dasatinib can be increased when combined with Insulin glargine.,Dasatinib
DB01418,The metabolism of Acenocoumarol can be increased when combined with Insulin glargine.,Acenocoumarol
DB08910,The metabolism of Pomalidomide can be increased when combined with Insulin glargine.,Pomalidomide
DB09256,The metabolism of Tegafur can be increased when combined with Insulin glargine.,Tegafur
DB13874,The metabolism of Enasidenib can be increased when combined with Insulin glargine.,Enasidenib
DB00675,The metabolism of Tamoxifen can be increased when combined with Insulin glargine.,Tamoxifen
DB00030,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Insulin glargine.,Insulin human
DB00046,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Insulin glargine.,Insulin lispro
DB00071,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Insulin pork.,Insulin pork
DB00197,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Troglitazone.,Troglitazone
DB00222,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Glimepiride.,Glimepiride
DB00280,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Disopyramide.,Disopyramide
DB00284,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Acarbose.,Acarbose
DB00414,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Acetohexamide.,Acetohexamide
DB00468,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Quinine.,Quinine
DB00491,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Miglitol.,Miglitol
DB00672,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Chlorpropamide.,Chlorpropamide
DB00731,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Nateglinide.,Nateglinide
DB00834,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Mifepristone.,Mifepristone
DB00839,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Tolazamide.,Tolazamide
DB00912,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Repaglinide.,Repaglinide
DB00914,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Phenformin.,Phenformin
DB01016,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Glyburide.,Glyburide
DB01067,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Glipizide.,Glipizide
DB01120,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Gliclazide.,Gliclazide
DB01124,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Tolbutamide.,Tolbutamide
DB01200,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Bromocriptine.,Bromocriptine
DB01251,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Gliquidone.,Gliquidone
DB01252,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Mitiglinide.,Mitiglinide
DB01268,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Sunitinib.,Sunitinib
DB01277,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Mecasermin.,Mecasermin
DB01289,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Glisoxepide.,Glisoxepide
DB01306,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Insulin aspart.,Insulin aspart
DB01307,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Insulin detemir.,Insulin detemir
DB01309,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Insulin glulisine.,Insulin glulisine
DB01700,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with AICA ribonucleotide.,AICA ribonucleotide
DB04830,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Buformin.,Buformin
DB04878,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Voglibose.,Voglibose
DB05115,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with NN344.,NN344
DB05819,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with NBI-6024.,NBI-6024
DB08962,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Glibornuride.,Glibornuride
DB09022,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Benfluorex.,Benfluorex
DB09198,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Lobeglitazone.,Lobeglitazone
DB09199,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Netoglitazone.,Netoglitazone
DB09200,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Rivoglitazone.,Rivoglitazone
DB09201,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Ciglitazone.,Ciglitazone
DB09456,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Insulin beef.,Insulin beef
DB09564,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Insulin degludec.,Insulin degludec
DB11567,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Insulin peglispro.,Insulin peglispro
DB11568,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Insulin tregopil.,Insulin tregopil
DB11698,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Ipragliflozin.,Ipragliflozin
DB11780,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Allicin.,Allicin
DB11824,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Tofogliflozin.,Tofogliflozin
DB11898,"The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with 2,4-thiazolidinedione.","2,4-thiazolidinedione"
DB12713,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Sotagliflozin.,Sotagliflozin
DB12781,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Balaglitazone.,Balaglitazone
DB12935,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Remogliflozin etabonate.,Remogliflozin etabonate
DB13406,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Carbutamide.,Carbutamide
DB13446,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Guar gum.,Guar gum
DB13675,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Metahexamide.,Metahexamide
DB14035,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Englitazone.,Englitazone
DB15171,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Tirzepatide.,Tirzepatide
DB15217,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Gastric inhibitory polypeptide.,Gastric inhibitory polypeptide
DB00270,The risk or severity of hypoglycemia can be increased when Isradipine is combined with Insulin glargine.,Isradipine
DB00343,The risk or severity of hypoglycemia can be increased when Diltiazem is combined with Insulin glargine.,Diltiazem
DB00347,The risk or severity of hypoglycemia can be increased when Trimethadione is combined with Insulin glargine.,Trimethadione
DB00381,The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Insulin glargine.,Amlodipine
DB00393,The risk or severity of hypoglycemia can be increased when Nimodipine is combined with Insulin glargine.,Nimodipine
DB00401,The risk or severity of hypoglycemia can be increased when Nisoldipine is combined with Insulin glargine.,Nisoldipine
DB00528,The risk or severity of hypoglycemia can be increased when Lercanidipine is combined with Insulin glargine.,Lercanidipine
DB00555,The risk or severity of hypoglycemia can be increased when Lamotrigine is combined with Insulin glargine.,Lamotrigine
DB00593,The risk or severity of hypoglycemia can be increased when Ethosuximide is combined with Insulin glargine.,Ethosuximide
DB00622,The risk or severity of hypoglycemia can be increased when Nicardipine is combined with Insulin glargine.,Nicardipine
DB00653,The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Insulin glargine.,Magnesium sulfate
DB00836,The risk or severity of hypoglycemia can be increased when Loperamide is combined with Insulin glargine.,Loperamide
DB01054,The risk or severity of hypoglycemia can be increased when Nitrendipine is combined with Insulin glargine.,Nitrendipine
DB01074,The risk or severity of hypoglycemia can be increased when Perhexiline is combined with Insulin glargine.,Perhexiline
DB01244,The risk or severity of hypoglycemia can be increased when Bepridil is combined with Insulin glargine.,Bepridil
DB01388,The risk or severity of hypoglycemia can be increased when Mibefradil is combined with Insulin glargine.,Mibefradil
DB04743,The risk or severity of hypoglycemia can be increased when Nimesulide is combined with Insulin glargine.,Nimesulide
DB04825,The risk or severity of hypoglycemia can be increased when Prenylamine is combined with Insulin glargine.,Prenylamine
DB04838,The risk or severity of hypoglycemia can be increased when Cyclandelate is combined with Insulin glargine.,Cyclandelate
DB04842,The risk or severity of hypoglycemia can be increased when Fluspirilene is combined with Insulin glargine.,Fluspirilene
DB04920,The risk or severity of hypoglycemia can be increased when Clevidipine is combined with Insulin glargine.,Clevidipine
DB05246,The risk or severity of hypoglycemia can be increased when Methsuximide is combined with Insulin glargine.,Methsuximide
DB05885,The risk or severity of hypoglycemia can be increased when Seletracetam is combined with Insulin glargine.,Seletracetam
DB06152,The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Insulin glargine.,Nylidrin
DB06283,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Insulin glargine.,Ziconotide
DB06446,The risk or severity of hypoglycemia can be increased when Dotarizine is combined with Insulin glargine.,Dotarizine
DB06694,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Insulin glargine.,Xylometazoline
DB06712,The risk or severity of hypoglycemia can be increased when Nilvadipine is combined with Insulin glargine.,Nilvadipine
DB07615,The risk or severity of hypoglycemia can be increased when Tranilast is combined with Insulin glargine.,Tranilast
DB08838,The risk or severity of hypoglycemia can be increased when Agmatine is combined with Insulin glargine.,Agmatine
DB08980,The risk or severity of hypoglycemia can be increased when Fendiline is combined with Insulin glargine.,Fendiline
DB08992,The risk or severity of hypoglycemia can be increased when Eperisone is combined with Insulin glargine.,Eperisone
DB09089,The risk or severity of hypoglycemia can be increased when Trimebutine is combined with Insulin glargine.,Trimebutine
DB09090,The risk or severity of hypoglycemia can be increased when Pinaverium is combined with Insulin glargine.,Pinaverium
DB09216,The risk or severity of hypoglycemia can be increased when Tolfenamic acid is combined with Insulin glargine.,Tolfenamic acid
DB09227,The risk or severity of hypoglycemia can be increased when Barnidipine is combined with Insulin glargine.,Barnidipine
DB09229,The risk or severity of hypoglycemia can be increased when Aranidipine is combined with Insulin glargine.,Aranidipine
DB09230,The risk or severity of hypoglycemia can be increased when Azelnidipine is combined with Insulin glargine.,Azelnidipine
DB09231,The risk or severity of hypoglycemia can be increased when Benidipine is combined with Insulin glargine.,Benidipine
DB09232,The risk or severity of hypoglycemia can be increased when Cilnidipine is combined with Insulin glargine.,Cilnidipine
DB09234,The risk or severity of hypoglycemia can be increased when Darodipine is combined with Insulin glargine.,Darodipine
DB09235,The risk or severity of hypoglycemia can be increased when Efonidipine is combined with Insulin glargine.,Efonidipine
DB09236,The risk or severity of hypoglycemia can be increased when Lacidipine is combined with Insulin glargine.,Lacidipine
DB09238,The risk or severity of hypoglycemia can be increased when Manidipine is combined with Insulin glargine.,Manidipine
DB09239,The risk or severity of hypoglycemia can be increased when Niguldipine is combined with Insulin glargine.,Niguldipine
DB09240,The risk or severity of hypoglycemia can be increased when Niludipine is combined with Insulin glargine.,Niludipine
DB11960,The risk or severity of hypoglycemia can be increased when Carboxyamidotriazole is combined with Insulin glargine.,Carboxyamidotriazole
DB12092,The risk or severity of hypoglycemia can be increased when Naftopidil is combined with Insulin glargine.,Naftopidil
DB12093,The risk or severity of hypoglycemia can be increased when Tetrahydropalmatine is combined with Insulin glargine.,Tetrahydropalmatine
DB12131,The risk or severity of hypoglycemia can be increased when Vinpocetine is combined with Insulin glargine.,Vinpocetine
DB12923,The risk or severity of hypoglycemia can be increased when Gallopamil is combined with Insulin glargine.,Gallopamil
DB13488,The risk or severity of hypoglycemia can be increased when Bencyclane is combined with Insulin glargine.,Bencyclane
DB13500,The risk or severity of hypoglycemia can be increased when Otilonium is combined with Insulin glargine.,Otilonium
DB13725,The risk or severity of hypoglycemia can be increased when Terodiline is combined with Insulin glargine.,Terodiline
DB13766,The risk or severity of hypoglycemia can be increased when Lidoflazine is combined with Insulin glargine.,Lidoflazine
DB13791,The risk or severity of hypoglycemia can be increased when Penfluridol is combined with Insulin glargine.,Penfluridol
DB13835,The risk or severity of hypoglycemia can be increased when Caroverine is combined with Insulin glargine.,Caroverine
DB13950,The risk or severity of hypoglycemia can be increased when WIN 55212-2 is combined with Insulin glargine.,WIN 55212-2
DB13961,The risk or severity of hypoglycemia can be increased when Fish oil is combined with Insulin glargine.,Fish oil
DB14063,The risk or severity of hypoglycemia can be increased when Dexverapamil is combined with Insulin glargine.,Dexverapamil
DB14064,The risk or severity of hypoglycemia can be increased when Emopamil is combined with Insulin glargine.,Emopamil
DB14065,The risk or severity of hypoglycemia can be increased when Lomerizine is combined with Insulin glargine.,Lomerizine
DB14066,The risk or severity of hypoglycemia can be increased when Tetrandrine is combined with Insulin glargine.,Tetrandrine
DB14068,The risk or severity of hypoglycemia can be increased when Dexniguldipine is combined with Insulin glargine.,Dexniguldipine
DB01023,The risk or severity of hypoglycemia can be increased when Felodipine is combined with Insulin glargine.,Felodipine
DB01118,The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Insulin glargine.,Amiodarone
DB00191,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Phentermine.,Phentermine
DB00268,The metabolism of Ropinirole can be increased when combined with Insulin glargine.,Ropinirole
DB13074,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Insulin glargine.,Macimorelin
DB00279,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Liothyronine.,Liothyronine
DB00331,The risk or severity of adverse effects can be increased when Insulin glargine is combined with Metformin.,Metformin
DB00542,The risk or severity of hypoglycemia can be increased when Benazepril is combined with Insulin glargine.,Benazepril
DB13946,The risk or severity of adverse effects can be increased when Testosterone undecanoate is combined with Insulin glargine.,Testosterone undecanoate
DB00945,The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Insulin glargine.,Acetylsalicylic acid
DB00181,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Baclofen.,Baclofen
DB00489,The risk or severity of hypoglycemia can be increased when Sotalol is combined with Insulin glargine.,Sotalol
DB00196,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Fluconazole.,Fluconazole
DB00040,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Glucagon.,Glucagon
DB00264,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Metoprolol.,Metoprolol
DB00335,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Atenolol.,Atenolol
DB00373,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Timolol.,Timolol
DB00598,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Labetalol.,Labetalol
DB00612,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Bisoprolol.,Bisoprolol
DB00866,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Alprenolol.,Alprenolol
DB00960,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Pindolol.,Pindolol
DB01193,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Acebutolol.,Acebutolol
DB01203,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Nadolol.,Nadolol
DB01295,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Bevantolol.,Bevantolol
DB01297,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Practolol.,Practolol
DB01359,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Penbutolol.,Penbutolol
DB01580,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Oxprenolol.,Oxprenolol
DB03322,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Dexpropranolol.,Dexpropranolol
DB04846,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Celiprolol.,Celiprolol
DB04861,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Nebivolol.,Nebivolol
DB06726,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Bufuralol.,Bufuralol
DB08807,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Bopindolol.,Bopindolol
DB08808,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Bupranolol.,Bupranolol
DB08952,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Indenolol.,Indenolol
DB09013,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Befunolol.,Befunolol
DB09204,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Arotinolol.,Arotinolol
DB09351,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Levobetaxolol.,Levobetaxolol
DB11770,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Talinolol.,Talinolol
DB11785,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Anisodamine.,Anisodamine
DB12212,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Landiolol.,Landiolol
DB12752,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Bucindolol.,Bucindolol
DB13443,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Esatenolol.,Esatenolol
DB13508,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Cloranolol.,Cloranolol
DB13530,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Mepindolol.,Mepindolol
DB13757,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Epanolol.,Epanolol
DB13775,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Tertatolol.,Tertatolol
DB00195,The therapeutic efficacy of Betaxolol can be increased when used in combination with Insulin glargine.,Betaxolol
DB00571,The therapeutic efficacy of Propranolol can be increased when used in combination with Insulin glargine.,Propranolol
DB01136,The therapeutic efficacy of Carvedilol can be increased when used in combination with Insulin glargine.,Carvedilol
DB01182,The therapeutic efficacy of Propafenone can be increased when used in combination with Insulin glargine.,Propafenone
DB01611,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Hydroxychloroquine.,Hydroxychloroquine
DB01233,The therapeutic efficacy of Metoclopramide can be increased when used in combination with Insulin glargine.,Metoclopramide
DB00394,The risk or severity of hyperglycemia can be increased when Beclomethasone dipropionate is combined with Insulin glargine.,Beclomethasone dipropionate
DB00443,The risk or severity of hyperglycemia can be increased when Betamethasone is combined with Insulin glargine.,Betamethasone
DB00620,The risk or severity of hyperglycemia can be increased when Triamcinolone is combined with Insulin glargine.,Triamcinolone
DB00635,The risk or severity of hyperglycemia can be increased when Prednisone is combined with Insulin glargine.,Prednisone
DB00687,The risk or severity of hyperglycemia can be increased when Fludrocortisone is combined with Insulin glargine.,Fludrocortisone
DB00741,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Insulin glargine.,Hydrocortisone
DB00764,The risk or severity of hyperglycemia can be increased when Mometasone is combined with Insulin glargine.,Mometasone
DB00860,The risk or severity of hyperglycemia can be increased when Prednisolone is combined with Insulin glargine.,Prednisolone
DB00959,The risk or severity of hyperglycemia can be increased when Methylprednisolone is combined with Insulin glargine.,Methylprednisolone
DB01234,The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Insulin glargine.,Dexamethasone
DB01285,The risk or severity of hyperglycemia can be increased when Corticotropin is combined with Insulin glargine.,Corticotropin
DB01380,The risk or severity of hyperglycemia can be increased when Cortisone acetate is combined with Insulin glargine.,Cortisone acetate
DB01384,The risk or severity of hyperglycemia can be increased when Paramethasone is combined with Insulin glargine.,Paramethasone
DB01410,The risk or severity of hyperglycemia can be increased when Ciclesonide is combined with Insulin glargine.,Ciclesonide
DB08906,The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Insulin glargine.,Fluticasone furoate
DB08970,The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Insulin glargine.,Fluprednidene
DB08971,The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Insulin glargine.,Fluocortolone
DB09383,The risk or severity of hyperglycemia can be increased when Meprednisone is combined with Insulin glargine.,Meprednisone
DB11487,The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Insulin glargine.,Dexamethasone isonicotinate
DB11750,The risk or severity of hyperglycemia can be increased when Clobetasol is combined with Insulin glargine.,Clobetasol
DB11921,The risk or severity of hyperglycemia can be increased when Deflazacort is combined with Insulin glargine.,Deflazacort
DB13003,The risk or severity of hyperglycemia can be increased when Cortivazol is combined with Insulin glargine.,Cortivazol
DB13208,The risk or severity of hyperglycemia can be increased when Prednylidene is combined with Insulin glargine.,Prednylidene
DB13843,The risk or severity of hyperglycemia can be increased when Cloprednol is combined with Insulin glargine.,Cloprednol
DB13867,The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Insulin glargine.,Fluticasone
DB14512,The risk or severity of hyperglycemia can be increased when Mometasone furoate is combined with Insulin glargine.,Mometasone furoate
DB00180,The risk or severity of hyperglycemia can be increased when Flunisolide is combined with Insulin glargine.,Flunisolide
DB01108,The risk or severity of hyperglycemia can be increased when Trilostane is combined with Insulin glargine.,Trilostane
DB01222,The risk or severity of hyperglycemia can be increased when Budesonide is combined with Insulin glargine.,Budesonide
DB04630,The risk or severity of hyperglycemia can be increased when Aldosterone is combined with Insulin glargine.,Aldosterone
DB09378,The risk or severity of hyperglycemia can be increased when Fluprednisolone is combined with Insulin glargine.,Fluprednisolone
DB11529,The risk or severity of hyperglycemia can be increased when Melengestrol is combined with Insulin glargine.,Melengestrol
DB14681,The risk or severity of hyperglycemia can be increased when Cortisone is combined with Insulin glargine.,Cortisone
DB00223,The risk or severity of hyperglycemia can be increased when Diflorasone is combined with Insulin glargine.,Diflorasone
DB00240,The risk or severity of hyperglycemia can be increased when Alclometasone is combined with Insulin glargine.,Alclometasone
DB00253,The risk or severity of hyperglycemia can be increased when Medrysone is combined with Insulin glargine.,Medrysone
DB00288,The risk or severity of hyperglycemia can be increased when Amcinonide is combined with Insulin glargine.,Amcinonide
DB00324,The risk or severity of hyperglycemia can be increased when Fluorometholone is combined with Insulin glargine.,Fluorometholone
DB00547,The risk or severity of hyperglycemia can be increased when Desoximetasone is combined with Insulin glargine.,Desoximetasone
DB00588,The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Insulin glargine.,Fluticasone propionate
DB00591,The risk or severity of hyperglycemia can be increased when Fluocinolone acetonide is combined with Insulin glargine.,Fluocinolone acetonide
DB00596,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Insulin glargine.,Ulobetasol
DB00663,The risk or severity of hyperglycemia can be increased when Flumethasone is combined with Insulin glargine.,Flumethasone
DB00838,The risk or severity of hyperglycemia can be increased when Clocortolone is combined with Insulin glargine.,Clocortolone
DB00846,The risk or severity of hyperglycemia can be increased when Flurandrenolide is combined with Insulin glargine.,Flurandrenolide
DB14596,The risk or severity of hyperglycemia can be increased when Loteprednol etabonate is combined with Insulin glargine.,Loteprednol etabonate
DB00896,The risk or severity of hyperglycemia can be increased when Rimexolone is combined with Insulin glargine.,Rimexolone
DB01013,The risk or severity of hyperglycemia can be increased when Clobetasol propionate is combined with Insulin glargine.,Clobetasol propionate
DB01047,The risk or severity of hyperglycemia can be increased when Fluocinonide is combined with Insulin glargine.,Fluocinonide
DB01130,The risk or severity of hyperglycemia can be increased when Prednicarbate is combined with Insulin glargine.,Prednicarbate
DB01260,The risk or severity of hyperglycemia can be increased when Desonide is combined with Insulin glargine.,Desonide
DB06781,The risk or severity of hyperglycemia can be increased when Difluprednate is combined with Insulin glargine.,Difluprednate
DB06786,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Insulin glargine.,Halcinonide
DB09091,The risk or severity of hyperglycemia can be increased when Tixocortol is combined with Insulin glargine.,Tixocortol
DB09095,The risk or severity of hyperglycemia can be increased when Difluocortolone is combined with Insulin glargine.,Difluocortolone
DB13158,The risk or severity of hyperglycemia can be increased when Clobetasone is combined with Insulin glargine.,Clobetasone
DB13223,The risk or severity of hyperglycemia can be increased when Fluocortin is combined with Insulin glargine.,Fluocortin
DB13491,The risk or severity of hyperglycemia can be increased when Fluperolone is combined with Insulin glargine.,Fluperolone
DB13664,The risk or severity of hyperglycemia can be increased when Formocortal is combined with Insulin glargine.,Formocortal
DB13728,The risk or severity of hyperglycemia can be increased when Halometasone is combined with Insulin glargine.,Halometasone
DB13856,The risk or severity of hyperglycemia can be increased when Fluclorolone is combined with Insulin glargine.,Fluclorolone
DB14538,The risk or severity of hyperglycemia can be increased when Hydrocortisone aceponate is combined with Insulin glargine.,Hydrocortisone aceponate
DB14539,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Insulin glargine.,Hydrocortisone acetate
DB14540,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Insulin glargine.,Hydrocortisone butyrate
DB14541,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Insulin glargine.,Hydrocortisone cypionate
DB14543,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Insulin glargine.,Hydrocortisone probutate
DB14544,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Insulin glargine.,Hydrocortisone valerate
DB14545,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Insulin glargine.,Hydrocortisone succinate
DB00873,The risk or severity of hyperglycemia can be increased when Loteprednol is combined with Insulin glargine.,Loteprednol
DB14631,The risk or severity of hyperglycemia can be increased when Prednisolone phosphate is combined with Insulin glargine.,Prednisolone phosphate
DB14633,The risk or severity of hyperglycemia can be increased when Prednisolone hemisuccinate is combined with Insulin glargine.,Prednisolone hemisuccinate
DB14634,The risk or severity of hyperglycemia can be increased when Fluprednidene acetate is combined with Insulin glargine.,Fluprednidene acetate
DB14643,The risk or severity of hyperglycemia can be increased when Methylprednisolone aceponate is combined with Insulin glargine.,Methylprednisolone aceponate
DB14644,The risk or severity of hyperglycemia can be increased when Methylprednisolone hemisuccinate is combined with Insulin glargine.,Methylprednisolone hemisuccinate
DB14646,The risk or severity of hyperglycemia can be increased when Prednisone acetate is combined with Insulin glargine.,Prednisone acetate
DB14652,The risk or severity of hyperglycemia can be increased when Clocortolone acetate is combined with Insulin glargine.,Clocortolone acetate
DB14659,The risk or severity of hyperglycemia can be increased when Melengestrol acetate is combined with Insulin glargine.,Melengestrol acetate
DB14669,The risk or severity of hyperglycemia can be increased when Betamethasone phosphate is combined with Insulin glargine.,Betamethasone phosphate
DB15566,The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Insulin glargine.,Prednisolone acetate
DB00451,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Levothyroxine.,Levothyroxine
DB00024,Thyrotropin alfa may decrease the hypoglycemic activities of Insulin glargine.,Thyrotropin alfa
DB01583,Liotrix may decrease the hypoglycemic activities of Insulin glargine.,Liotrix
DB03604,Tiratricol may decrease the hypoglycemic activities of Insulin glargine.,Tiratricol
DB09100,"Thyroid, porcine may decrease the hypoglycemic activities of Insulin glargine.","Thyroid, porcine"
DB00006,The risk or severity of adverse effects can be increased when Bivalirudin is combined with Collagenase clostridium histolyticum.,Bivalirudin
DB00054,The risk or severity of adverse effects can be increased when Abciximab is combined with Collagenase clostridium histolyticum.,Abciximab
DB00266,The risk or severity of adverse effects can be increased when Dicoumarol is combined with Collagenase clostridium histolyticum.,Dicoumarol
DB00278,The risk or severity of adverse effects can be increased when Argatroban is combined with Collagenase clostridium histolyticum.,Argatroban
DB00407,The risk or severity of adverse effects can be increased when Ardeparin is combined with Collagenase clostridium histolyticum.,Ardeparin
DB00498,The risk or severity of adverse effects can be increased when Phenindione is combined with Collagenase clostridium histolyticum.,Phenindione
DB00569,The risk or severity of adverse effects can be increased when Fondaparinux is combined with Collagenase clostridium histolyticum.,Fondaparinux
DB00682,The risk or severity of adverse effects can be increased when Warfarin is combined with Collagenase clostridium histolyticum.,Warfarin
DB00686,The risk or severity of adverse effects can be increased when Pentosan polysulfate is combined with Collagenase clostridium histolyticum.,Pentosan polysulfate
DB00946,The risk or severity of adverse effects can be increased when Phenprocoumon is combined with Collagenase clostridium histolyticum.,Phenprocoumon
DB00974,The risk or severity of adverse effects can be increased when Edetic acid is combined with Collagenase clostridium histolyticum.,Edetic acid
DB01109,The risk or severity of adverse effects can be increased when Heparin is combined with Collagenase clostridium histolyticum.,Heparin
DB01225,The risk or severity of adverse effects can be increased when Enoxaparin is combined with Collagenase clostridium histolyticum.,Enoxaparin
DB01418,The risk or severity of adverse effects can be increased when Acenocoumarol is combined with Collagenase clostridium histolyticum.,Acenocoumarol
DB04898,The risk or severity of adverse effects can be increased when Ximelagatran is combined with Collagenase clostridium histolyticum.,Ximelagatran
DB05099,The risk or severity of adverse effects can be increased when Ancrod is combined with Collagenase clostridium histolyticum.,Ancrod
DB06228,The risk or severity of adverse effects can be increased when Rivaroxaban is combined with Collagenase clostridium histolyticum.,Rivaroxaban
DB06271,The risk or severity of adverse effects can be increased when Sulodexide is combined with Collagenase clostridium histolyticum.,Sulodexide
DB06406,The risk or severity of adverse effects can be increased when Idraparinux is combined with Collagenase clostridium histolyticum.,Idraparinux
DB06605,The risk or severity of adverse effects can be increased when Apixaban is combined with Collagenase clostridium histolyticum.,Apixaban
DB06635,The risk or severity of adverse effects can be increased when Otamixaban is combined with Collagenase clostridium histolyticum.,Otamixaban
DB06695,The risk or severity of adverse effects can be increased when Dabigatran etexilate is combined with Collagenase clostridium histolyticum.,Dabigatran etexilate
DB06754,The risk or severity of adverse effects can be increased when Danaparoid is combined with Collagenase clostridium histolyticum.,Danaparoid
DB06779,The risk or severity of adverse effects can be increased when Dalteparin is combined with Collagenase clostridium histolyticum.,Dalteparin
DB07767,The risk or severity of adverse effects can be increased when Ferulic acid is combined with Collagenase clostridium histolyticum.,Ferulic acid
DB08794,The risk or severity of adverse effects can be increased when Ethyl biscoumacetate is combined with Collagenase clostridium histolyticum.,Ethyl biscoumacetate
DB08813,The risk or severity of adverse effects can be increased when Nadroparin is combined with Collagenase clostridium histolyticum.,Nadroparin
DB09075,The risk or severity of adverse effects can be increased when Edoxaban is combined with Collagenase clostridium histolyticum.,Edoxaban
DB09255,The risk or severity of adverse effects can be increased when Dextran is combined with Collagenase clostridium histolyticum.,Dextran
DB09259,The risk or severity of adverse effects can be increased when Reviparin is combined with Collagenase clostridium histolyticum.,Reviparin
DB09261,The risk or severity of adverse effects can be increased when Certoparin is combined with Collagenase clostridium histolyticum.,Certoparin
DB11095,The risk or severity of adverse effects can be increased when Desirudin is combined with Collagenase clostridium histolyticum.,Desirudin
DB11268,The risk or severity of adverse effects can be increased when Protocatechualdehyde is combined with Collagenase clostridium histolyticum.,Protocatechualdehyde
DB11312,The risk or severity of adverse effects can be increased when Protein C is combined with Collagenase clostridium histolyticum.,Protein C
DB11598,The risk or severity of adverse effects can be increased when Antithrombin III human is combined with Collagenase clostridium histolyticum.,Antithrombin III human
DB11984,The risk or severity of adverse effects can be increased when Letaxaban is combined with Collagenase clostridium histolyticum.,Letaxaban
DB12289,The risk or severity of adverse effects can be increased when Darexaban is combined with Collagenase clostridium histolyticum.,Darexaban
DB12598,The risk or severity of adverse effects can be increased when Nafamostat is combined with Collagenase clostridium histolyticum.,Nafamostat
DB12831,The risk or severity of adverse effects can be increased when Gabexate is combined with Collagenase clostridium histolyticum.,Gabexate
DB13124,The risk or severity of adverse effects can be increased when Troxerutin is combined with Collagenase clostridium histolyticum.,Troxerutin
DB13136,The risk or severity of adverse effects can be increased when Fluindione is combined with Collagenase clostridium histolyticum.,Fluindione
DB13149,The risk or severity of adverse effects can be increased when Protein S human is combined with Collagenase clostridium histolyticum.,Protein S human
DB13616,The risk or severity of adverse effects can be increased when Melagatran is combined with Collagenase clostridium histolyticum.,Melagatran
DB09125,The risk or severity of adverse effects can be increased when Potassium citrate is combined with Collagenase clostridium histolyticum.,Potassium citrate
DB09154,The risk or severity of adverse effects can be increased when Sodium citrate is combined with Collagenase clostridium histolyticum.,Sodium citrate
DB00031,The risk or severity of adverse effects can be increased when Tenecteplase is combined with Collagenase clostridium histolyticum.,Tenecteplase
DB00055,The risk or severity of adverse effects can be increased when Drotrecogin alfa is combined with Collagenase clostridium histolyticum.,Drotrecogin alfa
DB04932,The risk or severity of adverse effects can be increased when Defibrotide is combined with Collagenase clostridium histolyticum.,Defibrotide
DB06822,The risk or severity of adverse effects can be increased when Tinzaparin is combined with Collagenase clostridium histolyticum.,Tinzaparin
DB13199,The risk or severity of adverse effects can be increased when Brinase is combined with Collagenase clostridium histolyticum.,Brinase
DB13646,The risk or severity of adverse effects can be increased when Saruplase is combined with Collagenase clostridium histolyticum.,Saruplase
DB00086,The risk or severity of adverse effects can be increased when Streptokinase is combined with Collagenase clostridium histolyticum.,Streptokinase
DB00945,The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Collagenase clostridium histolyticum.,Acetylsalicylic acid
DB04925,The risk or severity of adverse effects can be increased when Desmoteplase is combined with Collagenase clostridium histolyticum.,Desmoteplase
DB05254,The risk or severity of adverse effects can be increased when Fibrinolysin is combined with Collagenase clostridium histolyticum.,Fibrinolysin
DB06543,The risk or severity of adverse effects can be increased when Astaxanthin is combined with Collagenase clostridium histolyticum.,Astaxanthin
DB00013,The risk or severity of adverse effects can be increased when Urokinase is combined with Collagenase clostridium histolyticum.,Urokinase
DB00975,The risk or severity of adverse effects can be increased when Dipyridamole is combined with Collagenase clostridium histolyticum.,Dipyridamole
DB01088,The risk or severity of adverse effects can be increased when Iloprost is combined with Collagenase clostridium histolyticum.,Iloprost
DB01240,The risk or severity of adverse effects can be increased when Epoprostenol is combined with Collagenase clostridium histolyticum.,Epoprostenol
DB05229,The risk or severity of adverse effects can be increased when Beraprost is combined with Collagenase clostridium histolyticum.,Beraprost
DB06209,The risk or severity of adverse effects can be increased when Prasugrel is combined with Collagenase clostridium histolyticum.,Prasugrel
DB06441,The risk or severity of adverse effects can be increased when Cangrelor is combined with Collagenase clostridium histolyticum.,Cangrelor
DB08814,The risk or severity of adverse effects can be increased when Triflusal is combined with Collagenase clostridium histolyticum.,Triflusal
DB08816,The risk or severity of adverse effects can be increased when Ticagrelor is combined with Collagenase clostridium histolyticum.,Ticagrelor
DB08994,The risk or severity of adverse effects can be increased when Ditazole is combined with Collagenase clostridium histolyticum.,Ditazole
DB09030,The risk or severity of adverse effects can be increased when Vorapaxar is combined with Collagenase clostridium histolyticum.,Vorapaxar
DB09258,The risk or severity of adverse effects can be increased when Bemiparin is combined with Collagenase clostridium histolyticum.,Bemiparin
DB09260,The risk or severity of adverse effects can be increased when Parnaparin is combined with Collagenase clostridium histolyticum.,Parnaparin
DB13275,The risk or severity of adverse effects can be increased when Clorindione is combined with Collagenase clostridium histolyticum.,Clorindione
DB13347,The risk or severity of adverse effects can be increased when Diphenadione is combined with Collagenase clostridium histolyticum.,Diphenadione
DB13451,The risk or severity of adverse effects can be increased when Tioclomarol is combined with Collagenase clostridium histolyticum.,Tioclomarol
DB00001,The risk or severity of adverse effects can be increased when Lepirudin is combined with Collagenase clostridium histolyticum.,Lepirudin
DB00009,The risk or severity of adverse effects can be increased when Alteplase is combined with Collagenase clostridium histolyticum.,Alteplase
DB00015,The risk or severity of adverse effects can be increased when Reteplase is combined with Collagenase clostridium histolyticum.,Reteplase
DB00029,The risk or severity of adverse effects can be increased when Anistreplase is combined with Collagenase clostridium histolyticum.,Anistreplase
DB14094,The risk or severity of adverse effects can be increased when Tocopherylquinone is combined with Collagenase clostridium histolyticum.,Tocopherylquinone
DB06679,The risk or severity of adverse effects can be increased when Amediplase is combined with Collagenase clostridium histolyticum.,Amediplase
DB03410,The risk or severity of adverse effects can be increased when 4-hydroxycoumarin is combined with Collagenase clostridium histolyticum.,4-hydroxycoumarin
DB08496,The risk or severity of adverse effects can be increased when (R)-warfarin is combined with Collagenase clostridium histolyticum.,(R)-warfarin
DB14055,The risk or severity of adverse effects can be increased when (S)-Warfarin is combined with Collagenase clostridium histolyticum.,(S)-Warfarin
DB12364,The risk or severity of adverse effects can be increased when Betrixaban is combined with Collagenase clostridium histolyticum.,Betrixaban
DB14598,The risk or severity of adverse effects can be increased when Edetate calcium disodium anhydrous is combined with Collagenase clostridium histolyticum.,Edetate calcium disodium anhydrous
DB11154,The risk or severity of adverse effects can be increased when Zinc citrate is combined with Collagenase clostridium histolyticum.,Zinc citrate
DB11166,The risk or severity of adverse effects can be increased when Antithrombin Alfa is combined with Collagenase clostridium histolyticum.,Antithrombin Alfa
DB04665,The risk or severity of adverse effects can be increased when Coumarin is combined with Collagenase clostridium histolyticum.,Coumarin
DB14726,The risk or severity of adverse effects can be increased when Dabigatran is combined with Collagenase clostridium histolyticum.,Dabigatran
DB06294,The risk or severity of adverse effects can be increased when Semuloparin is combined with Collagenase clostridium histolyticum.,Semuloparin
DB12726,The risk or severity of adverse effects can be increased when Monteplase is combined with Collagenase clostridium histolyticum.,Monteplase
DB00232,The therapeutic efficacy of Rasburicase can be decreased when used in combination with Methyclothiazide.,Methyclothiazide
DB00436,The therapeutic efficacy of Rasburicase can be decreased when used in combination with Bendroflumethiazide.,Bendroflumethiazide
DB00562,The therapeutic efficacy of Rasburicase can be decreased when used in combination with Benzthiazide.,Benzthiazide
DB00606,The therapeutic efficacy of Rasburicase can be decreased when used in combination with Cyclothiazide.,Cyclothiazide
DB00774,The therapeutic efficacy of Rasburicase can be decreased when used in combination with Hydroflumethiazide.,Hydroflumethiazide
DB00880,The therapeutic efficacy of Rasburicase can be decreased when used in combination with Chlorothiazide.,Chlorothiazide
DB00999,The therapeutic efficacy of Rasburicase can be decreased when used in combination with Hydrochlorothiazide.,Hydrochlorothiazide
DB01021,The therapeutic efficacy of Rasburicase can be decreased when used in combination with Trichlormethiazide.,Trichlormethiazide
DB01324,The therapeutic efficacy of Rasburicase can be decreased when used in combination with Polythiazide.,Polythiazide
DB13430,The therapeutic efficacy of Rasburicase can be decreased when used in combination with Mebutizide.,Mebutizide
DB13532,The therapeutic efficacy of Rasburicase can be decreased when used in combination with Cyclopenthiazide.,Cyclopenthiazide
DB01281,The risk or severity of infection can be increased when Adalimumab is combined with Abatacept.,Abatacept
DB00026,The risk or severity of adverse effects can be increased when Adalimumab is combined with Anakinra.,Anakinra
DB06168,The risk or severity of infection and neutropenia can be increased when Adalimumab is combined with Canakinumab.,Canakinumab
DB08904,The risk or severity of infection can be increased when Adalimumab is combined with Certolizumab pegol.,Certolizumab pegol
DB06643,The risk or severity of adverse effects can be increased when Denosumab is combined with Adalimumab.,Denosumab
DB00005,The risk or severity of adverse effects can be increased when Etanercept is combined with Adalimumab.,Etanercept
DB00008,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Adalimumab.,Peginterferon alfa-2a
DB00011,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Adalimumab.,Interferon alfa-n1
DB00018,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Adalimumab.,Interferon alfa-n3
DB00022,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Adalimumab.,Peginterferon alfa-2b
DB00033,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Adalimumab.,Interferon gamma-1b
DB00034,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Adalimumab.","Interferon alfa-2a, Recombinant"
DB00041,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Adalimumab.,Aldesleukin
DB00056,The risk or severity of adverse effects can be increased when Adalimumab is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin
DB00059,The risk or severity of adverse effects can be increased when Adalimumab is combined with Pegaspargase.,Pegaspargase
DB00068,The risk or severity of adverse effects can be increased when Adalimumab is combined with Interferon beta-1b.,Interferon beta-1b
DB00069,The risk or severity of adverse effects can be increased when Adalimumab is combined with Interferon alfacon-1.,Interferon alfacon-1
DB00073,The risk or severity of adverse effects can be increased when Adalimumab is combined with Rituximab.,Rituximab
DB00074,The risk or severity of adverse effects can be increased when Adalimumab is combined with Basiliximab.,Basiliximab
DB00075,The risk or severity of adverse effects can be increased when Adalimumab is combined with Muromonab.,Muromonab
DB00078,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ibritumomab tiuxetan.,Ibritumomab tiuxetan
DB00081,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tositumomab.,Tositumomab
DB00087,The risk or severity of adverse effects can be increased when Adalimumab is combined with Alemtuzumab.,Alemtuzumab
DB00092,The risk or severity of adverse effects can be increased when Adalimumab is combined with Alefacept.,Alefacept
DB00095,The risk or severity of adverse effects can be increased when Adalimumab is combined with Efalizumab.,Efalizumab
DB00098,The risk or severity of adverse effects can be increased when Adalimumab is combined with Antithymocyte immunoglobulin (rabbit).,Antithymocyte immunoglobulin (rabbit)
DB00105,The risk or severity of adverse effects can be increased when Adalimumab is combined with Interferon alfa-2b.,Interferon alfa-2b
DB00111,The risk or severity of adverse effects can be increased when Adalimumab is combined with Daclizumab.,Daclizumab
DB00112,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bevacizumab.,Bevacizumab
DB00120,The risk or severity of adverse effects can be increased when Adalimumab is combined with Phenylalanine.,Phenylalanine
DB00242,The risk or severity of adverse effects can be increased when Adalimumab is combined with Cladribine.,Cladribine
DB00276,The risk or severity of adverse effects can be increased when Adalimumab is combined with Amsacrine.,Amsacrine
DB00290,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bleomycin.,Bleomycin
DB00291,The risk or severity of adverse effects can be increased when Adalimumab is combined with Chlorambucil.,Chlorambucil
DB00293,The risk or severity of adverse effects can be increased when Adalimumab is combined with Raltitrexed.,Raltitrexed
DB00305,The risk or severity of adverse effects can be increased when Adalimumab is combined with Mitomycin.,Mitomycin
DB00322,The risk or severity of adverse effects can be increased when Adalimumab is combined with Floxuridine.,Floxuridine
DB00352,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tioguanine.,Tioguanine
DB00380,The risk or severity of adverse effects can be increased when Adalimumab is combined with Dexrazoxane.,Dexrazoxane
DB00428,The risk or severity of adverse effects can be increased when Adalimumab is combined with Streptozocin.,Streptozocin
DB00432,The risk or severity of adverse effects can be increased when Adalimumab is combined with Trifluridine.,Trifluridine
DB00441,The risk or severity of adverse effects can be increased when Adalimumab is combined with Gemcitabine.,Gemcitabine
DB00445,The risk or severity of adverse effects can be increased when Adalimumab is combined with Epirubicin.,Epirubicin
DB00446,The risk or severity of adverse effects can be increased when Adalimumab is combined with Chloramphenicol.,Chloramphenicol
DB00480,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lenalidomide.,Lenalidomide
DB00488,The risk or severity of adverse effects can be increased when Adalimumab is combined with Altretamine.,Altretamine
DB00515,The risk or severity of adverse effects can be increased when Adalimumab is combined with Cisplatin.,Cisplatin
DB00526,The risk or severity of adverse effects can be increased when Adalimumab is combined with Oxaliplatin.,Oxaliplatin
DB00550,The risk or severity of adverse effects can be increased when Adalimumab is combined with Propylthiouracil.,Propylthiouracil
DB00552,The risk or severity of adverse effects can be increased when Adalimumab is combined with Pentostatin.,Pentostatin
DB00601,The risk or severity of adverse effects can be increased when Adalimumab is combined with Linezolid.,Linezolid
DB00631,The risk or severity of adverse effects can be increased when Adalimumab is combined with Clofarabine.,Clofarabine
DB00763,The risk or severity of adverse effects can be increased when Adalimumab is combined with Methimazole.,Methimazole
DB00795,The risk or severity of adverse effects can be increased when Adalimumab is combined with Sulfasalazine.,Sulfasalazine
DB00853,The risk or severity of adverse effects can be increased when Adalimumab is combined with Temozolomide.,Temozolomide
DB00859,The risk or severity of adverse effects can be increased when Adalimumab is combined with Penicillamine.,Penicillamine
DB00888,The risk or severity of adverse effects can be increased when Adalimumab is combined with Mechlorethamine.,Mechlorethamine
DB00928,The risk or severity of adverse effects can be increased when Adalimumab is combined with Azacitidine.,Azacitidine
DB00958,The risk or severity of adverse effects can be increased when Adalimumab is combined with Carboplatin.,Carboplatin
DB00970,The risk or severity of adverse effects can be increased when Adalimumab is combined with Dactinomycin.,Dactinomycin
DB01005,The risk or severity of adverse effects can be increased when Adalimumab is combined with Hydroxyurea.,Hydroxyurea
DB01024,The risk or severity of adverse effects can be increased when Adalimumab is combined with Mycophenolic acid.,Mycophenolic acid
DB01030,The risk or severity of adverse effects can be increased when Adalimumab is combined with Topotecan.,Topotecan
DB01042,The risk or severity of adverse effects can be increased when Adalimumab is combined with Melphalan.,Melphalan
DB01073,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fludarabine.,Fludarabine
DB01099,The risk or severity of adverse effects can be increased when Adalimumab is combined with Flucytosine.,Flucytosine
DB01168,The risk or severity of adverse effects can be increased when Adalimumab is combined with Procarbazine.,Procarbazine
DB01169,The risk or severity of adverse effects can be increased when Adalimumab is combined with Arsenic trioxide.,Arsenic trioxide
DB01204,The risk or severity of adverse effects can be increased when Adalimumab is combined with Mitoxantrone.,Mitoxantrone
DB01206,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lomustine.,Lomustine
DB01257,The risk or severity of adverse effects can be increased when Adalimumab is combined with Eculizumab.,Eculizumab
DB01262,The risk or severity of adverse effects can be increased when Adalimumab is combined with Decitabine.,Decitabine
DB01280,The risk or severity of adverse effects can be increased when Adalimumab is combined with Nelarabine.,Nelarabine
DB01423,The risk or severity of adverse effects can be increased when Adalimumab is combined with Stepronin.,Stepronin
DB01816,The risk or severity of adverse effects can be increased when Adalimumab is combined with Castanospermine.,Castanospermine
DB02546,The risk or severity of adverse effects can be increased when Adalimumab is combined with Vorinostat.,Vorinostat
DB02806,The risk or severity of adverse effects can be increased when Adalimumab is combined with 2-Methoxyethanol.,2-Methoxyethanol
DB03523,The risk or severity of adverse effects can be increased when Adalimumab is combined with Brequinar.,Brequinar
DB04956,The risk or severity of adverse effects can be increased when Adalimumab is combined with Afelimomab.,Afelimomab
DB05258,The risk or severity of adverse effects can be increased when Adalimumab is combined with Interferon alfa.,Interferon alfa
DB05259,The risk or severity of adverse effects can be increased when Adalimumab is combined with Glatiramer.,Glatiramer
DB05260,The risk or severity of adverse effects can be increased when Adalimumab is combined with Gallium nitrate.,Gallium nitrate
DB05459,The risk or severity of adverse effects can be increased when Adalimumab is combined with Briakinumab.,Briakinumab
DB05472,The risk or severity of adverse effects can be increased when Adalimumab is combined with omega interferon.,omega interferon
DB06612,The risk or severity of adverse effects can be increased when Adalimumab is combined with Mepolizumab.,Mepolizumab
DB06662,The risk or severity of adverse effects can be increased when Adalimumab is combined with Abetimus.,Abetimus
DB06674,The risk or severity of adverse effects can be increased when Adalimumab is combined with Golimumab.,Golimumab
DB06681,The risk or severity of adverse effects can be increased when Adalimumab is combined with Belatacept.,Belatacept
DB06813,The risk or severity of adverse effects can be increased when Adalimumab is combined with Pralatrexate.,Pralatrexate
DB08059,The risk or severity of adverse effects can be increased when Adalimumab is combined with Wortmannin.,Wortmannin
DB08871,The risk or severity of adverse effects can be increased when Adalimumab is combined with Eribulin.,Eribulin
DB08879,The risk or severity of adverse effects can be increased when Adalimumab is combined with Belimumab.,Belimumab
DB08880,The risk or severity of adverse effects can be increased when Adalimumab is combined with Teriflunomide.,Teriflunomide
DB08889,The risk or severity of adverse effects can be increased when Adalimumab is combined with Carfilzomib.,Carfilzomib
DB08908,The risk or severity of adverse effects can be increased when Adalimumab is combined with Dimethyl fumarate.,Dimethyl fumarate
DB08935,The risk or severity of adverse effects can be increased when Adalimumab is combined with Obinutuzumab.,Obinutuzumab
DB09029,The risk or severity of adverse effects can be increased when Adalimumab is combined with Secukinumab.,Secukinumab
DB09036,The risk or severity of adverse effects can be increased when Adalimumab is combined with Siltuximab.,Siltuximab
DB09052,The risk or severity of adverse effects can be increased when Adalimumab is combined with Blinatumomab.,Blinatumomab
DB09077,The risk or severity of adverse effects can be increased when Adalimumab is combined with Dinutuximab.,Dinutuximab
DB09091,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tixocortol.,Tixocortol
DB09122,The risk or severity of adverse effects can be increased when Adalimumab is combined with Peginterferon beta-1a.,Peginterferon beta-1a
DB09312,The risk or severity of adverse effects can be increased when Adalimumab is combined with Antilymphocyte immunoglobulin (horse).,Antilymphocyte immunoglobulin (horse)
DB11466,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tepoxalin.,Tepoxalin
DB11569,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ixekizumab.,Ixekizumab
DB11580,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ravulizumab.,Ravulizumab
DB11616,The risk or severity of adverse effects can be increased when Adalimumab is combined with Pirarubicin.,Pirarubicin
DB11693,The risk or severity of adverse effects can be increased when Adalimumab is combined with Voclosporin.,Voclosporin
DB11708,The risk or severity of adverse effects can be increased when Adalimumab is combined with Peficitinib.,Peficitinib
DB11767,The risk or severity of adverse effects can be increased when Adalimumab is combined with Sarilumab.,Sarilumab
DB11776,The risk or severity of adverse effects can be increased when Adalimumab is combined with Brodalumab.,Brodalumab
DB11803,The risk or severity of adverse effects can be increased when Adalimumab is combined with Sirukumab.,Sirukumab
DB11834,The risk or severity of adverse effects can be increased when Adalimumab is combined with Guselkumab.,Guselkumab
DB11988,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ocrelizumab.,Ocrelizumab
DB12025,The risk or severity of adverse effects can be increased when Adalimumab is combined with Triptolide.,Triptolide
DB12612,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ozanimod.,Ozanimod
DB12617,The risk or severity of adverse effects can be increased when Adalimumab is combined with Mizoribine.,Mizoribine
DB12692,The risk or severity of adverse effects can be increased when Adalimumab is combined with Gusperimus.,Gusperimus
DB12814,The risk or severity of adverse effects can be increased when Adalimumab is combined with Cepeginterferon alfa-2B.,Cepeginterferon alfa-2B
DB12902,The risk or severity of adverse effects can be increased when Adalimumab is combined with Trofosfamide.,Trofosfamide
DB12947,The risk or severity of adverse effects can be increased when Adalimumab is combined with Doxifluridine.,Doxifluridine
DB12991,The risk or severity of adverse effects can be increased when Adalimumab is combined with Deoxyspergualin.,Deoxyspergualin
DB12996,The risk or severity of adverse effects can be increased when Adalimumab is combined with Acteoside.,Acteoside
DB13003,The risk or severity of adverse effects can be increased when Adalimumab is combined with Cortivazol.,Cortivazol
DB13014,The risk or severity of adverse effects can be increased when Adalimumab is combined with Hypericin.,Hypericin
DB13068,The risk or severity of adverse effects can be increased when Adalimumab is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.,9-(N-methyl-L-isoleucine)-cyclosporin A
DB13223,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fluocortin.,Fluocortin
DB13241,The risk or severity of adverse effects can be increased when Adalimumab is combined with Begelomab.,Begelomab
DB13491,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fluperolone.,Fluperolone
DB13664,The risk or severity of adverse effects can be increased when Adalimumab is combined with Formocortal.,Formocortal
DB13728,The risk or severity of adverse effects can be increased when Adalimumab is combined with Halometasone.,Halometasone
DB13843,The risk or severity of adverse effects can be increased when Adalimumab is combined with Cloprednol.,Cloprednol
DB13856,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fluclorolone.,Fluclorolone
DB14219,The risk or severity of adverse effects can be increased when Adalimumab is combined with Monomethyl fumarate.,Monomethyl fumarate
DB14724,The risk or severity of adverse effects can be increased when Adalimumab is combined with Emapalumab.,Emapalumab
DB14762,The risk or severity of adverse effects can be increased when Adalimumab is combined with Risankizumab.,Risankizumab
DB14919,The risk or severity of adverse effects can be increased when Adalimumab is combined with Rozanolixizumab.,Rozanolixizumab
DB15253,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bleselumab.,Bleselumab
DB00180,The risk or severity of adverse effects can be increased when Adalimumab is combined with Flunisolide.,Flunisolide
DB00394,The risk or severity of adverse effects can be increased when Adalimumab is combined with Beclomethasone dipropionate.,Beclomethasone dipropionate
DB00443,The risk or severity of adverse effects can be increased when Adalimumab is combined with Betamethasone.,Betamethasone
DB00591,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fluocinolone acetonide.,Fluocinolone acetonide
DB00635,The risk or severity of adverse effects can be increased when Adalimumab is combined with Prednisone.,Prednisone
DB00687,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fludrocortisone.,Fludrocortisone
DB00764,The risk or severity of adverse effects can be increased when Adalimumab is combined with Mometasone.,Mometasone
DB00860,The risk or severity of adverse effects can be increased when Adalimumab is combined with Prednisolone.,Prednisolone
DB00959,The risk or severity of adverse effects can be increased when Adalimumab is combined with Methylprednisolone.,Methylprednisolone
DB01196,The risk or severity of adverse effects can be increased when Adalimumab is combined with Estramustine.,Estramustine
DB01285,The risk or severity of adverse effects can be increased when Adalimumab is combined with Corticotropin.,Corticotropin
DB01380,The risk or severity of adverse effects can be increased when Adalimumab is combined with Cortisone acetate.,Cortisone acetate
DB01384,The risk or severity of adverse effects can be increased when Adalimumab is combined with Paramethasone.,Paramethasone
DB01611,The risk or severity of adverse effects can be increased when Adalimumab is combined with Hydroxychloroquine.,Hydroxychloroquine
DB04630,The risk or severity of adverse effects can be increased when Adalimumab is combined with Aldosterone.,Aldosterone
DB08970,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fluprednidene.,Fluprednidene
DB08971,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fluocortolone.,Fluocortolone
DB09082,The risk or severity of adverse effects can be increased when Adalimumab is combined with Vilanterol.,Vilanterol
DB09378,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fluprednisolone.,Fluprednisolone
DB09383,The risk or severity of adverse effects can be increased when Adalimumab is combined with Meprednisone.,Meprednisone
DB11487,The risk or severity of adverse effects can be increased when Adalimumab is combined with Dexamethasone isonicotinate.,Dexamethasone isonicotinate
DB11529,The risk or severity of adverse effects can be increased when Adalimumab is combined with Melengestrol.,Melengestrol
DB11750,The risk or severity of adverse effects can be increased when Adalimumab is combined with Clobetasol.,Clobetasol
DB11817,The risk or severity of adverse effects can be increased when Adalimumab is combined with Baricitinib.,Baricitinib
DB11921,The risk or severity of adverse effects can be increased when Adalimumab is combined with Deflazacort.,Deflazacort
DB13208,The risk or severity of adverse effects can be increased when Adalimumab is combined with Prednylidene.,Prednylidene
DB14066,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tetrandrine.,Tetrandrine
DB14512,The risk or severity of adverse effects can be increased when Adalimumab is combined with Mometasone furoate.,Mometasone furoate
DB14545,The risk or severity of adverse effects can be increased when Adalimumab is combined with Hydrocortisone succinate.,Hydrocortisone succinate
DB01222,The risk or severity of adverse effects can be increased when Adalimumab is combined with Budesonide.,Budesonide
DB01394,The risk or severity of adverse effects can be increased when Adalimumab is combined with Colchicine.,Colchicine
DB00108,The risk or severity of adverse effects can be increased when Adalimumab is combined with Natalizumab.,Natalizumab
DB00337,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Adalimumab.,Pimecrolimus
DB06372,The risk or severity of adverse effects can be increased when Adalimumab is combined with Rilonacept.,Rilonacept
DB01656,Adalimumab may increase the immunosuppressive activities of Roflumilast.,Roflumilast
DB06688,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Adalimumab.,Sipuleucel-T
DB06273,Tocilizumab may increase the immunosuppressive activities of Adalimumab.,Tocilizumab
DB08895,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tofacitinib.,Tofacitinib
DB09033,The risk or severity of infection can be increased when Adalimumab is combined with Vedolizumab.,Vedolizumab
DB00065,Adalimumab may increase the immunosuppressive activities of Infliximab.,Infliximab
DB00682,The serum concentration of Warfarin can be decreased when it is combined with Adalimumab.,Warfarin
DB00091,The serum concentration of Cyclosporine can be decreased when it is combined with Adalimumab.,Cyclosporine
DB00651,The serum concentration of Dyphylline can be decreased when it is combined with Adalimumab.,Dyphylline
DB01033,The serum concentration of Mercaptopurine can be decreased when it is combined with Adalimumab.,Mercaptopurine
DB01978,"The serum concentration of 7,9-Dimethylguanine can be decreased when it is combined with Adalimumab.","7,9-Dimethylguanine"
DB02245,The serum concentration of 7-Deazaguanine can be decreased when it is combined with Adalimumab.,7-Deazaguanine
DB02377,The serum concentration of Guanine can be decreased when it is combined with Adalimumab.,Guanine
DB06575,The serum concentration of Valomaciclovir can be decreased when it is combined with Adalimumab.,Valomaciclovir
DB07954,The serum concentration of 3-isobutyl-1-methyl-7H-xanthine can be decreased when it is combined with Adalimumab.,3-isobutyl-1-methyl-7H-xanthine
DB08844,The serum concentration of Uric acid can be decreased when it is combined with Adalimumab.,Uric acid
DB14029,The serum concentration of Furafylline can be decreased when it is combined with Adalimumab.,Furafylline
DB15122,The serum concentration of PCS-499 can be decreased when it is combined with Adalimumab.,PCS-499
DB00277,The serum concentration of Theophylline can be decreased when it is combined with Adalimumab.,Theophylline
DB01223,The serum concentration of Aminophylline can be decreased when it is combined with Adalimumab.,Aminophylline
DB00201,The serum concentration of Caffeine can be decreased when it is combined with Adalimumab.,Caffeine
DB00806,The serum concentration of Pentoxifylline can be decreased when it is combined with Adalimumab.,Pentoxifylline
DB01303,The serum concentration of Oxtriphylline can be decreased when it is combined with Adalimumab.,Oxtriphylline
DB01412,The serum concentration of Theobromine can be decreased when it is combined with Adalimumab.,Theobromine
DB01482,The serum concentration of Fenethylline can be decreased when it is combined with Adalimumab.,Fenethylline
DB01667,The serum concentration of 8-azaguanine can be decreased when it is combined with Adalimumab.,8-azaguanine
DB02134,The serum concentration of Xanthine can be decreased when it is combined with Adalimumab.,Xanthine
DB02489,The serum concentration of 9-Methylguanine can be decreased when it is combined with Adalimumab.,9-Methylguanine
DB02568,The serum concentration of Peldesine can be decreased when it is combined with Adalimumab.,Peldesine
DB04076,The serum concentration of Hypoxanthine can be decreased when it is combined with Adalimumab.,Hypoxanthine
DB04356,The serum concentration of 9-Deazaguanine can be decreased when it is combined with Adalimumab.,9-Deazaguanine
DB06479,The serum concentration of Propentofylline can be decreased when it is combined with Adalimumab.,Propentofylline
DB09273,The serum concentration of Doxofylline can be decreased when it is combined with Adalimumab.,Doxofylline
DB11919,The serum concentration of 6-O-benzylguanine can be decreased when it is combined with Adalimumab.,6-O-benzylguanine
DB12406,The serum concentration of Lisofylline can be decreased when it is combined with Adalimumab.,Lisofylline
DB12531,The serum concentration of Lobucavir can be decreased when it is combined with Adalimumab.,Lobucavir
DB12926,The serum concentration of Cafedrine can be decreased when it is combined with Adalimumab.,Cafedrine
DB12927,The serum concentration of Theodrenaline can be decreased when it is combined with Adalimumab.,Theodrenaline
DB13203,The serum concentration of Bamifylline can be decreased when it is combined with Adalimumab.,Bamifylline
DB13449,The serum concentration of Proxyphylline can be decreased when it is combined with Adalimumab.,Proxyphylline
DB13573,The serum concentration of Acefylline can be decreased when it is combined with Adalimumab.,Acefylline
DB13592,The serum concentration of Etamiphylline can be decreased when it is combined with Adalimumab.,Etamiphylline
DB13634,The serum concentration of Pentifylline can be decreased when it is combined with Adalimumab.,Pentifylline
DB13812,The serum concentration of Bufylline can be decreased when it is combined with Adalimumab.,Bufylline
DB14018,The serum concentration of Bromotheophylline can be decreased when it is combined with Adalimumab.,Bromotheophylline
DB14132,The serum concentration of 8-chlorotheophylline can be decreased when it is combined with Adalimumab.,8-chlorotheophylline
DB01015,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Adalimumab.,Sulfamethoxazole
DB00269,Chlorotrianisene may increase the thrombogenic activities of Adalimumab.,Chlorotrianisene
DB00655,Estrone may increase the thrombogenic activities of Adalimumab.,Estrone
DB00890,Dienestrol may increase the thrombogenic activities of Adalimumab.,Dienestrol
DB04573,Estriol may increase the thrombogenic activities of Adalimumab.,Estriol
DB04575,Quinestrol may increase the thrombogenic activities of Adalimumab.,Quinestrol
DB07931,Hexestrol may increase the thrombogenic activities of Adalimumab.,Hexestrol
DB09070,Tibolone may increase the thrombogenic activities of Adalimumab.,Tibolone
DB09369,Polyestradiol phosphate may increase the thrombogenic activities of Adalimumab.,Polyestradiol phosphate
DB11478,Zeranol may increase the thrombogenic activities of Adalimumab.,Zeranol
DB11674,Equol may increase the thrombogenic activities of Adalimumab.,Equol
DB12487,Promestriene may increase the thrombogenic activities of Adalimumab.,Promestriene
DB13143,Methallenestril may increase the thrombogenic activities of Adalimumab.,Methallenestril
DB13386,Epimestrol may increase the thrombogenic activities of Adalimumab.,Epimestrol
DB13418,Moxestrol may increase the thrombogenic activities of Adalimumab.,Moxestrol
DB15334,Biochanin A may increase the thrombogenic activities of Adalimumab.,Biochanin A
DB15335,Formononetin may increase the thrombogenic activities of Adalimumab.,Formononetin
DB09317,"Synthetic Conjugated Estrogens, A may increase the thrombogenic activities of Adalimumab.","Synthetic Conjugated Estrogens, A"
DB09318,"Synthetic Conjugated Estrogens, B may increase the thrombogenic activities of Adalimumab.","Synthetic Conjugated Estrogens, B"
DB09381,Esterified estrogens may increase the thrombogenic activities of Adalimumab.,Esterified estrogens
DB01097,The risk or severity of adverse effects can be increased when Adalimumab is combined with Leflunomide.,Leflunomide
DB00072,Trastuzumab may increase the neutropenic activities of Adalimumab.,Trastuzumab
DB08868,Adalimumab may increase the immunosuppressive activities of Fingolimod.,Fingolimod
DB00864,Tacrolimus may increase the immunosuppressive activities of Adalimumab.,Tacrolimus
DB04914,The therapeutic efficacy of G17DT can be decreased when used in combination with Adalimumab.,G17DT
DB05144,The therapeutic efficacy of PEV3A can be decreased when used in combination with Adalimumab.,PEV3A
DB05325,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Adalimumab.,INGN 225
DB05374,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Adalimumab.,Rindopepimut
DB05440,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Adalimumab.,SRP 299
DB05942,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Adalimumab.,GI-5005
DB06400,The therapeutic efficacy of Vitespen can be decreased when used in combination with Adalimumab.,Vitespen
DB06584,The therapeutic efficacy of TG4010 can be decreased when used in combination with Adalimumab.,TG4010
DB09057,The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Adalimumab.,Anthrax immune globulin human
DB10062,"The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Adalimumab.","Rabies virus inactivated antigen, B"
DB10076,The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Adalimumab.,Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen
DB10276,The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Adalimumab.,Rotavirus vaccine
DB10283,"The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Adalimumab.","Rabies virus inactivated antigen, A"
DB10342,The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Adalimumab.,Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen
DB10583,The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Adalimumab.,Clostridium tetani toxoid antigen (formaldehyde inactivated)
DB10584,The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Adalimumab.,Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)
DB10600,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Adalimumab.,Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated)
DB10769,The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Adalimumab.,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated)
DB10794,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) can be decreased when used in combination with Adalimumab.,Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated)
DB10803,The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Adalimumab.,Typhoid Vi polysaccharide vaccine
DB10989,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Adalimumab.,Hepatitis A Vaccine
DB10990,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Adalimumab.,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen
DB11038,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Adalimumab.,Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated)
DB11040,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Adalimumab.,Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated)
DB11041,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Adalimumab.,Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)
DB11044,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated) can be decreased when used in combination with Adalimumab.,Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated)
DB11603,The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Adalimumab.,Human rabies virus immune globulin
DB11627,The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Adalimumab.,Hepatitis B Vaccine (Recombinant)
DB12568,The therapeutic efficacy of Tecemotide can be decreased when used in combination with Adalimumab.,Tecemotide
DB14022,The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Adalimumab.,Typhoid vaccine
DB14384,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Adalimumab.,Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated)
DB14385,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Adalimumab.,Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated)
DB14394,The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with Adalimumab.,Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen
DB14445,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) can be decreased when used in combination with Adalimumab.,Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated)
DB14449,The therapeutic efficacy of Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen can be decreased when used in combination with Adalimumab.,Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen
DB14619,The therapeutic efficacy of Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated) can be decreased when used in combination with Adalimumab.,Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated)
DB14620,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Adalimumab.,Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated)
DB14711,The therapeutic efficacy of Vaccinia virus strain new york city board of health live antigen can be decreased when used in combination with Adalimumab.,Vaccinia virus strain new york city board of health live antigen
DB15274,The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Adalimumab.,Pertussis vaccine
DB15461,The therapeutic efficacy of Yersinia pestis 195/p antigen (formaldehyde inactivated) can be decreased when used in combination with Adalimumab.,Yersinia pestis 195/p antigen (formaldehyde inactivated)
DB13924,The therapeutic efficacy of Varicella Zoster Vaccine (Recombinant) can be decreased when used in combination with Adalimumab.,Varicella Zoster Vaccine (Recombinant)
DB15483,The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Adalimumab.,Modified vaccinia ankara
DB10317,The risk or severity of infection can be increased when Rubella virus vaccine is combined with Adalimumab.,Rubella virus vaccine
DB10318,The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Adalimumab.,Varicella Zoster Vaccine (Live/attenuated)
DB10343,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Adalimumab.,Bacillus calmette-guerin substrain tice live antigen
DB10804,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Adalimumab.,Bacillus calmette-guerin substrain connaught live antigen
DB10805,The risk or severity of infection can be increased when Yellow Fever Vaccine is combined with Adalimumab.,Yellow Fever Vaccine
DB11003,The risk or severity of infection can be increased when Anthrax vaccine is combined with Adalimumab.,Anthrax vaccine
DB11050,The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Adalimumab.,Typhoid Vaccine Live
DB12386,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain danish 1331 live antigen is combined with Adalimumab.,Bacillus calmette-guerin substrain danish 1331 live antigen
DB12768,The risk or severity of infection can be increased when BCG vaccine is combined with Adalimumab.,BCG vaccine
DB14409,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Adalimumab.,Human adenovirus e serotype 4 strain cl-68578 antigen
DB14443,The risk or severity of infection can be increased when Vibrio cholerae CVD 103-HgR strain live antigen is combined with Adalimumab.,Vibrio cholerae CVD 103-HgR strain live antigen
DB14685,The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Adalimumab.,Adenovirus type 7 vaccine live
DB00002,The risk or severity of adverse effects can be increased when Cetuximab is combined with Adalimumab.,Cetuximab
DB00028,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Adalimumab.,Human immunoglobulin G
DB00043,The risk or severity of adverse effects can be increased when Omalizumab is combined with Adalimumab.,Omalizumab
DB00054,The risk or severity of adverse effects can be increased when Adalimumab is combined with Abciximab.,Abciximab
DB00057,The risk or severity of adverse effects can be increased when Adalimumab is combined with Indium In-111 satumomab pendetide.,Indium In-111 satumomab pendetide
DB00076,The risk or severity of adverse effects can be increased when Adalimumab is combined with Digoxin Immune Fab (Ovine).,Digoxin Immune Fab (Ovine)
DB00089,The risk or severity of adverse effects can be increased when Adalimumab is combined with Capromab pendetide.,Capromab pendetide
DB00110,The risk or severity of adverse effects can be increased when Adalimumab is combined with Palivizumab.,Palivizumab
DB00113,The risk or severity of adverse effects can be increased when Adalimumab is combined with Technetium Tc-99m arcitumomab.,Technetium Tc-99m arcitumomab
DB01269,The risk or severity of adverse effects can be increased when Adalimumab is combined with Panitumumab.,Panitumumab
DB01270,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ranibizumab.,Ranibizumab
DB04901,The risk or severity of adverse effects can be increased when Adalimumab is combined with Galiximab.,Galiximab
DB04949,The risk or severity of adverse effects can be increased when Adalimumab is combined with Pexelizumab.,Pexelizumab
DB04958,The risk or severity of adverse effects can be increased when Adalimumab is combined with Epratuzumab.,Epratuzumab
DB04962,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bectumomab.,Bectumomab
DB04964,The risk or severity of adverse effects can be increased when Adalimumab is combined with Oregovomab.,Oregovomab
DB04988,The risk or severity of adverse effects can be increased when Adalimumab is combined with IGN311.,IGN311
DB05006,The risk or severity of adverse effects can be increased when Adalimumab is combined with Adecatumumab.,Adecatumumab
DB05097,The risk or severity of adverse effects can be increased when Adalimumab is combined with Labetuzumab.,Labetuzumab
DB05101,The risk or severity of adverse effects can be increased when Adalimumab is combined with Matuzumab.,Matuzumab
DB05111,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fontolizumab.,Fontolizumab
DB05136,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bavituximab.,Bavituximab
DB05139,The risk or severity of adverse effects can be increased when Adalimumab is combined with CR002.,CR002
DB05209,The risk or severity of adverse effects can be increased when Adalimumab is combined with Rozrolimupab.,Rozrolimupab
DB05304,The risk or severity of adverse effects can be increased when Adalimumab is combined with Girentuximab.,Girentuximab
DB05336,The risk or severity of adverse effects can be increased when Adalimumab is combined with Obiltoxaximab.,Obiltoxaximab
DB05405,The risk or severity of adverse effects can be increased when Adalimumab is combined with XTL-001.,XTL-001
DB05437,The risk or severity of adverse effects can be increased when Adalimumab is combined with NAV 1800.,NAV 1800
DB05496,The risk or severity of adverse effects can be increased when Adalimumab is combined with Otelixizumab.,Otelixizumab
DB05545,The risk or severity of adverse effects can be increased when Adalimumab is combined with AMG 108.,AMG 108
DB05550,The risk or severity of adverse effects can be increased when Adalimumab is combined with Iratumumab.,Iratumumab
DB05555,The risk or severity of adverse effects can be increased when Adalimumab is combined with Enokizumab.,Enokizumab
DB05578,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ramucirumab.,Ramucirumab
DB05595,The risk or severity of adverse effects can be increased when Adalimumab is combined with Farletuzumab.,Farletuzumab
DB05656,The risk or severity of adverse effects can be increased when Adalimumab is combined with Veltuzumab.,Veltuzumab
DB05793,The risk or severity of adverse effects can be increased when Adalimumab is combined with PRO-542.,PRO-542
DB05797,The risk or severity of adverse effects can be increased when Adalimumab is combined with TNX-901.,TNX-901
DB05889,The risk or severity of adverse effects can be increased when Adalimumab is combined with Inotuzumab ozogamicin.,Inotuzumab ozogamicin
DB05892,The risk or severity of adverse effects can be increased when Adalimumab is combined with RI 624.,RI 624
DB05915,The risk or severity of adverse effects can be increased when Adalimumab is combined with MYO-029.,MYO-029
DB05916,The risk or severity of adverse effects can be increased when Adalimumab is combined with CT-011.,CT-011
DB05941,The risk or severity of adverse effects can be increased when Adalimumab is combined with Leronlimab.,Leronlimab
DB05996,The risk or severity of adverse effects can be increased when Adalimumab is combined with Glembatumumab vedotin.,Glembatumumab vedotin
DB06043,The risk or severity of adverse effects can be increased when Adalimumab is combined with Olaratumab.,Olaratumab
DB06049,The risk or severity of adverse effects can be increased when Adalimumab is combined with IPH 2101.,IPH 2101
DB06050,The risk or severity of adverse effects can be increased when Adalimumab is combined with TB-402.,TB-402
DB06081,The risk or severity of adverse effects can be increased when Adalimumab is combined with Caplacizumab.,Caplacizumab
DB06101,The risk or severity of adverse effects can be increased when Adalimumab is combined with IMC-1C11.,IMC-1C11
DB06116,The risk or severity of adverse effects can be increased when Adalimumab is combined with Eldelumab.,Eldelumab
DB06162,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lumiliximab.,Lumiliximab
DB06186,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ipilimumab.,Ipilimumab
DB06192,The risk or severity of adverse effects can be increased when Adalimumab is combined with Nimotuzumab.,Nimotuzumab
DB06241,The risk or severity of adverse effects can be increased when Adalimumab is combined with Clenoliximab.,Clenoliximab
DB06304,The risk or severity of adverse effects can be increased when Adalimumab is combined with BIIB015.,BIIB015
DB06305,The risk or severity of adverse effects can be increased when Adalimumab is combined with Sonepcizumab.,Sonepcizumab
DB06310,The risk or severity of adverse effects can be increased when Adalimumab is combined with Motavizumab.,Motavizumab
DB06317,The risk or severity of adverse effects can be increased when Adalimumab is combined with Elotuzumab.,Elotuzumab
DB06318,The risk or severity of adverse effects can be increased when Adalimumab is combined with AVE9633.,AVE9633
DB06322,The risk or severity of adverse effects can be increased when Adalimumab is combined with Carotuximab.,Carotuximab
DB06324,The risk or severity of adverse effects can be increased when Adalimumab is combined with XmAb 2513.,XmAb 2513
DB06342,The risk or severity of adverse effects can be increased when Adalimumab is combined with Coltuximab ravtansine.,Coltuximab ravtansine
DB06343,The risk or severity of adverse effects can be increased when Adalimumab is combined with Teprotumumab.,Teprotumumab
DB06360,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lucatumumab.,Lucatumumab
DB06366,The risk or severity of adverse effects can be increased when Adalimumab is combined with Pertuzumab.,Pertuzumab
DB06371,The risk or severity of adverse effects can be increased when Adalimumab is combined with Siplizumab.,Siplizumab
DB06467,The risk or severity of adverse effects can be increased when Adalimumab is combined with Apolizumab.,Apolizumab
DB06474,The risk or severity of adverse effects can be increased when Adalimumab is combined with Sibrotuzumab.,Sibrotuzumab
DB06550,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bivatuzumab.,Bivatuzumab
DB06557,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lerdelimumab.,Lerdelimumab
DB06599,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lexatumumab.,Lexatumumab
DB06602,The risk or severity of adverse effects can be increased when Adalimumab is combined with Reslizumab.,Reslizumab
DB06606,The risk or severity of adverse effects can be increased when Adalimumab is combined with Teplizumab.,Teplizumab
DB06607,The risk or severity of adverse effects can be increased when Adalimumab is combined with Catumaxomab.,Catumaxomab
DB06647,The risk or severity of adverse effects can be increased when Adalimumab is combined with Volociximab.,Volociximab
DB06650,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ofatumumab.,Ofatumumab
DB08902,The risk or severity of adverse effects can be increased when Adalimumab is combined with Raxibacumab.,Raxibacumab
DB09035,The risk or severity of adverse effects can be increased when Adalimumab is combined with Nivolumab.,Nivolumab
DB09037,The risk or severity of adverse effects can be increased when Adalimumab is combined with Pembrolizumab.,Pembrolizumab
DB09045,The risk or severity of adverse effects can be increased when Adalimumab is combined with Dulaglutide.,Dulaglutide
DB09105,The risk or severity of adverse effects can be increased when Adalimumab is combined with Asfotase alfa.,Asfotase alfa
DB09264,The risk or severity of adverse effects can be increased when Adalimumab is combined with Idarucizumab.,Idarucizumab
DB09302,The risk or severity of adverse effects can be increased when Adalimumab is combined with Alirocumab.,Alirocumab
DB09303,The risk or severity of adverse effects can be increased when Adalimumab is combined with Evolocumab.,Evolocumab
DB09331,The risk or severity of adverse effects can be increased when Adalimumab is combined with Daratumumab.,Daratumumab
DB09559,The risk or severity of adverse effects can be increased when Adalimumab is combined with Necitumumab.,Necitumumab
DB11595,The risk or severity of adverse effects can be increased when Adalimumab is combined with Atezolizumab.,Atezolizumab
DB11604,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tetanus Immune Globulin.,Tetanus Immune Globulin
DB11608,The risk or severity of adverse effects can be increased when Adalimumab is combined with Eftrenonacog alfa.,Eftrenonacog alfa
DB11621,The risk or severity of adverse effects can be increased when Adalimumab is combined with Human Varicella-Zoster Immune Globulin.,Human Varicella-Zoster Immune Globulin
DB11646,The risk or severity of adverse effects can be increased when Adalimumab is combined with Conatumumab.,Conatumumab
DB11657,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tabalumab.,Tabalumab
DB11680,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ficlatuzumab.,Ficlatuzumab
DB11685,The risk or severity of adverse effects can be increased when Adalimumab is combined with Figitumumab.,Figitumumab
DB11714,The risk or severity of adverse effects can be increased when Adalimumab is combined with Durvalumab.,Durvalumab
DB11715,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bapineuzumab.,Bapineuzumab
DB11731,The risk or severity of adverse effects can be increased when Adalimumab is combined with Depatuxizumab mafodotin.,Depatuxizumab mafodotin
DB11746,The risk or severity of adverse effects can be increased when Adalimumab is combined with Onartuzumab.,Onartuzumab
DB11756,The risk or severity of adverse effects can be increased when Adalimumab is combined with Solanezumab.,Solanezumab
DB11771,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tremelimumab.,Tremelimumab
DB11826,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lampalizumab.,Lampalizumab
DB11840,The risk or severity of adverse effects can be increased when Adalimumab is combined with Dalotuzumab.,Dalotuzumab
DB11849,The risk or severity of adverse effects can be increased when Adalimumab is combined with Emibetuzumab.,Emibetuzumab
DB11850,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ublituximab.,Ublituximab
DB11856,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ligelizumab.,Ligelizumab
DB11857,The risk or severity of adverse effects can be increased when Adalimumab is combined with Seribantumab.,Seribantumab
DB11862,The risk or severity of adverse effects can be increased when Adalimumab is combined with Landogrozumab.,Landogrozumab
DB11866,The risk or severity of adverse effects can be increased when Adalimumab is combined with Romosozumab.,Romosozumab
DB11884,The risk or severity of adverse effects can be increased when Adalimumab is combined with Vadastuximab Talirine.,Vadastuximab Talirine
DB11914,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lebrikizumab.,Lebrikizumab
DB11930,The risk or severity of adverse effects can be increased when Adalimumab is combined with Varlilumab.,Varlilumab
DB11945,The risk or severity of adverse effects can be increased when Adalimumab is combined with Avelumab.,Avelumab
DB11959,The risk or severity of adverse effects can be increased when Adalimumab is combined with Crenezumab.,Crenezumab
DB11972,The risk or severity of adverse effects can be increased when Adalimumab is combined with Rilotumumab.,Rilotumumab
DB11976,The risk or severity of adverse effects can be increased when Adalimumab is combined with Anifrolumab.,Anifrolumab
DB12023,The risk or severity of adverse effects can be increased when Adalimumab is combined with Benralizumab.,Benralizumab
DB12034,The risk or severity of adverse effects can be increased when Adalimumab is combined with Gantenerumab.,Gantenerumab
DB12053,The risk or severity of adverse effects can be increased when Adalimumab is combined with Visilizumab.,Visilizumab
DB12077,The risk or severity of adverse effects can be increased when Adalimumab is combined with Urelumab.,Urelumab
DB12089,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lorvotuzumab mertansine.,Lorvotuzumab mertansine
DB12090,The risk or severity of adverse effects can be increased when Adalimumab is combined with Patritumab.,Patritumab
DB12102,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fulranumab.,Fulranumab
DB12104,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tarextumab.,Tarextumab
DB12118,The risk or severity of adverse effects can be increased when Adalimumab is combined with Sotatercept.,Sotatercept
DB12119,The risk or severity of adverse effects can be increased when Adalimumab is combined with Gevokizumab.,Gevokizumab
DB12142,The risk or severity of adverse effects can be increased when Adalimumab is combined with Duligotuzumab.,Duligotuzumab
DB12152,The risk or severity of adverse effects can be increased when Adalimumab is combined with Simtuzumab.,Simtuzumab
DB12157,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fasinumab.,Fasinumab
DB12159,The risk or severity of adverse effects can be increased when Adalimumab is combined with Dupilumab.,Dupilumab
DB12169,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tralokinumab.,Tralokinumab
DB12189,The risk or severity of adverse effects can be increased when Adalimumab is combined with Etrolizumab.,Etrolizumab
DB12202,The risk or severity of adverse effects can be increased when Adalimumab is combined with Zalutumumab.,Zalutumumab
DB12205,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ganitumab.,Ganitumab
DB12213,The risk or severity of adverse effects can be increased when Adalimumab is combined with Etaracizumab.,Etaracizumab
DB12246,The risk or severity of adverse effects can be increased when Adalimumab is combined with Inclacumab.,Inclacumab
DB12250,The risk or severity of adverse effects can be increased when Adalimumab is combined with Cixutumumab.,Cixutumumab
DB12261,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ascrinvacumab.,Ascrinvacumab
DB12274,The risk or severity of adverse effects can be increased when Adalimumab is combined with Aducanumab.,Aducanumab
DB12281,The risk or severity of adverse effects can be increased when Adalimumab is combined with Luspatercept.,Luspatercept
DB12296,The risk or severity of adverse effects can be increased when Adalimumab is combined with GS-5745.,GS-5745
DB12317,The risk or severity of adverse effects can be increased when Adalimumab is combined with Vanucizumab.,Vanucizumab
DB12331,The risk or severity of adverse effects can be increased when Adalimumab is combined with Labetuzumab govitecan.,Labetuzumab govitecan
DB12335,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tanezumab.,Tanezumab
DB12342,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ensituximab.,Ensituximab
DB12344,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fezakinumab.,Fezakinumab
DB12363,The risk or severity of adverse effects can be increased when Adalimumab is combined with Dusigitumab.,Dusigitumab
DB12396,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fresolimumab.,Fresolimumab
DB12413,The risk or severity of adverse effects can be increased when Adalimumab is combined with Indusatumab vedotin.,Indusatumab vedotin
DB12456,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bococizumab.,Bococizumab
DB12489,The risk or severity of adverse effects can be increased when Adalimumab is combined with Mirvetuximab Soravtansine.,Mirvetuximab Soravtansine
DB12498,The risk or severity of adverse effects can be increased when Adalimumab is combined with Mogamulizumab.,Mogamulizumab
DB12520,The risk or severity of adverse effects can be increased when Adalimumab is combined with Plozalizumab.,Plozalizumab
DB12534,The risk or severity of adverse effects can be increased when Adalimumab is combined with Mavrilimumab.,Mavrilimumab
DB12560,The risk or severity of adverse effects can be increased when Adalimumab is combined with Blosozumab.,Blosozumab
DB12584,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bimagrumab.,Bimagrumab
DB12589,The risk or severity of adverse effects can be increased when Adalimumab is combined with Dacetuzumab.,Dacetuzumab
DB12609,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tovetumab.,Tovetumab
DB12683,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lumretuzumab.,Lumretuzumab
DB12698,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ibalizumab.,Ibalizumab
DB12701,The risk or severity of adverse effects can be increased when Adalimumab is combined with Intetumumab.,Intetumumab
DB12718,The risk or severity of adverse effects can be increased when Adalimumab is combined with Carlumab.,Carlumab
DB12734,The risk or severity of adverse effects can be increased when Adalimumab is combined with Demcizumab.,Demcizumab
DB12773,The risk or severity of adverse effects can be increased when Adalimumab is combined with Sifalimumab.,Sifalimumab
DB12775,The risk or severity of adverse effects can be increased when Adalimumab is combined with Abituzumab.,Abituzumab
DB12797,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ecromeximab.,Ecromeximab
DB12807,The risk or severity of adverse effects can be increased when Adalimumab is combined with Naptumomab Estafenatox.,Naptumomab Estafenatox
DB12815,The risk or severity of adverse effects can be increased when Adalimumab is combined with Crotedumab.,Crotedumab
DB12820,The risk or severity of adverse effects can be increased when Adalimumab is combined with Concizumab.,Concizumab
DB12826,The risk or severity of adverse effects can be increased when Adalimumab is combined with Depatuxizumab.,Depatuxizumab
DB12844,The risk or severity of adverse effects can be increased when Adalimumab is combined with Rontalizumab.,Rontalizumab
DB12845,The risk or severity of adverse effects can be increased when Adalimumab is combined with Amatuximab.,Amatuximab
DB12849,The risk or severity of adverse effects can be increased when Adalimumab is combined with Clazakizumab.,Clazakizumab
DB12891,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ozanezumab.,Ozanezumab
DB12893,The risk or severity of adverse effects can be increased when Adalimumab is combined with Sacituzumab govitecan.,Sacituzumab govitecan
DB12917,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bimekizumab.,Bimekizumab
DB12943,The risk or severity of adverse effects can be increased when Adalimumab is combined with Milatuzumab.,Milatuzumab
DB12976,The risk or severity of adverse effects can be increased when Adalimumab is combined with Robatumumab.,Robatumumab
DB13017,The risk or severity of adverse effects can be increased when Adalimumab is combined with Rovalpituzumab Tesirine.,Rovalpituzumab Tesirine
DB13037,The risk or severity of adverse effects can be increased when Adalimumab is combined with Namilumab.,Namilumab
DB13045,The risk or severity of adverse effects can be increased when Adalimumab is combined with Racotumomab.,Racotumomab
DB13073,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tregalizumab.,Tregalizumab
DB13127,The risk or severity of adverse effects can be increased when Adalimumab is combined with Olokizumab.,Olokizumab
DB13140,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bezlotoxumab.,Bezlotoxumab
DB13375,The risk or severity of adverse effects can be increased when Adalimumab is combined with Edrecolomab.,Edrecolomab
DB13535,The risk or severity of adverse effects can be increased when Adalimumab is combined with Nebacumab.,Nebacumab
DB13886,The risk or severity of adverse effects can be increased when Adalimumab is combined with Human cytomegalovirus immune globulin.,Human cytomegalovirus immune globulin
DB13923,The risk or severity of adverse effects can be increased when Adalimumab is combined with Emicizumab.,Emicizumab
DB13976,The risk or severity of adverse effects can be increased when Adalimumab is combined with Sulesomab.,Sulesomab
DB13979,The risk or severity of adverse effects can be increased when Adalimumab is combined with Besilesomab.,Besilesomab
DB14012,The risk or severity of adverse effects can be increased when Adalimumab is combined with Burosumab.,Burosumab
DB14039,The risk or severity of adverse effects can be increased when Adalimumab is combined with Erenumab.,Erenumab
DB14040,The risk or severity of adverse effects can be increased when Adalimumab is combined with Eptinezumab.,Eptinezumab
DB14041,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fremanezumab.,Fremanezumab
DB14042,The risk or severity of adverse effects can be increased when Adalimumab is combined with Galcanezumab.,Galcanezumab
DB14211,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fanolesomab.,Fanolesomab
DB14580,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lecanemab.,Lecanemab
DB14597,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lanadelumab.,Lanadelumab
DB14707,The risk or severity of adverse effects can be increased when Adalimumab is combined with Cemiplimab.,Cemiplimab
DB14776,The risk or severity of adverse effects can be increased when Adalimumab is combined with Camrelizumab.,Camrelizumab
DB14778,The risk or severity of adverse effects can be increased when Adalimumab is combined with Setrusumab.,Setrusumab
DB14784,The risk or severity of adverse effects can be increased when Adalimumab is combined with Gancotamab.,Gancotamab
DB14809,The risk or severity of adverse effects can be increased when Adalimumab is combined with Anetumab ravtansine.,Anetumab ravtansine
DB14811,The risk or severity of adverse effects can be increased when Adalimumab is combined with Isatuximab.,Isatuximab
DB14824,The risk or severity of adverse effects can be increased when Adalimumab is combined with Icrucumab.,Icrucumab
DB14843,The risk or severity of adverse effects can be increased when Adalimumab is combined with Codrituzumab.,Codrituzumab
DB14864,The risk or severity of adverse effects can be increased when Adalimumab is combined with Brolucizumab.,Brolucizumab
DB14871,The risk or severity of adverse effects can be increased when Adalimumab is combined with Xentuzumab.,Xentuzumab
DB14877,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lintuzumab.,Lintuzumab
DB14891,The risk or severity of adverse effects can be increased when Adalimumab is combined with Vobarilizumab.,Vobarilizumab
DB14897,The risk or severity of adverse effects can be increased when Adalimumab is combined with Parsatuzumab.,Parsatuzumab
DB14905,The risk or severity of adverse effects can be increased when Adalimumab is combined with Emactuzumab.,Emactuzumab
DB14907,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bevacizumab zirconium Zr-89.,Bevacizumab zirconium Zr-89
DB14908,The risk or severity of adverse effects can be increased when Adalimumab is combined with Refanezumab.,Refanezumab
DB14947,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bermekimab.,Bermekimab
DB14952,The risk or severity of adverse effects can be increased when Adalimumab is combined with Pamrevlumab.,Pamrevlumab
DB14959,The risk or severity of adverse effects can be increased when Adalimumab is combined with Opicinumab.,Opicinumab
DB14962,The risk or severity of adverse effects can be increased when Adalimumab is combined with Trastuzumab deruxtecan.,Trastuzumab deruxtecan
DB14967,The risk or severity of adverse effects can be increased when Adalimumab is combined with Margetuximab.,Margetuximab
DB14988,The risk or severity of adverse effects can be increased when Adalimumab is combined with Dalantercept.,Dalantercept
DB14997,The risk or severity of adverse effects can be increased when Adalimumab is combined with Pateclizumab.,Pateclizumab
DB15014,The risk or severity of adverse effects can be increased when Adalimumab is combined with Gremubamab.,Gremubamab
DB15022,The risk or severity of adverse effects can be increased when Adalimumab is combined with Apomab.,Apomab
DB15044,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tafasitamab.,Tafasitamab
DB15045,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ipafricept.,Ipafricept
DB15076,The risk or severity of adverse effects can be increased when Adalimumab is combined with Abrilumab.,Abrilumab
DB15089,The risk or severity of adverse effects can be increased when Adalimumab is combined with Frovocimab.,Frovocimab
DB15090,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tezepelumab.,Tezepelumab
DB15101,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tigatuzumab.,Tigatuzumab
DB15104,The risk or severity of adverse effects can be increased when Adalimumab is combined with Telisotuzumab vedotin.,Telisotuzumab vedotin
DB15113,The risk or severity of adverse effects can be increased when Adalimumab is combined with Utomilumab.,Utomilumab
DB15118,The risk or severity of adverse effects can be increased when Adalimumab is combined with Zolbetuximab.,Zolbetuximab
DB15135,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ponezumab.,Ponezumab
DB15160,The risk or severity of adverse effects can be increased when Adalimumab is combined with Asunercept.,Asunercept
DB15172,The risk or severity of adverse effects can be increased when Adalimumab is combined with Suvratoxumab.,Suvratoxumab
DB15225,The risk or severity of adverse effects can be increased when Adalimumab is combined with Mitazalimab.,Mitazalimab
DB15252,The risk or severity of adverse effects can be increased when Adalimumab is combined with Nemolizumab.,Nemolizumab
DB15277,The risk or severity of adverse effects can be increased when Adalimumab is combined with Gedivumab.,Gedivumab
DB15336,The risk or severity of adverse effects can be increased when Adalimumab is combined with Valanafusp alfa.,Valanafusp alfa
DB15349,The risk or severity of adverse effects can be increased when Adalimumab is combined with Sofituzumab vedotin.,Sofituzumab vedotin
DB15354,The risk or severity of adverse effects can be increased when Adalimumab is combined with Evinacumab.,Evinacumab
DB15363,The risk or severity of adverse effects can be increased when Adalimumab is combined with Istiratumab.,Istiratumab
DB15383,The risk or severity of adverse effects can be increased when Adalimumab is combined with Pidilizumab.,Pidilizumab
DB15397,The risk or severity of adverse effects can be increased when Adalimumab is combined with GMA-161.,GMA-161
DB15409,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ladiratuzumab vedotin.,Ladiratuzumab vedotin
DB15415,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tomaralimab.,Tomaralimab
DB15428,The risk or severity of adverse effects can be increased when Adalimumab is combined with Vesencumab.,Vesencumab
DB15432,The risk or severity of adverse effects can be increased when Adalimumab is combined with Pinatuzumab vedotin.,Pinatuzumab vedotin
DB15441,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lulizumab pegol.,Lulizumab pegol
DB15443,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lorukafusp alfa.,Lorukafusp alfa
DB15453,The risk or severity of adverse effects can be increased when Adalimumab is combined with Naratuximab emtansine.,Naratuximab emtansine
DB14004,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tildrakizumab.,Tildrakizumab
DB05679,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ustekinumab.,Ustekinumab
DB12240,The risk or severity of adverse effects can be increased when Adalimumab is combined with Polatuzumab vedotin.,Polatuzumab vedotin
DB15559,The risk or severity of adverse effects can be increased when Adalimumab is combined with Zenocutuzumab.,Zenocutuzumab
DB00176,The metabolism of Fluvoxamine can be increased when combined with Adalimumab.,Fluvoxamine
DB00195,The metabolism of Betaxolol can be increased when combined with Adalimumab.,Betaxolol
DB00261,The metabolism of Anagrelide can be increased when combined with Adalimumab.,Anagrelide
DB00262,The metabolism of Carmustine can be increased when combined with Adalimumab.,Carmustine
DB00268,The metabolism of Ropinirole can be increased when combined with Adalimumab.,Ropinirole
DB00280,The metabolism of Disopyramide can be increased when combined with Adalimumab.,Disopyramide
DB00286,The metabolism of Conjugated estrogens can be increased when combined with Adalimumab.,Conjugated estrogens
DB00296,The metabolism of Ropivacaine can be increased when combined with Adalimumab.,Ropivacaine
DB00315,The metabolism of Zolmitriptan can be increased when combined with Adalimumab.,Zolmitriptan
DB00316,The metabolism of Acetaminophen can be increased when combined with Adalimumab.,Acetaminophen
DB00334,The metabolism of Olanzapine can be increased when combined with Adalimumab.,Olanzapine
DB00356,The metabolism of Chlorzoxazone can be increased when combined with Adalimumab.,Chlorzoxazone
DB00365,The metabolism of Grepafloxacin can be increased when combined with Adalimumab.,Grepafloxacin
DB00370,The metabolism of Mirtazapine can be increased when combined with Adalimumab.,Mirtazapine
DB00379,The metabolism of Mexiletine can be increased when combined with Adalimumab.,Mexiletine
DB00382,The metabolism of Tacrine can be increased when combined with Adalimumab.,Tacrine
DB00384,The metabolism of Triamterene can be increased when combined with Adalimumab.,Triamterene
DB00442,The metabolism of Entecavir can be increased when combined with Adalimumab.,Entecavir
DB00477,The metabolism of Chlorpromazine can be increased when combined with Adalimumab.,Chlorpromazine
DB00518,The metabolism of Albendazole can be increased when combined with Adalimumab.,Albendazole
DB00544,The metabolism of Fluorouracil can be increased when combined with Adalimumab.,Fluorouracil
DB00629,The metabolism of Guanabenz can be increased when combined with Adalimumab.,Guanabenz
DB00642,The metabolism of Pemetrexed can be increased when combined with Adalimumab.,Pemetrexed
DB00730,The metabolism of Thiabendazole can be increased when combined with Adalimumab.,Thiabendazole
DB00740,The metabolism of Riluzole can be increased when combined with Adalimumab.,Riluzole
DB00787,The metabolism of Acyclovir can be increased when combined with Adalimumab.,Acyclovir
DB00831,The metabolism of Trifluoperazine can be increased when combined with Adalimumab.,Trifluoperazine
DB00863,The metabolism of Ranitidine can be increased when combined with Adalimumab.,Ranitidine
DB00898,The metabolism of Ethanol can be increased when combined with Adalimumab.,Ethanol
DB00934,The metabolism of Maprotiline can be increased when combined with Adalimumab.,Maprotiline
DB00978,The metabolism of Lomefloxacin can be increased when combined with Adalimumab.,Lomefloxacin
DB00993,The metabolism of Azathioprine can be increased when combined with Adalimumab.,Azathioprine
DB00998,The metabolism of Frovatriptan can be increased when combined with Adalimumab.,Frovatriptan
DB01002,The metabolism of Levobupivacaine can be increased when combined with Adalimumab.,Levobupivacaine
DB01012,The metabolism of Cinacalcet can be increased when combined with Adalimumab.,Cinacalcet
DB01056,The metabolism of Tocainide can be increased when combined with Adalimumab.,Tocainide
DB01087,The metabolism of Primaquine can be increased when combined with Adalimumab.,Primaquine
DB01094,The metabolism of Hesperetin can be increased when combined with Adalimumab.,Hesperetin
DB01182,The metabolism of Propafenone can be increased when combined with Adalimumab.,Propafenone
DB01191,The metabolism of Dexfenfluramine can be increased when combined with Adalimumab.,Dexfenfluramine
DB01367,The metabolism of Rasagiline can be increased when combined with Adalimumab.,Rasagiline
DB01405,The metabolism of Temafloxacin can be increased when combined with Adalimumab.,Temafloxacin
DB01558,The metabolism of Bromazepam can be increased when combined with Adalimumab.,Bromazepam
DB01623,The metabolism of Thiothixene can be increased when combined with Adalimumab.,Thiothixene
DB01645,The metabolism of Genistein can be increased when combined with Adalimumab.,Genistein
DB02709,The metabolism of Resveratrol can be increased when combined with Adalimumab.,Resveratrol
DB04871,The metabolism of Lorcaserin can be increased when combined with Adalimumab.,Lorcaserin
DB04948,The metabolism of Lofexidine can be increased when combined with Adalimumab.,Lofexidine
DB04951,The metabolism of Pirfenidone can be increased when combined with Adalimumab.,Pirfenidone
DB06148,The metabolism of Mianserin can be increased when combined with Adalimumab.,Mianserin
DB06210,The metabolism of Eltrombopag can be increased when combined with Adalimumab.,Eltrombopag
DB06216,The metabolism of Asenapine can be increased when combined with Adalimumab.,Asenapine
DB06235,The metabolism of Vadimezan can be increased when combined with Adalimumab.,Vadimezan
DB06594,The metabolism of Agomelatine can be increased when combined with Adalimumab.,Agomelatine
DB06769,The metabolism of Bendamustine can be increased when combined with Adalimumab.,Bendamustine
DB06770,The metabolism of Benzyl alcohol can be increased when combined with Adalimumab.,Benzyl alcohol
DB06774,The metabolism of Capsaicin can be increased when combined with Adalimumab.,Capsaicin
DB08496,The metabolism of (R)-warfarin can be increased when combined with Adalimumab.,(R)-warfarin
DB09071,The metabolism of Tasimelteon can be increased when combined with Adalimumab.,Tasimelteon
DB09118,The metabolism of Stiripentol can be increased when combined with Adalimumab.,Stiripentol
DB09225,The metabolism of Zotepine can be increased when combined with Adalimumab.,Zotepine
DB09290,The metabolism of Ramosetron can be increased when combined with Adalimumab.,Ramosetron
DB11967,The metabolism of Binimetinib can be increased when combined with Adalimumab.,Binimetinib
DB12026,The metabolism of Voxilaprevir can be increased when combined with Adalimumab.,Voxilaprevir
DB12245,The metabolism of Triclabendazole can be increased when combined with Adalimumab.,Triclabendazole
DB12332,The metabolism of Rucaparib can be increased when combined with Adalimumab.,Rucaparib
DB12945,The metabolism of Dihydralazine can be increased when combined with Adalimumab.,Dihydralazine
DB11757,The metabolism of Istradefylline can be increased when combined with Adalimumab.,Istradefylline
DB04889,The metabolism of Bicifadine can be increased when combined with Adalimumab.,Bicifadine
DB05708,The metabolism of GTS-21 can be increased when combined with Adalimumab.,GTS-21
DB00977,The metabolism of Adalimumab can be increased when combined with Ethinylestradiol.,Ethinylestradiol
DB00425,The metabolism of Zolpidem can be increased when combined with Adalimumab.,Zolpidem
DB00458,The metabolism of Imipramine can be increased when combined with Adalimumab.,Imipramine
DB00532,The metabolism of Mephenytoin can be increased when combined with Adalimumab.,Mephenytoin
DB00540,The metabolism of Nortriptyline can be increased when combined with Adalimumab.,Nortriptyline
DB00575,The metabolism of Clonidine can be increased when combined with Adalimumab.,Clonidine
DB00924,The metabolism of Cyclobenzaprine can be increased when combined with Adalimumab.,Cyclobenzaprine
DB01242,The metabolism of Clomipramine can be increased when combined with Adalimumab.,Clomipramine
DB11689,The metabolism of Selumetinib can be increased when combined with Adalimumab.,Selumetinib
DB00564,The metabolism of Carbamazepine can be increased when combined with Adalimumab.,Carbamazepine
DB00697,The metabolism of Tizanidine can be increased when combined with Adalimumab.,Tizanidine
DB01100,The metabolism of Pimozide can be increased when combined with Adalimumab.,Pimozide
DB01418,The metabolism of Acenocoumarol can be increased when combined with Adalimumab.,Acenocoumarol
DB09256,The metabolism of Tegafur can be increased when combined with Adalimumab.,Tegafur
DB00851,The metabolism of Dacarbazine can be increased when combined with Adalimumab.,Dacarbazine
DB08910,The metabolism of Pomalidomide can be increased when combined with Adalimumab.,Pomalidomide
DB00238,The metabolism of Nevirapine can be increased when combined with Adalimumab.,Nevirapine
DB00471,The metabolism of Montelukast can be increased when combined with Adalimumab.,Montelukast
DB00690,The metabolism of Flurazepam can be increased when combined with Adalimumab.,Flurazepam
DB00916,The metabolism of Metronidazole can be increased when combined with Adalimumab.,Metronidazole
DB00983,The metabolism of Formoterol can be increased when combined with Adalimumab.,Formoterol
DB01006,The metabolism of Letrozole can be increased when combined with Adalimumab.,Letrozole
DB01028,The metabolism of Methoxyflurane can be increased when combined with Adalimumab.,Methoxyflurane
DB01159,The metabolism of Halothane can be increased when combined with Adalimumab.,Halothane
DB01236,The metabolism of Sevoflurane can be increased when combined with Adalimumab.,Sevoflurane
DB01274,The metabolism of Arformoterol can be increased when combined with Adalimumab.,Arformoterol
DB01544,The metabolism of Flunitrazepam can be increased when combined with Adalimumab.,Flunitrazepam
DB06292,The metabolism of Dapagliflozin can be increased when combined with Adalimumab.,Dapagliflozin
DB06470,The metabolism of Clomethiazole can be increased when combined with Adalimumab.,Clomethiazole
DB09068,The metabolism of Vortioxetine can be increased when combined with Adalimumab.,Vortioxetine
DB09327,The metabolism of Tegafur-uracil can be increased when combined with Adalimumab.,Tegafur-uracil
DB11586,The metabolism of Asunaprevir can be increased when combined with Adalimumab.,Asunaprevir
DB04977,The metabolism of Plitidepsin can be increased when combined with Adalimumab.,Plitidepsin
DB06119,The metabolism of Cenobamate can be increased when combined with Adalimumab.,Cenobamate
DB00193,The metabolism of Tramadol can be increased when combined with Adalimumab.,Tramadol
DB00333,The metabolism of Methadone can be increased when combined with Adalimumab.,Methadone
DB00349,The metabolism of Clobazam can be increased when combined with Adalimumab.,Clobazam
DB00625,The metabolism of Efavirenz can be increased when combined with Adalimumab.,Efavirenz
DB00753,The metabolism of Isoflurane can be increased when combined with Adalimumab.,Isoflurane
DB00818,The metabolism of Propofol can be increased when combined with Adalimumab.,Propofol
DB00835,The metabolism of Brompheniramine can be increased when combined with Adalimumab.,Brompheniramine
DB00836,The metabolism of Loperamide can be increased when combined with Adalimumab.,Loperamide
DB00849,The metabolism of Methylphenobarbital can be increased when combined with Adalimumab.,Methylphenobarbital
DB00865,The metabolism of Benzphetamine can be increased when combined with Adalimumab.,Benzphetamine
DB01069,The metabolism of Promethazine can be increased when combined with Adalimumab.,Promethazine
DB01074,The metabolism of Perhexiline can be increased when combined with Adalimumab.,Perhexiline
DB01221,The metabolism of Ketamine can be increased when combined with Adalimumab.,Ketamine
DB01466,The metabolism of Ethylmorphine can be increased when combined with Adalimumab.,Ethylmorphine
DB01559,The metabolism of Clotiazepam can be increased when combined with Adalimumab.,Clotiazepam
DB04938,The metabolism of Ospemifene can be increased when combined with Adalimumab.,Ospemifene
DB04975,The metabolism of Banoxantrone can be increased when combined with Adalimumab.,Banoxantrone
DB05541,The metabolism of Brivaracetam can be increased when combined with Adalimumab.,Brivaracetam
DB06176,The metabolism of Romidepsin can be increased when combined with Adalimumab.,Romidepsin
DB06209,The metabolism of Prasugrel can be increased when combined with Adalimumab.,Prasugrel
DB06697,The metabolism of Artemether can be increased when combined with Adalimumab.,Artemether
DB06710,The metabolism of Methyltestosterone can be increased when combined with Adalimumab.,Methyltestosterone
DB06738,The metabolism of Ketobemidone can be increased when combined with Adalimumab.,Ketobemidone
DB06739,The metabolism of Seratrodast can be increased when combined with Adalimumab.,Seratrodast
DB11613,The metabolism of Velpatasvir can be increased when combined with Adalimumab.,Velpatasvir
DB13132,The metabolism of Artemisinin can be increased when combined with Adalimumab.,Artemisinin
DB13943,The metabolism of Testosterone cypionate can be increased when combined with Adalimumab.,Testosterone cypionate
DB13944,The metabolism of Testosterone enanthate can be increased when combined with Adalimumab.,Testosterone enanthate
DB13946,The metabolism of Testosterone undecanoate can be increased when combined with Adalimumab.,Testosterone undecanoate
DB01156,The metabolism of Bupropion can be increased when combined with Adalimumab.,Bupropion
DB00956,The metabolism of Hydrocodone can be increased when combined with Adalimumab.,Hydrocodone
DB14975,The metabolism of Voxelotor can be increased when combined with Adalimumab.,Voxelotor
DB11837,The metabolism of Osilodrostat can be increased when combined with Adalimumab.,Osilodrostat
DB13384,The metabolism of Melitracen can be increased when combined with Adalimumab.,Melitracen
DB13411,The metabolism of Lofepramine can be increased when combined with Adalimumab.,Lofepramine
DB00714,The metabolism of Apomorphine can be increased when combined with Adalimumab.,Apomorphine
DB09167,The metabolism of Dosulepin can be increased when combined with Adalimumab.,Dosulepin
DB00213,The metabolism of Pantoprazole can be increased when combined with Adalimumab.,Pantoprazole
DB00215,The metabolism of Citalopram can be increased when combined with Adalimumab.,Citalopram
DB00312,The metabolism of Pentobarbital can be increased when combined with Adalimumab.,Pentobarbital
DB00338,The metabolism of Omeprazole can be increased when combined with Adalimumab.,Omeprazole
DB00347,The metabolism of Trimethadione can be increased when combined with Adalimumab.,Trimethadione
DB00395,The metabolism of Carisoprodol can be increased when combined with Adalimumab.,Carisoprodol
DB00448,The metabolism of Lansoprazole can be increased when combined with Adalimumab.,Lansoprazole
DB00474,The metabolism of Methohexital can be increased when combined with Adalimumab.,Methohexital
DB00582,The metabolism of Voriconazole can be increased when combined with Adalimumab.,Voriconazole
DB00679,The metabolism of Thioridazine can be increased when combined with Adalimumab.,Thioridazine
DB00736,The metabolism of Esomeprazole can be increased when combined with Adalimumab.,Esomeprazole
DB00794,The metabolism of Primidone can be increased when combined with Adalimumab.,Primidone
DB00909,The metabolism of Zonisamide can be increased when combined with Adalimumab.,Zonisamide
DB01129,The metabolism of Rabeprazole can be increased when combined with Adalimumab.,Rabeprazole
DB01131,The metabolism of Proguanil can be increased when combined with Adalimumab.,Proguanil
DB01175,The metabolism of Escitalopram can be increased when combined with Adalimumab.,Escitalopram
DB01259,The metabolism of Lapatinib can be increased when combined with Adalimumab.,Lapatinib
DB01323,The metabolism of St. John's Wort can be increased when combined with Adalimumab.,St. John's Wort
DB01355,The metabolism of Hexobarbital can be increased when combined with Adalimumab.,Hexobarbital
DB01483,The metabolism of Barbital can be increased when combined with Adalimumab.,Barbital
DB05246,The metabolism of Methsuximide can be increased when combined with Adalimumab.,Methsuximide
DB05351,The metabolism of Dexlansoprazole can be increased when combined with Adalimumab.,Dexlansoprazole
DB06218,The metabolism of Lacosamide can be increased when combined with Adalimumab.,Lacosamide
DB06414,The metabolism of Etravirine can be increased when combined with Adalimumab.,Etravirine
DB06605,The metabolism of Apixaban can be increased when combined with Adalimumab.,Apixaban
DB09166,The metabolism of Etizolam can be increased when combined with Adalimumab.,Etizolam
DB12130,The metabolism of Lorlatinib can be increased when combined with Adalimumab.,Lorlatinib
DB12474,The metabolism of Lynestrenol can be increased when combined with Adalimumab.,Lynestrenol
DB13762,The metabolism of Dexrabeprazole can be increased when combined with Adalimumab.,Dexrabeprazole
DB14055,The metabolism of (S)-Warfarin can be increased when combined with Adalimumab.,(S)-Warfarin
DB00715,The metabolism of Paroxetine can be increased when combined with Adalimumab.,Paroxetine
DB12500,The metabolism of Fedratinib can be increased when combined with Adalimumab.,Fedratinib
DB04861,The metabolism of Nebivolol can be increased when combined with Adalimumab.,Nebivolol
DB06684,The metabolism of Vilazodone can be increased when combined with Adalimumab.,Vilazodone
DB01104,The metabolism of Sertraline can be increased when combined with Adalimumab.,Sertraline
DB11823,The metabolism of Esketamine can be increased when combined with Adalimumab.,Esketamine
DB00252,The metabolism of Phenytoin can be increased when combined with Adalimumab.,Phenytoin
DB00599,The metabolism of Thiopental can be increased when combined with Adalimumab.,Thiopental
DB01174,The metabolism of Phenobarbital can be increased when combined with Adalimumab.,Phenobarbital
DB01320,The metabolism of Fosphenytoin can be increased when combined with Adalimumab.,Fosphenytoin
DB00613,The metabolism of Amodiaquine can be increased when combined with Adalimumab.,Amodiaquine
DB00799,The metabolism of Tazarotene can be increased when combined with Adalimumab.,Tazarotene
DB05229,The metabolism of Beraprost can be increased when combined with Adalimumab.,Beraprost
DB06510,The metabolism of Muraglitazar can be increased when combined with Adalimumab.,Muraglitazar
DB09296,The metabolism of Ombitasvir can be increased when combined with Adalimumab.,Ombitasvir
DB01217,The metabolism of Anastrozole can be increased when combined with Adalimumab.,Anastrozole
DB00255,The metabolism of Adalimumab can be increased when combined with Diethylstilbestrol.,Diethylstilbestrol
DB00295,The metabolism of Morphine can be increased when combined with Adalimumab.,Morphine
DB00359,The metabolism of Sulfadiazine can be increased when combined with Adalimumab.,Sulfadiazine
DB00402,The metabolism of Eszopiclone can be increased when combined with Adalimumab.,Eszopiclone
DB00622,The metabolism of Nicardipine can be increased when combined with Adalimumab.,Nicardipine
DB00912,The metabolism of Repaglinide can be increased when combined with Adalimumab.,Repaglinide
DB01261,The metabolism of Sitagliptin can be increased when combined with Adalimumab.,Sitagliptin
DB06670,The metabolism of Odanacatib can be increased when combined with Adalimumab.,Odanacatib
DB08502,The metabolism of Capravirine can be increased when combined with Adalimumab.,Capravirine
DB08931,The metabolism of Riociguat can be increased when combined with Adalimumab.,Riociguat
DB09198,The metabolism of Lobeglitazone can be increased when combined with Adalimumab.,Lobeglitazone
DB09199,The metabolism of Netoglitazone can be increased when combined with Adalimumab.,Netoglitazone
DB09200,The metabolism of Rivoglitazone can be increased when combined with Adalimumab.,Rivoglitazone
DB09201,The metabolism of Ciglitazone can be increased when combined with Adalimumab.,Ciglitazone
DB11362,The metabolism of Selexipag can be increased when combined with Adalimumab.,Selexipag
DB11901,The metabolism of Apalutamide can be increased when combined with Adalimumab.,Apalutamide
DB11978,The metabolism of Glasdegib can be increased when combined with Adalimumab.,Glasdegib
DB12781,The metabolism of Balaglitazone can be increased when combined with Adalimumab.,Balaglitazone
DB01132,The metabolism of Pioglitazone can be increased when combined with Adalimumab.,Pioglitazone
DB11652,The metabolism of Tucatinib can be increased when combined with Adalimumab.,Tucatinib
DB00946,The metabolism of Phenprocoumon can be increased when combined with Adalimumab.,Phenprocoumon
DB01229,The metabolism of Paclitaxel can be increased when combined with Adalimumab.,Paclitaxel
DB00177,The metabolism of Valsartan can be increased when combined with Adalimumab.,Valsartan
DB00184,The metabolism of Nicotine can be increased when combined with Adalimumab.,Nicotine
DB00197,The metabolism of Troglitazone can be increased when combined with Adalimumab.,Troglitazone
DB00214,The metabolism of Torasemide can be increased when combined with Adalimumab.,Torasemide
DB00222,The metabolism of Glimepiride can be increased when combined with Adalimumab.,Glimepiride
DB00285,The metabolism of Venlafaxine can be increased when combined with Adalimumab.,Venlafaxine
DB00304,The metabolism of Desogestrel can be increased when combined with Adalimumab.,Desogestrel
DB00307,The metabolism of Bexarotene can be increased when combined with Adalimumab.,Bexarotene
DB00327,The metabolism of Hydromorphone can be increased when combined with Adalimumab.,Hydromorphone
DB00328,The metabolism of Indomethacin can be increased when combined with Adalimumab.,Indomethacin
DB00343,The metabolism of Diltiazem can be increased when combined with Adalimumab.,Diltiazem
DB00374,The metabolism of Treprostinil can be increased when combined with Adalimumab.,Treprostinil
DB00412,The metabolism of Rosiglitazone can be increased when combined with Adalimumab.,Rosiglitazone
DB00414,The metabolism of Acetohexamide can be increased when combined with Adalimumab.,Acetohexamide
DB00420,The metabolism of Promazine can be increased when combined with Adalimumab.,Promazine
DB00440,The metabolism of Trimethoprim can be increased when combined with Adalimumab.,Trimethoprim
DB00461,The metabolism of Nabumetone can be increased when combined with Adalimumab.,Nabumetone
DB00468,The metabolism of Quinine can be increased when combined with Adalimumab.,Quinine
DB00469,The metabolism of Tenoxicam can be increased when combined with Adalimumab.,Tenoxicam
DB00472,The metabolism of Fluoxetine can be increased when combined with Adalimumab.,Fluoxetine
DB00476,The metabolism of Duloxetine can be increased when combined with Adalimumab.,Duloxetine
DB00482,The metabolism of Celecoxib can be increased when combined with Adalimumab.,Celecoxib
DB00495,The metabolism of Zidovudine can be increased when combined with Adalimumab.,Zidovudine
DB00502,The metabolism of Haloperidol can be increased when combined with Adalimumab.,Haloperidol
DB00531,The metabolism of Cyclophosphamide can be increased when combined with Adalimumab.,Cyclophosphamide
DB00533,The metabolism of Rofecoxib can be increased when combined with Adalimumab.,Rofecoxib
DB00549,The metabolism of Zafirlukast can be increased when combined with Adalimumab.,Zafirlukast
DB00554,The metabolism of Piroxicam can be increased when combined with Adalimumab.,Piroxicam
DB00559,The metabolism of Bosentan can be increased when combined with Adalimumab.,Bosentan
DB00568,The metabolism of Cinnarizine can be increased when combined with Adalimumab.,Cinnarizine
DB00580,The metabolism of Valdecoxib can be increased when combined with Adalimumab.,Valdecoxib
DB00586,The metabolism of Diclofenac can be increased when combined with Adalimumab.,Diclofenac
DB00617,The metabolism of Paramethadione can be increased when combined with Adalimumab.,Paramethadione
DB00661,The metabolism of Verapamil can be increased when combined with Adalimumab.,Verapamil
DB00672,The metabolism of Chlorpropamide can be increased when combined with Adalimumab.,Chlorpropamide
DB00678,The metabolism of Losartan can be increased when combined with Adalimumab.,Losartan
DB00701,The metabolism of Amprenavir can be increased when combined with Adalimumab.,Amprenavir
DB00712,The metabolism of Flurbiprofen can be increased when combined with Adalimumab.,Flurbiprofen
DB00731,The metabolism of Nateglinide can be increased when combined with Adalimumab.,Nateglinide
DB00744,The metabolism of Zileuton can be increased when combined with Adalimumab.,Zileuton
DB00749,The metabolism of Etodolac can be increased when combined with Adalimumab.,Etodolac
DB00755,The metabolism of Tretinoin can be increased when combined with Adalimumab.,Tretinoin
DB00758,The metabolism of Clopidogrel can be increased when combined with Adalimumab.,Clopidogrel
DB00783,The metabolism of Estradiol can be increased when combined with Adalimumab.,Estradiol
DB00784,The metabolism of Mefenamic acid can be increased when combined with Adalimumab.,Mefenamic acid
DB00788,The metabolism of Naproxen can be increased when combined with Adalimumab.,Naproxen
DB00796,The metabolism of Candesartan cilexetil can be increased when combined with Adalimumab.,Candesartan cilexetil
DB00812,The metabolism of Phenylbutazone can be increased when combined with Adalimumab.,Phenylbutazone
DB00814,The metabolism of Meloxicam can be increased when combined with Adalimumab.,Meloxicam
DB00839,The metabolism of Tolazamide can be increased when combined with Adalimumab.,Tolazamide
DB00843,The metabolism of Donepezil can be increased when combined with Adalimumab.,Donepezil
DB00857,The metabolism of Terbinafine can be increased when combined with Adalimumab.,Terbinafine
DB00904,The metabolism of Ondansetron can be increased when combined with Adalimumab.,Ondansetron
DB00921,The metabolism of Buprenorphine can be increased when combined with Adalimumab.,Buprenorphine
DB00936,The metabolism of Salicylic acid can be increased when combined with Adalimumab.,Salicylic acid
DB00945,The metabolism of Acetylsalicylic acid can be increased when combined with Adalimumab.,Acetylsalicylic acid
DB00969,The metabolism of Alosetron can be increased when combined with Adalimumab.,Alosetron
DB00972,The metabolism of Azelastine can be increased when combined with Adalimumab.,Azelastine
DB00980,The metabolism of Ramelteon can be increased when combined with Adalimumab.,Ramelteon
DB01016,The metabolism of Glyburide can be increased when combined with Adalimumab.,Glyburide
DB01029,The metabolism of Irbesartan can be increased when combined with Adalimumab.,Irbesartan
DB01036,The metabolism of Tolterodine can be increased when combined with Adalimumab.,Tolterodine
DB01037,The metabolism of Selegiline can be increased when combined with Adalimumab.,Selegiline
DB01041,The metabolism of Thalidomide can be increased when combined with Adalimumab.,Thalidomide
DB01050,The metabolism of Ibuprofen can be increased when combined with Adalimumab.,Ibuprofen
DB01065,The metabolism of Melatonin can be increased when combined with Adalimumab.,Melatonin
DB01067,The metabolism of Glipizide can be increased when combined with Adalimumab.,Glipizide
DB01072,The metabolism of Atazanavir can be increased when combined with Adalimumab.,Atazanavir
DB01075,The metabolism of Diphenhydramine can be increased when combined with Adalimumab.,Diphenhydramine
DB01095,The metabolism of Fluvastatin can be increased when combined with Adalimumab.,Fluvastatin
DB01098,The metabolism of Rosuvastatin can be increased when combined with Adalimumab.,Rosuvastatin
DB01120,The metabolism of Gliclazide can be increased when combined with Adalimumab.,Gliclazide
DB01124,The metabolism of Tolbutamide can be increased when combined with Adalimumab.,Tolbutamide
DB01136,The metabolism of Carvedilol can be increased when combined with Adalimumab.,Carvedilol
DB01154,The metabolism of Thiamylal can be increased when combined with Adalimumab.,Thiamylal
DB01171,The metabolism of Moclobemide can be increased when combined with Adalimumab.,Moclobemide
DB01177,The metabolism of Idarubicin can be increased when combined with Adalimumab.,Idarubicin
DB01198,The metabolism of Zopiclone can be increased when combined with Adalimumab.,Zopiclone
DB01251,The metabolism of Gliquidone can be increased when combined with Adalimumab.,Gliquidone
DB01283,The metabolism of Lumiracoxib can be increased when combined with Adalimumab.,Lumiracoxib
DB01289,The metabolism of Glisoxepide can be increased when combined with Adalimumab.,Glisoxepide
DB01357,The metabolism of Mestranol can be increased when combined with Adalimumab.,Mestranol
DB01424,The metabolism of Aminophenazone can be increased when combined with Adalimumab.,Aminophenazone
DB01435,The metabolism of Antipyrine can be increased when combined with Adalimumab.,Antipyrine
DB01589,The metabolism of Quazepam can be increased when combined with Adalimumab.,Quazepam
DB01628,The metabolism of Etoricoxib can be increased when combined with Adalimumab.,Etoricoxib
DB03756,The metabolism of Doconexent can be increased when combined with Adalimumab.,Doconexent
DB03783,The metabolism of Phenacetin can be increased when combined with Adalimumab.,Phenacetin
DB04557,The metabolism of Arachidonic Acid can be increased when combined with Adalimumab.,Arachidonic Acid
DB04574,The metabolism of Estrone sulfate can be increased when combined with Adalimumab.,Estrone sulfate
DB04665,The metabolism of Coumarin can be increased when combined with Adalimumab.,Coumarin
DB04725,The metabolism of Licofelone can be increased when combined with Adalimumab.,Licofelone
DB04841,The metabolism of Flunarizine can be increased when combined with Adalimumab.,Flunarizine
DB04898,The metabolism of Ximelagatran can be increased when combined with Adalimumab.,Ximelagatran
DB06204,The metabolism of Tapentadol can be increased when combined with Adalimumab.,Tapentadol
DB06268,The metabolism of Sitaxentan can be increased when combined with Adalimumab.,Sitaxentan
DB06370,The metabolism of Indisulam can be increased when combined with Adalimumab.,Indisulam
DB06652,The metabolism of Vicriviroc can be increased when combined with Adalimumab.,Vicriviroc
DB06725,The metabolism of Lornoxicam can be increased when combined with Adalimumab.,Lornoxicam
DB06737,The metabolism of Zaltoprofen can be increased when combined with Adalimumab.,Zaltoprofen
DB06803,The metabolism of Niclosamide can be increased when combined with Adalimumab.,Niclosamide
DB07615,The metabolism of Tranilast can be increased when combined with Adalimumab.,Tranilast
DB08439,The metabolism of Parecoxib can be increased when combined with Adalimumab.,Parecoxib
DB08828,The metabolism of Vismodegib can be increased when combined with Adalimumab.,Vismodegib
DB08860,The metabolism of Pitavastatin can be increased when combined with Adalimumab.,Pitavastatin
DB08875,The metabolism of Cabozantinib can be increased when combined with Adalimumab.,Cabozantinib
DB08899,The metabolism of Enzalutamide can be increased when combined with Adalimumab.,Enzalutamide
DB08962,The metabolism of Glibornuride can be increased when combined with Adalimumab.,Glibornuride
DB09048,The metabolism of Netupitant can be increased when combined with Adalimumab.,Netupitant
DB09061,The metabolism of Cannabidiol can be increased when combined with Adalimumab.,Cannabidiol
DB09080,The metabolism of Olodaterol can be increased when combined with Adalimumab.,Olodaterol
DB09288,The metabolism of Propacetamol can be increased when combined with Adalimumab.,Propacetamol
DB11560,The metabolism of Lesinurad can be increased when combined with Adalimumab.,Lesinurad
DB11614,The metabolism of Rupatadine can be increased when combined with Adalimumab.,Rupatadine
DB13406,The metabolism of Carbutamide can be increased when combined with Adalimumab.,Carbutamide
DB13675,The metabolism of Metahexamide can be increased when combined with Adalimumab.,Metahexamide
DB13919,The metabolism of Candesartan can be increased when combined with Adalimumab.,Candesartan
DB13941,The metabolism of Piperaquine can be increased when combined with Adalimumab.,Piperaquine
DB13952,The metabolism of Estradiol acetate can be increased when combined with Adalimumab.,Estradiol acetate
DB13953,The metabolism of Estradiol benzoate can be increased when combined with Adalimumab.,Estradiol benzoate
DB13954,The metabolism of Estradiol cypionate can be increased when combined with Adalimumab.,Estradiol cypionate
DB13955,The metabolism of Estradiol dienanthate can be increased when combined with Adalimumab.,Estradiol dienanthate
DB13956,The metabolism of Estradiol valerate can be increased when combined with Adalimumab.,Estradiol valerate
DB14009,The metabolism of Medical Cannabis can be increased when combined with Adalimumab.,Medical Cannabis
DB14011,The metabolism of Nabiximols can be increased when combined with Adalimumab.,Nabiximols
DB00829,The metabolism of Diazepam can be increased when combined with Adalimumab.,Diazepam
DB00514,The metabolism of Dextromethorphan can be increased when combined with Adalimumab.,Dextromethorphan
DB00470,The metabolism of Dronabinol can be increased when combined with Adalimumab.,Dronabinol
DB09213,The metabolism of Dexibuprofen can be increased when combined with Adalimumab.,Dexibuprofen
DB00465,The metabolism of Ketorolac can be increased when combined with Adalimumab.,Ketorolac
DB15233,The metabolism of Avapritinib can be increased when combined with Adalimumab.,Avapritinib
DB00321,The metabolism of Amitriptyline can be increased when combined with Adalimumab.,Amitriptyline
DB01142,The metabolism of Doxepin can be increased when combined with Adalimumab.,Doxepin
DB00216,The metabolism of Eletriptan can be increased when combined with Adalimumab.,Eletriptan
DB00404,The metabolism of Alprazolam can be increased when combined with Adalimumab.,Alprazolam
DB00726,The metabolism of Trimipramine can be increased when combined with Adalimumab.,Trimipramine
DB01101,The metabolism of Capecitabine can be increased when combined with Adalimumab.,Capecitabine
DB00266,The metabolism of Dicoumarol can be increased when combined with Adalimumab.,Dicoumarol
DB00313,The metabolism of Valproic acid can be increased when combined with Adalimumab.,Valproic acid
DB00908,The metabolism of Quinidine can be increased when combined with Adalimumab.,Quinidine
DB13136,The metabolism of Fluindione can be increased when combined with Adalimumab.,Fluindione
DB01224,The metabolism of Quetiapine can be increased when combined with Adalimumab.,Quetiapine
DB00182,The metabolism of Amphetamine can be increased when combined with Adalimumab.,Amphetamine
DB00187,The metabolism of Esmolol can be increased when combined with Adalimumab.,Esmolol
DB00245,The metabolism of Benzatropine can be increased when combined with Adalimumab.,Benzatropine
DB00289,The metabolism of Atomoxetine can be increased when combined with Adalimumab.,Atomoxetine
DB00335,The metabolism of Atenolol can be increased when combined with Adalimumab.,Atenolol
DB00373,The metabolism of Timolol can be increased when combined with Adalimumab.,Timolol
DB00409,The metabolism of Remoxipride can be increased when combined with Adalimumab.,Remoxipride
DB00592,The metabolism of Piperazine can be increased when combined with Adalimumab.,Piperazine
DB00699,The metabolism of Nicergoline can be increased when combined with Adalimumab.,Nicergoline
DB00737,The metabolism of Meclizine can be increased when combined with Adalimumab.,Meclizine
DB00805,The metabolism of Minaprine can be increased when combined with Adalimumab.,Minaprine
DB00866,The metabolism of Alprenolol can be increased when combined with Adalimumab.,Alprenolol
DB00914,The metabolism of Phenformin can be increased when combined with Adalimumab.,Phenformin
DB00933,The metabolism of Mesoridazine can be increased when combined with Adalimumab.,Mesoridazine
DB00960,The metabolism of Pindolol can be increased when combined with Adalimumab.,Pindolol
DB01071,The metabolism of Mequitazine can be increased when combined with Adalimumab.,Mequitazine
DB01079,The metabolism of Tegaserod can be increased when combined with Adalimumab.,Tegaserod
DB01193,The metabolism of Acebutolol can be increased when combined with Adalimumab.,Acebutolol
DB01203,The metabolism of Nadolol can be increased when combined with Adalimumab.,Nadolol
DB01228,The metabolism of Encainide can be increased when combined with Adalimumab.,Encainide
DB01233,The metabolism of Metoclopramide can be increased when combined with Adalimumab.,Metoclopramide
DB01255,The metabolism of Lisdexamfetamine can be increased when combined with Adalimumab.,Lisdexamfetamine
DB01295,The metabolism of Bevantolol can be increased when combined with Adalimumab.,Bevantolol
DB01297,The metabolism of Practolol can be increased when combined with Adalimumab.,Practolol
DB01359,The metabolism of Penbutolol can be increased when combined with Adalimumab.,Penbutolol
DB01403,The metabolism of Methotrimeprazine can be increased when combined with Adalimumab.,Methotrimeprazine
DB01429,The metabolism of Aprindine can be increased when combined with Adalimumab.,Aprindine
DB01454,The metabolism of Midomafetamine can be increased when combined with Adalimumab.,Midomafetamine
DB01472,The metabolism of 4-Methoxyamphetamine can be increased when combined with Adalimumab.,4-Methoxyamphetamine
DB01576,The metabolism of Dextroamphetamine can be increased when combined with Adalimumab.,Dextroamphetamine
DB01577,The metabolism of Metamfetamine can be increased when combined with Adalimumab.,Metamfetamine
DB01580,The metabolism of Oxprenolol can be increased when combined with Adalimumab.,Oxprenolol
DB04840,The metabolism of Debrisoquine can be increased when combined with Adalimumab.,Debrisoquine
DB04844,The metabolism of Tetrabenazine can be increased when combined with Adalimumab.,Tetrabenazine
DB04846,The metabolism of Celiprolol can be increased when combined with Adalimumab.,Celiprolol
DB06217,The metabolism of Vernakalant can be increased when combined with Adalimumab.,Vernakalant
DB06506,The metabolism of Repinotan can be increased when combined with Adalimumab.,Repinotan
DB06608,The metabolism of Tafenoquine can be increased when combined with Adalimumab.,Tafenoquine
DB06678,The metabolism of Esmirtazapine can be increased when combined with Adalimumab.,Esmirtazapine
DB06726,The metabolism of Bufuralol can be increased when combined with Adalimumab.,Bufuralol
DB06727,The metabolism of Sparteine can be increased when combined with Adalimumab.,Sparteine
DB06735,The metabolism of Enclomiphene can be increased when combined with Adalimumab.,Enclomiphene
DB08807,The metabolism of Bopindolol can be increased when combined with Adalimumab.,Bopindolol
DB08808,The metabolism of Bupranolol can be increased when combined with Adalimumab.,Bupranolol
DB08952,The metabolism of Indenolol can be increased when combined with Adalimumab.,Indenolol
DB09013,The metabolism of Befunolol can be increased when combined with Adalimumab.,Befunolol
DB09076,The metabolism of Umeclidinium can be increased when combined with Adalimumab.,Umeclidinium
DB09204,The metabolism of Arotinolol can be increased when combined with Adalimumab.,Arotinolol
DB09351,The metabolism of Levobetaxolol can be increased when combined with Adalimumab.,Levobetaxolol
DB11770,The metabolism of Talinolol can be increased when combined with Adalimumab.,Talinolol
DB11785,The metabolism of Anisodamine can be increased when combined with Adalimumab.,Anisodamine
DB11855,The metabolism of Revefenacin can be increased when combined with Adalimumab.,Revefenacin
DB11979,The metabolism of Elagolix can be increased when combined with Adalimumab.,Elagolix
DB12070,The metabolism of Letermovir can be increased when combined with Adalimumab.,Letermovir
DB12212,The metabolism of Landiolol can be increased when combined with Adalimumab.,Landiolol
DB12752,The metabolism of Bucindolol can be increased when combined with Adalimumab.,Bucindolol
DB13443,The metabolism of Esatenolol can be increased when combined with Adalimumab.,Esatenolol
DB13508,The metabolism of Cloranolol can be increased when combined with Adalimumab.,Cloranolol
DB13530,The metabolism of Mepindolol can be increased when combined with Adalimumab.,Mepindolol
DB13679,The metabolism of Dexchlorpheniramine can be increased when combined with Adalimumab.,Dexchlorpheniramine
DB13757,The metabolism of Epanolol can be increased when combined with Adalimumab.,Epanolol
DB13775,The metabolism of Tertatolol can be increased when combined with Adalimumab.,Tertatolol
DB00850,The metabolism of Perphenazine can be increased when combined with Adalimumab.,Perphenazine
DB09173,The metabolism of Butyrfentanyl can be increased when combined with Adalimumab.,Butyrfentanyl
DB00281,The metabolism of Lidocaine can be increased when combined with Adalimumab.,Lidocaine
DB00598,The metabolism of Labetalol can be increased when combined with Adalimumab.,Labetalol
DB14010,"The metabolism of 5-methoxy-N,N-dimethyltryptamine can be increased when combined with Adalimumab.","5-methoxy-N,N-dimethyltryptamine"
DB01410,The metabolism of Ciclesonide can be increased when combined with Adalimumab.,Ciclesonide
DB00918,The metabolism of Almotriptan can be increased when combined with Adalimumab.,Almotriptan
DB08918,The metabolism of Levomilnacipran can be increased when combined with Adalimumab.,Levomilnacipran
DB08922,The metabolism of Perospirone can be increased when combined with Adalimumab.,Perospirone
DB09183,The metabolism of Dasabuvir can be increased when combined with Adalimumab.,Dasabuvir
DB00185,The metabolism of Cevimeline can be increased when combined with Adalimumab.,Cevimeline
DB00243,The metabolism of Ranolazine can be increased when combined with Adalimumab.,Ranolazine
DB00297,The metabolism of Bupivacaine can be increased when combined with Adalimumab.,Bupivacaine
DB00318,The metabolism of Codeine can be increased when combined with Adalimumab.,Codeine
DB00377,The metabolism of Palonosetron can be increased when combined with Adalimumab.,Palonosetron
DB00589,The metabolism of Lisuride can be increased when combined with Adalimumab.,Lisuride
DB00647,The metabolism of Dextropropoxyphene can be increased when combined with Adalimumab.,Dextropropoxyphene
DB00674,The metabolism of Galantamine can be increased when combined with Adalimumab.,Galantamine
DB00705,The metabolism of Delavirdine can be increased when combined with Adalimumab.,Delavirdine
DB00706,The metabolism of Tamsulosin can be increased when combined with Adalimumab.,Tamsulosin
DB00757,The metabolism of Dolasetron can be increased when combined with Adalimumab.,Dolasetron
DB01149,The metabolism of Nefazodone can be increased when combined with Adalimumab.,Nefazodone
DB01192,The metabolism of Oxymorphone can be increased when combined with Adalimumab.,Oxymorphone
DB01244,The metabolism of Bepridil can be increased when combined with Adalimumab.,Bepridil
DB01392,The metabolism of Yohimbine can be increased when combined with Adalimumab.,Yohimbine
DB01409,The metabolism of Tiotropium can be increased when combined with Adalimumab.,Tiotropium
DB01551,The metabolism of Dihydrocodeine can be increased when combined with Adalimumab.,Dihydrocodeine
DB01591,The metabolism of Solifenacin can be increased when combined with Adalimumab.,Solifenacin
DB01621,The metabolism of Pipotiazine can be increased when combined with Adalimumab.,Pipotiazine
DB02703,The metabolism of Fusidic acid can be increased when combined with Adalimumab.,Fusidic acid
DB04829,The metabolism of Lysergic acid diethylamide can be increased when combined with Adalimumab.,Lysergic acid diethylamide
DB04884,The metabolism of Dapoxetine can be increased when combined with Adalimumab.,Dapoxetine
DB04905,The metabolism of Tesmilifene can be increased when combined with Adalimumab.,Tesmilifene
DB04920,The metabolism of Clevidipine can be increased when combined with Adalimumab.,Clevidipine
DB05271,The metabolism of Rotigotine can be increased when combined with Adalimumab.,Rotigotine
DB06016,The metabolism of Cariprazine can be increased when combined with Adalimumab.,Cariprazine
DB06144,The metabolism of Sertindole can be increased when combined with Adalimumab.,Sertindole
DB06203,The metabolism of Alogliptin can be increased when combined with Adalimumab.,Alogliptin
DB06702,The metabolism of Fesoterodine can be increased when combined with Adalimumab.,Fesoterodine
DB08893,The metabolism of Mirabegron can be increased when combined with Adalimumab.,Mirabegron
DB09128,The metabolism of Brexpiprazole can be increased when combined with Adalimumab.,Brexpiprazole
DB09195,The metabolism of Lorpiprazole can be increased when combined with Adalimumab.,Lorpiprazole
DB09555,The metabolism of Dexchlorpheniramine maleate can be increased when combined with Adalimumab.,Dexchlorpheniramine maleate
DB11130,The metabolism of Opium can be increased when combined with Adalimumab.,Opium
DB11642,The metabolism of Pitolisant can be increased when combined with Adalimumab.,Pitolisant
DB13293,The metabolism of Ipecac can be increased when combined with Adalimumab.,Ipecac
DB00344,The metabolism of Protriptyline can be increased when combined with Adalimumab.,Protriptyline
DB00496,The metabolism of Darifenacin can be increased when combined with Adalimumab.,Darifenacin
DB00543,The metabolism of Amoxapine can be increased when combined with Adalimumab.,Amoxapine
DB00932,The metabolism of Tipranavir can be increased when combined with Adalimumab.,Tipranavir
DB09039,The metabolism of Eliglustat can be increased when combined with Adalimumab.,Eliglustat
DB12930,The metabolism of Opipramol can be increased when combined with Adalimumab.,Opipramol
DB00489,The metabolism of Sotalol can be increased when combined with Adalimumab.,Sotalol
DB01035,The metabolism of Procainamide can be increased when combined with Adalimumab.,Procainamide
DB01195,The metabolism of Flecainide can be increased when combined with Adalimumab.,Flecainide
DB00228,The metabolism of Enflurane can be increased when combined with Adalimumab.,Enflurane
DB06712,The metabolism of Nilvadipine can be increased when combined with Adalimumab.,Nilvadipine
DB06728,The metabolism of Aniline can be increased when combined with Adalimumab.,Aniline
DB00949,The metabolism of Felbamate can be increased when combined with Adalimumab.,Felbamate
DB00593,The metabolism of Ethosuximide can be increased when combined with Adalimumab.,Ethosuximide
DB00186,The metabolism of Lorazepam can be increased when combined with Adalimumab.,Lorazepam
DB00191,The metabolism of Phentermine can be increased when combined with Adalimumab.,Phentermine
DB00207,The metabolism of Azithromycin can be increased when combined with Adalimumab.,Azithromycin
DB00208,The metabolism of Ticlopidine can be increased when combined with Adalimumab.,Ticlopidine
DB00264,The metabolism of Metoprolol can be increased when combined with Adalimumab.,Metoprolol
DB00426,The metabolism of Famciclovir can be increased when combined with Adalimumab.,Famciclovir
DB00433,The metabolism of Prochlorperazine can be increased when combined with Adalimumab.,Prochlorperazine
DB00567,The metabolism of Cephalexin can be increased when combined with Adalimumab.,Cephalexin
DB00590,The metabolism of Doxazosin can be increased when combined with Adalimumab.,Doxazosin
DB01039,The metabolism of Fenofibrate can be increased when combined with Adalimumab.,Fenofibrate
DB01395,The metabolism of Drospirenone can be increased when combined with Adalimumab.,Drospirenone
DB01411,The metabolism of Pranlukast can be increased when combined with Adalimumab.,Pranlukast
DB01431,The metabolism of Allylestrenol can be increased when combined with Adalimumab.,Allylestrenol
DB01624,The metabolism of Zuclopenthixol can be increased when combined with Adalimumab.,Zuclopenthixol
DB06201,The metabolism of Rufinamide can be increased when combined with Adalimumab.,Rufinamide
DB06480,The metabolism of Prucalopride can be increased when combined with Adalimumab.,Prucalopride
DB08882,The metabolism of Linagliptin can be increased when combined with Adalimumab.,Linagliptin
DB09030,The metabolism of Vorapaxar can be increased when combined with Adalimumab.,Vorapaxar
DB09034,The metabolism of Suvorexant can be increased when combined with Adalimumab.,Suvorexant
DB09079,The metabolism of Nintedanib can be increased when combined with Adalimumab.,Nintedanib
DB09299,The metabolism of Tenofovir alafenamide can be increased when combined with Adalimumab.,Tenofovir alafenamide
DB09330,The metabolism of Osimertinib can be increased when combined with Adalimumab.,Osimertinib
DB11094,The metabolism of Vitamin D can be increased when combined with Adalimumab.,Vitamin D
DB11273,The metabolism of Dihydroergocornine can be increased when combined with Adalimumab.,Dihydroergocornine
DB11730,The metabolism of Ribociclib can be increased when combined with Adalimumab.,Ribociclib
DB11952,The metabolism of Duvelisib can be increased when combined with Adalimumab.,Duvelisib
DB12141,The metabolism of Gilteritinib can be increased when combined with Adalimumab.,Gilteritinib
DB12515,The metabolism of 9-aminocamptothecin can be increased when combined with Adalimumab.,9-aminocamptothecin
DB12952,The metabolism of Methylprednisone can be increased when combined with Adalimumab.,Methylprednisone
DB13345,The metabolism of Dihydroergocristine can be increased when combined with Adalimumab.,Dihydroergocristine
DB13385,The metabolism of Dihydroergocryptine can be increased when combined with Adalimumab.,Dihydroergocryptine
DB14126,The metabolism of Tenofovir can be increased when combined with Adalimumab.,Tenofovir
DB15444,The metabolism of Elexacaftor can be increased when combined with Adalimumab.,Elexacaftor
DB06717,The metabolism of Fosaprepitant can be increased when combined with Adalimumab.,Fosaprepitant
DB12825,The metabolism of Lefamulin can be increased when combined with Adalimumab.,Lefamulin
DB12887,The metabolism of Tazemetostat can be increased when combined with Adalimumab.,Tazemetostat
DB00454,The metabolism of Meperidine can be increased when combined with Adalimumab.,Meperidine
DB01151,The metabolism of Desipramine can be increased when combined with Adalimumab.,Desipramine
DB12371,The metabolism of Siponimod can be increased when combined with Adalimumab.,Siponimod
DB00247,The metabolism of Methysergide can be increased when combined with Adalimumab.,Methysergide
DB08827,The metabolism of Lomitapide can be increased when combined with Adalimumab.,Lomitapide
DB11742,The metabolism of Ebastine can be increased when combined with Adalimumab.,Ebastine
DB05015,The metabolism of Belinostat can be increased when combined with Adalimumab.,Belinostat
DB01118,The metabolism of Amiodarone can be increased when combined with Adalimumab.,Amiodarone
DB00675,The metabolism of Tamoxifen can be increased when combined with Adalimumab.,Tamoxifen
DB00204,The metabolism of Dofetilide can be increased when combined with Adalimumab.,Dofetilide
DB00342,The metabolism of Terfenadine can be increased when combined with Adalimumab.,Terfenadine
DB00451,The metabolism of Levothyroxine can be increased when combined with Adalimumab.,Levothyroxine
DB00604,The metabolism of Cisapride can be increased when combined with Adalimumab.,Cisapride
DB00877,The metabolism of Sirolimus can be increased when combined with Adalimumab.,Sirolimus
DB01008,The metabolism of Busulfan can be increased when combined with Adalimumab.,Busulfan
DB01254,The metabolism of Dasatinib can be increased when combined with Adalimumab.,Dasatinib
DB01396,The metabolism of Digitoxin can be increased when combined with Adalimumab.,Digitoxin
DB01590,The metabolism of Everolimus can be increased when combined with Adalimumab.,Everolimus
DB03410,The metabolism of 4-hydroxycoumarin can be increased when combined with Adalimumab.,4-hydroxycoumarin
DB04855,The metabolism of Dronedarone can be increased when combined with Adalimumab.,Dronedarone
DB06287,The metabolism of Temsirolimus can be increased when combined with Adalimumab.,Temsirolimus
DB09053,The metabolism of Ibrutinib can be increased when combined with Adalimumab.,Ibrutinib
DB09289,The metabolism of Tianeptine can be increased when combined with Adalimumab.,Tianeptine
DB11633,The metabolism of Isavuconazole can be increased when combined with Adalimumab.,Isavuconazole
DB13275,The metabolism of Clorindione can be increased when combined with Adalimumab.,Clorindione
DB00398,The metabolism of Sorafenib can be increased when combined with Adalimumab.,Sorafenib
DB00444,The metabolism of Teniposide can be increased when combined with Adalimumab.,Teniposide
DB00530,The metabolism of Erlotinib can be increased when combined with Adalimumab.,Erlotinib
DB00541,The metabolism of Vincristine can be increased when combined with Adalimumab.,Vincristine
DB00619,The metabolism of Imatinib can be increased when combined with Adalimumab.,Imatinib
DB00773,The metabolism of Etoposide can be increased when combined with Adalimumab.,Etoposide
DB01248,The metabolism of Docetaxel can be increased when combined with Adalimumab.,Docetaxel
DB01268,The metabolism of Sunitinib can be increased when combined with Adalimumab.,Sunitinib
DB06626,The metabolism of Axitinib can be increased when combined with Adalimumab.,Axitinib
DB08865,The metabolism of Crizotinib can be increased when combined with Adalimumab.,Crizotinib
DB08901,The metabolism of Ponatinib can be increased when combined with Adalimumab.,Ponatinib
DB12483,The metabolism of Copanlisib can be increased when combined with Adalimumab.,Copanlisib
DB00188,The metabolism of Bortezomib can be increased when combined with Adalimumab.,Bortezomib
DB00363,The metabolism of Clozapine can be increased when combined with Adalimumab.,Clozapine
DB01181,The metabolism of Ifosfamide can be increased when combined with Adalimumab.,Ifosfamide
DB05109,The metabolism of Trabectedin can be increased when combined with Adalimumab.,Trabectedin
DB12147,The metabolism of Erdafitinib can be increased when combined with Adalimumab.,Erdafitinib
DB13874,The metabolism of Enasidenib can be increased when combined with Adalimumab.,Enasidenib
DB06589,The metabolism of Pazopanib can be increased when combined with Adalimumab.,Pazopanib
DB05239,The metabolism of Cobimetinib can be increased when combined with Adalimumab.,Cobimetinib
DB09063,The metabolism of Ceritinib can be increased when combined with Adalimumab.,Ceritinib
DB11963,The metabolism of Dacomitinib can be increased when combined with Adalimumab.,Dacomitinib
DB12015,The metabolism of Alpelisib can be increased when combined with Adalimumab.,Alpelisib
DB00309,The metabolism of Vindesine can be increased when combined with Adalimumab.,Vindesine
DB00361,The metabolism of Vinorelbine can be increased when combined with Adalimumab.,Vinorelbine
DB00570,The metabolism of Vinblastine can be increased when combined with Adalimumab.,Vinblastine
DB00694,The metabolism of Daunorubicin can be increased when combined with Adalimumab.,Daunorubicin
DB00987,The metabolism of Cytarabine can be increased when combined with Adalimumab.,Cytarabine
DB00997,The metabolism of Doxorubicin can be increased when combined with Adalimumab.,Doxorubicin
DB01108,The metabolism of Trilostane can be increased when combined with Adalimumab.,Trilostane
DB04572,The metabolism of Thiotepa can be increased when combined with Adalimumab.,Thiotepa
DB04845,The metabolism of Ixabepilone can be increased when combined with Adalimumab.,Ixabepilone
DB04868,The metabolism of Nilotinib can be increased when combined with Adalimumab.,Nilotinib
DB06603,The metabolism of Panobinostat can be increased when combined with Adalimumab.,Panobinostat
DB06616,The metabolism of Bosutinib can be increased when combined with Adalimumab.,Bosutinib
DB08870,The metabolism of Brentuximab vedotin can be increased when combined with Adalimumab.,Brentuximab vedotin
DB08877,The metabolism of Ruxolitinib can be increased when combined with Adalimumab.,Ruxolitinib
DB09073,The metabolism of Palbociclib can be increased when combined with Adalimumab.,Palbociclib
DB08912,The metabolism of Dabrafenib can be increased when combined with Adalimumab.,Dabrafenib
DB12267,The metabolism of Brigatinib can be increased when combined with Adalimumab.,Brigatinib
DB11718,The metabolism of Encorafenib can be increased when combined with Adalimumab.,Encorafenib
DB00563,The metabolism of Methotrexate can be increased when combined with Adalimumab.,Methotrexate
DB05294,The metabolism of Vandetanib can be increased when combined with Adalimumab.,Vandetanib
DB05812,The metabolism of Abiraterone can be increased when combined with Adalimumab.,Abiraterone
DB08881,The metabolism of Vemurafenib can be increased when combined with Adalimumab.,Vemurafenib
DB11363,The metabolism of Alectinib can be increased when combined with Adalimumab.,Alectinib
DB11581,The metabolism of Venetoclax can be increased when combined with Adalimumab.,Venetoclax
DB11641,The metabolism of Vinflunine can be increased when combined with Adalimumab.,Vinflunine
DB11703,The metabolism of Acalabrutinib can be increased when combined with Adalimumab.,Acalabrutinib
DB15035,The metabolism of Zanubrutinib can be increased when combined with Adalimumab.,Zanubrutinib
DB00248,The metabolism of Cabergoline can be increased when combined with Adalimumab.,Cabergoline
DB06595,The metabolism of Midostaurin can be increased when combined with Adalimumab.,Midostaurin
DB09143,The metabolism of Sonidegib can be increased when combined with Adalimumab.,Sonidegib
DB11828,The metabolism of Neratinib can be increased when combined with Adalimumab.,Neratinib
DB11986,The metabolism of Entrectinib can be increased when combined with Adalimumab.,Entrectinib
DB12978,The metabolism of Pexidartinib can be increased when combined with Adalimumab.,Pexidartinib
DB14568,The metabolism of Ivosidenib can be increased when combined with Adalimumab.,Ivosidenib
DB09054,The metabolism of Idelalisib can be increased when combined with Adalimumab.,Idelalisib
DB09570,The metabolism of Ixazomib can be increased when combined with Adalimumab.,Ixazomib
DB00199,The metabolism of Erythromycin can be increased when combined with Adalimumab.,Erythromycin
DB00246,The metabolism of Ziprasidone can be increased when combined with Adalimumab.,Ziprasidone
DB00439,The metabolism of Cerivastatin can be increased when combined with Adalimumab.,Cerivastatin
DB00499,The metabolism of Flutamide can be increased when combined with Adalimumab.,Flutamide
DB00528,The metabolism of Lercanidipine can be increased when combined with Adalimumab.,Lercanidipine
DB00571,The metabolism of Propranolol can be increased when combined with Adalimumab.,Propranolol
DB00588,The metabolism of Fluticasone propionate can be increased when combined with Adalimumab.,Fluticasone propionate
DB00608,The metabolism of Chloroquine can be increased when combined with Adalimumab.,Chloroquine
DB00688,The metabolism of Mycophenolate mofetil can be increased when combined with Adalimumab.,Mycophenolate mofetil
DB00717,The metabolism of Norethisterone can be increased when combined with Adalimumab.,Norethisterone
DB00738,The metabolism of Pentamidine can be increased when combined with Adalimumab.,Pentamidine
DB00741,The metabolism of Hydrocortisone can be increased when combined with Adalimumab.,Hydrocortisone
DB00762,The metabolism of Irinotecan can be increased when combined with Adalimumab.,Irinotecan
DB00822,The metabolism of Disulfiram can be increased when combined with Adalimumab.,Disulfiram
DB00834,The metabolism of Mifepristone can be increased when combined with Adalimumab.,Mifepristone
DB00938,The metabolism of Salmeterol can be increased when combined with Adalimumab.,Salmeterol
DB00962,The metabolism of Zaleplon can be increased when combined with Adalimumab.,Zaleplon
DB00976,The metabolism of Telithromycin can be increased when combined with Adalimumab.,Telithromycin
DB01054,The metabolism of Nitrendipine can be increased when combined with Adalimumab.,Nitrendipine
DB01058,The metabolism of Praziquantel can be increased when combined with Adalimumab.,Praziquantel
DB01062,The metabolism of Oxybutynin can be increased when combined with Adalimumab.,Oxybutynin
DB01076,The metabolism of Atorvastatin can be increased when combined with Adalimumab.,Atorvastatin
DB01103,The metabolism of Quinacrine can be increased when combined with Adalimumab.,Quinacrine
DB01115,The metabolism of Nifedipine can be increased when combined with Adalimumab.,Nifedipine
DB01126,The metabolism of Dutasteride can be increased when combined with Adalimumab.,Dutasteride
DB01166,The metabolism of Cilostazol can be increased when combined with Adalimumab.,Cilostazol
DB01184,The metabolism of Domperidone can be increased when combined with Adalimumab.,Domperidone
DB01211,The metabolism of Clarithromycin can be increased when combined with Adalimumab.,Clarithromycin
DB01216,The metabolism of Finasteride can be increased when combined with Adalimumab.,Finasteride
DB01218,The metabolism of Halofantrine can be increased when combined with Adalimumab.,Halofantrine
DB05521,The metabolism of Telaprevir can be increased when combined with Adalimumab.,Telaprevir
DB05773,The metabolism of Trastuzumab emtansine can be increased when combined with Adalimumab.,Trastuzumab emtansine
DB06267,The metabolism of Udenafil can be increased when combined with Adalimumab.,Udenafil
DB06335,The metabolism of Saxagliptin can be increased when combined with Adalimumab.,Saxagliptin
DB06403,The metabolism of Ambrisentan can be increased when combined with Adalimumab.,Ambrisentan
DB06419,The metabolism of Cethromycin can be increased when combined with Adalimumab.,Cethromycin
DB06772,The metabolism of Cabazitaxel can be increased when combined with Adalimumab.,Cabazitaxel
DB06789,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Adalimumab.,Hydroxyprogesterone caproate
DB08820,The metabolism of Ivacaftor can be increased when combined with Adalimumab.,Ivacaftor
DB08873,The metabolism of Boceprevir can be increased when combined with Adalimumab.,Boceprevir
DB08883,The metabolism of Perampanel can be increased when combined with Adalimumab.,Perampanel
DB08906,The metabolism of Fluticasone furoate can be increased when combined with Adalimumab.,Fluticasone furoate
DB09065,The metabolism of Cobicistat can be increased when combined with Adalimumab.,Cobicistat
DB09074,The metabolism of Olaparib can be increased when combined with Adalimumab.,Olaparib
DB09102,The metabolism of Daclatasvir can be increased when combined with Adalimumab.,Daclatasvir
DB09231,The metabolism of Benidipine can be increased when combined with Adalimumab.,Benidipine
DB09297,The metabolism of Paritaprevir can be increased when combined with Adalimumab.,Paritaprevir
DB11574,The metabolism of Elbasvir can be increased when combined with Adalimumab.,Elbasvir
DB11712,The metabolism of Tezacaftor can be increased when combined with Adalimumab.,Tezacaftor
DB11737,The metabolism of Icotinib can be increased when combined with Adalimumab.,Icotinib
DB12301,The metabolism of Doravirine can be increased when combined with Adalimumab.,Doravirine
DB13867,The metabolism of Fluticasone can be increased when combined with Adalimumab.,Fluticasone
DB14538,The metabolism of Hydrocortisone aceponate can be increased when combined with Adalimumab.,Hydrocortisone aceponate
DB14539,The metabolism of Hydrocortisone acetate can be increased when combined with Adalimumab.,Hydrocortisone acetate
DB14541,The metabolism of Hydrocortisone cypionate can be increased when combined with Adalimumab.,Hydrocortisone cypionate
DB14542,The metabolism of Hydrocortisone phosphate can be increased when combined with Adalimumab.,Hydrocortisone phosphate
DB00396,The metabolism of Progesterone can be increased when combined with Adalimumab.,Progesterone
DB04856,The metabolism of Dexloxiglumide can be increased when combined with Adalimumab.,Dexloxiglumide
DB04957,The metabolism of Azimilide can be increased when combined with Adalimumab.,Azimilide
DB00250,The metabolism of Dapsone can be increased when combined with Adalimumab.,Dapsone
DB00317,The metabolism of Gefitinib can be increased when combined with Adalimumab.,Gefitinib
DB00367,The metabolism of Levonorgestrel can be increased when combined with Adalimumab.,Levonorgestrel
DB00497,The metabolism of Oxycodone can be increased when combined with Adalimumab.,Oxycodone
DB00620,The metabolism of Triamcinolone can be increased when combined with Adalimumab.,Triamcinolone
DB00624,The metabolism of Testosterone can be increased when combined with Adalimumab.,Testosterone
DB00656,The metabolism of Trazodone can be increased when combined with Adalimumab.,Trazodone
DB00734,The metabolism of Risperidone can be increased when combined with Adalimumab.,Risperidone
DB01114,The metabolism of Chlorpheniramine can be increased when combined with Adalimumab.,Chlorpheniramine
DB01238,The metabolism of Aripiprazole can be increased when combined with Adalimumab.,Aripiprazole
DB01267,The metabolism of Paliperidone can be increased when combined with Adalimumab.,Paliperidone
DB04946,The metabolism of Iloperidone can be increased when combined with Adalimumab.,Iloperidone
DB11915,The metabolism of Valbenazine can be increased when combined with Adalimumab.,Valbenazine
DB12161,The metabolism of Deutetrabenazine can be increased when combined with Adalimumab.,Deutetrabenazine
DB14185,The metabolism of Aripiprazole lauroxil can be increased when combined with Adalimumab.,Aripiprazole lauroxil
DB01234,The metabolism of Dexamethasone can be increased when combined with Adalimumab.,Dexamethasone
DB09237,The metabolism of Levamlodipine can be increased when combined with Adalimumab.,Levamlodipine
DB11951,The metabolism of Lemborexant can be increased when combined with Adalimumab.,Lemborexant
DB00557,The metabolism of Hydroxyzine can be increased when combined with Adalimumab.,Hydroxyzine
DB00203,The metabolism of Sildenafil can be increased when combined with Adalimumab.,Sildenafil
DB00227,The metabolism of Lovastatin can be increased when combined with Adalimumab.,Lovastatin
DB00490,The metabolism of Buspirone can be increased when combined with Adalimumab.,Buspirone
DB00641,The metabolism of Simvastatin can be increased when combined with Adalimumab.,Simvastatin
DB00673,The metabolism of Aprepitant can be increased when combined with Adalimumab.,Aprepitant
DB00820,The metabolism of Tadalafil can be increased when combined with Adalimumab.,Tadalafil
DB00862,The metabolism of Vardenafil can be increased when combined with Adalimumab.,Vardenafil
DB01190,The metabolism of Clindamycin can be increased when combined with Adalimumab.,Clindamycin
DB00503,The metabolism of Ritonavir can be increased when combined with Adalimumab.,Ritonavir
DB00224,The metabolism of Indinavir can be increased when combined with Adalimumab.,Indinavir
DB00401,The metabolism of Nisoldipine can be increased when combined with Adalimumab.,Nisoldipine
DB00637,The metabolism of Astemizole can be increased when combined with Adalimumab.,Astemizole
DB00683,The metabolism of Midazolam can be increased when combined with Adalimumab.,Midazolam
DB00700,The metabolism of Eplerenone can be increased when combined with Adalimumab.,Eplerenone
DB00802,The metabolism of Alfentanil can be increased when combined with Adalimumab.,Alfentanil
DB00813,The metabolism of Fentanyl can be increased when combined with Adalimumab.,Fentanyl
DB00897,The metabolism of Triazolam can be increased when combined with Adalimumab.,Triazolam
DB01023,The metabolism of Felodipine can be increased when combined with Adalimumab.,Felodipine
DB01227,The metabolism of Levacetylmethadol can be increased when combined with Adalimumab.,Levacetylmethadol
DB01232,The metabolism of Saquinavir can be increased when combined with Adalimumab.,Saquinavir
DB06228,The metabolism of Rivaroxaban can be increased when combined with Adalimumab.,Rivaroxaban
DB05804,The metabolism of Prasterone sulfate can be increased when combined with Adalimumab.,Prasterone sulfate
DB05676,The therapeutic efficacy of Apremilast can be decreased when used in combination with Adalimumab.,Apremilast
DB15595,"The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Adalimumab.","Ebola Zaire vaccine (live, attenuated)"
DB14513,The serum concentration of Magnesium can be decreased when it is combined with Adalimumab.,Magnesium
DB01601,The serum concentration of Adalimumab can be increased when it is combined with Lopinavir.,Lopinavir
DB12530,The risk or severity of infection can be increased when Adalimumab is combined with Inebilizumab.,Inebilizumab
DB00635,The serum concentration of the active metabolites of Prednisone can be reduced when Prednisone is used in combination with Somatotropin resulting in a loss in efficacy.,Prednisone
DB00255,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Diethylstilbestrol.,Diethylstilbestrol
DB00269,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Chlorotrianisene.,Chlorotrianisene
DB00286,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Conjugated estrogens.,Conjugated estrogens
DB00783,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Estradiol.,Estradiol
DB00977,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Ethinylestradiol.,Ethinylestradiol
DB01357,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Mestranol.,Mestranol
DB04573,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Estriol.,Estriol
DB04574,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Estrone sulfate.,Estrone sulfate
DB04575,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Quinestrol.,Quinestrol
DB07931,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Hexestrol.,Hexestrol
DB09070,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Tibolone.,Tibolone
DB09317,"The therapeutic efficacy of Somatotropin can be decreased when used in combination with Synthetic Conjugated Estrogens, A.","Synthetic Conjugated Estrogens, A"
DB09318,"The therapeutic efficacy of Somatotropin can be decreased when used in combination with Synthetic Conjugated Estrogens, B.","Synthetic Conjugated Estrogens, B"
DB09369,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Polyestradiol phosphate.,Polyestradiol phosphate
DB09381,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Esterified estrogens.,Esterified estrogens
DB11478,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Zeranol.,Zeranol
DB11674,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Equol.,Equol
DB12487,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Promestriene.,Promestriene
DB13143,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Methallenestril.,Methallenestril
DB13386,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Epimestrol.,Epimestrol
DB13418,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Moxestrol.,Moxestrol
DB13952,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Estradiol acetate.,Estradiol acetate
DB13956,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Estradiol valerate.,Estradiol valerate
DB15334,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Biochanin A.,Biochanin A
DB15335,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Formononetin.,Formononetin
DB01380,The serum concentration of the active metabolites of Cortisone acetate can be reduced when Cortisone acetate is used in combination with Somatotropin resulting in a loss in efficacy.,Cortisone acetate
DB00007,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Somatotropin.",Leuprolide
DB00065,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Infliximab.",Infliximab
DB00080,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Daptomycin.",Daptomycin
DB00091,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Cyclosporine.",Cyclosporine
DB00175,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Pravastatin.",Pravastatin
DB00181,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Baclofen.",Baclofen
DB00203,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Sildenafil.",Sildenafil
DB00224,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Indinavir.",Indinavir
DB00227,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Lovastatin.",Lovastatin
DB00242,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Cladribine.",Cladribine
DB00252,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Phenytoin.",Phenytoin
DB00282,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Pamidronic acid.",Pamidronic acid
DB00358,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Mefloquine.",Mefloquine
DB00382,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Tacrine.",Tacrine
DB00389,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Carbimazole.",Carbimazole
DB00439,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Cerivastatin.",Cerivastatin
DB00440,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Trimethoprim.",Trimethoprim
DB00471,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Montelukast.",Montelukast
DB00495,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Zidovudine.",Zidovudine
DB00501,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Cimetidine.",Cimetidine
DB00503,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ritonavir.",Ritonavir
DB00528,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Lercanidipine.",Lercanidipine
DB00537,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ciprofloxacin.",Ciprofloxacin
DB00541,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Vincristine.",Vincristine
DB00550,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Propylthiouracil.",Propylthiouracil
DB00563,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Methotrexate.",Methotrexate
DB00584,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Enalapril.",Enalapril
DB00585,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Nizatidine.",Nizatidine
DB00602,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ivermectin.",Ivermectin
DB00608,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Chloroquine.",Chloroquine
DB00627,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Niacin.",Niacin
DB00630,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Alendronic acid.",Alendronic acid
DB00636,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Clofibrate.",Clofibrate
DB00641,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Simvastatin.",Simvastatin
DB00649,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Stavudine.",Stavudine
DB00666,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Nafarelin.",Nafarelin
DB00681,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Amphotericin B.",Amphotericin B
DB00688,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Mycophenolate mofetil.",Mycophenolate mofetil
DB00704,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Naltrexone.",Naltrexone
DB00709,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Lamivudine.",Lamivudine
DB00710,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ibandronate.",Ibandronate
DB00818,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Propofol.",Propofol
DB00857,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Terbinafine.",Terbinafine
DB00859,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Penicillamine.",Penicillamine
DB00863,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ranitidine.",Ranitidine
DB00864,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Tacrolimus.",Tacrolimus
DB00876,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Eprosartan.",Eprosartan
DB00884,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Risedronic acid.",Risedronic acid
DB00887,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Bumetanide.",Bumetanide
DB00897,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Triazolam.",Triazolam
DB00898,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ethanol.",Ethanol
DB00938,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Salmeterol.",Salmeterol
DB00951,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Isoniazid.",Isoniazid
DB00968,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Methyldopa.",Methyldopa
DB00982,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Isotretinoin.",Isotretinoin
DB00987,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Cytarabine.",Cytarabine
DB01004,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ganciclovir.",Ganciclovir
DB01006,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Letrozole.",Letrozole
DB01015,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Sulfamethoxazole.",Sulfamethoxazole
DB01017,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Minocycline.",Minocycline
DB01035,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Procainamide.",Procainamide
DB01039,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Fenofibrate.",Fenofibrate
DB01059,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Norfloxacin.",Norfloxacin
DB01076,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Atorvastatin.",Atorvastatin
DB01088,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Iloprost.",Iloprost
DB01095,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Fluvastatin.",Fluvastatin
DB01097,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Leflunomide.",Leflunomide
DB01098,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Rosuvastatin.",Rosuvastatin
DB01118,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Amiodarone.",Amiodarone
DB01165,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ofloxacin.",Ofloxacin
DB01168,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Procarbazine.",Procarbazine
DB01197,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Captopril.",Captopril
DB01229,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Paclitaxel.",Paclitaxel
DB01232,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Saquinavir.",Saquinavir
DB01233,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Metoclopramide.",Metoclopramide
DB01234,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Dexamethasone.",Dexamethasone
DB01241,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Gemfibrozil.",Gemfibrozil
DB01248,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Docetaxel.",Docetaxel
DB01393,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Bezafibrate.",Bezafibrate
DB01394,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Colchicine.",Colchicine
DB02703,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Fusidic acid.",Fusidic acid
DB05109,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Trabectedin.",Trabectedin
DB06693,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Mevastatin.",Mevastatin
DB06817,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Raltegravir.",Raltegravir
DB08860,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Pitavastatin.",Pitavastatin
DB08983,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Etofibrate.",Etofibrate
DB09055,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Acipimox.",Acipimox
DB09064,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ciprofibrate.",Ciprofibrate
DB09270,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ubidecarenone.",Ubidecarenone
DB09289,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Tianeptine.",Tianeptine
DB12554,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Mebeverine.",Mebeverine
DB13293,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ipecac.",Ipecac
DB13393,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Emetine.",Emetine
DB13433,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Simfibrate.",Simfibrate
DB13460,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ronifibrate.",Ronifibrate
DB13780,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Aluminium clofibrate.",Aluminium clofibrate
DB13849,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Clofibride.",Clofibride
DB13873,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Fenofibric acid.",Fenofibric acid
DB13074,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Somatotropin.,Macimorelin
DB00443,The therapeutic efficacy of Betamethasone can be decreased when used in combination with Somatotropin.,Betamethasone
DB00620,The therapeutic efficacy of Triamcinolone can be decreased when used in combination with Somatotropin.,Triamcinolone
DB00253,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Medrysone.,Medrysone
DB00324,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Fluorometholone.,Fluorometholone
DB00394,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Beclomethasone dipropionate.,Beclomethasone dipropionate
DB00764,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Mometasone.,Mometasone
DB00896,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Rimexolone.,Rimexolone
DB01384,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Paramethasone.,Paramethasone
DB01410,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Ciclesonide.,Ciclesonide
DB08906,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Fluticasone furoate.,Fluticasone furoate
DB08970,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Fluprednidene.,Fluprednidene
DB08971,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Fluocortolone.,Fluocortolone
DB09383,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Meprednisone.,Meprednisone
DB11487,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Dexamethasone isonicotinate.,Dexamethasone isonicotinate
DB11750,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Clobetasol.,Clobetasol
DB11921,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Deflazacort.,Deflazacort
DB13003,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Cortivazol.,Cortivazol
DB13208,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Prednylidene.,Prednylidene
DB13728,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Halometasone.,Halometasone
DB13843,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Cloprednol.,Cloprednol
DB13867,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Fluticasone.,Fluticasone
DB14512,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Mometasone furoate.,Mometasone furoate
DB14631,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Prednisolone phosphate.,Prednisolone phosphate
DB14633,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Prednisolone hemisuccinate.,Prednisolone hemisuccinate
DB14634,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Fluprednidene acetate.,Fluprednidene acetate
DB14644,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Methylprednisolone hemisuccinate.,Methylprednisolone hemisuccinate
DB14646,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Prednisone acetate.,Prednisone acetate
DB14652,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Clocortolone acetate.,Clocortolone acetate
DB14659,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Melengestrol acetate.,Melengestrol acetate
DB14669,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Betamethasone phosphate.,Betamethasone phosphate
DB14681,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Cortisone.,Cortisone
DB06605,Apixaban may increase the anticoagulant activities of Abciximab.,Apixaban
DB06695,Dabigatran etexilate may increase the anticoagulant activities of Abciximab.,Dabigatran etexilate
DB01254,The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Abciximab.,Dasatinib
DB01609,The risk or severity of gastrointestinal bleeding can be increased when Abciximab is combined with Deferasirox.,Deferasirox
DB09075,The risk or severity of bleeding can be increased when Edoxaban is combined with Abciximab.,Edoxaban
DB09053,The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with Abciximab.,Ibrutinib
DB06228,Abciximab may increase the anticoagulant activities of Rivaroxaban.,Rivaroxaban
DB06206,The risk or severity of bleeding and hemorrhage can be increased when Abciximab is combined with Sugammadex.,Sugammadex
DB09070,Tibolone may increase the anticoagulant activities of Abciximab.,Tibolone
DB00013,Urokinase may increase the anticoagulant activities of Abciximab.,Urokinase
DB09030,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Abciximab.,Vorapaxar
DB06692,The therapeutic efficacy of Abciximab can be decreased when used in combination with Aprotinin.,Aprotinin
DB01586,The risk or severity of adverse effects can be increased when Abciximab is combined with Ursodeoxycholic acid.,Ursodeoxycholic acid
DB02123,The risk or severity of adverse effects can be increased when Abciximab is combined with Glycochenodeoxycholic Acid.,Glycochenodeoxycholic Acid
DB02659,The risk or severity of adverse effects can be increased when Abciximab is combined with Cholic Acid.,Cholic Acid
DB02691,The risk or severity of adverse effects can be increased when Abciximab is combined with Glycocholic acid.,Glycocholic acid
DB03619,The risk or severity of adverse effects can be increased when Abciximab is combined with Deoxycholic acid.,Deoxycholic acid
DB04348,The risk or severity of adverse effects can be increased when Abciximab is combined with Taurocholic acid.,Taurocholic acid
DB05990,The risk or severity of adverse effects can be increased when Abciximab is combined with Obeticholic acid.,Obeticholic acid
DB06777,The risk or severity of adverse effects can be increased when Abciximab is combined with Chenodeoxycholic acid.,Chenodeoxycholic acid
DB08833,The risk or severity of adverse effects can be increased when Abciximab is combined with Taurochenodeoxycholic acid.,Taurochenodeoxycholic acid
DB08834,The risk or severity of adverse effects can be increased when Abciximab is combined with Tauroursodeoxycholic acid.,Tauroursodeoxycholic acid
DB08857,The risk or severity of adverse effects can be increased when Abciximab is combined with Bamet-UD2.,Bamet-UD2
DB11622,The risk or severity of adverse effects can be increased when Abciximab is combined with Dehydrocholic acid.,Dehydrocholic acid
DB11789,The risk or severity of adverse effects can be increased when Abciximab is combined with Hyodeoxycholic Acid.,Hyodeoxycholic Acid
DB01296,Glucosamine may increase the antiplatelet activities of Abciximab.,Glucosamine
DB00078,The risk or severity of adverse effects can be increased when Abciximab is combined with Ibritumomab tiuxetan.,Ibritumomab tiuxetan
DB08935,The risk or severity of adverse effects can be increased when Abciximab is combined with Obinutuzumab.,Obinutuzumab
DB00932,Tipranavir may increase the antiplatelet activities of Abciximab.,Tipranavir
DB00163,Vitamin E may increase the antiplatelet activities of Abciximab.,Vitamin E
DB01381,The therapeutic efficacy of Abciximab can be increased when used in combination with Ginkgo biloba.,Ginkgo biloba
DB01181,The risk or severity of bleeding can be increased when Ifosfamide is combined with Abciximab.,Ifosfamide
DB00468,The therapeutic efficacy of Abciximab can be increased when used in combination with Quinine.,Quinine
DB00908,The therapeutic efficacy of Abciximab can be increased when used in combination with Quinidine.,Quinidine
DB00675,The risk or severity of bleeding can be increased when Tamoxifen is combined with Abciximab.,Tamoxifen
DB00539,The risk or severity of bleeding can be increased when Toremifene is combined with Abciximab.,Toremifene
DB00806,The therapeutic efficacy of Abciximab can be increased when used in combination with Pentoxifylline.,Pentoxifylline
DB00686,The risk or severity of adverse effects can be increased when Pentosan polysulfate is combined with Abciximab.,Pentosan polysulfate
DB00583,The therapeutic efficacy of Abciximab can be increased when used in combination with Levocarnitine.,Levocarnitine
DB00655,Estrone may increase the thrombogenic activities of Abciximab.,Estrone
DB00890,Dienestrol may increase the thrombogenic activities of Abciximab.,Dienestrol
DB09255,Dextran may increase the anticoagulant activities of Abciximab.,Dextran
DB00255,Diethylstilbestrol may decrease the anticoagulant activities of Abciximab.,Diethylstilbestrol
DB00269,Chlorotrianisene may decrease the anticoagulant activities of Abciximab.,Chlorotrianisene
DB00286,Conjugated estrogens may decrease the anticoagulant activities of Abciximab.,Conjugated estrogens
DB00783,Estradiol may decrease the anticoagulant activities of Abciximab.,Estradiol
DB00977,Ethinylestradiol may decrease the anticoagulant activities of Abciximab.,Ethinylestradiol
DB01357,Mestranol may decrease the anticoagulant activities of Abciximab.,Mestranol
DB04573,Estriol may decrease the anticoagulant activities of Abciximab.,Estriol
DB04574,Estrone sulfate may decrease the anticoagulant activities of Abciximab.,Estrone sulfate
DB04575,Quinestrol may decrease the anticoagulant activities of Abciximab.,Quinestrol
DB07931,Hexestrol may decrease the anticoagulant activities of Abciximab.,Hexestrol
DB09317,"Synthetic Conjugated Estrogens, A may decrease the anticoagulant activities of Abciximab.","Synthetic Conjugated Estrogens, A"
DB09318,"Synthetic Conjugated Estrogens, B may decrease the anticoagulant activities of Abciximab.","Synthetic Conjugated Estrogens, B"
DB09369,Polyestradiol phosphate may decrease the anticoagulant activities of Abciximab.,Polyestradiol phosphate
DB09381,Esterified estrogens may decrease the anticoagulant activities of Abciximab.,Esterified estrogens
DB11478,Zeranol may decrease the anticoagulant activities of Abciximab.,Zeranol
DB11674,Equol may decrease the anticoagulant activities of Abciximab.,Equol
DB12487,Promestriene may decrease the anticoagulant activities of Abciximab.,Promestriene
DB13143,Methallenestril may decrease the anticoagulant activities of Abciximab.,Methallenestril
DB13386,Epimestrol may decrease the anticoagulant activities of Abciximab.,Epimestrol
DB13418,Moxestrol may decrease the anticoagulant activities of Abciximab.,Moxestrol
DB13952,Estradiol acetate may decrease the anticoagulant activities of Abciximab.,Estradiol acetate
DB13953,Estradiol benzoate may decrease the anticoagulant activities of Abciximab.,Estradiol benzoate
DB13954,Estradiol cypionate may decrease the anticoagulant activities of Abciximab.,Estradiol cypionate
DB13956,Estradiol valerate may decrease the anticoagulant activities of Abciximab.,Estradiol valerate
DB15334,Biochanin A may decrease the anticoagulant activities of Abciximab.,Biochanin A
DB15335,Formononetin may decrease the anticoagulant activities of Abciximab.,Formononetin
DB00159,The risk or severity of bleeding and hemorrhage can be increased when Icosapent is combined with Abciximab.,Icosapent
DB00244,The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Abciximab.,Mesalazine
DB00328,The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Abciximab.,Indomethacin
DB00461,The risk or severity of bleeding and hemorrhage can be increased when Nabumetone is combined with Abciximab.,Nabumetone
DB00465,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Abciximab.,Ketorolac
DB00469,The risk or severity of bleeding and hemorrhage can be increased when Tenoxicam is combined with Abciximab.,Tenoxicam
DB00482,The risk or severity of bleeding and hemorrhage can be increased when Celecoxib is combined with Abciximab.,Celecoxib
DB00500,The risk or severity of bleeding and hemorrhage can be increased when Tolmetin is combined with Abciximab.,Tolmetin
DB00533,The risk or severity of bleeding and hemorrhage can be increased when Rofecoxib is combined with Abciximab.,Rofecoxib
DB00554,The risk or severity of bleeding and hemorrhage can be increased when Piroxicam is combined with Abciximab.,Piroxicam
DB00573,The risk or severity of bleeding and hemorrhage can be increased when Fenoprofen is combined with Abciximab.,Fenoprofen
DB00580,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Abciximab.,Valdecoxib
DB00586,The risk or severity of bleeding and hemorrhage can be increased when Diclofenac is combined with Abciximab.,Diclofenac
DB00605,The risk or severity of bleeding and hemorrhage can be increased when Sulindac is combined with Abciximab.,Sulindac
DB00712,The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen is combined with Abciximab.,Flurbiprofen
DB00749,The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Abciximab.,Etodolac
DB00784,The risk or severity of bleeding and hemorrhage can be increased when Mefenamic acid is combined with Abciximab.,Mefenamic acid
DB00788,The risk or severity of bleeding and hemorrhage can be increased when Naproxen is combined with Abciximab.,Naproxen
DB00795,The risk or severity of bleeding and hemorrhage can be increased when Sulfasalazine is combined with Abciximab.,Sulfasalazine
DB00812,The risk or severity of bleeding and hemorrhage can be increased when Phenylbutazone is combined with Abciximab.,Phenylbutazone
DB00814,The risk or severity of bleeding and hemorrhage can be increased when Meloxicam is combined with Abciximab.,Meloxicam
DB00821,The risk or severity of bleeding and hemorrhage can be increased when Carprofen is combined with Abciximab.,Carprofen
DB00861,The risk or severity of bleeding and hemorrhage can be increased when Diflunisal is combined with Abciximab.,Diflunisal
DB00936,The risk or severity of bleeding and hemorrhage can be increased when Salicylic acid is combined with Abciximab.,Salicylic acid
DB00939,The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Abciximab.,Meclofenamic acid
DB00991,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Abciximab.,Oxaprozin
DB01009,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Abciximab.,Ketoprofen
DB01014,The risk or severity of bleeding and hemorrhage can be increased when Balsalazide is combined with Abciximab.,Balsalazide
DB01250,The risk or severity of bleeding and hemorrhage can be increased when Olsalazine is combined with Abciximab.,Olsalazine
DB01283,The risk or severity of bleeding and hemorrhage can be increased when Lumiracoxib is combined with Abciximab.,Lumiracoxib
DB01397,The risk or severity of bleeding and hemorrhage can be increased when Magnesium salicylate is combined with Abciximab.,Magnesium salicylate
DB01399,The risk or severity of bleeding and hemorrhage can be increased when Salsalate is combined with Abciximab.,Salsalate
DB01401,The risk or severity of bleeding and hemorrhage can be increased when Choline magnesium trisalicylate is combined with Abciximab.,Choline magnesium trisalicylate
DB01419,The risk or severity of bleeding and hemorrhage can be increased when Antrafenine is combined with Abciximab.,Antrafenine
DB01424,The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Abciximab.,Aminophenazone
DB01435,The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Abciximab.,Antipyrine
DB01600,The risk or severity of bleeding and hemorrhage can be increased when Tiaprofenic acid is combined with Abciximab.,Tiaprofenic acid
DB01628,The risk or severity of bleeding and hemorrhage can be increased when Etoricoxib is combined with Abciximab.,Etoricoxib
DB02224,The risk or severity of bleeding and hemorrhage can be increased when Taxifolin is combined with Abciximab.,Taxifolin
DB03585,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Abciximab.,Oxyphenbutazone
DB04552,The risk or severity of bleeding and hemorrhage can be increased when Niflumic acid is combined with Abciximab.,Niflumic acid
DB04725,The risk or severity of bleeding and hemorrhage can be increased when Licofelone is combined with Abciximab.,Licofelone
DB04812,The risk or severity of bleeding and hemorrhage can be increased when Benoxaprofen is combined with Abciximab.,Benoxaprofen
DB04817,The risk or severity of bleeding and hemorrhage can be increased when Metamizole is combined with Abciximab.,Metamizole
DB04828,The risk or severity of bleeding and hemorrhage can be increased when Zomepirac is combined with Abciximab.,Zomepirac
DB05095,The risk or severity of bleeding and hemorrhage can be increased when Cimicoxib is combined with Abciximab.,Cimicoxib
DB06725,The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is combined with Abciximab.,Lornoxicam
DB06736,The risk or severity of bleeding and hemorrhage can be increased when Aceclofenac is combined with Abciximab.,Aceclofenac
DB06737,The risk or severity of bleeding and hemorrhage can be increased when Zaltoprofen is combined with Abciximab.,Zaltoprofen
DB07402,The risk or severity of bleeding and hemorrhage can be increased when Azapropazone is combined with Abciximab.,Azapropazone
DB07477,The risk or severity of bleeding and hemorrhage can be increased when Felbinac is combined with Abciximab.,Felbinac
DB08439,The risk or severity of bleeding and hemorrhage can be increased when Parecoxib is combined with Abciximab.,Parecoxib
DB08797,The risk or severity of bleeding and hemorrhage can be increased when Salicylamide is combined with Abciximab.,Salicylamide
DB08940,The risk or severity of bleeding and hemorrhage can be increased when Kebuzone is combined with Abciximab.,Kebuzone
DB08942,The risk or severity of bleeding and hemorrhage can be increased when Isoxicam is combined with Abciximab.,Isoxicam
DB08951,The risk or severity of bleeding and hemorrhage can be increased when Indoprofen is combined with Abciximab.,Indoprofen
DB08955,The risk or severity of bleeding and hemorrhage can be increased when Ibuproxam is combined with Abciximab.,Ibuproxam
DB08976,The risk or severity of bleeding and hemorrhage can be increased when Floctafenine is combined with Abciximab.,Floctafenine
DB08981,The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Abciximab.,Fenbufen
DB08984,The risk or severity of bleeding and hemorrhage can be increased when Etofenamate is combined with Abciximab.,Etofenamate
DB08991,The risk or severity of bleeding and hemorrhage can be increased when Epirizole is combined with Abciximab.,Epirizole
DB09084,The risk or severity of bleeding and hemorrhage can be increased when Benzydamine is combined with Abciximab.,Benzydamine
DB09212,The risk or severity of bleeding and hemorrhage can be increased when Loxoprofen is combined with Abciximab.,Loxoprofen
DB09214,The risk or severity of bleeding and hemorrhage can be increased when Dexketoprofen is combined with Abciximab.,Dexketoprofen
DB09215,The risk or severity of bleeding and hemorrhage can be increased when Droxicam is combined with Abciximab.,Droxicam
DB09216,The risk or severity of bleeding and hemorrhage can be increased when Tolfenamic acid is combined with Abciximab.,Tolfenamic acid
DB09217,The risk or severity of bleeding and hemorrhage can be increased when Firocoxib is combined with Abciximab.,Firocoxib
DB09218,The risk or severity of bleeding and hemorrhage can be increased when Clonixin is combined with Abciximab.,Clonixin
DB09285,The risk or severity of bleeding and hemorrhage can be increased when Morniflumate is combined with Abciximab.,Morniflumate
DB09288,The risk or severity of bleeding and hemorrhage can be increased when Propacetamol is combined with Abciximab.,Propacetamol
DB09295,The risk or severity of bleeding and hemorrhage can be increased when Talniflumate is combined with Abciximab.,Talniflumate
DB11455,The risk or severity of bleeding and hemorrhage can be increased when Robenacoxib is combined with Abciximab.,Robenacoxib
DB11466,The risk or severity of bleeding and hemorrhage can be increased when Tepoxalin is combined with Abciximab.,Tepoxalin
DB11518,The risk or severity of bleeding and hemorrhage can be increased when Flunixin is combined with Abciximab.,Flunixin
DB12399,The risk or severity of bleeding and hemorrhage can be increased when Polmacoxib is combined with Abciximab.,Polmacoxib
DB12480,The risk or severity of bleeding and hemorrhage can be increased when Betulinic Acid is combined with Abciximab.,Betulinic Acid
DB12610,The risk or severity of bleeding and hemorrhage can be increased when Ebselen is combined with Abciximab.,Ebselen
DB13001,The risk or severity of bleeding and hemorrhage can be increased when Tinoridine is combined with Abciximab.,Tinoridine
DB13167,The risk or severity of bleeding and hemorrhage can be increased when Alclofenac is combined with Abciximab.,Alclofenac
DB13217,The risk or severity of bleeding and hemorrhage can be increased when Fentiazac is combined with Abciximab.,Fentiazac
DB13232,The risk or severity of bleeding and hemorrhage can be increased when Suxibuzone is combined with Abciximab.,Suxibuzone
DB13286,The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with Abciximab.,Bumadizone
DB13314,The risk or severity of bleeding and hemorrhage can be increased when Alminoprofen is combined with Abciximab.,Alminoprofen
DB13317,The risk or severity of bleeding and hemorrhage can be increased when Flunoxaprofen is combined with Abciximab.,Flunoxaprofen
DB13364,The risk or severity of bleeding and hemorrhage can be increased when Feprazone is combined with Abciximab.,Feprazone
DB13371,The risk or severity of bleeding and hemorrhage can be increased when Difenpiramide is combined with Abciximab.,Difenpiramide
DB13407,The risk or severity of bleeding and hemorrhage can be increased when Nifenazone is combined with Abciximab.,Nifenazone
DB13432,The risk or severity of bleeding and hemorrhage can be increased when Lonazolac is combined with Abciximab.,Lonazolac
DB13481,The risk or severity of bleeding and hemorrhage can be increased when Tenidap is combined with Abciximab.,Tenidap
DB13501,The risk or severity of bleeding and hemorrhage can be increased when Bendazac is combined with Abciximab.,Bendazac
DB13514,The risk or severity of bleeding and hemorrhage can be increased when Pranoprofen is combined with Abciximab.,Pranoprofen
DB13524,The risk or severity of bleeding and hemorrhage can be increased when Propyphenazone is combined with Abciximab.,Propyphenazone
DB13527,The risk or severity of bleeding and hemorrhage can be increased when Proglumetacin is combined with Abciximab.,Proglumetacin
DB13538,The risk or severity of bleeding and hemorrhage can be increased when Guacetisal is combined with Abciximab.,Guacetisal
DB13544,The risk or severity of bleeding and hemorrhage can be increased when Ethenzamide is combined with Abciximab.,Ethenzamide
DB13612,The risk or severity of bleeding and hemorrhage can be increased when Carbaspirin calcium is combined with Abciximab.,Carbaspirin calcium
DB13629,The risk or severity of bleeding and hemorrhage can be increased when Mofebutazone is combined with Abciximab.,Mofebutazone
DB13649,The risk or severity of bleeding and hemorrhage can be increased when Proquazone is combined with Abciximab.,Proquazone
DB13657,The risk or severity of bleeding and hemorrhage can be increased when Benorilate is combined with Abciximab.,Benorilate
DB13722,The risk or severity of bleeding and hemorrhage can be increased when Pirprofen is combined with Abciximab.,Pirprofen
DB13860,The risk or severity of bleeding and hemorrhage can be increased when Imidazole salicylate is combined with Abciximab.,Imidazole salicylate
DB14059,The risk or severity of bleeding and hemorrhage can be increased when SC-236 is combined with Abciximab.,SC-236
DB14060,The risk or severity of bleeding and hemorrhage can be increased when NS-398 is combined with Abciximab.,NS-398
DB14938,The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen axetil is combined with Abciximab.,Flurbiprofen axetil
DB04865,The risk or severity of bleeding can be increased when Abciximab is combined with Omacetaxine mepesuccinate.,Omacetaxine mepesuccinate
DB09211,The risk or severity of adverse effects can be increased when Limaprost is combined with Abciximab.,Limaprost
DB00048,The risk or severity of adverse effects can be increased when Abciximab is combined with Collagenase clostridium histolyticum.,Collagenase clostridium histolyticum
DB11133,Omega-3 fatty acids may increase the antiplatelet activities of Abciximab.,Omega-3 fatty acids
DB00081,The risk or severity of adverse effects can be increased when Abciximab is combined with Tositumomab.,Tositumomab
DB00389,Carbimazole may increase the anticoagulant activities of Abciximab.,Carbimazole
DB00550,Propylthiouracil may increase the anticoagulant activities of Abciximab.,Propylthiouracil
DB00763,Methimazole may increase the anticoagulant activities of Abciximab.,Methimazole
DB03374,"3,5-Diiodotyrosine may increase the anticoagulant activities of Abciximab.","3,5-Diiodotyrosine"
DB06715,Potassium Iodide may increase the anticoagulant activities of Abciximab.,Potassium Iodide
DB07637,Dibromotyrosine may increase the anticoagulant activities of Abciximab.,Dibromotyrosine
DB09418,Potassium perchlorate may increase the anticoagulant activities of Abciximab.,Potassium perchlorate
DB13644,Methylthiouracil may increase the anticoagulant activities of Abciximab.,Methylthiouracil
DB13804,Benzylthiouracil may increase the anticoagulant activities of Abciximab.,Benzylthiouracil
DB00834,The therapeutic efficacy of Abciximab can be decreased when used in combination with Mifepristone.,Mifepristone
DB04066,The therapeutic efficacy of Abciximab can be decreased when used in combination with p-Coumaric acid.,p-Coumaric acid
DB04682,The therapeutic efficacy of Abciximab can be decreased when used in combination with Octylphenoxy polyethoxyethanol.,Octylphenoxy polyethoxyethanol
DB05830,The therapeutic efficacy of Abciximab can be decreased when used in combination with Trestolone.,Trestolone
DB06266,The therapeutic efficacy of Abciximab can be decreased when used in combination with Lonidamine.,Lonidamine
DB08867,The therapeutic efficacy of Abciximab can be decreased when used in combination with Ulipristal.,Ulipristal
DB09401,The therapeutic efficacy of Abciximab can be decreased when used in combination with Isosorbide.,Isosorbide
DB11507,The therapeutic efficacy of Abciximab can be decreased when used in combination with Cloprostenol.,Cloprostenol
DB12025,The therapeutic efficacy of Abciximab can be decreased when used in combination with Triptolide.,Triptolide
DB13044,The therapeutic efficacy of Abciximab can be decreased when used in combination with Gossypol.,Gossypol
DB13310,The therapeutic efficacy of Abciximab can be decreased when used in combination with Ormeloxifene.,Ormeloxifene
DB00294,Etonogestrel may decrease the anticoagulant activities of Abciximab.,Etonogestrel
DB00304,Desogestrel may decrease the anticoagulant activities of Abciximab.,Desogestrel
DB00351,Megestrol acetate may decrease the anticoagulant activities of Abciximab.,Megestrol acetate
DB00367,Levonorgestrel may decrease the anticoagulant activities of Abciximab.,Levonorgestrel
DB00378,Dydrogesterone may decrease the anticoagulant activities of Abciximab.,Dydrogesterone
DB00396,Progesterone may decrease the anticoagulant activities of Abciximab.,Progesterone
DB00603,Medroxyprogesterone acetate may decrease the anticoagulant activities of Abciximab.,Medroxyprogesterone acetate
DB00717,Norethisterone may decrease the anticoagulant activities of Abciximab.,Norethisterone
DB00823,Ethynodiol diacetate may decrease the anticoagulant activities of Abciximab.,Ethynodiol diacetate
DB00957,Norgestimate may decrease the anticoagulant activities of Abciximab.,Norgestimate
DB01395,Drospirenone may decrease the anticoagulant activities of Abciximab.,Drospirenone
DB01431,Allylestrenol may decrease the anticoagulant activities of Abciximab.,Allylestrenol
DB04839,Cyproterone acetate may decrease the anticoagulant activities of Abciximab.,Cyproterone acetate
DB06713,Norelgestromin may decrease the anticoagulant activities of Abciximab.,Norelgestromin
DB06730,Gestodene may decrease the anticoagulant activities of Abciximab.,Gestodene
DB06789,Hydroxyprogesterone caproate may decrease the anticoagulant activities of Abciximab.,Hydroxyprogesterone caproate
DB09123,Dienogest may decrease the anticoagulant activities of Abciximab.,Dienogest
DB09124,Medrogestone may decrease the anticoagulant activities of Abciximab.,Medrogestone
DB09371,Norethynodrel may decrease the anticoagulant activities of Abciximab.,Norethynodrel
DB09389,Norgestrel may decrease the anticoagulant activities of Abciximab.,Norgestrel
DB11372,Altrenogest may decrease the anticoagulant activities of Abciximab.,Altrenogest
DB11619,Gestrinone may decrease the anticoagulant activities of Abciximab.,Gestrinone
DB11636,Nomegestrol may decrease the anticoagulant activities of Abciximab.,Nomegestrol
DB12474,Lynestrenol may decrease the anticoagulant activities of Abciximab.,Lynestrenol
DB13230,Gestonorone may decrease the anticoagulant activities of Abciximab.,Gestonorone
DB13528,Chlormadinone may decrease the anticoagulant activities of Abciximab.,Chlormadinone
DB13533,Methylestrenolone may decrease the anticoagulant activities of Abciximab.,Methylestrenolone
DB13563,Norgestrienone may decrease the anticoagulant activities of Abciximab.,Norgestrienone
DB13602,Promegestone may decrease the anticoagulant activities of Abciximab.,Promegestone
DB13685,Quingestanol may decrease the anticoagulant activities of Abciximab.,Quingestanol
DB13857,Demegestone may decrease the anticoagulant activities of Abciximab.,Demegestone
DB13866,Etynodiol may decrease the anticoagulant activities of Abciximab.,Etynodiol
DB13981,Nomegestrol acetate may decrease the anticoagulant activities of Abciximab.,Nomegestrol acetate
DB14570,Hydroxyprogesterone may decrease the anticoagulant activities of Abciximab.,Hydroxyprogesterone
DB14678,Norethindrone enanthate may decrease the anticoagulant activities of Abciximab.,Norethindrone enanthate
DB14679,Quingestanol acetate may decrease the anticoagulant activities of Abciximab.,Quingestanol acetate
DB00233,The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Abciximab.,Aminosalicylic acid
DB01294,The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Abciximab.,Bismuth subsalicylate
DB06251,The risk or severity of bleeding can be increased when Dersalazine is combined with Abciximab.,Dersalazine
DB06807,The risk or severity of bleeding can be increased when Phenyl aminosalicylate is combined with Abciximab.,Phenyl aminosalicylate
DB09543,The risk or severity of bleeding can be increased when Methyl salicylate is combined with Abciximab.,Methyl salicylate
DB11079,The risk or severity of bleeding can be increased when Trolamine salicylate is combined with Abciximab.,Trolamine salicylate
DB13509,The risk or severity of bleeding can be increased when Aloxiprin is combined with Abciximab.,Aloxiprin
DB14006,The risk or severity of bleeding can be increased when Choline salicylate is combined with Abciximab.,Choline salicylate
DB14026,The risk or severity of bleeding can be increased when Thiosalicylic acid is combined with Abciximab.,Thiosalicylic acid
DB00001,The risk or severity of bleeding can be increased when Abciximab is combined with Lepirudin.,Lepirudin
DB00006,The risk or severity of bleeding can be increased when Abciximab is combined with Bivalirudin.,Bivalirudin
DB00009,The risk or severity of bleeding can be increased when Abciximab is combined with Alteplase.,Alteplase
DB00015,The risk or severity of bleeding can be increased when Abciximab is combined with Reteplase.,Reteplase
DB00029,The risk or severity of bleeding can be increased when Abciximab is combined with Anistreplase.,Anistreplase
DB00031,The risk or severity of bleeding can be increased when Abciximab is combined with Tenecteplase.,Tenecteplase
DB00055,The risk or severity of bleeding can be increased when Abciximab is combined with Drotrecogin alfa.,Drotrecogin alfa
DB00086,The risk or severity of bleeding can be increased when Abciximab is combined with Streptokinase.,Streptokinase
DB00261,The risk or severity of bleeding can be increased when Abciximab is combined with Anagrelide.,Anagrelide
DB00266,The risk or severity of bleeding can be increased when Abciximab is combined with Dicoumarol.,Dicoumarol
DB00278,The risk or severity of bleeding can be increased when Abciximab is combined with Argatroban.,Argatroban
DB00407,The risk or severity of bleeding can be increased when Abciximab is combined with Ardeparin.,Ardeparin
DB00498,The risk or severity of bleeding can be increased when Abciximab is combined with Phenindione.,Phenindione
DB00569,The risk or severity of bleeding can be increased when Abciximab is combined with Fondaparinux.,Fondaparinux
DB00682,The risk or severity of bleeding can be increased when Abciximab is combined with Warfarin.,Warfarin
DB00946,The risk or severity of bleeding can be increased when Abciximab is combined with Phenprocoumon.,Phenprocoumon
DB00975,The risk or severity of bleeding can be increased when Abciximab is combined with Dipyridamole.,Dipyridamole
DB01088,The risk or severity of bleeding can be increased when Abciximab is combined with Iloprost.,Iloprost
DB01109,The risk or severity of bleeding can be increased when Abciximab is combined with Heparin.,Heparin
DB01225,The risk or severity of bleeding can be increased when Abciximab is combined with Enoxaparin.,Enoxaparin
DB01240,The risk or severity of bleeding can be increased when Abciximab is combined with Epoprostenol.,Epoprostenol
DB01418,The risk or severity of bleeding can be increased when Abciximab is combined with Acenocoumarol.,Acenocoumarol
DB03410,The risk or severity of bleeding can be increased when Abciximab is combined with 4-hydroxycoumarin.,4-hydroxycoumarin
DB04665,The risk or severity of bleeding can be increased when Abciximab is combined with Coumarin.,Coumarin
DB04898,The risk or severity of bleeding can be increased when Abciximab is combined with Ximelagatran.,Ximelagatran
DB04925,The risk or severity of bleeding can be increased when Abciximab is combined with Desmoteplase.,Desmoteplase
DB04932,The risk or severity of bleeding can be increased when Abciximab is combined with Defibrotide.,Defibrotide
DB05099,The risk or severity of bleeding can be increased when Abciximab is combined with Ancrod.,Ancrod
DB05229,The risk or severity of bleeding can be increased when Abciximab is combined with Beraprost.,Beraprost
DB05254,The risk or severity of bleeding can be increased when Abciximab is combined with Fibrinolysin.,Fibrinolysin
DB06209,The risk or severity of bleeding can be increased when Abciximab is combined with Prasugrel.,Prasugrel
DB06271,The risk or severity of bleeding can be increased when Abciximab is combined with Sulodexide.,Sulodexide
DB06294,The risk or severity of bleeding can be increased when Abciximab is combined with Semuloparin.,Semuloparin
DB06406,The risk or severity of bleeding can be increased when Abciximab is combined with Idraparinux.,Idraparinux
DB06441,The risk or severity of bleeding can be increased when Abciximab is combined with Cangrelor.,Cangrelor
DB06543,The risk or severity of bleeding can be increased when Abciximab is combined with Astaxanthin.,Astaxanthin
DB06635,The risk or severity of bleeding can be increased when Abciximab is combined with Otamixaban.,Otamixaban
DB06679,The risk or severity of bleeding can be increased when Abciximab is combined with Amediplase.,Amediplase
DB06754,The risk or severity of bleeding can be increased when Abciximab is combined with Danaparoid.,Danaparoid
DB06779,The risk or severity of bleeding can be increased when Abciximab is combined with Dalteparin.,Dalteparin
DB06822,The risk or severity of bleeding can be increased when Abciximab is combined with Tinzaparin.,Tinzaparin
DB07767,The risk or severity of bleeding can be increased when Abciximab is combined with Ferulic acid.,Ferulic acid
DB08496,The risk or severity of bleeding can be increased when Abciximab is combined with (R)-warfarin.,(R)-warfarin
DB08794,The risk or severity of bleeding can be increased when Abciximab is combined with Ethyl biscoumacetate.,Ethyl biscoumacetate
DB08813,The risk or severity of bleeding can be increased when Abciximab is combined with Nadroparin.,Nadroparin
DB08814,The risk or severity of bleeding can be increased when Abciximab is combined with Triflusal.,Triflusal
DB08816,The risk or severity of bleeding can be increased when Abciximab is combined with Ticagrelor.,Ticagrelor
DB08994,The risk or severity of bleeding can be increased when Abciximab is combined with Ditazole.,Ditazole
DB09125,The risk or severity of bleeding can be increased when Abciximab is combined with Potassium citrate.,Potassium citrate
DB09154,The risk or severity of bleeding can be increased when Abciximab is combined with Sodium citrate.,Sodium citrate
DB09258,The risk or severity of bleeding can be increased when Abciximab is combined with Bemiparin.,Bemiparin
DB09259,The risk or severity of bleeding can be increased when Abciximab is combined with Reviparin.,Reviparin
DB09260,The risk or severity of bleeding can be increased when Abciximab is combined with Parnaparin.,Parnaparin
DB09261,The risk or severity of bleeding can be increased when Abciximab is combined with Certoparin.,Certoparin
DB11095,The risk or severity of bleeding can be increased when Abciximab is combined with Desirudin.,Desirudin
DB11154,The risk or severity of bleeding can be increased when Abciximab is combined with Zinc citrate.,Zinc citrate
DB11166,The risk or severity of bleeding can be increased when Abciximab is combined with Antithrombin Alfa.,Antithrombin Alfa
DB11312,The risk or severity of bleeding can be increased when Abciximab is combined with Protein C.,Protein C
DB11598,The risk or severity of bleeding can be increased when Abciximab is combined with Antithrombin III human.,Antithrombin III human
DB11984,The risk or severity of bleeding can be increased when Abciximab is combined with Letaxaban.,Letaxaban
DB12289,The risk or severity of bleeding can be increased when Abciximab is combined with Darexaban.,Darexaban
DB12364,The risk or severity of bleeding can be increased when Abciximab is combined with Betrixaban.,Betrixaban
DB12598,The risk or severity of bleeding can be increased when Abciximab is combined with Nafamostat.,Nafamostat
DB12726,The risk or severity of bleeding can be increased when Abciximab is combined with Monteplase.,Monteplase
DB12831,The risk or severity of bleeding can be increased when Abciximab is combined with Gabexate.,Gabexate
DB13136,The risk or severity of bleeding can be increased when Abciximab is combined with Fluindione.,Fluindione
DB13149,The risk or severity of bleeding can be increased when Abciximab is combined with Protein S human.,Protein S human
DB13199,The risk or severity of bleeding can be increased when Abciximab is combined with Brinase.,Brinase
DB13275,The risk or severity of bleeding can be increased when Abciximab is combined with Clorindione.,Clorindione
DB13347,The risk or severity of bleeding can be increased when Abciximab is combined with Diphenadione.,Diphenadione
DB13451,The risk or severity of bleeding can be increased when Abciximab is combined with Tioclomarol.,Tioclomarol
DB13616,The risk or severity of bleeding can be increased when Abciximab is combined with Melagatran.,Melagatran
DB13646,The risk or severity of bleeding can be increased when Abciximab is combined with Saruplase.,Saruplase
DB14055,The risk or severity of bleeding can be increased when Abciximab is combined with (S)-Warfarin.,(S)-Warfarin
DB14094,The risk or severity of bleeding can be increased when Abciximab is combined with Tocopherylquinone.,Tocopherylquinone
DB14598,The risk or severity of bleeding can be increased when Abciximab is combined with Edetate calcium disodium anhydrous.,Edetate calcium disodium anhydrous
DB14726,The risk or severity of bleeding can be increased when Abciximab is combined with Dabigatran.,Dabigatran
DB00063,The risk or severity of bleeding can be increased when Eptifibatide is combined with Abciximab.,Eptifibatide
DB00208,The risk or severity of bleeding can be increased when Ticlopidine is combined with Abciximab.,Ticlopidine
DB00758,The risk or severity of bleeding can be increased when Clopidogrel is combined with Abciximab.,Clopidogrel
DB00775,The risk or severity of bleeding can be increased when Tirofiban is combined with Abciximab.,Tirofiban
DB01138,The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Abciximab.,Sulfinpyrazone
DB01166,The risk or severity of bleeding can be increased when Cilostazol is combined with Abciximab.,Cilostazol
DB01207,The risk or severity of bleeding can be increased when Ridogrel is combined with Abciximab.,Ridogrel
DB01236,The risk or severity of bleeding can be increased when Sevoflurane is combined with Abciximab.,Sevoflurane
DB02709,The risk or severity of bleeding can be increased when Resveratrol is combined with Abciximab.,Resveratrol
DB04743,The risk or severity of bleeding can be increased when Nimesulide is combined with Abciximab.,Nimesulide
DB04905,The risk or severity of bleeding can be increased when Tesmilifene is combined with Abciximab.,Tesmilifene
DB05266,The risk or severity of bleeding can be increased when Ibudilast is combined with Abciximab.,Ibudilast
DB05767,The risk or severity of bleeding can be increased when Andrographolide is combined with Abciximab.,Andrographolide
DB06081,The risk or severity of bleeding can be increased when Caplacizumab is combined with Abciximab.,Caplacizumab
DB07615,The risk or severity of bleeding can be increased when Tranilast is combined with Abciximab.,Tranilast
DB08887,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Abciximab.,Icosapent ethyl
DB09283,The risk or severity of bleeding can be increased when Trapidil is combined with Abciximab.,Trapidil
DB12092,The risk or severity of bleeding can be increased when Naftopidil is combined with Abciximab.,Naftopidil
DB12163,The risk or severity of bleeding can be increased when Sarpogrelate is combined with Abciximab.,Sarpogrelate
DB12321,The risk or severity of bleeding can be increased when Ifetroban is combined with Abciximab.,Ifetroban
DB12445,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Abciximab.,Nitroaspirin
DB12465,The risk or severity of bleeding can be increased when Ketanserin is combined with Abciximab.,Ketanserin
DB12545,The risk or severity of bleeding can be increased when Indobufen is combined with Abciximab.,Indobufen
DB12749,The risk or severity of bleeding can be increased when Butylphthalide is combined with Abciximab.,Butylphthalide
DB12771,The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Abciximab.,Hydroxytyrosol
DB13036,The risk or severity of bleeding can be increased when Ramatroban is combined with Abciximab.,Ramatroban
DB13327,The risk or severity of bleeding can be increased when Picotamide is combined with Abciximab.,Picotamide
DB13367,The risk or severity of bleeding can be increased when Cloricromen is combined with Abciximab.,Cloricromen
DB13400,The risk or severity of bleeding can be increased when Linsidomine is combined with Abciximab.,Linsidomine
DB13510,The risk or severity of bleeding can be increased when Buflomedil is combined with Abciximab.,Buflomedil
DB13929,The risk or severity of bleeding can be increased when Relcovaptan is combined with Abciximab.,Relcovaptan
DB00374,The risk or severity of adverse effects can be increased when Abciximab is combined with Treprostinil.,Treprostinil
DB00008,The risk or severity of bleeding can be increased when Abciximab is combined with Peginterferon alfa-2a.,Peginterferon alfa-2a
DB00011,The risk or severity of bleeding can be increased when Abciximab is combined with Interferon alfa-n1.,Interferon alfa-n1
DB00018,The risk or severity of bleeding can be increased when Abciximab is combined with Interferon alfa-n3.,Interferon alfa-n3
DB00022,The risk or severity of bleeding can be increased when Abciximab is combined with Peginterferon alfa-2b.,Peginterferon alfa-2b
DB00033,The risk or severity of bleeding can be increased when Abciximab is combined with Interferon gamma-1b.,Interferon gamma-1b
DB00034,"The risk or severity of bleeding can be increased when Abciximab is combined with Interferon alfa-2a, Recombinant.","Interferon alfa-2a, Recombinant"
DB00041,The risk or severity of bleeding can be increased when Abciximab is combined with Aldesleukin.,Aldesleukin
DB00068,The risk or severity of bleeding can be increased when Abciximab is combined with Interferon beta-1b.,Interferon beta-1b
DB00069,The risk or severity of bleeding can be increased when Abciximab is combined with Interferon alfacon-1.,Interferon alfacon-1
DB00105,The risk or severity of bleeding can be increased when Abciximab is combined with Interferon alfa-2b.,Interferon alfa-2b
DB00120,The risk or severity of bleeding can be increased when Abciximab is combined with Phenylalanine.,Phenylalanine
DB00188,The risk or severity of bleeding can be increased when Abciximab is combined with Bortezomib.,Bortezomib
DB00242,The risk or severity of bleeding can be increased when Abciximab is combined with Cladribine.,Cladribine
DB00262,The risk or severity of bleeding can be increased when Abciximab is combined with Carmustine.,Carmustine
DB00276,The risk or severity of bleeding can be increased when Abciximab is combined with Amsacrine.,Amsacrine
DB00291,The risk or severity of bleeding can be increased when Abciximab is combined with Chlorambucil.,Chlorambucil
DB00293,The risk or severity of bleeding can be increased when Abciximab is combined with Raltitrexed.,Raltitrexed
DB00305,The risk or severity of bleeding can be increased when Abciximab is combined with Mitomycin.,Mitomycin
DB00307,The risk or severity of bleeding can be increased when Abciximab is combined with Bexarotene.,Bexarotene
DB00309,The risk or severity of bleeding can be increased when Abciximab is combined with Vindesine.,Vindesine
DB00322,The risk or severity of bleeding can be increased when Abciximab is combined with Floxuridine.,Floxuridine
DB00352,The risk or severity of bleeding can be increased when Abciximab is combined with Tioguanine.,Tioguanine
DB00361,The risk or severity of bleeding can be increased when Abciximab is combined with Vinorelbine.,Vinorelbine
DB00380,The risk or severity of bleeding can be increased when Abciximab is combined with Dexrazoxane.,Dexrazoxane
DB00398,The risk or severity of bleeding can be increased when Abciximab is combined with Sorafenib.,Sorafenib
DB00428,The risk or severity of bleeding can be increased when Abciximab is combined with Streptozocin.,Streptozocin
DB00441,The risk or severity of bleeding can be increased when Abciximab is combined with Gemcitabine.,Gemcitabine
DB00444,The risk or severity of bleeding can be increased when Abciximab is combined with Teniposide.,Teniposide
DB00445,The risk or severity of bleeding can be increased when Abciximab is combined with Epirubicin.,Epirubicin
DB00446,The risk or severity of bleeding can be increased when Abciximab is combined with Chloramphenicol.,Chloramphenicol
DB00480,The risk or severity of bleeding can be increased when Abciximab is combined with Lenalidomide.,Lenalidomide
DB00488,The risk or severity of bleeding can be increased when Abciximab is combined with Altretamine.,Altretamine
DB00495,The risk or severity of bleeding can be increased when Abciximab is combined with Zidovudine.,Zidovudine
DB00515,The risk or severity of bleeding can be increased when Abciximab is combined with Cisplatin.,Cisplatin
DB00526,The risk or severity of bleeding can be increased when Abciximab is combined with Oxaliplatin.,Oxaliplatin
DB00531,The risk or severity of bleeding can be increased when Abciximab is combined with Cyclophosphamide.,Cyclophosphamide
DB00544,The risk or severity of bleeding can be increased when Abciximab is combined with Fluorouracil.,Fluorouracil
DB00552,The risk or severity of bleeding can be increased when Abciximab is combined with Pentostatin.,Pentostatin
DB00563,The risk or severity of bleeding can be increased when Abciximab is combined with Methotrexate.,Methotrexate
DB00564,The risk or severity of bleeding can be increased when Abciximab is combined with Carbamazepine.,Carbamazepine
DB00570,The risk or severity of bleeding can be increased when Abciximab is combined with Vinblastine.,Vinblastine
DB00619,The risk or severity of bleeding can be increased when Abciximab is combined with Imatinib.,Imatinib
DB00631,The risk or severity of bleeding can be increased when Abciximab is combined with Clofarabine.,Clofarabine
DB00642,The risk or severity of bleeding can be increased when Abciximab is combined with Pemetrexed.,Pemetrexed
DB00694,The risk or severity of bleeding can be increased when Abciximab is combined with Daunorubicin.,Daunorubicin
DB00762,The risk or severity of bleeding can be increased when Abciximab is combined with Irinotecan.,Irinotecan
DB00773,The risk or severity of bleeding can be increased when Abciximab is combined with Etoposide.,Etoposide
DB00851,The risk or severity of bleeding can be increased when Abciximab is combined with Dacarbazine.,Dacarbazine
DB00853,The risk or severity of bleeding can be increased when Abciximab is combined with Temozolomide.,Temozolomide
DB00859,The risk or severity of bleeding can be increased when Abciximab is combined with Penicillamine.,Penicillamine
DB00864,The risk or severity of bleeding can be increased when Abciximab is combined with Tacrolimus.,Tacrolimus
DB00877,The risk or severity of bleeding can be increased when Abciximab is combined with Sirolimus.,Sirolimus
DB00888,The risk or severity of bleeding can be increased when Abciximab is combined with Mechlorethamine.,Mechlorethamine
DB00928,The risk or severity of bleeding can be increased when Abciximab is combined with Azacitidine.,Azacitidine
DB00958,The risk or severity of bleeding can be increased when Abciximab is combined with Carboplatin.,Carboplatin
DB00970,The risk or severity of bleeding can be increased when Abciximab is combined with Dactinomycin.,Dactinomycin
DB00987,The risk or severity of bleeding can be increased when Abciximab is combined with Cytarabine.,Cytarabine
DB00997,The risk or severity of bleeding can be increased when Abciximab is combined with Doxorubicin.,Doxorubicin
DB01005,The risk or severity of bleeding can be increased when Abciximab is combined with Hydroxyurea.,Hydroxyurea
DB01008,The risk or severity of bleeding can be increased when Abciximab is combined with Busulfan.,Busulfan
DB01030,The risk or severity of bleeding can be increased when Abciximab is combined with Topotecan.,Topotecan
DB01033,The risk or severity of bleeding can be increased when Abciximab is combined with Mercaptopurine.,Mercaptopurine
DB01041,The risk or severity of bleeding can be increased when Abciximab is combined with Thalidomide.,Thalidomide
DB01042,The risk or severity of bleeding can be increased when Abciximab is combined with Melphalan.,Melphalan
DB01073,The risk or severity of bleeding can be increased when Abciximab is combined with Fludarabine.,Fludarabine
DB01099,The risk or severity of bleeding can be increased when Abciximab is combined with Flucytosine.,Flucytosine
DB01101,The risk or severity of bleeding can be increased when Abciximab is combined with Capecitabine.,Capecitabine
DB01169,The risk or severity of bleeding can be increased when Abciximab is combined with Arsenic trioxide.,Arsenic trioxide
DB01177,The risk or severity of bleeding can be increased when Abciximab is combined with Idarubicin.,Idarubicin
DB01204,The risk or severity of bleeding can be increased when Abciximab is combined with Mitoxantrone.,Mitoxantrone
DB01206,The risk or severity of bleeding can be increased when Abciximab is combined with Lomustine.,Lomustine
DB01229,The risk or severity of bleeding can be increased when Abciximab is combined with Paclitaxel.,Paclitaxel
DB01248,The risk or severity of bleeding can be increased when Abciximab is combined with Docetaxel.,Docetaxel
DB01262,The risk or severity of bleeding can be increased when Abciximab is combined with Decitabine.,Decitabine
DB01280,The risk or severity of bleeding can be increased when Abciximab is combined with Nelarabine.,Nelarabine
DB01590,The risk or severity of bleeding can be increased when Abciximab is combined with Everolimus.,Everolimus
DB02546,The risk or severity of bleeding can be increased when Abciximab is combined with Vorinostat.,Vorinostat
DB04572,The risk or severity of bleeding can be increased when Abciximab is combined with Thiotepa.,Thiotepa
DB04845,The risk or severity of bleeding can be increased when Abciximab is combined with Ixabepilone.,Ixabepilone
DB04868,The risk or severity of bleeding can be increased when Abciximab is combined with Nilotinib.,Nilotinib
DB05015,The risk or severity of bleeding can be increased when Abciximab is combined with Belinostat.,Belinostat
DB05109,The risk or severity of bleeding can be increased when Abciximab is combined with Trabectedin.,Trabectedin
DB05258,The risk or severity of bleeding can be increased when Abciximab is combined with Interferon alfa.,Interferon alfa
DB05472,The risk or severity of bleeding can be increased when Abciximab is combined with omega interferon.,omega interferon
DB06287,The risk or severity of bleeding can be increased when Abciximab is combined with Temsirolimus.,Temsirolimus
DB06616,The risk or severity of bleeding can be increased when Abciximab is combined with Bosutinib.,Bosutinib
DB06769,The risk or severity of bleeding can be increased when Abciximab is combined with Bendamustine.,Bendamustine
DB06772,The risk or severity of bleeding can be increased when Abciximab is combined with Cabazitaxel.,Cabazitaxel
DB08871,The risk or severity of bleeding can be increased when Abciximab is combined with Eribulin.,Eribulin
DB08877,The risk or severity of bleeding can be increased when Abciximab is combined with Ruxolitinib.,Ruxolitinib
DB08889,The risk or severity of bleeding can be increased when Abciximab is combined with Carfilzomib.,Carfilzomib
DB08895,The risk or severity of bleeding can be increased when Abciximab is combined with Tofacitinib.,Tofacitinib
DB08901,The risk or severity of bleeding can be increased when Abciximab is combined with Ponatinib.,Ponatinib
DB08910,The risk or severity of bleeding can be increased when Abciximab is combined with Pomalidomide.,Pomalidomide
DB09042,The risk or severity of bleeding can be increased when Abciximab is combined with Tedizolid phosphate.,Tedizolid phosphate
DB09073,The risk or severity of bleeding can be increased when Abciximab is combined with Palbociclib.,Palbociclib
DB09074,The risk or severity of bleeding can be increased when Abciximab is combined with Olaparib.,Olaparib
DB09122,The risk or severity of bleeding can be increased when Abciximab is combined with Peginterferon beta-1a.,Peginterferon beta-1a
DB12814,The risk or severity of bleeding can be increased when Abciximab is combined with Cepeginterferon alfa-2B.,Cepeginterferon alfa-2B
DB03404,Hemin may increase the anticoagulant activities of Abciximab.,Hemin
DB13783,The risk or severity of bleeding and hemorrhage can be increased when Acemetacin is combined with Abciximab.,Acemetacin
DB00624,Testosterone may increase the anticoagulant activities of Abciximab.,Testosterone
DB01420,Testosterone propionate may increase the anticoagulant activities of Abciximab.,Testosterone propionate
DB01481,1-Testosterone may increase the anticoagulant activities of Abciximab.,1-Testosterone
DB01485,4-Hydroxytestosterone may increase the anticoagulant activities of Abciximab.,4-Hydroxytestosterone
DB01510,Dehydrochloromethyltestosterone may increase the anticoagulant activities of Abciximab.,Dehydrochloromethyltestosterone
DB01541,Boldenone may increase the anticoagulant activities of Abciximab.,Boldenone
DB01543,18-methyl-19-nortestosterone may increase the anticoagulant activities of Abciximab.,18-methyl-19-nortestosterone
DB01564,Calusterone may increase the anticoagulant activities of Abciximab.,Calusterone
DB01569,Formebolone may increase the anticoagulant activities of Abciximab.,Formebolone
DB01572,Methyl-1-testosterone may increase the anticoagulant activities of Abciximab.,Methyl-1-testosterone
DB02901,Stanolone may increase the anticoagulant activities of Abciximab.,Stanolone
DB07447,5beta-dihydrotestosterone may increase the anticoagulant activities of Abciximab.,5beta-dihydrotestosterone
DB08619,Testosterone succinate may increase the anticoagulant activities of Abciximab.,Testosterone succinate
DB11429,Mibolerone may increase the anticoagulant activities of Abciximab.,Mibolerone
DB13943,Testosterone cypionate may increase the anticoagulant activities of Abciximab.,Testosterone cypionate
DB13944,Testosterone enanthate may increase the anticoagulant activities of Abciximab.,Testosterone enanthate
DB13946,Testosterone undecanoate may increase the anticoagulant activities of Abciximab.,Testosterone undecanoate
DB13947,Testosterone enantate benzilic acid hydrazone may increase the anticoagulant activities of Abciximab.,Testosterone enantate benzilic acid hydrazone
DB13951,Stanolone acetate may increase the anticoagulant activities of Abciximab.,Stanolone acetate
DB13958,Trestolone acetate may increase the anticoagulant activities of Abciximab.,Trestolone acetate
DB14093,"(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Abciximab.","(1,2,6,7-3H)Testosterone"
DB14655,Drostanolone propionate may increase the anticoagulant activities of Abciximab.,Drostanolone propionate
DB11051,The risk or severity of adverse effects can be increased when Abciximab is combined with Azficel-T.,Azficel-T
DB09568,The therapeutic efficacy of Abciximab can be increased when used in combination with Omega-3-carboxylic acids.,Omega-3-carboxylic acids
DB00002,The risk or severity of adverse effects can be increased when Cetuximab is combined with Abciximab.,Cetuximab
DB00028,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Abciximab.,Human immunoglobulin G
DB00043,The risk or severity of adverse effects can be increased when Omalizumab is combined with Abciximab.,Omalizumab
DB00051,The risk or severity of adverse effects can be increased when Adalimumab is combined with Abciximab.,Adalimumab
DB00056,The risk or severity of adverse effects can be increased when Abciximab is combined with Gemtuzumab ozogamicin.,Gemtuzumab ozogamicin
DB00057,The risk or severity of adverse effects can be increased when Abciximab is combined with Indium In-111 satumomab pendetide.,Indium In-111 satumomab pendetide
DB00065,The risk or severity of adverse effects can be increased when Abciximab is combined with Infliximab.,Infliximab
DB00072,The risk or severity of adverse effects can be increased when Abciximab is combined with Trastuzumab.,Trastuzumab
DB00073,The risk or severity of adverse effects can be increased when Abciximab is combined with Rituximab.,Rituximab
DB00074,The risk or severity of adverse effects can be increased when Abciximab is combined with Basiliximab.,Basiliximab
DB00075,The risk or severity of adverse effects can be increased when Abciximab is combined with Muromonab.,Muromonab
DB00076,The risk or severity of adverse effects can be increased when Abciximab is combined with Digoxin Immune Fab (Ovine).,Digoxin Immune Fab (Ovine)
DB00087,The risk or severity of adverse effects can be increased when Abciximab is combined with Alemtuzumab.,Alemtuzumab
DB00089,The risk or severity of adverse effects can be increased when Abciximab is combined with Capromab pendetide.,Capromab pendetide
DB00095,The risk or severity of adverse effects can be increased when Abciximab is combined with Efalizumab.,Efalizumab
DB00098,The risk or severity of adverse effects can be increased when Abciximab is combined with Antithymocyte immunoglobulin (rabbit).,Antithymocyte immunoglobulin (rabbit)
DB00108,The risk or severity of adverse effects can be increased when Abciximab is combined with Natalizumab.,Natalizumab
DB00110,The risk or severity of adverse effects can be increased when Abciximab is combined with Palivizumab.,Palivizumab
DB00111,The risk or severity of adverse effects can be increased when Abciximab is combined with Daclizumab.,Daclizumab
DB00112,The risk or severity of adverse effects can be increased when Abciximab is combined with Bevacizumab.,Bevacizumab
DB00113,The risk or severity of adverse effects can be increased when Abciximab is combined with Technetium Tc-99m arcitumomab.,Technetium Tc-99m arcitumomab
DB01257,The risk or severity of adverse effects can be increased when Abciximab is combined with Eculizumab.,Eculizumab
DB01269,The risk or severity of adverse effects can be increased when Abciximab is combined with Panitumumab.,Panitumumab
DB01270,The risk or severity of adverse effects can be increased when Abciximab is combined with Ranibizumab.,Ranibizumab
DB04901,The risk or severity of adverse effects can be increased when Abciximab is combined with Galiximab.,Galiximab
DB04949,The risk or severity of adverse effects can be increased when Abciximab is combined with Pexelizumab.,Pexelizumab
DB04956,The risk or severity of adverse effects can be increased when Abciximab is combined with Afelimomab.,Afelimomab
DB04958,The risk or severity of adverse effects can be increased when Abciximab is combined with Epratuzumab.,Epratuzumab
DB04962,The risk or severity of adverse effects can be increased when Abciximab is combined with Bectumomab.,Bectumomab
DB04964,The risk or severity of adverse effects can be increased when Abciximab is combined with Oregovomab.,Oregovomab
DB04988,The risk or severity of adverse effects can be increased when Abciximab is combined with IGN311.,IGN311
DB05006,The risk or severity of adverse effects can be increased when Abciximab is combined with Adecatumumab.,Adecatumumab
DB05097,The risk or severity of adverse effects can be increased when Abciximab is combined with Labetuzumab.,Labetuzumab
DB05101,The risk or severity of adverse effects can be increased when Abciximab is combined with Matuzumab.,Matuzumab
DB05111,The risk or severity of adverse effects can be increased when Abciximab is combined with Fontolizumab.,Fontolizumab
DB05136,The risk or severity of adverse effects can be increased when Abciximab is combined with Bavituximab.,Bavituximab
DB05139,The risk or severity of adverse effects can be increased when Abciximab is combined with CR002.,CR002
DB05209,The risk or severity of adverse effects can be increased when Abciximab is combined with Rozrolimupab.,Rozrolimupab
DB05304,The risk or severity of adverse effects can be increased when Abciximab is combined with Girentuximab.,Girentuximab
DB05336,The risk or severity of adverse effects can be increased when Abciximab is combined with Obiltoxaximab.,Obiltoxaximab
DB05405,The risk or severity of adverse effects can be increased when Abciximab is combined with XTL-001.,XTL-001
DB05437,The risk or severity of adverse effects can be increased when Abciximab is combined with NAV 1800.,NAV 1800
DB05459,The risk or severity of adverse effects can be increased when Abciximab is combined with Briakinumab.,Briakinumab
DB05496,The risk or severity of adverse effects can be increased when Abciximab is combined with Otelixizumab.,Otelixizumab
DB05545,The risk or severity of adverse effects can be increased when Abciximab is combined with AMG 108.,AMG 108
DB05550,The risk or severity of adverse effects can be increased when Abciximab is combined with Iratumumab.,Iratumumab
DB05555,The risk or severity of adverse effects can be increased when Abciximab is combined with Enokizumab.,Enokizumab
DB05578,The risk or severity of adverse effects can be increased when Abciximab is combined with Ramucirumab.,Ramucirumab
DB05595,The risk or severity of adverse effects can be increased when Abciximab is combined with Farletuzumab.,Farletuzumab
DB05656,The risk or severity of adverse effects can be increased when Abciximab is combined with Veltuzumab.,Veltuzumab
DB05679,The risk or severity of adverse effects can be increased when Abciximab is combined with Ustekinumab.,Ustekinumab
DB05773,The risk or severity of adverse effects can be increased when Abciximab is combined with Trastuzumab emtansine.,Trastuzumab emtansine
DB05793,The risk or severity of adverse effects can be increased when Abciximab is combined with PRO-542.,PRO-542
DB05797,The risk or severity of adverse effects can be increased when Abciximab is combined with TNX-901.,TNX-901
DB05889,The risk or severity of adverse effects can be increased when Abciximab is combined with Inotuzumab ozogamicin.,Inotuzumab ozogamicin
DB05892,The risk or severity of adverse effects can be increased when Abciximab is combined with RI 624.,RI 624
DB05915,The risk or severity of adverse effects can be increased when Abciximab is combined with MYO-029.,MYO-029
DB05916,The risk or severity of adverse effects can be increased when Abciximab is combined with CT-011.,CT-011
DB05941,The risk or severity of adverse effects can be increased when Abciximab is combined with Leronlimab.,Leronlimab
DB05996,The risk or severity of adverse effects can be increased when Abciximab is combined with Glembatumumab vedotin.,Glembatumumab vedotin
DB06043,The risk or severity of adverse effects can be increased when Abciximab is combined with Olaratumab.,Olaratumab
DB06049,The risk or severity of adverse effects can be increased when Abciximab is combined with IPH 2101.,IPH 2101
DB06050,The risk or severity of adverse effects can be increased when Abciximab is combined with TB-402.,TB-402
DB06101,The risk or severity of adverse effects can be increased when Abciximab is combined with IMC-1C11.,IMC-1C11
DB06116,The risk or severity of adverse effects can be increased when Abciximab is combined with Eldelumab.,Eldelumab
DB06162,The risk or severity of adverse effects can be increased when Abciximab is combined with Lumiliximab.,Lumiliximab
DB06168,The risk or severity of adverse effects can be increased when Abciximab is combined with Canakinumab.,Canakinumab
DB06186,The risk or severity of adverse effects can be increased when Abciximab is combined with Ipilimumab.,Ipilimumab
DB06192,The risk or severity of adverse effects can be increased when Abciximab is combined with Nimotuzumab.,Nimotuzumab
DB06241,The risk or severity of adverse effects can be increased when Abciximab is combined with Clenoliximab.,Clenoliximab
DB06273,The risk or severity of adverse effects can be increased when Abciximab is combined with Tocilizumab.,Tocilizumab
DB06304,The risk or severity of adverse effects can be increased when Abciximab is combined with BIIB015.,BIIB015
DB06305,The risk or severity of adverse effects can be increased when Abciximab is combined with Sonepcizumab.,Sonepcizumab
DB06310,The risk or severity of adverse effects can be increased when Abciximab is combined with Motavizumab.,Motavizumab
DB06317,The risk or severity of adverse effects can be increased when Abciximab is combined with Elotuzumab.,Elotuzumab
DB06318,The risk or severity of adverse effects can be increased when Abciximab is combined with AVE9633.,AVE9633
DB06322,The risk or severity of adverse effects can be increased when Abciximab is combined with Carotuximab.,Carotuximab
DB06324,The risk or severity of adverse effects can be increased when Abciximab is combined with XmAb 2513.,XmAb 2513
DB06342,The risk or severity of adverse effects can be increased when Abciximab is combined with Coltuximab ravtansine.,Coltuximab ravtansine
DB06343,The risk or severity of adverse effects can be increased when Abciximab is combined with Teprotumumab.,Teprotumumab
DB06360,The risk or severity of adverse effects can be increased when Abciximab is combined with Lucatumumab.,Lucatumumab
DB06366,The risk or severity of adverse effects can be increased when Abciximab is combined with Pertuzumab.,Pertuzumab
DB06371,The risk or severity of adverse effects can be increased when Abciximab is combined with Siplizumab.,Siplizumab
DB06467,The risk or severity of adverse effects can be increased when Abciximab is combined with Apolizumab.,Apolizumab
DB06474,The risk or severity of adverse effects can be increased when Abciximab is combined with Sibrotuzumab.,Sibrotuzumab
DB06550,The risk or severity of adverse effects can be increased when Abciximab is combined with Bivatuzumab.,Bivatuzumab
DB06557,The risk or severity of adverse effects can be increased when Abciximab is combined with Lerdelimumab.,Lerdelimumab
DB06599,The risk or severity of adverse effects can be increased when Abciximab is combined with Lexatumumab.,Lexatumumab
DB06602,The risk or severity of adverse effects can be increased when Abciximab is combined with Reslizumab.,Reslizumab
DB06606,The risk or severity of adverse effects can be increased when Abciximab is combined with Teplizumab.,Teplizumab
DB06607,The risk or severity of adverse effects can be increased when Abciximab is combined with Catumaxomab.,Catumaxomab
DB06612,The risk or severity of adverse effects can be increased when Abciximab is combined with Mepolizumab.,Mepolizumab
DB06643,The risk or severity of adverse effects can be increased when Abciximab is combined with Denosumab.,Denosumab
DB06647,The risk or severity of adverse effects can be increased when Abciximab is combined with Volociximab.,Volociximab
DB06650,The risk or severity of adverse effects can be increased when Abciximab is combined with Ofatumumab.,Ofatumumab
DB06674,The risk or severity of adverse effects can be increased when Abciximab is combined with Golimumab.,Golimumab
DB08870,The risk or severity of adverse effects can be increased when Abciximab is combined with Brentuximab vedotin.,Brentuximab vedotin
DB08879,The risk or severity of adverse effects can be increased when Abciximab is combined with Belimumab.,Belimumab
DB08902,The risk or severity of adverse effects can be increased when Abciximab is combined with Raxibacumab.,Raxibacumab
DB08904,The risk or severity of adverse effects can be increased when Abciximab is combined with Certolizumab pegol.,Certolizumab pegol
DB09029,The risk or severity of adverse effects can be increased when Abciximab is combined with Secukinumab.,Secukinumab
DB09033,The risk or severity of adverse effects can be increased when Abciximab is combined with Vedolizumab.,Vedolizumab
DB09035,The risk or severity of adverse effects can be increased when Abciximab is combined with Nivolumab.,Nivolumab
DB09036,The risk or severity of adverse effects can be increased when Abciximab is combined with Siltuximab.,Siltuximab
DB09037,The risk or severity of adverse effects can be increased when Abciximab is combined with Pembrolizumab.,Pembrolizumab
DB09045,The risk or severity of adverse effects can be increased when Abciximab is combined with Dulaglutide.,Dulaglutide
DB09052,The risk or severity of adverse effects can be increased when Abciximab is combined with Blinatumomab.,Blinatumomab
DB09057,The risk or severity of adverse effects can be increased when Abciximab is combined with Anthrax immune globulin human.,Anthrax immune globulin human
DB09077,The risk or severity of adverse effects can be increased when Abciximab is combined with Dinutuximab.,Dinutuximab
DB09105,The risk or severity of adverse effects can be increased when Abciximab is combined with Asfotase alfa.,Asfotase alfa
DB09264,The risk or severity of adverse effects can be increased when Abciximab is combined with Idarucizumab.,Idarucizumab
DB09302,The risk or severity of adverse effects can be increased when Abciximab is combined with Alirocumab.,Alirocumab
DB09303,The risk or severity of adverse effects can be increased when Abciximab is combined with Evolocumab.,Evolocumab
DB09312,The risk or severity of adverse effects can be increased when Abciximab is combined with Antilymphocyte immunoglobulin (horse).,Antilymphocyte immunoglobulin (horse)
DB09331,The risk or severity of adverse effects can be increased when Abciximab is combined with Daratumumab.,Daratumumab
DB09559,The risk or severity of adverse effects can be increased when Abciximab is combined with Necitumumab.,Necitumumab
DB11569,The risk or severity of adverse effects can be increased when Abciximab is combined with Ixekizumab.,Ixekizumab
DB11580,The risk or severity of adverse effects can be increased when Abciximab is combined with Ravulizumab.,Ravulizumab
DB11595,The risk or severity of adverse effects can be increased when Abciximab is combined with Atezolizumab.,Atezolizumab
DB11604,The risk or severity of adverse effects can be increased when Abciximab is combined with Tetanus Immune Globulin.,Tetanus Immune Globulin
DB11621,The risk or severity of adverse effects can be increased when Abciximab is combined with Human Varicella-Zoster Immune Globulin.,Human Varicella-Zoster Immune Globulin
DB11646,The risk or severity of adverse effects can be increased when Abciximab is combined with Conatumumab.,Conatumumab
DB11657,The risk or severity of adverse effects can be increased when Abciximab is combined with Tabalumab.,Tabalumab
DB11680,The risk or severity of adverse effects can be increased when Abciximab is combined with Ficlatuzumab.,Ficlatuzumab
DB11685,The risk or severity of adverse effects can be increased when Abciximab is combined with Figitumumab.,Figitumumab
DB11714,The risk or severity of adverse effects can be increased when Abciximab is combined with Durvalumab.,Durvalumab
DB11715,The risk or severity of adverse effects can be increased when Abciximab is combined with Bapineuzumab.,Bapineuzumab
DB11731,The risk or severity of adverse effects can be increased when Abciximab is combined with Depatuxizumab mafodotin.,Depatuxizumab mafodotin
DB11746,The risk or severity of adverse effects can be increased when Abciximab is combined with Onartuzumab.,Onartuzumab
DB11756,The risk or severity of adverse effects can be increased when Abciximab is combined with Solanezumab.,Solanezumab
DB11767,The risk or severity of adverse effects can be increased when Abciximab is combined with Sarilumab.,Sarilumab
DB11771,The risk or severity of adverse effects can be increased when Abciximab is combined with Tremelimumab.,Tremelimumab
DB11776,The risk or severity of adverse effects can be increased when Abciximab is combined with Brodalumab.,Brodalumab
DB11803,The risk or severity of adverse effects can be increased when Abciximab is combined with Sirukumab.,Sirukumab
DB11826,The risk or severity of adverse effects can be increased when Abciximab is combined with Lampalizumab.,Lampalizumab
DB11834,The risk or severity of adverse effects can be increased when Abciximab is combined with Guselkumab.,Guselkumab
DB11840,The risk or severity of adverse effects can be increased when Abciximab is combined with Dalotuzumab.,Dalotuzumab
DB11849,The risk or severity of adverse effects can be increased when Abciximab is combined with Emibetuzumab.,Emibetuzumab
DB11850,The risk or severity of adverse effects can be increased when Abciximab is combined with Ublituximab.,Ublituximab
DB11856,The risk or severity of adverse effects can be increased when Abciximab is combined with Ligelizumab.,Ligelizumab
DB11857,The risk or severity of adverse effects can be increased when Abciximab is combined with Seribantumab.,Seribantumab
DB11862,The risk or severity of adverse effects can be increased when Abciximab is combined with Landogrozumab.,Landogrozumab
DB11866,The risk or severity of adverse effects can be increased when Abciximab is combined with Romosozumab.,Romosozumab
DB11884,The risk or severity of adverse effects can be increased when Abciximab is combined with Vadastuximab Talirine.,Vadastuximab Talirine
DB11914,The risk or severity of adverse effects can be increased when Abciximab is combined with Lebrikizumab.,Lebrikizumab
DB11930,The risk or severity of adverse effects can be increased when Abciximab is combined with Varlilumab.,Varlilumab
DB11945,The risk or severity of adverse effects can be increased when Abciximab is combined with Avelumab.,Avelumab
DB11959,The risk or severity of adverse effects can be increased when Abciximab is combined with Crenezumab.,Crenezumab
DB11972,The risk or severity of adverse effects can be increased when Abciximab is combined with Rilotumumab.,Rilotumumab
DB11976,The risk or severity of adverse effects can be increased when Abciximab is combined with Anifrolumab.,Anifrolumab
DB11988,The risk or severity of adverse effects can be increased when Abciximab is combined with Ocrelizumab.,Ocrelizumab
DB12023,The risk or severity of adverse effects can be increased when Abciximab is combined with Benralizumab.,Benralizumab
DB12034,The risk or severity of adverse effects can be increased when Abciximab is combined with Gantenerumab.,Gantenerumab
DB12053,The risk or severity of adverse effects can be increased when Abciximab is combined with Visilizumab.,Visilizumab
DB12077,The risk or severity of adverse effects can be increased when Abciximab is combined with Urelumab.,Urelumab
DB12089,The risk or severity of adverse effects can be increased when Abciximab is combined with Lorvotuzumab mertansine.,Lorvotuzumab mertansine
DB12090,The risk or severity of adverse effects can be increased when Abciximab is combined with Patritumab.,Patritumab
DB12102,The risk or severity of adverse effects can be increased when Abciximab is combined with Fulranumab.,Fulranumab
DB12104,The risk or severity of adverse effects can be increased when Abciximab is combined with Tarextumab.,Tarextumab
DB12118,The risk or severity of adverse effects can be increased when Abciximab is combined with Sotatercept.,Sotatercept
DB12119,The risk or severity of adverse effects can be increased when Abciximab is combined with Gevokizumab.,Gevokizumab
DB12142,The risk or severity of adverse effects can be increased when Abciximab is combined with Duligotuzumab.,Duligotuzumab
DB12152,The risk or severity of adverse effects can be increased when Abciximab is combined with Simtuzumab.,Simtuzumab
DB12157,The risk or severity of adverse effects can be increased when Abciximab is combined with Fasinumab.,Fasinumab
DB12159,The risk or severity of adverse effects can be increased when Abciximab is combined with Dupilumab.,Dupilumab
DB12169,The risk or severity of adverse effects can be increased when Abciximab is combined with Tralokinumab.,Tralokinumab
DB12189,The risk or severity of adverse effects can be increased when Abciximab is combined with Etrolizumab.,Etrolizumab
DB12202,The risk or severity of adverse effects can be increased when Abciximab is combined with Zalutumumab.,Zalutumumab
DB12205,The risk or severity of adverse effects can be increased when Abciximab is combined with Ganitumab.,Ganitumab
DB12213,The risk or severity of adverse effects can be increased when Abciximab is combined with Etaracizumab.,Etaracizumab
DB12240,The risk or severity of adverse effects can be increased when Abciximab is combined with Polatuzumab vedotin.,Polatuzumab vedotin
DB12246,The risk or severity of adverse effects can be increased when Abciximab is combined with Inclacumab.,Inclacumab
DB12250,The risk or severity of adverse effects can be increased when Abciximab is combined with Cixutumumab.,Cixutumumab
DB12261,The risk or severity of adverse effects can be increased when Abciximab is combined with Ascrinvacumab.,Ascrinvacumab
DB12274,The risk or severity of adverse effects can be increased when Abciximab is combined with Aducanumab.,Aducanumab
DB12281,The risk or severity of adverse effects can be increased when Abciximab is combined with Luspatercept.,Luspatercept
DB12296,The risk or severity of adverse effects can be increased when Abciximab is combined with GS-5745.,GS-5745
DB12317,The risk or severity of adverse effects can be increased when Abciximab is combined with Vanucizumab.,Vanucizumab
DB12331,The risk or severity of adverse effects can be increased when Abciximab is combined with Labetuzumab govitecan.,Labetuzumab govitecan
DB12335,The risk or severity of adverse effects can be increased when Abciximab is combined with Tanezumab.,Tanezumab
DB12342,The risk or severity of adverse effects can be increased when Abciximab is combined with Ensituximab.,Ensituximab
DB12344,The risk or severity of adverse effects can be increased when Abciximab is combined with Fezakinumab.,Fezakinumab
DB12363,The risk or severity of adverse effects can be increased when Abciximab is combined with Dusigitumab.,Dusigitumab
DB12396,The risk or severity of adverse effects can be increased when Abciximab is combined with Fresolimumab.,Fresolimumab
DB12413,The risk or severity of adverse effects can be increased when Abciximab is combined with Indusatumab vedotin.,Indusatumab vedotin
DB12456,The risk or severity of adverse effects can be increased when Abciximab is combined with Bococizumab.,Bococizumab
DB12489,The risk or severity of adverse effects can be increased when Abciximab is combined with Mirvetuximab Soravtansine.,Mirvetuximab Soravtansine
DB12498,The risk or severity of adverse effects can be increased when Abciximab is combined with Mogamulizumab.,Mogamulizumab
DB12520,The risk or severity of adverse effects can be increased when Abciximab is combined with Plozalizumab.,Plozalizumab
DB12530,The risk or severity of adverse effects can be increased when Abciximab is combined with Inebilizumab.,Inebilizumab
DB12534,The risk or severity of adverse effects can be increased when Abciximab is combined with Mavrilimumab.,Mavrilimumab
DB12560,The risk or severity of adverse effects can be increased when Abciximab is combined with Blosozumab.,Blosozumab
DB12584,The risk or severity of adverse effects can be increased when Abciximab is combined with Bimagrumab.,Bimagrumab
DB12589,The risk or severity of adverse effects can be increased when Abciximab is combined with Dacetuzumab.,Dacetuzumab
DB12609,The risk or severity of adverse effects can be increased when Abciximab is combined with Tovetumab.,Tovetumab
DB12683,The risk or severity of adverse effects can be increased when Abciximab is combined with Lumretuzumab.,Lumretuzumab
DB12698,The risk or severity of adverse effects can be increased when Abciximab is combined with Ibalizumab.,Ibalizumab
DB12701,The risk or severity of adverse effects can be increased when Abciximab is combined with Intetumumab.,Intetumumab
DB12718,The risk or severity of adverse effects can be increased when Abciximab is combined with Carlumab.,Carlumab
DB12734,The risk or severity of adverse effects can be increased when Abciximab is combined with Demcizumab.,Demcizumab
DB12773,The risk or severity of adverse effects can be increased when Abciximab is combined with Sifalimumab.,Sifalimumab
DB12775,The risk or severity of adverse effects can be increased when Abciximab is combined with Abituzumab.,Abituzumab
DB12797,The risk or severity of adverse effects can be increased when Abciximab is combined with Ecromeximab.,Ecromeximab
DB12807,The risk or severity of adverse effects can be increased when Abciximab is combined with Naptumomab Estafenatox.,Naptumomab Estafenatox
DB12815,The risk or severity of adverse effects can be increased when Abciximab is combined with Crotedumab.,Crotedumab
DB12820,The risk or severity of adverse effects can be increased when Abciximab is combined with Concizumab.,Concizumab
DB12826,The risk or severity of adverse effects can be increased when Abciximab is combined with Depatuxizumab.,Depatuxizumab
DB12844,The risk or severity of adverse effects can be increased when Abciximab is combined with Rontalizumab.,Rontalizumab
DB12845,The risk or severity of adverse effects can be increased when Abciximab is combined with Amatuximab.,Amatuximab
DB12849,The risk or severity of adverse effects can be increased when Abciximab is combined with Clazakizumab.,Clazakizumab
DB12891,The risk or severity of adverse effects can be increased when Abciximab is combined with Ozanezumab.,Ozanezumab
DB12893,The risk or severity of adverse effects can be increased when Abciximab is combined with Sacituzumab govitecan.,Sacituzumab govitecan
DB12917,The risk or severity of adverse effects can be increased when Abciximab is combined with Bimekizumab.,Bimekizumab
DB12943,The risk or severity of adverse effects can be increased when Abciximab is combined with Milatuzumab.,Milatuzumab
DB12976,The risk or severity of adverse effects can be increased when Abciximab is combined with Robatumumab.,Robatumumab
DB13017,The risk or severity of adverse effects can be increased when Abciximab is combined with Rovalpituzumab Tesirine.,Rovalpituzumab Tesirine
DB13037,The risk or severity of adverse effects can be increased when Abciximab is combined with Namilumab.,Namilumab
DB13045,The risk or severity of adverse effects can be increased when Abciximab is combined with Racotumomab.,Racotumomab
DB13073,The risk or severity of adverse effects can be increased when Abciximab is combined with Tregalizumab.,Tregalizumab
DB13127,The risk or severity of adverse effects can be increased when Abciximab is combined with Olokizumab.,Olokizumab
DB13140,The risk or severity of adverse effects can be increased when Abciximab is combined with Bezlotoxumab.,Bezlotoxumab
DB13375,The risk or severity of adverse effects can be increased when Abciximab is combined with Edrecolomab.,Edrecolomab
DB13535,The risk or severity of adverse effects can be increased when Abciximab is combined with Nebacumab.,Nebacumab
DB13886,The risk or severity of adverse effects can be increased when Abciximab is combined with Human cytomegalovirus immune globulin.,Human cytomegalovirus immune globulin
DB13976,The risk or severity of adverse effects can be increased when Abciximab is combined with Sulesomab.,Sulesomab
DB13979,The risk or severity of adverse effects can be increased when Abciximab is combined with Besilesomab.,Besilesomab
DB14004,The risk or severity of adverse effects can be increased when Abciximab is combined with Tildrakizumab.,Tildrakizumab
DB14012,The risk or severity of adverse effects can be increased when Abciximab is combined with Burosumab.,Burosumab
DB14039,The risk or severity of adverse effects can be increased when Abciximab is combined with Erenumab.,Erenumab
DB14040,The risk or severity of adverse effects can be increased when Abciximab is combined with Eptinezumab.,Eptinezumab
DB14041,The risk or severity of adverse effects can be increased when Abciximab is combined with Fremanezumab.,Fremanezumab
DB14042,The risk or severity of adverse effects can be increased when Abciximab is combined with Galcanezumab.,Galcanezumab
DB14211,The risk or severity of adverse effects can be increased when Abciximab is combined with Fanolesomab.,Fanolesomab
DB14580,The risk or severity of adverse effects can be increased when Abciximab is combined with Lecanemab.,Lecanemab
DB14597,The risk or severity of adverse effects can be increased when Abciximab is combined with Lanadelumab.,Lanadelumab
DB14707,The risk or severity of adverse effects can be increased when Abciximab is combined with Cemiplimab.,Cemiplimab
DB14724,The risk or severity of adverse effects can be increased when Abciximab is combined with Emapalumab.,Emapalumab
DB14762,The risk or severity of adverse effects can be increased when Abciximab is combined with Risankizumab.,Risankizumab
DB14776,The risk or severity of adverse effects can be increased when Abciximab is combined with Camrelizumab.,Camrelizumab
DB14778,The risk or severity of adverse effects can be increased when Abciximab is combined with Setrusumab.,Setrusumab
DB14784,The risk or severity of adverse effects can be increased when Abciximab is combined with Gancotamab.,Gancotamab
DB14809,The risk or severity of adverse effects can be increased when Abciximab is combined with Anetumab ravtansine.,Anetumab ravtansine
DB14811,The risk or severity of adverse effects can be increased when Abciximab is combined with Isatuximab.,Isatuximab
DB14824,The risk or severity of adverse effects can be increased when Abciximab is combined with Icrucumab.,Icrucumab
DB14843,The risk or severity of adverse effects can be increased when Abciximab is combined with Codrituzumab.,Codrituzumab
DB14864,The risk or severity of adverse effects can be increased when Abciximab is combined with Brolucizumab.,Brolucizumab
DB14871,The risk or severity of adverse effects can be increased when Abciximab is combined with Xentuzumab.,Xentuzumab
DB14877,The risk or severity of adverse effects can be increased when Abciximab is combined with Lintuzumab.,Lintuzumab
DB14891,The risk or severity of adverse effects can be increased when Abciximab is combined with Vobarilizumab.,Vobarilizumab
DB14897,The risk or severity of adverse effects can be increased when Abciximab is combined with Parsatuzumab.,Parsatuzumab
DB14905,The risk or severity of adverse effects can be increased when Abciximab is combined with Emactuzumab.,Emactuzumab
DB14907,The risk or severity of adverse effects can be increased when Abciximab is combined with Bevacizumab zirconium Zr-89.,Bevacizumab zirconium Zr-89
DB14908,The risk or severity of adverse effects can be increased when Abciximab is combined with Refanezumab.,Refanezumab
DB14919,The risk or severity of adverse effects can be increased when Abciximab is combined with Rozanolixizumab.,Rozanolixizumab
DB14947,The risk or severity of adverse effects can be increased when Abciximab is combined with Bermekimab.,Bermekimab
DB14952,The risk or severity of adverse effects can be increased when Abciximab is combined with Pamrevlumab.,Pamrevlumab
DB14959,The risk or severity of adverse effects can be increased when Abciximab is combined with Opicinumab.,Opicinumab
DB14962,The risk or severity of adverse effects can be increased when Abciximab is combined with Trastuzumab deruxtecan.,Trastuzumab deruxtecan
DB14967,The risk or severity of adverse effects can be increased when Abciximab is combined with Margetuximab.,Margetuximab
DB14988,The risk or severity of adverse effects can be increased when Abciximab is combined with Dalantercept.,Dalantercept
DB14997,The risk or severity of adverse effects can be increased when Abciximab is combined with Pateclizumab.,Pateclizumab
DB15014,The risk or severity of adverse effects can be increased when Abciximab is combined with Gremubamab.,Gremubamab
DB15022,The risk or severity of adverse effects can be increased when Abciximab is combined with Apomab.,Apomab
DB15044,The risk or severity of adverse effects can be increased when Abciximab is combined with Tafasitamab.,Tafasitamab
DB15045,The risk or severity of adverse effects can be increased when Abciximab is combined with Ipafricept.,Ipafricept
DB15076,The risk or severity of adverse effects can be increased when Abciximab is combined with Abrilumab.,Abrilumab
DB15089,The risk or severity of adverse effects can be increased when Abciximab is combined with Frovocimab.,Frovocimab
DB15090,The risk or severity of adverse effects can be increased when Abciximab is combined with Tezepelumab.,Tezepelumab
DB15101,The risk or severity of adverse effects can be increased when Abciximab is combined with Tigatuzumab.,Tigatuzumab
DB15104,The risk or severity of adverse effects can be increased when Abciximab is combined with Telisotuzumab vedotin.,Telisotuzumab vedotin
DB15113,The risk or severity of adverse effects can be increased when Abciximab is combined with Utomilumab.,Utomilumab
DB15118,The risk or severity of adverse effects can be increased when Abciximab is combined with Zolbetuximab.,Zolbetuximab
DB15135,The risk or severity of adverse effects can be increased when Abciximab is combined with Ponezumab.,Ponezumab
DB15160,The risk or severity of adverse effects can be increased when Abciximab is combined with Asunercept.,Asunercept
DB15172,The risk or severity of adverse effects can be increased when Abciximab is combined with Suvratoxumab.,Suvratoxumab
DB15225,The risk or severity of adverse effects can be increased when Abciximab is combined with Mitazalimab.,Mitazalimab
DB15252,The risk or severity of adverse effects can be increased when Abciximab is combined with Nemolizumab.,Nemolizumab
DB15253,The risk or severity of adverse effects can be increased when Abciximab is combined with Bleselumab.,Bleselumab
DB15277,The risk or severity of adverse effects can be increased when Abciximab is combined with Gedivumab.,Gedivumab
DB15336,The risk or severity of adverse effects can be increased when Abciximab is combined with Valanafusp alfa.,Valanafusp alfa
DB15349,The risk or severity of adverse effects can be increased when Abciximab is combined with Sofituzumab vedotin.,Sofituzumab vedotin
DB15354,The risk or severity of adverse effects can be increased when Abciximab is combined with Evinacumab.,Evinacumab
DB15363,The risk or severity of adverse effects can be increased when Abciximab is combined with Istiratumab.,Istiratumab
DB15383,The risk or severity of adverse effects can be increased when Abciximab is combined with Pidilizumab.,Pidilizumab
DB15397,The risk or severity of adverse effects can be increased when Abciximab is combined with GMA-161.,GMA-161
DB15409,The risk or severity of adverse effects can be increased when Abciximab is combined with Ladiratuzumab vedotin.,Ladiratuzumab vedotin
DB15415,The risk or severity of adverse effects can be increased when Abciximab is combined with Tomaralimab.,Tomaralimab
DB15428,The risk or severity of adverse effects can be increased when Abciximab is combined with Vesencumab.,Vesencumab
DB15432,The risk or severity of adverse effects can be increased when Abciximab is combined with Pinatuzumab vedotin.,Pinatuzumab vedotin
DB15441,The risk or severity of adverse effects can be increased when Abciximab is combined with Lulizumab pegol.,Lulizumab pegol
DB15443,The risk or severity of adverse effects can be increased when Abciximab is combined with Lorukafusp alfa.,Lorukafusp alfa
DB15453,The risk or severity of adverse effects can be increased when Abciximab is combined with Naratuximab emtansine.,Naratuximab emtansine
DB15559,The risk or severity of adverse effects can be increased when Abciximab is combined with Zenocutuzumab.,Zenocutuzumab
DB00258,The therapeutic efficacy of Calcium acetate can be decreased when used in combination with Abciximab.,Calcium acetate
DB01164,The therapeutic efficacy of Calcium chloride can be decreased when used in combination with Abciximab.,Calcium chloride
DB01373,The therapeutic efficacy of Calcium can be decreased when used in combination with Abciximab.,Calcium
DB11126,The therapeutic efficacy of Calcium gluconate can be decreased when used in combination with Abciximab.,Calcium gluconate
DB11608,The therapeutic efficacy of Eftrenonacog alfa can be decreased when used in combination with Abciximab.,Eftrenonacog alfa
DB13884,The therapeutic efficacy of Albutrepenonacog alfa can be decreased when used in combination with Abciximab.,Albutrepenonacog alfa
DB13923,The therapeutic efficacy of Emicizumab can be decreased when used in combination with Abciximab.,Emicizumab
DB14738,The therapeutic efficacy of Turoctocog alfa pegol can be decreased when used in combination with Abciximab.,Turoctocog alfa pegol
DB00025,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Abciximab.","Antihemophilic factor, human recombinant"
DB00036,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Abciximab.,Coagulation factor VIIa Recombinant Human
DB00100,The therapeutic efficacy of Coagulation Factor IX (Recombinant) can be decreased when used in combination with Abciximab.,Coagulation Factor IX (Recombinant)
DB01783,The therapeutic efficacy of Pantothenic acid can be decreased when used in combination with Abciximab.,Pantothenic acid
DB01942,The therapeutic efficacy of Formic acid can be decreased when used in combination with Abciximab.,Formic acid
DB02261,The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Abciximab.,Platelet Activating Factor
DB06724,The therapeutic efficacy of Calcium carbonate can be decreased when used in combination with Abciximab.,Calcium carbonate
DB09109,The therapeutic efficacy of Turoctocog alfa can be decreased when used in combination with Abciximab.,Turoctocog alfa
DB09222,The therapeutic efficacy of Fibrinogen human can be decreased when used in combination with Abciximab.,Fibrinogen human
DB09310,The therapeutic efficacy of Catridecacog can be decreased when used in combination with Abciximab.,Catridecacog
DB09329,"The therapeutic efficacy of Antihemophilic Factor (Recombinant), PEGylated can be decreased when used in combination with Abciximab.","Antihemophilic Factor (Recombinant), PEGylated"
DB11093,The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Abciximab.,Calcium citrate
DB11168,The therapeutic efficacy of Calcium threonate can be decreased when used in combination with Abciximab.,Calcium threonate
DB11311,The therapeutic efficacy of Prothrombin can be decreased when used in combination with Abciximab.,Prothrombin
DB11330,The therapeutic efficacy of Factor IX Complex (Human) can be decreased when used in combination with Abciximab.,Factor IX Complex (Human)
DB11348,The therapeutic efficacy of Calcium Phosphate can be decreased when used in combination with Abciximab.,Calcium Phosphate
DB11606,The therapeutic efficacy of Susoctocog alfa can be decreased when used in combination with Abciximab.,Susoctocog alfa
DB11668,The therapeutic efficacy of Rusalatide acetate can be decreased when used in combination with Abciximab.,Rusalatide acetate
DB12409,The therapeutic efficacy of Vatreptacog alfa can be decreased when used in combination with Abciximab.,Vatreptacog alfa
DB12909,The therapeutic efficacy of Factor XIII (human) can be decreased when used in combination with Abciximab.,Factor XIII (human)
DB13133,The therapeutic efficacy of Von Willebrand Factor Human can be decreased when used in combination with Abciximab.,Von Willebrand Factor Human
DB13148,The therapeutic efficacy of Coagulation factor X human can be decreased when used in combination with Abciximab.,Coagulation factor X human
DB13150,The therapeutic efficacy of Coagulation factor VII human can be decreased when used in combination with Abciximab.,Coagulation factor VII human
DB13151,The therapeutic efficacy of Anti-inhibitor coagulant complex can be decreased when used in combination with Abciximab.,Anti-inhibitor coagulant complex
DB13152,The therapeutic efficacy of Coagulation Factor IX Human can be decreased when used in combination with Abciximab.,Coagulation Factor IX Human
DB13192,The therapeutic efficacy of Antihemophilic factor human can be decreased when used in combination with Abciximab.,Antihemophilic factor human
DB13197,The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Abciximab.,Kallidinogenase
DB13201,The therapeutic efficacy of Trenonacog alfa can be decreased when used in combination with Abciximab.,Trenonacog alfa
DB13933,The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Abciximab.,Nonacog beta pegol
DB13999,The therapeutic efficacy of Moroctocog alfa can be decreased when used in combination with Abciximab.,Moroctocog alfa
DB14473,The therapeutic efficacy of Beroctocog alfa can be decreased when used in combination with Abciximab.,Beroctocog alfa
DB14562,The therapeutic efficacy of Andexanet alfa can be decreased when used in combination with Abciximab.,Andexanet alfa
DB14577,The therapeutic efficacy of Calcium cation can be decreased when used in combination with Abciximab.,Calcium cation
DB14700,The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Abciximab.,Damoctocog alfa pegol
DB06731,The risk or severity of hemorrhage can be increased when Seproxetine is combined with Abciximab.,Seproxetine
DB00176,The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Abciximab.,Fluvoxamine
DB00215,The risk or severity of hemorrhage can be increased when Citalopram is combined with Abciximab.,Citalopram
DB00472,The risk or severity of hemorrhage can be increased when Fluoxetine is combined with Abciximab.,Fluoxetine
DB00476,The risk or severity of hemorrhage can be increased when Duloxetine is combined with Abciximab.,Duloxetine
DB00715,The risk or severity of hemorrhage can be increased when Paroxetine is combined with Abciximab.,Paroxetine
DB01105,The risk or severity of hemorrhage can be increased when Sibutramine is combined with Abciximab.,Sibutramine
DB01149,The risk or severity of hemorrhage can be increased when Nefazodone is combined with Abciximab.,Nefazodone
DB04832,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Abciximab.,Zimelidine
DB04884,The risk or severity of hemorrhage can be increased when Dapoxetine is combined with Abciximab.,Dapoxetine
DB04896,The risk or severity of hemorrhage can be increased when Milnacipran is combined with Abciximab.,Milnacipran
DB06700,The risk or severity of hemorrhage can be increased when Desvenlafaxine is combined with Abciximab.,Desvenlafaxine
DB08918,The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Abciximab.,Levomilnacipran
DB08953,The risk or severity of hemorrhage can be increased when Indalpine is combined with Abciximab.,Indalpine
DB12693,The risk or severity of hemorrhage can be increased when Ritanserin is combined with Abciximab.,Ritanserin
DB13233,The risk or severity of hemorrhage can be increased when Alaproclate is combined with Abciximab.,Alaproclate
DB00285,Venlafaxine may increase the antiplatelet activities of Abciximab.,Venlafaxine
DB00182,The risk or severity of bleeding and hemorrhage can be increased when Amphetamine is combined with Abciximab.,Amphetamine
DB00601,The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Abciximab.,Linezolid
DB00614,The risk or severity of bleeding and hemorrhage can be increased when Furazolidone is combined with Abciximab.,Furazolidone
DB00721,The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Abciximab.,Procaine
DB00752,The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Abciximab.,Tranylcypromine
DB00780,The risk or severity of bleeding and hemorrhage can be increased when Phenelzine is combined with Abciximab.,Phenelzine
DB00805,The risk or severity of bleeding and hemorrhage can be increased when Minaprine is combined with Abciximab.,Minaprine
DB01037,The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Abciximab.,Selegiline
DB01168,The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Abciximab.,Procarbazine
DB01171,The risk or severity of bleeding and hemorrhage can be increased when Moclobemide is combined with Abciximab.,Moclobemide
DB01247,The risk or severity of bleeding and hemorrhage can be increased when Isocarboxazid is combined with Abciximab.,Isocarboxazid
DB01367,The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Abciximab.,Rasagiline
DB01626,The risk or severity of bleeding and hemorrhage can be increased when Pargyline is combined with Abciximab.,Pargyline
DB04017,The risk or severity of bleeding and hemorrhage can be increased when Clorgiline is combined with Abciximab.,Clorgiline
DB04818,The risk or severity of bleeding and hemorrhage can be increased when Iproniazid is combined with Abciximab.,Iproniazid
DB04820,The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Abciximab.,Nialamide
DB06654,The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Abciximab.,Safinamide
DB08550,"The risk or severity of bleeding and hemorrhage can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Abciximab.","7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline"
DB09241,The risk or severity of bleeding and hemorrhage can be increased when Methylene blue is combined with Abciximab.,Methylene blue
DB09243,The risk or severity of bleeding and hemorrhage can be increased when Hydracarbazine is combined with Abciximab.,Hydracarbazine
DB09244,The risk or severity of bleeding and hemorrhage can be increased when Pirlindole is combined with Abciximab.,Pirlindole
DB09245,The risk or severity of bleeding and hemorrhage can be increased when Toloxatone is combined with Abciximab.,Toloxatone
DB09246,The risk or severity of bleeding and hemorrhage can be increased when Benmoxin is combined with Abciximab.,Benmoxin
DB09248,The risk or severity of bleeding and hemorrhage can be increased when Mebanazine is combined with Abciximab.,Mebanazine
DB09249,The risk or severity of bleeding and hemorrhage can be increased when Octamoxin is combined with Abciximab.,Octamoxin
DB09250,The risk or severity of bleeding and hemorrhage can be increased when Pheniprazine is combined with Abciximab.,Pheniprazine
DB09251,The risk or severity of bleeding and hemorrhage can be increased when Phenoxypropazine is combined with Abciximab.,Phenoxypropazine
DB09252,The risk or severity of bleeding and hemorrhage can be increased when Pivhydrazine is combined with Abciximab.,Pivhydrazine
DB09253,The risk or severity of bleeding and hemorrhage can be increased when Safrazine is combined with Abciximab.,Safrazine
DB09254,The risk or severity of bleeding and hemorrhage can be increased when Caroxazone is combined with Abciximab.,Caroxazone
DB13875,The risk or severity of bleeding and hemorrhage can be increased when Harmaline is combined with Abciximab.,Harmaline
DB13876,The risk or severity of bleeding and hemorrhage can be increased when Brofaromine is combined with Abciximab.,Brofaromine
DB00974,The risk or severity of bleeding can be increased when Abciximab is combined with Edetic acid.,Edetic acid
DB11268,The risk or severity of bleeding can be increased when Abciximab is combined with Protocatechualdehyde.,Protocatechualdehyde
DB13124,The risk or severity of bleeding can be increased when Abciximab is combined with Troxerutin.,Troxerutin
DB00203,The risk or severity of hemorrhage can be increased when Abciximab is combined with Sildenafil.,Sildenafil
DB00229,The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefotiam.,Cefotiam
